ID   ARHGA_HUMAN             Reviewed;        1369 AA.
AC   O15013; O14665; Q2KHR8; Q68D55; Q8IWD9; Q8IY77;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 4.
DT   22-APR-2020, entry version 168.
DE   RecName: Full=Rho guanine nucleotide exchange factor 10;
GN   Name=ARHGEF10; Synonyms=KIAA0294;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Duodenum, Prostate, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 353-1369 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=9314494; DOI=10.1101/gr.7.9.887;
RA   Ranta S., Lehesjoki A.-E., de Fatima Bonaldo M., Knowles J.A.,
RA   Hirvasniemi A., Ross B., de Jong P.J., Soares M.B., de la Chapelle A.,
RA   Gilliam T.C.;
RT   "High-resolution mapping and transcript identification at the progressive
RT   epilepsy with mental retardation locus on chromosome 8p.";
RL   Genome Res. 7:887-896(1997).
RN   [7]
RP   FUNCTION, AND VARIANT SNCV ILE-357.
RX   PubMed=14508709; DOI=10.1086/378159;
RA   Verhoeven K., De Jonghe P., Van de Putte T., Nelis E., Zwijsen A.,
RA   Verpoorten N., De Vriendt E., Jacobs A., Van Gerwen V., Francis A.,
RA   Ceuterick C., Huylebroeck D., Timmerman V.;
RT   "Slowed conduction and thin myelination of peripheral nerves associated
RT   with mutant rho Guanine-nucleotide exchange factor 10.";
RL   Am. J. Hum. Genet. 73:926-932(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1287, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   METHYLATION AT GLN-1338, AND MUTAGENESIS OF GLN-1338.
RX   PubMed=26797129; DOI=10.1074/jbc.m115.711952;
RA   Kusevic D., Kudithipudi S., Jeltsch A.;
RT   "Substrate specificity of the HEMK2 protein glutamine methyltransferase and
RT   identification of novel substrates.";
RL   J. Biol. Chem. 291:6124-6133(2016).
RN   [12]
RP   VARIANT HIS-227.
RX   PubMed=24627108; DOI=10.1007/s00415-014-7289-8;
RA   Schabhuettl M., Wieland T., Senderek J., Baets J., Timmerman V.,
RA   De Jonghe P., Reilly M.M., Stieglbauer K., Laich E., Windhager R., Erwa W.,
RA   Trajanoski S., Strom T.M., Auer-Grumbach M.;
RT   "Whole-exome sequencing in patients with inherited neuropathies: outcome
RT   and challenges.";
RL   J. Neurol. 261:970-982(2014).
CC   -!- FUNCTION: May play a role in developmental myelination of peripheral
CC       nerves. {ECO:0000269|PubMed:14508709}.
CC   -!- INTERACTION:
CC       O15013; O15066: KIF3B; NbExp=3; IntAct=EBI-2515636, EBI-3931791;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O15013-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15013-6; Sequence=VSP_040757;
CC       Name=3;
CC         IsoId=O15013-7; Sequence=VSP_040754, VSP_040756;
CC       Name=4;
CC         IsoId=O15013-4; Sequence=VSP_010704;
CC       Name=5;
CC         IsoId=O15013-5; Sequence=VSP_040754, VSP_040755;
CC   -!- PTM: Methylated at Gln-1338 by N6AMT1. {ECO:0000269|PubMed:26797129}.
CC   -!- DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected
CC       individuals present a reduction in nerve conduction velocities without
CC       any clinical signs of peripheral or central nervous system dysfunction.
CC       SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36809.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAH40474.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA20754.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAH18365.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR749570; CAH18365.1; ALT_TERM; mRNA.
DR   EMBL; AB002292; BAA20754.2; ALT_INIT; mRNA.
DR   EMBL; AC019257; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036809; AAH36809.1; ALT_SEQ; mRNA.
DR   EMBL; BC040474; AAH40474.1; ALT_SEQ; mRNA.
DR   EMBL; BC112926; AAI12927.1; -; mRNA.
DR   EMBL; AF009205; AAB71662.1; -; mRNA.
DR   CCDS; CCDS34794.1; -. [O15013-5]
DR   CCDS; CCDS78296.1; -. [O15013-6]
DR   CCDS; CCDS78297.1; -. [O15013-7]
DR   PIR; T03307; T03307.
DR   RefSeq; NP_001295081.1; NM_001308152.1. [O15013-7]
DR   RefSeq; NP_001295082.1; NM_001308153.1. [O15013-6]
DR   RefSeq; NP_055444.2; NM_014629.3. [O15013-5]
DR   RefSeq; XP_016869492.1; XM_017014003.1. [O15013-1]
DR   SMR; O15013; -.
DR   BioGrid; 114998; 18.
DR   IntAct; O15013; 12.
DR   STRING; 9606.ENSP00000340297; -.
DR   iPTMnet; O15013; -.
DR   PhosphoSitePlus; O15013; -.
DR   BioMuta; ARHGEF10; -.
DR   EPD; O15013; -.
DR   jPOST; O15013; -.
DR   MassIVE; O15013; -.
DR   MaxQB; O15013; -.
DR   PaxDb; O15013; -.
DR   PeptideAtlas; O15013; -.
DR   PRIDE; O15013; -.
DR   ProteomicsDB; 48364; -. [O15013-1]
DR   ProteomicsDB; 48365; -. [O15013-4]
DR   ProteomicsDB; 48366; -. [O15013-5]
DR   ProteomicsDB; 48367; -. [O15013-6]
DR   ProteomicsDB; 48368; -. [O15013-7]
DR   Antibodypedia; 8026; 150 antibodies.
DR   Ensembl; ENST00000349830; ENSP00000340297; ENSG00000104728. [O15013-5]
DR   Ensembl; ENST00000398564; ENSP00000381571; ENSG00000104728. [O15013-1]
DR   Ensembl; ENST00000518288; ENSP00000431012; ENSG00000104728. [O15013-6]
DR   Ensembl; ENST00000520359; ENSP00000427909; ENSG00000104728. [O15013-7]
DR   Ensembl; ENST00000610399; ENSP00000481974; ENSG00000274726. [O15013-1]
DR   Ensembl; ENST00000619613; ENSP00000477988; ENSG00000274726. [O15013-5]
DR   Ensembl; ENST00000631758; ENSP00000488343; ENSG00000274726. [O15013-7]
DR   Ensembl; ENST00000633616; ENSP00000488463; ENSG00000274726. [O15013-6]
DR   GeneID; 9639; -.
DR   KEGG; hsa:9639; -.
DR   UCSC; uc003wpr.4; human. [O15013-1]
DR   CTD; 9639; -.
DR   DisGeNET; 9639; -.
DR   GeneCards; ARHGEF10; -.
DR   GeneReviews; ARHGEF10; -.
DR   HGNC; HGNC:14103; ARHGEF10.
DR   HPA; ENSG00000104728; Low tissue specificity.
DR   MalaCards; ARHGEF10; -.
DR   MIM; 608136; gene.
DR   MIM; 608236; phenotype.
DR   neXtProt; NX_O15013; -.
DR   OpenTargets; ENSG00000104728; -.
DR   Orphanet; 140481; Autosomal dominant slowed nerve conduction velocity.
DR   PharmGKB; PA24967; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   InParanoid; O15013; -.
DR   KO; K16727; -.
DR   OMA; EVLQCHC; -.
DR   OrthoDB; 67600at2759; -.
DR   PhylomeDB; O15013; -.
DR   TreeFam; TF331430; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   ChiTaRS; ARHGEF10; human.
DR   GeneWiki; ARHGEF10; -.
DR   GenomeRNAi; 9639; -.
DR   Pharos; O15013; Tbio.
DR   PRO; PR:O15013; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O15013; protein.
DR   Bgee; ENSG00000104728; Expressed in tibial nerve and 226 other tissues.
DR   ExpressionAtlas; O15013; baseline and differential.
DR   Genevisible; O15013; HS.
DR   GO; GO:0005813; C:centrosome; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; NAS:BHF-UCL.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0019894; F:kinesin binding; IPI:BHF-UCL.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:BHF-UCL.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0090630; P:activation of GTPase activity; IDA:BHF-UCL.
DR   GO; GO:0051298; P:centrosome duplication; IMP:BHF-UCL.
DR   GO; GO:0090307; P:mitotic spindle assembly; IMP:BHF-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IMP:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:BHF-UCL.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR030632; ARHGEF10.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   PANTHER; PTHR12877:SF14; PTHR12877:SF14; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Disease mutation;
KW   Guanine-nucleotide releasing factor; Methylation; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN           1..1369
FT                   /note="Rho guanine nucleotide exchange factor 10"
FT                   /id="PRO_0000080926"
FT   DOMAIN          421..608
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   COILED          304..355
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1271..1304
FT                   /note="Ser-rich"
FT   MOD_RES         180
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C033"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1338
FT                   /note="N5-methylglutamine"
FT                   /evidence="ECO:0000269|PubMed:26797129"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9205841"
FT                   /id="VSP_040754"
FT   VAR_SEQ         185
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9205841"
FT                   /id="VSP_040755"
FT   VAR_SEQ         307..345
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040756"
FT   VAR_SEQ         545
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_040757"
FT   VAR_SEQ         897..925
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9314494"
FT                   /id="VSP_010704"
FT   VARIANT         227
FT                   /note="N -> H (found in a patient with hereditary motor and
FT                   sensory neuropathy; unknown pathological significance;
FT                   dbSNP:rs767902219)"
FT                   /evidence="ECO:0000269|PubMed:24627108"
FT                   /id="VAR_073288"
FT   VARIANT         357
FT                   /note="T -> I (in SNCV; dbSNP:rs28940281)"
FT                   /evidence="ECO:0000269|PubMed:14508709"
FT                   /id="VAR_019118"
FT   VARIANT         700
FT                   /note="V -> I (in dbSNP:rs2294039)"
FT                   /id="VAR_038603"
FT   VARIANT         725
FT                   /note="V -> I (in dbSNP:rs2294039)"
FT                   /id="VAR_057188"
FT   MUTAGEN         1338
FT                   /note="Q->R: Abolishes methylation by N6AMT1."
FT                   /evidence="ECO:0000269|PubMed:26797129"
FT   CONFLICT        395
FT                   /note="L -> F (in Ref. 5; AAI12927)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        500
FT                   /note="D -> V (in Ref. 5; AAH40474)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1024
FT                   /note="T -> S (in Ref. 6; AAB71662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1046
FT                   /note="S -> T (in Ref. 6; AAB71662)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1369 AA;  151612 MW;  6F87869C7C6A5759 CRC64;
     MRPPGFLSRA PSLNRAERGI WSCSMDQREP LPPAPAENEM KYDTNNNEEE EGEQFDFDSG
     DEIPEADRQA PSAPETGGAG ASEAPAPTGG EDGAGAETTP VAEPTKLVLP MKVNPYSVID
     ITPFQEDQPP TPVPSAEEEN VGLHVPCGYL VPVPCGYAVP SNLPLLLPAY SSPVIICATS
     LDEEAETPEV TEDRQPNSLS SEEPPTSEDQ VGREDSALAR WAADPANTAW MENPEEAIYD
     DVPRENSDSE PDEMIYDDVE NGDEGGNSSL EYGWSSSEFE SYEEQSDSEC KNGIPRSFLR
     SNHKKQLSHD LTRLKEHYEK KMRDLMASTV GVVEIQQLRQ KHELKMQKLV KAAKDGTKDG
     LERTRAAVKR GRSFIRTKSL IAQDHRSSLE EEQNLFIDVD CKHPEAILTP MPEGLSQQQV
     VRRYILGSVV DSEKNYVDAL KRILEQYEKP LSEMEPKVLS ERKLKTVFYR VKEILQCHSL
     FQIALASRVS EWDSVEMIGD VFVASFSKSM VLDAYSEYVN NFSTAVAVLK KTCATKPAFL
     EFLKQEQEAS PDRTTLYSLM MKPIQRFPQF ILLLQDMLKN TSKGHPDRLP LQMALTELET
     LAEKLNERKR DADQRCEVKQ IAKAINERYL NKLLSSGSRY LIRSDDMIET VYNDRGEIVK
     TKERRVFMLN DVLMCATVSS RPSHDSRVMS SQRYLLKWSV PLGHVDAIEY GSSAGTGEHS
     RHLAVHPPES LAVVANAKPN KVYMGPGQLY QDLQNLLHDL NVIGQITQLI GNLKGNYQNL
     NQSVAHDWTS GLQRLILKKE DEIRAADCCR IQLQLPGKQD KSGRPTFFTA VFNTFTPAIK
     ESWVNSLQMA KLALEEENHM GWFCVEDDGN HIKKEKHPLL VGHMPVMVAK QQEFKIECAA
     YNPEPYLNNE SQPDSFSTAH GFLWIGSCTH QMGQIAIVSF QNSTPKVIEC FNVESRILCM
     LYVPVEEKRR EPGAPPDPET PAVRASDVPT ICVGTEEGSI SIYKSSQGSK KVRLQHFFTP
     EKSTVMSLAC TSQSLYAGLV NGAVASYARA PDGSWDSEPQ KVIKLGVLPV RSLLMMEDTL
     WAASGGQVFI ISVETHAVEG QLEAHQEEGM VISHMAVSGV GIWIAFTSGS TLRLFHTETL
     KHLQDINIAT PVHNMLPGHQ RLSVTSLLVC HGLLMVGTSL GVLVALPVPR LQGIPKVTGR
     GMVSYHAHNS PVKFIVLATA LHEKDKDKSR DSLAPGPEPQ DEDQKDALPS GGAGSSLSQG
     DPDAAIWLGD SLGSMTQKSD LSSSSGSLSL SHGSSSLEHR SEDSTIYDLL KDPVSLRSKA
     RRAKKAKASS ALVVCGGQGH RRVHRKARQP HQEELAPTVM VWQIPLLNI
//
ID   B4DTL3_HUMAN            Unreviewed;      1042 AA.
AC   B4DTL3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 64.
DE   SubName: Full=cDNA FLJ53192, highly similar to Homo sapiens Rho guanine nucleotide exchange factor (GEF) 10-like, transcript variant 1, mRNA {ECO:0000313|EMBL:BAG62025.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62025.1};
RN   [1] {ECO:0000313|EMBL:BAG62025.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG62025.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK300264; BAG62025.1; -; mRNA.
DR   RefSeq; NP_001315053.1; NM_001328124.1.
DR   MaxQB; B4DTL3; -.
DR   PeptideAtlas; B4DTL3; -.
DR   PRIDE; B4DTL3; -.
DR   GeneID; 55160; -.
DR   CTD; 55160; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GenomeRNAi; 55160; -.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          94..281
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   REGION          40..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          908..936
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          261..294
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        44..58
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1042 AA;  114497 MW;  56DFD28E48C65344 CRC64;
     MLPSSSWGKR KLRGRLGWVR SDARGVMWAR QEGLHHPHPH AVIRCPSSSS SSVSCSGDSE
     EEDMGLLEVS VSDIKPPAPE LGPMPEGLSP QQVVRRHILG SIVQSEGSYV ESLKRILQDY
     RNPLMEMEPK ALSARKCQVV FFRVKEILHC HSMFQIALSS RVAEWDSTEK IGDLFVASFS
     KSMVLDVYSD YVNNFTSAMS IIKKACLTKP AFLEFLKRRQ VCSPDRVTLY GLMVKPIQRF
     PQFILLLQDM LKNTPRGHPD RLSLQLALTE LETLAEKLNE QKRLADQVAE IQQLTKSVSD
     RSSLNKLLTS GQRQLLLCET LTETVYGDRG QLIKSKERRV FLLNDMLVCA NINFKGQLEI
     SSLVPLGPKY VVKWNTALPQ VQVVEVGQDG GTYDKDNVLI QHSGAKKASA SGQAQNKVYL
     GPPRLFQELQ DLQKDLAVVE QITLLISTLH GTYQNLNMTV AQDWCLALQR LMRVKEEEIH
     SANKCRLRLL LPGKPDKSGR PISFMVVFIT PNPLSKISWV NRLHLAKIGL REENQPGWLC
     PDEDKKSKAP FWCPILACCI PAFSSRALSL QLGALVHSPV NCPLLGFSAV STSLPQGYLW
     VGGGQEGAGG QVEIFSLNRP SPRTVKSFPL AAPVLCMEYI PELEEEAESR DESPTVADPS
     ATVHPTICLG LQDGSILLYS SVDTGTQCLV SCRSPGLQPV LCLRHSPFHL LAGLQDGTLA
     AYPRTSGGVL WDLESPPVCL TVGPGPVRTL LSLEDAVWAS CGPRVTVLEA TTLQPQQSFE
     AHQDEAVSVT HMVKAGSGVW MAFSSGTSIR LFHTETLEHL QEINIATRTT FLLPGQKHLC
     VTSLLICQGL LWVGTDQGVI VLLPVPRLEG IPKITGKGMV SLNGHCGPVA FLAVATSILA
     PDILRSDQEE AEGPRAEEDK PDGQAHEPMP DSHVGRELTR KKGILLQYRL RSTAHLPGPL
     LSMREPAPAD GAALEHSEED GSIYEMAFFL KAKNTKPHNC LASPVSLVWA LAGLQGSHTP
     LLEGCVRVSV CECVGWCVNI YK
//
ID   Q5VXI4_HUMAN            Unreviewed;      1052 AA.
AC   Q5VXI4;
DT   07-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   22-APR-2020, entry version 120.
DE   SubName: Full=Rho guanine nucleotide exchange factor 10-like protein {ECO:0000313|Ensembl:ENSP00000364557};
GN   Name=ARHGEF10L {ECO:0000313|Ensembl:ENSP00000364557};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000364557, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000364557, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000364557}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL139250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF495877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005245986.2; XM_005245929.2.
DR   jPOST; Q5VXI4; -.
DR   PeptideAtlas; Q5VXI4; -.
DR   PRIDE; Q5VXI4; -.
DR   ProteomicsDB; 65594; -.
DR   Antibodypedia; 29390; 37 antibodies.
DR   Ensembl; ENST00000375408; ENSP00000364557; ENSG00000074964.
DR   GeneID; 55160; -.
DR   UCSC; uc010ocs.3; human.
DR   CTD; 55160; -.
DR   EuPathDB; HostDB:ENSG00000074964.16; -.
DR   HGNC; HGNC:25540; ARHGEF10L.
DR   OpenTargets; ENSG00000074964; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   ChiTaRS; ARHGEF10L; human.
DR   GenomeRNAi; 55160; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000074964; Expressed in right lobe of liver and 226 other tissues.
DR   ExpressionAtlas; Q5VXI4; baseline and differential.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|MaxQB:Q5VXI4,
KW   ECO:0000213|PeptideAtlas:Q5VXI4, ECO:0000213|ProteomicsDB:Q5VXI4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          94..281
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   REGION          40..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          908..936
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          959..981
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          261..294
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        44..58
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1052 AA;  115568 MW;  38BF19D3CBD9B8B9 CRC64;
     MLPSSSWGKR KLRGRLGWVR SDARGVMWAR QEGLHHPHPH AVIRCPSSSS SSVSCSGDSE
     EEDMGLLEVS VSDIKPPAPE LGPMPEGLSP QQVVRRHILG SIVQSEGSYV ESLKRILQDY
     RNPLMEMEPK ALSARKCQVV FFRVKEILHC HSMFQIALSS RVAEWDSTEK IGDLFVASFS
     KSMVLDVYSD YVNNFTSAMS IIKKACLTKP AFLEFLKRRQ VCSPDRVTLY GLMVKPIQRF
     PQFILLLQDM LKNTPRGHPD RLSLQLALTE LETLAEKLNE QKRLADQVAE IQQLTKSVSD
     RSSLNKLLTS GQRQLLLCET LTETVYGDRG QLIKSKERRV FLLNDMLVCA NINFKGQLEI
     SSLVPLGPKY VVKWNTALPQ VQVVEVGQDG GTYDKDNVLI QHSGAKKASA SGQAQNKVYL
     GPPRLFQELQ DLQKDLAVVE QITLLISTLH GTYQNLNMTV AQDWCLALQR LMRVKEEEIH
     SANKCRLRLL LPGKPDKSGR PISFMVVFIT PNPLSKISWV NRLHLAKIGL REENQPGWLC
     PDEDKKSKAP FWCPILACCI PAFSSRALSL QLGALVHSPV NCPLLGFSAV STSLPQGYLW
     VGGGQEGAGG QVEIFSLNRP SPRTVKSFPL AAPVLCMEYI PELEEEAESR DESPTVADPS
     ATVHPTICLG LQDGSILLYS SVDTGTQCLV SCRSPGLQPV LCLRHSPFHL LAGLQDGTLA
     AYPRTSGGVL WDLESPPVCL TVGPGPVRTL LSLEDAVWAS CGPRVTVLEA TTLQPQQSFE
     AHQDEAVSVT HMVKAGSGVW MAFSSGTSIR LFHTETLEHL QEINIATRTT FLLPGQKHLC
     VTSLLICQGL LWVGTDQGVI VLLPVPRLEG IPKITGKGMV SLNGHCGPVA FLAVATSILA
     PDILRSDQEE AEGPRAEEDK PDGQAHEPMP DSHVGRELTR KKGILLQYRL RSTAHLPGPL
     LSMREPAPAD GAALEHSEED GSIYEMADDP DIWVRSRPCA RDAHRKEICS VAIISGGQGY
     RNFGSALGSS GRQAPCGETD STLLIWQVPL ML
//
ID   ARGAL_HUMAN             Reviewed;        1279 AA.
AC   Q9HCE6; B7ZKS1; Q17RW1; Q3YFJ4; Q5VXI5; Q5VXI6; Q66K51; Q6P0L7; Q8NAV5;
AC   Q9NVT3;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 4.
DT   22-APR-2020, entry version 134.
DE   RecName: Full=Rho guanine nucleotide exchange factor 10-like protein;
DE   AltName: Full=GrinchGEF;
GN   Name=ARHGEF10L; Synonyms=GRINCHGEF, KIAA1626;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, INTERACTION WITH RHOA;
RP   RHOB AND RHOC, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT
RP   VAL-1219.
RC   TISSUE=Embryonic kidney;
RX   PubMed=16112081; DOI=10.1016/j.bbrc.2005.08.025;
RA   Winkler S., Mohl M., Wieland T., Lutz S.;
RT   "GrinchGEF -- a novel Rho-specific guanine nucleotide exchange factor.";
RL   Biochem. Biophys. Res. Commun. 335:1280-1286(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-1219.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 457-1279 (ISOFORM 5).
RC   TISSUE=Mesangial cell, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   VAL-1219.
RC   TISSUE=Colon, Eye, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND SER-281, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-96.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for RHOA,
CC       RHOB and RHOC. {ECO:0000269|PubMed:16112081}.
CC   -!- SUBUNIT: Interacts with RHOA, RHOB and RHOC.
CC       {ECO:0000269|PubMed:16112081}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16112081}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9HCE6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCE6-2; Sequence=VSP_034421;
CC       Name=3;
CC         IsoId=Q9HCE6-3; Sequence=VSP_034421, VSP_034424;
CC       Name=4;
CC         IsoId=Q9HCE6-4; Sequence=VSP_034420, VSP_034422, VSP_034423,
CC                                  VSP_034424;
CC       Name=5;
CC         IsoId=Q9HCE6-5; Sequence=VSP_034424, VSP_034425, VSP_034426;
CC   -!- TISSUE SPECIFICITY: Detected in heart, liver, skeletal muscle, kidney
CC       and pancreas. {ECO:0000269|PubMed:16112081}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91663.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB13452.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC03792.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ139833; AAZ73162.1; -; mRNA.
DR   EMBL; AB046846; BAB13452.1; ALT_INIT; mRNA.
DR   EMBL; AK001383; BAA91663.1; ALT_INIT; mRNA.
DR   EMBL; AK092020; BAC03792.1; ALT_SEQ; mRNA.
DR   EMBL; AL139250; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358593; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC065561; AAH65561.1; -; mRNA.
DR   EMBL; BC080596; AAH80596.1; -; mRNA.
DR   EMBL; BC117171; AAI17172.1; -; mRNA.
DR   EMBL; BC143347; AAI43348.1; -; mRNA.
DR   CCDS; CCDS182.1; -. [Q9HCE6-1]
DR   CCDS; CCDS30617.1; -. [Q9HCE6-2]
DR   RefSeq; NP_001011722.2; NM_001011722.2. [Q9HCE6-2]
DR   RefSeq; NP_001306766.1; NM_001319837.1. [Q9HCE6-3]
DR   RefSeq; NP_001306767.1; NM_001319838.1. [Q9HCE6-4]
DR   RefSeq; NP_001315053.1; NM_001328124.1.
DR   RefSeq; NP_060595.3; NM_018125.3. [Q9HCE6-1]
DR   RefSeq; XP_005245982.2; XM_005245925.2. [Q9HCE6-2]
DR   RefSeq; XP_016857106.1; XM_017001617.1. [Q9HCE6-3]
DR   RefSeq; XP_016857110.1; XM_017001621.1. [Q9HCE6-1]
DR   IntAct; Q9HCE6; 12.
DR   STRING; 9606.ENSP00000355060; -.
DR   iPTMnet; Q9HCE6; -.
DR   PhosphoSitePlus; Q9HCE6; -.
DR   BioMuta; ARHGEF10L; -.
DR   DMDM; 317373481; -.
DR   EPD; Q9HCE6; -.
DR   jPOST; Q9HCE6; -.
DR   MassIVE; Q9HCE6; -.
DR   PaxDb; Q9HCE6; -.
DR   PeptideAtlas; Q9HCE6; -.
DR   PRIDE; Q9HCE6; -.
DR   ProteomicsDB; 81688; -. [Q9HCE6-1]
DR   ProteomicsDB; 81689; -. [Q9HCE6-2]
DR   ProteomicsDB; 81690; -. [Q9HCE6-3]
DR   ProteomicsDB; 81691; -. [Q9HCE6-4]
DR   ProteomicsDB; 81692; -. [Q9HCE6-5]
DR   Antibodypedia; 29390; 37 antibodies.
DR   Ensembl; ENST00000361221; ENSP00000355060; ENSG00000074964. [Q9HCE6-1]
DR   Ensembl; ENST00000375415; ENSP00000364564; ENSG00000074964. [Q9HCE6-2]
DR   GeneID; 55160; -.
DR   KEGG; hsa:55160; -.
DR   UCSC; uc001ban.4; human. [Q9HCE6-1]
DR   CTD; 55160; -.
DR   DisGeNET; 55160; -.
DR   GeneCards; ARHGEF10L; -.
DR   HGNC; HGNC:25540; ARHGEF10L.
DR   HPA; ENSG00000074964; Tissue enhanced (liver).
DR   MIM; 612494; gene.
DR   neXtProt; NX_Q9HCE6; -.
DR   OpenTargets; ENSG00000074964; -.
DR   PharmGKB; PA142672586; -.
DR   eggNOG; KOG3522; Eukaryota.
DR   eggNOG; KOG3524; Eukaryota.
DR   eggNOG; ENOG410ZJK1; LUCA.
DR   GeneTree; ENSGT00940000153798; -.
DR   HOGENOM; CLU_001213_1_0_1; -.
DR   InParanoid; Q9HCE6; -.
DR   KO; K16727; -.
DR   OMA; SIKSNCQ; -.
DR   OrthoDB; 67600at2759; -.
DR   PhylomeDB; Q9HCE6; -.
DR   TreeFam; TF331430; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   ChiTaRS; ARHGEF10L; human.
DR   GenomeRNAi; 55160; -.
DR   Pharos; Q9HCE6; Tdark.
DR   PRO; PR:Q9HCE6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9HCE6; protein.
DR   Bgee; ENSG00000074964; Expressed in right lobe of liver and 226 other tissues.
DR   ExpressionAtlas; Q9HCE6; baseline and differential.
DR   Genevisible; Q9HCE6; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC-UCL.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:HGNC-UCL.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IDA:HGNC-UCL.
DR   GO; GO:0032933; P:SREBP signaling pathway; IDA:HGNC-UCL.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR039919; ARHGEF10/ARHGEF17.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR12877; PTHR12877; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Guanine-nucleotide releasing factor;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN           1..1279
FT                   /note="Rho guanine nucleotide exchange factor 10-like
FT                   protein"
FT                   /id="PRO_0000342361"
FT   DOMAIN          316..503
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         131
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AWP8"
FT   MOD_RES         152
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AWP8"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..221
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034420"
FT   VAR_SEQ         203..241
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16112081"
FT                   /id="VSP_034421"
FT   VAR_SEQ         222..278
FT                   /note="ILALRVGGRDMQELKHKYDCKMTQLMKAAKSGTKDGLEKTRMAVMRKVSFLH
FT                   RKDVL -> MLPSSSWGKRKLRGRLGWVRSDARGVMWARQEGLHHPHPHAVIRCPSSSS
FT                   SSVSCS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034422"
FT   VAR_SEQ         401..470
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034423"
FT   VAR_SEQ         578..582
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16112081"
FT                   /id="VSP_034424"
FT   VAR_SEQ         1062..1072
FT                   /note="GQKHLCVTSLL -> DRSLIKCSPRA (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034425"
FT   VAR_SEQ         1073..1279
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_034426"
FT   VARIANT         47
FT                   /note="S -> N (in dbSNP:rs34417109)"
FT                   /id="VAR_061794"
FT   VARIANT         69
FT                   /note="D -> N (in dbSNP:rs35497285)"
FT                   /id="VAR_044183"
FT   VARIANT         96
FT                   /note="A -> V (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1421731181)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_044184"
FT   VARIANT         991
FT                   /note="R -> W (in dbSNP:rs6695710)"
FT                   /id="VAR_044185"
FT   VARIANT         1219
FT                   /note="I -> V (in dbSNP:rs2270976)"
FT                   /evidence="ECO:0000269|PubMed:10997877,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:16112081"
FT                   /id="VAR_044186"
FT   CONFLICT        24
FT                   /note="S -> P (in Ref. 1; AAZ73162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        924
FT                   /note="L -> P (in Ref. 3; BAA91663)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1006
FT                   /note="F -> S (in Ref. 3; BAA91663)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1279 AA;  140379 MW;  1ED000F0C8864CD7 CRC64;
     MASSNPPPQP AIGDQLVPGV PGPSSEAEDD PGEAFEFDDS DDEEDTSAAL GVPSLAPERD
     TDPPLIHLDS IPVTDPDPAA APPGTGVPAW VSNGDAADAA FSGARHSSWK RKSSRRIDRF
     TFPALEEDVI YDDVPCESPD AHQPGAERNL LYEDAHRAGA PRQAEDLGWS SSEFESYSED
     SGEEAKPEVE VEPAKHRVSF QPKLSPDLTR LKERYARTKR DILALRVGGR DMQELKHKYD
     CKMTQLMKAA KSGTKDGLEK TRMAVMRKVS FLHRKDVLGD SEEEDMGLLE VSVSDIKPPA
     PELGPMPEGL SPQQVVRRHI LGSIVQSEGS YVESLKRILQ DYRNPLMEME PKALSARKCQ
     VVFFRVKEIL HCHSMFQIAL SSRVAEWDST EKIGDLFVAS FSKSMVLDVY SDYVNNFTSA
     MSIIKKACLT KPAFLEFLKR RQVCSPDRVT LYGLMVKPIQ RFPQFILLLQ DMLKNTPRGH
     PDRLSLQLAL TELETLAEKL NEQKRLADQV AEIQQLTKSV SDRSSLNKLL TSGQRQLLLC
     ETLTETVYGD RGQLIKSKER RVFLLNDMLV CANINFKPAN HRGQLEISSL VPLGPKYVVK
     WNTALPQVQV VEVGQDGGTY DKDNVLIQHS GAKKASASGQ AQNKVYLGPP RLFQELQDLQ
     KDLAVVEQIT LLISTLHGTY QNLNMTVAQD WCLALQRLMR VKEEEIHSAN KCRLRLLLPG
     KPDKSGRPIS FMVVFITPNP LSKISWVNRL HLAKIGLREE NQPGWLCPDE DKKSKAPFWC
     PILACCIPAF SSRALSLQLG ALVHSPVNCP LLGFSAVSTS LPQGYLWVGG GQEGAGGQVE
     IFSLNRPSPR TVKSFPLAAP VLCMEYIPEL EEEAESRDES PTVADPSATV HPTICLGLQD
     GSILLYSSVD TGTQCLVSCR SPGLQPVLCL RHSPFHLLAG LQDGTLAAYP RTSGGVLWDL
     ESPPVCLTVG PGPVRTLLSL EDAVWASCGP RVTVLEATTL QPQQSFEAHQ DEAVSVTHMV
     KAGSGVWMAF SSGTSIRLFH TETLEHLQEI NIATRTTFLL PGQKHLCVTS LLICQGLLWV
     GTDQGVIVLL PVPRLEGIPK ITGKGMVSLN GHCGPVAFLA VATSILAPDI LRSDQEEAEG
     PRAEEDKPDG QAHEPMPDSH VGRELTRKKG ILLQYRLRST AHLPGPLLSM REPAPADGAA
     LEHSEEDGSI YEMADDPDIW VRSRPCARDA HRKEICSVAI ISGGQGYRNF GSALGSSGRQ
     APCGETDSTL LIWQVPLML
//
ID   ASXL2_HUMAN             Reviewed;        1435 AA.
AC   Q76L83; Q53TC9; Q5H9U4; Q76L81; Q86XM1; Q9C0H8; Q9NV67;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 130.
DE   RecName: Full=Putative Polycomb group protein ASXL2;
DE   AltName: Full=Additional sex combs-like protein 2;
GN   Name=ASXL2; Synonyms=ASXH2, KIAA1685;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION WITH
RP   KAT6A.
RC   TISSUE=Bone marrow;
RA   Hosoda F., Kitabayashi I., Kakazu N., Fukushima M., Aikawa Y., Abe T.,
RA   Hibi S., Yagi T., Ohki M.;
RT   "MOZ is fused to a novel Polycomb group gene in a therapy-related
RT   myelodysplastic syndrome with t(2;8)(p23;p11.2).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT VAL-796.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 890-1435 (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH PPARA AND PPARG.
RX   PubMed=21047783; DOI=10.1074/jbc.m110.177816;
RA   Park U.H., Yoon S.K., Park T., Kim E.J., Um S.J.;
RT   "Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in
RT   adipogenesis via reciprocal regulation of peroxisome proliferator-activated
RT   receptor {gamma}.";
RL   J. Biol. Chem. 286:1354-1363(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-562; SER-571;
RP   SER-600; SER-637; SER-648 AND SER-1319, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   INVOLVEMENT IN SHAPNS.
RX   PubMed=27693232; DOI=10.1016/j.ajhg.2016.08.017;
RG   Undiagnosed Diseases Network;
RA   Shashi V., Pena L.D., Kim K., Burton B., Hempel M., Schoch K.,
RA   Walkiewicz M., McLaughlin H.M., Cho M., Stong N., Hickey S.E., Shuss C.M.,
RA   Freemark M.S., Bellet J.S., Keels M.A., Bonner M.J., El-Dairi M.,
RA   Butler M., Kranz P.G., Stumpel C.T., Klinkenberg S., Oberndorff K.,
RA   Alawi M., Santer R., Petrovski S., Kuismin O., Korpi-Heikkilae S.,
RA   Pietilainen O., Aarno P., Kurki M.I., Hoischen A., Need A.C.,
RA   Goldstein D.B., Kortuem F.;
RT   "De novo truncating variants in ASXL2 are associated with a unique and
RT   recognizable clinical phenotype.";
RL   Am. J. Hum. Genet. 99:991-999(2016).
CC   -!- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by
CC       forming multiprotein complexes, which are required to maintain the
CC       transcriptionally repressive state of homeotic genes throughout
CC       development. PcG proteins are not required to initiate repression, but
CC       to maintain it during later stages of development. They probably act
CC       via methylation of histones, rendering chromatin heritably changed in
CC       its expressibility (By similarity). Involved in transcriptional
CC       regulation mediated by ligand-bound nuclear hormone receptors, such as
CC       peroxisome proliferator-activated receptor gamma (PPARG). Acts as
CC       coactivator for PPARG and enhances its adipocyte differentiation-
CC       inducing activity; the function seems to involve differential
CC       recruitment of acetylated and methylated histone H3. {ECO:0000250,
CC       ECO:0000269|PubMed:21047783}.
CC   -!- SUBUNIT: Interacts with PPARA and PPARG. {ECO:0000269|PubMed:21047783}.
CC   -!- INTERACTION:
CC       Q76L83-2; Q96DN6: MBD6; NbExp=4; IntAct=EBI-12043951, EBI-719591;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q76L83-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q76L83-2; Sequence=VSP_030163, VSP_030164;
CC   -!- DOMAIN: Contains two Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs, which may be
CC       required for an association with nuclear receptors. {ECO:0000250}.
CC   -!- DISEASE: Shashi-Pena syndrome (SHAPNS) [MIM:617190]: An autosomal
CC       dominant syndrome characterized by delayed psychomotor development,
CC       intellectual disability of variable severity, macrocephaly, prominent
CC       eyes, arched eyebrows, hypertelorism, a glabellar nevus flammeus,
CC       neonatal feeding difficulties, and hypotonia. Some patients may also
CC       have atrial septal defect, episodic hypoglycemia, changes in bone
CC       mineral density, and/or seizures. {ECO:0000269|PubMed:27693232}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ASXL2 is a cause of
CC       therapy-related myelodysplastic syndrome. Translocation
CC       t(2;8)(p23;p11.2) with KAT6A generates a KAT6A-ASXL2 fusion protein.
CC   -!- SIMILARITY: Belongs to the Asx family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91889.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB21776.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD00088.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB084279; BAD00086.1; -; mRNA.
DR   EMBL; AB084281; BAD00088.1; ALT_INIT; mRNA.
DR   EMBL; AB051472; BAB21776.2; ALT_INIT; mRNA.
DR   EMBL; CR933613; CAI45930.1; -; mRNA.
DR   EMBL; AC010150; AAY14841.1; -; Genomic_DNA.
DR   EMBL; BC042999; AAH42999.1; -; mRNA.
DR   EMBL; AK001760; BAA91889.1; ALT_INIT; mRNA.
DR   RefSeq; NP_060733.4; NM_018263.4. [Q76L83-1]
DR   SMR; Q76L83; -.
DR   BioGrid; 120543; 28.
DR   IntAct; Q76L83; 13.
DR   MINT; Q76L83; -.
DR   STRING; 9606.ENSP00000383920; -.
DR   CarbonylDB; Q76L83; -.
DR   iPTMnet; Q76L83; -.
DR   PhosphoSitePlus; Q76L83; -.
DR   BioMuta; ASXL2; -.
DR   DMDM; 74712929; -.
DR   EPD; Q76L83; -.
DR   jPOST; Q76L83; -.
DR   MassIVE; Q76L83; -.
DR   MaxQB; Q76L83; -.
DR   PaxDb; Q76L83; -.
DR   PeptideAtlas; Q76L83; -.
DR   PRIDE; Q76L83; -.
DR   ProteomicsDB; 68680; -. [Q76L83-1]
DR   ProteomicsDB; 68681; -. [Q76L83-2]
DR   Antibodypedia; 27772; 53 antibodies.
DR   DNASU; 55252; -.
DR   Ensembl; ENST00000404843; ENSP00000383920; ENSG00000143970. [Q76L83-2]
DR   Ensembl; ENST00000435504; ENSP00000391447; ENSG00000143970. [Q76L83-1]
DR   GeneID; 55252; -.
DR   KEGG; hsa:55252; -.
DR   UCSC; uc002rgt.2; human. [Q76L83-1]
DR   CTD; 55252; -.
DR   DisGeNET; 55252; -.
DR   GeneCards; ASXL2; -.
DR   HGNC; HGNC:23805; ASXL2.
DR   HPA; ENSG00000143970; Low tissue specificity.
DR   MalaCards; ASXL2; -.
DR   MIM; 612991; gene.
DR   MIM; 617190; phenotype.
DR   neXtProt; NX_Q76L83; -.
DR   OpenTargets; ENSG00000143970; -.
DR   PharmGKB; PA134884863; -.
DR   eggNOG; ENOG410IIF3; Eukaryota.
DR   eggNOG; ENOG4111F3G; LUCA.
DR   GeneTree; ENSGT00520000055578; -.
DR   HOGENOM; CLU_005155_0_0_1; -.
DR   InParanoid; Q76L83; -.
DR   KO; K11471; -.
DR   OMA; SSNMNGP; -.
DR   OrthoDB; 123355at2759; -.
DR   PhylomeDB; Q76L83; -.
DR   TreeFam; TF328464; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   ChiTaRS; ASXL2; human.
DR   GenomeRNAi; 55252; -.
DR   Pharos; Q76L83; Tbio.
DR   PRO; PR:Q76L83; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q76L83; protein.
DR   Bgee; ENSG00000143970; Expressed in colon and 237 other tissues.
DR   ExpressionAtlas; Q76L83; baseline and differential.
DR   Genevisible; Q76L83; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0035517; C:PR-DUB complex; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IDA:UniProtKB.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IDA:UniProtKB.
DR   GO; GO:0010884; P:positive regulation of lipid storage; IEA:Ensembl.
DR   GO; GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR026905; ASX-like_PHD.
DR   InterPro; IPR024811; ASX/ASX-like.
DR   InterPro; IPR028020; ASXH.
DR   InterPro; IPR024817; ASXL2.
DR   InterPro; IPR007759; HB1/Asxl_HTH.
DR   PANTHER; PTHR13578; PTHR13578; 1.
DR   PANTHER; PTHR13578:SF11; PTHR13578:SF11; 1.
DR   Pfam; PF13919; ASXH; 1.
DR   Pfam; PF05066; HARE-HTH; 1.
DR   Pfam; PF13922; PHD_3; 1.
DR   PROSITE; PS51913; HTH_HARE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Mental retardation;
KW   Metal-binding; Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..1435
FT                   /note="Putative Polycomb group protein ASXL2"
FT                   /id="PRO_0000313826"
FT   DOMAIN          11..86
FT                   /note="HTH HARE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01261"
FT   ZN_FING         1397..1434
FT                   /note="PHD-type; atypical"
FT   MOTIF           174..178
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           303..307
FT                   /note="LXXLL motif 1"
FT   MOTIF           887..891
FT                   /note="LXXLL motif 2"
FT   COMPBIAS        95..235
FT                   /note="Ser-rich"
FT   COMPBIAS        303..307
FT                   /note="Poly-Leu"
FT   COMPBIAS        654..684
FT                   /note="Ala-rich"
FT   COMPBIAS        687..739
FT                   /note="Gly-rich"
FT   COMPBIAS        1173..1176
FT                   /note="Poly-Ser"
FT   SITE            20..21
FT                   /note="Breakpoint for translocation to form KAT6A-ASXL2
FT                   protein"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         641
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BZ32"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..260
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030163"
FT   VAR_SEQ         838..1094
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030164"
FT   VARIANT         731
FT                   /note="L -> P (in dbSNP:rs13385963)"
FT                   /id="VAR_037773"
FT   VARIANT         796
FT                   /note="A -> V (in dbSNP:rs17854251)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_037774"
FT   VARIANT         1210
FT                   /note="T -> P (in dbSNP:rs12991178)"
FT                   /id="VAR_037775"
FT   VARIANT         1242
FT                   /note="T -> P (in dbSNP:rs12990978)"
FT                   /id="VAR_037776"
FT   CONFLICT        473
FT                   /note="E -> G (in Ref. 3; CAI45930)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        651
FT                   /note="R -> K (in Ref. 3; CAI45930)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1334
FT                   /note="S -> P (in Ref. 7; BAA91889)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1435 AA;  153820 MW;  A01026E3C2D1035D CRC64;
     MREKGRRKKG RTWAEAAKTV LEKYPNTPMS HKEILQVIQR EGLKEIRSGT SPLACLNAML
     HTNSRGEEGI FYKVPGRMGV YTLKKDVPDG VKELSEGSEE SSDGQSDSQS SENSSSSSDG
     GSNKEGKKSR WKRKVSSSSP QSGCPSPTIP AGKVISPSQK HSKKALKQAL KQQQQKKQQQ
     QCRPSISISS NQHLSLKTVK AASDSVPAKP ATWEGKQSDG QTGSPQNSNS SFSSSVKVEN
     TLLGLGKKSF QRSERLHTRQ MKRTKCADID VETPDSILVN TNLRALINKH TFSVLPGDCQ
     QRLLLLLPEV DRQVGPDGLM KLNGSALNNE FFTSAAQGWK ERLSEGEFTP EMQVRIRQEI
     EKEKKVEPWK EQFFESYYGQ SSGLSLEDSK KLTASPSDPK VKKTPAEQPK SMPVSEASLI
     RIVPVVSQSE CKEEALQMSS PGRKEECESQ GEVQPNFSTS SEPLLSSALN THELSSILPI
     KCPKDEDLLE QKPVTSAEQE SEKNHLTTAS NYNKSESQES LVTSPSKPKS PGVEKPIVKP
     TAGAGPQETN MKEPLATLVD QSPESLKRKS SLTQEEAPVS WEKRPRVTEN RQHQQPFQVS
     PQPFLNRGDR IQVRKVPPLK IPVSRISPMP FHPSQVSPRA RFPVSITSPN RTGARTLADI
     KAKAQLVKAQ RAAAAAAAAA AAAASVGGTI PGPGPGGGQG PGEGGEGQTA RGGSPGSDRV
     SETGKGPTLE LAGTGSRGGT RELLPCGPET QPQSETKTTP SQAQPHSVSG AQLQQTPPVP
     PTPAVSGACT SVPSPAHIEK LDNEKLNPTR ATATVASVSH PQGPSSCRQE KAPSPTGPAL
     ISGASPVHCA ADGTVELKAG PSKNIPNPSA SSKTDASVPV AVTPSPLTSL LTTATLEKLP
     VPQVSATTAP AGSAPPSSTL PAASSLKTPG TSLNMNGPTL RPTSSIPANN PLVTQLLQGK
     DVPMEQILPK PLTKVEMKTV PLTAKEERGM GALIATNTTE NSTREEVNER QSHPATQQQL
     GKTLQSKQLP QVPRPLQLFS AKELRDSSID THQYHEGLSK ATQDQILQTL IQRVRRQNLL
     SVVPPSQFNF AHSGFQLEDI STSQRFMLGF AGRRTSKPAM AGHYLLNIST YGRGSESFRR
     THSVNPEDRF CLSSPTEALK MGYTDCKNAT GESSSSKEDD TDEESTGDEQ ESVTVKEEPQ
     VSQSAGKGDT SSGPHSRETL STSDCLASKN VKAEIPLNEQ TTLSKENYLF TRGQTFDEKT
     LARDLIQAAQ KQMAHAVRGK AIRSSPELFS STVLPLPADS PTHQPLLLPP LQTPKLYGSP
     TQIGPSYRGM INVSTSSDMD HNSAVPGSQV SSNVGDVMSF SVTVTTIPAS QAMNPSSHGQ
     TIPVQAFSEE NSIEGTPSKC YCRLKAMIMC KGCGAFCHDD CIGPSKLCVS CLVVR
//
ID   BAZ1A_HUMAN             Reviewed;        1556 AA.
AC   Q9NRL2; Q9NZ15; Q9P065; Q9UIG1; Q9Y3V3;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-APR-2020, entry version 197.
DE   RecName: Full=Bromodomain adjacent to zinc finger domain protein 1A;
DE   AltName: Full=ATP-dependent chromatin-remodeling protein;
DE   AltName: Full=ATP-utilizing chromatin assembly and remodeling factor 1;
DE            Short=hACF1;
DE   AltName: Full=CHRAC subunit ACF1;
DE   AltName: Full=Williams syndrome transcription factor-related chromatin-remodeling factor 180;
DE            Short=WCRF180;
DE   AltName: Full=hWALp1;
GN   Name=BAZ1A; Synonyms=ACF1, WCRF180; ORFNames=HSPC317;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, IDENTIFICATION IN THE CHRAC COMPLEX, AND VARIANT LYS-1366.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10880450; DOI=10.1093/emboj/19.13.3377;
RA   Poot R.A., Dellaire G., Huelsmann B.B., Grimaldi M.A., Corona D.F.V.,
RA   Becker P.B., Bickmore W.A., Varga-Weisz P.D.;
RT   "HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two
RT   novel histone-fold proteins.";
RL   EMBO J. 19:3377-3387(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10655480; DOI=10.1073/pnas.97.3.1038;
RA   Bochar D.A., Savard J., Wang W., Lafleur D.W., Moore P., Cote J.,
RA   Shiekhattar R.;
RT   "A family of chromatin remodeling factors related to Williams syndrome
RT   transcription factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1038-1043(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=10662543; DOI=10.1006/geno.1999.6071;
RA   Jones M.H., Hamana N., Nezu J., Shimane M.;
RT   "A novel family of bromodomain genes.";
RL   Genomics 63:40-45(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-540 (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RA   Ye M., Zhang Q.-H., Zhou J., Shen Y., Wu X.-Y., Guan Z.Q., Wang L.,
RA   Fan H.-Y., Mao Y.-F., Dai M., Huang Q.-H., Chen S.-J., Chen Z.;
RT   "Human partial CDS from CD34+ stem cells.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 746-1556 (ISOFORM 1), AND VARIANT
RP   LYS-1366.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH SMARCA5 IN THE AFC COMPLEX.
RX   PubMed=12434153; DOI=10.1038/ng1046;
RA   Collins N., Poot R.A., Kukimoto I., Garcia-Jimenez C., Dellaire G.,
RA   Varga-Weisz P.D.;
RT   "An ACF1-ISWI chromatin-remodeling complex is required for DNA replication
RT   through heterochromatin.";
RL   Nat. Genet. 32:627-632(2002).
RN   [9]
RP   ASSOCIATION WITH THE CHRAC1/POLE3 COMPLEX, AND FUNCTION OF THE CHRAC
RP   COMPLEX.
RX   PubMed=14759371; DOI=10.1016/s1097-2765(03)00523-9;
RA   Kukimoto I., Elderkin S., Grimaldi M., Oelgeschlager T., Varga-Weisz P.D.;
RT   "The histone-fold protein complex CHRAC-15/17 enhances nucleosome sliding
RT   and assembly mediated by ACF.";
RL   Mol. Cell 13:265-277(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1413 AND SER-1417, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION OF ACF COMPLEX.
RX   PubMed=17099699; DOI=10.1038/nsmb1170;
RA   Yang J.G., Madrid T.S., Sevastopoulos E., Narlikar G.J.;
RT   "The chromatin-remodeling enzyme ACF is an ATP-dependent DNA length sensor
RT   that regulates nucleosome spacing.";
RL   Nat. Struct. Mol. Biol. 13:1078-1083(2006).
RN   [12]
RP   INTERACTION WITH NCOR1, AND POSSIBLE FUNCTION.
RX   PubMed=17519354; DOI=10.1210/me.2007-0095;
RA   Ewing A.K., Attner M., Chakravarti D.;
RT   "Novel regulatory role for human Acf1 in transcriptional repression of
RT   vitamin D3 receptor-regulated genes.";
RL   Mol. Endocrinol. 21:1791-1806(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1402; SER-1413 AND SER-1417,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270 AND SER-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270; SER-1371 AND SER-1402,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-731; SER-1281 AND SER-1413,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-731; SER-961; SER-1281;
RP   SER-1320; SER-1363; SER-1413; SER-1417 AND THR-1547, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-952, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Component of the ACF complex, an ATP-dependent chromatin
CC       remodeling complex, that regulates spacing of nucleosomes using ATP to
CC       generate evenly spaced nucleosomes along the chromatin. The ATPase
CC       activity of the complex is regulated by the length of flanking DNA.
CC       Also involved in facilitating the DNA replication process. BAZ1A is the
CC       accessory, non-catalytic subunit of the complex which can enhance and
CC       direct the process provided by the ATPase subunit, SMARCA5, probably
CC       through targeting pericentromeric heterochromatin in late S phase.
CC       Moves end-positioned nucleosomes to a predominantly central position.
CC       May have a role in nuclear receptor-mediated transcription repression.
CC   -!- FUNCTION: Component of the histone-fold protein complex CHRAC complex
CC       which facilitates nucleosome sliding by the ACF complex and enhances
CC       ACF-mediated chromatin assembly. The C-terminal regions of both CHRAC1
CC       and POLE1 are required for these functions.
CC   -!- SUBUNIT: Component of the ACF chromatin remodeling complex that
CC       includes BAZ1A and SMARCA5. Additional this complex can form, together
CC       with CHRAC1 and POLE1, the histone-fold protein complex, CHRAC.
CC       Interacts with NCOR1 (via its RD1 domain); the interaction corepresses
CC       a number of NCOR1-regulated genes. {ECO:0000269|PubMed:10880450,
CC       ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:17519354}.
CC   -!- INTERACTION:
CC       Q9NRL2; P42858: HTT; NbExp=4; IntAct=EBI-927511, EBI-466029;
CC       Q9NRL2; O60264: SMARCA5; NbExp=3; IntAct=EBI-927511, EBI-352588;
CC       Q9NRL2; O95365: ZBTB7A; NbExp=2; IntAct=EBI-927511, EBI-2795384;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=May target the CHRAC complex to
CC       heterochromatin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRL2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRL2-2; Sequence=VSP_000551;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis and at low or
CC       undetectable levels in other tissues analyzed.
CC   -!- MISCELLANEOUS: Stimulated by double-stranded DNA and nucleosomal DNA.
CC   -!- SIMILARITY: Belongs to the WAL family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF28995.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF213467; AAF70601.1; -; mRNA.
DR   EMBL; AF221130; AAF32366.1; -; mRNA.
DR   EMBL; AB032252; BAA89209.1; -; mRNA.
DR   EMBL; AL121603; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355885; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW65900.1; -; Genomic_DNA.
DR   EMBL; AF161435; AAF28995.1; ALT_FRAME; mRNA.
DR   EMBL; AL050089; CAB43261.1; -; mRNA.
DR   CCDS; CCDS41943.1; -. [Q9NRL2-2]
DR   CCDS; CCDS9651.1; -. [Q9NRL2-1]
DR   PIR; T08738; T08738.
DR   RefSeq; NP_038476.2; NM_013448.2. [Q9NRL2-1]
DR   RefSeq; NP_872589.1; NM_182648.1. [Q9NRL2-2]
DR   PDB; 5UIY; X-ray; 1.69 A; A/B/C/D=1425-1538.
DR   PDBsum; 5UIY; -.
DR   SMR; Q9NRL2; -.
DR   BioGrid; 116347; 70.
DR   ComplexPortal; CPX-434; ACF complex.
DR   ComplexPortal; CPX-785; CHRAC chromatin remodeling complex.
DR   CORUM; Q9NRL2; -.
DR   DIP; DIP-36071N; -.
DR   IntAct; Q9NRL2; 37.
DR   MINT; Q9NRL2; -.
DR   STRING; 9606.ENSP00000353458; -.
DR   ChEMBL; CHEMBL4105737; -.
DR   iPTMnet; Q9NRL2; -.
DR   MetOSite; Q9NRL2; -.
DR   PhosphoSitePlus; Q9NRL2; -.
DR   SwissPalm; Q9NRL2; -.
DR   BioMuta; BAZ1A; -.
DR   DMDM; 116241266; -.
DR   EPD; Q9NRL2; -.
DR   jPOST; Q9NRL2; -.
DR   MassIVE; Q9NRL2; -.
DR   MaxQB; Q9NRL2; -.
DR   PaxDb; Q9NRL2; -.
DR   PeptideAtlas; Q9NRL2; -.
DR   PRIDE; Q9NRL2; -.
DR   ProteomicsDB; 82383; -. [Q9NRL2-1]
DR   ProteomicsDB; 82384; -. [Q9NRL2-2]
DR   Antibodypedia; 113; 128 antibodies.
DR   Ensembl; ENST00000358716; ENSP00000351555; ENSG00000198604. [Q9NRL2-2]
DR   Ensembl; ENST00000360310; ENSP00000353458; ENSG00000198604. [Q9NRL2-1]
DR   Ensembl; ENST00000382422; ENSP00000371859; ENSG00000198604. [Q9NRL2-1]
DR   GeneID; 11177; -.
DR   KEGG; hsa:11177; -.
DR   UCSC; uc001wsk.4; human. [Q9NRL2-1]
DR   CTD; 11177; -.
DR   DisGeNET; 11177; -.
DR   GeneCards; BAZ1A; -.
DR   HGNC; HGNC:960; BAZ1A.
DR   HPA; ENSG00000198604; Low tissue specificity.
DR   MIM; 605680; gene.
DR   neXtProt; NX_Q9NRL2; -.
DR   OpenTargets; ENSG00000198604; -.
DR   PharmGKB; PA25270; -.
DR   eggNOG; KOG1245; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   GeneTree; ENSGT00940000158135; -.
DR   HOGENOM; CLU_002479_1_0_1; -.
DR   InParanoid; Q9NRL2; -.
DR   KO; K11655; -.
DR   OMA; YYVLESM; -.
DR   OrthoDB; 858930at2759; -.
DR   PhylomeDB; Q9NRL2; -.
DR   TreeFam; TF316326; -.
DR   ChiTaRS; BAZ1A; human.
DR   GenomeRNAi; 11177; -.
DR   Pharos; Q9NRL2; Tbio.
DR   PRO; PR:Q9NRL2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9NRL2; protein.
DR   Bgee; ENSG00000198604; Expressed in oocyte and 221 other tissues.
DR   ExpressionAtlas; Q9NRL2; baseline and differential.
DR   Genevisible; Q9NRL2; HS.
DR   GO; GO:0016590; C:ACF complex; TAS:BHF-UCL.
DR   GO; GO:0008623; C:CHRAC; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006338; P:chromatin remodeling; TAS:BHF-UCL.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IDA:UniProtKB.
DR   GO; GO:0016573; P:histone acetylation; IEA:GOC.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; NAS:BHF-UCL.
DR   CDD; cd05504; Bromo_Acf1_like; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR037325; Acf1_Bromo.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR018501; DDT_dom.
DR   InterPro; IPR028942; WHIM1_dom.
DR   InterPro; IPR028941; WHIM2_dom.
DR   InterPro; IPR013136; WSTF_Acf1_Cbp146.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF02791; DDT; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF10537; WAC_Acf1_DNA_bd; 1.
DR   Pfam; PF15612; WHIM1; 1.
DR   Pfam; PF15613; WSD; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00571; DDT; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS50827; DDT; 1.
DR   PROSITE; PS51136; WAC; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Bromodomain; Coiled coil;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1556
FT                   /note="Bromodomain adjacent to zinc finger domain protein
FT                   1A"
FT                   /id="PRO_0000211167"
FT   DOMAIN          22..128
FT                   /note="WAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00475"
FT   DOMAIN          422..487
FT                   /note="DDT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00063"
FT   DOMAIN          1446..1516
FT                   /note="Bromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   ZN_FING         1148..1198
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   REGION          1..133
FT                   /note="Required for interaction with NCOR1"
FT                   /evidence="ECO:0000269|PubMed:17519354"
FT   REGION          1..128
FT                   /note="Required for association with the CHRAC1/POLE3
FT                   complex"
FT   REGION          667..933
FT                   /note="Interaction with SMARCA5"
FT   COILED          306..397
FT                   /evidence="ECO:0000255"
FT   COILED          634..709
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        487..491
FT                   /note="Poly-Glu"
FT   COMPBIAS        1239..1257
FT                   /note="Glu-rich"
FT   MOD_RES         270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         731
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         960
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88379"
FT   MOD_RES         961
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88379"
FT   MOD_RES         1353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O88379"
FT   MOD_RES         1363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         1413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1547
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        952
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         504..535
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10655480"
FT                   /id="VSP_000551"
FT   VARIANT         344
FT                   /note="D -> E (in dbSNP:rs1133285)"
FT                   /id="VAR_028049"
FT   VARIANT         1366
FT                   /note="N -> K (in dbSNP:rs1044140)"
FT                   /evidence="ECO:0000269|PubMed:10880450,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_048423"
FT   CONFLICT        135
FT                   /note="R -> T (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236
FT                   /note="D -> E (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        494
FT                   /note="K -> Q (in Ref. 6; AAF28995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503..508
FT                   /note="KDLTEA -> QDFTEP (in Ref. 6; AAF28995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        525
FT                   /note="S -> P (in Ref. 6; AAF28995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        536..540
FT                   /note="GCSLK -> AALKF (in Ref. 6; AAF28995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        551
FT                   /note="E -> D (in Ref. 1; AAF70601)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730
FT                   /note="V -> F (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        769
FT                   /note="P -> L (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1201
FT                   /note="S -> C (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1206
FT                   /note="S -> F (in Ref. 3; BAA89209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1409
FT                   /note="R -> K (in Ref. 1; AAF70601 and 7; CAB43261)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1436..1447
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   HELIX           1449..1454
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   TURN            1460..1462
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   HELIX           1466..1469
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   HELIX           1476..1484
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   HELIX           1491..1508
FT                   /evidence="ECO:0000244|PDB:5UIY"
FT   HELIX           1514..1532
FT                   /evidence="ECO:0000244|PDB:5UIY"
SQ   SEQUENCE   1556 AA;  178702 MW;  4D78B9A8ADBF715B CRC64;
     MPLLHRKPFV RQKPPADLRP DEEVFYCKVT NEIFRHYDDF FERTILCNSL VWSCAVTGRP
     GLTYQEALES EKKARQNLQS FPEPLIIPVL YLTSLTHRSR LHEICDDIFA YVKDRYFVEE
     TVEVIRNNGA RLQCRILEVL PPSHQNGFAN GHVNSVDGET IIISDSDDSE TQSCSFQNGK
     KKDAIDPLLF KYKVQPTKKE LHESAIVKAT QISRRKHLFS RDKLKLFLKQ HCEPQDGVIK
     IKASSLSTYK IAEQDFSYFF PDDPPTFIFS PANRRRGRPP KRIHISQEDN VANKQTLASY
     RSKATKERDK LLKQEEMKSL AFEKAKLKRE KADALEAKKK EKEDKEKKRE ELKKIVEEER
     LKKKEEKERL KVEREKEREK LREEKRKYVE YLKQWSKPRE DMECDDLKEL PEPTPVKTRL
     PPEIFGDALM VLEFLNAFGE LFDLQDEFPD GVTLEVLEEA LVGNDSEGPL CELLFFFLTA
     IFQAIAEEEE EVAKEQLTDA DTKDLTEALD EDADPTKSAL SAVASLAAAW PQLHQGCSLK
     SLDLDSCTLS EILRLHILAS GADVTSANAK YRYQKRGGFD ATDDACMELR LSNPSLVKKL
     SSTSVYDLTP GEKMKILHAL CGKLLTLVST RDFIEDYVDI LRQAKQEFRE LKAEQHRKER
     EEAAARIRKR KEEKLKEQEQ KMKEKQEKLK EDEQRNSTAD ISIGEEERED FDTSIESKDT
     EQKELDQDMV TEDEDDPGSH KRGRRGKRGQ NGFKEFTRQE QINCVTREPL TADEEEALKQ
     EHQRKEKELL EKIQSAIACT NIFPLGRDRM YRRYWIFPSI PGLFIEEDYS GLTEDMLLPR
     PSSFQNNVQS QDPQVSTKTG EPLMSESTSN IDQGPRDHSV QLPKPVHKPN RWCFYSSCEQ
     LDQLIEALNS RGHRESALKE TLLQEKSRIC AQLARFSEEK FHFSDKPQPD SKPTYSRGRS
     SNAYDPSQMC AEKQLELRLR DFLLDIEDRI YQGTLGAIKV TDRHIWRSAL ESGRYELLSE
     ENKENGIIKT VNEDVEEMEI DEQTKVIVKD RLLGIKTETP STVSTNASTP QSVSSVVHYL
     AMALFQIEQG IERRFLKAPL DASDSGRSYK TVLDRWRESL LSSASLSQVF LHLSTLDRSV
     IWSKSILNAR CKICRKKGDA ENMVLCDGCD RGHHTYCVRP KLKTVPEGDW FCPECRPKQR
     SRRLSSRQRP SLESDEDVED SMGGEDDEVD GDEEEGQSEE EEYEVEQDED DSQEEEEVSL
     PKRGRPQVRL PVKTRGKLSS SFSSRGQQQE PGRYPSRSQQ STPKTTVSSK TGRSLRKINS
     APPTETKSLR IASRSTRHSH GPLQADVFVE LLSPRRKRRG RKSANNTPEN SPNFPNFRVI
     ATKSSEQSRS VNIASKLSLQ ESESKRRCRK RQSPEPSPVT LGRRSSGRQG GVHELSAFEQ
     LVVELVRHDD SWPFLKLVSK IQVPDYYDII KKPIALNIIR EKVNKCEYKL ASEFIDDIEL
     MFSNCFEYNP RNTSEAKAGT RLQAFFHIQA QKLGLHVTPS NVDQVSTPPA AKKSRI
//
ID   CASP3_HUMAN             Reviewed;         277 AA.
AC   P42574; A8K5M2; D3DP53; Q96AN1; Q96KP2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   22-APR-2020, entry version 227.
DE   RecName: Full=Caspase-3;
DE            Short=CASP-3;
DE            EC=3.4.22.56;
DE   AltName: Full=Apopain;
DE   AltName: Full=Cysteine protease CPP32;
DE            Short=CPP-32;
DE   AltName: Full=Protein Yama;
DE   AltName: Full=SREBP cleavage activity 1;
DE            Short=SCA-1;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p17;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p12;
DE   Flags: Precursor;
GN   Name=CASP3; Synonyms=CPP32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
RC   TISSUE=T-cell;
RX   PubMed=7983002;
RA   Fernandes-Alnemri T., Litwack G., Alnemri E.S.;
RT   "CPP32, a novel human apoptotic protein with homology to Caenorhabditis
RT   elegans cell death protein Ced-3 and mammalian interleukin-1 beta-
RT   converting enzyme.";
RL   J. Biol. Chem. 269:30761-30764(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7774019; DOI=10.1016/0092-8674(95)90541-3;
RA   Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R.,
RA   Poirier G.G., Salvesen G.S., Dixit V.M.;
RT   "Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable
RT   protease that cleaves the death substrate poly(ADP-ribose) polymerase.";
RL   Cell 81:801-809(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
RX   PubMed=15003516; DOI=10.1016/j.bbrc.2004.02.021;
RA   Pelletier M., Cartron P.F., Delaval F., Meflah K., Vallette F.M.,
RA   Oliver L.;
RT   "Caspase 3 activation is controlled by a sequence located in the N-terminus
RT   of its large subunit.";
RL   Biochem. Biophys. Res. Commun. 316:93-99(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 29-46 AND 176-193, FUNCTION, AND VARIANT ASP-190.
RX   PubMed=7596430; DOI=10.1038/376037a0;
RA   Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K.,
RA   Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A.,
RA   Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Li V.L., Miller D.K.;
RT   "Identification and inhibition of the ICE/CED-3 protease necessary for
RT   mammalian apoptosis.";
RL   Nature 376:37-43(1995).
RN   [9]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=8755496; DOI=10.1073/pnas.93.15.7464;
RA   Fernandes-Alnemri T., Armstrong R.C., Krebs J.F., Srinivasula S.M.,
RA   Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J., Litwack G.,
RA   Alnemri E.S.;
RT   "In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic
RT   cysteine protease containing two FADD-like domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7464-7469(1996).
RN   [10]
RP   CLEAVAGE OF HUNTINGTIN.
RX   PubMed=8696339; DOI=10.1038/ng0896-442;
RA   Goldberg Y.P., Nicholson D.W., Rasper D.M., Kalchman M.A., Koide H.B.,
RA   Graham R.K., Bromm M., Kazemi-Esfarjani P., Thornberry N.A.,
RA   Vaillancourt J.P., Hayden M.R.;
RT   "Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is
RT   modulated by the polyglutamine tract.";
RL   Nat. Genet. 13:442-449(1996).
RN   [11]
RP   S-NITROSYLATION AT CYS-163.
RX   PubMed=10213689; DOI=10.1126/science.284.5414.651;
RA   Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X.,
RA   Kane L.S., Gow A.J., Stamler J.S.;
RT   "Fas-induced caspase denitrosylation.";
RL   Science 284:651-654(1999).
RN   [12]
RP   INTERACTION WITH BIRC6/BRUCE.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin
RT   ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION IN CELL ADHESION.
RX   PubMed=21357690; DOI=10.1074/jbc.m110.195461;
RA   Cabrera J.R., Bouzas-Rodriguez J., Tauszig-Delamasure S., Mehlen P.;
RT   "RET modulates cell adhesion via its cleavage by caspase in sympathetic
RT   neurons.";
RL   J. Biol. Chem. 286:14628-14638(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 28-277.
RX   PubMed=8673606; DOI=10.1038/nsb0796-619;
RA   Rotonda J., Nicholson D.W., Fazil K.M., Gallant M., Gareau Y., Labelle M.,
RA   Peterson E.P., Rasper D.M., Ruel R., Vaillancourt J.P., Thornberry N.A.,
RA   Becker J.W.;
RT   "The three-dimensional structure of apopain/CPP32, a key mediator of
RT   apoptosis.";
RL   Nat. Struct. Biol. 3:619-625(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 35-173 AND 185-277.
RX   PubMed=9045680; DOI=10.1074/jbc.272.10.6539;
RA   Mittl P.R.E., di Marco S., Krebs J.F., Bai X., Karanewsky D.S.,
RA   Priestle J.P., Tomaselli K.J., Gruetter M.G.;
RT   "Structure of recombinant human CPP32 in complex with the tetrapeptide
RT   acetyl-Asp-Val-Ala-Asp fluoromethyl ketone.";
RL   J. Biol. Chem. 272:6539-6547(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   PubMed=10821855; DOI=10.1074/jbc.275.21.16007;
RA   Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A.,
RA   Kikly K., Winkler J.D., Sung C.-M., Debouck C., Richardson S., Levy M.A.,
RA   DeWolf W.E. Jr., Keller P.M., Tomaszek T., Head M.S., Ryan M.D.,
RA   Haltiwanger R.C., Liang P.-H., Janson C.A., McDevitt P.J., Johanson K.,
RA   Concha N.O., Chan W., Abdel-Meguid S.S., Badger A.M., Lark M.W.,
RA   Nadeau D.P., Suva L.J., Gowen M., Nuttall M.E.;
RT   "Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit
RT   apoptosis and maintain cell functionality.";
RL   J. Biol. Chem. 275:16007-16014(2000).
CC   -!- FUNCTION: Involved in the activation cascade of caspases responsible
CC       for apoptosis execution. At the onset of apoptosis it proteolytically
CC       cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217'
CC       bond. Cleaves and activates sterol regulatory element binding proteins
CC       (SREBPs) between the basic helix-loop-helix leucine zipper domain and
CC       the membrane attachment domain. Cleaves and activates caspase-6, -7 and
CC       -9. Involved in the cleavage of huntingtin. Triggers cell adhesion in
CC       sympathetic neurons through RET cleavage. {ECO:0000269|PubMed:21357690,
CC       ECO:0000269|PubMed:7596430}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for an Asp residue at positions P1 and P4.
CC         It has a preferred cleavage sequence of Asp-Xaa-Xaa-Asp-|- with a
CC         hydrophobic amino-acid residue at P2 and a hydrophilic amino-acid
CC         residue at P3, although Val or Ala are also accepted at this
CC         position.; EC=3.4.22.56;
CC   -!- ACTIVITY REGULATION: Inhibited by isatin sulfonamides.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel arranged
CC       heterodimers, each one formed by a 17 kDa (p17) and a 12 kDa (p12)
CC       subunit. Interacts with BIRC6/bruce. {ECO:0000269|PubMed:15200957}.
CC   -!- INTERACTION:
CC       P42574; O43823: AKAP8; NbExp=5; IntAct=EBI-524064, EBI-1237481;
CC       P42574; Q9Y243: AKT3; NbExp=2; IntAct=EBI-524064, EBI-296115;
CC       P42574; P55212: CASP6; NbExp=2; IntAct=EBI-524064, EBI-718729;
CC       P42574; P55211: CASP9; NbExp=2; IntAct=EBI-524064, EBI-516799;
CC       P42574; Q00987: MDM2; NbExp=2; IntAct=EBI-524064, EBI-389668;
CC       P42574; O60551: NMT2; NbExp=2; IntAct=EBI-524064, EBI-3920273;
CC       P42574; P09874: PARP1; NbExp=2; IntAct=EBI-524064, EBI-355676;
CC       P42574; Q5JUK2: SOHLH1; NbExp=3; IntAct=EBI-524064, EBI-12288855;
CC       P42574; P10599: TXN; NbExp=6; IntAct=EBI-524064, EBI-594644;
CC       P42574; Q9BYP7: WNK3; NbExp=2; IntAct=EBI-524064, EBI-1182602;
CC       P42574; P98170: XIAP; NbExp=4; IntAct=EBI-524064, EBI-517127;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung, spleen, heart, liver and
CC       kidney. Moderate levels in brain and skeletal muscle, and low in
CC       testis. Also found in many cell lines, highest expression in cells of
CC       the immune system.
CC   -!- PTM: Cleavage by granzyme B, caspase-6, caspase-8 and caspase-10
CC       generates the two active subunits. Additional processing of the
CC       propeptides is likely due to the autocatalytic activity of the
CC       activated protease. Active heterodimers between the small subunit of
CC       caspase-7 protease and the large subunit of caspase-3 also occur and
CC       vice versa.
CC   -!- PTM: S-nitrosylated on its catalytic site cysteine in unstimulated
CC       human cell lines and denitrosylated upon activation of the Fas
CC       apoptotic pathway, associated with an increase in intracellular caspase
CC       activity. Fas therefore activates caspase-3 not only by inducing the
CC       cleavage of the caspase zymogen to its active subunits, but also by
CC       stimulating the denitrosylation of its active site thiol.
CC       {ECO:0000269|PubMed:10213689}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/casp3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U13737; AAA65015.1; -; mRNA.
DR   EMBL; U13738; AAB60355.1; -; mRNA.
DR   EMBL; U26943; AAA74929.1; -; mRNA.
DR   EMBL; AJ413269; CAC88866.1; -; mRNA.
DR   EMBL; AK291337; BAF84026.1; -; mRNA.
DR   EMBL; AY219866; AAO25654.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04673.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04674.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04675.1; -; Genomic_DNA.
DR   EMBL; BC016926; AAH16926.1; -; mRNA.
DR   CCDS; CCDS3836.1; -.
DR   PIR; A55315; A55315.
DR   RefSeq; NP_004337.2; NM_004346.3.
DR   RefSeq; NP_116786.1; NM_032991.2.
DR   RefSeq; XP_011530603.1; XM_011532301.1.
DR   PDB; 1CP3; X-ray; 2.30 A; A/B=1-277.
DR   PDB; 1GFW; X-ray; 2.80 A; A=29-175, B=181-277.
DR   PDB; 1I3O; X-ray; 2.70 A; A/C=1-175, B/D=176-277.
DR   PDB; 1NME; X-ray; 1.60 A; A=29-174, B=186-277.
DR   PDB; 1NMQ; X-ray; 2.40 A; A/B=29-277.
DR   PDB; 1NMS; X-ray; 1.70 A; A/B=29-277.
DR   PDB; 1PAU; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1QX3; X-ray; 1.90 A; A=29-277.
DR   PDB; 1RE1; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1RHJ; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 1RHK; X-ray; 2.50 A; A=29-175, B=176-277.
DR   PDB; 1RHM; X-ray; 2.50 A; A/C=29-175, B/D=176-277.
DR   PDB; 1RHQ; X-ray; 3.00 A; A/D=29-175, B/E=176-277.
DR   PDB; 1RHR; X-ray; 3.00 A; A=29-175, B=176-277.
DR   PDB; 1RHU; X-ray; 2.51 A; A=29-175, B=176-277.
DR   PDB; 2C1E; X-ray; 1.77 A; A=29-175, B=176-277.
DR   PDB; 2C2K; X-ray; 1.87 A; A=29-175, B=176-277.
DR   PDB; 2C2M; X-ray; 1.94 A; A=29-175, B=176-277.
DR   PDB; 2C2O; X-ray; 2.45 A; A=29-175, B=176-277.
DR   PDB; 2CDR; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CJX; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CJY; X-ray; 1.67 A; A=29-175, B=176-277.
DR   PDB; 2CNK; X-ray; 1.75 A; A=29-175, B=176-277.
DR   PDB; 2CNL; X-ray; 1.67 A; A=29-175, B=176-277.
DR   PDB; 2CNN; X-ray; 1.70 A; A=29-175, B=176-277.
DR   PDB; 2CNO; X-ray; 1.95 A; A=29-175, B=176-277.
DR   PDB; 2DKO; X-ray; 1.06 A; A=29-174, B=175-277.
DR   PDB; 2H5I; X-ray; 1.69 A; A=29-174, B=184-277.
DR   PDB; 2H5J; X-ray; 2.00 A; A/C=29-174, B/D=184-277.
DR   PDB; 2H65; X-ray; 2.30 A; A/C=29-174, B/D=184-277.
DR   PDB; 2J30; X-ray; 1.40 A; A=29-277.
DR   PDB; 2J31; X-ray; 1.50 A; A=29-277.
DR   PDB; 2J32; X-ray; 1.30 A; A=29-277.
DR   PDB; 2J33; X-ray; 2.00 A; A=29-277.
DR   PDB; 2XYG; X-ray; 1.54 A; A=29-174, B=185-277.
DR   PDB; 2XYH; X-ray; 1.89 A; A=29-174, B=185-277.
DR   PDB; 2XYP; X-ray; 1.86 A; A=29-174, B=185-277.
DR   PDB; 2XZD; X-ray; 2.10 A; A/C=27-175, B/D=176-277.
DR   PDB; 2XZT; X-ray; 2.70 A; A/C=29-175, B/D=176-277.
DR   PDB; 2Y0B; X-ray; 2.10 A; A/C=29-175, B/D=176-277.
DR   PDB; 3DEH; X-ray; 2.50 A; A/B/C/D=29-277.
DR   PDB; 3DEI; X-ray; 2.80 A; A/B/C/D=29-277.
DR   PDB; 3DEJ; X-ray; 2.60 A; A/B/C/D=29-277.
DR   PDB; 3DEK; X-ray; 2.40 A; A/B/C/D=29-277.
DR   PDB; 3EDQ; X-ray; 1.61 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJQ; X-ray; 2.60 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJR; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJS; X-ray; 1.90 A; A/C=29-175, B/D=176-277.
DR   PDB; 3GJT; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
DR   PDB; 3H0E; X-ray; 2.00 A; A/B=29-277.
DR   PDB; 3ITN; X-ray; 1.63 A; A=29-277.
DR   PDB; 3KJF; X-ray; 2.00 A; A=29-175, B=176-277.
DR   PDB; 3PCX; X-ray; 1.50 A; A=29-277.
DR   PDB; 3PD0; X-ray; 2.00 A; A=29-277.
DR   PDB; 3PD1; X-ray; 1.62 A; A=29-277.
DR   PDB; 4DCJ; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4DCO; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4DCP; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
DR   PDB; 4EHA; X-ray; 1.70 A; A/C=1-277.
DR   PDB; 4EHD; X-ray; 1.58 A; A=1-277.
DR   PDB; 4EHF; X-ray; 1.66 A; A=1-277.
DR   PDB; 4EHH; X-ray; 1.78 A; A=1-277.
DR   PDB; 4EHK; X-ray; 1.67 A; A/C=1-277.
DR   PDB; 4EHL; X-ray; 1.80 A; A/C=1-277.
DR   PDB; 4EHN; X-ray; 1.69 A; A=1-277.
DR   PDB; 4JJE; X-ray; 1.48 A; A=29-277.
DR   PDB; 4JQY; X-ray; 2.50 A; A/B=34-277.
DR   PDB; 4JQZ; X-ray; 2.89 A; A/B=34-277.
DR   PDB; 4JR0; X-ray; 1.80 A; A/B=34-277.
DR   PDB; 4PRY; X-ray; 1.70 A; A=1-277.
DR   PDB; 4PS0; X-ray; 1.63 A; A/B=1-277.
DR   PDB; 4QTX; X-ray; 1.97 A; A=1-277.
DR   PDB; 4QTY; X-ray; 1.60 A; A=29-277.
DR   PDB; 4QU0; X-ray; 1.95 A; A=1-277.
DR   PDB; 4QU5; X-ray; 1.91 A; A=1-277.
DR   PDB; 4QU8; X-ray; 1.72 A; A=1-277.
DR   PDB; 4QU9; X-ray; 1.56 A; A=1-277.
DR   PDB; 4QUA; X-ray; 1.89 A; A=1-277.
DR   PDB; 4QUB; X-ray; 1.69 A; A=1-277.
DR   PDB; 4QUD; X-ray; 2.00 A; A/B=1-277.
DR   PDB; 4QUE; X-ray; 1.84 A; A/C=1-277.
DR   PDB; 4QUG; X-ray; 1.92 A; A/C=1-277.
DR   PDB; 4QUH; X-ray; 1.76 A; A/C=1-277.
DR   PDB; 4QUI; X-ray; 1.76 A; A/B=1-277.
DR   PDB; 4QUJ; X-ray; 1.50 A; A=1-277.
DR   PDB; 4QUL; X-ray; 1.90 A; A/C=1-277.
DR   PDB; 5I9B; X-ray; 1.80 A; A=1-277.
DR   PDB; 5I9T; X-ray; 1.95 A; A/C=1-277.
DR   PDB; 5IAB; X-ray; 1.79 A; A/C=1-277.
DR   PDB; 5IAE; X-ray; 1.55 A; A/C=1-277.
DR   PDB; 5IAG; X-ray; 1.98 A; A=1-277.
DR   PDB; 5IAJ; X-ray; 1.58 A; A=1-277.
DR   PDB; 5IAK; X-ray; 1.82 A; A=1-277.
DR   PDB; 5IAN; X-ray; 2.70 A; A=1-277.
DR   PDB; 5IAR; X-ray; 1.76 A; A=1-277.
DR   PDB; 5IAS; X-ray; 1.54 A; A=1-277.
DR   PDB; 5IBC; X-ray; 1.66 A; A=1-277.
DR   PDB; 5IBP; X-ray; 1.38 A; A=1-277.
DR   PDB; 5IBR; X-ray; 1.74 A; A/C=1-277.
DR   PDB; 5IC4; X-ray; 2.65 A; A/C/E/G=1-175, B/D/F/H=176-276.
DR   PDBsum; 1CP3; -.
DR   PDBsum; 1GFW; -.
DR   PDBsum; 1I3O; -.
DR   PDBsum; 1NME; -.
DR   PDBsum; 1NMQ; -.
DR   PDBsum; 1NMS; -.
DR   PDBsum; 1PAU; -.
DR   PDBsum; 1QX3; -.
DR   PDBsum; 1RE1; -.
DR   PDBsum; 1RHJ; -.
DR   PDBsum; 1RHK; -.
DR   PDBsum; 1RHM; -.
DR   PDBsum; 1RHQ; -.
DR   PDBsum; 1RHR; -.
DR   PDBsum; 1RHU; -.
DR   PDBsum; 2C1E; -.
DR   PDBsum; 2C2K; -.
DR   PDBsum; 2C2M; -.
DR   PDBsum; 2C2O; -.
DR   PDBsum; 2CDR; -.
DR   PDBsum; 2CJX; -.
DR   PDBsum; 2CJY; -.
DR   PDBsum; 2CNK; -.
DR   PDBsum; 2CNL; -.
DR   PDBsum; 2CNN; -.
DR   PDBsum; 2CNO; -.
DR   PDBsum; 2DKO; -.
DR   PDBsum; 2H5I; -.
DR   PDBsum; 2H5J; -.
DR   PDBsum; 2H65; -.
DR   PDBsum; 2J30; -.
DR   PDBsum; 2J31; -.
DR   PDBsum; 2J32; -.
DR   PDBsum; 2J33; -.
DR   PDBsum; 2XYG; -.
DR   PDBsum; 2XYH; -.
DR   PDBsum; 2XYP; -.
DR   PDBsum; 2XZD; -.
DR   PDBsum; 2XZT; -.
DR   PDBsum; 2Y0B; -.
DR   PDBsum; 3DEH; -.
DR   PDBsum; 3DEI; -.
DR   PDBsum; 3DEJ; -.
DR   PDBsum; 3DEK; -.
DR   PDBsum; 3EDQ; -.
DR   PDBsum; 3GJQ; -.
DR   PDBsum; 3GJR; -.
DR   PDBsum; 3GJS; -.
DR   PDBsum; 3GJT; -.
DR   PDBsum; 3H0E; -.
DR   PDBsum; 3ITN; -.
DR   PDBsum; 3KJF; -.
DR   PDBsum; 3PCX; -.
DR   PDBsum; 3PD0; -.
DR   PDBsum; 3PD1; -.
DR   PDBsum; 4DCJ; -.
DR   PDBsum; 4DCO; -.
DR   PDBsum; 4DCP; -.
DR   PDBsum; 4EHA; -.
DR   PDBsum; 4EHD; -.
DR   PDBsum; 4EHF; -.
DR   PDBsum; 4EHH; -.
DR   PDBsum; 4EHK; -.
DR   PDBsum; 4EHL; -.
DR   PDBsum; 4EHN; -.
DR   PDBsum; 4JJE; -.
DR   PDBsum; 4JQY; -.
DR   PDBsum; 4JQZ; -.
DR   PDBsum; 4JR0; -.
DR   PDBsum; 4PRY; -.
DR   PDBsum; 4PS0; -.
DR   PDBsum; 4QTX; -.
DR   PDBsum; 4QTY; -.
DR   PDBsum; 4QU0; -.
DR   PDBsum; 4QU5; -.
DR   PDBsum; 4QU8; -.
DR   PDBsum; 4QU9; -.
DR   PDBsum; 4QUA; -.
DR   PDBsum; 4QUB; -.
DR   PDBsum; 4QUD; -.
DR   PDBsum; 4QUE; -.
DR   PDBsum; 4QUG; -.
DR   PDBsum; 4QUH; -.
DR   PDBsum; 4QUI; -.
DR   PDBsum; 4QUJ; -.
DR   PDBsum; 4QUL; -.
DR   PDBsum; 5I9B; -.
DR   PDBsum; 5I9T; -.
DR   PDBsum; 5IAB; -.
DR   PDBsum; 5IAE; -.
DR   PDBsum; 5IAG; -.
DR   PDBsum; 5IAJ; -.
DR   PDBsum; 5IAK; -.
DR   PDBsum; 5IAN; -.
DR   PDBsum; 5IAR; -.
DR   PDBsum; 5IAS; -.
DR   PDBsum; 5IBC; -.
DR   PDBsum; 5IBP; -.
DR   PDBsum; 5IBR; -.
DR   PDBsum; 5IC4; -.
DR   SMR; P42574; -.
DR   BioGrid; 107286; 105.
DR   ComplexPortal; CPX-970; Caspase-3 complex.
DR   DIP; DIP-268N; -.
DR   ELM; P42574; -.
DR   IntAct; P42574; 60.
DR   MINT; P42574; -.
DR   STRING; 9606.ENSP00000311032; -.
DR   BindingDB; P42574; -.
DR   ChEMBL; CHEMBL2334; -.
DR   DrugBank; DB08498; (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate.
DR   DrugBank; DB08497; (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate.
DR   DrugBank; DB08213; 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE.
DR   DrugBank; DB06862; 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID.
DR   DrugBank; DB08251; 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID.
DR   DrugBank; DB03124; 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid.
DR   DrugBank; DB08229; [N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB05408; Emricasan.
DR   DrugBank; DB13751; Glycyrrhizic acid.
DR   DrugBank; DB07696; methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate.
DR   DrugBank; DB01017; Minocycline.
DR   DrugBank; DB08499; N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide.
DR   DrugCentral; P42574; -.
DR   GuidetoPHARMACOLOGY; 1619; -.
DR   MEROPS; C14.003; -.
DR   iPTMnet; P42574; -.
DR   MetOSite; P42574; -.
DR   PhosphoSitePlus; P42574; -.
DR   BioMuta; CASP3; -.
DR   DMDM; 77416852; -.
DR   OGP; P42574; -.
DR   EPD; P42574; -.
DR   jPOST; P42574; -.
DR   MassIVE; P42574; -.
DR   MaxQB; P42574; -.
DR   PaxDb; P42574; -.
DR   PeptideAtlas; P42574; -.
DR   PRIDE; P42574; -.
DR   ProteomicsDB; 55518; -.
DR   ABCD; P42574; -.
DR   Antibodypedia; 1222; 2316 antibodies.
DR   DNASU; 836; -.
DR   Ensembl; ENST00000308394; ENSP00000311032; ENSG00000164305.
DR   Ensembl; ENST00000523916; ENSP00000428929; ENSG00000164305.
DR   GeneID; 836; -.
DR   KEGG; hsa:836; -.
DR   UCSC; uc003iwh.3; human.
DR   CTD; 836; -.
DR   DisGeNET; 836; -.
DR   GeneCards; CASP3; -.
DR   HGNC; HGNC:1504; CASP3.
DR   HPA; ENSG00000164305; Tissue enhanced (blood).
DR   MIM; 600636; gene.
DR   neXtProt; NX_P42574; -.
DR   OpenTargets; ENSG00000164305; -.
DR   PharmGKB; PA26087; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000153232; -.
DR   HOGENOM; CLU_036904_2_0_1; -.
DR   InParanoid; P42574; -.
DR   KO; K02187; -.
DR   OMA; NKLEFMH; -.
DR   OrthoDB; 984395at2759; -.
DR   PhylomeDB; P42574; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.56; 2681.
DR   Reactome; R-HSA-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-HSA-111463; SMAC (DIABLO) binds to IAPs.
DR   Reactome; R-HSA-111464; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-HSA-111469; SMAC, XIAP-regulated apoptotic response.
DR   Reactome; R-HSA-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-205025; NADE modulates death signalling.
DR   Reactome; R-HSA-211736; Stimulation of the cell death response by PAK-2p34.
DR   Reactome; R-HSA-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-HSA-351906; Apoptotic cleavage of cell adhesion proteins.
DR   Reactome; R-HSA-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   SABIO-RK; P42574; -.
DR   SIGNOR; P42574; -.
DR   ChiTaRS; CASP3; human.
DR   EvolutionaryTrace; P42574; -.
DR   GeneWiki; Caspase_3; -.
DR   GenomeRNAi; 836; -.
DR   Pharos; P42574; Tchem.
DR   PRO; PR:P42574; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P42574; protein.
DR   Bgee; ENSG00000164305; Expressed in jejunal mucosa and 193 other tissues.
DR   ExpressionAtlas; P42574; baseline and differential.
DR   Genevisible; P42574; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031264; C:death-inducing signaling complex; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:Ensembl.
DR   GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IEA:Ensembl.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB.
DR   GO; GO:0005123; F:death receptor binding; IEA:Ensembl.
DR   GO; GO:0008233; F:peptidase activity; IDA:UniProtKB.
DR   GO; GO:0016005; F:phospholipase A2 activator activity; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0061713; P:anterior neural tube closure; IEA:Ensembl.
DR   GO; GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0007413; P:axonal fasciculation; IEA:Ensembl.
DR   GO; GO:0001782; P:B cell homeostasis; IEA:Ensembl.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0072734; P:cellular response to staurosporine; IMP:CAFA.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IBA:GO_Central.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0071887; P:leukocyte apoptotic process; IEA:Ensembl.
DR   GO; GO:0001554; P:luteolysis; IEA:Ensembl.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:MGI.
DR   GO; GO:0030220; P:platelet formation; TAS:UniProtKB.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IDA:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0016485; P:protein processing; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0032025; P:response to cobalt ion; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; TAS:BHF-UCL.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0010165; P:response to X-ray; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0043029; P:T cell homeostasis; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   S-nitrosylation; Thiol protease; Zymogen.
FT   PROPEP          1..9
FT                   /id="PRO_0000004569"
FT   PROPEP          10..28
FT                   /evidence="ECO:0000269|PubMed:7596430"
FT                   /id="PRO_0000004570"
FT   CHAIN           29..175
FT                   /note="Caspase-3 subunit p17"
FT                   /id="PRO_0000004571"
FT   CHAIN           176..277
FT                   /note="Caspase-3 subunit p12"
FT                   /id="PRO_0000004572"
FT   ACT_SITE        121
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        163
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P70677"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         163
FT                   /note="S-nitrosocysteine; in inhibited form"
FT                   /evidence="ECO:0000269|PubMed:10213689"
FT   VARIANT         22
FT                   /note="H -> R (in dbSNP:rs35578277)"
FT                   /id="VAR_048616"
FT   VARIANT         190
FT                   /note="E -> D (in dbSNP:rs1049210)"
FT                   /evidence="ECO:0000269|PubMed:15003516,
FT                   ECO:0000269|PubMed:7596430, ECO:0000269|PubMed:7983002"
FT                   /id="VAR_001401"
FT   CONFLICT        31..36
FT                   /note="ISLDNS -> MSWDTG (in Ref. 3; CAC88866)"
FT                   /evidence="ECO:0000305"
FT   STRAND          41..51
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           57..59
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           67..80
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          84..90
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           93..105
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           108..110
FT                   /evidence="ECO:0000244|PDB:1I3O"
FT   STRAND          111..120
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          126..129
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          132..135
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           136..141
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   TURN            145..147
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           149..151
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          156..162
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          165..167
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          178..181
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   TURN            183..185
FT                   /evidence="ECO:0000244|PDB:1NMS"
FT   TURN            189..192
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          193..199
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          206..208
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   TURN            209..211
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           214..226
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   TURN            227..229
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           232..246
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   HELIX           254..256
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          264..267
FT                   /evidence="ECO:0000244|PDB:2DKO"
FT   STRAND          270..272
FT                   /evidence="ECO:0000244|PDB:2DKO"
SQ   SEQUENCE   277 AA;  31608 MW;  2F35CD3BCF7FF64A CRC64;
     MENTENSVDS KSIKNLEPKI IHGSESMDSG ISLDNSYKMD YPEMGLCIII NNKNFHKSTG
     MTSRSGTDVD AANLRETFRN LKYEVRNKND LTREEIVELM RDVSKEDHSK RSSFVCVLLS
     HGEEGIIFGT NGPVDLKKIT NFFRGDRCRS LTGKPKLFII QACRGTELDC GIETDSGVDD
     DMACHKIPVE ADFLYAYSTA PGYYSWRNSK DGSWFIQSLC AMLKQYADKL EFMHILTRVN
     RKVATEFESF SFDATFHAKK QIPCIVSMLT KELYFYH
//
ID   F8VVS7_HUMAN            Unreviewed;       421 AA.
AC   F8VVS7;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   22-APR-2020, entry version 80.
DE   SubName: Full=Caspase-9 {ECO:0000313|Ensembl:ENSP00000449584};
GN   Name=CASP9 {ECO:0000313|Ensembl:ENSP00000449584};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000449584, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000449584, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [4] {ECO:0000313|Ensembl:ENSP00000449584}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- SIMILARITY: Belongs to the peptidase C14A family.
CC       {ECO:0000256|RuleBase:RU003971, ECO:0000256|SAAS:SAAS01080359}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL512883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011540575.1; XM_011542273.2.
DR   SMR; F8VVS7; -.
DR   EPD; F8VVS7; -.
DR   MaxQB; F8VVS7; -.
DR   PeptideAtlas; F8VVS7; -.
DR   PRIDE; F8VVS7; -.
DR   ProteomicsDB; 28875; -.
DR   Antibodypedia; 749; 1746 antibodies.
DR   Ensembl; ENST00000546424; ENSP00000449584; ENSG00000132906.
DR   GeneID; 842; -.
DR   UCSC; uc001awm.3; human.
DR   CTD; 842; -.
DR   EuPathDB; HostDB:ENSG00000132906.17; -.
DR   HGNC; HGNC:1511; CASP9.
DR   OpenTargets; ENSG00000132906; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000159698; -.
DR   OrthoDB; 1092723at2759; -.
DR   GenomeRNAi; 842; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000132906; Expressed in adrenal tissue and 231 other tissues.
DR   ExpressionAtlas; F8VVS7; baseline and differential.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   CDD; cd08326; CARD_CASP9; 1.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR042147; CARD_CASP9.
DR   InterPro; IPR033171; Caspase-9.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   PANTHER; PTHR10454:SF157; PTHR10454:SF157; 1.
DR   Pfam; PF00619; CARD; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00114; CARD; 1.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS00710708};
KW   Protease {ECO:0000256|SAAS:SAAS00710708};
KW   Proteomics identification {ECO:0000213|EPD:F8VVS7,
KW   ECO:0000213|MaxQB:F8VVS7, ECO:0000213|PeptideAtlas:F8VVS7,
KW   ECO:0000213|ProteomicsDB:F8VVS7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Thiol protease {ECO:0000256|SAAS:SAAS00710708}.
FT   DOMAIN          1..92
FT                   /note="CARD"
FT                   /evidence="ECO:0000259|PROSITE:PS50209"
FT   DOMAIN          159..291
FT                   /note="CASPASE_P20"
FT                   /evidence="ECO:0000259|PROSITE:PS50208"
FT   DOMAIN          331..397
FT                   /note="CASPASE_P10"
FT                   /evidence="ECO:0000259|PROSITE:PS50207"
FT   REGION          294..320
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   421 AA;  46453 MW;  6B5EC6A06494125F CRC64;
     MDEADRRLLR RCRLRLVEEL QVDQLWDALL SRELFRPHMI EDIQRAGSGS RRDQARQLII
     DLETRGSQAL PLFISCLEDT GQDMLASFLR TNRQAAKLSK PTLENLTPVV LRPEIRKPEV
     LRPETPRPVD IGSGGFGDVG ALESLRGNAD LAYILSMEPC GHCLIINNVN FCRESGLRTR
     TGSNIDCEKL RRRFSSLHFM VEVKGDLTAK KMVLALLELA QQDHGALDCC VVVILSHGCQ
     ASHLQFPGAV YGTDGCPVSV EKIVNIFNGT SCPSLGGKPK LFFIQACGGE QKDHGFEVAS
     TSPEDESPGS NPEPDATPFQ EGLRTFDQLD AISSLPTPSD IFVSYSTFPG FVSWRDPKSG
     SWYVETLDDI FEQWAHSEDL QSLLLRVSAA FLCKGEGRLL RGSVSSWGWG FGVSRAGPNQ
     G
//
ID   CASP9_HUMAN             Reviewed;         416 AA.
AC   P55211; B4E1A3; O95348; Q53Y70; Q5JRU9; Q5UGI1; Q92852; Q9BQ62; Q9UEQ3;
AC   Q9UIJ8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-FEB-2003, sequence version 3.
DT   22-APR-2020, entry version 221.
DE   RecName: Full=Caspase-9;
DE            Short=CASP-9;
DE            EC=3.4.22.62 {ECO:0000269|PubMed:23516580};
DE   AltName: Full=Apoptotic protease Mch-6;
DE   AltName: Full=Apoptotic protease-activating factor 3;
DE            Short=APAF-3;
DE   AltName: Full=ICE-like apoptotic protease 6;
DE            Short=ICE-LAP6;
DE   Contains:
DE     RecName: Full=Caspase-9 subunit p35;
DE   Contains:
DE     RecName: Full=Caspase-9 subunit p10;
DE   Flags: Precursor;
GN   Name=CASP9; Synonyms=MCH6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VAL-28 AND ARG-221.
RX   PubMed=8663294;
RA   Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.-W.,
RA   Dixit V.M.;
RT   "ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the
RT   cytotoxic T cell protease granzyme B.";
RL   J. Biol. Chem. 271:16720-16724(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEOLYTIC PROCESSING.
RC   TISSUE=T-cell;
RX   PubMed=8900201; DOI=10.1074/jbc.271.43.27099;
RA   Srinivasula S.M., Fernandes-Alnemri T., Zangrilli J., Robertson N.,
RA   Armstrong R.C., Wang L., Trapani J.A., Tomaselli K.J., Litwack G.,
RA   Alnemri E.S.;
RT   "The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the
RT   lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator
RT   CPP32.";
RL   J. Biol. Chem. 271:27099-27106(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10384055; DOI=10.1007/s003359901086;
RA   Hadano S., Nasir J., Nichol K., Rasper D.M., Vaillancourt J.P.,
RA   Sherer S.W., Beatty B.G., Ikeda J.E., Nicholson D.W., Hayden M.R.;
RT   "Genomic organization of the human caspase-9 gene on chromosome 1p36.1-
RT   p36.3.";
RL   Mamm. Genome 10:757-760(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10070954;
RA   Srinivasula S.M., Ahmad M., Guo Y., Zhan Y., Lazebnik Y.,
RA   Fernandes-Alnemri T., Alnemri E.S.;
RT   "Identification of an endogenous dominant-negative short isoform of
RT   caspase-9 that can regulate apoptosis.";
RL   Cancer Res. 59:999-1002(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Stomach cancer;
RA   Izawa M., Mori T., Ito H., Sairenji T.;
RT   "Molecular cloning and sequencing of a cDNA predicting an alternative form
RT   of pro-caspase-9 from human gastric cancer cell lines.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Miho Y., Momoi T., Fujita E.;
RT   "A novel splicing product of human caspase-9 lacking protease activity.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-28.
RX   PubMed=9890966; DOI=10.1074/jbc.274.4.2072;
RA   Seol D.W., Billiar T.R.;
RT   "A caspase-9 variant missing the catalytic site is an endogenous inhibitor
RT   of apoptosis.";
RL   J. Biol. Chem. 274:2072-2076(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT VAL-28.
RX   PubMed=16780893; DOI=10.1016/j.lfs.2006.04.026;
RA   Wang P., Shi T., Ma D.;
RT   "Cloning of a novel human caspase-9 splice variant containing only the CARD
RT   domain.";
RL   Life Sci. 79:934-940(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-28; LEU-99; ILE-102;
RP   VAL-106; ASP-114; HIS-173 AND ARG-221.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   PHOSPHORYLATION AT THR-125.
RX   PubMed=12792650; DOI=10.1038/ncb1005;
RA   Allan L.A., Morrice N., Brady S., Magee G., Pathak S., Clarke P.R.;
RT   "Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK.";
RL   Nat. Cell Biol. 5:647-654(2003).
RN   [16]
RP   INTERACTION WITH BIRC6/BRUCE.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin
RT   ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [17]
RP   FUNCTION IN APOPTOSIS, INTERACTION WITH ABL1, PROTEOLYTIC PROCESSING,
RP   PHOSPHORYLATION AT TYR-153 BY ABL1, AND MUTAGENESIS OF TYR-153.
RX   PubMed=15657060; DOI=10.1074/jbc.m413787200;
RA   Raina D., Pandey P., Ahmad R., Bharti A., Ren J., Kharbanda S.,
RA   Weichselbaum R., Kufe D.;
RT   "c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic
RT   response to DNA damage.";
RL   J. Biol. Chem. 280:11147-11151(2005).
RN   [18]
RP   INTERACTION WITH HAX1, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16857965; DOI=10.1161/01.res.0000237387.05259.a5;
RA   Han Y., Chen Y.S., Liu Z., Bodyak N., Rigor D., Bisping E., Pu W.T.,
RA   Kang P.M.;
RT   "Overexpression of HAX-1 protects cardiac myocytes from apoptosis through
RT   caspase-9 inhibition.";
RL   Circ. Res. 99:415-423(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-125; SER-302 AND SER-307, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   INTERACTION WITH EFHD2.
RX   PubMed=19118655; DOI=10.1016/j.jprot.2008.11.016;
RA   Checinska A., Giaccone G., Rodriguez J.A., Kruyt F.A.E., Jimenez C.R.;
RT   "Comparative proteomics analysis of caspase-9-protein complexes in
RT   untreated and cytochrome c/dATP stimulated lysates of NSCLC cells.";
RL   J. Proteomics 72:575-585(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 140-416, AND SUBUNIT.
RX   PubMed=11734640; DOI=10.1073/pnas.231465798;
RA   Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., Salvesen G.S.;
RT   "Dimer formation drives the activation of the cell death protease caspase
RT   9.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:14250-14255(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 140-416 IN COMPLEX WITH
RP   BIRC4/XIAP.
RX   PubMed=12620238; DOI=10.1016/s1097-2765(03)00054-6;
RA   Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M.,
RA   Alnemri E.S., Fairman R., Shi Y.;
RT   "Mechanism of XIAP-mediated inhibition of caspase-9.";
RL   Mol. Cell 11:519-527(2003).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (3.49 ANGSTROMS) OF 140-416 IN COMPLEX WITH E.COLI
RP   NLEF, INTERACTION WITH E.COLI NLEF, SUBUNIT, CATALYTIC ACTIVITY, FUNCTION,
RP   AND ACTIVITY REGULATION.
RX   PubMed=23516580; DOI=10.1371/journal.pone.0058937;
RA   Blasche S., Mortl M., Steuber H., Siszler G., Nisa S., Schwarz F.,
RA   Lavrik I., Gronewold T.M., Maskos K., Donnenberg M.S., Ullmann D., Uetz P.,
RA   Kogl M.;
RT   "The E. coli effector protein NleF is a caspase inhibitor.";
RL   PLoS ONE 8:E58937-E58937(2013).
CC   -!- FUNCTION: Involved in the activation cascade of caspases responsible
CC       for apoptosis execution. Binding of caspase-9 to Apaf-1 leads to
CC       activation of the protease which then cleaves and activates caspase-3.
CC       Promotes DNA damage-induced apoptosis in a ABL1/c-Abl-dependent manner.
CC       Proteolytically cleaves poly(ADP-ribose) polymerase (PARP).
CC   -!- FUNCTION: Isoform 2 lacks activity is an dominant-negative inhibitor of
CC       caspase-9.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for an Asp residue at position P1 and with
CC         a marked preference for His at position P2. It has a preferred
CC         cleavage sequence of Leu-Gly-His-Asp-|-Xaa.; EC=3.4.22.62;
CC         Evidence={ECO:0000269|PubMed:23516580};
CC   -!- ACTIVITY REGULATION: Inhibited by the effector protein NleF that is
CC       produced by pathogenic E.coli; this inhibits apoptosis.
CC       {ECO:0000269|PubMed:23516580}.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel arranged
CC       heterodimers, each one formed by a 35 kDa (p35) and a 10 kDa (p10)
CC       subunit. Caspase-9 and APAF1 bind to each other via their respective
CC       NH2-terminal CED-3 homologous domains in the presence of cytochrome C
CC       and ATP. Interacts (inactive form) with EFHD2. Interacts with HAX1.
CC       Interacts with BIRC2/c-IAP1, XIAP/BIRC4, BIRC5/survivin, BIRC6/bruce
CC       and BIRC7/livin. Interacts with ABL1 (via SH3 domain); the interaction
CC       is direct and increases in the response of cells to genotoxic stress
CC       and ABL1/c-Abl activation. Interacts with NleF from pathogenic E.coli.
CC       {ECO:0000269|PubMed:11734640, ECO:0000269|PubMed:12620238,
CC       ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:15657060,
CC       ECO:0000269|PubMed:16857965, ECO:0000269|PubMed:19118655,
CC       ECO:0000269|PubMed:23516580}.
CC   -!- INTERACTION:
CC       P55211-1; P55211-1; NbExp=3; IntAct=EBI-15553290, EBI-15553290;
CC       P55211; O14727: APAF1; NbExp=22; IntAct=EBI-516799, EBI-446492;
CC       P55211; Q13490: BIRC2; NbExp=12; IntAct=EBI-516799, EBI-514538;
CC       P55211; Q13489: BIRC3; NbExp=2; IntAct=EBI-516799, EBI-517709;
CC       P55211; O15392: BIRC5; NbExp=2; IntAct=EBI-516799, EBI-518823;
CC       P55211; Q96CA5: BIRC7; NbExp=12; IntAct=EBI-516799, EBI-517623;
CC       P55211; Q6PIA0: BIRC8; NbExp=3; IntAct=EBI-516799, EBI-2129837;
CC       P55211; P42574: CASP3; NbExp=2; IntAct=EBI-516799, EBI-524064;
CC       P55211; P43146: DCC; NbExp=2; IntAct=EBI-516799, EBI-1222919;
CC       P55211; Q13418: ILK; NbExp=2; IntAct=EBI-516799, EBI-747644;
CC       P55211; P98170: XIAP; NbExp=23; IntAct=EBI-516799, EBI-517127;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=9L, Alpha;
CC         IsoId=P55211-1; Sequence=Displayed;
CC       Name=2; Synonyms=9S, Beta;
CC         IsoId=P55211-2; Sequence=VSP_000818;
CC       Name=3; Synonyms=Gamma;
CC         IsoId=P55211-3; Sequence=VSP_043910, VSP_043911;
CC       Name=4;
CC         IsoId=P55211-4; Sequence=VSP_044256;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with highest expression in the heart,
CC       moderate expression in liver, skeletal muscle, and pancreas. Low levels
CC       in all other tissues. Within the heart, specifically expressed in
CC       myocytes. {ECO:0000269|PubMed:16857965}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at low levels in fetal heart, at
CC       moderate levels in neonate heart, and at high levels in adult heart.
CC       {ECO:0000269|PubMed:16857965}.
CC   -!- PTM: Cleavages at Asp-315 by granzyme B and at Asp-330 by caspase-3
CC       generate the two active subunits. Caspase-8 and -10 can also be
CC       involved in these processing events.
CC   -!- PTM: Phosphorylated at Thr-125 by MAPK1/ERK2. Phosphorylation at Thr-
CC       125 is sufficient to block caspase-9 processing and subsequent caspase-
CC       3 activation. Phosphorylation on Tyr-153 by ABL1/c-Abl; occurs in the
CC       response of cells to DNA damage. {ECO:0000269|PubMed:12792650,
CC       ECO:0000269|PubMed:15657060}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May function as an endogenous apoptotic
CC       inhibitor, inhibits the BAX-mediated cleavage of procaspase-3.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CASP9ID423ch1p36.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/casp9/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Caspase-9 entry;
CC       URL="https://en.wikipedia.org/wiki/Caspase-9";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U56390; AAC50640.1; -; mRNA.
DR   EMBL; U60521; AAC50776.1; -; mRNA.
DR   EMBL; AB019205; BAA82697.1; -; Genomic_DNA.
DR   EMBL; AF093130; AAD12248.1; -; mRNA.
DR   EMBL; AB015653; BAA78780.1; -; mRNA.
DR   EMBL; AB020979; BAA87905.1; -; mRNA.
DR   EMBL; AF110376; AAD13615.1; -; mRNA.
DR   EMBL; AY732490; AAV33129.1; -; mRNA.
DR   EMBL; AY214168; AAO21133.1; -; Genomic_DNA.
DR   EMBL; BT006911; AAP35557.1; -; mRNA.
DR   EMBL; AK303743; BAG64715.1; -; mRNA.
DR   EMBL; AL512883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471167; EAW51730.1; -; Genomic_DNA.
DR   EMBL; CH471167; EAW51731.1; -; Genomic_DNA.
DR   EMBL; BC002452; AAH02452.1; -; mRNA.
DR   EMBL; BC006463; AAH06463.1; -; mRNA.
DR   CCDS; CCDS158.1; -. [P55211-1]
DR   CCDS; CCDS159.2; -. [P55211-4]
DR   CCDS; CCDS59995.1; -. [P55211-2]
DR   PIR; G02635; G02635.
DR   RefSeq; NP_001220.2; NM_001229.4. [P55211-1]
DR   RefSeq; NP_001264983.1; NM_001278054.1. [P55211-2]
DR   RefSeq; NP_127463.2; NM_032996.3. [P55211-4]
DR   RefSeq; XP_005246071.1; XM_005246014.2. [P55211-4]
DR   PDB; 1JXQ; X-ray; 2.80 A; A/B/C/D=140-416.
DR   PDB; 1NW9; X-ray; 2.40 A; B=140-416.
DR   PDB; 2AR9; X-ray; 2.80 A; A/B/C/D=139-416.
DR   PDB; 3D9T; X-ray; 1.50 A; C/D=316-321.
DR   PDB; 3V3K; X-ray; 3.49 A; A/C/E/G/I/K/M/O=141-416.
DR   PDB; 3YGS; X-ray; 2.50 A; P=1-95.
DR   PDB; 4RHW; X-ray; 2.10 A; E/F=1-100.
DR   PDB; 5JUY; EM; 4.10 A; O/P/Q/R=1-95.
DR   PDB; 5WVC; X-ray; 2.99 A; B/D/F=1-128.
DR   PDB; 5WVE; EM; 4.40 A; S/T/U/V/Y=1-100.
DR   PDBsum; 1JXQ; -.
DR   PDBsum; 1NW9; -.
DR   PDBsum; 2AR9; -.
DR   PDBsum; 3D9T; -.
DR   PDBsum; 3V3K; -.
DR   PDBsum; 3YGS; -.
DR   PDBsum; 4RHW; -.
DR   PDBsum; 5JUY; -.
DR   PDBsum; 5WVC; -.
DR   PDBsum; 5WVE; -.
DR   SMR; P55211; -.
DR   BioGrid; 107292; 39.
DR   ComplexPortal; CPX-3762; Apoptosome.
DR   ComplexPortal; CPX-991; Caspase-9 complex.
DR   CORUM; P55211; -.
DR   DIP; DIP-27625N; -.
DR   ELM; P55211; -.
DR   IntAct; P55211; 30.
DR   MINT; P55211; -.
DR   STRING; 9606.ENSP00000330237; -.
DR   BindingDB; P55211; -.
DR   ChEMBL; CHEMBL2273; -.
DR   GuidetoPHARMACOLOGY; 1625; -.
DR   MEROPS; C14.010; -.
DR   iPTMnet; P55211; -.
DR   PhosphoSitePlus; P55211; -.
DR   BioMuta; CASP9; -.
DR   DMDM; 28558771; -.
DR   EPD; P55211; -.
DR   jPOST; P55211; -.
DR   MassIVE; P55211; -.
DR   MaxQB; P55211; -.
DR   PaxDb; P55211; -.
DR   PeptideAtlas; P55211; -.
DR   PRIDE; P55211; -.
DR   ProteomicsDB; 56814; -. [P55211-1]
DR   ProteomicsDB; 56815; -. [P55211-2]
DR   ProteomicsDB; 56816; -. [P55211-3]
DR   ProteomicsDB; 5741; -.
DR   Antibodypedia; 749; 1746 antibodies.
DR   DNASU; 842; -.
DR   Ensembl; ENST00000333868; ENSP00000330237; ENSG00000132906. [P55211-1]
DR   Ensembl; ENST00000348549; ENSP00000255256; ENSG00000132906. [P55211-2]
DR   Ensembl; ENST00000375890; ENSP00000365051; ENSG00000132906. [P55211-4]
DR   GeneID; 842; -.
DR   KEGG; hsa:842; -.
DR   UCSC; uc001awn.5; human. [P55211-1]
DR   CTD; 842; -.
DR   DisGeNET; 842; -.
DR   GeneCards; CASP9; -.
DR   HGNC; HGNC:1511; CASP9.
DR   HPA; ENSG00000132906; Low tissue specificity.
DR   MIM; 602234; gene.
DR   neXtProt; NX_P55211; -.
DR   OpenTargets; ENSG00000132906; -.
DR   PharmGKB; PA26094; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   eggNOG; ENOG410ZQIE; LUCA.
DR   GeneTree; ENSGT00940000159698; -.
DR   HOGENOM; CLU_036904_5_0_1; -.
DR   InParanoid; P55211; -.
DR   KO; K04399; -.
DR   PhylomeDB; P55211; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.62; 2681.
DR   Reactome; R-HSA-111458; Formation of apoptosome.
DR   Reactome; R-HSA-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-HSA-111463; SMAC (DIABLO) binds to IAPs.
DR   Reactome; R-HSA-111464; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-198323; AKT phosphorylates targets in the cytosol.
DR   Reactome; R-HSA-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   Reactome; R-HSA-5674400; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; R-HSA-9627069; Regulation of the apoptosome activity.
DR   SABIO-RK; P55211; -.
DR   SIGNOR; P55211; -.
DR   EvolutionaryTrace; P55211; -.
DR   GeneWiki; Caspase-9; -.
DR   GenomeRNAi; 842; -.
DR   Pharos; P55211; Tchem.
DR   PRO; PR:P55211; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P55211; protein.
DR   Bgee; ENSG00000132906; Expressed in adrenal tissue and 231 other tissues.
DR   ExpressionAtlas; P55211; baseline and differential.
DR   Genevisible; P55211; HS.
DR   GO; GO:0043293; C:apoptosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IBA:GO_Central.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008233; F:peptidase activity; IDA:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IBA:GO_Central.
DR   GO; GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:Reactome.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0071887; P:leukocyte apoptotic process; IEA:Ensembl.
DR   GO; GO:0030220; P:platelet formation; TAS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0032025; P:response to cobalt ion; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; IDA:UniProtKB.
DR   CDD; cd08326; CARD_CASP9; 1.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR042147; CARD_CASP9.
DR   InterPro; IPR033171; Caspase-9.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   PANTHER; PTHR10454:SF157; PTHR10454:SF157; 1.
DR   Pfam; PF00619; CARD; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00114; CARD; 1.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Hydrolase; Phosphoprotein;
KW   Polymorphism; Protease; Reference proteome; Thiol protease; Zymogen.
FT   PROPEP          1..?
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000004640"
FT   CHAIN           ?..315
FT                   /note="Caspase-9 subunit p35"
FT                   /id="PRO_0000004641"
FT   PROPEP          316..330
FT                   /id="PRO_0000004642"
FT   CHAIN           331..416
FT                   /note="Caspase-9 subunit p10"
FT                   /id="PRO_0000004643"
FT   DOMAIN          1..92
FT                   /note="CARD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   ACT_SITE        237
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        287
FT                   /evidence="ECO:0000250"
FT   MOD_RES         125
FT                   /note="Phosphothreonine; by MAPK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000269|PubMed:12792650"
FT   MOD_RES         153
FT                   /note="Phosphotyrosine; by ABL1"
FT                   /evidence="ECO:0000269|PubMed:15657060"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..83
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044256"
FT   VAR_SEQ         140..289
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10070954,
FT                   ECO:0000303|PubMed:9890966, ECO:0000303|Ref.5,
FT                   ECO:0000303|Ref.6"
FT                   /id="VSP_000818"
FT   VAR_SEQ         152..154
FT                   /note="AYI -> TVL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16780893"
FT                   /id="VSP_043910"
FT   VAR_SEQ         155..416
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16780893"
FT                   /id="VSP_043911"
FT   VARIANT         28
FT                   /note="A -> V (in dbSNP:rs1052571)"
FT                   /evidence="ECO:0000269|PubMed:16780893,
FT                   ECO:0000269|PubMed:8663294, ECO:0000269|PubMed:9890966,
FT                   ECO:0000269|Ref.9"
FT                   /id="VAR_015415"
FT   VARIANT         99
FT                   /note="S -> L (in dbSNP:rs4646008)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_015416"
FT   VARIANT         102
FT                   /note="T -> I (in dbSNP:rs2308941)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_015417"
FT   VARIANT         106
FT                   /note="L -> V (in dbSNP:rs2308938)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_015418"
FT   VARIANT         114
FT                   /note="E -> D (in dbSNP:rs2020897)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_015419"
FT   VARIANT         136
FT                   /note="F -> L (in dbSNP:rs1132312)"
FT                   /id="VAR_059198"
FT   VARIANT         173
FT                   /note="R -> H (in dbSNP:rs2308950)"
FT                   /evidence="ECO:0000269|Ref.9"
FT                   /id="VAR_015420"
FT   VARIANT         176
FT                   /note="G -> R (in dbSNP:rs2308949)"
FT                   /id="VAR_016131"
FT   VARIANT         185
FT                   /note="I -> M (in dbSNP:rs9282624)"
FT                   /id="VAR_022053"
FT   VARIANT         192
FT                   /note="R -> C (in dbSNP:rs2308939)"
FT                   /id="VAR_016132"
FT   VARIANT         221
FT                   /note="Q -> R (in dbSNP:rs1052576)"
FT                   /evidence="ECO:0000269|PubMed:8663294, ECO:0000269|Ref.9"
FT                   /id="VAR_015421"
FT   MUTAGEN         153
FT                   /note="Y->F: Inhibits tyrosine phosphorylation. Reduces
FT                   caspase-9 subunit p35 formation in response to genotoxic
FT                   stress. Attenuates ABL1/c-Abl-mediated caspase-3
FT                   activation, DNA fragmentation and UV irradiation-induced
FT                   apoptosis."
FT                   /evidence="ECO:0000269|PubMed:15657060"
FT   CONFLICT        32
FT                   /note="R -> S (in Ref. 2; AAC50776, 3; BAA82697 and 6;
FT                   BAA87905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        96
FT                   /note="A -> G (in Ref. 1; AAC50640)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="L -> P (in Ref. 2; AAC50776 and 3; BAA82697)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..11
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           13..19
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   TURN            23..25
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           26..31
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           37..44
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           51..62
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           69..79
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           83..93
FT                   /evidence="ECO:0000244|PDB:4RHW"
FT   HELIX           143..147
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   TURN            149..151
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          157..159
FT                   /evidence="ECO:0000244|PDB:1JXQ"
FT   STRAND          161..167
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           173..175
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           183..196
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          199..206
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           209..221
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           224..226
FT                   /evidence="ECO:0000244|PDB:2AR9"
FT   STRAND          228..239
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          244..246
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          249..251
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          257..259
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           260..265
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   TURN            269..271
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           273..275
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          280..287
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          317..319
FT                   /evidence="ECO:0000244|PDB:3D9T"
FT   STRAND          340..346
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          351..353
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          354..356
FT                   /evidence="ECO:0000244|PDB:3V3K"
FT   TURN            357..359
FT                   /evidence="ECO:0000244|PDB:1JXQ"
FT   HELIX           362..374
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   TURN            375..377
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   HELIX           380..392
FT                   /evidence="ECO:0000244|PDB:1NW9"
FT   STRAND          395..398
FT                   /evidence="ECO:0000244|PDB:1JXQ"
FT   STRAND          402..406
FT                   /evidence="ECO:0000244|PDB:1JXQ"
FT   STRAND          408..410
FT                   /evidence="ECO:0000244|PDB:1NW9"
SQ   SEQUENCE   416 AA;  46281 MW;  78E0180DF2A3BDD2 CRC64;
     MDEADRRLLR RCRLRLVEEL QVDQLWDALL SRELFRPHMI EDIQRAGSGS RRDQARQLII
     DLETRGSQAL PLFISCLEDT GQDMLASFLR TNRQAAKLSK PTLENLTPVV LRPEIRKPEV
     LRPETPRPVD IGSGGFGDVG ALESLRGNAD LAYILSMEPC GHCLIINNVN FCRESGLRTR
     TGSNIDCEKL RRRFSSLHFM VEVKGDLTAK KMVLALLELA QQDHGALDCC VVVILSHGCQ
     ASHLQFPGAV YGTDGCPVSV EKIVNIFNGT SCPSLGGKPK LFFIQACGGE QKDHGFEVAS
     TSPEDESPGS NPEPDATPFQ EGLRTFDQLD AISSLPTPSD IFVSYSTFPG FVSWRDPKSG
     SWYVETLDDI FEQWAHSEDL QSLLLRVANA VSVKGIYKQM PGCFNFLRKK LFFKTS
//
ID   CCNC_HUMAN              Reviewed;         283 AA.
AC   P24863; B4DPZ1; Q9H543;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   22-APR-2020, entry version 197.
DE   RecName: Full=Cyclin-C;
DE   AltName: Full=SRB11 homolog;
DE            Short=hSRB11;
GN   Name=CCNC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1833066; DOI=10.1016/0092-8674(91)90042-w;
RA   Lew D.J., Dulic V., Reed S.I.;
RT   "Isolation of three novel human cyclins by rescue of G1 cyclin (Cln)
RT   function in yeast.";
RL   Cell 66:1197-1206(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8833152; DOI=10.1006/geno.1996.0112;
RA   Li H., Lahti J.M., Valentine M., Saito M., Reed S.I., Look A.T., Kidd V.J.;
RT   "Molecular cloning and chromosomal localization of the human cyclin C
RT   (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human
RT   tumors.";
RL   Genomics 32:253-259(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   FUNCTION.
RX   PubMed=8700522;
RA   Rickert P., Seghezzi W., Shanahan F., Cho H., Lees E.;
RT   "Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II.";
RL   Oncogene 12:2631-2640(1996).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN A FORM OF THE
RP   MEDIATOR COMPLEX.
RX   PubMed=9734358; DOI=10.1016/s1097-2765(00)80131-8;
RA   Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W.S., Reinberg D.;
RT   "NAT, a human complex containing Srb polypeptides that functions as a
RT   negative regulator of activated transcription.";
RL   Mol. Cell 2:213-222(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SMCC
RP   COMPLEX.
RX   PubMed=10024883; DOI=10.1016/s1097-2765(00)80178-1;
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X., Martinez E.,
RA   Qin J., Roeder R.G.;
RT   "A novel human SRB/MED-containing cofactor complex, SMCC, involved in
RT   transcription regulation.";
RL   Mol. Cell 3:97-108(1999).
RN   [8]
RP   ERRATUM OF PUBMED:10024883.
RA   Gu W., Malik S., Ito M., Yuan C.-X., Fondell J.D., Zhang X., Martinez E.,
RA   Qin J., Roeder R.G.;
RL   Mol. Cell 3:541-541(1999).
RN   [9]
RP   INTERACTION WITH MED6.
RX   PubMed=10993082; DOI=10.1038/35024111;
RA   Akoulitchev S., Chuikov S., Reinberg D.;
RT   "TFIIH is negatively regulated by cdk8-containing mediator complexes.";
RL   Nature 407:102-106(2000).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE MEDIATOR
RP   COMPLEX.
RX   PubMed=15175163; DOI=10.1016/j.molcel.2004.05.006;
RA   Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B.,
RA   Swanson S.K., Banks C.A.S., Jin J., Cai Y., Washburn M.P., Conaway J.W.,
RA   Conaway R.C.;
RT   "A set of consensus mammalian mediator subunits identified by
RT   multidimensional protein identification technology.";
RL   Mol. Cell 14:685-691(2004).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH MED1 AND MED10.
RX   PubMed=16595664; DOI=10.1074/jbc.m601983200;
RA   Baek H.J., Kang Y.K., Roeder R.G.;
RT   "Human Mediator enhances basal transcription by facilitating recruitment of
RT   transcription factor IIB during preinitiation complex assembly.";
RL   J. Biol. Chem. 281:15172-15181(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH CDK8 AND INHIBITOR.
RX   PubMed=21806996; DOI=10.1016/j.jmb.2011.07.020;
RA   Schneider E.V., Bottcher J., Blaesse M., Neumann L., Huber R., Maskos K.;
RT   "The structure of CDK8/CycC implicates specificity in the CDK/cyclin family
RT   and reveals interaction with a deep pocket binder.";
RL   J. Mol. Biol. 412:251-266(2011).
CC   -!- FUNCTION: Component of the Mediator complex, a coactivator involved in
CC       regulated gene transcription of nearly all RNA polymerase II-dependent
CC       genes. Mediator functions as a bridge to convey information from gene-
CC       specific regulatory proteins to the basal RNA polymerase II
CC       transcription machinery. Mediator is recruited to promoters by direct
CC       interactions with regulatory proteins and serves as a scaffold for the
CC       assembly of a functional preinitiation complex with RNA polymerase II
CC       and the general transcription factors. Binds to and activates cyclin-
CC       dependent kinase CDK8 that phosphorylates the CTD (C-terminal domain)
CC       of the large subunit of RNA polymerase II (RNAp II), which may inhibit
CC       the formation of a transcription initiation complex.
CC       {ECO:0000269|PubMed:16595664, ECO:0000269|PubMed:8700522}.
CC   -!- SUBUNIT: Component of the Mediator complex, which is composed of MED1,
CC       MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L,
CC       MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23,
CC       MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and
CC       CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct
CC       module termed the CDK8 module. Mediator containing the CDK8 module is
CC       less active than Mediator lacking this module in supporting
CC       transcriptional activation. Individual preparations of the Mediator
CC       complex lacking one or more distinct subunits have been variously
CC       termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. The cylin/CDK pair formed
CC       by CCNC/CDK8 also associates with the large subunit of RNA polymerase
CC       II. {ECO:0000269|PubMed:10024883, ECO:0000269|PubMed:15175163,
CC       ECO:0000269|PubMed:21806996, ECO:0000269|PubMed:9734358}.
CC   -!- INTERACTION:
CC       P24863; P24863; NbExp=3; IntAct=EBI-395261, EBI-395261;
CC       P24863; Q9UBL3: ASH2L; NbExp=3; IntAct=EBI-395261, EBI-540797;
CC       P24863; Q6QNY1: BLOC1S2; NbExp=3; IntAct=EBI-395261, EBI-465872;
CC       P24863; Q9BX70: BTBD2; NbExp=3; IntAct=EBI-395261, EBI-710091;
CC       P24863; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-395261, EBI-10175300;
CC       P24863; Q00526: CDK3; NbExp=7; IntAct=EBI-395261, EBI-1245761;
CC       P24863; Q00535: CDK5; NbExp=2; IntAct=EBI-395261, EBI-1041567;
CC       P24863; P49336: CDK8; NbExp=36; IntAct=EBI-395261, EBI-394377;
CC       P24863; P42772: CDKN2B; NbExp=3; IntAct=EBI-395261, EBI-711280;
CC       P24863; Q96M91: CFAP53; NbExp=3; IntAct=EBI-395261, EBI-742422;
CC       P24863; P61024: CKS1B; NbExp=3; IntAct=EBI-395261, EBI-456371;
CC       P24863; O43186: CRX; NbExp=4; IntAct=EBI-395261, EBI-748171;
CC       P24863; Q8WWB3: DYDC1; NbExp=3; IntAct=EBI-395261, EBI-740680;
CC       P24863; Q3B820: FAM161A; NbExp=3; IntAct=EBI-395261, EBI-719941;
CC       P24863; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-395261, EBI-742802;
CC       P24863; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-395261, EBI-6658203;
CC       P24863; O15409: FOXP2; NbExp=3; IntAct=EBI-395261, EBI-983612;
CC       P24863; Q6PJQ5: FOXR2; NbExp=3; IntAct=EBI-395261, EBI-8468543;
CC       P24863; Q8TAE8: GADD45GIP1; NbExp=3; IntAct=EBI-395261, EBI-372506;
CC       P24863; Q49A26: GLYR1; NbExp=3; IntAct=EBI-395261, EBI-2804292;
CC       P24863; Q08379: GOLGA2; NbExp=3; IntAct=EBI-395261, EBI-618309;
CC       P24863; A0A024R8L2: hCG_1987119; NbExp=3; IntAct=EBI-395261, EBI-14103818;
CC       P24863; Q9ULR0: ISY1; NbExp=3; IntAct=EBI-395261, EBI-2557660;
CC       P24863; A1A4E9: KRT13; NbExp=3; IntAct=EBI-395261, EBI-10171552;
CC       P24863; P19012: KRT15; NbExp=3; IntAct=EBI-395261, EBI-739566;
CC       P24863; P08779: KRT16; NbExp=3; IntAct=EBI-395261, EBI-356410;
CC       P24863; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-395261, EBI-3044087;
CC       P24863; Q15323: KRT31; NbExp=6; IntAct=EBI-395261, EBI-948001;
CC       P24863; O76011: KRT34; NbExp=3; IntAct=EBI-395261, EBI-1047093;
CC       P24863; P80188: LCN2; NbExp=3; IntAct=EBI-395261, EBI-11911016;
CC       P24863; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-395261, EBI-741037;
CC       P24863; O95983-2: MBD3; NbExp=3; IntAct=EBI-395261, EBI-11978579;
CC       P24863; Q9NS73-5: MBIP; NbExp=3; IntAct=EBI-395261, EBI-10182361;
CC       P24863; P50222: MEOX2; NbExp=3; IntAct=EBI-395261, EBI-748397;
CC       P24863; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-395261, EBI-16439278;
CC       P24863; O14880: MGST3; NbExp=3; IntAct=EBI-395261, EBI-724754;
CC       P24863; P17568: NDUFB7; NbExp=3; IntAct=EBI-395261, EBI-1246238;
CC       P24863; P19404: NDUFV2; NbExp=3; IntAct=EBI-395261, EBI-713665;
CC       P24863; I6L9F6: NEFL; NbExp=3; IntAct=EBI-395261, EBI-10178578;
CC       P24863; Q9HAN9: NMNAT1; NbExp=4; IntAct=EBI-395261, EBI-3917542;
CC       P24863; Q96F24: NRBF2; NbExp=3; IntAct=EBI-395261, EBI-2362014;
CC       P24863; Q02548: PAX5; NbExp=3; IntAct=EBI-395261, EBI-296331;
CC       P24863; Q96AQ6: PBXIP1; NbExp=3; IntAct=EBI-395261, EBI-740845;
CC       P24863; Q8TD55-2: PLEKHO2; NbExp=3; IntAct=EBI-395261, EBI-12905986;
CC       P24863; O60664: PLIN3; NbExp=3; IntAct=EBI-395261, EBI-725795;
CC       P24863; Q96PV4: PNMA5; NbExp=4; IntAct=EBI-395261, EBI-10171633;
CC       P24863; P78424: POU6F2; NbExp=3; IntAct=EBI-395261, EBI-12029004;
CC       P24863; Q99633: PRPF18; NbExp=3; IntAct=EBI-395261, EBI-2798416;
CC       P24863; Q9UHX1: PUF60; NbExp=3; IntAct=EBI-395261, EBI-1053259;
CC       P24863; P06400: RB1; NbExp=4; IntAct=EBI-395261, EBI-491274;
CC       P24863; Q96IZ5: RBM41; NbExp=3; IntAct=EBI-395261, EBI-740773;
CC       P24863; Q04864-2: REL; NbExp=3; IntAct=EBI-395261, EBI-10829018;
CC       P24863; P40937: RFC5; NbExp=5; IntAct=EBI-395261, EBI-712376;
CC       P24863; Q8N443: RIBC1; NbExp=5; IntAct=EBI-395261, EBI-10265323;
CC       P24863; P15927: RPA2; NbExp=3; IntAct=EBI-395261, EBI-621404;
CC       P24863; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-395261, EBI-6257312;
CC       P24863; Q9UJW9: SERTAD3; NbExp=3; IntAct=EBI-395261, EBI-748621;
CC       P24863; Q92529: SHC3; NbExp=3; IntAct=EBI-395261, EBI-79084;
CC       P24863; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-395261, EBI-11959123;
CC       P24863; Q6ZRS2-3: SRCAP; NbExp=3; IntAct=EBI-395261, EBI-12029182;
CC       P24863; O75528: TADA3; NbExp=3; IntAct=EBI-395261, EBI-473249;
CC       P24863; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-395261, EBI-11955057;
CC       P24863; Q96N21: TEPSIN; NbExp=3; IntAct=EBI-395261, EBI-11139477;
CC       P24863; Q9BXU0: TEX12; NbExp=3; IntAct=EBI-395261, EBI-12090309;
CC       P24863; Q9Y228: TRAF3IP3; NbExp=3; IntAct=EBI-395261, EBI-765817;
CC       P24863; Q9HCM9: TRIM39; NbExp=4; IntAct=EBI-395261, EBI-739510;
CC       P24863; P61086: UBE2K; NbExp=3; IntAct=EBI-395261, EBI-473850;
CC       P24863; P40337-2: VHL; NbExp=3; IntAct=EBI-395261, EBI-12157263;
CC       P24863; Q9NP79: VTA1; NbExp=3; IntAct=EBI-395261, EBI-740160;
CC       P24863; Q8TF47: ZFP90; NbExp=3; IntAct=EBI-395261, EBI-11419867;
CC       P24863; P17022: ZNF18; NbExp=4; IntAct=EBI-395261, EBI-8648067;
CC       P24863; Q9BUY5: ZNF426; NbExp=3; IntAct=EBI-395261, EBI-743265;
CC       P24863; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-395261, EBI-4395669;
CC       P24863; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-395261, EBI-4395732;
CC       P24863; Q3KQV3: ZNF792; NbExp=3; IntAct=EBI-395261, EBI-10240849;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24863-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24863-2; Sequence=VSP_043075;
CC   -!- TISSUE SPECIFICITY: Highest levels in pancreas. High levels in heart,
CC       liver, skeletal muscle and kidney. Low levels in brain.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin C subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50825.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M74091; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U40739; AAC50825.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U40728; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40729; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40730; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40731; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40732; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40733; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40734; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40735; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40736; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40737; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; U40738; AAC50825.1; JOINED; Genomic_DNA.
DR   EMBL; AK298558; BAG60753.1; -; mRNA.
DR   EMBL; AL137784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS34502.1; -. [P24863-1]
DR   CCDS; CCDS47461.1; -. [P24863-2]
DR   PIR; A40268; A40268.
DR   RefSeq; NP_001013417.1; NM_001013399.1. [P24863-2]
DR   RefSeq; NP_005181.2; NM_005190.3. [P24863-1]
DR   PDB; 3RGF; X-ray; 2.20 A; B=1-283.
DR   PDB; 4CRL; X-ray; 2.40 A; B=1-283.
DR   PDB; 4F6S; X-ray; 2.60 A; B=1-283.
DR   PDB; 4F6U; X-ray; 2.10 A; B=1-283.
DR   PDB; 4F6W; X-ray; 2.39 A; B=1-283.
DR   PDB; 4F70; X-ray; 3.00 A; B=1-283.
DR   PDB; 4F7J; X-ray; 2.60 A; B=1-283.
DR   PDB; 4F7L; X-ray; 2.90 A; B=1-283.
DR   PDB; 4F7N; X-ray; 2.65 A; B=1-283.
DR   PDB; 4F7S; X-ray; 2.20 A; B=1-283.
DR   PDB; 4G6L; X-ray; 2.70 A; B=1-283.
DR   PDB; 5BNJ; X-ray; 2.64 A; B=1-283.
DR   PDB; 5CEI; X-ray; 2.24 A; B=1-283.
DR   PDB; 5FGK; X-ray; 2.36 A; B=1-264.
DR   PDB; 5HBE; X-ray; 2.38 A; B=1-264.
DR   PDB; 5HBH; X-ray; 2.50 A; B=1-264.
DR   PDB; 5HBJ; X-ray; 3.00 A; B=1-264.
DR   PDB; 5HNB; X-ray; 2.35 A; B=1-264.
DR   PDB; 5HVY; X-ray; 2.39 A; B=1-283.
DR   PDB; 5I5Z; X-ray; 2.60 A; B=1-264.
DR   PDB; 5ICP; X-ray; 2.18 A; B=1-264.
DR   PDB; 5IDN; X-ray; 2.26 A; B=1-264.
DR   PDB; 5IDP; X-ray; 2.65 A; B=1-264.
DR   PDB; 5XQX; X-ray; 2.30 A; B=2-264.
DR   PDB; 5XS2; X-ray; 2.04 A; B=2-264.
DR   PDB; 6T41; X-ray; 2.45 A; B=1-283.
DR   PDBsum; 3RGF; -.
DR   PDBsum; 4CRL; -.
DR   PDBsum; 4F6S; -.
DR   PDBsum; 4F6U; -.
DR   PDBsum; 4F6W; -.
DR   PDBsum; 4F70; -.
DR   PDBsum; 4F7J; -.
DR   PDBsum; 4F7L; -.
DR   PDBsum; 4F7N; -.
DR   PDBsum; 4F7S; -.
DR   PDBsum; 4G6L; -.
DR   PDBsum; 5BNJ; -.
DR   PDBsum; 5CEI; -.
DR   PDBsum; 5FGK; -.
DR   PDBsum; 5HBE; -.
DR   PDBsum; 5HBH; -.
DR   PDBsum; 5HBJ; -.
DR   PDBsum; 5HNB; -.
DR   PDBsum; 5HVY; -.
DR   PDBsum; 5I5Z; -.
DR   PDBsum; 5ICP; -.
DR   PDBsum; 5IDN; -.
DR   PDBsum; 5IDP; -.
DR   PDBsum; 5XQX; -.
DR   PDBsum; 5XS2; -.
DR   PDBsum; 6T41; -.
DR   SMR; P24863; -.
DR   BioGrid; 107333; 75.
DR   ComplexPortal; CPX-1969; Cyclin C-CDK8 complex.
DR   ComplexPortal; CPX-3232; CKM complex variant 1.
DR   ComplexPortal; CPX-3263; CKM complex variant 2.
DR   ComplexPortal; CPX-330; Cyclin C-CDK3 complex.
DR   CORUM; P24863; -.
DR   DIP; DIP-32920N; -.
DR   IntAct; P24863; 107.
DR   MINT; P24863; -.
DR   STRING; 9606.ENSP00000428982; -.
DR   BindingDB; P24863; -.
DR   ChEMBL; CHEMBL3038474; -.
DR   ChEMBL; CHEMBL3883323; -.
DR   iPTMnet; P24863; -.
DR   PhosphoSitePlus; P24863; -.
DR   SwissPalm; P24863; -.
DR   BioMuta; CCNC; -.
DR   DMDM; 166214910; -.
DR   EPD; P24863; -.
DR   jPOST; P24863; -.
DR   MassIVE; P24863; -.
DR   PaxDb; P24863; -.
DR   PeptideAtlas; P24863; -.
DR   PRIDE; P24863; -.
DR   ProteomicsDB; 54234; -. [P24863-1]
DR   ProteomicsDB; 54235; -. [P24863-2]
DR   Antibodypedia; 4188; 317 antibodies.
DR   DNASU; 892; -.
DR   Ensembl; ENST00000520429; ENSP00000428982; ENSG00000112237. [P24863-1]
DR   Ensembl; ENST00000523799; ENSP00000430014; ENSG00000112237. [P24863-2]
DR   Ensembl; ENST00000523985; ENSP00000430119; ENSG00000112237. [P24863-2]
DR   GeneID; 892; -.
DR   KEGG; hsa:892; -.
DR   UCSC; uc003pqd.4; human. [P24863-1]
DR   CTD; 892; -.
DR   DisGeNET; 892; -.
DR   GeneCards; CCNC; -.
DR   HGNC; HGNC:1581; CCNC.
DR   HPA; ENSG00000112237; Low tissue specificity.
DR   MIM; 123838; gene.
DR   neXtProt; NX_P24863; -.
DR   OpenTargets; ENSG00000112237; -.
DR   PharmGKB; PA26149; -.
DR   eggNOG; KOG0794; Eukaryota.
DR   eggNOG; COG5333; LUCA.
DR   GeneTree; ENSGT00940000155625; -.
DR   InParanoid; P24863; -.
DR   KO; K15161; -.
DR   OMA; ANYWEST; -.
DR   PhylomeDB; P24863; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; P24863; -.
DR   SIGNOR; P24863; -.
DR   ChiTaRS; CCNC; human.
DR   GeneWiki; CCNC_(gene); -.
DR   GenomeRNAi; 892; -.
DR   Pharos; P24863; Tbio.
DR   PRO; PR:P24863; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P24863; protein.
DR   Bgee; ENSG00000112237; Expressed in nasal cavity mucosa and 235 other tissues.
DR   ExpressionAtlas; P24863; baseline and differential.
DR   Genevisible; P24863; HS.
DR   GO; GO:0016592; C:mediator complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR031658; Cyclin_C_2.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR028367; CyclinC/Ssn8.
DR   PANTHER; PTHR10026:SF7; PTHR10026:SF7; 1.
DR   Pfam; PF16899; Cyclin_C_2; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Cyclin; Nucleus;
KW   Phosphoprotein; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..283
FT                   /note="Cyclin-C"
FT                   /id="PRO_0000080420"
FT   DOMAIN          46..144
FT                   /note="Cyclin N-terminal"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   VAR_SEQ         1..85
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043075"
FT   TURN            1..3
FT                   /evidence="ECO:0000244|PDB:4F6U"
FT   HELIX           5..7
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           9..13
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           18..25
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   TURN            26..31
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           34..54
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           59..75
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   TURN            78..80
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           83..97
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   STRAND          98..100
FT                   /evidence="ECO:0000244|PDB:5HBE"
FT   HELIX           105..119
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   TURN            121..123
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           132..145
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   TURN            146..148
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           156..166
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           169..183
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   TURN            184..187
FT                   /evidence="ECO:0000244|PDB:4F7S"
FT   HELIX           188..191
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           194..208
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           214..218
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           224..243
FT                   /evidence="ECO:0000244|PDB:5XS2"
FT   HELIX           246..256
FT                   /evidence="ECO:0000244|PDB:5XS2"
SQ   SEQUENCE   283 AA;  33243 MW;  CF8AC5E94E621F4C CRC64;
     MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
     VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA AATSVLKTRF
     SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED MLLPLAWRIV
     NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
     WKNFDERKEM ATILSKMPKP KPPPNSEGEQ GPNGSQNSSY SQS
//
ID   Q7Z4L3_HUMAN            Unreviewed;       283 AA.
AC   Q7Z4L3;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   22-APR-2020, entry version 160.
DE   SubName: Full=Cyclin C {ECO:0000313|EMBL:AAH56153.1};
DE   SubName: Full=Cyclin C, isoform CRA_a {ECO:0000313|EMBL:EAW48465.1};
GN   Name=CCNC {ECO:0000313|EMBL:AAH56153.1};
GN   ORFNames=hCG_1757197 {ECO:0000313|EMBL:EAW48465.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH56153.1};
RN   [1] {ECO:0000313|EMBL:EAW48465.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAD00144.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ouchida M., Ohata N., Shimizu K.;
RT   "Expression of the CCNC gene in human tumor cells.";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AAH56153.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon {ECO:0000313|EMBL:AAH41123.1},
RC   Muscle {ECO:0000313|EMBL:AAH10135.1}, and
RC   Skin {ECO:0000313|EMBL:AAH56153.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:EAW48465.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cyclin family.
CC       {ECO:0000256|RuleBase:RU000383}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC010135; AAH10135.1; -; mRNA.
DR   EMBL; BC041123; AAH41123.1; -; mRNA.
DR   EMBL; BC056153; AAH56153.1; -; mRNA.
DR   EMBL; AB125137; BAD00144.1; -; mRNA.
DR   EMBL; CH471051; EAW48465.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48466.1; -; Genomic_DNA.
DR   RefSeq; NP_001013417.1; NM_001013399.1.
DR   RefSeq; NP_005181.2; NM_005190.3.
DR   Antibodypedia; 4188; 317 antibodies.
DR   DNASU; 892; -.
DR   GeneID; 892; -.
DR   KEGG; hsa:892; -.
DR   UCSC; uc003pqe.4; human.
DR   CTD; 892; -.
DR   EuPathDB; HostDB:ENSG00000112237.12; -.
DR   PharmGKB; PA26149; -.
DR   eggNOG; KOG0794; Eukaryota.
DR   eggNOG; COG5333; LUCA.
DR   KO; K15161; -.
DR   OMA; ANYWEST; -.
DR   OrthoDB; 1079428at2759; -.
DR   ChiTaRS; CCNC; human.
DR   GenomeRNAi; 892; -.
DR   Bgee; ENSG00000112237; Expressed in nasal cavity mucosa and 235 other tissues.
DR   GO; GO:0016592; C:mediator complex; IEA:Ensembl.
DR   GO; GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro.
DR   CDD; cd00043; CYCLIN; 2.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR031658; Cyclin_C_2.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR028367; CyclinC/Ssn8.
DR   PANTHER; PTHR10026:SF7; PTHR10026:SF7; 1.
DR   Pfam; PF16899; Cyclin_C_2; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 2.
DR   SUPFAM; SSF47954; SSF47954; 2.
PE   2: Evidence at transcript level;
KW   Cyclin {ECO:0000256|RuleBase:RU000383}.
FT   DOMAIN          46..144
FT                   /note="CYCLIN"
FT                   /evidence="ECO:0000259|SMART:SM00385"
FT   DOMAIN          161..236
FT                   /note="CYCLIN"
FT                   /evidence="ECO:0000259|SMART:SM00385"
FT   REGION          252..283
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        268..283
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   283 AA;  33243 MW;  CF8AC5E94E621F4C CRC64;
     MAGNFWQSSH YLQWILDKQD LLKERQKDLK FLSEEEYWKL QIFFTNVIQA LGEHLKLRQQ
     VIATATVYFK RFYARYSLKS IDPVLMAPTC VFLASKVEEF GVVSNTRLIA AATSVLKTRF
     SYAFPKEFPY RMNHILECEF YLLELMDCCL IVYHPYRPLL QYVQDMGQED MLLPLAWRIV
     NDTYRTDLCL LYPPFMIALA CLHVACVVQQ KDARQWFAEL SVDMEKILEI IRVILKLYEQ
     WKNFDERKEM ATILSKMPKP KPPPNSEGEQ GPNGSQNSSY SQS
//
ID   CAD10_HUMAN             Reviewed;         788 AA.
AC   Q9Y6N8; Q9ULB3;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-APR-2020, entry version 161.
DE   RecName: Full=Cadherin-10;
DE   AltName: Full=T2-cadherin;
DE   Flags: Precursor;
GN   Name=CDH10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10386616; DOI=10.1016/s0014-5793(99)00672-9;
RA   Kools P., Vanhalst K., van den Eynde E., van Roy F.;
RT   "The human cadherin-10 gene: complete coding sequence, predominant
RT   expression in the brain, and mapping on chromosome 5p13-14.";
RL   FEBS Lett. 452:328-334(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10861224; DOI=10.1042/0264-6021:3490159;
RA   Shimoyama Y., Tsujimoto G., Kitajima M., Natori M.;
RT   "Identification of three human type-II classic cadherins and frequent
RT   heterophilic interactions between different subclasses of type-II classic
RT   cadherins.";
RL   Biochem. J. 349:159-167(2000).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-784, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-371.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They
CC       preferentially interact with themselves in a homophilic manner in
CC       connecting cells; cadherins may thus contribute to the sorting of
CC       heterogeneous cell types.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain. Also found in
CC       adult and fetal kidney. Very low levels detected in prostate and fetal
CC       lung. {ECO:0000269|PubMed:10386616}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of each
CC       cadherin domain and rigidify the connections, imparting a strong
CC       curvature to the full-length ectodomain. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF039747; AAD44017.1; -; mRNA.
DR   EMBL; AB035303; BAA87417.1; -; mRNA.
DR   CCDS; CCDS3892.1; -.
DR   RefSeq; NP_006718.2; NM_006727.4.
DR   RefSeq; XP_011512225.1; XM_011513923.2.
DR   SMR; Q9Y6N8; -.
DR   BioGrid; 107443; 6.
DR   IntAct; Q9Y6N8; 5.
DR   STRING; 9606.ENSP00000264463; -.
DR   iPTMnet; Q9Y6N8; -.
DR   PhosphoSitePlus; Q9Y6N8; -.
DR   BioMuta; CDH10; -.
DR   DMDM; 116241276; -.
DR   MassIVE; Q9Y6N8; -.
DR   PaxDb; Q9Y6N8; -.
DR   PeptideAtlas; Q9Y6N8; -.
DR   PRIDE; Q9Y6N8; -.
DR   ProteomicsDB; 86749; -.
DR   Antibodypedia; 2223; 187 antibodies.
DR   DNASU; 1008; -.
DR   Ensembl; ENST00000264463; ENSP00000264463; ENSG00000040731.
DR   GeneID; 1008; -.
DR   KEGG; hsa:1008; -.
DR   CTD; 1008; -.
DR   DisGeNET; 1008; -.
DR   GeneCards; CDH10; -.
DR   HGNC; HGNC:1749; CDH10.
DR   HPA; ENSG00000040731; Tissue enriched (brain).
DR   MIM; 604555; gene.
DR   neXtProt; NX_Q9Y6N8; -.
DR   OpenTargets; ENSG00000040731; -.
DR   PharmGKB; PA26283; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00940000154187; -.
DR   HOGENOM; CLU_005284_3_1_1; -.
DR   InParanoid; Q9Y6N8; -.
DR   KO; K06802; -.
DR   OMA; MFDIVTQ; -.
DR   OrthoDB; 201053at2759; -.
DR   PhylomeDB; Q9Y6N8; -.
DR   TreeFam; TF329887; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   ChiTaRS; CDH10; human.
DR   GeneWiki; CDH10; -.
DR   GenomeRNAi; 1008; -.
DR   Pharos; Q9Y6N8; Tbio.
DR   PRO; PR:Q9Y6N8; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9Y6N8; protein.
DR   Bgee; ENSG00000040731; Expressed in middle temporal gyrus and 118 other tissues.
DR   ExpressionAtlas; Q9Y6N8; baseline and differential.
DR   Genevisible; Q9Y6N8; HS.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0016342; C:catenin complex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0034332; P:adherens junction organization; IBA:GO_Central.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IBA:GO_Central.
DR   GO; GO:0007043; P:cell-cell junction assembly; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane; Cleavage on pair of basic residues;
KW   Glycoprotein; Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   PROPEP          23..54
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000003781"
FT   CHAIN           55..788
FT                   /note="Cadherin-10"
FT                   /id="PRO_0000003782"
FT   TOPO_DOM        55..613
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        614..634
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        635..788
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          55..160
FT                   /note="Cadherin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          161..269
FT                   /note="Cadherin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          270..384
FT                   /note="Cadherin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          385..487
FT                   /note="Cadherin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          488..606
FT                   /note="Cadherin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   MOD_RES         784
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   MOD_RES         788
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97326"
FT   CARBOHYD        256
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        456
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        534
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         371
FT                   /note="V -> L (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036102"
FT   VARIANT         413
FT                   /note="S -> F (in dbSNP:rs1395027)"
FT                   /id="VAR_028751"
FT   CONFLICT        34
FT                   /note="Q -> R (in Ref. 1; AAD44017)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        482
FT                   /note="V -> A (in Ref. 1; AAD44017)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   788 AA;  88451 MW;  E92908F9C19270B2 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVIVVL FAALKRQRKK EPLILSKEDI RDNIVSYNDE
     GGGEEDTQAF DIGTLRNPAA IEEKKLRRDI IPETLFIPRR TPTAPDNTDV RDFINERLKE
     HDLDPTAPPY DSLATYAYEG NDSIAESLSS LESGTTEGDQ NYDYLREWGP RFNKLAEMYG
     GGESDKDS
//
ID   X5D8X5_HUMAN            Unreviewed;       788 AA.
AC   X5D8X5;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Cadherin 10 type 2 isoform A {ECO:0000313|EMBL:AHW56448.1};
DE   SubName: Full=Cadherin 10, type 2 (T2-cadherin) {ECO:0000313|EMBL:EAX10742.1};
DE   Flags: Fragment;
GN   Name=CDH10 {ECO:0000313|EMBL:AHW56448.1};
GN   ORFNames=hCG_36812 {ECO:0000313|EMBL:EAX10742.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56448.1};
RN   [1] {ECO:0000313|EMBL:EAX10742.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX10742.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AHW56448.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Fetal whole brain {ECO:0000313|EMBL:AHW56448.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L., Broly M.,
RA   Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S., Tasan M., Lemmens I.,
RA   Kuang X., Zhao N., Malhotra D., Michaelson J.J., Vacic V., Calderwood M.A.,
RA   Roth F.P., Tavernier J., Horvath S., Salehi-Ashtiani K., Korkin D.,
RA   Sebat J., Hill D.E., Hao T., Vidal M., Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from brain
RT   links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|RuleBase:RU003318};
CC       Single-pass type I membrane protein {ECO:0000256|RuleBase:RU003318}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KJ534808; AHW56448.1; -; mRNA.
DR   EMBL; CH471118; EAX10742.1; -; Genomic_DNA.
DR   RefSeq; NP_006718.2; NM_006727.4.
DR   RefSeq; XP_011512225.1; XM_011513923.2.
DR   Antibodypedia; 2223; 187 antibodies.
DR   GeneID; 1008; -.
DR   KEGG; hsa:1008; -.
DR   UCSC; uc003jgr.3; human.
DR   CTD; 1008; -.
DR   EuPathDB; HostDB:ENSG00000040731.10; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   HOGENOM; CLU_005284_3_1_1; -.
DR   KO; K06802; -.
DR   OMA; MFDIVTQ; -.
DR   OrthoDB; 201053at2759; -.
DR   ChiTaRS; CDH10; human.
DR   GenomeRNAi; 1008; -.
DR   Bgee; ENSG00000040731; Expressed in middle temporal gyrus and 118 other tissues.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00020193};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318};
KW   Membrane {ECO:0000256|SAAS:SAAS00662277, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00020163}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00662277, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           23..788
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5011954870"
FT   TRANSMEM        603..634
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          77..158
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          182..267
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          291..383
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          406..487
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          510..594
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   NON_TER         788
FT                   /evidence="ECO:0000313|EMBL:AHW56448.1"
SQ   SEQUENCE   788 AA;  88451 MW;  E92908F9C19270B2 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVIVVL FAALKRQRKK EPLILSKEDI RDNIVSYNDE
     GGGEEDTQAF DIGTLRNPAA IEEKKLRRDI IPETLFIPRR TPTAPDNTDV RDFINERLKE
     HDLDPTAPPY DSLATYAYEG NDSIAESLSS LESGTTEGDQ NYDYLREWGP RFNKLAEMYG
     GGESDKDS
//
ID   X5DNG6_HUMAN            Unreviewed;       786 AA.
AC   X5DNG6;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   22-APR-2020, entry version 36.
DE   SubName: Full=Cadherin 10 type 2 isoform B {ECO:0000313|EMBL:AHW56446.1};
DE   Flags: Fragment;
GN   Name=CDH10 {ECO:0000313|EMBL:AHW56446.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56446.1};
RN   [1] {ECO:0000313|EMBL:AHW56446.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Fetal whole brain {ECO:0000313|EMBL:AHW56446.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L., Broly M.,
RA   Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S., Tasan M., Lemmens I.,
RA   Kuang X., Zhao N., Malhotra D., Michaelson J.J., Vacic V., Calderwood M.A.,
RA   Roth F.P., Tavernier J., Horvath S., Salehi-Ashtiani K., Korkin D.,
RA   Sebat J., Hill D.E., Hao T., Vidal M., Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from brain
RT   links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|RuleBase:RU003318};
CC       Single-pass type I membrane protein {ECO:0000256|RuleBase:RU003318}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KJ534806; AHW56446.1; -; mRNA.
DR   RefSeq; NP_001304153.1; NM_001317224.1.
DR   RefSeq; XP_016864404.1; XM_017008915.1.
DR   PeptideAtlas; X5DNG6; -.
DR   PRIDE; X5DNG6; -.
DR   GeneID; 1008; -.
DR   CTD; 1008; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   ChiTaRS; CDH10; human.
DR   GenomeRNAi; 1008; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00020193};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318};
KW   Membrane {ECO:0000256|SAAS:SAAS00662277, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00020163}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00662277, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00662277,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           23..786
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004954902"
FT   TRANSMEM        603..632
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          77..158
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          182..267
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          291..383
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          406..487
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          510..594
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   NON_TER         786
FT                   /evidence="ECO:0000313|EMBL:AHW56446.1"
SQ   SEQUENCE   786 AA;  88239 MW;  3BE3B1BD6B060377 CRC64;
     MTIHQFLLLF LFWVCLPHFC SPEIMFRRTP VPQQRILSSR VPRSDGKILH RQKRGWMWNQ
     FFLLEEYTGS DYQYVGKLHS DQDKGDGSLK YILSGDGAGT LFIIDEKTGD IHATRRIDRE
     EKAFYTLRAQ AINRRTLRPV EPESEFVIKI HDINDNEPTF PEEIYTASVP EMSVVGTSVV
     QVTATDADDP SYGNSARVIY SILQGQPYFS VEPETGIIRT ALPNMNRENR EQYQVVIQAK
     DMGGQMGGLS GTTTVNITLT DVNDNPPRFP QNTIHLRVLE SSPVGTAIGS VKATDADTGK
     NAEVEYRIID GDGTDMFDIV TEKDTQEGII TVKKPLDYES RRLYTLKVEA ENTHVDPRFY
     YLGPFKDTTI VKISIEDVDE PPVFSRSSYL FEVHEDIEVG TIIGTVMARD PDSISSPIRF
     SLDRHTDLDR IFNIHSGNGS LYTSKPLDRE LSQWHNLTVI AAEINNPKET TRVAVFVRIL
     DVNDNAPQFA VFYDTFVCEN ARPGQLIQTI SAVDKDDPLG GQKFFFSLAA VNPNFTVQDN
     EDNTARILTR KNGFNRHEIS TYLLPVVISD NDYPIQSSTG TLTIRVCACD SQGNMQSCSA
     EALLLPAGLS TGALIAILLC IIILLVVLFA ALKRQRKKEP LILSKEDIRD NIVSYNDEGG
     GEEDTQAFDI GTLRNPAAIE EKKLRRDIIP ETLFIPRRTP TAPDNTDVRD FINERLKEHD
     LDPTAPPYDS LATYAYEGND SIAESLSSLE SGTTEGDQNY DYLREWGPRF NKLAEMYGGG
     ESDKDS
//
ID   CHD2_HUMAN              Reviewed;        1828 AA.
AC   O14647; C6G482; Q96IP5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 2.
DT   22-APR-2020, entry version 182.
DE   RecName: Full=Chromodomain-helicase-DNA-binding protein 2;
DE            Short=CHD-2;
DE            EC=3.6.4.12;
DE   AltName: Full=ATP-dependent helicase CHD2;
GN   Name=CHD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9326634; DOI=10.1073/pnas.94.21.11472;
RA   Woodage T., Basrai M.A., Baxevanis A.D., Hieter P., Collins F.S.;
RT   "Characterization of the CHD family of proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:11472-11477(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1635-1828 (ISOFORM 1).
RC   TISSUE=T-cell;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-240 AND SER-242, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207 AND SER-208, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-208; THR-240 AND
RP   SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1365; SER-1386 AND SER-1807,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207; SER-208; SER-1085 AND
RP   SER-1087, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS EEOC 121-ARG--THR-1828 DEL; ARG-548 AND PRO-823.
RX   PubMed=23708187; DOI=10.1038/ng.2646;
RA   Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J., Cook J.,
RA   Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S., Wallace G.,
RA   Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S., Mackay M.T.,
RA   Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z., Zelnick N.,
RA   Lerman-Sagie T., Lev D., Moeller R.S., Gill D., Andrade D.M., Freeman J.L.,
RA   Sadleir L.G., Shendure J., Berkovic S.F., Scheffer I.E., Mefford H.C.;
RT   "Targeted resequencing in epileptic encephalopathies identifies de novo
RT   mutations in CHD2 and SYNGAP1.";
RL   Nat. Genet. 45:825-830(2013).
RN   [15]
RP   VARIANT EEOC 112-SER--THR-1828 DEL.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C., Patry L.,
RA   Massicotte C., Ambalavanan A., Spiegelman D., Diallo O., Henrion E.,
RA   Dionne-Laporte A., Fougerat A., Pshezhetsky A.V., Venkateswaran S.,
RA   Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
CC   -!- FUNCTION: DNA-binding helicase that specifically binds to the promoter
CC       of target genes, leading to chromatin remodeling, possibly by promoting
CC       deposition of histone H3.3. Involved in myogenesis via interaction with
CC       MYOD1: binds to myogenic gene regulatory sequences and mediates
CC       incorporation of histone H3.3 prior to the onset of myogenic gene
CC       expression, promoting their expression (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- SUBUNIT: Interacts with MYOD1. Interacts with histone H3.3 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O14647; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-1210503, EBI-10181188;
CC       O14647-3; Q8IYF1: ELOA2; NbExp=3; IntAct=EBI-11985957, EBI-741705;
CC       O14647-3; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11985957, EBI-16439278;
CC       O14647; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-1210503, EBI-10172526;
CC       O14647; Q969V4: TEKT1; NbExp=3; IntAct=EBI-1210503, EBI-10180409;
CC       O14647; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-1210503, EBI-741515;
CC       O14647; Q8WV44: TRIM41; NbExp=4; IntAct=EBI-1210503, EBI-725997;
CC       O14647-3; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-11985957, EBI-2130429;
CC       O14647-3; Q8TD17: ZNF398; NbExp=3; IntAct=EBI-11985957, EBI-8643207;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Binds to myogenic
CC       gene promoters. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O14647-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14647-2; Sequence=VSP_021918, VSP_021919;
CC       Name=3;
CC         IsoId=O14647-3; Sequence=VSP_042791;
CC   -!- DISEASE: Epileptic encephalopathy, childhood-onset (EEOC) [MIM:615369]:
CC       A severe form of epilepsy characterized by onset of multiple seizure
CC       types in the first few years of life and associated with poor
CC       prognosis. Affected individuals have cognitive regression and
CC       intellectual disability. {ECO:0000269|PubMed:23708187,
CC       ECO:0000269|PubMed:25356899}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF006514; AAB87382.1; -; mRNA.
DR   EMBL; BT007050; AAP35699.1; -; mRNA.
DR   EMBL; FJ515838; ACS13730.1; -; Genomic_DNA.
DR   EMBL; AC013394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471101; EAX02160.1; -; Genomic_DNA.
DR   EMBL; BC007347; AAH07347.1; -; mRNA.
DR   EMBL; CR978407; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS10374.2; -. [O14647-1]
DR   CCDS; CCDS45356.1; -. [O14647-3]
DR   RefSeq; NP_001036037.1; NM_001042572.2. [O14647-3]
DR   RefSeq; NP_001262.3; NM_001271.3. [O14647-1]
DR   SMR; O14647; -.
DR   BioGrid; 107531; 27.
DR   IntAct; O14647; 20.
DR   MINT; O14647; -.
DR   STRING; 9606.ENSP00000377747; -.
DR   iPTMnet; O14647; -.
DR   PhosphoSitePlus; O14647; -.
DR   SwissPalm; O14647; -.
DR   BioMuta; CHD2; -.
DR   EPD; O14647; -.
DR   jPOST; O14647; -.
DR   MassIVE; O14647; -.
DR   MaxQB; O14647; -.
DR   PaxDb; O14647; -.
DR   PeptideAtlas; O14647; -.
DR   PRIDE; O14647; -.
DR   ProteomicsDB; 48144; -. [O14647-1]
DR   ProteomicsDB; 48145; -. [O14647-2]
DR   ProteomicsDB; 48146; -. [O14647-3]
DR   Antibodypedia; 29044; 184 antibodies.
DR   DNASU; 1106; -.
DR   Ensembl; ENST00000394196; ENSP00000377747; ENSG00000173575. [O14647-1]
DR   Ensembl; ENST00000420239; ENSP00000406581; ENSG00000173575. [O14647-3]
DR   Ensembl; ENST00000626874; ENSP00000486629; ENSG00000173575. [O14647-2]
DR   GeneID; 1106; -.
DR   KEGG; hsa:1106; -.
DR   UCSC; uc002bsn.4; human. [O14647-1]
DR   CTD; 1106; -.
DR   DisGeNET; 1106; -.
DR   GeneCards; CHD2; -.
DR   GeneReviews; CHD2; -.
DR   HGNC; HGNC:1917; CHD2.
DR   HPA; ENSG00000173575; Low tissue specificity.
DR   MalaCards; CHD2; -.
DR   MIM; 602119; gene.
DR   MIM; 615369; phenotype.
DR   neXtProt; NX_O14647; -.
DR   OpenTargets; ENSG00000173575; -.
DR   Orphanet; 2382; Lennox-Gastaut syndrome.
DR   Orphanet; 1942; Myoclonic-astastic epilepsy.
DR   PharmGKB; PA26453; -.
DR   eggNOG; KOG0383; Eukaryota.
DR   eggNOG; COG0553; LUCA.
DR   GeneTree; ENSGT00940000155888; -.
DR   HOGENOM; CLU_645515_0_0_1; -.
DR   InParanoid; O14647; -.
DR   KO; K20091; -.
DR   OMA; NIWKDDD; -.
DR   OrthoDB; 57339at2759; -.
DR   PhylomeDB; O14647; -.
DR   TreeFam; TF313461; -.
DR   ChiTaRS; CHD2; human.
DR   GeneWiki; CHD2; -.
DR   GenomeRNAi; 1106; -.
DR   Pharos; O14647; Tbio.
DR   PRO; PR:O14647; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; O14647; protein.
DR   Bgee; ENSG00000173575; Expressed in corpus callosum and 204 other tissues.
DR   ExpressionAtlas; O14647; baseline and differential.
DR   Genevisible; O14647; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0003678; F:DNA helicase activity; TAS:ProtInc.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl.
DR   GO; GO:0007517; P:muscle organ development; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   Gene3D; 3.40.50.10810; -; 1.
DR   InterPro; IPR040793; CDH1_2_SANT_HL1.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR023779; Chromodomain_CS.
DR   InterPro; IPR025260; DUF4208.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR038718; SNF2-like_sf.
DR   InterPro; IPR000330; SNF2_N.
DR   Pfam; PF18375; CDH1_2_SANT_HL1; 1.
DR   Pfam; PF00385; Chromo; 2.
DR   Pfam; PF13907; DUF4208; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF00176; SNF2_N; 1.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM01176; DUF4208; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF54160; SSF54160; 2.
DR   PROSITE; PS00598; CHROMO_1; 2.
DR   PROSITE; PS50013; CHROMO_2; 2.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Chromatin regulator; Disease mutation;
KW   DNA-binding; Epilepsy; Helicase; Hydrolase; Myogenesis; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..1828
FT                   /note="Chromodomain-helicase-DNA-binding protein 2"
FT                   /id="PRO_0000080226"
FT   DOMAIN          261..353
FT                   /note="Chromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT   DOMAIN          378..456
FT                   /note="Chromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00053"
FT   DOMAIN          496..666
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          795..946
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   NP_BIND         509..516
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOTIF           617..620
FT                   /note="DEAH box"
FT   COMPBIAS        13..74
FT                   /note="Ser-rich"
FT   COMPBIAS        121..139
FT                   /note="Ser-rich"
FT   COMPBIAS        966..1066
FT                   /note="Glu-rich"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         240
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         242
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         1085
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1087
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1386
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1807
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         502..1828
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.2"
FT                   /id="VSP_042791"
FT   VAR_SEQ         1719..1739
FT                   /note="HHHDSKRRRSDEFRPQNYHQQ -> YAKGCETPGANLCQELFLGRK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9326634"
FT                   /id="VSP_021918"
FT   VAR_SEQ         1740..1828
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9326634"
FT                   /id="VSP_021919"
FT   VARIANT         112..1828
FT                   /note="Missing (in EEOC)"
FT                   /evidence="ECO:0000269|PubMed:25356899"
FT                   /id="VAR_078614"
FT   VARIANT         121..1828
FT                   /note="Missing (in EEOC)"
FT                   /evidence="ECO:0000269|PubMed:23708187"
FT                   /id="VAR_078615"
FT   VARIANT         548
FT                   /note="W -> R (in EEOC; dbSNP:rs864309537)"
FT                   /evidence="ECO:0000269|PubMed:23708187"
FT                   /id="VAR_070209"
FT   VARIANT         823
FT                   /note="L -> P (in EEOC; dbSNP:rs864309540)"
FT                   /evidence="ECO:0000269|PubMed:23708187"
FT                   /id="VAR_070210"
FT   VARIANT         1574
FT                   /note="G -> A (in dbSNP:rs56227200)"
FT                   /id="VAR_061099"
FT   CONFLICT        1156
FT                   /note="I -> L (in Ref. 1; AAB87382)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1828 AA;  211344 MW;  13139D6059210F00 CRC64;
     MMRNKDKSQE EDSSLHSNAS SHSASEEASG SDSGSQSESE QGSDPGSGHG SESNSSSESS
     ESQSESESES AGSKSQPVLP EAKEKPASKK ERIADVKKMW EEYPDVYGVR RSNRSRQEPS
     RFNIKEEASS GSESGSPKRR GQRQLKKQEK WKQEPSEDEQ EQGTSAESEP EQKKVKARRP
     VPRRTVPKPR VKKQPKTQRG KRKKQDSSDE DDDDDEAPKR QTRRRAAKNV SYKEDDDFET
     DSDDLIEMTG EGVDEQQDNS ETIEKVLDSR LGKKGATGAS TTVYAIEANG DPSGDFDTEK
     DEGEIQYLIK WKGWSYIHST WESEESLQQQ KVKGLKKLEN FKKKEDEIKQ WLGKVSPEDV
     EYFNCQQELA SELNKQYQIV ERVIAVKTSK STLGQTDFPA HSRKPAPSNE PEYLCKWMGL
     PYSECSWEDE ALIGKKFQNC IDSFHSRNNS KTIPTRECKA LKQRPRFVAL KKQPAYLGGE
     NLELRDYQLE GLNWLAHSWC KNNSVILADE MGLGKTIQTI SFLSYLFHQH QLYGPFLIVV
     PLSTLTSWQR EFEIWAPEIN VVVYIGDLMS RNTIREYEWI HSQTKRLKFN ALITTYEILL
     KDKTVLGSIN WAFLGVDEAH RLKNDDSLLY KTLIDFKSNH RLLITGTPLQ NSLKELWSLL
     HFIMPEKFEF WEDFEEDHGK GRENGYQSLH KVLEPFLLRR VKKDVEKSLP AKVEQILRVE
     MSALQKQYYK WILTRNYKAL AKGTRGSTSG FLNIVMELKK CCNHCYLIKP PEENERENGQ
     EILLSLIRSS GKLILLDKLL TRLRERGNRV LIFSQMVRML DILAEYLTIK HYPFQRLDGS
     IKGEIRKQAL DHFNADGSED FCFLLSTRAG GLGINLASAD TVVIFDSDWN PQNDLQAQAR
     AHRIGQKKQV NIYRLVTKGT VEEEIIERAK KKMVLDHLVI QRMDTTGRTI LENNSGRSNS
     NPFNKEELTA ILKFGAEDLF KELEGEESEP QEMDIDEILR LAETRENEVS TSATDELLSQ
     FKVANFATME DEEELEERPH KDWDEIIPEE QRKKVEEEER QKELEEIYML PRIRSSTKKA
     QTNDSDSDTE SKRQAQRSSA SESETEDSDD DKKPKRRGRP RSVRKDLVEG FTDAEIRRFI
     KAYKKFGLPL ERLECIARDA ELVDKSVADL KRLGELIHNS CVSAMQEYEE QLKENASEGK
     GPGKRRGPTI KISGVQVNVK SIIQHEEEFE MLHKSIPVDP EEKKKYCLTC RVKAAHFDVE
     WGVEDDSRLL LGIYEHGYGN WELIKTDPEL KLTDKILPVE TDKKPQGKQL QTRADYLLKL
     LRKGLEKKGA VTGGEEAKLK KRKPRVKKEN KVPRLKEEHG IELSSPRHSD NPSEEGEVKD
     DGLEKSPMKK KQKKKENKEN KEKQMSSRKD KEGDKERKKS KDKKEKPKSG DAKSSSKSKR
     SQGPVHITAG SEPVPIGEDE DDDLDQETFS ICKERMRPVK KALKQLDKPD KGLNVQEQLE
     HTRNCLLKIG DRIAECLKAY SDQEHIKLWR RNLWIFVSKF TEFDARKLHK LYKMAHKKRS
     QEEEEQKKKD DVTGGKKPFR PEASGSSRDS LISQSHTSHN LHPQKPHLPA SHGPQMHGHP
     RDNYNHPNKR HFSNADRGDW QRERKFNYGG GNNNPPWGSD RHHQYEQHWY KDHHYGDRRH
     MDAHRSGSYR PNNMSRKRPY DQYSSDRDHR GHRDYYDRHH HDSKRRRSDE FRPQNYHQQD
     FRRMSDHRPA MGYHGQGPSD HYRSFHTDKL GEYKQPLPPL HPAVSDPRSP PSQKSPHDSK
     SPLDHRSPLE RSLEQKNNPD YNWNVRKT
//
ID   A0A090N7T7_HUMAN        Unreviewed;      1331 AA.
AC   A0A090N7T7;
DT   26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT   26-NOV-2014, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   SubName: Full=Contactin associated protein-like 2 {ECO:0000313|EMBL:EAL24417.1};
DE   SubName: Full=Contactin associated protein-like 2, isoform CRA_b {ECO:0000313|EMBL:EAW80083.1};
GN   Name=CNTNAP2 {ECO:0000313|EMBL:EAL24417.1};
GN   ORFNames=hCG_15499 {ECO:0000313|EMBL:EAW80083.1},
GN   tcag7.496 {ECO:0000313|EMBL:EAL24417.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24417.1};
RN   [1] {ECO:0000313|EMBL:EAW80083.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24417.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J., Grzeschik K.H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H.,
RA   Dohner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24417.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F., Zeesman S., Teshima I.,
RA   Chitayat D., Shuman C., Weksberg R., Zackai E.H., Grebe T.A., Cox S.R.,
RA   Kirkpatrick S.J., Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.,
RA   Lococo F., Belloni E., Shaffer L.G., Morton C.C., Pober B., Gusella J.,
RA   Bruns G., Korf B.R., Quade B.J., Ligon A.H., Ferguson H., Higgins A.W.,
RA   Leach N.T., Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P.,
RA   Zlotorynski E., Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J.,
RA   Doehner H., Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW80083.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00122}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AACC02000041; EAL24417.1; -; Genomic_DNA.
DR   EMBL; CH471146; EAW80083.1; -; Genomic_DNA.
DR   RefSeq; NP_054860.1; NM_014141.5.
DR   Antibodypedia; 682; 261 antibodies.
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   CTD; 26047; -.
DR   EuPathDB; HostDB:ENSG00000174469.17; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   HOGENOM; CLU_003504_1_0_1; -.
DR   KO; K07380; -.
DR   OMA; LWIVSSC; -.
DR   OrthoDB; 338397at2759; -.
DR   ChiTaRS; CNTNAP2; human.
DR   GenomeRNAi; 26047; -.
DR   Bgee; ENSG00000174469; Expressed in forebrain and 162 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; IEA:InterPro.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR15036:SF33; PTHR15036:SF33; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   4: Predicted;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00122,
KW   ECO:0000256|SAAS:SAAS00814887};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAAS:SAAS00465062, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00814929}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00465062, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00465062,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..1331
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014219317"
FT   TRANSMEM        1262..1283
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          35..181
FT                   /note="F5/8 type C"
FT                   /evidence="ECO:0000259|PROSITE:PS50022"
FT   DOMAIN          187..368
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          373..552
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          554..591
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          590..642
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51406"
FT   DOMAIN          799..963
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          964..1002
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          1023..1214
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   REGION          1026..1045
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        936..963
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00122"
SQ   SEQUENCE   1331 AA;  148167 MW;  CFB2CB55BEFB99C2 CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYFFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   B2RCH4_HUMAN            Unreviewed;      1331 AA.
AC   B2RCH4;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   11-DEC-2019, entry version 94.
DE   SubName: Full=cDNA, FLJ96073, highly similar to Homo sapiens contactin associated protein-like 2 (CNTNAP2), mRNA {ECO:0000313|EMBL:BAG37571.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37571.1};
RN   [1] {ECO:0000313|EMBL:BAG37571.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG37571.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00122}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK315113; BAG37571.1; -; mRNA.
DR   RefSeq; NP_054860.1; NM_014141.5.
DR   PRIDE; B2RCH4; -.
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   CTD; 26047; -.
DR   PharmGKB; PA26692; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   KO; K07380; -.
DR   OrthoDB; 338397at2759; -.
DR   GenomeRNAi; 26047; -.
DR   Genevisible; B2RCH4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; IEA:InterPro.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR15036:SF33; PTHR15036:SF33; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00122,
KW   ECO:0000256|SAAS:SAAS00814887};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAAS:SAAS00465062, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00814929}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00465062, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00465062,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..1331
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002779571"
FT   TRANSMEM        1262..1283
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          35..181
FT                   /note="F5/8 type C"
FT                   /evidence="ECO:0000259|PROSITE:PS50022"
FT   DOMAIN          187..368
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          373..552
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          554..591
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          590..642
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000259|PROSITE:PS51406"
FT   DOMAIN          799..963
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          964..1002
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          1023..1214
FT                   /note="LAM_G_DOMAIN"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   REGION          1026..1045
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        936..963
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00122"
SQ   SEQUENCE   1331 AA;  148133 MW;  59962C173F56F35B CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYLFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   CNTP2_HUMAN             Reviewed;        1331 AA.
AC   Q9UHC6; D3DWG2; Q14DG2; Q52LV1; Q5H9Q7; Q9UQ12;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-APR-2020, entry version 195.
DE   RecName: Full=Contactin-associated protein-like 2;
DE   AltName: Full=Cell recognition molecule Caspr2;
DE   Flags: Precursor;
GN   Name=CNTNAP2; Synonyms=CASPR2 {ECO:0000303|PubMed:10624965}, KIAA0868;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH KCNA2, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10624965; DOI=10.1016/s0896-6273(00)81049-1;
RA   Poliak S., Gollan L., Martinez R., Custer A., Einheber S., Salzer J.L.,
RA   Trimmer J.S., Shrager P., Peles E.;
RT   "Caspr2, a new member of the neurexin superfamily, is localized at the
RT   juxtaparanodes of myelinated axons and associates with K+ channels.";
RL   Neuron 24:1037-1047(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11352571; DOI=10.1006/geno.2001.6517;
RA   Nakabayashi K., Scherer S.W.;
RT   "The human contactin-associated protein-like 2 gene (CNTNAP2) spans over 2
RT   Mb of DNA at chromosome 7q35.";
RL   Genomics 73:108-112(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INVOLVEMENT IN PTHSL1.
RX   PubMed=16571880; DOI=10.1056/nejmoa052773;
RA   Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E.,
RA   Parod J.M., Stephan D.A., Morton D.H.;
RT   "Recessive symptomatic focal epilepsy and mutant contactin-associated
RT   protein-like 2.";
RL   N. Engl. J. Med. 354:1370-1377(2006).
RN   [8]
RP   INVOLVEMENT IN PTHSL1.
RX   PubMed=19896112; DOI=10.1016/j.ajhg.2009.10.004;
RA   Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B., Collins A.L.,
RA   Bijlsma E.K., Oortveld M.A., Ekici A.B., Reis A., Schenck A., Rauch A.;
RT   "CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like
RT   mental retardation and determine the level of a common synaptic protein in
RT   Drosophila.";
RL   Am. J. Hum. Genet. 85:655-666(2009).
RN   [9]
RP   INVOLVEMENT IN AUTS15, VARIANTS GLN-114; MET-218; MET-226; CYS-283;
RP   ASN-382; SER-407; ASP-418; LYS-680; GLN-699; CYS-716; SER-731; ASP-779;
RP   THR-869; HIS-906; ASN-1038; ALA-1102; GLY-1114; HIS-1119; HIS-1129;
RP   THR-1227; THR-1253 AND ILE-1278, AND CHROMOSOMAL REARRANGEMENT.
RX   PubMed=18179895; DOI=10.1016/j.ajhg.2007.09.017;
RA   Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F.,
RA   Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A.,
RA   Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M., Geschwind D.H.,
RA   Biederer T., Gunel M., Lifton R.P., State M.W.;
RT   "Molecular cytogenetic analysis and resequencing of contactin associated
RT   protein-like 2 in autism spectrum disorders.";
RL   Am. J. Hum. Genet. 82:165-173(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Required, with CNTNAP1, for radial and longitudinal
CC       organization of myelinated axons. Plays a role in the formation of
CC       functional distinct domains critical for saltatory conduction of nerve
CC       impulses in myelinated nerve fibers. Demarcates the juxtaparanodal
CC       region of the axo-glial junction. {ECO:0000250|UniProtKB:Q9CPW0}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with KCNA2.
CC       {ECO:0000269|PubMed:10624965}.
CC   -!- INTERACTION:
CC       Q9UHC6-1; P27824: CANX; NbExp=2; IntAct=EBI-16594440, EBI-355947;
CC       Q9UHC6; Q12860: CNTN1; NbExp=5; IntAct=EBI-310892, EBI-5564336;
CC       Q9UHC6; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-310892, EBI-739467;
CC       Q9UHC6; P50222: MEOX2; NbExp=3; IntAct=EBI-310892, EBI-748397;
CC       Q9UHC6; P62487: POLR2G; NbExp=3; IntAct=EBI-310892, EBI-347928;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9CPW0}; Single-
CC       pass type I membrane protein {ECO:0000305}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q9CPW0}. Cell junction, paranodal septate
CC       junction {ECO:0000250|UniProtKB:Q9CPW0}. Note=Expressed in the
CC       juxtaparadonal region. {ECO:0000250|UniProtKB:Q9CPW0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UHC6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHC6-2; Sequence=VSP_014976;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in nervous system.
CC       {ECO:0000269|PubMed:10624965}.
CC   -!- DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial,
CC       pervasive developmental disorder characterized by impairments in
CC       reciprocal social interaction and communication, restricted and
CC       stereotyped patterns of interests and activities, and the presence of
CC       developmental abnormalities by 3 years of age. Most individuals with
CC       autism also manifest moderate mental retardation.
CC       {ECO:0000269|PubMed:18179895}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a
CC       patient with autism spectrum disorder. Paracentric inversion
CC       46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes
CC       AUTS2 and CNTNAP2.
CC   -!- DISEASE: Pitt-Hopkins-like syndrome 1 (PTHSL1) [MIM:610042]: A syndrome
CC       characterized by severe mental retardation and variable additional
CC       symptoms, such as impaired speech development, seizures, autistic
CC       behavior, breathing anomalies and a broad mouth, resembling Pitt-
CC       Hopkins syndrome. In contrast to patients with Pitt-Hopkins syndrome,
CC       PTHSL1 patients present with normal or only mildly to moderately
CC       delayed motor milestones. {ECO:0000269|PubMed:16571880,
CC       ECO:0000269|PubMed:19896112}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74891.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF193613; AAF25199.1; -; mRNA.
DR   EMBL; AF319045; AAK34932.1; -; mRNA.
DR   EMBL; AF318292; AAK49902.1; -; Genomic_DNA.
DR   EMBL; AF318298; AAK49903.1; -; Genomic_DNA.
DR   EMBL; AB020675; BAA74891.1; ALT_INIT; mRNA.
DR   EMBL; CR933671; CAI45967.1; -; mRNA.
DR   EMBL; CH471146; EAW80084.1; -; Genomic_DNA.
DR   EMBL; BC093780; AAH93780.1; -; mRNA.
DR   EMBL; BC113373; AAI13374.1; -; mRNA.
DR   CCDS; CCDS5889.1; -. [Q9UHC6-1]
DR   RefSeq; NP_054860.1; NM_014141.5. [Q9UHC6-1]
DR   PDB; 5Y4M; X-ray; 1.31 A; A=35-181.
DR   PDBsum; 5Y4M; -.
DR   SMR; Q9UHC6; -.
DR   BioGrid; 117510; 10.
DR   IntAct; Q9UHC6; 13.
DR   MINT; Q9UHC6; -.
DR   STRING; 9606.ENSP00000354778; -.
DR   iPTMnet; Q9UHC6; -.
DR   PhosphoSitePlus; Q9UHC6; -.
DR   SwissPalm; Q9UHC6; -.
DR   BioMuta; CNTNAP2; -.
DR   DMDM; 17433089; -.
DR   jPOST; Q9UHC6; -.
DR   MassIVE; Q9UHC6; -.
DR   PaxDb; Q9UHC6; -.
DR   PeptideAtlas; Q9UHC6; -.
DR   PRIDE; Q9UHC6; -.
DR   ProteomicsDB; 84311; -. [Q9UHC6-1]
DR   ProteomicsDB; 84312; -. [Q9UHC6-2]
DR   Antibodypedia; 682; 261 antibodies.
DR   Ensembl; ENST00000361727; ENSP00000354778; ENSG00000174469. [Q9UHC6-1]
DR   Ensembl; ENST00000463592; ENSP00000486292; ENSG00000174469. [Q9UHC6-2]
DR   Ensembl; ENST00000613345; ENSP00000481057; ENSG00000278728. [Q9UHC6-2]
DR   GeneID; 26047; -.
DR   KEGG; hsa:26047; -.
DR   UCSC; uc003weu.3; human. [Q9UHC6-1]
DR   CTD; 26047; -.
DR   DisGeNET; 26047; -.
DR   GeneCards; CNTNAP2; -.
DR   HGNC; HGNC:13830; CNTNAP2.
DR   HPA; ENSG00000174469; Tissue enhanced (brain).
DR   MalaCards; CNTNAP2; -.
DR   MIM; 604569; gene.
DR   MIM; 610042; phenotype.
DR   MIM; 612100; phenotype.
DR   neXtProt; NX_Q9UHC6; -.
DR   OpenTargets; ENSG00000174469; -.
DR   Orphanet; 163681; Cortical dysplasia-focal epilepsy syndrome.
DR   Orphanet; 106; NON RARE IN EUROPE: Autism.
DR   Orphanet; 221150; Pitt-Hopkins-like syndrome.
DR   PharmGKB; PA26692; -.
DR   eggNOG; KOG3516; Eukaryota.
DR   eggNOG; ENOG410XPHG; LUCA.
DR   GeneTree; ENSGT00940000154516; -.
DR   HOGENOM; CLU_003504_1_0_1; -.
DR   InParanoid; Q9UHC6; -.
DR   KO; K07380; -.
DR   OMA; LWIVSSC; -.
DR   PhylomeDB; Q9UHC6; -.
DR   TreeFam; TF321823; -.
DR   SIGNOR; Q9UHC6; -.
DR   ChiTaRS; CNTNAP2; human.
DR   GeneWiki; CNTNAP2; -.
DR   GenomeRNAi; 26047; -.
DR   Pharos; Q9UHC6; Tbio.
DR   PRO; PR:Q9UHC6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9UHC6; protein.
DR   Bgee; ENSG00000174469; Expressed in forebrain and 162 other tissues.
DR   ExpressionAtlas; Q9UHC6; baseline and differential.
DR   Genevisible; Q9UHC6; HS.
DR   GO; GO:0030673; C:axolemma; IDA:BHF-UCL.
DR   GO; GO:0030424; C:axon; NAS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; NAS:BHF-UCL.
DR   GO; GO:0005769; C:early endosome; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0044224; C:juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; NAS:BHF-UCL.
DR   GO; GO:0033010; C:paranodal junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; NAS:BHF-UCL.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0030534; P:adult behavior; IMP:BHF-UCL.
DR   GO; GO:0007420; P:brain development; TAS:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:BHF-UCL.
DR   GO; GO:0045163; P:clustering of voltage-gated potassium channels; ISS:BHF-UCL.
DR   GO; GO:0007612; P:learning; IMP:BHF-UCL.
DR   GO; GO:0021761; P:limbic system development; IEP:BHF-UCL.
DR   GO; GO:0031175; P:neuron projection development; ISS:BHF-UCL.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0008038; P:neuron recognition; NAS:UniProtKB.
DR   GO; GO:0071205; P:protein localization to juxtaparanode region of axon; ISS:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; IMP:BHF-UCL.
DR   GO; GO:0021756; P:striatum development; IEP:BHF-UCL.
DR   GO; GO:0071109; P:superior temporal gyrus development; IEP:BHF-UCL.
DR   GO; GO:0021794; P:thalamus development; IEP:BHF-UCL.
DR   GO; GO:0019226; P:transmission of nerve impulse; NAS:UniProtKB.
DR   GO; GO:0042297; P:vocal learning; IMP:BHF-UCL.
DR   GO; GO:0071625; P:vocalization behavior; IMP:BHF-UCL.
DR   CDD; cd00057; FA58C; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR029831; Caspr2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   PANTHER; PTHR15036:SF33; PTHR15036:SF33; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 4.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 4.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF49899; SSF49899; 4.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Autism; Autism spectrum disorder;
KW   Cell adhesion; Cell junction; Cell projection; Chromosomal rearrangement;
KW   Disulfide bond; EGF-like domain; Epilepsy; Glycoprotein; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..1331
FT                   /note="Contactin-associated protein-like 2"
FT                   /id="PRO_0000019506"
FT   TOPO_DOM        28..1262
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1263..1283
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1284..1331
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          35..181
FT                   /note="F5/8 type C"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          216..368
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          401..552
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          554..591
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          592..798
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DOMAIN          799..963
FT                   /note="Laminin G-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          963..1002
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1055..1214
FT                   /note="Laminin G-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   MOD_RES         1303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CPW0"
FT   MOD_RES         1306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CPW0"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        346
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        436
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        506
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        507
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        546
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        630
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        735
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1198
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        35..181
FT                   /evidence="ECO:0000250"
FT   DISULFID        336..368
FT                   /evidence="ECO:0000250"
FT   DISULFID        520..552
FT                   /evidence="ECO:0000250"
FT   DISULFID        558..569
FT                   /evidence="ECO:0000250"
FT   DISULFID        563..578
FT                   /evidence="ECO:0000250"
FT   DISULFID        580..590
FT                   /evidence="ECO:0000250"
FT   DISULFID        936..963
FT                   /evidence="ECO:0000250"
FT   DISULFID        967..980
FT                   /evidence="ECO:0000250"
FT   DISULFID        974..989
FT                   /evidence="ECO:0000250"
FT   DISULFID        991..1001
FT                   /evidence="ECO:0000250"
FT   DISULFID        1178..1214
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..1223
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014976"
FT   VARIANT         114
FT                   /note="R -> Q (in dbSNP:rs189731792)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046227"
FT   VARIANT         218
FT                   /note="T -> M (in dbSNP:rs771028883)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046228"
FT   VARIANT         226
FT                   /note="L -> M (in dbSNP:rs372345438)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046229"
FT   VARIANT         283
FT                   /note="R -> C (in dbSNP:rs794727802)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046230"
FT   VARIANT         382
FT                   /note="S -> N (in dbSNP:rs371839994)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046231"
FT   VARIANT         407
FT                   /note="N -> S (in dbSNP:rs143877693)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046232"
FT   VARIANT         418
FT                   /note="N -> D (in dbSNP:rs772179690)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046233"
FT   VARIANT         680
FT                   /note="E -> K (in dbSNP:rs368905425)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046234"
FT   VARIANT         699
FT                   /note="P -> Q (in dbSNP:rs764412489)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046235"
FT   VARIANT         716
FT                   /note="Y -> C (in dbSNP:rs760930032)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046236"
FT   VARIANT         731
FT                   /note="G -> S (in dbSNP:rs369867547)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046237"
FT   VARIANT         779
FT                   /note="G -> D (in dbSNP:rs200413148)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046238"
FT   VARIANT         869
FT                   /note="I -> T (rare polymorphism; may be a risk factor for
FT                   autism; dbSNP:rs121908445)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046239"
FT   VARIANT         906
FT                   /note="R -> H (in dbSNP:rs759801195)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046240"
FT   VARIANT         1038
FT                   /note="D -> N (in dbSNP:rs144003410)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046241"
FT   VARIANT         1102
FT                   /note="V -> A (in dbSNP:rs111599875)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046242"
FT   VARIANT         1114
FT                   /note="S -> G (in dbSNP:rs983036503)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046243"
FT   VARIANT         1119
FT                   /note="R -> H (in dbSNP:rs774709566)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046244"
FT   VARIANT         1129
FT                   /note="D -> H (in dbSNP:rs781236853)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046245"
FT   VARIANT         1227
FT                   /note="A -> T (in dbSNP:rs761684414)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046246"
FT   VARIANT         1253
FT                   /note="I -> T (in dbSNP:rs767821521)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046247"
FT   VARIANT         1278
FT                   /note="T -> I (in dbSNP:rs760047247)"
FT                   /evidence="ECO:0000269|PubMed:18179895"
FT                   /id="VAR_046248"
FT   STRAND          37..40
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   HELIX           45..47
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          48..51
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   HELIX           56..58
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   HELIX           60..62
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          72..74
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          85..101
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          110..123
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          140..143
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          146..166
FT                   /evidence="ECO:0000244|PDB:5Y4M"
FT   STRAND          174..181
FT                   /evidence="ECO:0000244|PDB:5Y4M"
SQ   SEQUENCE   1331 AA;  148167 MW;  CFB2CB55BEFB99C2 CRC64;
     MQAAPRAGCG AALLLWIVSS CLCRAWTAPS TSQKCDEPLV SGLPHVAFSS SSSISGSYSP
     GYAKINKRGG AGGWSPSDSD HYQWLQVDFG NRKQISAIAT QGRYSSSDWV TQYRMLYSDT
     GRNWKPYHQD GNIWAFPGNI NSDGVVRHEL QHPIIARYVR IVPLDWNGEG RIGLRIEVYG
     CSYWADVINF DGHVVLPYRF RNKKMKTLKD VIALNFKTSE SEGVILHGEG QQGDYITLEL
     KKAKLVLSLN LGSNQLGPIY GHTSVMTGSL LDDHHWHSVV IERQGRSINL TLDRSMQHFR
     TNGEFDYLDL DYEITFGGIP FSGKPSSSSR KNFKGCMESI NYNGVNITDL ARRKKLEPSN
     VGNLSFSCVE PYTVPVFFNA TSYLEVPGRL NQDLFSVSFQ FRTWNPNGLL VFSHFADNLG
     NVEIDLTESK VGVHINITQT KMSQIDISSG SGLNDGQWHE VRFLAKENFA ILTIDGDEAS
     AVRTNSPLQV KTGEKYFFGG FLNQMNNSSH SVLQPSFQGC MQLIQVDDQL VNLYEVAQRK
     PGSFANVSID MCAIIDRCVP NHCEHGGKCS QTWDSFKCTC DETGYSGATC HNSIYEPSCE
     AYKHLGQTSN YYWIDPDGSG PLGPLKVYCN MTEDKVWTIV SHDLQMQTPV VGYNPEKYSV
     TQLVYSASMD QISAITDSAE YCEQYVSYFC KMSRLLNTPD GSPYTWWVGK ANEKHYYWGG
     SGPGIQKCAC GIERNCTDPK YYCNCDADYK QWRKDAGFLS YKDHLPVSQV VVGDTDRQGS
     EAKLSVGPLR CQGDRNYWNA ASFPNPSSYL HFSTFQGETS ADISFYFKTL TPWGVFLENM
     GKEDFIKLEL KSATEVSFSF DVGNGPVEIV VRSPTPLNDD QWHRVTAERN VKQASLQVDR
     LPQQIRKAPT EGHTRLELYS QLFVGGAGGQ QGFLGCIRSL RMNGVTLDLE ERAKVTSGFI
     SGCSGHCTSY GTNCENGGKC LERYHGYSCD CSNTAYDGTF CNKDVGAFFE EGMWLRYNFQ
     APATNARDSS SRVDNAPDQQ NSHPDLAQEE IRFSFSTTKA PCILLYISSF TTDFLAVLVK
     PTGSLQIRYN LGGTREPYNI DVDHRNMANG QPHSVNITRH EKTIFLKLDH YPSVSYHLPS
     SSDTLFNSPK SLFLGKVIET GKIDQEIHKY NTPGFTGCLS RVQFNQIAPL KAALRQTNAS
     AHVHIQGELV ESNCGASPLT LSPMSSATDP WHLDHLDSAS ADFPYNPGQG QAIRNGVNRN
     SAIIGGVIAV VIFTILCTLV FLIRYMFRHK GTYHTNEAKG AESAESADAA IMNNDPNFTE
     TIDESKKEWL I
//
ID   B3KXC1_HUMAN            Unreviewed;       390 AA.
AC   B3KXC1;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 60.
DE   SubName: Full=Cytoplasmic polyadenylation element binding protein 3, isoform CRA_b {ECO:0000313|EMBL:EAW50098.1};
DE   SubName: Full=cDNA FLJ45117 fis, clone BRAWH3035403, highly similar to Mus musculus cytoplasmic polyadenylation element binding protein 3 (Cpeb3), mRNA {ECO:0000313|EMBL:BAG54433.1};
GN   Name=CPEB3 {ECO:0000313|EMBL:EAW50098.1};
GN   ORFNames=hCG_20317 {ECO:0000313|EMBL:EAW50098.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54433.1};
RN   [1] {ECO:0000313|EMBL:EAW50098.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG54433.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG54433.1};
RA   Ota T., Nakagawa S., Senoh A., Mizuguchi H., Inagaki H., Sugiyama T.,
RA   Irie R., Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H., Matsuo K.,
RA   Nakamura Y., Sekine M., Kikuchi H., Kanda K., Wagatsuma M., Murakawa K.,
RA   Kanehori K., Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B.,
RA   Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW50098.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK127060; BAG54433.1; -; mRNA.
DR   EMBL; CH471066; EAW50098.1; -; Genomic_DNA.
DR   RefSeq; NP_055727.3; NM_014912.4.
DR   PeptideAtlas; B3KXC1; -.
DR   PRIDE; B3KXC1; -.
DR   DNASU; 22849; -.
DR   GeneID; 22849; -.
DR   KEGG; hsa:22849; -.
DR   CTD; 22849; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   KO; K02602; -.
DR   OrthoDB; 1075356at2759; -.
DR   ChiTaRS; CPEB3; human.
DR   GenomeRNAi; 22849; -.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:InterPro.
DR   GO; GO:0045182; F:translation regulator activity; IEA:InterPro.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          133..220
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          241..319
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
SQ   SEQUENCE   390 AA;  44200 MW;  BD86765B618E5F22 CRC64;
     MEDNAFRTDN GNNLLPFQDR SRPYDTFNLH SLENSLMDMI RTDHEPLKGK HYPPSGPPMS
     FADIMWRNHF AGRMGINFHH PGTDNIMALN SRSSLFPFED AFLDDSHGDQ ALSSGLSSPT
     RCQNGERVER YSRKVFVGGL PPDIDEDEIT ASFRRFGPLV VDWPHKAESK SYFPPKGYAF
     LLFQEESSVQ ALIDACLEED GKLYLCVSSP TIKDKPVQIR PWNLSDSDFV MDGSQPLDPR
     KTIFVGGVPR PLRAVELAMI MDRLYGGVCY AGIDTDPELK YPKGAGRVAF SNQQSYIAAI
     SARFVQLQHN DIDKRVEVKP YVLDDQMCDE CQGTRCGGKF APFFCANVTC LQYYCEYCWA
     SIHSRAGREF HKPLVKEGGD RPRHVPFRWS
//
ID   Q5QP71_HUMAN            Unreviewed;       684 AA.
AC   Q5QP71;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   22-APR-2020, entry version 90.
DE   SubName: Full=Cytoplasmic polyadenylation element binding protein 3, isoform CRA_a {ECO:0000313|EMBL:EAW50097.1};
DE   SubName: Full=cDNA FLJ61637, highly similar to Homo sapiens cytoplasmic polyadenylation element binding protein 3 (CPEB3), mRNA {ECO:0000313|EMBL:BAH13751.1};
GN   Name=CPEB3 {ECO:0000313|EMBL:EAW50097.1};
GN   ORFNames=hCG_20317 {ECO:0000313|EMBL:EAW50097.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13751.1};
RN   [1] {ECO:0000313|EMBL:EAW50097.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50097.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAH13751.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH13751.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK302576; BAH13751.1; -; mRNA.
DR   EMBL; CH471066; EAW50097.1; -; Genomic_DNA.
DR   RefSeq; NP_001171608.1; NM_001178137.1.
DR   RefSeq; XP_005269687.1; XM_005269630.4.
DR   Antibodypedia; 30391; 111 antibodies.
DR   DNASU; 22849; -.
DR   GeneID; 22849; -.
DR   CTD; 22849; -.
DR   EuPathDB; HostDB:ENSG00000107864.14; -.
DR   PharmGKB; PA134903478; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   HOGENOM; CLU_014948_2_1_1; -.
DR   OrthoDB; 1075356at2759; -.
DR   ChiTaRS; CPEB3; human.
DR   GenomeRNAi; 22849; -.
DR   Bgee; ENSG00000107864; Expressed in buccal mucosa cell and 205 other tissues.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:InterPro.
DR   GO; GO:0045182; F:translation regulator activity; IEA:InterPro.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          427..514
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          535..613
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   REGION          1..114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          158..208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        7..48
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        83..99
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        164..189
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   684 AA;  74440 MW;  7CD47A66E821AE71 CRC64;
     MQDDLLMDKS KTQPQPQQQQ RQQQQPQPES SVSEAPSTPL SSETPKPEEN SAVPALSPAA
     APPAPNGPDK MQMESPLLPG LSFHQPPQQP PPPQEPAAPG ASLSPSFGST WSTGTTNAVE
     DSFFQGITPV NGTMLFQNFP HHVNPVFGGT FSPQIGLAQT QHHQQPPPPA PAPQPAQPAQ
     PPQAQPPQQR RSPASPSQAP YAQRSAAAAY GHQPIMTSKP SSSSAVAAAA AAAAASSASS
     SWNTHQSVNA AWSAPSNPWG GLQAGRDPRR AVGVGVGVGV GVPSPLNPIS PLKKPFSSNV
     IAPPKFPRAA PLTSKSWMED NAFRTDNGNN LLPFQDRSRP YDTFNLHSLE NSLMDMIRTD
     HEPLKGRMGI NFHHPGTDNI MALNSRSSLF PFEDAFLDDS HGDQALSSGL SSPTRCQNGE
     RVERYSRKVF VGGLPPDIDE DEITASFRRF GPLVVDWPHK AESKSYFPPK GYAFLLFQEE
     SSVQALIDAC LEEDGKLYLC VSSPTIKDKP VQIRPWNLSD SDFVMDGSQP LDPRKTIFVG
     GVPRPLRAVE LAMIMDRLYG GVCYAGIDTD PELKYPKGAG RVAFSNQQSY IAAISARFVQ
     LQHNDIDKRV EVKPYVLDDQ MCDECQGTRC GGKFAPFFCA NVTCLQYYCE YCWASIHSRA
     GREFHKPLVK EGGDRPRHVP FRWS
//
ID   CPEB3_HUMAN             Reviewed;         698 AA.
AC   Q8NE35; Q5T389; Q9NQJ7; Q9Y2E9;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   12-DEC-2006, sequence version 2.
DT   22-APR-2020, entry version 147.
DE   RecName: Full=Cytoplasmic polyadenylation element-binding protein 3;
DE            Short=CPE-BP3;
DE            Short=CPE-binding protein 3;
DE            Short=hCPEB-3;
GN   Name=CPEB3; Synonyms=KIAA0940;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-324.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   RIBOZYME-ENCODING INTRON.
RX   PubMed=16990549; DOI=10.1126/science.1129308;
RA   Salehi-Ashtiani K., Luptak A., Litovchick A., Szostak J.W.;
RT   "A genomewide search for ribozymes reveals an HDV-like sequence in the
RT   human CPEB3 gene.";
RL   Science 313:1788-1792(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   ROLE OF RIBOZYME POLYMORPHISM IN MEMORY.
RX   PubMed=19503753; DOI=10.3389/neuro.08.004.2009;
RA   Vogler C., Spalek K., Aerni A., Demougin P., Mueller A., Huynh K.D.,
RA   Papassotiropoulos A., de Quervain D.J.;
RT   "CPEB3 is associated with human episodic memory.";
RL   Front. Behav. Neurosci. 3:4-4(2009).
RN   [7]
RP   FUNCTION, INTERACTION WITH STAT5B, AND SUBCELLULAR LOCATION.
RX   PubMed=20639532; DOI=10.1093/nar/gkq634;
RA   Peng S.C., Lai Y.T., Huang H.Y., Huang H.D., Huang Y.S.;
RT   "A novel role of CPEB3 in regulating EGFR gene transcription via
RT   association with Stat5b in neurons.";
RL   Nucleic Acids Res. 38:7446-7457(2010).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH TOB1.
RX   PubMed=21336257; DOI=10.1038/emboj.2011.37;
RA   Hosoda N., Funakoshi Y., Hirasawa M., Yamagishi R., Asano Y., Miyagawa R.,
RA   Ogami K., Tsujimoto M., Hoshino S.;
RT   "Anti-proliferative protein Tob negatively regulates CPEB3 target by
RT   recruiting Caf1 deadenylase.";
RL   EMBO J. 30:1311-1323(2011).
RN   [9]
RP   INTERACTION WITH IPO5 AND XPO1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LEU-349 AND LEU-353.
RX   PubMed=22730302; DOI=10.1093/nar/gks598;
RA   Chao H.W., Lai Y.T., Lu Y.L., Lin C.L., Mai W., Huang Y.S.;
RT   "NMDAR signaling facilitates the IPO5-mediated nuclear import of CPEB3.";
RL   Nucleic Acids Res. 40:8484-8498(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   SITES IMPORTANT FOR BINDING RNA, AND MUTAGENESIS OF ARG-441; PHE-444;
RP   GLY-446; ARG-463; ASP-470; LYS-474; SER-479; PHE-488 AND ARG-528.
RX   PubMed=24343026; DOI=10.1093/nar/gkt1299;
RA   Chen Y.C., Sargsyan K., Wright J.D., Huang Y.S., Lim C.;
RT   "Identifying RNA-binding residues based on evolutionary conserved
RT   structural and energetic features.";
RL   Nucleic Acids Res. 42:E15-E15(2014).
RN   [13]
RP   FUNCTION.
RX   PubMed=26398195; DOI=10.1371/journal.pone.0138794;
RA   Giangarra V., Igea A., Castellazzi C.L., Bava F.A., Mendez R.;
RT   "Global analysis of CPEBs reveals sequential and non-redundant functions in
RT   mitotic cell cycle.";
RL   PLoS ONE 10:E0138794-E0138794(2015).
RN   [14]
RP   STRUCTURE BY NMR OF 440-540.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RNA binding domain in cytoplasmic polyadenylation
RT   element binding protein 3.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [15]
RP   STRUCTURE BY NMR OF 440-540.
RX   PubMed=25066254; DOI=10.1002/prot.24651;
RA   Tsuda K., Kuwasako K., Nagata T., Takahashi M., Kigawa T., Kobayashi N.,
RA   Guentert P., Shirouzu M., Yokoyama S., Muto Y.;
RT   "Novel RNA recognition motif domain in the cytoplasmic polyadenylation
RT   element binding protein 3.";
RL   Proteins 82:2879-2886(2014).
CC   -!- FUNCTION: Sequence-specific RNA-binding protein which acts as a
CC       translational repressor in the basal unstimulated state but, following
CC       neuronal stimulation, acts as a translational activator (By
CC       similarity). In contrast to CPEB1, does not bind to the cytoplasmic
CC       polyadenylation element (CPE), a uridine-rich sequence element within
CC       the mRNA 3'-UTR, but binds to a U-rich loop within a stem-loop
CC       structure (By similarity). Required for the consolidation and
CC       maintenance of hippocampal-based long term memory (By similarity). In
CC       the basal state, binds to the mRNA 3'-UTR of the glutamate receptors
CC       GRIA2/GLUR2 mRNA and negatively regulates their translation (By
CC       similarity). Also represses the translation of DLG4, GRIN1, GRIN2A and
CC       GRIN2B (By similarity). When activated, acts as a translational
CC       activator of GRIA1 and GRIA2 (By similarity). In the basal state,
CC       suppresses SUMO2 translation but activates it following neuronal
CC       stimulation (By similarity). Binds to the 3'-UTR of TRPV1 mRNA and
CC       represses TRPV1 translation which is required to maintain normal
CC       thermoception (By similarity). Binds actin mRNA, leading to actin
CC       translational repression in the basal state and to translational
CC       activation following neuronal stimulation (By similarity). Negatively
CC       regulates target mRNA levels by binding to TOB1 which recruits
CC       CNOT7/CAF1 to a ternary complex and this leads to target mRNA
CC       deadenylation and decay (PubMed:21336257). In addition to its role in
CC       translation, binds to and inhibits the transcriptional activation
CC       activity of STAT5B without affecting its dimerization or DNA-binding
CC       activity. This, in turn, represses transcription of the STAT5B target
CC       gene EGFR which has been shown to play a role in enhancing learning and
CC       memory performance (PubMed:20639532). In contrast to CPEB1, CPEB2 and
CC       CPEB4, not required for cell cycle progression (PubMed:26398195).
CC       {ECO:0000250|UniProtKB:Q7TN99, ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:21336257, ECO:0000269|PubMed:26398195}.
CC   -!- SUBUNIT: Following synaptic activity, forms amyloid-like oligomers (By
CC       similarity). Aggregation requires an intact actin cytoskeleton (By
CC       similarity). Interacts with STAT5B; this inhibits STAT5B-mediated
CC       transcriptional activation (PubMed:20639532). Interacts with E3
CC       ubiquitin-protein ligase NEURL1; this leads to monoubiquitination and
CC       activation of CPEB3 (By similarity). Interacts with CAPN2; this leads
CC       to cleavage of CPEB3 (By similarity). Interacts (via C-terminal RNA-
CC       binding region) with TOB1; TOB1 also binds CNOT7/CAF1 and recruits it
CC       to CPEB3 to form a ternary complex (PubMed:21336257). Interacts with
CC       SUMO-conjugating enzyme UBC9 (By similarity). Interacts with IPO5; the
CC       interaction is enhanced in a RAN-regulated manner following neuronal
CC       stimulation and mediates CPEB3 nuclear import (PubMed:22730302).
CC       Interacts with exportin XPO1/CRM1 (PubMed:22730302).
CC       {ECO:0000250|UniProtKB:Q7TN99, ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:21336257, ECO:0000269|PubMed:22730302}.
CC   -!- INTERACTION:
CC       Q8NE35; P50616: TOB1; NbExp=7; IntAct=EBI-8596191, EBI-723281;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:22730302}. Nucleus {ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:22730302}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q7TN99}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q7TN99}. Cell junction, synapse, postsynaptic
CC       density {ECO:0000250|UniProtKB:Q7TN99}. Note=Predominantly cytoplasmic
CC       in unstimulated neurons but translocates to the nucleus following
CC       neuronal stimulation (PubMed:20639532, PubMed:22730302). Nuclear import
CC       is mediated by importin IPO5 (By similarity).
CC       {ECO:0000250|UniProtKB:Q7TN99, ECO:0000269|PubMed:20639532,
CC       ECO:0000269|PubMed:22730302}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NE35-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NE35-2; Sequence=VSP_022034, VSP_022035;
CC   -!- DOMAIN: The N-terminal Gln-rich region is required for the formation of
CC       amyloid-like oligomers and for the stability of long-term potentiation
CC       and spatial memory. {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Activated by NEURL1-mediated monoubiquitination, resulting in the
CC       growth of new dendritic spines and increased levels of GRIA1 and GRIA2.
CC       NEURL1-mediated monoubiquitination facilitates synaptic plasticity and
CC       hippocampal-dependent memory storage. {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Under basal unstimulated conditions when CPEB3 is mainly
CC       unaggregated, sumoylated and acts as a translational repressor.
CC       Following neuronal stimulation, becomes desumoylated and aggregated
CC       which is required for the translation of mRNA targets and for dendritic
CC       filopodia formation. {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Following neuronal stimulation, cleaved by CAPN2 which abolishes
CC       its translational repressor activity, leading to translation of CPEB3
CC       target mRNAs. {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- PTM: Phosphorylation is enhanced by neuronal stimulation.
CC       {ECO:0000250|UniProtKB:Q7TN99}.
CC   -!- MISCELLANEOUS: The CPEB3 gene contains an intron-encoded self-cleaving
CC       ribozyme which is structurally and biochemically related to human
CC       hepatitis delta virus ribozymes and which may play a role in the
CC       regulation of CPEB3 translation (PubMed:16990549). A polymorphism in
CC       the ribozyme sequence which influences cleavage activity of the
CC       ribozyme may play a role in episodic memory with carriers of a rare C
CC       allele-containing ribozyme showing significantly poorer memory recall
CC       performance than T allele carriers (PubMed:19503753).
CC       {ECO:0000269|PubMed:16990549, ECO:0000269|PubMed:19503753}.
CC   -!- SIMILARITY: Belongs to the RRM CPEB family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76784.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Tenacious memory - Issue 185
CC       of November 2016;
CC       URL="https://web.expasy.org/spotlight/back_issues/185/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB023157; BAA76784.2; ALT_INIT; mRNA.
DR   EMBL; AL158040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036444; AAH36444.1; -; mRNA.
DR   CCDS; CCDS31246.1; -. [Q8NE35-1]
DR   CCDS; CCDS53553.1; -. [Q8NE35-2]
DR   RefSeq; NP_001171608.1; NM_001178137.1. [Q8NE35-2]
DR   RefSeq; NP_055727.3; NM_014912.4. [Q8NE35-1]
DR   RefSeq; XP_005269687.1; XM_005269630.4. [Q8NE35-2]
DR   PDB; 2DNL; NMR; -; A=440-540.
DR   PDB; 2RUG; NMR; -; A=440-540.
DR   PDBsum; 2DNL; -.
DR   PDBsum; 2RUG; -.
DR   SMR; Q8NE35; -.
DR   BioGrid; 116521; 5.
DR   IntAct; Q8NE35; 9.
DR   MINT; Q8NE35; -.
DR   STRING; 9606.ENSP00000482128; -.
DR   iPTMnet; Q8NE35; -.
DR   PhosphoSitePlus; Q8NE35; -.
DR   BioMuta; CPEB3; -.
DR   DMDM; 119368633; -.
DR   jPOST; Q8NE35; -.
DR   MassIVE; Q8NE35; -.
DR   MaxQB; Q8NE35; -.
DR   PaxDb; Q8NE35; -.
DR   PeptideAtlas; Q8NE35; -.
DR   PRIDE; Q8NE35; -.
DR   ProteomicsDB; 73124; -. [Q8NE35-1]
DR   ProteomicsDB; 73125; -. [Q8NE35-2]
DR   Antibodypedia; 30391; 111 antibodies.
DR   DNASU; 22849; -.
DR   Ensembl; ENST00000265997; ENSP00000265997; ENSG00000107864. [Q8NE35-1]
DR   Ensembl; ENST00000412050; ENSP00000398310; ENSG00000107864. [Q8NE35-2]
DR   Ensembl; ENST00000614585; ENSP00000482128; ENSG00000107864. [Q8NE35-1]
DR   GeneID; 22849; -.
DR   KEGG; hsa:22849; -.
DR   UCSC; uc001khv.3; human. [Q8NE35-1]
DR   CTD; 22849; -.
DR   DisGeNET; 22849; -.
DR   GeneCards; CPEB3; -.
DR   HGNC; HGNC:21746; CPEB3.
DR   HPA; ENSG00000107864; Tissue enhanced (brain, liver).
DR   MIM; 610606; gene.
DR   neXtProt; NX_Q8NE35; -.
DR   OpenTargets; ENSG00000107864; -.
DR   PharmGKB; PA134903478; -.
DR   eggNOG; KOG0129; Eukaryota.
DR   eggNOG; ENOG410Y1XZ; LUCA.
DR   GeneTree; ENSGT00940000158949; -.
DR   HOGENOM; CLU_014948_2_1_1; -.
DR   InParanoid; Q8NE35; -.
DR   KO; K02602; -.
DR   OMA; FPHVNPV; -.
DR   OrthoDB; 1075356at2759; -.
DR   PhylomeDB; Q8NE35; -.
DR   TreeFam; TF317658; -.
DR   ChiTaRS; CPEB3; human.
DR   EvolutionaryTrace; Q8NE35; -.
DR   GenomeRNAi; 22849; -.
DR   Pharos; Q8NE35; Tbio.
DR   PRO; PR:Q8NE35; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8NE35; protein.
DR   Bgee; ENSG00000107864; Expressed in buccal mucosa cell and 205 other tissues.
DR   ExpressionAtlas; Q8NE35; baseline and differential.
DR   Genevisible; Q8NE35; HS.
DR   GO; GO:0097440; C:apical dendrite; ISS:UniProtKB.
DR   GO; GO:0030014; C:CCR4-NOT complex; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:1990124; C:messenger ribonucleoprotein complex; IBA:GO_Central.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0035613; F:RNA stem-loop binding; ISS:UniProtKB.
DR   GO; GO:0008135; F:translation factor activity, RNA binding; IDA:UniProtKB.
DR   GO; GO:0000900; F:translation repressor activity, mRNA regulatory element binding; ISS:UniProtKB.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; IDA:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB.
DR   GO; GO:0007616; P:long-term memory; ISS:UniProtKB.
DR   GO; GO:2000766; P:negative regulation of cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:1900248; P:negative regulation of cytoplasmic translational elongation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:1900365; P:positive regulation of mRNA polyadenylation; ISS:UniProtKB.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   Gene3D; 3.30.40.130; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR032296; CEBP_ZZ.
DR   InterPro; IPR038446; CEBP_ZZ_sf.
DR   InterPro; IPR034819; CPEB.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR12566; PTHR12566; 1.
DR   Pfam; PF16366; CEBP_ZZ; 1.
DR   Pfam; PF16367; RRM_7; 1.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Amyloid; Cell junction;
KW   Cell projection; Cytoplasm; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Repressor; RNA-binding; Synapse;
KW   Translation regulation; Ubl conjugation.
FT   CHAIN           1..698
FT                   /note="Cytoplasmic polyadenylation element-binding protein
FT                   3"
FT                   /id="PRO_0000269261"
FT   DOMAIN          441..532
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          549..631
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   COMPBIAS        13..27
FT                   /note="Gln-rich"
FT   COMPBIAS        26..200
FT                   /note="Pro-rich"
FT   COMPBIAS        170..238
FT                   /note="Ala-rich"
FT   SITE            441..442
FT                   /note="Cleavage; by CAPN2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TN99"
FT   SITE            444
FT                   /note="Required for RNA-binding activity"
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   SITE            488
FT                   /note="Required for RNA-binding activity"
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MOD_RES         192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TN99"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TN99"
FT   MOD_RES         308
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TN99"
FT   VAR_SEQ         366..388
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10231032"
FT                   /id="VSP_022034"
FT   VAR_SEQ         408
FT                   /note="N -> SRSSLFPFED (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10231032"
FT                   /id="VSP_022035"
FT   VARIANT         324
FT                   /note="R -> W (in dbSNP:rs17853616)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_029776"
FT   MUTAGEN         349
FT                   /note="L->A: Abolishes nuclear export; when associated with
FT                   A-353."
FT                   /evidence="ECO:0000269|PubMed:22730302"
FT   MUTAGEN         353
FT                   /note="L->A: Abolishes nuclear export; when associated with
FT                   A-349."
FT                   /evidence="ECO:0000269|PubMed:22730302"
FT   MUTAGEN         441
FT                   /note="R->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         444
FT                   /note="F->A,N: Abolishes RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         444
FT                   /note="F->Y: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         446
FT                   /note="G->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         463
FT                   /note="R->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         470
FT                   /note="D->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         474
FT                   /note="K->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         479
FT                   /note="S->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         488
FT                   /note="F->A: Reduced RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         488
FT                   /note="F->Y: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   MUTAGEN         528
FT                   /note="R->A: Does not impair RNA binding."
FT                   /evidence="ECO:0000269|PubMed:24343026"
FT   CONFLICT        519
FT                   /note="Missing (in Ref. 3; AAH36444)"
FT                   /evidence="ECO:0000305"
FT   STRAND          443..446
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   HELIX           454..460
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   TURN            461..464
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          467..470
FT                   /evidence="ECO:0000244|PDB:2RUG"
FT   STRAND          474..477
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          478..481
FT                   /evidence="ECO:0000244|PDB:2RUG"
FT   STRAND          485..489
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   HELIX           494..503
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          504..507
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          510..515
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          518..520
FT                   /evidence="ECO:0000244|PDB:2DNL"
FT   STRAND          522..528
FT                   /evidence="ECO:0000244|PDB:2DNL"
SQ   SEQUENCE   698 AA;  76014 MW;  0E67DCB7F8A40C96 CRC64;
     MQDDLLMDKS KTQPQPQQQQ RQQQQPQPES SVSEAPSTPL SSETPKPEEN SAVPALSPAA
     APPAPNGPDK MQMESPLLPG LSFHQPPQQP PPPQEPAAPG ASLSPSFGST WSTGTTNAVE
     DSFFQGITPV NGTMLFQNFP HHVNPVFGGT FSPQIGLAQT QHHQQPPPPA PAPQPAQPAQ
     PPQAQPPQQR RSPASPSQAP YAQRSAAAAY GHQPIMTSKP SSSSAVAAAA AAAAASSASS
     SWNTHQSVNA AWSAPSNPWG GLQAGRDPRR AVGVGVGVGV GVPSPLNPIS PLKKPFSSNV
     IAPPKFPRAA PLTSKSWMED NAFRTDNGNN LLPFQDRSRP YDTFNLHSLE NSLMDMIRTD
     HEPLKGKHYP PSGPPMSFAD IMWRNHFAGR MGINFHHPGT DNIMALNNAF LDDSHGDQAL
     SSGLSSPTRC QNGERVERYS RKVFVGGLPP DIDEDEITAS FRRFGPLVVD WPHKAESKSY
     FPPKGYAFLL FQEESSVQAL IDACLEEDGK LYLCVSSPTI KDKPVQIRPW NLSDSDFVMD
     GSQPLDPRKT IFVGGVPRPL RAVELAMIMD RLYGGVCYAG IDTDPELKYP KGAGRVAFSN
     QQSYIAAISA RFVQLQHNDI DKRVEVKPYV LDDQMCDECQ GTRCGGKFAP FFCANVTCLQ
     YYCEYCWASI HSRAGREFHK PLVKEGGDRP RHVPFRWS
//
ID   CSMD3_HUMAN             Reviewed;        3707 AA.
AC   Q7Z407; Q96PZ3;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 3.
DT   22-APR-2020, entry version 139.
DE   RecName: Full=CUB and sushi domain-containing protein 3;
DE   AltName: Full=CUB and sushi multiple domains protein 3;
GN   Name=CSMD3; Synonyms=KIAA1894;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12906867; DOI=10.1016/s0888-7543(03)00149-6;
RA   Lau W.L., Scholnick S.B.;
RT   "Identification of two new members of the CSMD gene family.";
RL   Genomics 82:412-415(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   VARIANTS MET-219 AND HIS-3621.
RC   TISSUE=Brain, and Testis;
RX   PubMed=12943675; DOI=10.1016/s0006-291x(03)01555-9;
RA   Shimizu A., Asakawa S., Shimizu N.;
RT   "A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple
RT   domains: a candidate gene for benign adult familial myoclonic epilepsy on
RT   human chromosome 8q23.3-q24.1.";
RL   Biochem. Biophys. Res. Commun. 309:143-154(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 661-3707 (ISOFORM 4), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI. The
RT   complete sequences of 60 new cDNA clones from brain which code for large
RT   proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2271-3707 (ISOFORM 5).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-322; HIS-3079 AND GLN-3359.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [6]
RP   VARIANT CYS-2020.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H.,
RA   Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J.,
RA   Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M.,
RA   Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A., Mudie L.,
RA   Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S., Kahnoski R.J.,
RA   Anema J., Tuveson D.A., Perez-Mancera P.A., Mustonen V., Fischer A.,
RA   Adams D.J., Rust A., Chan-On W., Subimerb C., Dykema K., Furge K.,
RA   Campbell P.J., Teh B.T., Stratton M.R., Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene
RT   PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Involved in dendrite development.
CC       {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q80T79};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z407-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z407-2; Sequence=VSP_009047;
CC       Name=3;
CC         IsoId=Q7Z407-3; Sequence=VSP_009048, VSP_009049;
CC       Name=4;
CC         IsoId=Q7Z407-4; Sequence=VSP_009050;
CC       Name=5;
CC         IsoId=Q7Z407-5; Sequence=VSP_009051, VSP_009052;
CC   -!- TISSUE SPECIFICITY: Weakly expressed in most tissues, except in brain.
CC       Expressed at intermediate level in brain, including cerebellum,
CC       substantia nigra, thalamus, spinal cord, hippocampus and fetal brain.
CC       Also expressed in testis. {ECO:0000269|PubMed:11572484,
CC       ECO:0000269|PubMed:12943675}.
CC   -!- DOMAIN: The intracellular region is dispensable for its function.
CC       {ECO:0000250|UniProtKB:Q80T79}.
CC   -!- SIMILARITY: Belongs to the CSMD family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO34702.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY210419; AAO34702.1; ALT_INIT; mRNA.
DR   EMBL; AB114604; BAC82443.1; -; mRNA.
DR   EMBL; AB114605; BAC82444.1; -; mRNA.
DR   EMBL; AB067481; BAB67787.2; -; mRNA.
DR   EMBL; AK126252; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS6315.1; -. [Q7Z407-1]
DR   CCDS; CCDS6316.2; -. [Q7Z407-3]
DR   CCDS; CCDS6317.1; -. [Q7Z407-2]
DR   RefSeq; NP_443132.3; NM_052900.2. [Q7Z407-3]
DR   RefSeq; NP_937756.1; NM_198123.1. [Q7Z407-1]
DR   RefSeq; NP_937757.1; NM_198124.1. [Q7Z407-2]
DR   RefSeq; XP_016868498.1; XM_017013009.1. [Q7Z407-4]
DR   SMR; Q7Z407; -.
DR   BioGrid; 125350; 1.
DR   IntAct; Q7Z407; 1.
DR   MINT; Q7Z407; -.
DR   STRING; 9606.ENSP00000297405; -.
DR   iPTMnet; Q7Z407; -.
DR   PhosphoSitePlus; Q7Z407; -.
DR   BioMuta; CSMD3; -.
DR   DMDM; 257051058; -.
DR   jPOST; Q7Z407; -.
DR   MaxQB; Q7Z407; -.
DR   PaxDb; Q7Z407; -.
DR   PeptideAtlas; Q7Z407; -.
DR   PRIDE; Q7Z407; -.
DR   ProteomicsDB; 69118; -. [Q7Z407-1]
DR   ProteomicsDB; 69119; -. [Q7Z407-2]
DR   ProteomicsDB; 69120; -. [Q7Z407-3]
DR   ProteomicsDB; 69121; -. [Q7Z407-4]
DR   ProteomicsDB; 69122; -. [Q7Z407-5]
DR   Antibodypedia; 26636; 98 antibodies.
DR   Ensembl; ENST00000297405; ENSP00000297405; ENSG00000164796. [Q7Z407-1]
DR   Ensembl; ENST00000343508; ENSP00000345799; ENSG00000164796. [Q7Z407-2]
DR   Ensembl; ENST00000455883; ENSP00000412263; ENSG00000164796. [Q7Z407-3]
DR   GeneID; 114788; -.
DR   KEGG; hsa:114788; -.
DR   UCSC; uc003ynt.4; human. [Q7Z407-1]
DR   CTD; 114788; -.
DR   DisGeNET; 114788; -.
DR   GeneCards; CSMD3; -.
DR   HGNC; HGNC:19291; CSMD3.
DR   HPA; ENSG00000164796; Tissue enriched (brain).
DR   MIM; 608399; gene.
DR   neXtProt; NX_Q7Z407; -.
DR   OpenTargets; ENSG00000164796; -.
DR   PharmGKB; PA134926063; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   GeneTree; ENSGT00940000155549; -.
DR   HOGENOM; CLU_000277_0_0_1; -.
DR   InParanoid; Q7Z407; -.
DR   KO; K17495; -.
DR   OMA; FKIRYVA; -.
DR   OrthoDB; 2377at2759; -.
DR   PhylomeDB; Q7Z407; -.
DR   TreeFam; TF316872; -.
DR   ChiTaRS; CSMD3; human.
DR   GenomeRNAi; 114788; -.
DR   Pharos; Q7Z407; Tbio.
DR   PRO; PR:Q7Z407; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q7Z407; protein.
DR   Bgee; ENSG00000164796; Expressed in middle temporal gyrus and 82 other tissues.
DR   ExpressionAtlas; Q7Z407; baseline and differential.
DR   Genevisible; Q7Z407; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0050773; P:regulation of dendrite development; ISS:UniProtKB.
DR   CDD; cd00033; CCP; 28.
DR   CDD; cd00041; CUB; 14.
DR   Gene3D; 2.60.120.290; -; 14.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   Pfam; PF00431; CUB; 14.
DR   Pfam; PF00084; Sushi; 28.
DR   SMART; SM00032; CCP; 28.
DR   SMART; SM00042; CUB; 14.
DR   SUPFAM; SSF49854; SSF49854; 14.
DR   SUPFAM; SSF57535; SSF57535; 28.
DR   PROSITE; PS01180; CUB; 14.
DR   PROSITE; PS50923; SUSHI; 28.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Membrane; Polymorphism; Reference proteome; Repeat; Sushi; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..3707
FT                   /note="CUB and sushi domain-containing protein 3"
FT                   /id="PRO_0000021027"
FT   TOPO_DOM        1..42
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        43..63
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        64..3630
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        3631..3651
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3652..3707
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          65..173
FT                   /note="CUB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          176..237
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          241..345
FT                   /note="CUB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          484..545
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          548..659
FT                   /note="CUB 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          662..719
FT                   /note="Sushi 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          721..829
FT                   /note="CUB 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          832..893
FT                   /note="Sushi 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          895..1003
FT                   /note="CUB 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1008..1065
FT                   /note="Sushi 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1067..1177
FT                   /note="CUB 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1180..1239
FT                   /note="Sushi 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1241..1349
FT                   /note="CUB 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1352..1412
FT                   /note="Sushi 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1414..1523
FT                   /note="CUB 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1526..1586
FT                   /note="Sushi 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1588..1696
FT                   /note="CUB 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1699..1760
FT                   /note="Sushi 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1762..1870
FT                   /note="CUB 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          1876..1937
FT                   /note="Sushi 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          1939..2047
FT                   /note="CUB 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          2050..2109
FT                   /note="Sushi 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2111..2219
FT                   /note="CUB 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          2222..2281
FT                   /note="Sushi 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2283..2394
FT                   /note="CUB 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          2393..2454
FT                   /note="Sushi 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2456..2567
FT                   /note="CUB 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          2567..2629
FT                   /note="Sushi 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2630..2691
FT                   /note="Sushi 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2692..2756
FT                   /note="Sushi 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2757..2814
FT                   /note="Sushi 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2815..2872
FT                   /note="Sushi 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2873..2930
FT                   /note="Sushi 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2931..2992
FT                   /note="Sushi 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          2993..3050
FT                   /note="Sushi 21"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3054..3111
FT                   /note="Sushi 22"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3112..3170
FT                   /note="Sushi 23"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3171..3230
FT                   /note="Sushi 24"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3231..3288
FT                   /note="Sushi 25"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3289..3346
FT                   /note="Sushi 26"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3350..3408
FT                   /note="Sushi 27"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          3409..3468
FT                   /note="Sushi 28"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        361
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        724
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        823
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        966
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1092
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1126
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1171
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1280
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1536
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1709
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1781
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1929
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2019
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2155
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2291
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2495
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2537
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2711
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2742
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2862
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2932
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2952
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3099
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3158
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3194
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3218
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3276
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3364
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3522
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3529
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3612
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3618
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        65..91
FT                   /evidence="ECO:0000250"
FT   DISULFID        178..218
FT                   /evidence="ECO:0000250"
FT   DISULFID        204..235
FT                   /evidence="ECO:0000250"
FT   DISULFID        241..267
FT                   /evidence="ECO:0000250"
FT   DISULFID        486..526
FT                   /evidence="ECO:0000250"
FT   DISULFID        512..543
FT                   /evidence="ECO:0000250"
FT   DISULFID        548..574
FT                   /evidence="ECO:0000250"
FT   DISULFID        664..704
FT                   /evidence="ECO:0000250"
FT   DISULFID        690..717
FT                   /evidence="ECO:0000250"
FT   DISULFID        721..747
FT                   /evidence="ECO:0000250"
FT   DISULFID        834..875
FT                   /evidence="ECO:0000250"
FT   DISULFID        860..891
FT                   /evidence="ECO:0000250"
FT   DISULFID        895..921
FT                   /evidence="ECO:0000250"
FT   DISULFID        1010..1050
FT                   /evidence="ECO:0000250"
FT   DISULFID        1036..1063
FT                   /evidence="ECO:0000250"
FT   DISULFID        1067..1093
FT                   /evidence="ECO:0000250"
FT   DISULFID        1182..1222
FT                   /evidence="ECO:0000250"
FT   DISULFID        1208..1237
FT                   /evidence="ECO:0000250"
FT   DISULFID        1241..1267
FT                   /evidence="ECO:0000250"
FT   DISULFID        1354..1395
FT                   /evidence="ECO:0000250"
FT   DISULFID        1381..1410
FT                   /evidence="ECO:0000250"
FT   DISULFID        1414..1441
FT                   /evidence="ECO:0000250"
FT   DISULFID        1528..1568
FT                   /evidence="ECO:0000250"
FT   DISULFID        1554..1584
FT                   /evidence="ECO:0000250"
FT   DISULFID        1588..1614
FT                   /evidence="ECO:0000250"
FT   DISULFID        1701..1741
FT                   /evidence="ECO:0000250"
FT   DISULFID        1727..1758
FT                   /evidence="ECO:0000250"
FT   DISULFID        1762..1788
FT                   /evidence="ECO:0000250"
FT   DISULFID        1878..1918
FT                   /evidence="ECO:0000250"
FT   DISULFID        1904..1935
FT                   /evidence="ECO:0000250"
FT   DISULFID        1939..1965
FT                   /evidence="ECO:0000250"
FT   DISULFID        2052..2092
FT                   /evidence="ECO:0000250"
FT   DISULFID        2078..2107
FT                   /evidence="ECO:0000250"
FT   DISULFID        2111..2137
FT                   /evidence="ECO:0000250"
FT   DISULFID        2224..2264
FT                   /evidence="ECO:0000250"
FT   DISULFID        2250..2279
FT                   /evidence="ECO:0000250"
FT   DISULFID        2283..2309
FT                   /evidence="ECO:0000250"
FT   DISULFID        2395..2437
FT                   /evidence="ECO:0000250"
FT   DISULFID        2423..2452
FT                   /evidence="ECO:0000250"
FT   DISULFID        2456..2484
FT                   /evidence="ECO:0000250"
FT   DISULFID        2569..2610
FT                   /evidence="ECO:0000250"
FT   DISULFID        2596..2627
FT                   /evidence="ECO:0000250"
FT   DISULFID        2632..2674
FT                   /evidence="ECO:0000250"
FT   DISULFID        2658..2689
FT                   /evidence="ECO:0000250"
FT   DISULFID        2694..2739
FT                   /evidence="ECO:0000250"
FT   DISULFID        2725..2754
FT                   /evidence="ECO:0000250"
FT   DISULFID        2759..2799
FT                   /evidence="ECO:0000250"
FT   DISULFID        2785..2812
FT                   /evidence="ECO:0000250"
FT   DISULFID        2817..2857
FT                   /evidence="ECO:0000250"
FT   DISULFID        2843..2870
FT                   /evidence="ECO:0000250"
FT   DISULFID        2875..2915
FT                   /evidence="ECO:0000250"
FT   DISULFID        2901..2928
FT                   /evidence="ECO:0000250"
FT   DISULFID        2933..2977
FT                   /evidence="ECO:0000250"
FT   DISULFID        2963..2990
FT                   /evidence="ECO:0000250"
FT   DISULFID        2995..3035
FT                   /evidence="ECO:0000250"
FT   DISULFID        3021..3048
FT                   /evidence="ECO:0000250"
FT   DISULFID        3056..3096
FT                   /evidence="ECO:0000250"
FT   DISULFID        3082..3109
FT                   /evidence="ECO:0000250"
FT   DISULFID        3114..3155
FT                   /evidence="ECO:0000250"
FT   DISULFID        3141..3168
FT                   /evidence="ECO:0000250"
FT   DISULFID        3173..3215
FT                   /evidence="ECO:0000250"
FT   DISULFID        3199..3228
FT                   /evidence="ECO:0000250"
FT   DISULFID        3233..3273
FT                   /evidence="ECO:0000250"
FT   DISULFID        3259..3286
FT                   /evidence="ECO:0000250"
FT   DISULFID        3291..3331
FT                   /evidence="ECO:0000250"
FT   DISULFID        3317..3344
FT                   /evidence="ECO:0000250"
FT   DISULFID        3352..3393
FT                   /evidence="ECO:0000250"
FT   DISULFID        3379..3406
FT                   /evidence="ECO:0000250"
FT   DISULFID        3411..3453
FT                   /evidence="ECO:0000250"
FT   DISULFID        3438..3466
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..59
FT                   /note="MKGIRKGESRAKESKPWEPGKRRCAKCGRLDFILMKKMGIKSGFTFWNLVFL
FT                   LTVSCVK -> MWSWFLCWKPVQLDRQTAS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12943675"
FT                   /id="VSP_009047"
FT   VAR_SEQ         344..447
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12906867"
FT                   /id="VSP_009048"
FT   VAR_SEQ         1799..1868
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11572484"
FT                   /id="VSP_009050"
FT   VAR_SEQ         2629..2675
FT                   /note="AISCGIPKAPTNGGILTTDYLVGTRVTYFCNDGYRLSSKELTTAVCQ -> G
FT                   EVYYAKMNKNMNVRLAPFNVFIWITHFSENGNIRKHIVNSFHKNKA (in isoform
FT                   5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_009051"
FT   VAR_SEQ         2676..3707
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_009052"
FT   VAR_SEQ         2692..2756
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12906867"
FT                   /id="VSP_009049"
FT   VARIANT         219
FT                   /note="I -> M (in dbSNP:rs2219898)"
FT                   /evidence="ECO:0000269|PubMed:12943675"
FT                   /id="VAR_017404"
FT   VARIANT         322
FT                   /note="W -> G (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035688"
FT   VARIANT         2020
FT                   /note="S -> C (found in a renal cell carcinoma case;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21248752"
FT                   /id="VAR_064703"
FT   VARIANT         3000
FT                   /note="V -> L (in dbSNP:rs2193430)"
FT                   /id="VAR_017405"
FT   VARIANT         3079
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs780986269)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035689"
FT   VARIANT         3359
FT                   /note="R -> Q (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs139968762)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035690"
FT   VARIANT         3621
FT                   /note="N -> H (in dbSNP:rs1592624)"
FT                   /evidence="ECO:0000269|PubMed:12943675"
FT                   /id="VAR_017406"
FT   CONFLICT        510
FT                   /note="F -> L (in Ref. 1; AAO34702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        726
FT                   /note="T -> A (in Ref. 1; AAO34702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        977
FT                   /note="S -> I (in Ref. 3; BAB67787)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2104
FT                   /note="I -> T (in Ref. 1; AAO34702)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   3707 AA;  406000 MW;  3194CBF8FE56ED76 CRC64;
     MKGIRKGESR AKESKPWEPG KRRCAKCGRL DFILMKKMGI KSGFTFWNLV FLLTVSCVKG
     FIYTCGGTLK GLNGTIESPG FPYGYPNGAN CTWVIIAEER NRIQIVFQSF ALEEEYDYLS
     LYDGHPHPTN FRTRLTGFHL PPPVTSTKSV FSLRLTSDFA VSAHGFKVYY EELQSSSCGN
     PGVPPKGVLY GTRFDVGDKI RYSCVTGYIL DGHPQLTCIA NSVNTASWDF PVPICRAEDA
     CGGTMRGSSG IISSPSFPNE YHNNADCTWT IVAEPGDTIS LIFTDFQMEE KYDYLEIEGS
     EPPTIWLSGM NIPPPIISNK NWLRLHFVTD SNHRYRGFSA PYQGSSTLTH TTSTGELEEH
     NRTTTGAIAV ASTPADVTVS SVTAVTIHRL SEEQRVQVTS LRNSGLDPNT SKDGLSPHPA
     DTQSTRRRPR HAEQIERTKE LAVVTHRVKK AIDFKSRGFK LFPGKDNSNK FSILNEGGIK
     TASNLCPDPG EPENGKRIGS DFSLGSTVQF SCDEDYVLQG AKSITCQRIA EVFAAWSDHR
     PVCKVKTCGS NLQGPSGTFT SPNFPFQYDS NAQCVWVITA VNTNKVIQIN FEEFDLEIGY
     DTLTIGDGGE VGDPRTVLQV LTGSFVPDLI VSMSSQMWLH LQTDESVGSV GFKVNYKEIE
     KESCGDPGTP LYGIREGDGF SNRDVLRFEC QFGFELIGEK SIVCQENNQW SANIPICIFP
     CLSNFTAPMG TVLSPDYPEG YGNNLNCIWT IISDPGSRIH LSFNDFDLES QFDFLAVKDG
     DSPESPILGT FTGAEVPSHL TSNSHILRLE FQADHSMSGR GFNITYNTFG HNECPDPGIP
     INARRFGDNF QLGSSISVIC EEGFIKTQGT ETITCILMDG KVMWSGLIPK CGAPCGGHFS
     APSGVILSPG WPGYYKDSLN CEWVIEAEPG HSIKITFERF QTELNYDVLE VHDGPNLLSP
     LLGSYNGTQV PQFLFSSSNF IYLLFTTDNS RSNNGFKIHY ESVTVNTYSC LDPGIPVHGR
     RYGHDFSIGS TVSFSCDSGY RLSHEEPLLC EKNHWWSHPL PTCDALCGGD VRGPSGTILS
     PGYPEFYPNS LNCTWTVDVT HGKGVQFNFH TFHLEDHHDY LLITENGSFT QPLARLTGSD
     LPPTINAGLY GNFRAQLRFI SDFSISYEGF NITFSEYNLE PCEDPGIPQY GSRIGFNFGI
     GDTLTFSCSS GYRLEGTSEI ICLGGGRRVW SAPLPRCVAE CGASATNNEG ILLSPNYPLN
     YENNHECIYS IQVQAGKGIN ISARTFHLAQ GDVLKIYDGK DKTTHLLGAF TGASMRGLTL
     SSTSNQLWLE FNSDTEGTDE GFQLVYTSFE LSHCEDPGIP QFGYKISDQG HFAGSTIIYG
     CNPGYTLHGS SLLKCMTGER RAWDYPLPSC IAECGGRFKG ESSGRILSPG YPFPYDNNLR
     CMWMIEVDPG NIVSLQFLAF DTEASHDILR VWDGPPENDM LLKEISGSLI PEGIHSTLNI
     VTIQFDTDFY ISKSGFAIQF SSSVATACRD PGVPMNGTRN GDGREPGDTV VFQCDPGYEL
     QGEERITCIQ VENRYFWQPS PPVCIAPCGG NLTGSSGFIL SPNFPHPYPH SRDCDWTITV
     NADYVISLAF ISFSIEPNYD FLYIYDGPDS NSPLIGSFQD SKLPERIESS SNTMHLAFRS
     DGSVSYTGFH LEYKAKLRES CFDPGNIMNG TRLGMDYKLG STVTYYCDAG YVLQGYSTLT
     CIMGDDGRPG WNRALPSCHA PCGSRSTGSE GTVLSPNYPK NYSVGHNCVY SIAVPKEFVV
     FGQFVFFQTS LHDVVEVYDG PTQQSSLLSS LSGSHSGESL PLSSGNQITI RFTSVGPITA
     KGFHFVYQAV PRTSSTQCSS VPEPRFGRRI GNEFAVGSSV LFDCNPGYIL HGSIAIRCET
     VPNSLAQWND SLPTCIVPCG GILTKRKGTI LSPGYPEPYD NNLNCVWKIT VPEGAGIQVQ
     VVSFATEHNW DSLDFYDGGD NNAPRLGSYS GTTIPHLLNS TSNNLYLNFQ SDISVSAAGF
     HLEYTAIGLD SCPEPQTPSS GIKIGDRYMV GDVVSFQCDQ GYSLQGHSHI TCMPGPVRRW
     NYPIPICLAQ CGGAMSDFSG VILSPGFPGN YPSSLDCTWT INLPIGFGVH LQFVNFSTET
     IHDYLEVRSG SSETSTVIGR LSGPQIPSSL FSTTHETSLY FHSDYSQNKQ GFHIVYQAYQ
     LQSCPDPRPF RNGFVIGNDF TVGQTISFEC FPGYTLIGNS ALTCLHGVSR NWNHPLPRCE
     ALCGGNITAM NGTIYSPGYP DEYPNFQDCF WLVRVPPGNG IYINFTVLQT EPIYDFITVW
     DGPDQNSPQI GQFSGNTALE SVYSTSNQIL IKFHSDFTTS GFFVLSYHAY QLRVCQPPPP
     VPNAEILTED DEFEIGDIIR YQCLPGFTLV GNAILTCRLG ERLQMDGAPP VCQVLCPANE
     LRLDSTGVIL SPGYPDSYPN LQMCAWSISV EKGYNITMFV EFFQTEKEFD VLQVYDGPNI
     QSPVLISLSG DYSSAFNITS NGHEVFLQWS ADHGNNKKGF RIRYIAFYCS TPESPPHGYI
     ISQTGGQLNS VVRWACDRGF RLVGKSSAVC RKSSYGYHAW DAPVPACQAI SCGIPKAPTN
     GGILTTDYLV GTRVTYFCND GYRLSSKELT TAVCQSDGTW SNHNKTPRCV VVTCPSINSF
     ILEHGRWRIV NGSHYEYKTK VVFSCDPGYH GLGPASIECL PNGTWSWRNE RPYCQIISCG
     ELPTPPNGNK IGTQTSYGST AIFTCDLGFM LVGSAVRECL SSGLWSESET RCLAGHCGIP
     ELIVNGQVIG ENYGYRDTVV YQCNPGFRLI GSSVRICQQD HNWSGQLPSC VPVSCGHPGS
     PIYGRTSGNG FNFNDVVTFS CNIGYLMQGP TKAQCQANRQ WSHPPPMCKV VNCSDPGIPA
     NSKRESKIEH GNFTYGTVVF YDCNPGYFLF GSSVLICQPN GQWDKPLPEC IMIDCGHPGV
     PPNAVLSGEK YTFGSTVHYS CTGKRSLLGQ SSRTCQLNGH WSGSQPHCSG DATGTCGDPG
     TPGHGSRQES NFRTKSTVRY ACDTGYILHG SEERTCLANG SWTGRQPECK AVQCGNPGTT
     ANGKVFRIDG TTFSSSVIYS CMEGYILSGP SVRQCTANGT WSGTLPNCTI ISCGDPGIPA
     NGLRYGDDYV VGQNVSYMCQ PGYTMELNGS RIRTCTINGT WSGVMPTCRA VTCPTPPQIS
     NGRLEGTNFD WGFSISYICS PGYELSFPAV LTCVGNGTWS GEVPQCLPKF CGDPGIPAQG
     KREGKSFIYQ SEVSFSCNFP FILVGSSTRI CQADGTWSGS SPHCIEPTQT SCENPGVPRH
     GSQNNTFGFQ VGSVVQFHCK KGHLLQGSTT RTCLPDLTWS GIQPECIPHS CKQPETPAHA
     NVVGMDLPSH GYTLIYTCQP GFFLAGGTEH RVCRSDNTWT GKVPICEAGS KILVKDPRPA
     LGTPSPKLSV PDDVFAQNYI WKGSYNFKGR KQPMTLTVTS FNASTGRVNA TLSNSNMELL
     LSGVYKSQEA RLMLRIYLIK VPAHASVKKM KEENWAMDGF VSAEPDGATY VFQGFIQGKD
     YGQFGLQRLG LNMSEGSNSS NQPHGTNSSS VAIAILVPFF ALIFAGFGFY LYKQRTAPKT
     QYTGCSVHEN NNGQAAFENP MYDTNAKSVE GKAVRFDPNL NTVCTMV
//
ID   A0A024R475_HUMAN        Unreviewed;       768 AA.
AC   A0A024R475;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 37.
DE   SubName: Full=Cullin 3, isoform CRA_a {ECO:0000313|EMBL:EAW70830.1};
GN   Name=CUL3 {ECO:0000313|EMBL:EAW70830.1};
GN   ORFNames=hCG_21435 {ECO:0000313|EMBL:EAW70830.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW70830.1};
RN   [1] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW70830.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471063; EAW70830.1; -; Genomic_DNA.
DR   RefSeq; NP_003581.1; NM_003590.4.
DR   SMR; A0A024R475; -.
DR   PRIDE; A0A024R475; -.
DR   Antibodypedia; 3632; 373 antibodies.
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   CTD; 8452; -.
DR   EuPathDB; HostDB:ENSG00000036257.12; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   KO; K03869; -.
DR   OMA; EIHTKNA; -.
DR   PhylomeDB; A0A024R475; -.
DR   ChiTaRS; CUL3; human.
DR   GenomeRNAi; 8452; -.
DR   Bgee; ENSG00000036257; Expressed in sperm and 229 other tissues.
DR   ExpressionAtlas; A0A024R475; baseline and differential.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0040016; P:embryonic cleavage; IEA:Ensembl.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; IEA:Ensembl.
DR   GO; GO:0017145; P:stem cell division; IEA:Ensembl.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   3: Inferred from homology;
FT   DOMAIN          383..635
FT                   /note="CULLIN_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50069"
FT   REGION          677..698
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        682..698
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   B7Z600_HUMAN            Unreviewed;       550 AA.
AC   B7Z600;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   22-APR-2020, entry version 54.
DE   SubName: Full=cDNA FLJ53180, highly similar to Cullin-3 {ECO:0000313|EMBL:BAH13086.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13086.1};
RN   [1] {ECO:0000313|EMBL:BAH13086.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH13086.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299644; BAH13086.1; -; mRNA.
DR   RefSeq; NP_001244126.1; NM_001257197.1.
DR   PeptideAtlas; B7Z600; -.
DR   PRIDE; B7Z600; -.
DR   GeneID; 8452; -.
DR   CTD; 8452; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   GenomeRNAi; 8452; -.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IEA:InterPro.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          165..417
FT                   /note="CULLIN_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50069"
FT   REGION          459..480
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        464..480
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   550 AA;  63310 MW;  511659C88F9360D0 CRC64;
     MESQKFLAEN SASVYIKKVE ARINEEIERV MHCLDKSTEE PIVKVVEREL ISKHMKTIVE
     MENSGLVHML KNGKTEDLGC MYKLFSRVPN GLKTMCECMS SYLREQGKAL VSEEGEGKNP
     VDYIQGLLDL KSRFDRFLLE SFNNDRLFKQ TIAGDFEYFL NLNSRSPEYL SLFIDDKLKK
     GVKGLTEQEV ETILDKAMVL FRFMQEKDVF ERYYKQHLAR RLLTNKSVSD DSEKNMISKL
     KTECGCQFTS KLEGMFRDMS ISNTTMDEFR QHLQATGVSL GGVDLTVRVL TTGYWPTQSA
     TPKCNIPPAP RHAFEIFRRF YLAKHSGRQL TLQHHMGSAD LNATFYGPIK KEDGSEVGVG
     GAQVTGSNTR KHILQVSTFQ MTILMLFNNR EKYTFEEIQQ ETDIPERELV RALQSLACGK
     PTQRVLTKEP KSKEIENGHI FTVNDQFTSK LHRVKIQTVA AKQGESDPER KETRQKVDDD
     RKHEIEAAIV RIMKSRKKMQ HNVLVAEVTQ QLKARFLPSP VVIKKRIEGL IEREYLARTP
     EDRKVYTYVA
//
ID   CUL3_HUMAN              Reviewed;         768 AA.
AC   Q13618; A8K536; B8ZZC3; O75415; Q569L3; Q9UBI8; Q9UET7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   22-APR-2020, entry version 205.
DE   RecName: Full=Cullin-3;
DE            Short=CUL-3;
GN   Name=CUL3; Synonyms=KIAA0617;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9733711; DOI=10.1074/jbc.273.38.24289;
RA   Du M., Sansores-Garcia L., Zu Z., Wu K.K.;
RT   "Cloning and expression analysis of a novel salicylate suppressible gene,
RT   Hs-CUL-3, a member of cullin/Cdc53 family.";
RL   J. Biol. Chem. 273:24289-24292(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9663463;
RA   Michel J.J., Xiong Y.;
RT   "Human CUL-1, but not other cullin family members, selectively interacts
RT   with SKP1 to form a complex with SKP2 and cyclin A.";
RL   Cell Growth Differ. 9:435-449(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Xu M., Huang X.Y., Yin L.L., Xu Z.Y., Lu L., Zhou Z.M., Sha J.H.;
RT   "Cloning and characterization of a new isoform of CUL3 gene in testis.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 192-768.
RX   PubMed=8681378; DOI=10.1016/s0092-8674(00)81267-2;
RA   Kipreos E.T., Lander L.E., Wing J.P., He W.W., Hedgecock E.M.;
RT   "cul-1 is required for cell cycle exit in C. elegans and identifies a novel
RT   gene family.";
RL   Cell 85:829-839(1996).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 398-768.
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 3), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH CYCE, AND NEDDYLATION.
RX   PubMed=10500095; DOI=10.1101/gad.13.18.2375;
RA   Singer J.D., Gurian-West M., Clurman B., Roberts J.M.;
RT   "Cullin-3 targets cyclin E for ubiquitination and controls S phase in
RT   mammalian cells.";
RL   Genes Dev. 13:2375-2387(1999).
RN   [12]
RP   FUNCTION.
RX   PubMed=11311237; DOI=10.1016/s0014-5793(01)02343-2;
RA   Maeda I., Ohta T., Koizumi H., Fukuda M.;
RT   "In vitro ubiquitination of cyclin D1 by ROC1-CUL1 and ROC1-CUL3.";
RL   FEBS Lett. 494:181-185(2001).
RN   [13]
RP   NEDDYLATION.
RX   PubMed=10597293; DOI=10.1038/sj.onc.1203093;
RA   Hori T., Osaka F., Chiba T., Miyamoto C., Okabayashi K., Shimbara N.,
RA   Kato S., Tanaka K.;
RT   "Covalent modification of all members of human cullin family proteins by
RT   NEDD8.";
RL   Oncogene 18:6829-6834(1999).
RN   [14]
RP   INTERACTION WITH RBX1 AND RNF7.
RX   PubMed=10230407; DOI=10.1016/s1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with an
RT   associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [15]
RP   INTERACTION WITH TIP120A.
RX   PubMed=12609982; DOI=10.1074/jbc.m213070200;
RA   Min K.-W., Hwang J.-W., Lee J.-S., Park Y., Tamura T.-A., Yoon J.-B.;
RT   "TIP120A associates with cullins and modulates ubiquitin ligase activity.";
RL   J. Biol. Chem. 278:15905-15910(2003).
RN   [16]
RP   INTERACTION WITH GAN; ZBTB16; KLHL9; KLHL13; KLHL21; KLHL3; KLHL15; KLHL20;
RP   KLHL36; GMCL2; BTBD1 AND SPOP.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [17]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL41) COMPLEX, IDENTIFICATION IN THE
RP   BCR(ENC1) COMPLEX, IDENTIFICATION IN THE BCR(KEAP1) COMPLEX, AND
RP   IDENTIFICATION IN THE BCR(GAN) COMPLEX.
RX   PubMed=15983046; DOI=10.1074/jbc.m501279200;
RA   Zhang D.D., Lo S.C., Sun Z., Habib G.M., Lieberman M.W., Hannink M.;
RT   "Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3,
RT   targets Keap1 for degradation by a proteasome-independent pathway.";
RL   J. Biol. Chem. 280:30091-30099(2005).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH SPOP AND BMI1, IDENTIFICATION IN A COMPLEX
RP   WITH SPOP AND MACROH2A1, AND FUNCTION.
RX   PubMed=15897469; DOI=10.1073/pnas.0408918102;
RA   Hernandez-Munoz I., Lund A.H., van der Stoop P., Boutsma E., Muijrers I.,
RA   Verhoeven E., Nusinow D.A., Panning B., Marahrens Y., van Lohuizen M.;
RT   "Stable X chromosome inactivation involves the PRC1 Polycomb complex and
RT   requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7635-7640(2005).
RN   [19]
RP   IDENTIFICATION IN THE BCR(SPOP) COMPLEX, INTERACTION WITH SPOP, AND
RP   FUNCTION IN UBIQUITINATION OF DAXX.
RX   PubMed=16524876; DOI=10.1074/jbc.m600204200;
RA   Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., Baek S.H.,
RA   Chiba T., Tanaka K., Bang O.S., Joe C.O., Chung C.H.;
RT   "BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor
RT   of Daxx for ubiquitination by Cul3-based ubiquitin ligase.";
RL   J. Biol. Chem. 281:12664-12672(2006).
RN   [20]
RP   FUNCTION OF THE BCR(KEAP1) COMPLEX, AND IDENTIFICATION IN THE BCR(KEAP1)
RP   COMPLEX.
RX   PubMed=15601839; DOI=10.1128/mcb.25.1.162-171.2005;
RA   Furukawa M., Xiong Y.;
RT   "BTB protein Keap1 targets antioxidant transcription factor Nrf2 for
RT   ubiquitination by the Cullin 3-Roc1 ligase.";
RL   Mol. Cell. Biol. 25:162-171(2005).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH KLHL9 AND KLHL13.
RX   PubMed=17543862; DOI=10.1016/j.devcel.2007.03.019;
RA   Sumara I., Quadroni M., Frei C., Olma M.H., Sumara G., Ricci R., Peter M.;
RT   "A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes,
RT   regulating mitotic progression and completion of cytokinesis in human
RT   cells.";
RL   Dev. Cell 12:887-900(2007).
RN   [22]
RP   SELF-ASSOCIATION.
RX   PubMed=17254749; DOI=10.1016/j.cellsig.2006.12.002;
RA   Chew E.H., Poobalasingam T., Hawkey C.J., Hagen T.;
RT   "Characterization of cullin-based E3 ubiquitin ligases in intact mammalian
RT   cells -- evidence for cullin dimerization.";
RL   Cell. Signal. 19:1071-1080(2007).
RN   [23]
RP   BCR COMPLEX HOMODIMERIZATION.
RX   PubMed=17192413; DOI=10.1091/mbc.e06-06-0542;
RA   Wimuttisuk W., Singer J.D.;
RT   "The Cullin3 ubiquitin ligase functions as a Nedd8-bound heterodimer.";
RL   Mol. Biol. Cell 18:899-909(2007).
RN   [24]
RP   INTERACTION WITH KCTD5.
RX   PubMed=18573101; DOI=10.1111/j.1742-4658.2008.06537.x;
RA   Bayon Y., Trinidad A.G., de la Puerta M.L., Del Carmen Rodriguez M.,
RA   Bogetz J., Rojas A., De Pereda J.M., Rahmouni S., Williams S.,
RA   Matsuzawa S., Reed J.C., Crespo M.S., Mustelin T., Alonso A.;
RT   "KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases.";
RL   FEBS J. 275:3900-3910(2008).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH ATF2 AND KAT5.
RX   PubMed=18397884; DOI=10.1074/jbc.m802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [26]
RP   FUNCTION OF THE BCR(KEAP1) COMPLEX.
RX   PubMed=16006525; DOI=10.1073/pnas.0502402102;
RA   Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., Mesecar A.D.;
RT   "Modifying specific cysteines of the electrophile-sensing human Keap1
RT   protein is insufficient to disrupt binding to the Nrf2 domain Neh2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:10070-10075(2005).
RN   [27]
RP   IDENTIFICATION IN THE BCR(KLHL42) COMPLEX, FUNCTION IN UBIQUITINATION OF
RP   KATNA1, AND INTERACTION WITH KATNA1 AND KLHL42.
RX   PubMed=19261606; DOI=10.1074/jbc.m809374200;
RA   Cummings C.M., Bentley C.A., Perdue S.A., Baas P.W., Singer J.D.;
RT   "The Cul3/Klhdc5 E3 ligase regulates p60/katanin and is required for normal
RT   mitosis in mammalian cells.";
RL   J. Biol. Chem. 284:11663-11675(2009).
RN   [28]
RP   IDENTIFICATION IN THE BCR(KLHL21) COMPLEX, AND FUNCTION.
RX   PubMed=19995937; DOI=10.1083/jcb.200906117;
RA   Maerki S., Olma M.H., Staubli T., Steigemann P., Gerlich D.W., Quadroni M.,
RA   Sumara I., Peter M.;
RT   "The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone
RT   microtubules in anaphase and is required for cytokinesis.";
RL   J. Cell Biol. 187:791-800(2009).
RN   [29]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN LIGASE
RP   COMPLEX.
RX   PubMed=20389280; DOI=10.1038/emboj.2010.62;
RA   Lee Y.R., Yuan W.C., Ho H.C., Chen C.H., Shih H.M., Chen R.H.;
RT   "The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to
RT   control interferon responses.";
RL   EMBO J. 29:1748-1761(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH SPOP
RP   AND BRMS1.
RX   PubMed=22085717; DOI=10.1016/j.bbrc.2011.10.154;
RA   Kim B., Nam H.J., Pyo K.E., Jang M.J., Kim I.S., Kim D., Boo K., Lee S.H.,
RA   Yoon J.B., Baek S.H., Kim J.H.;
RT   "Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-
RT   SPOP E3 ubiquitin ligase complex.";
RL   Biochem. Biophys. Res. Commun. 415:720-726(2011).
RN   [32]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN LIGASE
RP   COMPLEX.
RX   PubMed=21840486; DOI=10.1016/j.ccr.2011.07.008;
RA   Yuan W.C., Lee Y.R., Huang S.F., Lin Y.M., Chen T.Y., Chung H.C.,
RA   Tsai C.H., Chen H.Y., Chiang C.T., Lai C.K., Lu L.T., Chen C.H., Gu D.L.,
RA   Pu Y.S., Jou Y.S., Lu K.P., Hsiao P.W., Shih H.M., Chen R.H.;
RT   "A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to
RT   potentiate HIF-1 signaling and prostate cancer progression.";
RL   Cancer Cell 20:214-228(2011).
RN   [33]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN LIGASE
RP   COMPLEX.
RX   PubMed=21670212; DOI=10.1083/jcb.201103015;
RA   Lin M.Y., Lin Y.M., Kao T.C., Chuang H.H., Chen R.H.;
RT   "PDZ-RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-induced
RT   neurite outgrowth.";
RL   J. Cell Biol. 193:985-994(2011).
RN   [34]
RP   INTERACTION WITH KCTD7.
RX   PubMed=22748208; DOI=10.1016/j.ajhg.2012.05.023;
RA   Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N., Romansky S.G.,
RA   Leydiker K.B., Coppel S.H., Barone R., Xin W., MacDonald M.E.,
RA   Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L.;
RT   "A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the
RT   ubiquitin-proteasome system.";
RL   Am. J. Hum. Genet. 91:202-208(2012).
RN   [35]
RP   FUNCTION, INTERACTION WITH AURKA AND KLHL18, AND SUBCELLULAR LOCATION.
RX   PubMed=23213400; DOI=10.1242/bio.2011018;
RA   Moghe S., Jiang F., Miura Y., Cerny R.L., Tsai M.Y., Furukawa M.;
RT   "The CUL3-KLHL18 ligase regulates mitotic entry and ubiquitylates Aurora-
RT   A.";
RL   Biol. Open 1:82-91(2012).
RN   [36]
RP   INTERACTION WITH PPP2R5B.
RX   PubMed=23135275; DOI=10.1074/jbc.m112.420281;
RA   Oberg E.A., Nifoussi S.K., Gingras A.C., Strack S.;
RT   "Selective proteasomal degradation of the B'beta subunit of protein
RT   phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15.";
RL   J. Biol. Chem. 287:43378-43389(2012).
RN   [37]
RP   IDENTIFICATION IN THE BCR(KLHL25) COMPLEX, AND FUNCTION.
RX   PubMed=22578813; DOI=10.1016/j.molcel.2012.04.004;
RA   Yanagiya A., Suyama E., Adachi H., Svitkin Y.V., Aza-Blanc P., Imataka H.,
RA   Mikami S., Martineau Y., Ronai Z.A., Sonenberg N.;
RT   "Translational homeostasis via the mRNA cap-binding protein, eIF4E.";
RL   Mol. Cell 46:847-858(2012).
RN   [38]
RP   IDENTIFICATION IN THE BCR(KLHL12) COMPLEX, AND FUNCTION.
RX   PubMed=22358839; DOI=10.1038/nature10822;
RA   Jin L., Pahuja K.B., Wickliffe K.E., Gorur A., Baumgartel C., Schekman R.,
RA   Rape M.;
RT   "Ubiquitin-dependent regulation of COPII coat size and function.";
RL   Nature 482:495-500(2012).
RN   [39]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   FUNCTION, AND INTERACTION WITH KLHL3.
RX   PubMed=23387299; DOI=10.1042/bj20121903;
RA   Ohta A., Schumacher F.R., Mehellou Y., Johnson C., Knebel A.,
RA   Macartney T.J., Wood N.T., Alessi D.R., Kurz T.;
RT   "The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome
RT   interacts with and ubiquitylates WNK isoforms: disease-causing mutations in
RT   KLHL3 and WNK4 disrupt interaction.";
RL   Biochem. J. 451:111-122(2013).
RN   [41]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23453970; DOI=10.1016/j.celrep.2013.02.024;
RA   Wakabayashi M., Mori T., Isobe K., Sohara E., Susa K., Araki Y., Chiga M.,
RA   Kikuchi E., Nomura N., Mori Y., Matsuo H., Murata T., Nomura S., Asano T.,
RA   Kawaguchi H., Nonoyama S., Rai T., Sasaki S., Uchida S.;
RT   "Impaired KLHL3-mediated ubiquitination of WNK4 causes human
RT   hypertension.";
RL   Cell Rep. 3:858-868(2013).
RN   [42]
RP   INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=24076655; DOI=10.1038/emboj.2013.209;
RA   Kelsall I.R., Duda D.M., Olszewski J.L., Hofmann K., Knebel A.,
RA   Langevin F., Wood N., Wightman M., Schulman B.A., Alpi A.F.;
RT   "TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-
RT   RING ligase complexes.";
RL   EMBO J. 32:2848-2860(2013).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-585, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [44]
RP   IDENTIFICATION IN THE BCR(KLHL22) COMPLEX, AND FUNCTION.
RX   PubMed=23455478; DOI=10.1038/ncb2695;
RA   Beck J., Maerki S., Posch M., Metzger T., Persaud A., Scheel H.,
RA   Hofmann K., Rotin D., Pedrioli P., Swedlow J.R., Peter M., Sumara I.;
RT   "Ubiquitylation-dependent localization of PLK1 in mitosis.";
RL   Nat. Cell Biol. 15:430-439(2013).
RN   [45]
RP   INTERACTION WITH COPS9.
RX   PubMed=23776465; DOI=10.1371/journal.pone.0065285;
RA   Ebina M., Tsuruta F., Katoh M.C., Kigoshi Y., Someya A., Chiba T.;
RT   "Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear localization
RT   through Nedd8 modification.";
RL   PLoS ONE 8:E65285-E65285(2013).
RN   [46]
RP   FUNCTION, AND IDENTIFICATION IN THE BCR(KLHL3) COMPLEX.
RX   PubMed=23576762; DOI=10.1073/pnas.1304592110;
RA   Shibata S., Zhang J., Puthumana J., Stone K.L., Lifton R.P.;
RT   "Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via
RT   ubiquitination and degradation of WNK4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:7838-7843(2013).
RN   [47]
RP   INTERACTION WITH DCUN1D3.
RX   PubMed=25349211; DOI=10.1074/jbc.m114.585505;
RA   Huang G., Stock C., Bommelje C.C., Weeda V.B., Shah K., Bains S., Buss E.,
RA   Shaha M., Rechler W., Ramanathan S.Y., Singh B.;
RT   "SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of
RT   SCCRO (DCUN1D1).";
RL   J. Biol. Chem. 289:34728-34742(2014).
RN   [48]
RP   FUNCTION, AND IDENTIFICATION IN A BCR (BTB-CUL3-RBX1) E3 UBIQUITIN LIGASE
RP   COMPLEX.
RX   PubMed=24768539; DOI=10.1016/j.molcel.2014.03.035;
RA   Yuan W.C., Lee Y.R., Lin S.Y., Chang L.Y., Tan Y.P., Hung C.C., Kuo J.C.,
RA   Liu C.H., Lin M.Y., Xu M., Chen Z.J., Chen R.H.;
RT   "K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin E3
RT   ligase regulates protein trafficking.";
RL   Mol. Cell 54:586-600(2014).
RN   [49]
RP   INTERACTION WITH KCTD17, IDENTIFICATION IN THE BCR(KCTD17) E3 UBIQUITIN
RP   LIGASE COMPLEX, AND FUNCTION.
RX   PubMed=25270598; DOI=10.1038/ncomms6081;
RA   Kasahara K., Kawakami Y., Kiyono T., Yonemura S., Kawamura Y., Era S.,
RA   Matsuzaki F., Goshima N., Inagaki M.;
RT   "Ubiquitin-proteasome system controls ciliogenesis at the initial step of
RT   axoneme extension.";
RL   Nat. Commun. 5:5081-5081(2014).
RN   [50]
RP   FUNCTION, AND INTERACTION WITH KBTBD8.
RX   PubMed=26399832; DOI=10.1038/nature14978;
RA   Werner A., Iwasaki S., McGourty C.A., Medina-Ruiz S., Teerikorpi N.,
RA   Fedrigo I., Ingolia N.T., Rape M.;
RT   "Cell-fate determination by ubiquitin-dependent regulation of
RT   translation.";
RL   Nature 525:523-527(2015).
RN   [51]
RP   FUNCTION.
RX   PubMed=27716508; DOI=10.1016/j.cell.2016.09.026;
RA   McGourty C.A., Akopian D., Walsh C., Gorur A., Werner A., Schekman R.,
RA   Bautista D., Rape M.;
RT   "Regulation of the CUL3 ubiquitin ligase by a calcium-dependent co-
RT   adaptor.";
RL   Cell 167:525-538(2016).
RN   [52]
RP   FUNCTION, INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=27565346; DOI=10.1016/j.cell.2016.07.027;
RA   Scott D.C., Rhee D.Y., Duda D.M., Kelsall I.R., Olszewski J.L., Paulo J.A.,
RA   de Jong A., Ovaa H., Alpi A.F., Harper J.W., Schulman B.A.;
RT   "Two distinct types of E3 ligases work in unison to regulate substrate
RT   ubiquitylation.";
RL   Cell 166:1198-1214(2016).
RN   [53]
RP   INTERACTION WITH KLHL15 AND RBBP8, AND NEDDYLATION.
RX   PubMed=27561354; DOI=10.1038/ncomms12628;
RA   Ferretti L.P., Himmels S.F., Trenner A., Walker C., von Aesch C.,
RA   Eggenschwiler A., Murina O., Enchev R.I., Peter M., Freire R., Porro A.,
RA   Sartori A.A.;
RT   "Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-
RT   tune DNA-end resection.";
RL   Nat. Commun. 7:12628-12628(2016).
RN   [54]
RP   FUNCTION, IDENTIFICATION IN THE BCR(KLHL24) COMPLEX, AND INTERACTION WITH
RP   KLHL24.
RX   PubMed=27798626; DOI=10.1038/ng.3701;
RA   Lin Z., Li S., Feng C., Yang S., Wang H., Ma D., Zhang J., Gou M., Bu D.,
RA   Zhang T., Kong X., Wang X., Sarig O., Ren Y., Dai L., Liu H., Zhang J.,
RA   Li F., Hu Y., Padalon-Brauch G., Vodo D., Zhou F., Chen T., Deng H.,
RA   Sprecher E., Yang Y., Tan X.;
RT   "Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14
RT   and human skin fragility.";
RL   Nat. Genet. 48:1508-1516(2016).
RN   [55]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28395323; DOI=10.1095/biolreprod.116.143479;
RA   Jumeau F., Chalmel F., Fernandez-Gomez F.J., Carpentier C., Obriot H.,
RA   Tardivel M., Caillet-Boudin M.L., Rigot J.M., Rives N., Buee L.,
RA   Sergeant N., Mitchell V.;
RT   "Defining the human sperm microtubulome: an integrated genomics approach.";
RL   Biol. Reprod. 96:93-106(2017).
RN   [56]
RP   INTERACTION WITH RHOBTB2.
RX   PubMed=29276004; DOI=10.1016/j.ajhg.2017.11.008;
RG   Deciphering Developmental Disorders Study;
RA   Straub J., Konrad E.D.H., Gruener J., Toutain A., Bok L.A., Cho M.T.,
RA   Crawford H.P., Dubbs H., Douglas G., Jobling R., Johnson D., Krock B.,
RA   Mikati M.A., Nesbitt A., Nicolai J., Phillips M., Poduri A.,
RA   Ortiz-Gonzalez X.R., Powis Z., Santani A., Smith L., Stegmann A.P.A.,
RA   Stumpel C., Vreeburg M., Fliedner A., Gregor A., Sticht H., Zweier C.;
RT   "Missense variants in RHOBTB2 cause a developmental and epileptic
RT   encephalopathy in humans, and altered levels cause neurological defects in
RT   Drosophila.";
RL   Am. J. Hum. Genet. 102:44-57(2018).
RN   [57]
RP   FUNCTION.
RX   PubMed=29769719; DOI=10.1038/s41586-018-0128-9;
RA   Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y.;
RT   "KLHL22 activates amino-acid-dependent mTORC1 signalling to promote
RT   tumorigenesis and ageing.";
RL   Nature 557:585-589(2018).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 20-381 IN COMPLEX WITH SPOP,
RP   FUNCTION, IDENTIFICATION IN UBIQUITIN LIGASE COMPLEXES WITH SPOP AND SPOPL,
RP   AND SUBUNIT.
RX   PubMed=22632832; DOI=10.1016/j.str.2012.04.009;
RA   Errington W.J., Khan M.Q., Bueler S.A., Rubinstein J.L., Chakrabartty A.,
RA   Prive G.G.;
RT   "Adaptor protein self-assembly drives the control of a cullin-RING
RT   ubiquitin ligase.";
RL   Structure 20:1141-1153(2012).
RN   [59]
RP   X-RAY CRYSTALLOGRAPHY (3.51 ANGSTROMS) OF 20-381 IN COMPLEX WITH KLHL3.
RX   PubMed=23573258; DOI=10.1371/journal.pone.0060445;
RA   Ji A.X., Prive G.G.;
RT   "Crystal structure of KLHL3 in complex with Cullin3.";
RL   PLoS ONE 8:E60445-E60445(2013).
RN   [60]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-388 IN COMPLEX WITH KLHL11, AND
RP   INTERACTION WITH KLHL11.
RX   PubMed=23349464; DOI=10.1074/jbc.m112.437996;
RA   Canning P., Cooper C.D., Krojer T., Murray J.W., Pike A.C., Chaikuad A.,
RA   Keates T., Thangaratnarajah C., Hojzan V., Marsden B.D., Gileadi O.,
RA   Knapp S., von Delft F., Bullock A.N.;
RT   "Structural basis for Cul3 assembly with the BTB-Kelch family of E3
RT   ubiquitin ligases.";
RL   J. Biol. Chem. 288:7803-7814(2013).
RN   [61]
RP   VARIANTS PHA2E GLY-413 AND ARG-459.
RX   PubMed=22266938; DOI=10.1038/nature10814;
RA   Boyden L.M., Choi M., Choate K.A., Nelson-Williams C.J., Farhi A.,
RA   Toka H.R., Tikhonova I.R., Bjornson R., Mane S.M., Colussi G., Lebel M.,
RA   Gordon R.D., Semmekrot B.A., Poujol A., Valimaki M.J., De Ferrari M.E.,
RA   Sanjad S.A., Gutkin M., Karet F.E., Tucci J.R., Stockigt J.R.,
RA   Keppler-Noreuil K.M., Porter C.C., Anand S.K., Whiteford M.L., Davis I.D.,
RA   Dewar S.B., Bettinelli A., Fadrowski J.J., Belsha C.W., Hunley T.E.,
RA   Nelson R.D., Trachtman H., Cole T.R., Pinsk M., Bockenhauer D., Shenoy M.,
RA   Vaidyanathan P., Foreman J.W., Rasoulpour M., Thameem F.,
RA   Al-Shahrouri H.Z., Radhakrishnan J., Gharavi A.G., Goilav B., Lifton R.P.;
RT   "Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte
RT   abnormalities.";
RL   Nature 482:98-102(2012).
RN   [62]
RP   VARIANT ARG-719.
RX   PubMed=25969726; DOI=10.1186/s13229-015-0017-0;
RA   Codina-Sola M., Rodriguez-Santiago B., Homs A., Santoyo J., Rigau M.,
RA   Aznar-Lain G., Del Campo M., Gener B., Gabau E., Botella M.P.,
RA   Gutierrez-Arumi A., Antinolo G., Perez-Jurado L.A., Cusco I.;
RT   "Integrated analysis of whole-exome sequencing and transcriptome profiling
RT   in males with autism spectrum disorders.";
RL   Mol. Autism 6:21-21(2015).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based BCR (BTB-CUL3-
CC       RBX1) E3 ubiquitin-protein ligase complexes which mediate the
CC       ubiquitination and subsequent proteasomal degradation of target
CC       proteins. BCR complexes and ARIH1 collaborate in tandem to mediate
CC       ubiquitination of target proteins (PubMed:27565346). As a scaffold
CC       protein may contribute to catalysis through positioning of the
CC       substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-
CC       protein ligase activity of the complex is dependent on the neddylation
CC       of the cullin subunit and is inhibited by the association of the
CC       deneddylated cullin subunit with TIP120A/CAND1. The functional
CC       specificity of the BCR complex depends on the BTB domain-containing
CC       protein as the substrate recognition component. BCR(KLHL42) is involved
CC       in ubiquitination of KATNA1. BCR(SPOP) is involved in ubiquitination of
CC       BMI1/PCGF4, BRMS1, MACROH2A1 and DAXX, GLI2 and GLI3. Can also form a
CC       cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase
CC       complex containing homodimeric SPOPL or the heterodimer formed by SPOP
CC       and SPOPL; these complexes have lower ubiquitin ligase activity.
CC       BCR(KLHL9-KLHL13) controls the dynamic behavior of AURKB on mitotic
CC       chromosomes and thereby coordinates faithful mitotic progression and
CC       completion of cytokinesis. BCR(KLHL12) is involved in ER-Golgi
CC       transport by regulating the size of COPII coats, thereby playing a key
CC       role in collagen export, which is required for embryonic stem (ES)
CC       cells division: BCR(KLHL12) acts by mediating monoubiquitination of
CC       SEC31 (SEC31A or SEC31B) (PubMed:22358839, PubMed:27716508). BCR(KLHL3)
CC       acts as a regulator of ion transport in the distal nephron; by
CC       mediating ubiquitination of WNK4 (PubMed:23387299, PubMed:23453970,
CC       PubMed:23576762). The BCR(KLHL20) E3 ubiquitin ligase complex is
CC       involved in interferon response and anterograde Golgi to endosome
CC       transport: it mediates both ubiquitination leading to degradation and
CC       'Lys-33'-linked ubiquitination (PubMed:20389280, PubMed:21840486,
CC       PubMed:21670212, PubMed:24768539). The BCR(KLHL21) E3 ubiquitin ligase
CC       complex regulates localization of the chromosomal passenger complex
CC       (CPC) from chromosomes to the spindle midzone in anaphase and mediates
CC       the ubiquitination of AURKB (PubMed:19995937). The BCR(KLHL22)
CC       ubiquitin ligase complex mediates monoubiquitination of PLK1, leading
CC       to PLK1 dissociation from phosphoreceptor proteins and subsequent
CC       removal from kinetochores, allowing silencing of the spindle assembly
CC       checkpoint (SAC) and chromosome segregation (PubMed:23455478). The
CC       BCR(KLHL22) ubiquitin ligase complex is also responsible for the amino
CC       acid-stimulated 'Lys-48' polyubiquitination and proteasomal degradation
CC       of DEPDC5. Through the degradation of DEPDC5, releases the GATOR1
CC       complex-mediated inhibition of the TORC1 pathway (PubMed:29769719). The
CC       BCR(KLHL25) ubiquitin ligase complex is involved in translational
CC       homeostasis by mediating ubiquitination and subsequent degradation of
CC       hypophosphorylated EIF4EBP1 (4E-BP1) (PubMed:22578813). The BCR(KBTBD8)
CC       complex acts by mediating monoubiquitination of NOLC1 and TCOF1,
CC       leading to remodel the translational program of differentiating cells
CC       in favor of neural crest specification (PubMed:26399832). Involved in
CC       ubiquitination of cyclin E and of cyclin D1 (in vitro) thus involved in
CC       regulation of G1/S transition. Involved in the ubiquitination of KEAP1,
CC       ENC1 and KLHL41 (PubMed:15983046). In concert with ATF2 and RBX1,
CC       promotes degradation of KAT5 thereby attenuating its ability to
CC       acetylate and activate ATM. The BCR(KCTD17) E3 ubiquitin ligase complex
CC       mediates ubiquitination and degradation of TCHP, a down-regulator of
CC       cilium assembly, thereby inducing ciliogenesis (PubMed:25270598). The
CC       BCR(KLHL24) E3 ubiquitin ligase complex mediates ubiquitination of
CC       KRT14, controls KRT14 levels during keratinocytes differentiation, and
CC       is essential for skin integrity (PubMed:27798626). The BCR(KLHL18) E3
CC       ubiquitin ligase complex mediates the ubiquitination of AURKA leading
CC       to its activation at the centrosome which is required for initiating
CC       mitotic entry (PubMed:23213400). The BCR(KEAP1) E3 ubiquitin ligase
CC       complex acts as a key sensor of oxidative and electrophilic stress by
CC       mediating ubiquitination and degradation of NFE2L2/NRF2, a
CC       transcription factor regulating expression of many cytoprotective genes
CC       (PubMed:15601839, PubMed:16006525). {ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:11311237, ECO:0000269|PubMed:15601839,
CC       ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046,
CC       ECO:0000269|PubMed:16006525, ECO:0000269|PubMed:16524876,
CC       ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:18397884,
CC       ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937,
CC       ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717,
CC       ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813,
CC       ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:23213400,
CC       ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23453970,
CC       ECO:0000269|PubMed:23455478, ECO:0000269|PubMed:23576762,
CC       ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598,
CC       ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:27716508, ECO:0000269|PubMed:27798626,
CC       ECO:0000269|PubMed:29769719}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Forms neddylation-dependent homodimers. Component of multiple
CC       BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complexes formed of
CC       CUL3, RBX1 and a variable BTB domain-containing protein acting as both,
CC       adapter to cullin and substrate recognition subunit. The BCR complex
CC       may be active as a heterodimeric complex, in which NEDD8, covalently
CC       attached to one CUL3 molecule, binds to the C-terminus of a second CUL3
CC       molecule. Interacts with RBX1, RNF7, CYCE and TIP120A/CAND1
CC       (PubMed:10500095, PubMed:10230407, PubMed:12609982). Part of the
CC       BCR(SPOP) containing SPOP, and of BCR containing homodimeric SPOPL or
CC       the heterodimer formed by SPOP and SPOPL. Part of the probable
CC       BCR(KLHL9-KLHL13) complex with BTB domain proteins KLHL9 and KLHL13.
CC       Part of the BCR(KLHL41) complex containing KLHL41. Component of the
CC       BCR(KLHL12) E3 ubiquitin ligase complex, at least composed of CUL3 and
CC       KLHL12 and RBX1. Component of the BCR(KLHL3) E3 ubiquitin ligase
CC       complex, at least composed of CUL3 and KLHL3 and RBX1 (Probable). Part
CC       of the BCR(ENC1) complex containing ENC1. Part of a complex consisting
CC       of BMI1/PCGF4, CUL3 and SPOP. Part of a complex consisting of BRMS1,
CC       CUL3 and SPOP. Component of the BCR(KLHL21) E3 ubiquitin ligase
CC       complex, at least composed of CUL3, KLHL21 and RBX1. Component of the
CC       BCR(KLHL22) E3 ubiquitin ligase complex, at least composed of CUL3,
CC       KLHL22 and RBX1. Component of the BCR(KLHL25) E3 ubiquitin ligase
CC       complex, at least composed of CUL3, KLHL25 and RBX1. Part of a complex
CC       consisting of MACROH2A1, CUL3 and SPOP. Component of the BCR(KLHL42) E3
CC       ubiquitin ligase complex, at least composed of CUL3 and KLHL42.
CC       Interacts with KLHL42 (via the BTB domain). Interacts with KATNA1; the
CC       interaction is enhanced by KLHL42. Component of the BCR(KBTBD8) E3
CC       ubiquitin ligase complex, at least composed of CUL3, KBTBD8 and RBX1
CC       (PubMed:26399832). Interacts with KCTD5, KLHL9, KLHL11, KLHL13, GAN,
CC       ZBTB16, KLHL3, KLHL15, KLHL20, KLHL36, GMCL2, BTBD1. Part of a complex
CC       that contains CUL3, RBX1 and GAN. Interacts (via BTB domain) with
CC       KLHL17; the interaction regulates surface GRIK2 expression. Interacts
CC       with KCTD7. Part of the BCR(GAN) complex containing GAN. Part of the
CC       BCR(KEAP1) complex containing KEAP1 (PubMed:15983046, PubMed:15601839).
CC       Interacts with KLHL10 (By similarity). Interacts with KAT5 and ATF2.
CC       Interacts with DCUN1D3. Interacts with KCTD17 in the BCR(KCTD17) E3
CC       ubiquitin ligase complex, at least composed of CUL3, KCTD17 and RBX1
CC       (PubMed:25270598). Interacts (when neddylated) with ARIH1; leading to
CC       activate the E3 ligase activity of ARIH1 (PubMed:24076655,
CC       PubMed:27565346). Interacts with COPS9 isoform 2 (PubMed:23776465).
CC       Interacts with PPP2R5B; this interaction is indirect and mediated
CC       through KLHL15-binding and leads to PPP2R5B proteasomal degradation
CC       (PubMed:23135275). Interacts with RBBP8/CtIP; this interaction is
CC       indirect and mediated through KLHL15-binding and leads to RBBP8
CC       proteasomal degradation (PubMed:27561354). Interacts with KLHL24 in the
CC       BCR(KLHL24) E3 ubiquitin ligase complex, composed of CUL3, RBX1 and
CC       KLHL24 (PubMed:27798626). Interacts with RHOBTB2 (PubMed:29276004).
CC       Interacts with AURKA and KLHL18 (via BTB domain) (PubMed:23213400).
CC       {ECO:0000250|UniProtKB:Q9JLV5, ECO:0000269|PubMed:10230407,
CC       ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:12609982,
CC       ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15601839,
CC       ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:15983046,
CC       ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:17543862,
CC       ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:18573101,
CC       ECO:0000269|PubMed:19261606, ECO:0000269|PubMed:19995937,
CC       ECO:0000269|PubMed:20389280, ECO:0000269|PubMed:21670212,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22085717,
CC       ECO:0000269|PubMed:22358839, ECO:0000269|PubMed:22578813,
CC       ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:22748208,
CC       ECO:0000269|PubMed:23135275, ECO:0000269|PubMed:23213400,
CC       ECO:0000269|PubMed:23349464, ECO:0000269|PubMed:23387299,
CC       ECO:0000269|PubMed:23453970, ECO:0000269|PubMed:23455478,
CC       ECO:0000269|PubMed:23573258, ECO:0000269|PubMed:23576762,
CC       ECO:0000269|PubMed:23776465, ECO:0000269|PubMed:24076655,
CC       ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:25270598,
CC       ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26399832,
CC       ECO:0000269|PubMed:27561354, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:27798626, ECO:0000269|PubMed:29276004, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q13618; Q969K4: ABTB1; NbExp=5; IntAct=EBI-456129, EBI-7223971;
CC       Q13618; Q9H0C5: BTBD1; NbExp=7; IntAct=EBI-456129, EBI-935503;
CC       Q13618; Q9BSF8: BTBD10; NbExp=4; IntAct=EBI-456129, EBI-720180;
CC       Q13618; Q9BX70: BTBD2; NbExp=7; IntAct=EBI-456129, EBI-710091;
CC       Q13618; Q9Y2F9: BTBD3; NbExp=3; IntAct=EBI-456129, EBI-311155;
CC       Q13618; Q96KE9-2: BTBD6; NbExp=3; IntAct=EBI-456129, EBI-12012762;
CC       Q13618; Q86VP6: CAND1; NbExp=6; IntAct=EBI-456129, EBI-456077;
CC       Q13618; Q14790: CASP8; NbExp=6; IntAct=EBI-456129, EBI-78060;
CC       Q13618; O60826: CCDC22; NbExp=2; IntAct=EBI-456129, EBI-3943153;
CC       Q13618; Q8IWE4: DCUN1D3; NbExp=2; IntAct=EBI-456129, EBI-15794102;
CC       Q13618-1; Q8IWE4: DCUN1D3; NbExp=3; IntAct=EBI-15794202, EBI-15794102;
CC       Q13618; Q15369: ELOC; NbExp=3; IntAct=EBI-456129, EBI-301231;
CC       Q13618; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-456129, EBI-10172181;
CC       Q13618; Q96IK5: GMCL1; NbExp=5; IntAct=EBI-456129, EBI-2548508;
CC       Q13618; P08238: HSP90AB1; NbExp=3; IntAct=EBI-456129, EBI-352572;
CC       Q13618; Q9H3F6: KCTD10; NbExp=6; IntAct=EBI-456129, EBI-2505886;
CC       Q13618; Q8WZ19: KCTD13; NbExp=7; IntAct=EBI-456129, EBI-742916;
CC       Q13618; Q8NC69: KCTD6; NbExp=11; IntAct=EBI-456129, EBI-2511344;
CC       Q13618; Q96MP8-2: KCTD7; NbExp=3; IntAct=EBI-456129, EBI-11954971;
CC       Q13618; Q7L273: KCTD9; NbExp=10; IntAct=EBI-456129, EBI-4397613;
CC       Q13618; Q14145: KEAP1; NbExp=5; IntAct=EBI-456129, EBI-751001;
CC       Q13618; Q53G59: KLHL12; NbExp=12; IntAct=EBI-456129, EBI-740929;
CC       Q13618; Q9P2N7: KLHL13; NbExp=7; IntAct=EBI-456129, EBI-1996321;
CC       Q13618; O95198: KLHL2; NbExp=5; IntAct=EBI-456129, EBI-746999;
CC       Q13618; Q9Y2M5: KLHL20; NbExp=6; IntAct=EBI-456129, EBI-714379;
CC       Q13618; Q8N4I8: KLHL3; NbExp=3; IntAct=EBI-456129, EBI-10230467;
CC       Q13618; Q9UH77: KLHL3; NbExp=7; IntAct=EBI-456129, EBI-8524663;
CC       Q13618; Q96PQ7: KLHL5; NbExp=4; IntAct=EBI-456129, EBI-2692595;
CC       Q13618; Q8IXQ5: KLHL7; NbExp=9; IntAct=EBI-456129, EBI-6153160;
CC       Q13618; Q8TBC3: SHKBP1; NbExp=6; IntAct=EBI-456129, EBI-724292;
CC       Q13618; O43791: SPOP; NbExp=2; IntAct=EBI-456129, EBI-743549;
CC       Q13618; Q13829: TNFAIP1; NbExp=4; IntAct=EBI-456129, EBI-2505861;
CC       Q13618; P50591: TNFSF10; NbExp=2; IntAct=EBI-456129, EBI-495373;
CC       Q13618; O94888: UBXN7; NbExp=6; IntAct=EBI-456129, EBI-1993627;
CC       Q13618; Q9H898: ZMAT4; NbExp=3; IntAct=EBI-456129, EBI-2548542;
CC       Q13618; Q9H898-2: ZMAT4; NbExp=3; IntAct=EBI-456129, EBI-11529334;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10500095,
CC       ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:23213400}. Golgi
CC       apparatus {ECO:0000269|PubMed:10500095}. Cell projection, cilium,
CC       flagellum {ECO:0000269|PubMed:28395323}. Cytoplasm, cytoskeleton,
CC       spindle {ECO:0000269|PubMed:23213400}. Cytoplasm. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:23213400}. Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:23213400}. Note=Detected along the length of the
CC       sperm flagellum and in the cytoplasm of the germ cells
CC       (PubMed:28395323). Predominantly found in the nucleus in interphase
CC       cells, found at the centrosome at late G2 or prophase, starts
CC       accumulating at the spindle poles in prometaphase and stays on the
CC       spindle poles and the mitotic spindle at metaphase (PubMed:23213400).
CC       {ECO:0000269|PubMed:23213400, ECO:0000269|PubMed:28395323}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Cul-3 Long;
CC         IsoId=Q13618-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13618-2; Sequence=VSP_008824;
CC       Name=3; Synonyms=Cul-3 Short;
CC         IsoId=Q13618-3; Sequence=VSP_008825;
CC   -!- TISSUE SPECIFICITY: Brain, spermatozoa, and testis (at protein level).
CC       Widely expressed. {ECO:0000269|PubMed:28395323}.
CC   -!- PTM: Neddylated. Attachment of NEDD8 is required for the E3 ubiquitin-
CC       protein ligase activity of the BCR complex. Deneddylated via its
CC       interaction with the COP9 signalosome (CSN) complex.
CC       {ECO:0000269|PubMed:10500095, ECO:0000269|PubMed:10597293,
CC       ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.
CC   -!- DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An autosomal
CC       dominant disorder characterized by severe hypertension, hyperkalemia,
CC       hyperchloremia, hyperchloremic metabolic acidosis, and correction of
CC       physiologic abnormalities by thiazide diuretics.
CC       {ECO:0000269|PubMed:22266938}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC28621.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAC36682.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA31592.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF064087; AAC36304.1; -; mRNA.
DR   EMBL; AB014517; BAA31592.2; ALT_INIT; mRNA.
DR   EMBL; AF062537; AAC36682.1; ALT_FRAME; mRNA.
DR   EMBL; AY337761; AAQ01660.1; -; mRNA.
DR   EMBL; AK291151; BAF83840.1; -; mRNA.
DR   EMBL; AC073052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092679; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70828.1; -; Genomic_DNA.
DR   EMBL; BC031844; AAH31844.1; -; mRNA.
DR   EMBL; BC039598; AAH39598.1; -; mRNA.
DR   EMBL; BC092409; AAH92409.1; -; mRNA.
DR   EMBL; U58089; AAC50546.1; -; mRNA.
DR   EMBL; AF052147; AAC28621.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS2462.1; -. [Q13618-1]
DR   CCDS; CCDS58751.1; -. [Q13618-3]
DR   RefSeq; NP_001244126.1; NM_001257197.1. [Q13618-3]
DR   RefSeq; NP_001244127.1; NM_001257198.1.
DR   RefSeq; NP_003581.1; NM_003590.4. [Q13618-1]
DR   PDB; 2MYL; NMR; -; A=49-68.
DR   PDB; 2MYM; NMR; -; A=49-68.
DR   PDB; 4AP2; X-ray; 2.80 A; B=1-388.
DR   PDB; 4APF; X-ray; 3.10 A; B=23-388.
DR   PDB; 4EOZ; X-ray; 2.40 A; B/D=20-381.
DR   PDB; 4HXI; X-ray; 3.51 A; B=20-381.
DR   PDB; 5NLB; X-ray; 3.45 A; B=26-381.
DR   PDB; 6I2M; X-ray; 2.30 A; B=23-388.
DR   PDBsum; 2MYL; -.
DR   PDBsum; 2MYM; -.
DR   PDBsum; 4AP2; -.
DR   PDBsum; 4APF; -.
DR   PDBsum; 4EOZ; -.
DR   PDBsum; 4HXI; -.
DR   PDBsum; 5NLB; -.
DR   PDBsum; 6I2M; -.
DR   SMR; Q13618; -.
DR   BioGrid; 114030; 1243.
DR   CORUM; Q13618; -.
DR   DIP; DIP-31611N; -.
DR   IntAct; Q13618; 1040.
DR   MINT; Q13618; -.
DR   STRING; 9606.ENSP00000264414; -.
DR   iPTMnet; Q13618; -.
DR   PhosphoSitePlus; Q13618; -.
DR   BioMuta; CUL3; -.
DR   DMDM; 12643396; -.
DR   EPD; Q13618; -.
DR   jPOST; Q13618; -.
DR   MassIVE; Q13618; -.
DR   MaxQB; Q13618; -.
DR   PaxDb; Q13618; -.
DR   PeptideAtlas; Q13618; -.
DR   PRIDE; Q13618; -.
DR   ProteomicsDB; 59606; -. [Q13618-1]
DR   ProteomicsDB; 59607; -. [Q13618-2]
DR   ProteomicsDB; 59608; -. [Q13618-3]
DR   Antibodypedia; 3632; 373 antibodies.
DR   Ensembl; ENST00000264414; ENSP00000264414; ENSG00000036257. [Q13618-1]
DR   Ensembl; ENST00000344951; ENSP00000343601; ENSG00000036257. [Q13618-3]
DR   Ensembl; ENST00000409096; ENSP00000387200; ENSG00000036257. [Q13618-2]
DR   Ensembl; ENST00000409777; ENSP00000386525; ENSG00000036257. [Q13618-2]
DR   GeneID; 8452; -.
DR   KEGG; hsa:8452; -.
DR   UCSC; uc002vny.4; human. [Q13618-1]
DR   CTD; 8452; -.
DR   DisGeNET; 8452; -.
DR   GeneCards; CUL3; -.
DR   GeneReviews; CUL3; -.
DR   HGNC; HGNC:2553; CUL3.
DR   HPA; ENSG00000036257; Low tissue specificity.
DR   MalaCards; CUL3; -.
DR   MIM; 603136; gene.
DR   MIM; 614496; phenotype.
DR   neXtProt; NX_Q13618; -.
DR   OpenTargets; ENSG00000036257; -.
DR   Orphanet; 300530; Pseudohypoaldosteronism type 2E.
DR   PharmGKB; PA27049; -.
DR   eggNOG; KOG2167; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   GeneTree; ENSGT00940000155066; -.
DR   HOGENOM; CLU_004747_7_1_1; -.
DR   InParanoid; Q13618; -.
DR   KO; K03869; -.
DR   OMA; EIHTKNA; -.
DR   OrthoDB; 1040292at2759; -.
DR   PhylomeDB; Q13618; -.
DR   TreeFam; TF105858; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q13618; -.
DR   SIGNOR; Q13618; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL3; human.
DR   GeneWiki; CUL3; -.
DR   GenomeRNAi; 8452; -.
DR   Pharos; Q13618; Tbio.
DR   PRO; PR:Q13618; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q13618; protein.
DR   Bgee; ENSG00000036257; Expressed in sperm and 229 other tissues.
DR   ExpressionAtlas; Q13618; baseline and differential.
DR   Genevisible; Q13618; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005827; C:polar microtubule; IDA:UniProtKB.
DR   GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0030332; F:cyclin binding; IEA:Ensembl.
DR   GO; GO:0005112; F:Notch binding; IPI:MGI.
DR   GO; GO:0031208; F:POZ domain binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; IDA:MGI.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0048208; P:COPII vesicle coating; IMP:UniProtKB.
DR   GO; GO:0040016; P:embryonic cleavage; ISS:UniProtKB.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IDA:UniProtKB.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0072576; P:liver morphogenesis; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0071630; P:nuclear protein quality control by the ubiquitin-proteasome system; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:1901992; P:positive regulation of mitotic cell cycle phase transition; IMP:UniProtKB.
DR   GO; GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IGI:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IGI:BHF-UCL.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0017145; P:stem cell division; ISS:UniProtKB.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle; Cell division;
KW   Cell projection; Cilium; Cilium biogenesis/degradation; Cytoplasm;
KW   Cytoskeleton; Disease mutation; ER-Golgi transport; Flagellum;
KW   Golgi apparatus; Isopeptide bond; Mitosis; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transport; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..768
FT                   /note="Cullin-3"
FT                   /id="PRO_0000119793"
FT   REGION          2..41
FT                   /note="Interaction with KLHL18"
FT                   /evidence="ECO:0000269|PubMed:23213400"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         585
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        712
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in NEDD8)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13616"
FT   VAR_SEQ         1..24
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_008824"
FT   VAR_SEQ         23..88
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_008825"
FT   VARIANT         13
FT                   /note="D -> H (in dbSNP:rs2969802)"
FT                   /id="VAR_017194"
FT   VARIANT         184
FT                   /note="R -> S (in dbSNP:rs17480168)"
FT                   /id="VAR_048839"
FT   VARIANT         413
FT                   /note="D -> G (in PHA2E; dbSNP:rs199469656)"
FT                   /evidence="ECO:0000269|PubMed:22266938"
FT                   /id="VAR_067532"
FT   VARIANT         459
FT                   /note="K -> R (in PHA2E; dbSNP:rs199469658)"
FT                   /evidence="ECO:0000269|PubMed:22266938"
FT                   /id="VAR_067533"
FT   VARIANT         567
FT                   /note="V -> I (in dbSNP:rs3738952)"
FT                   /id="VAR_017195"
FT   VARIANT         719
FT                   /note="H -> R (found in a patient with autism spectrum
FT                   disorder; unknown pathological significance;
FT                   dbSNP:rs763087632)"
FT                   /evidence="ECO:0000269|PubMed:25969726"
FT                   /id="VAR_078688"
FT   CONFLICT        13
FT                   /note="D -> G (in Ref. 3; AAC36682)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397
FT                   /note="K -> T (in Ref. 4; AAQ01660)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        481
FT                   /note="N -> T (in Ref. 4; AAQ01660)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        609
FT                   /note="E -> G (in Ref. 8; AAH31844)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        666
FT                   /note="T -> I (in Ref. 4; AAQ01660)"
FT                   /evidence="ECO:0000305"
FT   HELIX           26..45
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           49..51
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           54..66
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           70..87
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           89..94
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   STRAND          97..100
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           101..122
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           124..128
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           130..133
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           139..150
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   TURN            151..153
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           155..174
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           180..192
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   STRAND          195..198
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           199..204
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           206..227
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           230..251
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           254..256
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           257..268
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           270..272
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           273..277
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   TURN            280..282
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           284..290
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           293..303
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           309..327
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           345..358
FT                   /evidence="ECO:0000244|PDB:6I2M"
FT   HELIX           364..380
FT                   /evidence="ECO:0000244|PDB:6I2M"
SQ   SEQUENCE   768 AA;  88930 MW;  A1A02022480BF099 CRC64;
     MSNLSKGTGS RKDTKMRIRA FPMTMDEKYV NSIWDLLKNA IQEIQRKNNS GLSFEELYRN
     AYTMVLHKHG EKLYTGLREV VTEHLINKVR EDVLNSLNNN FLQTLNQAWN DHQTAMVMIR
     DILMYMDRVY VQQNNVENVY NLGLIIFRDQ VVRYGCIRDH LRQTLLDMIA RERKGEVVDR
     GAIRNACQML MILGLEGRSV YEEDFEAPFL EMSAEFFQME SQKFLAENSA SVYIKKVEAR
     INEEIERVMH CLDKSTEEPI VKVVERELIS KHMKTIVEME NSGLVHMLKN GKTEDLGCMY
     KLFSRVPNGL KTMCECMSSY LREQGKALVS EEGEGKNPVD YIQGLLDLKS RFDRFLLESF
     NNDRLFKQTI AGDFEYFLNL NSRSPEYLSL FIDDKLKKGV KGLTEQEVET ILDKAMVLFR
     FMQEKDVFER YYKQHLARRL LTNKSVSDDS EKNMISKLKT ECGCQFTSKL EGMFRDMSIS
     NTTMDEFRQH LQATGVSLGG VDLTVRVLTT GYWPTQSATP KCNIPPAPRH AFEIFRRFYL
     AKHSGRQLTL QHHMGSADLN ATFYGPVKKE DGSEVGVGGA QVTGSNTRKH ILQVSTFQMT
     ILMLFNNREK YTFEEIQQET DIPERELVRA LQSLACGKPT QRVLTKEPKS KEIENGHIFT
     VNDQFTSKLH RVKIQTVAAK QGESDPERKE TRQKVDDDRK HEIEAAIVRI MKSRKKMQHN
     VLVAEVTQQL KARFLPSPVV IKKRIEGLIE REYLARTPED RKVYTYVA
//
ID   E9PJK2_HUMAN            Unreviewed;       361 AA.
AC   E9PJK2;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   22-APR-2020, entry version 65.
DE   SubName: Full=Polycomb protein EED {ECO:0000313|Ensembl:ENSP00000431778};
GN   Name=EED {ECO:0000313|Ensembl:ENSP00000431778};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431778, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431778, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000431778}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP003084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317263.1; NM_001330334.1.
DR   EPD; E9PJK2; -.
DR   jPOST; E9PJK2; -.
DR   MaxQB; E9PJK2; -.
DR   PeptideAtlas; E9PJK2; -.
DR   PRIDE; E9PJK2; -.
DR   ProteomicsDB; 21167; -.
DR   Antibodypedia; 31435; 360 antibodies.
DR   Ensembl; ENST00000528180; ENSP00000431778; ENSG00000074266.
DR   GeneID; 8726; -.
DR   UCSC; uc058gfr.1; human.
DR   CTD; 8726; -.
DR   EuPathDB; HostDB:ENSG00000074266.17; -.
DR   HGNC; HGNC:3188; EED.
DR   NIAGADS; ENSG00000074266; -.
DR   OpenTargets; ENSG00000074266; -.
DR   GeneTree; ENSGT00510000047334; -.
DR   HOGENOM; CLU_032683_4_0_1; -.
DR   SignaLink; E9PJK2; -.
DR   ChiTaRS; EED; human.
DR   GenomeRNAi; 8726; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000074266; Expressed in endocervix and 106 other tissues.
DR   ExpressionAtlas; E9PJK2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0016571; P:histone methylation; IEA:InterPro.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR037352; Polycomb_EED.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10253:SF5; PTHR10253:SF5; 2.
DR   Pfam; PF00400; WD40; 1.
DR   SMART; SM00320; WD40; 4.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:E9PJK2,
KW   ECO:0000213|MaxQB:E9PJK2, ECO:0000213|PeptideAtlas:E9PJK2,
KW   ECO:0000213|ProteomicsDB:E9PJK2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221}.
FT   REPEAT          186..228
FT                   /note="WD"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00221"
FT   DOMAIN          186..228
FT                   /note="WD_REPEATS_REGION"
FT                   /evidence="ECO:0000259|PROSITE:PS50294"
FT   REGION          1..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        41..64
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   361 AA;  40635 MW;  B8E21C011F16AA49 CRC64;
     MSEREVSTAP AGTDMPAAKK QKLSSDENSN PDLSGDENDD AVSIESGTNT ERPDTPTNTP
     NAPGRKSWGK GKWKSKKCKY SFKCVNSLKE DHNQPLFGVQ FNWHSKEGDP LVFATVGSNR
     VTLYECHSQG EIRLLQSYVD ADADENFYTC AWTYDSNTSH PLLAVAGSRG IIRIINPITM
     QCIKHYVGHG NAINELKFHP RDPNLLLSVS KDHALRLWNI QTDTLVAIFG GVEGHRDEVL
     SASCENAIVC WKPGKMEDDI DKIKPSESNV TILGRFDYSQ CDIWYMRFSM DFWQKMLALG
     NQVGKLYVWD LEVEDPHKAK CTTLTHHKCG AAIRQTSFSR DSSILIAVCD DASIWRWDRL
     R
//
ID   EED_HUMAN               Reviewed;         441 AA.
AC   O75530; A8K7V5; O00149; Q6NTH2; Q7LDA5; Q7LDG8; Q86VV2; Q9UNY7;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   22-APR-2020, entry version 174.
DE   RecName: Full=Polycomb protein EED {ECO:0000305};
DE            Short=hEED;
DE   AltName: Full=Embryonic ectoderm development protein {ECO:0000303|PubMed:28229514};
DE   AltName: Full=WD protein associating with integrin cytoplasmic tails 1;
DE            Short=WAIT-1;
GN   Name=EED {ECO:0000312|HGNC:HGNC:3188};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9806832; DOI=10.1006/geno.1998.5509;
RA   Schumacher A., Lichtarge O., Schwartz S., Magnuson T.;
RT   "The murine Polycomb-group gene eed and its human orthologue: functional
RT   implications of evolutionary conservation.";
RL   Genomics 54:79-88(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH EZH2,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF ILE-193 AND
RP   LEU-196, AND PUTATIVE ALTERNATIVE INITIATION.
RX   PubMed=9584199; DOI=10.1128/mcb.18.6.3586;
RA   Sewalt R.G.A.B., van der Vlag J., Gunster M.J., Hamer K.M.,
RA   den Blaauwen J.L., Satijn D.P.E., Hendrix T., van Driel R., Otte A.P.;
RT   "Characterization of interactions between the mammalian polycomb-group
RT   proteins Enx1/EZH2 and EED suggests the existence of different mammalian
RT   polycomb-group protein complexes.";
RL   Mol. Cell. Biol. 18:3586-3595(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), INTERACTION WITH THE HIV-1
RP   MA PROTEIN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   300-SER-THR-301 AND 305-HIS-TYR-308.
RC   TISSUE=Spleen;
RX   PubMed=9880543; DOI=10.1074/jbc.274.3.1635;
RA   Peytavi R., Hong S.S., Gay B., d'Angeac A.D., Selig L., Benichou S.,
RA   Benarous R., Boulanger P.;
RT   "HEED, the product of the human homolog of the murine eed gene, binds to
RT   the matrix protein of HIV-1.";
RL   J. Biol. Chem. 274:1635-1645(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 15-441 (ISOFORM 1).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-441 (ISOFORM 1), INTERACTION WITH ITGA4;
RP   ITGAE AND ITGB7, AND TISSUE SPECIFICITY.
RX   PubMed=9765275; DOI=10.1074/jbc.273.42.27459;
RA   Rietzler M., Bittner M., Kolanus W., Schuster A., Holzmann B.;
RT   "The human WD repeat protein WAIT-1 specifically interacts with the
RT   cytoplasmic tails of beta7-integrins.";
RL   J. Biol. Chem. 273:27459-27466(1998).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH EZH2; HDAC1 AND HDAC2.
RX   PubMed=10581039; DOI=10.1038/70602;
RA   van der Vlag J., Otte A.P.;
RT   "Transcriptional repression mediated by the human polycomb-group protein
RT   EED involves histone deacetylation.";
RL   Nat. Genet. 23:474-478(1999).
RN   [10]
RP   INTERACTION WITH EZH2 AND YY1.
RX   PubMed=11158321; DOI=10.1128/mcb.21.4.1360-1369.2001;
RA   Satijn D.P.E., Hamer K.M., den Blaauwen J., Otte A.P.;
RT   "The polycomb group protein EED interacts with YY1, and both proteins
RT   induce neural tissue in Xenopus embryos.";
RL   Mol. Cell. Biol. 21:1360-1369(2001).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2 COMPLEX
RP   WITH EZH2; RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE
RP   PRC2 COMPLEX.
RX   PubMed=12435631; DOI=10.1101/gad.1035902;
RA   Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D.;
RT   "Histone methyltransferase activity associated with a human multiprotein
RT   complex containing the Enhancer of Zeste protein.";
RL   Genes Dev. 16:2893-2905(2002).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12101246; DOI=10.1128/mcb.22.15.5539-5553.2002;
RA   Sewalt R.G.A.B., Lachner M., Vargas M., Hamer K.M., den Blaauwen J.L.,
RA   Hendrix T., Melcher M., Schweizer D., Jenuwein T., Otte A.P.;
RT   "Selective interactions between vertebrate polycomb homologs and the
RT   SUV39H1 histone lysine methyltransferase suggest that histone H3-K9
RT   methylation contributes to chromosomal targeting of Polycomb group
RT   proteins.";
RL   Mol. Cell. Biol. 22:5539-5553(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE PRC2 COMPLEX
RP   WITH EZH2; RBBP4; RBBP7 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE
RP   PRC2 COMPLEX.
RX   PubMed=12351676; DOI=10.1126/science.1076997;
RA   Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P.,
RA   Jones R.S., Zhang Y.;
RT   "Role of histone H3 lysine 27 methylation in Polycomb-group silencing.";
RL   Science 298:1039-1043(2002).
RN   [14]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=14532106; DOI=10.1093/emboj/cdg542;
RA   Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K.;
RT   "EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and
RT   amplified in cancer.";
RL   EMBO J. 22:5323-5335(2003).
RN   [15]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12649488; DOI=10.1126/science.1084274;
RA   Plath K., Fang J., Mlynarczyk-Evans S.K., Cao R., Worringer K.A., Wang H.,
RA   de la Cruz C.C., Otte A.P., Panning B., Zhang Y.;
RT   "Role of histone H3 lysine 27 methylation in X inactivation.";
RL   Science 300:131-135(2003).
RN   [16]
RP   FUNCTION, INTERACTION WITH EZH2, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2
RP   COMPLEX.
RX   PubMed=15385962; DOI=10.1038/sj.emboj.7600402;
RA   Pasini D., Bracken A.P., Jensen M.R., Lazzerini Denchi E., Helin K.;
RT   "Suz12 is essential for mouse development and for EZH2 histone
RT   methyltransferase activity.";
RL   EMBO J. 23:4061-4071(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15231737; DOI=10.1101/gad.1200204;
RA   Kirmizis A., Bartley S.M., Kuzmichev A., Margueron R., Reinberg D.,
RA   Green R., Farnham P.J.;
RT   "Silencing of human polycomb target genes is associated with methylation of
RT   histone H3 Lys 27.";
RL   Genes Dev. 18:1592-1605(2004).
RN   [18]
RP   CHARACTERIZATION OF THE PRC2 AND PRC3 COMPLEXES INCLUDING EED; EZH2; RBBP4;
RP   RBBP7 AND SUZ12, METHYLTRANSFERASE ACTIVITY OF THE PRC2 AND PRC3 COMPLEXES,
RP   AND PUTATIVE ALTERNATIVE INITIATION.
RX   PubMed=15099518; DOI=10.1016/s1097-2765(04)00185-6;
RA   Kuzmichev A., Jenuwein T., Tempst P., Reinberg D.;
RT   "Different EZH2-containing complexes target methylation of histone H1 or
RT   nucleosomal histone H3.";
RL   Mol. Cell 14:183-193(2004).
RN   [19]
RP   FUNCTION, CHARACTERIZATION OF THE PRC2 COMPLEX INCLUDING AEBP2; EED; EZH2;
RP   RBBP4 AND SUZ12, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=15225548; DOI=10.1016/j.molcel.2004.06.020;
RA   Cao R., Zhang Y.;
RT   "SUZ12 is required for both the histone methyltransferase activity and the
RT   silencing function of the EED-EZH2 complex.";
RL   Mol. Cell 15:57-67(2004).
RN   [20]
RP   CHARACTERIZATION OF THE PRC4 COMPLEX INCLUDING EED; EZH2; RBBP4; RBBP7;
RP   SUZ12 AND SIRT1, METHYLTRANSFERASE ACTIVITY OF THE PRC4 COMPLEX, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15684044; DOI=10.1073/pnas.0409875102;
RA   Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M.,
RA   Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P.J.,
RA   Reinberg D.;
RT   "Composition and histone substrates of polycomb repressive group complexes
RT   change during cellular differentiation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1859-1864(2005).
RN   [21]
RP   METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX, AND INTERACTION WITH
RP   HISTONE H1.
RX   PubMed=16431907; DOI=10.1074/jbc.m513425200;
RA   Martin C., Cao R., Zhang Y.;
RT   "Substrate preferences of the EZH2 histone methyltransferase complex.";
RL   J. Biol. Chem. 281:8365-8370(2006).
RN   [22]
RP   FUNCTION, AND INTERACTION OF THE PRC2 COMPLEX WITH DNMT1; DNMT3A AND
RP   DNMT3B.
RX   PubMed=16357870; DOI=10.1038/nature04431;
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RT   "The Polycomb group protein EZH2 directly controls DNA methylation.";
RL   Nature 439:871-874(2006).
RN   [23]
RP   ERRATUM OF PUBMED:16357870.
RA   Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C.,
RA   Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M.,
RA   Esteller M., Di Croce L., de Launoit Y., Fuks F.;
RL   Nature 446:824-824(2007).
RN   [24]
RP   DE NOVO DNA METHYLATION OF PRC2 TARGET GENES.
RX   PubMed=17200670; DOI=10.1038/ng1950;
RA   Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M.,
RA   Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E.,
RA   Bergman Y., Simon I., Cedar H.;
RT   "Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for
RT   de novo methylation in cancer.";
RL   Nat. Genet. 39:232-236(2007).
RN   [25]
RP   IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX.
RX   PubMed=19026781; DOI=10.1016/j.molcel.2008.11.004;
RA   Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L.,
RA   Dynlacht B.D., Reinberg D.;
RT   "Ezh1 and Ezh2 maintain repressive chromatin through different
RT   mechanisms.";
RL   Mol. Cell 32:503-518(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION OF THE PRC2 COMPLEX WITH
RP   PHF1, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=18086877; DOI=10.1128/mcb.01589-07;
RA   Cao R., Wang H., He J., Erdjument-Bromage H., Tempst P., Zhang Y.;
RT   "Role of hPHF1 in H3K27 methylation and Hox gene silencing.";
RL   Mol. Cell. Biol. 28:1862-1872(2008).
RN   [27]
RP   FUNCTION, INTERACTION WITH EZH2 AND SUZ12, INTERACTION OF THE PRC2 COMPLEX
RP   WITH PHF1, AND METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX.
RX   PubMed=18285464; DOI=10.1128/mcb.02017-07;
RA   Sarma K., Margueron R., Ivanov A., Pirrotta V., Reinberg D.;
RT   "Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in
RT   vivo.";
RL   Mol. Cell. Biol. 28:2718-2731(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-55, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   INTERACTION WITH CDYL.
RX   PubMed=22009739; DOI=10.1074/jbc.m111.271064;
RA   Zhang Y., Yang X., Gui B., Xie G., Zhang D., Shang Y., Liang J.;
RT   "Corepressor protein CDYL functions as a molecular bridge between polycomb
RT   repressor complex 2 and repressive chromatin mark trimethylated histone
RT   lysine 27.";
RL   J. Biol. Chem. 286:42414-42425(2011).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 40-441 ALONE AND IN COMPLEX WITH
RP   METHYLATED HISTONE PEPTIDES, FUNCTION, DOMAIN WD REPEATS, METHYLATION AT
RP   LYS-66; LYS-197; LYS-268 AND LYS-284, AND MUTAGENESIS OF PHE-97; TYR-148;
RP   TRP-364 AND TYR-365.
RX   PubMed=20974918; DOI=10.1073/pnas.1008937107;
RA   Xu C., Bian C., Yang W., Galka M., Ouyang H., Chen C., Qiu W., Liu H.,
RA   Jones A.E., MacKenzie F., Pan P., Li S.S., Wang H., Min J.;
RT   "Binding of different histone marks differentially regulates the activity
RT   and specificity of polycomb repressive complex 2 (PRC2).";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19266-19271(2010).
RN   [35]
RP   INVOLVEMENT IN COGIS, AND VARIANT COGIS SER-302.
RX   PubMed=25787343; DOI=10.1038/jhg.2015.26;
RA   Cohen A.S., Tuysuz B., Shen Y., Bhalla S.K., Jones S.J., Gibson W.T.;
RT   "A novel mutation in EED associated with overgrowth.";
RL   J. Hum. Genet. 60:339-342(2015).
RN   [36]
RP   VARIANT COGIS TYR-258.
RX   PubMed=27193220; DOI=10.1038/jhg.2016.51;
RA   Cohen A.S., Gibson W.T.;
RT   "EED-associated overgrowth in a second male patient.";
RL   J. Hum. Genet. 61:831-834(2016).
RN   [37]
RP   VARIANTS COGIS SER-194 AND GLY-236.
RX   PubMed=28475857; DOI=10.1016/j.ajhg.2017.03.010;
RG   Childhood Overgrowth Collaboration;
RA   Tatton-Brown K., Loveday C., Yost S., Clarke M., Ramsay E., Zachariou A.,
RA   Elliott A., Wylie H., Ardissone A., Rittinger O., Stewart F., Temple I.K.,
RA   Cole T., Mahamdallie S., Seal S., Ruark E., Rahman N.;
RT   "Mutations in epigenetic regulation genes are a major cause of overgrowth
RT   with intellectual disability.";
RL   Am. J. Hum. Genet. 100:725-736(2017).
RN   [38]
RP   VARIANT COGIS GLY-302.
RX   PubMed=27868325; DOI=10.1002/ajmg.a.38055;
RA   Cooney E., Bi W., Schlesinger A.E., Vinson S., Potocki L.;
RT   "Novel EED mutation in patient with Weaver syndrome.";
RL   Am. J. Med. Genet. A 173:541-545(2017).
RN   [39]
RP   VARIANT COGIS THR-236, CHARACTERIZATION OF VARIANTS COGIS THR-236 AND
RP   SER-302, AND FUNCTION.
RX   PubMed=28229514; DOI=10.1002/humu.23200;
RA   Imagawa E., Higashimoto K., Sakai Y., Numakura C., Okamoto N.,
RA   Matsunaga S., Ryo A., Sato Y., Sanefuji M., Ihara K., Takada Y.,
RA   Nishimura G., Saitsu H., Mizuguchi T., Miyatake S., Nakashima M.,
RA   Miyake N., Soejima H., Matsumoto N.;
RT   "Mutations in genes encoding polycomb repressive complex 2 subunits cause
RT   Weaver syndrome.";
RL   Hum. Mutat. 38:637-648(2017).
CC   -!- FUNCTION: Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2
CC       complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading
CC       to transcriptional repression of the affected target gene. Also
CC       recognizes 'Lys-26' trimethylated histone H1 with the effect of
CC       inhibiting PRC2 complex methyltransferase activity on nucleosomal
CC       histone H3 'Lys-27', whereas H3 'Lys-27' recognition has the opposite
CC       effect, enabling the propagation of this repressive mark. The PRC2/EED-
CC       EZH2 complex may also serve as a recruiting platform for DNA
CC       methyltransferases, thereby linking two epigenetic repression systems.
CC       Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1
CC       and CDKN2A. {ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:14532106,
CC       ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:15231737,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16357870,
CC       ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:20974918,
CC       ECO:0000269|PubMed:28229514, ECO:0000269|PubMed:9584199}.
CC   -!- SUBUNIT: Component of the PRC2/EED-EZH2 complex, which includes EED,
CC       EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components
CC       required for methyltransferase activity of the PRC2/EED-EZH2 complex
CC       are EED, EZH2 and SUZ12. Component of the PRC2/EED-EZH1 complex, which
CC       includes EED, EZH1, SUZ12, RBBP4 and AEBP2. The PRC2 complex may also
CC       interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and
CC       with SIRT1 via the SUZ12 subunit. Interacts with HDAC, HDAC2, histone
CC       H1 and YY1. May interact with ITGA4, ITGAE and ITGB7. Interacts with
CC       CDYL. Interacts with ARNTL/BMAL1. Interacts with KMT2A/MLL1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q921E6,
CC       ECO:0000269|PubMed:10581039, ECO:0000269|PubMed:11158321,
CC       ECO:0000269|PubMed:12351676, ECO:0000269|PubMed:12435631,
CC       ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16357870,
CC       ECO:0000269|PubMed:16431907, ECO:0000269|PubMed:18086877,
CC       ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:19026781,
CC       ECO:0000269|PubMed:20974918, ECO:0000269|PubMed:22009739,
CC       ECO:0000269|PubMed:9584199, ECO:0000269|PubMed:9765275}.
CC   -!- SUBUNIT: (Microbial infection) May interact with the MA protein of HIV-
CC       1. {ECO:0000269|PubMed:9880543}.
CC   -!- INTERACTION:
CC       O75530; O75530; NbExp=2; IntAct=EBI-923794, EBI-923794;
CC       O75530; Q8IXJ9: ASXL1; NbExp=5; IntAct=EBI-923794, EBI-1646500;
CC       O75530; P49368: CCT3; NbExp=2; IntAct=EBI-923794, EBI-356673;
CC       O75530; Q16531: DDB1; NbExp=4; IntAct=EBI-923794, EBI-350322;
CC       O75530; P26358: DNMT1; NbExp=3; IntAct=EBI-923794, EBI-719459;
CC       O75530; Q9Y6K1: DNMT3A; NbExp=2; IntAct=EBI-923794, EBI-923653;
CC       O75530; Q9UBC3: DNMT3B; NbExp=4; IntAct=EBI-923794, EBI-80125;
CC       O75530-2; Q92800-2: EZH1; NbExp=3; IntAct=EBI-11132357, EBI-12322467;
CC       O75530; Q15910: EZH2; NbExp=11; IntAct=EBI-923794, EBI-530054;
CC       O75530-2; Q15910-2: EZH2; NbExp=3; IntAct=EBI-11132357, EBI-10699473;
CC       O75530; Q92833-1: JARID2; NbExp=4; IntAct=EBI-923794, EBI-15825247;
CC       O75530; Q15156: PML-RAR; NbExp=2; IntAct=EBI-923794, EBI-867256;
CC       O75530; P63244: RACK1; NbExp=3; IntAct=EBI-923794, EBI-296739;
CC       O75530; Q9NY59: SMPD3; NbExp=2; IntAct=EBI-923794, EBI-715400;
CC       O75530; Q9JJY3: Smpd3; Xeno; NbExp=5; IntAct=EBI-923794, EBI-9817007;
CC       O75530; Q15022: SUZ12; NbExp=8; IntAct=EBI-923794, EBI-1264675;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Transiently colocalizes
CC       with XIST at inactive X chromosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=Additional isoforms may be produced by alternative
CC         initiation, both from non-canonical start codons upstream of the
CC         initiator methionine displayed and from other canonical start codons
CC         downstream of that displayed (PubMed:15099518 and PubMed:15684044).
CC         The precise sites of translation initiation have not been
CC         unambiguously identified.;
CC       Name=1;
CC         IsoId=O75530-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75530-2; Sequence=VSP_034691;
CC       Name=3;
CC         IsoId=O75530-3; Sequence=VSP_034692;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, colon, heart, kidney, liver,
CC       lung, muscle, ovary, peripheral blood leukocytes, pancreas, placenta,
CC       prostate, spleen, small intestine, testis, thymus and uterus. Appears
CC       to be overexpressed in breast and colon cancer.
CC       {ECO:0000269|PubMed:15684044, ECO:0000269|PubMed:9584199,
CC       ECO:0000269|PubMed:9765275, ECO:0000269|PubMed:9806832,
CC       ECO:0000269|PubMed:9880543}.
CC   -!- DEVELOPMENTAL STAGE: Expression peaks at the G1/S phase boundary.
CC       {ECO:0000269|PubMed:14532106}.
CC   -!- INDUCTION: Expression is induced by E2F1, E2F2 and E2F3.
CC       {ECO:0000269|PubMed:14532106}.
CC   -!- DOMAIN: The WD repeat domain mediates recognition of trimethylated
CC       histone peptides at the consensus sequence Ala-Arg-Lys-Ser. This is
CC       achieved through an aromatic cage encircling the methyllysine, and
CC       involving Phe-97, Tyr-148 and Tyr-365. {ECO:0000269|PubMed:20974918}.
CC   -!- PTM: Methylated. Binding to histone H1 'Lys-26' promotes mono-, di-,
CC       and trimethylation of internal lysines. {ECO:0000269|PubMed:20974918}.
CC   -!- DISEASE: Cohen-Gibson syndrome (COGIS) [MIM:617561]: An autosomal
CC       dominant overgrowth disorder characterized by accelerated osseous
CC       maturation, advanced bone age, skeletal abnormalities including flaring
CC       of the metaphyses of the long bones, large hands with long fingers and
CC       camptodactyly, scoliosis, cervical spine anomalies, dysmorphic facial
CC       features, and variable intellectual disability.
CC       {ECO:0000269|PubMed:25787343, ECO:0000269|PubMed:27193220,
CC       ECO:0000269|PubMed:27868325, ECO:0000269|PubMed:28229514,
CC       ECO:0000269|PubMed:28475857}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the WD repeat ESC family. {ECO:0000305}.
CC   -!- CAUTION: Two variants of the PRC2 complex have been described, termed
CC       PRC3 and PRC4. Each of the three complexes may include a different
CC       complement of EED isoforms, although the precise sequences of the
CC       isoforms in each complex have not been determined. The PRC2 and PRC4
CC       complexes may also methylate 'Lys-26' of histone H1 in addition to
CC       'Lys-27' of histone H3 (PubMed:15099518 and PubMed:15684044), although
CC       other studies have demonstrated no methylation of 'Lys-26' of histone
CC       H1 by PRC2 (PubMed:16431907). {ECO:0000305|PubMed:16431907}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC23685.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC68675.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF080227; AAC95144.1; -; mRNA.
DR   EMBL; AF070418; AAC23685.1; ALT_INIT; mRNA.
DR   EMBL; U90651; AAD08714.1; -; mRNA.
DR   EMBL; AF099032; AAD08815.1; -; mRNA.
DR   EMBL; AK292120; BAF84809.1; -; mRNA.
DR   EMBL; AP003084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW75129.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW75130.1; -; Genomic_DNA.
DR   EMBL; BC047672; AAH47672.1; -; mRNA.
DR   EMBL; BC068995; AAH68995.1; -; mRNA.
DR   EMBL; AF078933; AAC68675.1; ALT_INIT; mRNA.
DR   CCDS; CCDS76463.1; -. [O75530-2]
DR   CCDS; CCDS8273.1; -. [O75530-1]
DR   RefSeq; NP_001294936.1; NM_001308007.1. [O75530-2]
DR   RefSeq; NP_003788.2; NM_003797.4. [O75530-1]
DR   PDB; 3IIW; X-ray; 1.80 A; A=77-441.
DR   PDB; 3IIY; X-ray; 2.65 A; A=77-441.
DR   PDB; 3IJ0; X-ray; 2.45 A; A=77-441.
DR   PDB; 3IJ1; X-ray; 2.10 A; A=77-441.
DR   PDB; 3IJC; X-ray; 1.95 A; A=77-441.
DR   PDB; 3JPX; X-ray; 2.05 A; A=40-441.
DR   PDB; 3JZG; X-ray; 2.10 A; A=40-441.
DR   PDB; 3JZH; X-ray; 2.05 A; A=40-441.
DR   PDB; 3JZN; X-ray; 2.60 A; A=76-441.
DR   PDB; 3K26; X-ray; 1.58 A; A=76-441.
DR   PDB; 3K27; X-ray; 1.76 A; A=76-441.
DR   PDB; 4W2R; X-ray; 2.81 A; E/F=81-441.
DR   PDB; 4X3E; X-ray; 2.30 A; A=77-441.
DR   PDB; 5GSA; X-ray; 2.49 A; A/B=76-441.
DR   PDB; 5H13; X-ray; 1.90 A; A=76-441.
DR   PDB; 5H14; X-ray; 1.90 A; A/B=76-441.
DR   PDB; 5H15; X-ray; 2.27 A; A/B=76-441.
DR   PDB; 5H17; X-ray; 2.30 A; A=76-441.
DR   PDB; 5H19; X-ray; 1.90 A; A=76-441.
DR   PDB; 5H24; X-ray; 2.50 A; A/B=76-441.
DR   PDB; 5H25; X-ray; 2.88 A; A/B=76-441.
DR   PDB; 5HYN; X-ray; 2.95 A; B/G/L/R=77-441.
DR   PDB; 5IJ7; X-ray; 2.62 A; E/F=81-441.
DR   PDB; 5IJ8; X-ray; 2.99 A; E/F=81-441.
DR   PDB; 5K0M; X-ray; 1.83 A; A=77-441.
DR   PDB; 5LS6; X-ray; 3.47 A; B/E/H/K=77-441.
DR   PDB; 5TTW; X-ray; 1.74 A; A/C=76-441.
DR   PDB; 5U5H; X-ray; 1.80 A; A=76-441.
DR   PDB; 5U5K; X-ray; 2.33 A; A=76-441.
DR   PDB; 5U5T; X-ray; 1.60 A; A/B=76-441.
DR   PDB; 5U62; X-ray; 1.90 A; A/B=76-441.
DR   PDB; 5U69; X-ray; 1.28 A; A=77-441.
DR   PDB; 5U6D; X-ray; 1.64 A; A=77-441.
DR   PDB; 5U8A; X-ray; 1.45 A; A=77-441.
DR   PDB; 5U8F; X-ray; 1.34 A; A=77-441.
DR   PDB; 5WG6; X-ray; 3.90 A; B/D=2-441.
DR   PDB; 5WP3; X-ray; 2.55 A; A=75-441.
DR   PDB; 5WUK; X-ray; 2.03 A; A=76-441.
DR   PDB; 6B3W; X-ray; 3.05 A; E/F=81-441.
DR   PDB; 6C23; EM; 3.90 A; L=1-441.
DR   PDB; 6C24; EM; 3.50 A; L=1-441.
DR   PDB; 6SFB; X-ray; 1.52 A; A/B=76-441.
DR   PDB; 6SFC; X-ray; 2.00 A; A/B=76-441.
DR   PDBsum; 3IIW; -.
DR   PDBsum; 3IIY; -.
DR   PDBsum; 3IJ0; -.
DR   PDBsum; 3IJ1; -.
DR   PDBsum; 3IJC; -.
DR   PDBsum; 3JPX; -.
DR   PDBsum; 3JZG; -.
DR   PDBsum; 3JZH; -.
DR   PDBsum; 3JZN; -.
DR   PDBsum; 3K26; -.
DR   PDBsum; 3K27; -.
DR   PDBsum; 4W2R; -.
DR   PDBsum; 4X3E; -.
DR   PDBsum; 5GSA; -.
DR   PDBsum; 5H13; -.
DR   PDBsum; 5H14; -.
DR   PDBsum; 5H15; -.
DR   PDBsum; 5H17; -.
DR   PDBsum; 5H19; -.
DR   PDBsum; 5H24; -.
DR   PDBsum; 5H25; -.
DR   PDBsum; 5HYN; -.
DR   PDBsum; 5IJ7; -.
DR   PDBsum; 5IJ8; -.
DR   PDBsum; 5K0M; -.
DR   PDBsum; 5LS6; -.
DR   PDBsum; 5TTW; -.
DR   PDBsum; 5U5H; -.
DR   PDBsum; 5U5K; -.
DR   PDBsum; 5U5T; -.
DR   PDBsum; 5U62; -.
DR   PDBsum; 5U69; -.
DR   PDBsum; 5U6D; -.
DR   PDBsum; 5U8A; -.
DR   PDBsum; 5U8F; -.
DR   PDBsum; 5WG6; -.
DR   PDBsum; 5WP3; -.
DR   PDBsum; 5WUK; -.
DR   PDBsum; 6B3W; -.
DR   PDBsum; 6C23; -.
DR   PDBsum; 6C24; -.
DR   PDBsum; 6SFB; -.
DR   PDBsum; 6SFC; -.
DR   SMR; O75530; -.
DR   BioGrid; 114265; 537.
DR   CORUM; O75530; -.
DR   DIP; DIP-36673N; -.
DR   IntAct; O75530; 77.
DR   MINT; O75530; -.
DR   STRING; 9606.ENSP00000263360; -.
DR   BindingDB; O75530; -.
DR   ChEMBL; CHEMBL2189117; -.
DR   DrugCentral; O75530; -.
DR   GuidetoPHARMACOLOGY; 2487; -.
DR   iPTMnet; O75530; -.
DR   MetOSite; O75530; -.
DR   PhosphoSitePlus; O75530; -.
DR   BioMuta; EED; -.
DR   EPD; O75530; -.
DR   jPOST; O75530; -.
DR   MassIVE; O75530; -.
DR   MaxQB; O75530; -.
DR   PaxDb; O75530; -.
DR   PeptideAtlas; O75530; -.
DR   PRIDE; O75530; -.
DR   ProteomicsDB; 50068; -. [O75530-1]
DR   ProteomicsDB; 50069; -. [O75530-2]
DR   ProteomicsDB; 50070; -. [O75530-3]
DR   Antibodypedia; 31435; 360 antibodies.
DR   DNASU; 8726; -.
DR   Ensembl; ENST00000263360; ENSP00000263360; ENSG00000074266. [O75530-1]
DR   Ensembl; ENST00000327320; ENSP00000315587; ENSG00000074266. [O75530-3]
DR   Ensembl; ENST00000351625; ENSP00000338186; ENSG00000074266. [O75530-2]
DR   Ensembl; ENST00000672825; ENSP00000500834; ENSG00000074266. [O75530-1]
DR   GeneID; 8726; -.
DR   KEGG; hsa:8726; -.
DR   UCSC; uc001pbp.4; human. [O75530-1]
DR   CTD; 8726; -.
DR   DisGeNET; 8726; -.
DR   GeneCards; EED; -.
DR   HGNC; HGNC:3188; EED.
DR   HPA; ENSG00000074266; Low tissue specificity.
DR   MalaCards; EED; -.
DR   MIM; 605984; gene.
DR   MIM; 617561; phenotype.
DR   neXtProt; NX_O75530; -.
DR   NIAGADS; ENSG00000074266; -.
DR   OpenTargets; ENSG00000074266; -.
DR   Orphanet; 3447; Weaver syndrome.
DR   PharmGKB; PA27624; -.
DR   eggNOG; KOG1034; Eukaryota.
DR   eggNOG; ENOG410XRQI; LUCA.
DR   GeneTree; ENSGT00510000047334; -.
DR   HOGENOM; CLU_032683_1_0_1; -.
DR   InParanoid; O75530; -.
DR   KO; K11462; -.
DR   OMA; DIWFIRF; -.
DR   OrthoDB; 1191277at2759; -.
DR   PhylomeDB; O75530; -.
DR   TreeFam; TF314451; -.
DR   Reactome; R-HSA-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-8953750; Transcriptional Regulation by E2F6.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   SignaLink; O75530; -.
DR   SIGNOR; O75530; -.
DR   ChiTaRS; EED; human.
DR   EvolutionaryTrace; O75530; -.
DR   GeneWiki; EED; -.
DR   GenomeRNAi; 8726; -.
DR   Pharos; O75530; Tchem.
DR   PRO; PR:O75530; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O75530; protein.
DR   Bgee; ENSG00000074266; Expressed in endocervix and 106 other tissues.
DR   ExpressionAtlas; O75530; baseline and differential.
DR   Genevisible; O75530; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0045120; C:pronucleus; IEA:Ensembl.
DR   GO; GO:0001739; C:sex chromatin; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0006342; P:chromatin silencing; IBA:GO_Central.
DR   GO; GO:0070734; P:histone H3-K27 methylation; IEA:GOC.
DR   GO; GO:0070317; P:negative regulation of G0 to G1 transition; TAS:Reactome.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0061087; P:positive regulation of histone H3-K27 methylation; IEA:Ensembl.
DR   GO; GO:2000011; P:regulation of adaxial/abaxial pattern formation; IEA:Ensembl.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR037352; Polycomb_EED.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR10253:SF5; PTHR10253:SF5; 1.
DR   Pfam; PF00400; WD40; 2.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Alternative splicing;
KW   Chromatin regulator; Chromosome; Disease mutation; Host-virus interaction;
KW   Methylation; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; WD repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..441
FT                   /note="Polycomb protein EED"
FT                   /id="PRO_0000343725"
FT   REPEAT          91..134
FT                   /note="WD 1"
FT   REPEAT          142..185
FT                   /note="WD 2"
FT   REPEAT          188..228
FT                   /note="WD 3"
FT   REPEAT          234..275
FT                   /note="WD 4"
FT   REPEAT          304..341
FT                   /note="WD 5"
FT   REPEAT          359..399
FT                   /note="WD 6"
FT   REPEAT          408..441
FT                   /note="WD 7"
FT   REGION          81..441
FT                   /note="Interaction with EZH2"
FT                   /evidence="ECO:0000250"
FT   REGION          149..303
FT                   /note="Required for interaction with the matrix protein MA
FT                   of HIV-1"
FT   REGION          301..441
FT                   /note="Required for interaction with the matrix protein MA
FT                   of HIV-1"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q921E6"
FT   MOD_RES         55
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         66
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         66
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         66
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         197
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         197
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         197
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         268
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         268
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         268
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         284
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         284
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MOD_RES         284
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   VAR_SEQ         322
FT                   /note="K -> KSGRAILHSHQQCMRDPVSPNLRQHL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034691"
FT   VAR_SEQ         401..441
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9880543"
FT                   /id="VSP_034692"
FT   VARIANT         194
FT                   /note="N -> S (in COGIS)"
FT                   /evidence="ECO:0000269|PubMed:28475857"
FT                   /id="VAR_079255"
FT   VARIANT         236
FT                   /note="R -> G (in COGIS)"
FT                   /evidence="ECO:0000269|PubMed:28475857"
FT                   /id="VAR_079256"
FT   VARIANT         236
FT                   /note="R -> T (in COGIS; decreased trimethylation of 'Lys-
FT                   27' of histone H3; no effect on interaction with EZH2;
FT                   dbSNP:rs1131692176)"
FT                   /evidence="ECO:0000269|PubMed:28229514"
FT                   /id="VAR_078316"
FT   VARIANT         258
FT                   /note="H -> Y (in COGIS; dbSNP:rs1131692174)"
FT                   /evidence="ECO:0000269|PubMed:27193220"
FT                   /id="VAR_079257"
FT   VARIANT         302
FT                   /note="R -> G (in COGIS; dbSNP:rs1131692175)"
FT                   /evidence="ECO:0000269|PubMed:27868325"
FT                   /id="VAR_079258"
FT   VARIANT         302
FT                   /note="R -> S (in COGIS; decreased trimethylation of 'Lys-
FT                   27' of histone H3; dbSNP:rs1131692173)"
FT                   /evidence="ECO:0000269|PubMed:25787343,
FT                   ECO:0000269|PubMed:28229514"
FT                   /id="VAR_078317"
FT   MUTAGEN         97
FT                   /note="F->A: Abolishes binding to H3K27me3."
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MUTAGEN         148
FT                   /note="Y->A: Abolishes binding to H3K27me3."
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MUTAGEN         193
FT                   /note="I->N: Impairs interaction with EZH2."
FT                   /evidence="ECO:0000269|PubMed:9584199"
FT   MUTAGEN         196
FT                   /note="L->P: Impairs interaction with EZH2."
FT                   /evidence="ECO:0000269|PubMed:9584199"
FT   MUTAGEN         300..301
FT                   /note="ST->AA: Impairs interaction with the matrix protein
FT                   MA of HIV-1."
FT                   /evidence="ECO:0000269|PubMed:9880543"
FT   MUTAGEN         305..308
FT                   /note="HRNY->AAAA: Impairs interaction with the matrix
FT                   protein MA of HIV-1."
FT                   /evidence="ECO:0000269|PubMed:9880543"
FT   MUTAGEN         364
FT                   /note="W->A: Abolishes binding to H3K27me3."
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MUTAGEN         364
FT                   /note="W->L: Abolishes binding to H3K27me3."
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   MUTAGEN         365
FT                   /note="Y->A: Abolishes binding to H3K27me3."
FT                   /evidence="ECO:0000269|PubMed:20974918"
FT   CONFLICT        32
FT                   /note="D -> E (in Ref. 8; AAC68675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="K -> S (in Ref. 3; AAD08714/AAD08815)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337
FT                   /note="E -> K (in Ref. 3; AAD08714/AAD08815)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        417
FT                   /note="S -> G (in Ref. 4; BAF84809)"
FT                   /evidence="ECO:0000305"
FT   STRAND          83..89
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          96..101
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          103..105
FT                   /evidence="ECO:0000244|PDB:5H17"
FT   STRAND          107..109
FT                   /evidence="ECO:0000244|PDB:5U5K"
FT   STRAND          111..117
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          120..126
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   HELIX           128..130
FT                   /evidence="ECO:0000244|PDB:6SFB"
FT   STRAND          132..139
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          147..154
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   TURN            156..158
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          161..167
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   TURN            168..170
FT                   /evidence="ECO:0000244|PDB:6C24"
FT   STRAND          171..175
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   TURN            177..179
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          182..190
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          193..198
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          200..202
FT                   /evidence="ECO:0000244|PDB:6C24"
FT   STRAND          205..210
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          211..213
FT                   /evidence="ECO:0000244|PDB:6C24"
FT   STRAND          215..219
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   TURN            220..223
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          224..229
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          231..234
FT                   /evidence="ECO:0000244|PDB:6SFC"
FT   STRAND          239..244
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          248..255
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          260..265
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   HELIX           268..279
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   HELIX           282..284
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          292..294
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          298..301
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          311..315
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          318..322
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          324..335
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   HELIX           340..342
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          350..357
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          363..365
FT                   /evidence="ECO:0000244|PDB:5GSA"
FT   STRAND          368..370
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          372..374
FT                   /evidence="ECO:0000244|PDB:4W2R"
FT   STRAND          376..380
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          382..384
FT                   /evidence="ECO:0000244|PDB:4W2R"
FT   STRAND          386..390
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          393..395
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   HELIX           396..398
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          400..404
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          413..418
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          422..429
FT                   /evidence="ECO:0000244|PDB:5U69"
FT   STRAND          432..438
FT                   /evidence="ECO:0000244|PDB:5U69"
SQ   SEQUENCE   441 AA;  50198 MW;  D2E0A5BA27C0499A CRC64;
     MSEREVSTAP AGTDMPAAKK QKLSSDENSN PDLSGDENDD AVSIESGTNT ERPDTPTNTP
     NAPGRKSWGK GKWKSKKCKY SFKCVNSLKE DHNQPLFGVQ FNWHSKEGDP LVFATVGSNR
     VTLYECHSQG EIRLLQSYVD ADADENFYTC AWTYDSNTSH PLLAVAGSRG IIRIINPITM
     QCIKHYVGHG NAINELKFHP RDPNLLLSVS KDHALRLWNI QTDTLVAIFG GVEGHRDEVL
     SADYDLLGEK IMSCGMDHSL KLWRINSKRM MNAIKESYDY NPNKTNRPFI SQKIHFPDFS
     TRDIHRNYVD CVRWLGDLIL SKSCENAIVC WKPGKMEDDI DKIKPSESNV TILGRFDYSQ
     CDIWYMRFSM DFWQKMLALG NQVGKLYVWD LEVEDPHKAK CTTLTHHKCG AAIRQTSFSR
     DSSILIAVCD DASIWRWDRL R
//
ID   A0A024R974_HUMAN        Unreviewed;       371 AA.
AC   A0A024R974;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 48.
DE   SubName: Full=E74-like factor 3 (Ets domain transcription factor, epithelial-specific ), isoform CRA_b {ECO:0000313|EMBL:EAW91391.1};
GN   Name=ELF3 {ECO:0000313|EMBL:EAW91391.1};
GN   ORFNames=hCG_96709 {ECO:0000313|EMBL:EAW91391.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW91391.1};
RN   [1] {ECO:0000313|EMBL:EAW91391.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW91391.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594387}.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594391}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471067; EAW91390.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91391.1; -; Genomic_DNA.
DR   RefSeq; NP_001107781.1; NM_001114309.1.
DR   RefSeq; NP_004424.3; NM_004433.4.
DR   Antibodypedia; 924; 414 antibodies.
DR   GeneID; 1999; -.
DR   KEGG; hsa:1999; -.
DR   CTD; 1999; -.
DR   EuPathDB; HostDB:ENSG00000163435.15; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   HOGENOM; CLU_048172_0_0_1; -.
DR   KO; K09429; -.
DR   OMA; NCAPEEL; -.
DR   OrthoDB; 837296at2759; -.
DR   ChiTaRS; ELF3; human.
DR   GenomeRNAi; 1999; -.
DR   Bgee; ENSG00000163435; Expressed in ectocervix and 132 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0001824; P:blastocyst development; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0060056; P:mammary gland involution; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:InterPro.
DR   CDD; cd08537; SAM_PNT-ESE-1-like; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   InterPro; IPR042693; Elf-3_PNT.
DR   InterPro; IPR033074; Elf3.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11849:SF13; PTHR11849:SF13; 1.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   3: Inferred from homology;
KW   DNA-binding {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594397};
KW   Nucleus {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594400}.
FT   DOMAIN          46..132
FT                   /note="PNT"
FT                   /evidence="ECO:0000259|PROSITE:PS51433"
FT   DOMAIN          273..355
FT                   /note="ETS"
FT                   /evidence="ECO:0000259|PROSITE:PS50061"
FT   REGION          173..251
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        190..216
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   371 AA;  41454 MW;  81A23A7DECBE2EF9 CRC64;
     MAATCEISNI FSNYFSAMYS SEDSTLASVP PAATFGADDL VLTLSNPQMS LEGTEKASWL
     GEQPQFWSKT QVLDWISYQV EKNKYDASAI DFSRCDMDGA TLCNCALEEL RLVFGPLGDQ
     LHAQLRDLTS SSSDELSWII ELLEKDGMAF QEALDPGPFD QGSPFAQELL DDGQQASPYH
     PGSCGAGAPS PGSSDVSTAG TGASRSSHSS DSGGSDVDLD PTDGKLFPSD GFRDCKKGDP
     KHGKRKRGRP RKLSKEYWDC LEGKKSKHAP RGTHLWEFIR DILIHPELNE GLMKWENRHE
     GVFKFLRSEA VAQLWGQKKK NSNMTYEKLS RAMRYYYKRE ILERVDGRRL VYKFGKNSSG
     WKEEEVLQSR N
//
ID   ELF3_HUMAN              Reviewed;         371 AA.
AC   P78545; B2R5Q6; Q6IAP8; Q7RU03; Q7Z3X2; Q8NFG2; Q99718;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-APR-2020, entry version 184.
DE   RecName: Full=ETS-related transcription factor Elf-3;
DE   AltName: Full=E74-like factor 3;
DE   AltName: Full=Epithelial-restricted with serine box;
DE   AltName: Full=Epithelium-restricted Ets protein ESX;
DE   AltName: Full=Epithelium-specific Ets transcription factor 1;
DE            Short=ESE-1;
GN   Name=ELF3 {ECO:0000312|HGNC:HGNC:3318};
GN   Synonyms=ERT {ECO:0000312|EMBL:AAB67238.1},
GN   ESX {ECO:0000312|EMBL:AAB58075.1}, JEN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAB65823.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=9234700; DOI=10.1128/mcb.17.8.4419;
RA   Oettgen P., Alani R.M., Barcinski M.A., Brown L., Akbarali Y., Boltax J.,
RA   Kunsch C., Munger K., Libermann T.A.;
RT   "Isolation and characterization of a novel epithelium-specific
RT   transcription factor, ESE-1, a member of the ets family.";
RL   Mol. Cell. Biol. 17:4419-4433(1997).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAC51884.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=9336459; DOI=10.1093/nar/25.21.4287;
RA   Andreoli J.M., Jang S.-I., Chung E., Coticchia C.M., Steinert P.M.,
RA   Markova N.G.;
RT   "The expression of a novel, epithelium-specific ets transcription factor is
RT   restricted to the most differentiated layers in the epidermis.";
RL   Nucleic Acids Res. 25:4287-4295(1997).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAB58075.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAB58075.1};
RX   PubMed=9129154; DOI=10.1038/sj.onc.1200978;
RA   Chang C.-H., Scott G.K., Kuo W.-L., Xiong X., Suzdaltseva Y., Park J.W.,
RA   Sayre P., Erny K., Collins C., Gray J.W., Benz C.C.;
RT   "ESX: a structurally unique Ets overexpressed early during human breast
RT   tumorigenesis.";
RL   Oncogene 14:1617-1622(1997).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAB96586.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal lung {ECO:0000312|EMBL:AAB96586.1};
RX   PubMed=9395241; DOI=10.1038/sj.onc.1201427;
RA   Tymms M.J., Ng A.Y.N., Thomas R.S., Schutte B.C., Zhou J., Eyre H.J.,
RA   Sutherland G.R., Seth A., Rosenberg M., Papas T., Debouck C., Kola I.;
RT   "A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA
RT   sequences, murine genomic organization, human mapping to 1q32.2 and
RT   expression in tissues and cancer.";
RL   Oncogene 15:2449-2462(1997).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAB67238.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAB67238.1};
RX   PubMed=9417054; DOI=10.1074/jbc.273.1.110;
RA   Choi S.-G., Yi Y., Kim Y.-S., Kato M., Chang J., Chung H.-W., Hahm K.-B.,
RA   Yang H.-K., Rhee H.H., Bang Y.-J., Kim S.-J.;
RT   "A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates
RT   expression of the transforming growth factor-beta type II receptor.";
RL   J. Biol. Chem. 273:110-117(1998).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAD45237.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   TBP, AND SUBCELLULAR LOCATION.
RX   PubMed=10391676; DOI=10.1038/sj.onc.1202674;
RA   Chang C.-H., Scott G.K., Baldwin M.A., Benz C.C.;
RT   "Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX,
RT   confers potent transactivating capacity and binds to TATA-binding protein
RT   (TBP).";
RL   Oncogene 18:3682-3695(1999).
RN   [7] {ECO:0000305, ECO:0000312|EMBL:CAD29859.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=12119107; DOI=10.1016/s0378-1119(02)00650-9;
RA   Piesse C., Tymms M., Garrafa E., Gouzy C., Lacasa M., Cadel S., Cohen P.,
RA   Foulon T.;
RT   "Human aminopeptidase B (rnpep) on chromosome 1q32.2: complementary DNA,
RT   genomic structure and expression.";
RL   Gene 292:129-140(2002).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAM70481.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Mammary cancer {ECO:0000269|PubMed:14997048};
RX   PubMed=14997048; DOI=10.1023/b:brea.0000010710.51614.2d;
RA   Kaplan M.H., Wang X.P., Xu H.P., Dosik M.H.;
RT   "Partially unspliced and fully spliced ELF3 mRNA, including a new Alu
RT   element in human breast cancer.";
RL   Breast Cancer Res. Treat. 83:171-187(2004).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [12] {ECO:0000312|EMBL:AL691482}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [13] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14] {ECO:0000305, ECO:0000312|EMBL:AAH03569.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung {ECO:0000312|EMBL:AAH03569.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=10644990; DOI=10.1038/sj.onc.1203252;
RA   Chang J., Lee C., Hahm K.-B., Yi Y., Choi S.-G., Kim S.-J.;
RT   "Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription
RT   factor, induces endogenous TGF-beta type II receptor expression and
RT   restores the TGF-beta signaling pathway in Hs578t human breast cancer
RT   cells.";
RL   Oncogene 19:151-154(2000).
RN   [16] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF 247-ARG--PRO-250; TRP-315; LYS-319 AND
RP   334-ARG--TYR-337.
RX   PubMed=10773884; DOI=10.1038/sj.onc.1203441;
RA   Brembeck F.H., Opitz O.G., Libermann T.A., Rustgi A.K.;
RT   "Dual function of the epithelial specific ets transcription factor, ELF3,
RT   in modulating differentiation.";
RL   Oncogene 19:1941-1949(2000).
RN   [17] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=11036073; DOI=10.1074/jbc.m006507200;
RA   Rudders S., Gaspar J., Madore R., Voland C., Grall F., Patel A.,
RA   Pellacani A., Perrella M.A., Libermann T.A., Oettgen P.;
RT   "ESE-1 is a novel transcriptional mediator of inflammation that interacts
RT   with NF-kappa B to regulate the inducible nitric-oxide synthase gene.";
RL   J. Biol. Chem. 276:3302-3309(2001).
RN   [18] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=11313868; DOI=10.1038/sj.onc.1204227;
RA   Park S.H., Kim Y.S., Park B.-K., Hougaard S., Kim S.-J.;
RT   "Sequence-specific enhancer binding protein is responsible for the
RT   differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric
RT   cancer cell lines: implication for the loss of TGF-beta type II receptor
RT   expression.";
RL   Oncogene 20:1235-1245(2001).
RN   [19] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=12032832; DOI=10.1038/sj.onc.1205503;
RA   Neve R.M., Ylstra B., Chang C.-H., Albertson D.G., Benz C.C.;
RT   "ErbB2 activation of ESX gene expression.";
RL   Oncogene 21:3934-3938(2002).
RN   [20] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12713734; DOI=10.1089/104454903321515896;
RA   Eckel K.L., Tentler J.J., Cappetta G.J., Diamond S.E.,
RA   Gutierrez-Hartmann A.;
RT   "The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates
RT   breast cancer-associated gene expression.";
RL   DNA Cell Biol. 22:79-94(2003).
RN   [21] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=12414801; DOI=10.1074/jbc.m208241200;
RA   Kwon J.H., Keates S., Simeonidis S., Grall F., Libermann T.A., Keates A.C.;
RT   "ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-
RT   3alpha gene expression in Caco-2 human colonic epithelial cells.";
RL   J. Biol. Chem. 278:875-884(2003).
RN   [22] {ECO:0000305}
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=12624109; DOI=10.1074/jbc.m300508200;
RA   Cabral A., Fischer D.F., Vermeij W.P., Backendorf C.;
RT   "Distinct functional interactions of human Skn-1 isoforms with Ese-1 during
RT   keratinocyte terminal differentiation.";
RL   J. Biol. Chem. 278:17792-17799(2003).
RN   [23] {ECO:0000305}
RP   FUNCTION, AND INDUCTION.
RX   PubMed=12682075; DOI=10.1074/jbc.m212258200;
RA   Reddy S.P.M., Vuong H., Adiseshaiah P.;
RT   "Interplay between proximal and distal promoter elements is required for
RT   squamous differentiation marker induction in the bronchial epithelium: role
RT   for ESE-1, Sp1, and AP-1 proteins.";
RL   J. Biol. Chem. 278:21378-21387(2003).
RN   [24] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14715662; DOI=10.1074/jbc.m308593200;
RA   Brown C., Gaspar J., Pettit A., Lee R., Gu X., Wang H., Manning C.,
RA   Voland C., Goldring S.R., Goldring M.B., Libermann T.A., Gravallese E.M.,
RA   Oettgen P.;
RT   "ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in
RT   the setting of inflammation.";
RL   J. Biol. Chem. 279:12794-12803(2004).
RN   [25] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH CREBBP; EP300; XRCC5 AND XRCC6.
RX   PubMed=15075319; DOI=10.1074/jbc.m401356200;
RA   Wang H., Fang R., Cho J.-Y., Libermann T.A., Oettgen P.;
RT   "Positive and negative modulation of the transcriptional activity of the
RT   ETS factor ESE-1 through interaction with p300, CREB-binding protein, and
RT   Ku 70/86.";
RL   J. Biol. Chem. 279:25241-25250(2004).
RN   [26] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15169914; DOI=10.1128/mcb.24.12.5548-5564.2004;
RA   Prescott J.D., Koto K.S.N., Singh M., Gutierrez-Hartmann A.;
RT   "The ETS transcription factor ESE-1 transforms MCF-12A human mammary
RT   epithelial cells via a novel cytoplasmic mechanism.";
RL   Mol. Cell. Biol. 24:5548-5564(2004).
RN   [27] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14767472; DOI=10.1038/sj.onc.1207391;
RA   Schedin P.J., Eckel-Mahan K.L., McDaniel S.M., Prescott J.D., Brodsky K.S.,
RA   Tentler J.J., Gutierrez-Hartmann A.;
RT   "ESX induces transformation and functional epithelial to mesenchymal
RT   transition in MCF-12A mammary epithelial cells.";
RL   Oncogene 23:1766-1779(2004).
RN   [28] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=15794755; DOI=10.1111/j.1742-4658.2005.04592.x;
RA   Grall F.T., Prall W.C., Wei W., Gu X., Cho J.-Y., Choy B.K., Zerbini L.F.,
RA   Inan M.S., Goldring S.R., Gravallese E.M., Goldring M.B., Oettgen P.,
RA   Libermann T.A.;
RT   "The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by
RT   LPS in monocytes.";
RL   FEBS J. 272:1676-1687(2005).
RN   [29] {ECO:0000305}
RP   FUNCTION, AND INDUCTION.
RX   PubMed=16307850; DOI=10.1016/j.gene.2005.10.001;
RA   Neve R.M., Parmar H., Amend C., Chen C., Rizzino A., Benz C.C.;
RT   "Identification of an epithelial-specific enhancer regulating ESX
RT   expression.";
RL   Gene 367:118-125(2006).
RN   [30] {ECO:0000305}
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=17060315; DOI=10.1074/jbc.m608389200;
RA   Kohno Y., Okamoto T., Ishibe T., Nagayama S., Shima Y., Nishijo K.,
RA   Shibata K.R., Fukiage K., Otsuka S., Uejima D., Araki N., Naka N.,
RA   Nakashima Y., Aoyama T., Nakayama T., Nakamura T., Toguchida J.;
RT   "Expression of claudin7 is tightly associated with epithelial structures in
RT   synovial sarcomas and regulated by an Ets family transcription factor,
RT   ELF3.";
RL   J. Biol. Chem. 281:38941-38950(2006).
RN   [31]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P., Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33] {ECO:0000305, ECO:0000312|EMBL:CAD97611.1}
RP   STRUCTURE BY NMR OF 45-132.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal SAM-domain of E74-like factor 3.";
RL   Submitted (JUL-2007) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional activator that binds and transactivates ETS
CC       sequences containing the consensus nucleotide core sequence GGA[AT].
CC       Acts synergistically with POU2F3 to transactivate the SPRR2A promoter
CC       and with RUNX1 to transactivate the ANGPT1 promoter. Also
CC       transactivates collagenase, CCL20, CLND7, FLG, KRT8, NOS2, PTGS2,
CC       SPRR2B, TGFBR2 and TGM3 promoters. Represses KRT4 promoter activity.
CC       Involved in mediating vascular inflammation. May play an important role
CC       in epithelial cell differentiation and tumorigenesis. May be a critical
CC       downstream effector of the ERBB2 signaling pathway. May be associated
CC       with mammary gland development and involution. Plays an important role
CC       in the regulation of transcription with TATA-less promoters in
CC       preimplantation embryos, which is essential in preimplantation
CC       development (By similarity). {ECO:0000250, ECO:0000269|PubMed:10391676,
CC       ECO:0000269|PubMed:10644990, ECO:0000269|PubMed:10773884,
CC       ECO:0000269|PubMed:11036073, ECO:0000269|PubMed:11313868,
CC       ECO:0000269|PubMed:12414801, ECO:0000269|PubMed:12624109,
CC       ECO:0000269|PubMed:12682075, ECO:0000269|PubMed:12713734,
CC       ECO:0000269|PubMed:14715662, ECO:0000269|PubMed:14767472,
CC       ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:15169914,
CC       ECO:0000269|PubMed:15794755, ECO:0000269|PubMed:16307850,
CC       ECO:0000269|PubMed:17060315, ECO:0000269|PubMed:9129154,
CC       ECO:0000269|PubMed:9234700, ECO:0000269|PubMed:9336459,
CC       ECO:0000269|PubMed:9395241, ECO:0000269|PubMed:9417054}.
CC   -!- SUBUNIT: Interacts with TBP. Interacts with CREBBP and EP300; these act
CC       as transcriptional coactivators of ELF3 and positively modulate its
CC       function. Interacts with XRCC5/KU86 and XRCC6/KU70; these inhibit the
CC       ability of ELF3 to bind DNA and negatively modulate its transcriptional
CC       activity. Associated with CLND7 and POU2F3.
CC       {ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:12624109,
CC       ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:17060315}.
CC   -!- INTERACTION:
CC       P78545; P41743: PRKCI; NbExp=2; IntAct=EBI-1057285, EBI-286199;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10391676,
CC       ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:17060315}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00237, ECO:0000269|PubMed:10391676,
CC       ECO:0000269|PubMed:15169914, ECO:0000269|PubMed:17060315}.
CC       Note=Localizes to the cytoplasm where it has been shown to transform
CC       MCF-12A mammary epithelial cells via a novel cytoplasmic mechanism.
CC       Also transiently expressed and localized to the nucleus where it
CC       induces apoptosis in non-transformed breast epithelial cells MCF-10A
CC       and MCF-12A via a transcription-dependent mechanism.
CC       {ECO:0000269|PubMed:10391676, ECO:0000269|PubMed:15169914,
CC       ECO:0000269|PubMed:17060315}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms may exist. {ECO:0000269|PubMed:9234700};
CC       Name=1 {ECO:0000269|PubMed:9234700}; Synonyms=ESE-1b
CC       {ECO:0000269|PubMed:9234700};
CC         IsoId=P78545-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9234700}; Synonyms=ESE-1a
CC       {ECO:0000269|PubMed:9234700};
CC         IsoId=P78545-2; Sequence=VSP_052433;
CC   -!- TISSUE SPECIFICITY: Expressed exclusively in tissues containing a high
CC       content of terminally differentiated epithelial cells including mammary
CC       gland, colon, trachea, kidney, prostate, uterus, stomach and skin.
CC       {ECO:0000269|PubMed:9129154, ECO:0000269|PubMed:9234700,
CC       ECO:0000269|PubMed:9336459, ECO:0000269|PubMed:9395241}.
CC   -!- INDUCTION: Transcriptionally regulated by ERBB2 receptor signaling in
CC       breast cancer epithelial cells. Up-regulated by phorbol 12-myristate
CC       13-acetate (PMA) in bronchial epithelial cells. By retinoic acid in
CC       MCF-7 mammary epithelial cells (at protein level).
CC       {ECO:0000269|PubMed:12032832, ECO:0000269|PubMed:12682075,
CC       ECO:0000269|PubMed:16307850}.
CC   -!- DOMAIN: the 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:17467953}.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U73843; AAB65823.1; -; mRNA.
DR   EMBL; U73844; AAB65824.1; -; mRNA.
DR   EMBL; U97156; AAC51884.1; -; mRNA.
DR   EMBL; U66894; AAB58075.1; -; mRNA.
DR   EMBL; AF016295; AAB96586.1; -; mRNA.
DR   EMBL; AF017307; AAB67238.1; -; mRNA.
DR   EMBL; AF110184; AAD45237.1; -; Genomic_DNA.
DR   EMBL; BN000001; CAD29859.1; -; Genomic_DNA.
DR   EMBL; AF517841; AAM70481.1; -; mRNA.
DR   EMBL; CR457106; CAG33387.1; -; mRNA.
DR   EMBL; AK312273; BAG35203.1; -; mRNA.
DR   EMBL; BX537368; CAD97611.1; -; mRNA.
DR   EMBL; AL691482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW91389.1; -; Genomic_DNA.
DR   EMBL; BC003569; AAH03569.1; -; mRNA.
DR   CCDS; CCDS1419.1; -. [P78545-1]
DR   RefSeq; NP_001107781.1; NM_001114309.1. [P78545-1]
DR   RefSeq; NP_004424.3; NM_004433.4. [P78545-1]
DR   PDB; 2E8P; NMR; -; A=48-132.
DR   PDBsum; 2E8P; -.
DR   SMR; P78545; -.
DR   BioGrid; 108314; 31.
DR   IntAct; P78545; 5.
DR   STRING; 9606.ENSP00000352673; -.
DR   iPTMnet; P78545; -.
DR   PhosphoSitePlus; P78545; -.
DR   BioMuta; ELF3; -.
DR   DMDM; 74739735; -.
DR   jPOST; P78545; -.
DR   MassIVE; P78545; -.
DR   MaxQB; P78545; -.
DR   PaxDb; P78545; -.
DR   PeptideAtlas; P78545; -.
DR   PRIDE; P78545; -.
DR   ProteomicsDB; 57646; -. [P78545-1]
DR   ProteomicsDB; 57647; -. [P78545-2]
DR   Antibodypedia; 924; 414 antibodies.
DR   DNASU; 1999; -.
DR   Ensembl; ENST00000359651; ENSP00000352673; ENSG00000163435. [P78545-1]
DR   Ensembl; ENST00000367283; ENSP00000356252; ENSG00000163435. [P78545-1]
DR   Ensembl; ENST00000367284; ENSP00000356253; ENSG00000163435. [P78545-1]
DR   GeneID; 1999; -.
DR   KEGG; hsa:1999; -.
DR   UCSC; uc001gxg.5; human. [P78545-1]
DR   CTD; 1999; -.
DR   DisGeNET; 1999; -.
DR   GeneCards; ELF3; -.
DR   HGNC; HGNC:3318; ELF3.
DR   HPA; ENSG00000163435; Tissue enhanced (intestine).
DR   MIM; 602191; gene.
DR   neXtProt; NX_P78545; -.
DR   OpenTargets; ENSG00000163435; -.
DR   PharmGKB; PA27746; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   GeneTree; ENSGT00940000158955; -.
DR   HOGENOM; CLU_048172_0_0_1; -.
DR   InParanoid; P78545; -.
DR   KO; K09429; -.
DR   OMA; NCAPEEL; -.
DR   PhylomeDB; P78545; -.
DR   TreeFam; TF318679; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   SIGNOR; P78545; -.
DR   ChiTaRS; ELF3; human.
DR   EvolutionaryTrace; P78545; -.
DR   GenomeRNAi; 1999; -.
DR   Pharos; P78545; Tbio.
DR   PRO; PR:P78545; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P78545; protein.
DR   Bgee; ENSG00000163435; Expressed in ectocervix and 132 other tissues.
DR   ExpressionAtlas; P78545; baseline and differential.
DR   Genevisible; P78545; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0001824; P:blastocyst development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008544; P:epidermis development; NAS:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEP:UniProtKB.
DR   GO; GO:0060056; P:mammary gland involution; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   CDD; cd08537; SAM_PNT-ESE-1-like; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   InterPro; IPR042693; Elf-3_PNT.
DR   InterPro; IPR033074; Elf3.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11849:SF13; PTHR11849:SF13; 1.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Cytoplasm;
KW   Developmental protein; Differentiation; DNA-binding; Inflammatory response;
KW   Nucleus; Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..371
FT                   /note="ETS-related transcription factor Elf-3"
FT                   /id="PRO_0000287681"
FT   DOMAIN          46..132
FT                   /note="PNT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00762"
FT   DNA_BIND        273..355
FT                   /note="ETS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00237"
FT   MOTIF           137..145
FT                   /note="9aaTAD"
FT   VAR_SEQ         173..195
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9234700"
FT                   /id="VSP_052433"
FT   VARIANT         317
FT                   /note="Q -> K (in dbSNP:rs1135542)"
FT                   /id="VAR_048945"
FT   MUTAGEN         247..250
FT                   /note="RGRP->AAAA: No effect on transcriptional repression
FT                   on KRT4 promoter."
FT                   /evidence="ECO:0000269|PubMed:10773884"
FT   MUTAGEN         315
FT                   /note="W->A: Partially abrogates repressive effect on the
FT                   KRT4 promoter; when associated with A-319."
FT                   /evidence="ECO:0000269|PubMed:10773884"
FT   MUTAGEN         319
FT                   /note="K->A: Partially abrogates repressive effect on the
FT                   KRT4 promoter; when associated with A-315."
FT                   /evidence="ECO:0000269|PubMed:10773884"
FT   MUTAGEN         334..337
FT                   /note="RYYY->AAAA: Partially abrogates repressive effect on
FT                   the KRT4 promoter."
FT                   /evidence="ECO:0000269|PubMed:10773884"
FT   CONFLICT        3
FT                   /note="A -> T (in Ref. 8; AAM70481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        55..56
FT                   /note="EK -> GE (in Ref. 7; CAD29859)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        68
FT                   /note="S -> L (in Ref. 8; AAM70481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129..130
FT                   /note="TS -> SA (in Ref. 7; CAD29859)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="D -> Y (in Ref. 8; AAM70481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        160..161
FT                   /note="DQ -> GE (in Ref. 7; CAD29859)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="T -> A (in Ref. 7; CAD29859)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        242
FT                   /note="H -> L (in Ref. 9; CAG33387)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="K -> E (in Ref. 11; CAD97611)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="Y -> C (in Ref. 8; AAM70481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        269
FT                   /note="A -> G (in Ref. 7; CAD29859)"
FT                   /evidence="ECO:0000305"
FT   STRAND          60..62
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           64..66
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           69..82
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   TURN            92..94
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           100..104
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           107..113
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           115..117
FT                   /evidence="ECO:0000244|PDB:2E8P"
FT   HELIX           118..130
FT                   /evidence="ECO:0000244|PDB:2E8P"
SQ   SEQUENCE   371 AA;  41454 MW;  81A23A7DECBE2EF9 CRC64;
     MAATCEISNI FSNYFSAMYS SEDSTLASVP PAATFGADDL VLTLSNPQMS LEGTEKASWL
     GEQPQFWSKT QVLDWISYQV EKNKYDASAI DFSRCDMDGA TLCNCALEEL RLVFGPLGDQ
     LHAQLRDLTS SSSDELSWII ELLEKDGMAF QEALDPGPFD QGSPFAQELL DDGQQASPYH
     PGSCGAGAPS PGSSDVSTAG TGASRSSHSS DSGGSDVDLD PTDGKLFPSD GFRDCKKGDP
     KHGKRKRGRP RKLSKEYWDC LEGKKSKHAP RGTHLWEFIR DILIHPELNE GLMKWENRHE
     GVFKFLRSEA VAQLWGQKKK NSNMTYEKLS RAMRYYYKRE ILERVDGRRL VYKFGKNSSG
     WKEEEVLQSR N
//
ID   FBLN2_HUMAN             Reviewed;        1184 AA.
AC   P98095; B7Z9C5; Q8IUI0; Q8IUI1;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 2.
DT   22-APR-2020, entry version 186.
DE   RecName: Full=Fibulin-2;
DE            Short=FIBL-2;
DE   Flags: Precursor;
GN   Name=FBLN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-854.
RC   TISSUE=Fibroblast;
RX   PubMed=7806230; DOI=10.1006/geno.1994.1404;
RA   Zhang R.-Z., Pan T.-C., Zhang Z.-Y., Mattei M.-G., Timpl R., Chu M.-L.;
RT   "Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression, and mapping of
RT   the gene on human and mouse chromosomes.";
RL   Genomics 22:425-430(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND ALTERNATIVE
RP   SPLICING.
RA   Li D., Marian A.J., Roberts R.;
RT   "Identification of a novel alternatively spliced isoform of human fibulin-2
RT   gene abundantly expressed in heart and genetic evaluation in patients with
RT   ARVD.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=8737292; DOI=10.1007/bf02331415;
RA   Miosge N., Gotz W., Sasaki T., Chu M.-L., Timpl R., Herken R.;
RT   "The extracellular matrix proteins fibulin-1 and fibulin-2 in the early
RT   human embryo.";
RL   Histochem. J. 28:109-116(1996).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH FBN1 AND ELN.
RX   PubMed=17255108; DOI=10.1074/jbc.m608204200;
RA   El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K.,
RA   Brinckmann J., Baetge B., Davis E.C., Reinhardt D.P.;
RT   "Fibrillin-1 interactions with fibulins depend on the first hybrid domain
RT   and provide an adaptor function to tropoelastin.";
RL   J. Biol. Chem. 282:8935-8946(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1035.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   GLYCOSYLATION, STRUCTURE OF CARBOHYDRATES, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.m111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of N- and
RT   O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
CC   -!- FUNCTION: Its binding to fibronectin and some other ligands is calcium
CC       dependent. May act as an adapter that mediates the interaction between
CC       FBN1 and ELN (PubMed:17255108). {ECO:0000269|PubMed:17255108}.
CC   -!- SUBUNIT: Homotrimer; disulfide-linked. Interacts with LAMA2 (By
CC       similarity). Interacts with FBN1 (via N-terminal domain). Forms a
CC       ternary complex with ELN and FBN1 (PubMed:17255108).
CC       {ECO:0000250|UniProtKB:P37889, ECO:0000269|PubMed:17255108}.
CC   -!- INTERACTION:
CC       P98095; P27658: COL8A1; NbExp=3; IntAct=EBI-947973, EBI-747133;
CC       P98095; Q969U6: FBXW5; NbExp=3; IntAct=EBI-947973, EBI-741068;
CC       P98095; Q9H2F3: HSD3B7; NbExp=3; IntAct=EBI-947973, EBI-3918847;
CC       P98095; Q15040: JOSD1; NbExp=3; IntAct=EBI-947973, EBI-2510602;
CC       P98095; Q9BYE3: LCE3D; NbExp=3; IntAct=EBI-947973, EBI-6658837;
CC       P98095; P32242: OTX1; NbExp=3; IntAct=EBI-947973, EBI-740446;
CC       P98095; Q96IQ9: ZNF414; NbExp=3; IntAct=EBI-947973, EBI-744257;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P98095-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P98095-2; Sequence=VSP_041404;
CC   -!- TISSUE SPECIFICITY: Component of both basement membranes and other
CC       connective tissues. Expressed in heart, placenta and ovary.
CC   -!- DEVELOPMENTAL STAGE: Widely expressed during embryonic development.
CC       Primarily detected within the neuropithelium, spinal ganglia and
CC       peripheral nerves. {ECO:0000269|PubMed:8737292}.
CC   -!- PTM: O-glycosylated with core 1 or possibly core 8 glycans. It is
CC       unsure if the O-glycosylation is on Thr-347 or Ser-348.
CC       {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22171320}.
CC   -!- SIMILARITY: Belongs to the fibulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X82494; CAA57876.1; -; mRNA.
DR   EMBL; AY130458; AAN05435.1; -; Genomic_DNA.
DR   EMBL; AY130456; AAN05435.1; JOINED; Genomic_DNA.
DR   EMBL; AY130457; AAN05435.1; JOINED; Genomic_DNA.
DR   EMBL; AY130459; AAN05436.1; -; mRNA.
DR   EMBL; AK304827; BAH14261.1; -; mRNA.
DR   EMBL; AC090509; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS46761.1; -. [P98095-2]
DR   CCDS; CCDS46762.1; -. [P98095-1]
DR   PIR; A55184; A55184.
DR   RefSeq; NP_001004019.1; NM_001004019.1. [P98095-2]
DR   RefSeq; NP_001158507.1; NM_001165035.1. [P98095-2]
DR   RefSeq; NP_001989.2; NM_001998.2. [P98095-1]
DR   SMR; P98095; -.
DR   BioGrid; 108493; 37.
DR   CORUM; P98095; -.
DR   IntAct; P98095; 13.
DR   STRING; 9606.ENSP00000384169; -.
DR   GlyConnect; 751; -.
DR   iPTMnet; P98095; -.
DR   PhosphoSitePlus; P98095; -.
DR   UniCarbKB; P98095; -.
DR   BioMuta; FBLN2; -.
DR   DMDM; 224471827; -.
DR   EPD; P98095; -.
DR   jPOST; P98095; -.
DR   MassIVE; P98095; -.
DR   MaxQB; P98095; -.
DR   PaxDb; P98095; -.
DR   PeptideAtlas; P98095; -.
DR   PRIDE; P98095; -.
DR   ProteomicsDB; 57790; -. [P98095-1]
DR   ProteomicsDB; 57791; -. [P98095-2]
DR   Antibodypedia; 1165; 253 antibodies.
DR   Ensembl; ENST00000295760; ENSP00000295760; ENSG00000163520. [P98095-1]
DR   Ensembl; ENST00000404922; ENSP00000384169; ENSG00000163520. [P98095-2]
DR   Ensembl; ENST00000492059; ENSP00000420042; ENSG00000163520. [P98095-2]
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   UCSC; uc011ava.3; human. [P98095-1]
DR   CTD; 2199; -.
DR   DisGeNET; 2199; -.
DR   GeneCards; FBLN2; -.
DR   HGNC; HGNC:3601; FBLN2.
DR   HPA; ENSG00000163520; Tissue enhanced (heart).
DR   MIM; 135821; gene.
DR   neXtProt; NX_P98095; -.
DR   OpenTargets; ENSG00000163520; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   GeneTree; ENSGT00940000156047; -.
DR   HOGENOM; CLU_268948_0_0_1; -.
DR   InParanoid; P98095; -.
DR   KO; K17307; -.
DR   OMA; CQRLITC; -.
DR   PhylomeDB; P98095; -.
DR   TreeFam; TF317514; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   ChiTaRS; FBLN2; human.
DR   GeneWiki; FBLN2; -.
DR   GenomeRNAi; 2199; -.
DR   Pharos; P98095; Tbio.
DR   PRO; PR:P98095; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P98095; protein.
DR   Bgee; ENSG00000163520; Expressed in right atrium auricular region and 189 other tissues.
DR   ExpressionAtlas; P98095; baseline and differential.
DR   Genevisible; P98095; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; TAS:ProtInc.
DR   GO; GO:0050840; F:extracellular matrix binding; IBA:GO_Central.
DR   GO; GO:0030023; F:extracellular matrix constituent conferring elasticity; ISS:BHF-UCL.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IBA:GO_Central.
DR   CDD; cd00017; ANATO; 2.
DR   InterPro; IPR000020; Anaphylatoxin/fibulin.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR24039:SF32; PTHR24039:SF32; 2.
DR   Pfam; PF01821; ANATO; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 5.
DR   SMART; SM00104; ANATO; 3.
DR   SMART; SM00181; EGF; 11.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 4.
DR   PROSITE; PS01177; ANAPHYLATOXIN_1; 3.
DR   PROSITE; PS01178; ANAPHYLATOXIN_2; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Disulfide bond; EGF-like domain;
KW   Extracellular matrix; Glycoprotein; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..1184
FT                   /note="Fibulin-2"
FT                   /id="PRO_0000007568"
FT   DOMAIN          445..480
FT                   /note="Anaphylatoxin-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00022"
FT   DOMAIN          488..519
FT                   /note="Anaphylatoxin-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00022"
FT   DOMAIN          521..553
FT                   /note="Anaphylatoxin-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00022"
FT   DOMAIN          604..645
FT                   /note="EGF-like 1; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          679..718
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          719..763
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          764..809
FT                   /note="EGF-like 4; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          810..857
FT                   /note="EGF-like 5; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          858..900
FT                   /note="EGF-like 6; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          901..942
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          943..981
FT                   /note="EGF-like 8; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          982..1024
FT                   /note="EGF-like 9; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1025..1069
FT                   /note="EGF-like 10; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          28..444
FT                   /note="N"
FT   REGION          28..177
FT                   /note="Subdomain NA (Cys-rich)"
FT   REGION          178..444
FT                   /note="Subdomain NB (Cys-free)"
FT   REGION          1070..1184
FT                   /note="Domain III"
FT   MOD_RES         277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18318008"
FT   CARBOHYD        180
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        507
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1035
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   DISULFID        445..472
FT                   /evidence="ECO:0000250"
FT   DISULFID        446..479
FT                   /evidence="ECO:0000250"
FT   DISULFID        459..480
FT                   /evidence="ECO:0000250"
FT   DISULFID        489..518
FT                   /evidence="ECO:0000250"
FT   DISULFID        502..519
FT                   /evidence="ECO:0000250"
FT   DISULFID        521..545
FT                   /evidence="ECO:0000250"
FT   DISULFID        522..552
FT                   /evidence="ECO:0000250"
FT   DISULFID        535..553
FT                   /evidence="ECO:0000250"
FT   DISULFID        608..620
FT                   /evidence="ECO:0000250"
FT   DISULFID        616..629
FT                   /evidence="ECO:0000250"
FT   DISULFID        631..644
FT                   /evidence="ECO:0000250"
FT   DISULFID        683..693
FT                   /evidence="ECO:0000250"
FT   DISULFID        689..702
FT                   /evidence="ECO:0000250"
FT   DISULFID        704..717
FT                   /evidence="ECO:0000250"
FT   DISULFID        723..736
FT                   /evidence="ECO:0000250"
FT   DISULFID        730..745
FT                   /evidence="ECO:0000250"
FT   DISULFID        751..762
FT                   /evidence="ECO:0000250"
FT   DISULFID        768..781
FT                   /evidence="ECO:0000250"
FT   DISULFID        775..790
FT                   /evidence="ECO:0000250"
FT   DISULFID        796..808
FT                   /evidence="ECO:0000250"
FT   DISULFID        814..827
FT                   /evidence="ECO:0000250"
FT   DISULFID        821..836
FT                   /evidence="ECO:0000250"
FT   DISULFID        843..856
FT                   /evidence="ECO:0000250"
FT   DISULFID        862..875
FT                   /evidence="ECO:0000250"
FT   DISULFID        869..884
FT                   /evidence="ECO:0000250"
FT   DISULFID        886..899
FT                   /evidence="ECO:0000250"
FT   DISULFID        905..917
FT                   /evidence="ECO:0000250"
FT   DISULFID        913..926
FT                   /evidence="ECO:0000250"
FT   DISULFID        928..941
FT                   /evidence="ECO:0000250"
FT   DISULFID        947..956
FT                   /evidence="ECO:0000250"
FT   DISULFID        952..965
FT                   /evidence="ECO:0000250"
FT   DISULFID        967..980
FT                   /evidence="ECO:0000250"
FT   DISULFID        986..998
FT                   /evidence="ECO:0000250"
FT   DISULFID        994..1007
FT                   /evidence="ECO:0000250"
FT   DISULFID        1009..1023
FT                   /evidence="ECO:0000250"
FT   DISULFID        1029..1042
FT                   /evidence="ECO:0000250"
FT   DISULFID        1036..1051
FT                   /evidence="ECO:0000250"
FT   DISULFID        1056..1068
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         718
FT                   /note="E -> EDQDECLMGAHDCSRRQFCVNTLGSFYCVNHTVLCADGYILNAHRKC
FT                   V (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_041404"
FT   VARIANT         45
FT                   /note="I -> V (in dbSNP:rs60850813)"
FT                   /id="VAR_061159"
FT   VARIANT         144
FT                   /note="H -> R (in dbSNP:rs28587534)"
FT                   /id="VAR_061160"
FT   VARIANT         361
FT                   /note="S -> G (in dbSNP:rs3732666)"
FT                   /id="VAR_059266"
FT   VARIANT         387
FT                   /note="N -> T (in dbSNP:rs3796318)"
FT                   /id="VAR_059267"
FT   VARIANT         854
FT                   /note="T -> A (in dbSNP:rs9843344)"
FT                   /evidence="ECO:0000269|PubMed:7806230"
FT                   /id="VAR_059268"
FT   VARIANT         1114
FT                   /note="G -> R (in dbSNP:rs1061375)"
FT                   /id="VAR_055722"
FT   CONFLICT        145
FT                   /note="K -> E (in Ref. 1; CAA57876 and 2; AAN05436)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        664
FT                   /note="E -> G (in Ref. 3; BAH14261)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1184 AA;  126573 MW;  D46890D93518B343 CRC64;
     MVLLWEPAGA WLALGLALAL GPSVAAAAPR QDCTGVECPP LENCIEEALE PGACCATCVQ
     QGCACEGYQY YDCLQGGFVR GRVPAGQSYF VDFGSTECSC PPGGGKISCQ FMLCPELPPN
     CIEAVVVADS CPQCGQVGCV HAGHKYAAGH TVHLPPCRAC HCPDAGGELI CYQLPGCHGN
     FSDAEEGDPE RHYEDPYSYD QEVAEVEAAT ALGGEVQAGA VQAGAGGPPA ALGGGSQPLS
     TIQAPPWPAV LPRPTAAAAL GPPAPVQAKA RRVTEDSEEE EEEEEEREEM AVTEQLAAGG
     HRGLDGLPTT APAGPSLPIQ EERAEAGARA EAGARPEENL ILDAQATSRS TGPEGVTHAP
     SLGKAALVPT QAVPGSPRDP VKPSPHNILS TSLPDAAWIP PTREVPRKPQ VLPHSHVEED
     TDPNSVHSIP RSSPEGSTKD LIETCCAAGQ QWAIDNDECL EIPESGTEDN VCRTAQRHCC
     VSYLQEKSCM AGVLGAKEGE TCGAEDNDSC GISLYKQCCD CCGLGLRVRA EGQSCESNPN
     LGYPCNHVML SCCEGEEPLI VPEVRRPPEP AAAPRRVSEA EMAGREALSL GTEAELPNSL
     PGDDQDECLL LPGELCQHLC INTVGSYHCA CFPGFSLQDD GRTCRPEGHP PQPEAPQEPA
     LKSEFSQVAS NTIPLPLPQP NTCKDNGPCK QVCSTVGGSA ICSCFPGYAI MADGVSCEDI
     NECVTDLHTC SRGEHCVNTL GSFHCYKALT CEPGYALKDG ECEDVDECAM GTHTCQPGFL
     CQNTKGSFYC QARQRCMDGF LQDPEGNCVD INECTSLSEP CRPGFSCINT VGSYTCQRNP
     LICARGYHAS DDGTKCVDVN ECETGVHRCG EGQVCHNLPG SYRCDCKAGF QRDAFGRGCI
     DVNECWASPG RLCQHTCENT LGSYRCSCAS GFLLAADGKR CEDVNECEAQ RCSQECANIY
     GSYQCYCRQG YQLAEDGHTC TDIDECAQGA GILCTFRCLN VPGSYQCACP EQGYTMTANG
     RSCKDVDECA LGTHNCSEAE TCHNIQGSFR CLRFECPPNY VQVSKTKCER TTCHDFLECQ
     NSPARITHYQ LNFQTGLLVP AHIFRIGPAP AFTGDTIALN IIKGNEEGYF GTRRLNAYTG
     VVYLQRAVLE PRDFALDVEM KLWRQGSVTT FLAKMHIFFT TFAL
//
ID   Q86V58_HUMAN            Unreviewed;      1184 AA.
AC   Q86V58;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   11-DEC-2019, entry version 136.
DE   SubName: Full=Fibulin 2 {ECO:0000313|EMBL:AAH51690.1};
GN   Name=FBLN2 {ECO:0000313|EMBL:AAH51690.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH51690.1};
RN   [1] {ECO:0000313|EMBL:AAH51690.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH51690.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC051690; AAH51690.1; -; mRNA.
DR   RefSeq; NP_001004019.1; NM_001004019.1.
DR   RefSeq; NP_001158507.1; NM_001165035.1.
DR   RefSeq; NP_001989.2; NM_001998.2.
DR   IntAct; Q86V58; 1.
DR   PeptideAtlas; Q86V58; -.
DR   PRIDE; Q86V58; -.
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   CTD; 2199; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   KO; K17307; -.
DR   OrthoDB; 1174178at2759; -.
DR   ChiTaRS; FBLN2; human.
DR   GenomeRNAi; 2199; -.
DR   Genevisible; Q86V58; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   CDD; cd00017; ANATO; 2.
DR   InterPro; IPR000020; Anaphylatoxin/fibulin.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR24039:SF32; PTHR24039:SF32; 2.
DR   Pfam; PF01821; ANATO; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 5.
DR   SMART; SM00104; ANATO; 3.
DR   SMART; SM00181; EGF; 11.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 4.
DR   PROSITE; PS01177; ANAPHYLATOXIN_1; 1.
DR   PROSITE; PS01178; ANAPHYLATOXIN_2; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 3.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|SAAS:SAAS00909960};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00438935}; Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           28..1184
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004300515"
FT   DOMAIN          445..480
FT                   /note="Anaphylatoxin-like"
FT                   /evidence="ECO:0000259|PROSITE:PS01178"
FT   DOMAIN          488..519
FT                   /note="Anaphylatoxin-like"
FT                   /evidence="ECO:0000259|PROSITE:PS01178"
FT   DOMAIN          521..553
FT                   /note="Anaphylatoxin-like"
FT                   /evidence="ECO:0000259|PROSITE:PS01178"
FT   DOMAIN          604..645
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          858..896
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          901..942
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          943..981
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          221..293
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          399..437
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        409..425
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1184 AA;  126509 MW;  4240CD6ADBB9EC5D CRC64;
     MVLLWEPAGA WLALGLALAL GPSVAAAAPR QDCTGVECPP LENCIEEALE PGACCATCVQ
     QGCACEGYQY YDCLQGGFVR GRVPAGQSYF VDFGSTECSC PPGGGKISCQ FMLCPELPPN
     CIEAVVVADS CPQCGQVGCV HAGHKYAAGH TVHLPPCRAC HCPDAGGELI CYQLPGCHGN
     FSDAEEGDPE RHYEDPYSYD QEVAEVEAAT ALGGEVQAGA VQAGAGGPPA ALGGGSQPLS
     TIQAPPWPAV LPRPTAAAAL GPPAPVQAKA RRVTEDSEEE EEEEEEREEM AVTEQLAAGG
     HRGLDGLPTT APAGPSLPIQ EERAEAGARA EAGARPEENL ILDAQATSRS TGPEGVTHAP
     SLGKAALVPT QAVPGSPRDP VKPSPHNILS TSLPDAAWIP PTREVPRKPQ VLPHSHVEED
     TDPNSVHSIP RSSPEGSTKD LIETCCAAGQ QWAIDNDECL EIPESGTEDN VCRTAQRHCC
     VSYLQEKSCM AGVLGAKEGE TCGAEDNDSC GISLYKQCCD CCGLGLRVRA EGQSCESNPN
     LGYPCNHVML SCCEGEEPLI VPEVRRPPEP AAAPRRVSEA EMAGREALSL GTEAELPNSL
     PGDDQDECLL LPGELCQHLC INTVGSYHCA CFPGFSLQDD GRTCRPEGHP PQPEAPQEPA
     LKSEFSQVAS NTIPLPLPQP NTCKDNGPCK QVCSTVGGSA ICSCFPGYAI MADGVSCEDI
     NECVTDLHTC SRGEHCVNTL GSFHCYKALT CEPGYALKDG ECEDVDECAM GTHTCQPGFL
     CQNTKGSFYC QARQRCMDGF LQDPEGNCVD INECTSLSEP CRPGFSCINT VGSYTCQRNP
     LICARGYHAS DDGAKCVDVN ECETGVHRCG EGQVCHNLPG SYRCDCKAGF QRDAFGRGCI
     DVNECWASPG RLCQHTCENT LGSYRCSCAS GFLLAADGKR CEDVNECEAQ RCSQECANIY
     GSYQCYCRQG YQLAEDGHTC TDIDECAQGA GILCTFRCLN VPGSYQCACP EQGYTMTANG
     RSCKDVDECA LGTHNCSEAE TCHNIQGSFR CLRLECPPNY VQVSKTKCER TTCHDFLECQ
     NSPARITHYQ LNFQTGLLVP AHIFRIGPAP AFTGDTIALN IIKGNEEGYF GTRRLNAYTG
     VVYLQRAVLE PRDFALDVEM KLWRQGSVTT FLAKMHIFFT TFAL
//
ID   Q9Y3V7_HUMAN            Unreviewed;       576 AA.
AC   Q9Y3V7;
DT   01-NOV-1999, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1999, sequence version 1.
DT   11-DEC-2019, entry version 112.
DE   SubName: Full=Uncharacterized protein DKFZp586A1519 {ECO:0000313|EMBL:CAB43267.1};
DE   Flags: Fragment;
GN   Name=DKFZp586A1519 {ECO:0000313|EMBL:CAB43267.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAB43267.1};
RN   [1] {ECO:0000313|EMBL:CAB43267.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:CAB43267.1};
RG   The German cDNA Consortium;
RA   Wambutt R., Heubner D., Mewes H.W., Weil B., Amid C., Osanger A., Fobo G.,
RA   Han M., Wiemann S.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL050095; CAB43267.1; -; mRNA.
DR   RefSeq; NP_001004019.1; NM_001004019.1.
DR   RefSeq; NP_001158507.1; NM_001165035.1.
DR   RefSeq; NP_001989.2; NM_001998.2.
DR   PeptideAtlas; Q9Y3V7; -.
DR   GeneID; 2199; -.
DR   KEGG; hsa:2199; -.
DR   CTD; 2199; -.
DR   PharmGKB; PA28014; -.
DR   eggNOG; ENOG410IR7F; Eukaryota.
DR   eggNOG; ENOG410Y194; LUCA.
DR   KO; K17307; -.
DR   OrthoDB; 1174178at2759; -.
DR   GenomeRNAi; 2199; -.
DR   Genevisible; Q9Y3V7; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0016504; F:peptidase activator activity; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR017048; Fibulin-1.
DR   InterPro; IPR037286; Fibulin-2.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR24039:SF32; PTHR24039:SF32; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 6.
DR   PIRSF; PIRSF036313; Fibulin-1; 2.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 9.
DR   SUPFAM; SSF57184; SSF57184; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS01187; EGF_CA; 3.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00602928}; Repeat {ECO:0000256|SAAS:SAAS00594563}.
FT   DOMAIN          250..288
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          293..334
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   DOMAIN          335..373
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:CAB43267.1"
SQ   SEQUENCE   576 AA;  63274 MW;  FF2F0E9B185D8AC3 CRC64;
     PQEPALKSEF SQVASNTIPL PLPQPNTCKD NGPCKQVCST VGGSAICSCF PGYAIMADGV
     SCEDQDECLM GAHDCSRRQF CVNTLGSFYC VNHTVLCADG YILNAHRKCV DINECVTDLH
     TCSRGEHCVN TLGSFHCYKA LTCEPGYALK DGECEDVDEC AMGTHTCQPG FLCQNTKGSF
     YCQARQRCMD GFLQDPEGNC VDINECTSLS EPCRPGFSCI NTVGSYTCQR NPLICARGYH
     ASDDGTKCVD VNECETGVHR CGEGQVCHNL PGSYRCDCKA GFQRDAFGRG CIDVNECWAS
     PGRLCQHTCE NTLGSYRCSC ASGFLLAADG KRCEDVNECE AQRCSQECAN IYGSYQCYCR
     QGYQLAEDGH TCTDIDECAQ GAGILCTFRC LNVPGSYQCA CPEQGYTMTA NGRSCKDVDE
     CALGTHNCSE AETCHNIQGS FRCLRFECPP NYVQVSKTKC ERTTCHDFLE CQNSPARITH
     YQLNFQTGLL VPAHIFRIGP APAFTGDTIA LNIIKGNEEG YFGTRRLNAY TGVVYLQRAV
     LEPRDFALDV EMKLWRQGSV TTFLAKMHIF FTTFAL
//
ID   FEN1_HUMAN              Reviewed;         380 AA.
AC   P39748;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   22-APR-2020, entry version 201.
DE   RecName: Full=Flap endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            Short=FEN-1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE            EC=3.1.-.- {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=DNase IV;
DE   AltName: Full=Flap structure-specific endonuclease 1 {ECO:0000255|HAMAP-Rule:MF_03140};
DE   AltName: Full=Maturation factor 1;
DE            Short=MF1;
DE            Short=hFEN-1;
GN   Name=FEN1 {ECO:0000255|HAMAP-Rule:MF_03140}; Synonyms=RAD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8007985; DOI=10.1128/mcb.14.7.4878;
RA   Murray J.M., Tavassoli M., Al-Harithy R., Sheldrick K.S., Lehmann A.R.,
RA   Carr A.M., Watts F.Z.;
RT   "Structural and functional conservation of the human homolog of the
RT   Schizosaccharomyces pombe rad2 gene, which is required for chromosome
RT   segregation and recovery from DNA damage.";
RL   Mol. Cell. Biol. 14:4878-4888(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=7774922; DOI=10.1016/0888-7543(95)80129-a;
RA   Hiraoka L.R., Harrington J.J., Gerhard D.S., Lieber M.R., Hsieh C.-L.;
RT   "Sequence of human FEN-1, a structure-specific endonuclease, and
RT   chromosomal localization of the gene (FEN1) in mouse and human.";
RL   Genomics 25:220-225(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=7961795;
RA   Robins P., Pappin D.J.C., Wood R.D., Lindahl T.;
RT   "Structural and functional homology between mammalian DNase IV and the 5'-
RT   nuclease domain of Escherichia coli DNA polymerase I.";
RL   J. Biol. Chem. 269:28535-28538(1994).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE-BINDING SITES, AND MUTAGENESIS OF
RP   ASP-34; ASP-86; ARG-103; GLU-158; ASP-179; ASP-181; GLY-231 AND ASP-233.
RX   PubMed=8621570; DOI=10.1074/jbc.271.16.9173;
RA   Shen B., Nolan J.P., Sklar L.A., Park M.S.;
RT   "Essential amino acids for substrate binding and catalysis of human flap
RT   endonuclease 1.";
RL   J. Biol. Chem. 271:9173-9176(1996).
RN   [8]
RP   INTERACTION WITH PCNA.
RX   PubMed=9305916; DOI=10.1074/jbc.272.39.24522;
RA   Gary R., Ludwig D.L., Cornelius H.L., MacInnes M.A., Park M.S.;
RT   "The DNA repair endonuclease XPG binds to proliferating cell nuclear
RT   antigen (PCNA) and shares sequence elements with the PCNA-binding regions
RT   of FEN-1 and cyclin-dependent kinase inhibitor p21.";
RL   J. Biol. Chem. 272:24522-24529(1997).
RN   [9]
RP   FUNCTION.
RX   PubMed=10744741; DOI=10.1074/jbc.275.14.10498;
RA   Tom S., Henricksen L.A., Bambara R.A.;
RT   "Mechanism whereby proliferating cell nuclear antigen stimulates flap
RT   endonuclease 1.";
RL   J. Biol. Chem. 275:10498-10505(2000).
RN   [10]
RP   INTERACTION WITH PCNA AND P300, AND ACETYLATION AT LYS-354; LYS-375;
RP   LYS-377 AND LYS-380.
RX   PubMed=11430825; DOI=10.1016/s1097-2765(01)00272-6;
RA   Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P.,
RA   Hubscher U., Hottiger M.O.;
RT   "Regulation of human flap endonuclease-1 activity by acetylation through
RT   the transcriptional coactivator p300.";
RL   Mol. Cell 7:1221-1231(2001).
RN   [11]
RP   FUNCTION, SUBSTRATE-BINDING SITES ARG-47 AND ARG-70, AND MUTAGENESIS OF
RP   ARG-29; ARG-47; ARG-70; ARG-73 AND LYS-80.
RX   PubMed=11986308; DOI=10.1074/jbc.m111941200;
RA   Qiu J., Bimston D.N., Partikian A., Shen B.;
RT   "Arginine residues 47 and 70 of human flap endonuclease-1 are involved in
RT   DNA substrate interactions and cleavage site determination.";
RL   J. Biol. Chem. 277:24659-24666(2002).
RN   [12]
RP   INTERACTION WITH DDX11.
RX   PubMed=18499658; DOI=10.1074/jbc.m802696200;
RA   Farina A., Shin J.H., Kim D.H., Bermudez V.P., Kelman Z., Seo Y.S.,
RA   Hurwitz J.;
RT   "Studies with the human cohesin establishment factor, ChlR1. Association of
RT   ChlR1 with Ctf18-RFC and Fen1.";
RL   J. Biol. Chem. 283:20925-20936(2008).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-187.
RX   PubMed=18443037; DOI=10.1128/mcb.00200-08;
RA   Guo Z., Qian L., Liu R., Dai H., Zhou M., Zheng L., Shen B.;
RT   "Nucleolar localization and dynamic roles of flap endonuclease 1 in
RT   ribosomal DNA replication and damage repair.";
RL   Mol. Cell. Biol. 28:4310-4319(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-80 AND LYS-375, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   FUNCTION, MUTAGENESIS OF ARG-192, METHYLATION AT ARG-19; ARG-100; ARG-104
RP   AND ARG-192, AND PHOSPHORYLATION AT SER-187.
RX   PubMed=20729856; DOI=10.1038/nchembio.422;
RA   Guo Z., Zheng L., Xu H., Dai H., Zhou M., Pascua M.R., Chen Q.M., Shen B.;
RT   "Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA
RT   binding.";
RL   Nat. Chem. Biol. 6:766-773(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-197 AND THR-364, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255; SER-293; SER-335 AND
RP   THR-336, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   ALTERNATIVE INITIATION (ISOFORM FENMIT), AND SUBCELLULAR LOCATION (ISOFORM
RP   FENMIT).
RX   PubMed=23675412; DOI=10.1371/journal.pone.0062340;
RA   Kazak L., Reyes A., He J., Wood S.R., Brea-Calvo G., Holen T.T., Holt I.J.;
RT   "A cryptic targeting signal creates a mitochondrial FEN1 isoform with
RT   tailed R-loop binding properties.";
RL   PLoS ONE 8:E62340-E62340(2013).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH WDR4.
RX   PubMed=26751069; DOI=10.1371/journal.pbio.1002349;
RA   Cheng I.C., Chen B.C., Shuai H.H., Chien F.C., Chen P., Hsieh T.S.;
RT   "Wuho is a new member in maintaining genome stability through its
RT   interaction with flap endonuclease 1.";
RL   PLoS Biol. 14:E1002349-E1002349(2016).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) OF 331-350.
RX   PubMed=15576034; DOI=10.1016/j.str.2004.09.018;
RA   Bruning J.B., Shamoo Y.;
RT   "Structural and thermodynamic analysis of human PCNA with peptides derived
RT   from DNA polymerase-delta p66 subunit and flap endonuclease-1.";
RL   Structure 12:2209-2219(2004).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 2-380 IN COMPLEX WITH PCNA.
RX   PubMed=15616578; DOI=10.1038/sj.emboj.7600519;
RA   Sakurai S., Kitano K., Yamaguchi H., Hamada K., Okada K., Fukuda K.,
RA   Uchida M., Ohtsuka E., Morioka H., Hakoshima T.;
RT   "Structural basis for recruitment of human flap endonuclease 1 to PCNA.";
RL   EMBO J. 24:683-693(2005).
CC   -!- FUNCTION: Structure-specific nuclease with 5'-flap endonuclease and 5'-
CC       3' exonuclease activities involved in DNA replication and repair.
CC       During DNA replication, cleaves the 5'-overhanging flap structure that
CC       is generated by displacement synthesis when DNA polymerase encounters
CC       the 5'-end of a downstream Okazaki fragment. It enters the flap from
CC       the 5'-end and then tracks to cleave the flap base, leaving a nick for
CC       ligation. Also involved in the long patch base excision repair (LP-BER)
CC       pathway, by cleaving within the apurinic/apyrimidinic (AP) site-
CC       terminated flap. Acts as a genome stabilization factor that prevents
CC       flaps from equilibrating into structurs that lead to duplications and
CC       deletions. Also possesses 5'-3' exonuclease activity on nicked or
CC       gapped double-stranded DNA, and exhibits RNase H activity. Also
CC       involved in replication and repair of rDNA and in repairing
CC       mitochondrial DNA. {ECO:0000255|HAMAP-Rule:MF_03140,
CC       ECO:0000269|PubMed:10744741, ECO:0000269|PubMed:11986308,
CC       ECO:0000269|PubMed:18443037, ECO:0000269|PubMed:20729856,
CC       ECO:0000269|PubMed:26751069, ECO:0000269|PubMed:7961795,
CC       ECO:0000269|PubMed:8621570}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per subunit. They probably participate in
CC       the reaction catalyzed by the enzyme. May bind an additional third
CC       magnesium ion after substrate binding.;
CC   -!- SUBUNIT: Three molecules of FEN1 bind to one PCNA trimer with each
CC       molecule binding to one PCNA monomer (PubMed:15616578). PCNA stimulates
CC       the nuclease activity without altering cleavage specificity
CC       (PubMed:15616578). The C-terminal domain binds EP300; can bind
CC       simultaneously to both PCNA and EP300 (PubMed:11430825). Interacts with
CC       PCNA; can bind simultaneously to both PCNA and EP300 (PubMed:9305916,
CC       PubMed:11430825). Interacts with DDX11; this interaction is direct and
CC       increases flap endonuclease activity of FEN1 (PubMed:18499658).
CC       Interacts with WDR4; regulating its endonuclease activity
CC       (PubMed:26751069). {ECO:0000255|HAMAP-Rule:MF_03140,
CC       ECO:0000269|PubMed:11430825, ECO:0000269|PubMed:15616578,
CC       ECO:0000269|PubMed:18499658, ECO:0000269|PubMed:26751069,
CC       ECO:0000269|PubMed:9305916}.
CC   -!- INTERACTION:
CC       P39748; P54132: BLM; NbExp=4; IntAct=EBI-707816, EBI-621372;
CC       P39748; Q96NY9: MUS81; NbExp=5; IntAct=EBI-707816, EBI-2370806;
CC       P39748; P12004: PCNA; NbExp=19; IntAct=EBI-707816, EBI-358311;
CC       P39748; P57081: WDR4; NbExp=8; IntAct=EBI-707816, EBI-750427;
CC       P39748; Q14191: WRN; NbExp=9; IntAct=EBI-707816, EBI-368417;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus. Nucleus,
CC       nucleoplasm. Note=Resides mostly in the nucleoli and relocalizes to the
CC       nucleoplasm upon DNA damage.
CC   -!- SUBCELLULAR LOCATION: [Isoform FENMIT]: Mitochondrion
CC       {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:23675412}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1;
CC         IsoId=P39748-1; Sequence=Displayed;
CC       Name=FENMIT;
CC         IsoId=P39748-2; Sequence=VSP_047520;
CC   -!- PTM: Acetylated by EP300. Acetylation inhibits both endonuclease and
CC       exonuclease activity. Acetylation also reduces DNA-binding activity but
CC       does not affect interaction with PCNA or EP300. {ECO:0000255|HAMAP-
CC       Rule:MF_03140, ECO:0000269|PubMed:11430825}.
CC   -!- PTM: Phosphorylation upon DNA damage induces relocalization to the
CC       nuclear plasma. Phosphorylation at Ser-187 by CDK2 occurs during late
CC       S-phase and results in dissociation from PCNA. {ECO:0000255|HAMAP-
CC       Rule:MF_03140, ECO:0000269|PubMed:20729856}.
CC   -!- PTM: Methylation at Arg-192 by PRMT5 impedes Ser-187 phosphorylation
CC       and increases interaction with PCNA. {ECO:0000255|HAMAP-Rule:MF_03140,
CC       ECO:0000269|PubMed:20729856}.
CC   -!- MISCELLANEOUS: [Isoform FENMIT]: No nuclease activity. Binds
CC       preferentially to RNA flap structures and R-loops. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the XPG/RAD2 endonuclease family. FEN1
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_03140}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/fen1/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FEN1ID40543ch11q12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X76771; CAA54166.1; -; mRNA.
DR   EMBL; L37374; AAA91331.1; -; mRNA.
DR   EMBL; AF523117; AAM74238.1; -; Genomic_DNA.
DR   EMBL; AC004770; AAC23394.1; -; Genomic_DNA.
DR   EMBL; BC000323; AAH00323.1; -; mRNA.
DR   CCDS; CCDS8010.1; -. [P39748-1]
DR   PIR; A56531; A56531.
DR   RefSeq; NP_004102.1; NM_004111.5. [P39748-1]
DR   PDB; 1U7B; X-ray; 1.88 A; B=331-350.
DR   PDB; 1UL1; X-ray; 2.90 A; X/Y/Z=2-380.
DR   PDB; 3Q8K; X-ray; 2.20 A; A=2-336.
DR   PDB; 3Q8L; X-ray; 2.32 A; A=2-336.
DR   PDB; 3Q8M; X-ray; 2.60 A; A/B=2-336.
DR   PDB; 3UVU; X-ray; 2.38 A; B=352-370.
DR   PDB; 5E0V; X-ray; 2.07 A; C/D=335-350.
DR   PDB; 5FV7; X-ray; 2.84 A; A/B=1-336.
DR   PDB; 5K97; X-ray; 2.10 A; A=2-336.
DR   PDB; 5KSE; X-ray; 2.10 A; A=2-336.
DR   PDB; 5UM9; X-ray; 2.81 A; A=2-336.
DR   PDB; 5ZOD; X-ray; 1.90 A; A=1-333.
DR   PDB; 5ZOE; X-ray; 1.95 A; A=1-333.
DR   PDB; 5ZOF; X-ray; 2.25 A; A=1-333.
DR   PDB; 5ZOG; X-ray; 2.30 A; A=1-333.
DR   PDB; 6TNZ; EM; 4.05 A; H=1-380.
DR   PDBsum; 1U7B; -.
DR   PDBsum; 1UL1; -.
DR   PDBsum; 3Q8K; -.
DR   PDBsum; 3Q8L; -.
DR   PDBsum; 3Q8M; -.
DR   PDBsum; 3UVU; -.
DR   PDBsum; 5E0V; -.
DR   PDBsum; 5FV7; -.
DR   PDBsum; 5K97; -.
DR   PDBsum; 5KSE; -.
DR   PDBsum; 5UM9; -.
DR   PDBsum; 5ZOD; -.
DR   PDBsum; 5ZOE; -.
DR   PDBsum; 5ZOF; -.
DR   PDBsum; 5ZOG; -.
DR   PDBsum; 6TNZ; -.
DR   SMR; P39748; -.
DR   BioGrid; 108528; 104.
DR   CORUM; P39748; -.
DR   DIP; DIP-24216N; -.
DR   ELM; P39748; -.
DR   IntAct; P39748; 47.
DR   MINT; P39748; -.
DR   STRING; 9606.ENSP00000305480; -.
DR   BindingDB; P39748; -.
DR   ChEMBL; CHEMBL5027; -.
DR   DrugBank; DB14490; Ferrous ascorbate.
DR   DrugBank; DB14491; Ferrous fumarate.
DR   DrugBank; DB14488; Ferrous gluconate.
DR   DrugBank; DB14501; Ferrous glycine sulfate.
DR   DrugBank; DB14489; Ferrous succinate.
DR   DrugBank; DB01592; Iron.
DR   iPTMnet; P39748; -.
DR   MetOSite; P39748; -.
DR   PhosphoSitePlus; P39748; -.
DR   SwissPalm; P39748; -.
DR   BioMuta; FEN1; -.
DR   DMDM; 729475; -.
DR   CPTAC; CPTAC-1409; -.
DR   CPTAC; CPTAC-1410; -.
DR   CPTAC; CPTAC-1411; -.
DR   CPTAC; CPTAC-3230; -.
DR   CPTAC; CPTAC-700; -.
DR   EPD; P39748; -.
DR   jPOST; P39748; -.
DR   MassIVE; P39748; -.
DR   PaxDb; P39748; -.
DR   PeptideAtlas; P39748; -.
DR   PRIDE; P39748; -.
DR   ProteomicsDB; 55319; -. [P39748-1]
DR   TopDownProteomics; P39748-1; -. [P39748-1]
DR   ABCD; P39748; -.
DR   Antibodypedia; 1878; 545 antibodies.
DR   DNASU; 2237; -.
DR   Ensembl; ENST00000305885; ENSP00000305480; ENSG00000168496. [P39748-1]
DR   GeneID; 2237; -.
DR   KEGG; hsa:2237; -.
DR   CTD; 2237; -.
DR   DisGeNET; 2237; -.
DR   GeneCards; FEN1; -.
DR   HGNC; HGNC:3650; FEN1.
DR   HPA; ENSG00000168496; Tissue enhanced (lymphoid).
DR   MIM; 600393; gene.
DR   neXtProt; NX_P39748; -.
DR   OpenTargets; ENSG00000168496; -.
DR   PharmGKB; PA28090; -.
DR   eggNOG; KOG2519; Eukaryota.
DR   eggNOG; COG0258; LUCA.
DR   GeneTree; ENSGT00940000155807; -.
DR   HOGENOM; CLU_032444_2_0_1; -.
DR   InParanoid; P39748; -.
DR   KO; K04799; -.
DR   OMA; CDYLDPI; -.
DR   PhylomeDB; P39748; -.
DR   TreeFam; TF105701; -.
DR   Reactome; R-HSA-110362; POLB-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-162594; Early Phase of HIV Life Cycle.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   SignaLink; P39748; -.
DR   SIGNOR; P39748; -.
DR   ChiTaRS; FEN1; human.
DR   EvolutionaryTrace; P39748; -.
DR   GeneWiki; Flap_structure-specific_endonuclease_1; -.
DR   GenomeRNAi; 2237; -.
DR   Pharos; P39748; Tchem.
DR   PRO; PR:P39748; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P39748; protein.
DR   Bgee; ENSG00000168496; Expressed in amniotic fluid and 218 other tissues.
DR   ExpressionAtlas; P39748; baseline and differential.
DR   Genevisible; P39748; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IMP:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; TAS:ProtInc.
DR   GO; GO:0008309; F:double-stranded DNA exodeoxyribonuclease activity; TAS:ProtInc.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0004527; F:exonuclease activity; TAS:ProtInc.
DR   GO; GO:0048256; F:flap endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IBA:GO_Central.
DR   GO; GO:0030145; F:manganese ion binding; IBA:GO_Central.
DR   GO; GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IEA:UniProtKB-UniRule.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0043137; P:DNA replication, removal of RNA primer; IDA:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; TAS:ProtInc.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:UniProtKB.
DR   GO; GO:0045876; P:positive regulation of sister chromatid cohesion; IMP:UniProtKB.
DR   GO; GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome.
DR   GO; GO:0009650; P:UV protection; TAS:ProtInc.
DR   DisProt; DP01974; -.
DR   HAMAP; MF_00614; Fen; 1.
DR   InterPro; IPR036279; 5-3_exonuclease_C_sf.
DR   InterPro; IPR023426; Flap_endonuc.
DR   InterPro; IPR008918; HhH2.
DR   InterPro; IPR029060; PIN-like_dom_sf.
DR   InterPro; IPR006086; XPG-I_dom.
DR   InterPro; IPR006084; XPG/Rad2.
DR   InterPro; IPR019974; XPG_CS.
DR   InterPro; IPR006085; XPG_DNA_repair_N.
DR   PANTHER; PTHR11081; PTHR11081; 1.
DR   Pfam; PF00867; XPG_I; 1.
DR   Pfam; PF00752; XPG_N; 1.
DR   PRINTS; PR00853; XPGRADSUPER.
DR   SMART; SM00279; HhH2; 1.
DR   SMART; SM00484; XPGI; 1.
DR   SMART; SM00485; XPGN; 1.
DR   SUPFAM; SSF47807; SSF47807; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
DR   PROSITE; PS00841; XPG_1; 1.
DR   PROSITE; PS00842; XPG_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Direct protein sequencing; DNA damage; DNA repair; DNA replication;
KW   Endonuclease; Exonuclease; Hydrolase; Magnesium; Metal-binding;
KW   Methylation; Mitochondrion; Nuclease; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..380
FT                   /note="Flap endonuclease 1"
FT                   /id="PRO_0000154069"
FT   REGION          1..104
FT                   /note="N-domain"
FT   REGION          122..253
FT                   /note="I-domain"
FT   REGION          336..344
FT                   /note="Interaction with PCNA"
FT                   /evidence="ECO:0000269|PubMed:9305916"
FT   METAL           34
FT                   /note="Magnesium 1"
FT   METAL           86
FT                   /note="Magnesium 1"
FT   METAL           158
FT                   /note="Magnesium 1"
FT   METAL           160
FT                   /note="Magnesium 1"
FT   METAL           179
FT                   /note="Magnesium 2"
FT   METAL           181
FT                   /note="Magnesium 2"
FT   METAL           233
FT                   /note="Magnesium 2"
FT   BINDING         47
FT                   /note="DNA substrate"
FT   BINDING         70
FT                   /note="DNA substrate"
FT   BINDING         158
FT                   /note="DNA substrate"
FT   BINDING         231
FT                   /note="DNA substrate"
FT   BINDING         233
FT                   /note="DNA substrate"
FT   MOD_RES         19
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:20729856"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         100
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:20729856"
FT   MOD_RES         104
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:20729856"
FT   MOD_RES         187
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:20729856"
FT   MOD_RES         192
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:20729856"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         354
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:11430825"
FT   MOD_RES         364
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         375
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861, ECO:0000255|HAMAP-
FT                   Rule:MF_03140, ECO:0000269|PubMed:11430825"
FT   MOD_RES         377
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:11430825"
FT   MOD_RES         380
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03140,
FT                   ECO:0000269|PubMed:11430825"
FT   VAR_SEQ         1..64
FT                   /note="Missing (in isoform FENMIT)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047520"
FT   MUTAGEN         29
FT                   /note="R->A: No significant effect on exonuclease activity
FT                   or flap endonuclease activity."
FT                   /evidence="ECO:0000269|PubMed:11986308"
FT   MUTAGEN         34
FT                   /note="D->A: Loss of flap endonuclease activity but
FT                   substrate binding activity is retained."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         47
FT                   /note="R->A: Significantly reduced exonuclease activity and
FT                   reduced substrate binding. The positions of the cleavage
FT                   sites are also shifted."
FT                   /evidence="ECO:0000269|PubMed:11986308"
FT   MUTAGEN         70
FT                   /note="R->A: Loss of exonuclease activity and reduced
FT                   endonuclease activity. Reduced substrate binding."
FT                   /evidence="ECO:0000269|PubMed:11986308"
FT   MUTAGEN         73
FT                   /note="R->A: No significant effect on exonuclease activity
FT                   or flap endonuclease activity."
FT                   /evidence="ECO:0000269|PubMed:11986308"
FT   MUTAGEN         80
FT                   /note="K->A: No significant effect on exonuclease activity
FT                   or flap endonuclease activity."
FT                   /evidence="ECO:0000269|PubMed:11986308"
FT   MUTAGEN         86
FT                   /note="D->A: Loss of flap endonuclease activity but
FT                   substrate binding activity is retained."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         103
FT                   /note="R->A: No effect on flap endonuclease activity or
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         158
FT                   /note="E->A: Loss of flap endonuclease activity and
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         179
FT                   /note="D->A: No effect on flap endonuclease activity or
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         181
FT                   /note="D->A: Loss of flap endonuclease activity but
FT                   substrate binding activity is retained."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         187
FT                   /note="S->A: Fails to translocate from nucleoli to the
FT                   nuclear plasma."
FT                   /evidence="ECO:0000269|PubMed:18443037"
FT   MUTAGEN         187
FT                   /note="S->D: Diminishes nucleolar localization."
FT                   /evidence="ECO:0000269|PubMed:18443037"
FT   MUTAGEN         192
FT                   /note="R->K: Impairs ability to localize to sites of DNA
FT                   replication or repair."
FT                   /evidence="ECO:0000269|PubMed:20729856"
FT   MUTAGEN         231
FT                   /note="G->A: Loss of flap endonuclease activity and
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   MUTAGEN         233
FT                   /note="D->A: Loss of flap endonuclease activity and
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8621570"
FT   HELIX           6..13
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           15..17
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          18..21
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           23..26
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          30..34
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   TURN            35..37
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          46..48
FT                   /evidence="ECO:0000244|PDB:5ZOE"
FT   HELIX           64..76
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          80..85
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           91..93
FT                   /evidence="ECO:0000244|PDB:5K97"
FT   HELIX           94..116
FT                   /evidence="ECO:0000244|PDB:5K97"
FT   STRAND          120..122
FT                   /evidence="ECO:0000244|PDB:5K97"
FT   HELIX           123..129
FT                   /evidence="ECO:0000244|PDB:5K97"
FT   HELIX           139..148
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          152..154
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           159..168
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          171..176
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           181..184
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          188..193
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           198..200
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          204..208
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           209..216
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           220..230
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   STRAND          232..235
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           243..253
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           256..262
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   TURN            265..267
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           276..284
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   TURN            291..293
FT                   /evidence="ECO:0000244|PDB:5ZOE"
FT   HELIX           303..311
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   TURN            312..314
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           318..330
FT                   /evidence="ECO:0000244|PDB:5ZOD"
FT   HELIX           340..342
FT                   /evidence="ECO:0000244|PDB:1U7B"
FT   STRAND          344..351
FT                   /evidence="ECO:0000244|PDB:1UL1"
SQ   SEQUENCE   380 AA;  42593 MW;  5154F2F6E57592C5 CRC64;
     MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
     TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
     QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
     DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
     IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
     PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
     KGSTKKKAKT GAAGKFKRGK
//
ID   Q6FHX6_HUMAN            Unreviewed;       380 AA.
AC   Q6FHX6;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 139.
DE   RecName: Full=Flap endonuclease 1 {ECO:0000256|HAMAP-Rule:MF_03140};
DE            Short=FEN-1 {ECO:0000256|HAMAP-Rule:MF_03140};
DE            EC=3.1.-.- {ECO:0000256|HAMAP-Rule:MF_03140};
DE   AltName: Full=Flap structure-specific endonuclease 1 {ECO:0000256|HAMAP-Rule:MF_03140};
GN   Name=FEN1 {ECO:0000256|HAMAP-Rule:MF_03140, ECO:0000313|EMBL:CAG38799.1};
GN   ORFNames=hCG_40848 {ECO:0000313|EMBL:EAW73972.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG38799.1};
RN   [1] {ECO:0000313|EMBL:EAW73972.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG38799.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AAV38331.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW73972.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG35627.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast {ECO:0000313|EMBL:BAG35627.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Structure-specific nuclease with 5'-flap endonuclease and 5'-
CC       3' exonuclease activities involved in DNA replication and repair.
CC       During DNA replication, cleaves the 5'-overhanging flap structure that
CC       is generated by displacement synthesis when DNA polymerase encounters
CC       the 5'-end of a downstream Okazaki fragment. It enters the flap from
CC       the 5'-end and then tracks to cleave the flap base, leaving a nick for
CC       ligation. Also involved in the long patch base excision repair (LP-BER)
CC       pathway, by cleaving within the apurinic/apyrimidinic (AP) site-
CC       terminated flap. Acts as a genome stabilization factor that prevents
CC       flaps from equilibrating into structurs that lead to duplications and
CC       deletions. Also possesses 5'-3' exonuclease activity on nicked or
CC       gapped double-stranded DNA, and exhibits RNase H activity. Also
CC       involved in replication and repair of rDNA and in repairing
CC       mitochondrial DNA. {ECO:0000256|HAMAP-Rule:MF_03140,
CC       ECO:0000256|SAAS:SAAS00537581}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03140};
CC       Note=Binds 2 magnesium ions per subunit. They probably participate in
CC       the reaction catalyzed by the enzyme. May bind an additional third
CC       magnesium ion after substrate binding. {ECO:0000256|HAMAP-
CC       Rule:MF_03140};
CC   -!- SUBUNIT: Interacts with PCNA. Three molecules of FEN1 bind to one PCNA
CC       trimer with each molecule binding to one PCNA monomer. PCNA stimulates
CC       the nuclease activity without altering cleavage specificity. The C-
CC       terminal domain binds EP300. Can bind simultaneously to both PCNA and
CC       EP300. Interacts with DDX11. {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03140,
CC       ECO:0000256|SAAS:SAAS00537654}. Nucleus, nucleolus {ECO:0000256|HAMAP-
CC       Rule:MF_03140}. Nucleus, nucleoplasm {ECO:0000256|HAMAP-Rule:MF_03140}.
CC       Note=Resides mostly in the nucleoli and relocalizes to the nucleoplasm
CC       upon DNA damage. {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- PTM: Acetylated by EP300. Acetylation inhibits both endonuclease and
CC       exonuclease activity. Acetylation also reduces DNA-binding activity but
CC       does not affect interaction with PCNA or EP300. {ECO:0000256|HAMAP-
CC       Rule:MF_03140}.
CC   -!- PTM: Methylation at Arg-192 by PRMT5 impedes Ser-187 phosphorylation
CC       and increases interaction with PCNA. {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   -!- PTM: Phosphorylation upon DNA damage induces relocalization to the
CC       nuclear plasma. Phosphorylation at Ser-187 by CDK2 occurs during late
CC       S-phase and results in dissociation from PCNA. {ECO:0000256|HAMAP-
CC       Rule:MF_03140}.
CC   -!- SIMILARITY: Belongs to the XPG/RAD2 endonuclease family. FEN1
CC       subfamily. {ECO:0000256|HAMAP-Rule:MF_03140}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BT019524; AAV38331.1; -; mRNA.
DR   EMBL; AK312761; BAG35627.1; -; mRNA.
DR   EMBL; CR536562; CAG38799.1; -; mRNA.
DR   EMBL; CH471076; EAW73972.1; -; Genomic_DNA.
DR   RefSeq; NP_004102.1; NM_004111.5.
DR   IntAct; Q6FHX6; 1.
DR   Antibodypedia; 1878; 545 antibodies.
DR   DNASU; 2237; -.
DR   GeneID; 2237; -.
DR   KEGG; hsa:2237; -.
DR   UCSC; uc001nsg.4; human.
DR   CTD; 2237; -.
DR   EuPathDB; HostDB:ENSG00000168496.3; -.
DR   PharmGKB; PA28090; -.
DR   eggNOG; KOG2519; Eukaryota.
DR   eggNOG; COG0258; LUCA.
DR   HOGENOM; CLU_032444_2_0_1; -.
DR   KO; K04799; -.
DR   OMA; CDYLDPI; -.
DR   OrthoDB; 1094524at2759; -.
DR   ChiTaRS; FEN1; human.
DR   GenomeRNAi; 2237; -.
DR   Bgee; ENSG00000168496; Expressed in amniotic fluid and 218 other tissues.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0008409; F:5'-3' exonuclease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0017108; F:5'-flap endonuclease activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006284; P:base-excision repair; IEA:UniProtKB-UniRule.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0043137; P:DNA replication, removal of RNA primer; IEA:UniProtKB-UniRule.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   HAMAP; MF_00614; Fen; 1.
DR   InterPro; IPR036279; 5-3_exonuclease_C_sf.
DR   InterPro; IPR023426; Flap_endonuc.
DR   InterPro; IPR008918; HhH2.
DR   InterPro; IPR029060; PIN-like_dom_sf.
DR   InterPro; IPR006086; XPG-I_dom.
DR   InterPro; IPR006084; XPG/Rad2.
DR   InterPro; IPR019974; XPG_CS.
DR   InterPro; IPR006085; XPG_DNA_repair_N.
DR   PANTHER; PTHR11081; PTHR11081; 1.
DR   Pfam; PF00867; XPG_I; 1.
DR   Pfam; PF00752; XPG_N; 1.
DR   PRINTS; PR00853; XPGRADSUPER.
DR   SMART; SM00279; HhH2; 1.
DR   SMART; SM00484; XPGI; 1.
DR   SMART; SM00485; XPGN; 1.
DR   SUPFAM; SSF47807; SSF47807; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
DR   PROSITE; PS00841; XPG_1; 1.
DR   PROSITE; PS00842; XPG_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA damage {ECO:0000256|HAMAP-Rule:MF_03140};
KW   DNA repair {ECO:0000256|HAMAP-Rule:MF_03140};
KW   DNA replication {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Endonuclease {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000313|EMBL:AAV38331.1};
KW   Exonuclease {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Hydrolase {ECO:0000256|HAMAP-Rule:MF_03140, ECO:0000313|EMBL:AAV38331.1};
KW   Magnesium {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Methylation {ECO:0000256|HAMAP-Rule:MF_03140};
KW   Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03140,
KW   ECO:0000256|SAAS:SAAS00198237};
KW   Nuclease {ECO:0000256|HAMAP-Rule:MF_03140, ECO:0000313|EMBL:AAV38331.1};
KW   Nucleus {ECO:0000256|HAMAP-Rule:MF_03140, ECO:0000256|SAAS:SAAS00080459};
KW   Phosphoprotein {ECO:0000256|HAMAP-Rule:MF_03140}.
FT   DOMAIN          1..107
FT                   /note="XPGN"
FT                   /evidence="ECO:0000259|SMART:SM00485"
FT   DOMAIN          146..218
FT                   /note="XPGI"
FT                   /evidence="ECO:0000259|SMART:SM00484"
FT   REGION          1..104
FT                   /note="N-domain"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   REGION          122..253
FT                   /note="I-domain"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   REGION          327..380
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          336..344
FT                   /note="Interaction with PCNA"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   COILED          97..136
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        328..342
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        352..366
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   METAL           34
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           86
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           158
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           160
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           179
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           181
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   METAL           233
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   BINDING         47
FT                   /note="DNA substrate"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   BINDING         70
FT                   /note="DNA substrate"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   BINDING         158
FT                   /note="DNA substrate"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   BINDING         231
FT                   /note="DNA substrate"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   BINDING         233
FT                   /note="DNA substrate"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   MOD_RES         19
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   MOD_RES         100
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   MOD_RES         104
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   MOD_RES         187
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
FT   MOD_RES         192
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03140"
SQ   SEQUENCE   380 AA;  42593 MW;  5154F2F6E57592C5 CRC64;
     MGIQGLAKLI ADVAPSAIRE NDIKSYFGRK VAIDASMSIY QFLIAVRQGG DVLQNEEGET
     TSHLMGMFYR TIRMMENGIK PVYVFDGKPP QLKSGELAKR SERRAEAEKQ LQQAQAAGAE
     QEVEKFTKRL VKVTKQHNDE CKHLLSLMGI PYLDAPSEAE ASCAALVKAG KVYAAATEDM
     DCLTFGSPVL MRHLTASEAK KLPIQEFHLS RILQELGLNQ EQFVDLCILL GSDYCESIRG
     IGPKRAVDLI QKHKSIEEIV RRLDPNKYPV PENWLHKEAH QLFLEPEVLD PESVELKWSE
     PNEEELIKFM CGEKQFSEER IRSGVKRLSK SRQGSTQGRL DDFFKVTGSL SSAKRKEPEP
     KGSTKKKAKT GAAGKFKRGK
//
ID   GPC5_HUMAN              Reviewed;         572 AA.
AC   P78333; B2R726; O60436; Q9BX27;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-APR-2020, entry version 163.
DE   RecName: Full=Glypican-5;
DE   Contains:
DE     RecName: Full=Secreted glypican-5;
DE   Flags: Precursor;
GN   Name=GPC5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9070915; DOI=10.1006/geno.1996.4518;
RA   Veugelers M., Vermeesch J., Reekmans G., Steinfeld R., Marynen P.,
RA   David G.;
RT   "Characterization of glypican-5 and chromosomal localization of human GPC5,
RT   a new member of the glypican gene family.";
RL   Genomics 40:24-30(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9331333; DOI=10.1006/dbio.1997.8690;
RA   Saunders S., Paine-Saunders S., Lander A.D.;
RT   "Expression of the cell surface proteoglycan glypican-5 is developmentally
RT   regulated in kidney, limb, and brain.";
RL   Dev. Biol. 190:78-93(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250}; Extracellular side {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Secreted glypican-5]: Secreted, extracellular
CC       space {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In adult, primarily expressed in the brain. Also
CC       detected in fetal brain, lung and liver. {ECO:0000269|PubMed:9070915,
CC       ECO:0000269|PubMed:9331333}.
CC   -!- SIMILARITY: Belongs to the glypican family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GPC5ID45705ch13q31.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U66033; AAC51118.1; -; mRNA.
DR   EMBL; AF001462; AAC12261.1; -; mRNA.
DR   EMBL; AK312815; BAG35673.1; -; mRNA.
DR   EMBL; AL157363; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL138714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL163537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL162456; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039730; AAH39730.1; -; mRNA.
DR   CCDS; CCDS9468.1; -.
DR   RefSeq; NP_004457.1; NM_004466.5.
DR   SMR; P78333; -.
DR   BioGrid; 108553; 6.
DR   IntAct; P78333; 3.
DR   STRING; 9606.ENSP00000366267; -.
DR   iPTMnet; P78333; -.
DR   PhosphoSitePlus; P78333; -.
DR   BioMuta; GPC5; -.
DR   DMDM; 2829667; -.
DR   jPOST; P78333; -.
DR   MassIVE; P78333; -.
DR   MaxQB; P78333; -.
DR   PaxDb; P78333; -.
DR   PeptideAtlas; P78333; -.
DR   PRIDE; P78333; -.
DR   ProteomicsDB; 57571; -.
DR   Antibodypedia; 24761; 246 antibodies.
DR   DNASU; 2262; -.
DR   Ensembl; ENST00000377067; ENSP00000366267; ENSG00000179399.
DR   GeneID; 2262; -.
DR   KEGG; hsa:2262; -.
DR   UCSC; uc010tif.3; human.
DR   CTD; 2262; -.
DR   DisGeNET; 2262; -.
DR   GeneCards; GPC5; -.
DR   HGNC; HGNC:4453; GPC5.
DR   HPA; ENSG00000179399; Tissue enhanced (brain, kidney, testis).
DR   MIM; 602446; gene.
DR   neXtProt; NX_P78333; -.
DR   OpenTargets; ENSG00000179399; -.
DR   PharmGKB; PA28834; -.
DR   eggNOG; KOG3821; Eukaryota.
DR   eggNOG; ENOG410XST2; LUCA.
DR   GeneTree; ENSGT00950000182687; -.
DR   InParanoid; P78333; -.
DR   KO; K08111; -.
DR   OMA; PKPDKWE; -.
DR   OrthoDB; 1097767at2759; -.
DR   PhylomeDB; P78333; -.
DR   TreeFam; TF105317; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   ChiTaRS; GPC5; human.
DR   GeneWiki; Glypican_5; -.
DR   GenomeRNAi; 2262; -.
DR   Pharos; P78333; Tbio.
DR   PRO; PR:P78333; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; P78333; protein.
DR   Bgee; ENSG00000179399; Expressed in amygdala and 120 other tissues.
DR   ExpressionAtlas; P78333; baseline and differential.
DR   Genevisible; P78333; HS.
DR   GO; GO:0046658; C:anchored component of plasma membrane; IEA:InterPro.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:1905475; P:regulation of protein localization to membrane; IBA:GO_Central.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   InterPro; IPR001863; Glypican.
DR   InterPro; IPR031188; Glypican-5.
DR   InterPro; IPR019803; Glypican_CS.
DR   PANTHER; PTHR10822; PTHR10822; 1.
DR   PANTHER; PTHR10822:SF12; PTHR10822:SF12; 1.
DR   Pfam; PF01153; Glypican; 1.
DR   PROSITE; PS01207; GLYPICAN; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Glycoprotein; GPI-anchor; Heparan sulfate; Lipoprotein;
KW   Membrane; Polymorphism; Proteoglycan; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..?
FT                   /note="Glypican-5"
FT                   /id="PRO_0000012319"
FT   CHAIN           25..?
FT                   /note="Secreted glypican-5"
FT                   /id="PRO_0000333849"
FT   PROPEP          ?..572
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000012320"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        237
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        441
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        486
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        495
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        507
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        509
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        527
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         155
FT                   /note="A -> V (in dbSNP:rs553717)"
FT                   /id="VAR_024228"
FT   CONFLICT        205
FT                   /note="G -> C (in Ref. 2; AAC12261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        245
FT                   /note="S -> F (in Ref. 2; AAC12261)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   572 AA;  63707 MW;  A17969FE0DD0D308 CRC64;
     MDAQTWPVGF RCLLLLALVG SARSEGVQTC EEVRKLFQWR LLGAVRGLPD SPRAGPDLQV
     CISKKPTCCT RKMEERYQIA ARQDMQQFLQ TSSSTLKFLI SRNAAAFQET LETLIKQAEN
     YTSILFCSTY RNMALEAAAS VQEFFTDVGL YLFGADVNPE EFVNRFFDSL FPLVYNHLIN
     PGVTDSSLEY SECIRMARRD VSPFGNIPQR VMGQMGRSLL PSRTFLQALN LGIEVINTTD
     YLHFSKECSR ALLKMQYCPH CQGLALTKPC MGYCLNVMRG CLAHMAELNP HWHAYIRSLE
     ELSDAMHGTY DIGHVLLNFH LLVNDAVLQA HLNGQKLLEQ VNRICGRPVR TPTQSPRCSF
     DQSKEKHGMK TTTRNSEETL ANRRKEFINS LRLYRSFYGG LADQLCANEL AAADGLPCWN
     GEDIVKSYTQ RVVGNGIKAQ SGNPEVKVKG IDPVINQIID KLKHVVQLLQ GRSPKPDKWE
     LLQLGSGGGM VEQVSGDCDD EDGCGGSGSG EVKRTLKITD WMPDDMNFSD VKQIHQTDTG
     STLDTTGAGC AVATESMTFT LISVVMLLPG IW
//
ID   ID3_HUMAN               Reviewed;         119 AA.
AC   Q02535; A8K1T8; O75641;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   22-APR-2020, entry version 187.
DE   RecName: Full=DNA-binding protein inhibitor ID-3;
DE   AltName: Full=Class B basic helix-loop-helix protein 25;
DE            Short=bHLHb25;
DE   AltName: Full=Helix-loop-helix protein HEIR-1;
DE   AltName: Full=ID-like protein inhibitor HLH 1R21;
DE   AltName: Full=Inhibitor of DNA binding 3;
DE   AltName: Full=Inhibitor of differentiation 3;
GN   Name=ID3; Synonyms=1R21, BHLHB25, HEIR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-105.
RX   PubMed=1628620; DOI=10.1002/j.1460-2075.1992.tb05321.x;
RA   Ellmeier W., Aguzzi A., Kleiner E., Kurzbauer R., Weith A.;
RT   "Mutually exclusive expression of a helix-loop-helix gene and N-myc in
RT   human neuroblastomas and in normal development.";
RL   EMBO J. 11:2563-2571(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANT ALA-105.
RX   PubMed=8437843;
RA   Deed R.W., Bianchi S.M., Atherton G.T., Johnston D., Santibanez-Koref M.,
RA   Murphy J.J., Norton J.D.;
RT   "An immediate early human gene encodes an Id-like helix-loop-helix protein
RT   and is regulated by protein kinase C activation in diverse cell types.";
RL   Oncogene 8:599-607(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-105.
RC   TISSUE=Blood;
RX   PubMed=7828896; DOI=10.1016/0378-1119(94)90676-9;
RA   Deed R.W., Hirose T., Mitchell E.L.D., Santibanez-Koref M.F., Norton J.D.;
RT   "Structural organisation and chromosomal mapping of the human Id-3 gene.";
RL   Gene 151:309-314(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-105.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-105.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH CLOCK AND ARNTL.
RX   PubMed=20861012; DOI=10.1074/jbc.m110.175182;
RA   Ward S.M., Fernando S.J., Hou T.Y., Duffield G.E.;
RT   "The transcriptional repressor ID2 can interact with the canonical clock
RT   components CLOCK and BMAL1 and mediate inhibitory effects on mPer1
RT   expression.";
RL   J. Biol. Chem. 285:38987-39000(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Transcriptional regulator (lacking a basic DNA binding
CC       domain) which negatively regulates the basic helix-loop-helix (bHLH)
CC       transcription factors by forming heterodimers and inhibiting their DNA
CC       binding and transcriptional activity. Implicated in regulating a
CC       variety of cellular processes, including cellular growth, senescence,
CC       differentiation, apoptosis, angiogenesis, and neoplastic
CC       transformation. Involved in myogenesis by inhibiting skeletal muscle
CC       and cardiac myocyte differentiation and promoting muscle precursor
CC       cells proliferation. Inhibits the binding of E2A-containing protein
CC       complexes to muscle creatine kinase E-box enhancer. Regulates the
CC       circadian clock by repressing the transcriptional activator activity of
CC       the CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000269|PubMed:8437843}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with other HLH proteins. Interacts
CC       with COPS5 and COPS7A. Interacts with IFI204. Interacts with GATA4 and
CC       NKX2-5. Interacts with ANKRD2; both proteins cooperate in myoblast
CC       differentiation (By similarity). Interacts with CLOCK and ARNTL/BMAL1.
CC       {ECO:0000250, ECO:0000269|PubMed:20861012}.
CC   -!- INTERACTION:
CC       Q02535; Q49AR9: ANKS1A; NbExp=3; IntAct=EBI-1387094, EBI-11954519;
CC       Q02535; A0A087WZT3: BOLA2B; NbExp=3; IntAct=EBI-1387094, EBI-12006120;
CC       Q02535; Q6P5X5: C22orf39; NbExp=3; IntAct=EBI-1387094, EBI-7317823;
CC       Q02535; Q02930-3: CREB5; NbExp=5; IntAct=EBI-1387094, EBI-10192698;
CC       Q02535; Q5RGS3: FAM74A1; NbExp=3; IntAct=EBI-1387094, EBI-10244822;
CC       Q02535; Q14192: FHL2; NbExp=4; IntAct=EBI-1387094, EBI-701903;
CC       Q02535; O43559: FRS3; NbExp=3; IntAct=EBI-1387094, EBI-725515;
CC       Q02535; Q96NT3-2: GUCD1; NbExp=3; IntAct=EBI-1387094, EBI-11978177;
CC       Q02535; P49639: HOXA1; NbExp=3; IntAct=EBI-1387094, EBI-740785;
CC       Q02535; Q92993: KAT5; NbExp=3; IntAct=EBI-1387094, EBI-399080;
CC       Q02535; Q6PEX3: KRTAP26-1; NbExp=3; IntAct=EBI-1387094, EBI-3957672;
CC       Q02535; P61968: LMO4; NbExp=3; IntAct=EBI-1387094, EBI-2798728;
CC       Q02535; A6NI15: MSGN1; NbExp=3; IntAct=EBI-1387094, EBI-11991020;
CC       Q02535; P13349: MYF5; NbExp=3; IntAct=EBI-1387094, EBI-17491620;
CC       Q02535; O00560: SDCBP; NbExp=3; IntAct=EBI-1387094, EBI-727004;
CC       Q02535; Q99081: TCF12; NbExp=4; IntAct=EBI-1387094, EBI-722877;
CC       Q02535; Q99081-3: TCF12; NbExp=4; IntAct=EBI-1387094, EBI-11952764;
CC       Q02535; P15923: TCF3; NbExp=3; IntAct=EBI-1387094, EBI-769630;
CC       Q02535; P15923-3: TCF3; NbExp=3; IntAct=EBI-1387094, EBI-12000326;
CC       Q02535; P15884: TCF4; NbExp=5; IntAct=EBI-1387094, EBI-533224;
CC       Q02535; P15884-3: TCF4; NbExp=3; IntAct=EBI-1387094, EBI-13636688;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in lung, kidney and adrenal
CC       gland, but not in adult brain.
CC   -!- INDUCTION: By phorbol 12-myristate 13-acetate (PMA).
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA47360.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X66924; CAA47360.1; ALT_INIT; mRNA.
DR   EMBL; X69111; CAA48862.1; -; mRNA.
DR   EMBL; X73428; CAA51827.1; -; Genomic_DNA.
DR   EMBL; BT006791; AAP35437.1; -; mRNA.
DR   EMBL; AK290003; BAF82692.1; -; mRNA.
DR   EMBL; AL021154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471134; EAW95060.1; -; Genomic_DNA.
DR   EMBL; BC003107; AAH03107.1; -; mRNA.
DR   CCDS; CCDS237.1; -.
DR   PIR; I37092; S28529.
DR   RefSeq; NP_002158.3; NM_002167.4.
DR   PDB; 2LFH; NMR; -; A/B=29-83.
DR   PDBsum; 2LFH; -.
DR   SMR; Q02535; -.
DR   BioGrid; 109625; 33.
DR   DIP; DIP-713N; -.
DR   IntAct; Q02535; 31.
DR   MINT; Q02535; -.
DR   STRING; 9606.ENSP00000363689; -.
DR   iPTMnet; Q02535; -.
DR   PhosphoSitePlus; Q02535; -.
DR   BioMuta; ID3; -.
DR   DMDM; 322510035; -.
DR   EPD; Q02535; -.
DR   jPOST; Q02535; -.
DR   MassIVE; Q02535; -.
DR   MaxQB; Q02535; -.
DR   PaxDb; Q02535; -.
DR   PeptideAtlas; Q02535; -.
DR   PRIDE; Q02535; -.
DR   ProteomicsDB; 58106; -.
DR   Antibodypedia; 4480; 576 antibodies.
DR   DNASU; 3399; -.
DR   Ensembl; ENST00000374561; ENSP00000363689; ENSG00000117318.
DR   Ensembl; ENST00000634790; ENSP00000489102; ENSG00000283060.
DR   GeneID; 3399; -.
DR   KEGG; hsa:3399; -.
DR   UCSC; uc001bhh.5; human.
DR   CTD; 3399; -.
DR   DisGeNET; 3399; -.
DR   GeneCards; ID3; -.
DR   HGNC; HGNC:5362; ID3.
DR   HPA; ENSG00000117318; Tissue enhanced (seminal).
DR   MIM; 600277; gene.
DR   neXtProt; NX_Q02535; -.
DR   OpenTargets; ENSG00000117318; -.
DR   PharmGKB; PA29610; -.
DR   eggNOG; ENOG410IYKY; Eukaryota.
DR   eggNOG; ENOG4112051; LUCA.
DR   GeneTree; ENSGT00940000160504; -.
DR   HOGENOM; CLU_116790_1_0_1; -.
DR   InParanoid; Q02535; -.
DR   KO; K17694; -.
DR   OMA; LYDMNDC; -.
DR   OrthoDB; 1624054at2759; -.
DR   PhylomeDB; Q02535; -.
DR   TreeFam; TF326217; -.
DR   SIGNOR; Q02535; -.
DR   ChiTaRS; ID3; human.
DR   GeneWiki; ID3_(gene); -.
DR   GenomeRNAi; 3399; -.
DR   Pharos; Q02535; Tbio.
DR   PRO; PR:Q02535; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q02535; protein.
DR   Bgee; ENSG00000117318; Expressed in right lobe of thyroid gland and 213 other tissues.
DR   Genevisible; Q02535; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:1901707; F:leptomycin B binding; IEA:Ensembl.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0072750; P:cellular response to leptomycin B; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:GDB.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0030903; P:notochord development; IEA:Ensembl.
DR   GO; GO:0042476; P:odontogenesis; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0006275; P:regulation of DNA replication; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR026052; DNA-bd_prot-inh.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   PANTHER; PTHR11723; PTHR11723; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Myogenesis; Nucleus; Polymorphism;
KW   Reference proteome; Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..119
FT                   /note="DNA-binding protein inhibitor ID-3"
FT                   /id="PRO_0000127247"
FT   DOMAIN          28..80
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   VARIANT         105
FT                   /note="T -> A (in dbSNP:rs11574)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:1628620,
FT                   ECO:0000269|PubMed:7828896, ECO:0000269|PubMed:8437843,
FT                   ECO:0000269|Ref.4, ECO:0000269|Ref.7"
FT                   /id="VAR_016122"
FT   VARIANT         111
FT                   /note="S -> A (in dbSNP:rs11542317)"
FT                   /id="VAR_030739"
FT   STRAND          40..42
FT                   /evidence="ECO:0000244|PDB:2LFH"
FT   HELIX           43..54
FT                   /evidence="ECO:0000244|PDB:2LFH"
FT   HELIX           66..81
FT                   /evidence="ECO:0000244|PDB:2LFH"
SQ   SEQUENCE   119 AA;  12999 MW;  7FC38B56B4DCEFBC CRC64;
     MKALSPVRGC YEAVCCLSER SLAIARGRGK GPAAEEPLSL LDDMNHCYSR LRELVPGVPR
     GTQLSQVEIL QRVIDYILDL QVVLAEPAPG PPDGPHLPIQ TAELTPELVI SNDKRSFCH
//
ID   B3FTN5_HUMAN            Unreviewed;        55 AA.
AC   B3FTN5;
DT   22-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 46.
DE   SubName: Full=Truncated insulin-like 2 growth factor 2-binding protein 2 {ECO:0000313|EMBL:ACB86628.1};
GN   Name=IGF2BP2 {ECO:0000313|EMBL:ACB86628.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACB86628.1};
RN   [1] {ECO:0000313|EMBL:ACB86628.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Prokunina-Olsson L., Hanisch J.J., Jackson A., Chines P.S., Erdos M.R.,
RA   Bonnycastle L.L., Swift A., Narisu N., Scott L.J., Morken M., Mohlke K.,
RA   Bergman R., Tuomilehto J., Boehnke M., Rotimi C.N., Watanabe R.N.,
RA   Collins F.S.;
RT   "A novel type 2 diabetes-associated variant of IGF2BP2 gene affects
RT   expression of a functional alternative splicing form.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU408704; ACB86628.1; -; mRNA.
DR   RefSeq; NP_001278804.1; NM_001291875.2.
DR   PRIDE; B3FTN5; -.
DR   GeneID; 10644; -.
DR   CTD; 10644; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   ChiTaRS; IGF2BP2; human.
DR   GenomeRNAi; 10644; -.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   SUPFAM; SSF54928; SSF54928; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   55 AA;  6361 MW;  04DBD5934A111D4B CRC64;
     MFSCPGHYHV DGFLNPGSRK IQIRNIPPHL QWEVLDGLLA QYGTVENVEQ EPWRS
//
ID   B4DKT5_HUMAN            Unreviewed;       300 AA.
AC   B4DKT5;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=cDNA FLJ53054, highly similar to Insulin-like growth factor 2 mRNA-binding protein 2 {ECO:0000313|EMBL:BAG59297.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59297.1};
RN   [1] {ECO:0000313|EMBL:BAG59297.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59297.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK296703; BAG59297.1; -; mRNA.
DR   RefSeq; NP_001278803.1; NM_001291874.2.
DR   PeptideAtlas; B4DKT5; -.
DR   PRIDE; B4DKT5; -.
DR   GeneID; 10644; -.
DR   CTD; 10644; -.
DR   GenomeRNAi; 10644; -.
DR   GO; GO:0003729; F:mRNA binding; IEA:InterPro.
DR   Gene3D; 3.30.1370.10; -; 1.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 2.
DR   Pfam; PF00013; KH_1; 3.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; SSF54791; 3.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          17..90
FT                   /note="KH"
FT                   /evidence="ECO:0000259|SMART:SM00322"
FT   DOMAIN          127..198
FT                   /note="KH"
FT                   /evidence="ECO:0000259|SMART:SM00322"
FT   DOMAIN          209..281
FT                   /note="KH"
FT                   /evidence="ECO:0000259|SMART:SM00322"
FT   COILED          269..289
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   300 AA;  33323 MW;  955E57C0D69902D0 CRC64;
     MILEIMQKEA DETKLAEEIP LKILAHNGLV GRLIGKEGRN LKKIEHETGT KITISSLQDL
     SIYNPERTIT VKGTVEACAS AEIEIMKKLR EAFENDMLAV NTHSGYFSSL YPHHQFGPFP
     HHHSYPEQEI VNLFIPTQAV GAIIGKKGAH IKQLARFAGA SIKIAPAEGP DVSERMVIIT
     GPPEAQFKAQ GRIFGKLKEE NFFNPKEEVK LEAHIRVPSS TAGRVIGKGG KTVNELQNLT
     SAEVIVPRGQ TPDENEEVIV RIIGHFFASQ TAQRKIREIV QQVKQQEQKY PQGVASQRSK
//
ID   F8W930_HUMAN            Unreviewed;       605 AA.
AC   F8W930;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   22-APR-2020, entry version 75.
DE   SubName: Full=Insulin-like growth factor 2 mRNA-binding protein 2 {ECO:0000313|Ensembl:ENSP00000410242};
GN   Name=IGF2BP2 {ECO:0000313|Ensembl:ENSP00000410242};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000410242, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000410242, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7] {ECO:0000313|Ensembl:ENSP00000410242}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [8] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [9] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC016961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278798.1; NM_001291869.2.
DR   IntAct; F8W930; 1.
DR   EPD; F8W930; -.
DR   jPOST; F8W930; -.
DR   MaxQB; F8W930; -.
DR   PeptideAtlas; F8W930; -.
DR   PRIDE; F8W930; -.
DR   ProteomicsDB; 30251; -.
DR   Antibodypedia; 33841; 578 antibodies.
DR   Ensembl; ENST00000457616; ENSP00000410242; ENSG00000073792.
DR   GeneID; 10644; -.
DR   UCSC; uc062qzi.1; human.
DR   CTD; 10644; -.
DR   EuPathDB; HostDB:ENSG00000073792.15; -.
DR   HGNC; HGNC:28867; IGF2BP2.
DR   OpenTargets; ENSG00000073792; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   GeneTree; ENSGT00940000154913; -.
DR   OMA; SYETQEQ; -.
DR   OrthoDB; 286875at2759; -.
DR   PhylomeDB; F8W930; -.
DR   ChiTaRS; IGF2BP2; human.
DR   GenomeRNAi; 10644; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000073792; Expressed in kidney and 203 other tissues.
DR   ExpressionAtlas; F8W930; baseline and differential.
DR   GO; GO:0003729; F:mRNA binding; IEA:InterPro.
DR   CDD; cd12626; RRM1_IGF2BP2; 1.
DR   Gene3D; 3.30.1370.10; -; 2.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR034843; IGF2BP2_RRM1.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 1.
DR   Pfam; PF00013; KH_1; 4.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00322; KH; 4.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54791; SSF54791; 4.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:F8W930,
KW   ECO:0000213|MaxQB:F8W930, ECO:0000213|PeptideAtlas:F8W930,
KW   ECO:0000213|ProteomicsDB:F8W930};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          3..76
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          82..163
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   REGION          163..194
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          574..594
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   605 AA;  66786 MW;  8A8554375CE9ED0D CRC64;
     MMNKLYIGNL SPAVTADDLR QLFGDRKLPL AGQVLLKSGY AFVDYPDQNW AIRAIETLSG
     KVELHGKIME VDYSVSKKLR SRKIQIRNIP PHLQWEVLDG LLAQYGTVEN VEQVFAFSLV
     NTDTETAVVN VTYATREEAK IAMEKLSGHQ FENYSFKISY IPDEEVSSPS PPQRAQRGDH
     SSREQGHAPG GTSQARQIDF PLRILVPTQF VGAIIGKEGL TIKNITKQTQ SRVDIHRKEN
     SGAAEKPVTI HATPEGTSEA CRMILEIMQK EADETKLAEE IPLKILAHNG LVGRLIGKEG
     RNLKKIEHET GTKITISSLQ DLSIYNPERT ITVKGTVEAC ASAEIEIMKK LREAFENDML
     AVNQQANLIP GLNLSALGIF STGLSVLSPP AGPRGAPPAA PYHPFTTHSG YFSSLYPHHQ
     FGPFPHHHSY PEQEIVNLFI PTQAVGAIIG KKGAHIKQLA RFAGASIKIA PAEGPDVSER
     MVIITGPPEA QFKAQGRIFG KLKEENFFNP KEEVKLEAHI RVPSSTAGRV IGKGGKTVNE
     LQNLTSAEVI VPRDQTPDEN EEVIVRIIGH FFASQTAQRK IREIVQQVKQ QEQKYPQGVA
     SQRSK
//
ID   IF2B2_HUMAN             Reviewed;         599 AA.
AC   Q9Y6M1; A0A4Z0; B3FTN2; B3FTN3; B3FTN4;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 2.
DT   22-APR-2020, entry version 174.
DE   RecName: Full=Insulin-like growth factor 2 mRNA-binding protein 2;
DE            Short=IGF2 mRNA-binding protein 2;
DE            Short=IMP-2;
DE   AltName: Full=Hepatocellular carcinoma autoantigen p62;
DE   AltName: Full=IGF-II mRNA-binding protein 2;
DE   AltName: Full=VICKZ family member 2;
GN   Name=IGF2BP2; Synonyms=IMP2, VICKZ2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), IDENTIFICATION AS A HEPATOCELLULAR
RP   CARCINOMA ANTIGEN, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=10190901; DOI=10.1084/jem.189.7.1101;
RA   Zhang J.-Y., Chan E.K.L., Peng X.-X., Tan E.M.;
RT   "A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in
RT   human hepatocellular carcinoma.";
RL   J. Exp. Med. 189:1101-1110(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Pancreatic islet;
RA   Prokunina-Olsson L., Hanisch J.J., Jackson A., Chines P.S., Erdos M.R.,
RA   Bonnycastle L.L., Swift A., Narisu N., Scott L.J., Morken M., Mohlke K.,
RA   Bergman R., Tuomilehto J., Boehnke M., Rotimi C.N., Watanabe R.N.,
RA   Collins F.S.;
RT   "A novel type 2 diabetes-associated variant of IGF2BP2 gene affects
RT   expression of a functional alternative splicing form.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9891060; DOI=10.1128/mcb.19.2.1262;
RA   Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M.,
RA   Nielsen F.C.;
RT   "A family of insulin-like growth factor II mRNA-binding proteins represses
RT   translation in late development.";
RL   Mol. Cell. Biol. 19:1262-1270(1999).
RN   [6]
RP   INTERACTION WITH HNRPD.
RX   PubMed=12674497; DOI=10.1515/bc.2003.004;
RA   Moraes K.C., Quaresma A.J., Maehnss K., Kobarg J.;
RT   "Identification and characterization of proteins that selectively interact
RT   with isoforms of the mRNA binding protein AUF1 (hnRNP D).";
RL   Biol. Chem. 384:25-37(2003).
RN   [7]
RP   REVIEW.
RX   PubMed=15601260; DOI=10.1042/bc20040151;
RA   Yisraeli J.K.;
RT   "VICKZ proteins: a multi-talented family of regulatory RNA-binding
RT   proteins.";
RL   Biol. Cell 97:87-96(2005).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16049158; DOI=10.1530/rep.1.00664;
RA   Hammer N.A., Hansen T.O., Byskov A.G., Rajpert-De Meyts E., Groendahl M.L.,
RA   Bredkjaer H.E., Wewer U.M., Christiansen J., Nielsen F.C.;
RT   "Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular
RT   cancer.";
RL   Reproduction 130:203-212(2005).
RN   [9]
RP   INTERACTION WITH IGF2BP1, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   RNA-BINDING, AND DOMAIN.
RX   PubMed=20080952; DOI=10.1101/gad.1862910;
RA   Chao J.A., Patskovsky Y., Patel V., Levy M., Almo S.C., Singer R.H.;
RT   "ZBP1 recognition of beta-actin zipcode induces RNA looping.";
RL   Genes Dev. 24:148-158(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 6), AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ALTERNATIVE INITIATION (ISOFORM 6).
RX   PubMed=22427968; DOI=10.1371/journal.pone.0033140;
RA   Le H.T., Sorrell A.M., Siddle K.;
RT   "Two isoforms of the mRNA binding protein IGF2BP2 are generated by
RT   alternative translational initiation.";
RL   PLoS ONE 7:E33140-E33140(2012).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 6), AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   FUNCTION, RNA-BINDING, OLIGOMERIZATION, INTERACTION WITH ELAVL1; DHX9 AND
RP   HNRNPU, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF LYS-211; LYS-292;
RP   445-LYS-LYS-446 AND 527-LYS-GLY-528.
RX   PubMed=23640942; DOI=10.1515/hsz-2013-0111;
RA   Wachter K., Kohn M., Stohr N., Huttelmaier S.;
RT   "Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding
RT   proteins) is modulated by distinct RNA-binding domains.";
RL   Biol. Chem. 394:1077-1090(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   STRUCTURE BY NMR OF 2-81.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA binding domain of IGF-II mRNA-binding
RT   protein 2.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: RNA-binding factor that recruits target transcripts to
CC       cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging'
CC       into mRNPs allows mRNA transport and transient storage. It also
CC       modulates the rate and location at which target transcripts encounter
CC       the translational apparatus and shields them from endonuclease attacks
CC       or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR
CC       of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-
CC       specific. Binds to beta-actin/ACTB and MYC transcripts. {ECO:0000250,
CC       ECO:0000269|PubMed:23640942, ECO:0000269|PubMed:9891060}.
CC   -!- SUBUNIT: Can form homooligomers and heterooligomers with IGF2BP1 and
CC       IGF2BP3 in an RNA-dependent manner. Interacts with HNRPD and IGF2BP1.
CC       Interacts with ELAVL1, DHX9 and HNRNPU. {ECO:0000269|PubMed:12674497,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:23640942}.
CC   -!- INTERACTION:
CC       Q9Y6M1; Q14103-4: HNRNPD; NbExp=4; IntAct=EBI-1024419, EBI-432545;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Localized in cytoplasmic
CC       mRNP granules containing untranslated mRNAs. Localizes at the
CC       connecting piece and the tail of the spermatozoa. In response to
CC       cellular stress, such as oxidative stress, recruited to stress
CC       granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9Y6M1-2; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6M1-1; Sequence=VSP_036553;
CC       Name=3;
CC         IsoId=Q9Y6M1-3; Sequence=VSP_036550;
CC       Name=4;
CC         IsoId=Q9Y6M1-4; Sequence=VSP_036550, VSP_036552;
CC       Name=5;
CC         IsoId=Q9Y6M1-5; Sequence=VSP_036550, VSP_036553;
CC       Name=6;
CC         IsoId=Q9Y6M1-6; Sequence=VSP_043699;
CC   -!- TISSUE SPECIFICITY: Expressed in oocytes, granulosa cells of small and
CC       growing follicles, Leydig cells, spermatogonia and semen (at protein
CC       level). Expressed in testicular cancer (at protein level). Expressed
CC       weakly in heart, placenta, skeletal muscle, bone marrow, colon, kidney,
CC       salivary glands, testis and pancreas. Detected in fetal liver, fetal
CC       ovary, gonocytes and interstitial cells of the testis.
CC       {ECO:0000269|PubMed:10190901, ECO:0000269|PubMed:16049158}.
CC   -!- DOMAIN: Domain KH3 and KH4 are the major RNA-binding modules, although
CC       KH1 and KH2 may also contribute. The contribution to RNA-binding of
CC       individual KH domains may be target-specific. KH1 and KH2, and possibly
CC       KH3 and KH4, promote the formation of higher ordered protein-RNA
CC       complexes, which may be essential for IGF2BP1 cytoplasmic retention. KH
CC       domains are required for RNA-dependent homo- and heterooligomerization
CC       and for localization to stress granules. {ECO:0000269|PubMed:20080952,
CC       ECO:0000269|PubMed:23640942}.
CC   -!- MISCELLANEOUS: Autoantibodies against IGF2BP2 are detected in sera from
CC       some patients with hepatocellular carcinoma.
CC   -!- MISCELLANEOUS: [Isoform 6]: Generated by alternative initiation at Met-
CC       69. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the RRM IMP/VICKZ family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH21290.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF057352; AAD31596.1; -; mRNA.
DR   EMBL; EU408701; ACB86625.1; -; mRNA.
DR   EMBL; EU408702; ACB86626.1; -; mRNA.
DR   EMBL; EU408703; ACB86627.1; -; mRNA.
DR   EMBL; AC016961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021290; AAH21290.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3273.2; -. [Q9Y6M1-2]
DR   CCDS; CCDS33903.1; -. [Q9Y6M1-1]
DR   CCDS; CCDS77869.1; -. [Q9Y6M1-3]
DR   RefSeq; NP_001007226.1; NM_001007225.2. [Q9Y6M1-1]
DR   RefSeq; NP_001278801.1; NM_001291872.2. [Q9Y6M1-4]
DR   RefSeq; NP_001278802.1; NM_001291873.2. [Q9Y6M1-3]
DR   RefSeq; NP_001278803.1; NM_001291874.2. [Q9Y6M1-5]
DR   RefSeq; NP_001278804.1; NM_001291875.2.
DR   RefSeq; NP_006539.3; NM_006548.5. [Q9Y6M1-2]
DR   PDB; 2CQH; NMR; -; A=2-81.
DR   PDB; 6ROL; X-ray; 2.10 A; A/B/C/D=426-588.
DR   PDBsum; 2CQH; -.
DR   PDBsum; 6ROL; -.
DR   SMR; Q9Y6M1; -.
DR   BioGrid; 115888; 137.
DR   DIP; DIP-35539N; -.
DR   IntAct; Q9Y6M1; 47.
DR   MINT; Q9Y6M1; -.
DR   STRING; 9606.ENSP00000371634; -.
DR   iPTMnet; Q9Y6M1; -.
DR   PhosphoSitePlus; Q9Y6M1; -.
DR   SwissPalm; Q9Y6M1; -.
DR   BioMuta; IGF2BP2; -.
DR   DMDM; 224471831; -.
DR   EPD; Q9Y6M1; -.
DR   jPOST; Q9Y6M1; -.
DR   MassIVE; Q9Y6M1; -.
DR   MaxQB; Q9Y6M1; -.
DR   PaxDb; Q9Y6M1; -.
DR   PeptideAtlas; Q9Y6M1; -.
DR   PRIDE; Q9Y6M1; -.
DR   ProteomicsDB; 86724; -. [Q9Y6M1-2]
DR   ProteomicsDB; 86725; -. [Q9Y6M1-1]
DR   ProteomicsDB; 86726; -. [Q9Y6M1-3]
DR   ProteomicsDB; 86727; -. [Q9Y6M1-4]
DR   ProteomicsDB; 86728; -. [Q9Y6M1-5]
DR   ProteomicsDB; 86729; -. [Q9Y6M1-6]
DR   Antibodypedia; 33841; 578 antibodies.
DR   DNASU; 10644; -.
DR   Ensembl; ENST00000346192; ENSP00000320204; ENSG00000073792. [Q9Y6M1-1]
DR   Ensembl; ENST00000382199; ENSP00000371634; ENSG00000073792. [Q9Y6M1-2]
DR   Ensembl; ENST00000421047; ENSP00000413787; ENSG00000073792. [Q9Y6M1-3]
DR   GeneID; 10644; -.
DR   KEGG; hsa:10644; -.
DR   UCSC; uc003fpo.4; human. [Q9Y6M1-2]
DR   CTD; 10644; -.
DR   DisGeNET; 10644; -.
DR   GeneCards; IGF2BP2; -.
DR   HGNC; HGNC:28867; IGF2BP2.
DR   HPA; ENSG00000073792; Tissue enhanced (placenta).
DR   MalaCards; IGF2BP2; -.
DR   MIM; 608289; gene.
DR   neXtProt; NX_Q9Y6M1; -.
DR   OpenTargets; ENSG00000073792; -.
DR   PharmGKB; PA128394577; -.
DR   eggNOG; KOG2193; Eukaryota.
DR   eggNOG; ENOG410ZKB4; LUCA.
DR   GeneTree; ENSGT00940000154913; -.
DR   HOGENOM; CLU_020744_1_0_1; -.
DR   InParanoid; Q9Y6M1; -.
DR   KO; K17392; -.
DR   PhylomeDB; Q9Y6M1; -.
DR   TreeFam; TF320229; -.
DR   Reactome; R-HSA-428359; Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA.
DR   ChiTaRS; IGF2BP2; human.
DR   EvolutionaryTrace; Q9Y6M1; -.
DR   GeneWiki; IGF2BP2; -.
DR   GenomeRNAi; 10644; -.
DR   Pharos; Q9Y6M1; Tbio.
DR   PRO; PR:Q9Y6M1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9Y6M1; protein.
DR   Bgee; ENSG00000073792; Expressed in kidney and 203 other tissues.
DR   ExpressionAtlas; Q9Y6M1; baseline and differential.
DR   Genevisible; Q9Y6M1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0045182; F:translation regulator activity; ISS:BHF-UCL.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0017148; P:negative regulation of translation; ISS:BHF-UCL.
DR   GO; GO:0042035; P:regulation of cytokine biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   CDD; cd12626; RRM1_IGF2BP2; 1.
DR   Gene3D; 3.30.1370.10; -; 2.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR028743; IGF2BP2.
DR   InterPro; IPR034843; IGF2BP2_RRM1.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR10288:SF93; PTHR10288:SF93; 1.
DR   Pfam; PF00013; KH_1; 4.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00322; KH; 4.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54791; SSF54791; 4.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 4.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Alternative splicing;
KW   Cytoplasm; mRNA transport; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; RNA-binding; Translation regulation; Transport.
FT   CHAIN           1..599
FT                   /note="Insulin-like growth factor 2 mRNA-binding protein 2"
FT                   /id="PRO_0000244496"
FT   DOMAIN          3..76
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          82..157
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          193..258
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          274..341
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          427..492
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          509..575
FT                   /note="KH 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         550
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SF07"
FT   VAR_SEQ         1..80
FT                   /note="MMNKLYIGNLSPAVTADDLRQLFGDRKLPLAGQVLLKSGYAFVDYPDQNWAI
FT                   RAIETLSGKVELHGKIMEVDYSVSKKLR -> MFSCPGHYHVDGFLNPG (in
FT                   isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_036550"
FT   VAR_SEQ         1..68
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_043699"
FT   VAR_SEQ         113
FT                   /note="Q -> QVFAFSL (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_036552"
FT   VAR_SEQ         358..400
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10190901, ECO:0000303|Ref.2"
FT                   /id="VSP_036553"
FT   MUTAGEN         211
FT                   /note="K->E: Significantly impaired binding to ACTB
FT                   transcript, but little effect on MYC transcript binding,
FT                   accumulation in the nucleus; when associated with E-292.
FT                   Loss of homo- and heterooligomerization with IGF2BP1 and
FT                   IGF2BP2, almost complete loss of ACTB and MYC transcript
FT                   binding, almost complete loss of ELAVL1-, DHX9- and HNRNPU-
FT                   binding and perturbed subcellular location, including
FT                   accumulation in the nucleus and loss of localization to
FT                   stress granules; when associated with E-292; 445-E-E-446
FT                   and 526-E-E-527."
FT                   /evidence="ECO:0000269|PubMed:23640942"
FT   MUTAGEN         292
FT                   /note="K->E: Significantly impaired binding to ACTB
FT                   transcript, but little effect on MYC transcript binding,
FT                   accumulation in the nucleus; when associated with E-211.
FT                   Loss of homo- and heterooligomerization with IGF2BP1 and
FT                   IGF2BP2, almost complete loss of ACTB and MYC transcript
FT                   binding, almost complete loss of ELAVL1-, DHX9- and HNRNPU-
FT                   binding and perturbed subcellular location, including
FT                   accumulation in the nucleus and loss of localization to
FT                   stress granules; when associated with E-211; 445-E-E-445
FT                   and 526-E-E-527."
FT                   /evidence="ECO:0000269|PubMed:23640942"
FT   MUTAGEN         445..446
FT                   /note="KK->EE: Significantly impaired binding to ACTB and
FT                   MYC transcripts; when associated with 527-E-E-528. Loss of
FT                   homo- and heterooligomerization with IGF2BP1 and IGF2BP2,
FT                   almost complete loss of ACTB and MYC transcript binding,
FT                   almost complete loss of ELAVL1-, DHX9- and HNRNPU-binding
FT                   and perturbed subcellular location, including accumulation
FT                   in the nucleus and loss of localization to stress granules;
FT                   when associated with E-211; E-292 and 527-E-E-528."
FT                   /evidence="ECO:0000269|PubMed:23640942"
FT   MUTAGEN         527..528
FT                   /note="KG->EE: Significantly impaired binding to ACTB and
FT                   MYC transcripts; when associated with 445-E-E-446. Loss of
FT                   homo- and heterooligomerization with IGF2BP1 and IGF2BP2,
FT                   almost complete loss of ACTB and MYC transcript binding,
FT                   almost complete loss of ELAVL1-, DHX9- and HNRNPU-binding
FT                   and perturbed subcellular location, including accumulation
FT                   in the nucleus and loss of localization to stress granules;
FT                   when associated with E-211; E-292 and 445-E-E-446."
FT                   /evidence="ECO:0000269|PubMed:23640942"
FT   STRAND          5..8
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   HELIX           16..25
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   STRAND          34..37
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   STRAND          40..43
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   HELIX           48..58
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   TURN            59..61
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   STRAND          70..73
FT                   /evidence="ECO:0000244|PDB:2CQH"
FT   STRAND          428..435
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           436..438
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           439..443
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           445..447
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           448..457
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   STRAND          459..463
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   STRAND          472..480
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           482..498
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   STRAND          510..517
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           518..520
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           521..525
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           527..529
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           530..539
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   STRAND          542..544
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   STRAND          555..563
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   HELIX           565..584
FT                   /evidence="ECO:0000244|PDB:6ROL"
FT   MOD_RES         Q9Y6M1-6:1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378"
SQ   SEQUENCE   599 AA;  66121 MW;  EA656F8733BBB39A CRC64;
     MMNKLYIGNL SPAVTADDLR QLFGDRKLPL AGQVLLKSGY AFVDYPDQNW AIRAIETLSG
     KVELHGKIME VDYSVSKKLR SRKIQIRNIP PHLQWEVLDG LLAQYGTVEN VEQVNTDTET
     AVVNVTYATR EEAKIAMEKL SGHQFENYSF KISYIPDEEV SSPSPPQRAQ RGDHSSREQG
     HAPGGTSQAR QIDFPLRILV PTQFVGAIIG KEGLTIKNIT KQTQSRVDIH RKENSGAAEK
     PVTIHATPEG TSEACRMILE IMQKEADETK LAEEIPLKIL AHNGLVGRLI GKEGRNLKKI
     EHETGTKITI SSLQDLSIYN PERTITVKGT VEACASAEIE IMKKLREAFE NDMLAVNQQA
     NLIPGLNLSA LGIFSTGLSV LSPPAGPRGA PPAAPYHPFT THSGYFSSLY PHHQFGPFPH
     HHSYPEQEIV NLFIPTQAVG AIIGKKGAHI KQLARFAGAS IKIAPAEGPD VSERMVIITG
     PPEAQFKAQG RIFGKLKEEN FFNPKEEVKL EAHIRVPSST AGRVIGKGGK TVNELQNLTS
     AEVIVPRDQT PDENEEVIVR IIGHFFASQT AQRKIREIVQ QVKQQEQKYP QGVASQRSK
//
ID   LAR4B_HUMAN             Reviewed;         738 AA.
AC   Q92615; A7MD20; Q5T3R3; Q5T3R4; Q5T3R5; Q68CY4;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 3.
DT   22-APR-2020, entry version 170.
DE   RecName: Full=La-related protein 4B;
DE   AltName: Full=La ribonucleoprotein domain family member 4B;
DE   AltName: Full=La ribonucleoprotein domain family member 5;
DE   AltName: Full=La-related protein 5;
GN   Name=LARP4B; Synonyms=KIAA0217, LARP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI. The
RT   coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of
RT   cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 495-738.
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434 AND THR-566, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424; SER-434; SER-451;
RP   SER-524; SER-727 AND SER-736, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-424; THR-518 AND SER-524, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-724, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PABPC1 AND RACK1.
RX   PubMed=20573744; DOI=10.1261/rna.2146910;
RA   Schaffler K., Schulz K., Hirmer A., Wiesner J., Grimm M., Sickmann A.,
RA   Fischer U.;
RT   "A stimulatory role for the La-related protein 4B in translation.";
RL   RNA 16:1488-1499(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-451; SER-488; SER-524;
RP   SER-556; SER-568; SER-601; SER-664 AND SER-718, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-404 AND ARG-419, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [23] {ECO:0000244|PDB:3PTH}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 55-69 IN COMPLEX WITH PABPC1.
RA   Grimm C., Pelz J.P.;
RT   "LARP4B binds to the PABC1 MLLE domain via a variant PAM2 motif.";
RL   Submitted (DEC-2010) to the PDB data bank.
CC   -!- FUNCTION: Stimulates mRNA translation. {ECO:0000269|PubMed:20573744}.
CC   -!- SUBUNIT: Interacts with PABPC1 (PubMed:20573744, Ref.23). Interacts
CC       with RACK1 (PubMed:20573744). Associates with polysomes via the 40S
CC       ribosomal subunit (PubMed:20573744). {ECO:0000269|PubMed:20573744,
CC       ECO:0000269|Ref.23}.
CC   -!- INTERACTION:
CC       Q92615; E9KL35; NbExp=3; IntAct=EBI-1052558, EBI-8456500;
CC       Q92615; P0C7T5: ATXN1L; NbExp=3; IntAct=EBI-1052558, EBI-8624731;
CC       Q92615; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-1052558, EBI-716006;
CC       Q92615; P63244: RACK1; NbExp=5; IntAct=EBI-1052558, EBI-296739;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20573744}.
CC       Note=Localized in cytoplasmic mRNP granules containing untranslated
CC       mRNAs in response to arsenite treatment. {ECO:0000269|PubMed:20573744}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13207.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D86971; BAA13207.2; ALT_INIT; mRNA.
DR   EMBL; AK292946; BAF85635.1; -; mRNA.
DR   EMBL; AL359878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157709; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86530.1; -; Genomic_DNA.
DR   EMBL; BC131630; AAI31631.1; -; mRNA.
DR   EMBL; BC152443; AAI52444.1; -; mRNA.
DR   EMBL; CR749653; CAH18446.1; -; mRNA.
DR   CCDS; CCDS31131.1; -.
DR   RefSeq; NP_055970.1; NM_015155.2.
DR   PDB; 3PTH; X-ray; 1.70 A; B=55-69.
DR   PDBsum; 3PTH; -.
DR   SMR; Q92615; -.
DR   BioGrid; 116795; 108.
DR   ELM; Q92615; -.
DR   IntAct; Q92615; 37.
DR   MINT; Q92615; -.
DR   STRING; 9606.ENSP00000482767; -.
DR   iPTMnet; Q92615; -.
DR   PhosphoSitePlus; Q92615; -.
DR   BioMuta; LARP4B; -.
DR   DMDM; 134034150; -.
DR   EPD; Q92615; -.
DR   jPOST; Q92615; -.
DR   MassIVE; Q92615; -.
DR   MaxQB; Q92615; -.
DR   PaxDb; Q92615; -.
DR   PeptideAtlas; Q92615; -.
DR   PRIDE; Q92615; -.
DR   ProteomicsDB; 75363; -.
DR   Antibodypedia; 52530; 42 antibodies.
DR   Ensembl; ENST00000316157; ENSP00000326128; ENSG00000107929.
DR   Ensembl; ENST00000612396; ENSP00000482767; ENSG00000107929.
DR   GeneID; 23185; -.
DR   KEGG; hsa:23185; -.
DR   UCSC; uc031ptb.1; human.
DR   CTD; 23185; -.
DR   DisGeNET; 23185; -.
DR   GeneCards; LARP4B; -.
DR   HGNC; HGNC:28987; LARP4B.
DR   HPA; ENSG00000107929; Low tissue specificity.
DR   MIM; 616513; gene.
DR   neXtProt; NX_Q92615; -.
DR   OpenTargets; ENSG00000107929; -.
DR   PharmGKB; PA165548762; -.
DR   eggNOG; ENOG410IN3Y; Eukaryota.
DR   eggNOG; ENOG4111REM; LUCA.
DR   GeneTree; ENSGT00940000157755; -.
DR   HOGENOM; CLU_025110_0_0_1; -.
DR   InParanoid; Q92615; -.
DR   KO; K18763; -.
DR   OMA; PPDSCKE; -.
DR   OrthoDB; 263288at2759; -.
DR   PhylomeDB; Q92615; -.
DR   TreeFam; TF321960; -.
DR   ChiTaRS; LARP4B; human.
DR   GenomeRNAi; 23185; -.
DR   Pharos; Q92615; Tbio.
DR   PRO; PR:Q92615; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q92615; protein.
DR   Bgee; ENSG00000107929; Expressed in adrenal tissue and 225 other tissues.
DR   ExpressionAtlas; Q92615; baseline and differential.
DR   Genevisible; Q92615; HS.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0042788; C:polysomal ribosome; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:UniProtKB.
DR   CDD; cd12706; RRM_LARP5; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR006630; La_HTH.
DR   InterPro; IPR034900; LARP5_RRM.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF05383; La; 1.
DR   SMART; SM00715; LA; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50961; HTH_LA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Methylation; Phosphoprotein;
KW   Reference proteome; RNA-binding; Translation regulation.
FT   CHAIN           1..738
FT                   /note="La-related protein 4B"
FT                   /id="PRO_0000281139"
FT   DOMAIN          150..239
FT                   /note="HTH La-type RNA-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00332"
FT   DOMAIN          240..307
FT                   /note="RRM"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6A0A2"
FT   MOD_RES         404
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         419
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648"
FT   MOD_RES         451
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         493
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6A0A2"
FT   MOD_RES         498
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6A0A2"
FT   MOD_RES         518
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         556
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         566
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243"
FT   MOD_RES         568
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         664
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         718
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         724
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         727
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         732
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6A0A2"
FT   MOD_RES         736
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
SQ   SEQUENCE   738 AA;  80552 MW;  A0E5D44ECA58265D CRC64;
     MTSDQDAKVV AEPQTQRVQE GKDSAHLMNG PISQTTSQTS SIPPLSQVPA TKVSELNPNA
     EVWGAPVLHL EASSAADGVS AAWEEVAGHH ADRGPQGSDA NGDGDQGHEN AALPDPQESD
     PADMNALALG PSEYDSLPEN SETGGNESQP DSQEDPREVL KKTLEFCLSR ENLASDMYLI
     SQMDSDQYVP ITTVANLDHI KKLSTDVDLI VEVLRSLPLV QVDEKGEKVR PNQNRCIVIL
     REISESTPVE EVEALFKGDN LPKFINCEFA YNDNWFITFE TEADAQQAYK YLREEVKTFQ
     GKPIKARIKA KAIAINTFLP KNGFRPLDVS LYAQQRYATS FYFPPMYSPQ QQFPLYSLIT
     PQTWSATHSY LDPPLVTPFP NTGFINGFTS PAFKPAASPL TSLRQYPPRS RNPSKSHLRH
     AIPSAERGPG LLESPSIFNF TADRLINGVR SPQTRQAGQT RTRIQNPSAY AKREAGPGRV
     EPGSLESSPG LGRGRKNSFG YRKKREEKFT SSQTQSPTPP KPPSPSFELG LSSFPPLPGA
     AGNLKTEDLF ENRLSSLIIG PSKERTLSAD ASVNTLPVVV SREPSVPASC AVSATYERSP
     SPAHLPDDPK VAEKQRETHS VDRLPSALTA TACKSVQVNG AATELRKPSY AEICQRTSKE
     PPSSPLQPQK EQKPNTVGCG KEEKKLAEPA ERYREPPALK STPGAPRDQR RPAGGRPSPS
     AMGKRLSREQ STPPKSPQ
//
ID   LERL1_HUMAN             Reviewed;         131 AA.
AC   O95214; E9PHP8; Q9BW48;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   22-APR-2020, entry version 142.
DE   RecName: Full=Leptin receptor overlapping transcript-like 1;
DE   AltName: Full=Endospanin-2;
GN   Name=LEPROTL1; ORFNames=My047, UNQ577/PRO1139;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=11342119; DOI=10.1016/s0167-4781(00)00266-9;
RA   Huang Y., Ying K., Xie Y., Zhou Z., Wang W., Tang R., Zhao W., Zhao S.,
RA   Wu H., Gu S., Mao Y.M.;
RT   "Cloning and characterization of a novel human leptin receptor overlapping
RT   transcript-like 1 gene (LEPROTL1).";
RL   Biochim. Biophys. Acta 1517:327-331(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=19907080; DOI=10.1172/jci34997;
RA   Touvier T., Conte-Auriol F., Briand O., Cudejko C., Paumelle R., Caron S.,
RA   Bauge E., Rouille Y., Salles J.P., Staels B., Bailleul B.;
RT   "LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action
RT   in mice.";
RL   J. Clin. Invest. 119:3830-3838(2009).
CC   -!- FUNCTION: Negatively regulates growth hormone (GH) receptor cell
CC       surface expression in liver. May play a role in liver resistance to GH
CC       during periods of reduced nutrient availability.
CC       {ECO:0000269|PubMed:19907080}.
CC   -!- SUBUNIT: Interacts with RAB13. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O95214; O95214; NbExp=3; IntAct=EBI-750776, EBI-750776;
CC       O95214; Q9NRZ5: AGPAT4; NbExp=3; IntAct=EBI-750776, EBI-1754287;
CC       O95214; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-750776, EBI-11343438;
CC       O95214; O14523: C2CD2L; NbExp=3; IntAct=EBI-750776, EBI-12822627;
CC       O95214; Q08708: CD300C; NbExp=3; IntAct=EBI-750776, EBI-3915344;
CC       O95214; P11912: CD79A; NbExp=3; IntAct=EBI-750776, EBI-7797864;
CC       O95214; Q8N5K1: CISD2; NbExp=3; IntAct=EBI-750776, EBI-1045797;
CC       O95214; O95471: CLDN7; NbExp=3; IntAct=EBI-750776, EBI-740744;
CC       O95214; Q9UHP7-3: CLEC2D; NbExp=3; IntAct=EBI-750776, EBI-11749983;
CC       O95214; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-750776, EBI-6942903;
CC       O95214; P78329: CYP4F2; NbExp=3; IntAct=EBI-750776, EBI-1752413;
CC       O95214; Q92838: EDA; NbExp=4; IntAct=EBI-750776, EBI-529425;
CC       O95214; Q08426: EHHADH; NbExp=5; IntAct=EBI-750776, EBI-2339219;
CC       O95214; Q9GZR5: ELOVL4; NbExp=3; IntAct=EBI-750776, EBI-18535450;
CC       O95214; P54849: EMP1; NbExp=3; IntAct=EBI-750776, EBI-4319440;
CC       O95214; O15552: FFAR2; NbExp=3; IntAct=EBI-750776, EBI-2833872;
CC       O95214; Q01740: FMO1; NbExp=3; IntAct=EBI-750776, EBI-12701460;
CC       O95214; P36382: GJA5; NbExp=3; IntAct=EBI-750776, EBI-750433;
CC       O95214; P48165: GJA8; NbExp=3; IntAct=EBI-750776, EBI-17458373;
CC       O95214; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-750776, EBI-13345167;
CC       O95214; O15529: GPR42; NbExp=3; IntAct=EBI-750776, EBI-18076404;
CC       O95214; Q8TED1: GPX8; NbExp=3; IntAct=EBI-750776, EBI-11721746;
CC       O95214; Q9HDC5: JPH1; NbExp=3; IntAct=EBI-750776, EBI-465137;
CC       O95214; P48051: KCNJ6; NbExp=3; IntAct=EBI-750776, EBI-12017638;
CC       O95214; Q96E93: KLRG1; NbExp=4; IntAct=EBI-750776, EBI-750770;
CC       O95214; Q8WVP7: LMBR1; NbExp=3; IntAct=EBI-750776, EBI-6138627;
CC       O95214; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-750776, EBI-739832;
CC       O95214; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-750776, EBI-12033434;
CC       O95214; Q9HCJ2: LRRC4C; NbExp=3; IntAct=EBI-750776, EBI-3925442;
CC       O95214; Q13021: MALL; NbExp=3; IntAct=EBI-750776, EBI-750078;
CC       O95214; Q5SR56: MFSD14B; NbExp=3; IntAct=EBI-750776, EBI-373355;
CC       O95214; P21757: MSR1; NbExp=4; IntAct=EBI-750776, EBI-1776976;
CC       O95214; Q9UHE5: NAT8; NbExp=3; IntAct=EBI-750776, EBI-2863634;
CC       O95214; O95167: NDUFA3; NbExp=3; IntAct=EBI-750776, EBI-1246131;
CC       O95214; Q8IXM6: NRM; NbExp=3; IntAct=EBI-750776, EBI-10262547;
CC       O95214; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-750776, EBI-1054848;
CC       O95214; Q8N138: ORMDL3; NbExp=3; IntAct=EBI-750776, EBI-721750;
CC       O95214; Q8TEZ7: PAQR8; NbExp=3; IntAct=EBI-750776, EBI-12847818;
CC       O95214; Q13113: PDZK1IP1; NbExp=3; IntAct=EBI-750776, EBI-716063;
CC       O95214; Q9Y5Y5: PEX16; NbExp=3; IntAct=EBI-750776, EBI-981985;
CC       O95214; P60201-2: PLP1; NbExp=3; IntAct=EBI-750776, EBI-12188331;
CC       O95214; Q8N0V3: RBFA; NbExp=3; IntAct=EBI-750776, EBI-3232108;
CC       O95214; Q9H6H4: REEP4; NbExp=3; IntAct=EBI-750776, EBI-7545592;
CC       O95214; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-750776, EBI-14065960;
CC       O95214; Q99942: RNF5; NbExp=3; IntAct=EBI-750776, EBI-348482;
CC       O95214; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-750776, EBI-10244780;
CC       O95214; Q9NY72: SCN3B; NbExp=3; IntAct=EBI-750776, EBI-17247926;
CC       O95214; O00560: SDCBP; NbExp=3; IntAct=EBI-750776, EBI-727004;
CC       O95214; A0A1P0AYU5: SFXN3; NbExp=3; IntAct=EBI-750776, EBI-14193895;
CC       O95214; Q96AG3: SLC25A46; NbExp=3; IntAct=EBI-750776, EBI-10281975;
CC       O95214; O14863: SLC30A4; NbExp=3; IntAct=EBI-750776, EBI-13918058;
CC       O95214; Q9NQQ7-3: SLC35C2; NbExp=3; IntAct=EBI-750776, EBI-17295964;
CC       O95214; P30825: SLC7A1; NbExp=3; IntAct=EBI-750776, EBI-4289564;
CC       O95214; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-750776, EBI-8640191;
CC       O95214; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-750776, EBI-742688;
CC       O95214; Q8WWF3: SSMEM1; NbExp=3; IntAct=EBI-750776, EBI-17280858;
CC       O95214; Q86Y82: STX12; NbExp=3; IntAct=EBI-750776, EBI-2691717;
CC       O95214; Q9H7V2: SYNDIG1; NbExp=3; IntAct=EBI-750776, EBI-726331;
CC       O95214; P01135-2: TGFA; NbExp=3; IntAct=EBI-750776, EBI-12367411;
CC       O95214; P17152: TMEM11; NbExp=3; IntAct=EBI-750776, EBI-723946;
CC       O95214; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-750776, EBI-8638294;
CC       O95214; Q86WV6: TMEM173; NbExp=3; IntAct=EBI-750776, EBI-2800345;
CC       O95214; Q96HH6: TMEM19; NbExp=3; IntAct=EBI-750776, EBI-741829;
CC       O95214; Q96Q45-2: TMEM237; NbExp=3; IntAct=EBI-750776, EBI-10982110;
CC       O95214; Q9NWD8: TMEM248; NbExp=3; IntAct=EBI-750776, EBI-10314986;
CC       O95214; Q69YG0: TMEM42; NbExp=3; IntAct=EBI-750776, EBI-12038591;
CC       O95214; O95807: TMEM50A; NbExp=3; IntAct=EBI-750776, EBI-12903814;
CC       O95214; P56557: TMEM50B; NbExp=3; IntAct=EBI-750776, EBI-12366453;
CC       O95214; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-750776, EBI-2852148;
CC       O95214; Q9Y320: TMX2; NbExp=3; IntAct=EBI-750776, EBI-6447886;
CC       O95214; A0AVG3: TSNARE1; NbExp=3; IntAct=EBI-750776, EBI-12003468;
CC       O95214; O60636: TSPAN2; NbExp=3; IntAct=EBI-750776, EBI-3914288;
CC       O95214; A6NH52: TVP23A; NbExp=3; IntAct=EBI-750776, EBI-13296313;
CC       O95214; Q9P0L0: VAPA; NbExp=3; IntAct=EBI-750776, EBI-1059156;
CC       O95214; Q9BWQ6: YIPF2; NbExp=3; IntAct=EBI-750776, EBI-751204;
CC       O95214; Q96MV8: ZDHHC15; NbExp=3; IntAct=EBI-750776, EBI-12837904;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95214-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95214-2; Sequence=VSP_046307;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in heart,
CC       testis, adrenal gland, thymus, and spleen, and lowest expression in
CC       lung and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the OB-RGRP/VPS55 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF063605; AAC98697.1; -; mRNA.
DR   EMBL; AY358674; AAQ89037.1; -; mRNA.
DR   EMBL; AC026979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC044849; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL546441; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC000642; AAH00642.1; -; mRNA.
DR   CCDS; CCDS47834.1; -. [O95214-2]
DR   CCDS; CCDS6075.1; -. [O95214-1]
DR   RefSeq; NP_001121680.1; NM_001128208.1. [O95214-2]
DR   RefSeq; NP_056159.2; NM_015344.2. [O95214-1]
DR   BioGrid; 117042; 6.
DR   IntAct; O95214; 75.
DR   STRING; 9606.ENSP00000428281; -.
DR   SwissPalm; O95214; -.
DR   BioMuta; LEPROTL1; -.
DR   EPD; O95214; -.
DR   jPOST; O95214; -.
DR   MassIVE; O95214; -.
DR   PaxDb; O95214; -.
DR   PeptideAtlas; O95214; -.
DR   PRIDE; O95214; -.
DR   ProteomicsDB; 20577; -.
DR   ProteomicsDB; 50721; -. [O95214-1]
DR   Antibodypedia; 63110; 26 antibodies.
DR   DNASU; 23484; -.
DR   Ensembl; ENST00000321250; ENSP00000314625; ENSG00000104660. [O95214-1]
DR   Ensembl; ENST00000523116; ENSP00000428281; ENSG00000104660. [O95214-2]
DR   GeneID; 23484; -.
DR   KEGG; hsa:23484; -.
DR   UCSC; uc003xhx.3; human. [O95214-1]
DR   CTD; 23484; -.
DR   DisGeNET; 23484; -.
DR   GeneCards; LEPROTL1; -.
DR   HGNC; HGNC:6555; LEPROTL1.
DR   HPA; ENSG00000104660; Low tissue specificity.
DR   MIM; 607338; gene.
DR   neXtProt; NX_O95214; -.
DR   OpenTargets; ENSG00000104660; -.
DR   PharmGKB; PA30334; -.
DR   eggNOG; KOG2174; Eukaryota.
DR   eggNOG; ENOG4111UCZ; LUCA.
DR   GeneTree; ENSGT00390000006503; -.
DR   HOGENOM; CLU_1577984_0_0_1; -.
DR   InParanoid; O95214; -.
DR   OrthoDB; 1642378at2759; -.
DR   PhylomeDB; O95214; -.
DR   TreeFam; TF313689; -.
DR   ChiTaRS; LEPROTL1; human.
DR   GenomeRNAi; 23484; -.
DR   Pharos; O95214; Tdark.
DR   PRO; PR:O95214; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O95214; protein.
DR   Bgee; ENSG00000104660; Expressed in forebrain and 226 other tissues.
DR   ExpressionAtlas; O95214; baseline and differential.
DR   Genevisible; O95214; HS.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0032511; P:late endosome to vacuole transport via multivesicular body sorting pathway; IBA:GO_Central.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IBA:GO_Central.
DR   InterPro; IPR007262; Vps55/LEPROT.
DR   PANTHER; PTHR12050; PTHR12050; 1.
DR   Pfam; PF04133; Vps55; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..131
FT                   /note="Leptin receptor overlapping transcript-like 1"
FT                   /id="PRO_0000215197"
FT   TRANSMEM        7..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        32..52
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        69..89
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        100..120
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         94..131
FT                   /note="IEWGACALVLTGNTVIFATILGFFLVFGSNDDFSWQQW -> MGRLPFFSKM
FT                   GTAESEGRETLTQQLPLPAAAMRRLLPASRVSTQPVLRLADSAESLLGRPALWALGFLL
FT                   CPPSQAQ (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_046307"
FT   CONFLICT        123
FT                   /note="N -> K (in Ref. 1; AAC98697)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   131 AA;  14428 MW;  E5E75B7C77A99DD7 CRC64;
     MAGIKALISL SFGGAIGLMF LMLGCALPIY NKYWPLFVLF FYILSPIPYC IARRLVDDTD
     AMSNACKELA IFLTTGIVVS AFGLPIVFAR AHLIEWGACA LVLTGNTVIF ATILGFFLVF
     GSNDDFSWQQ W
//
ID   Q6FHL7_HUMAN            Unreviewed;       131 AA.
AC   Q6FHL7;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 118.
DE   SubName: Full=LEPROTL1 protein {ECO:0000313|EMBL:CAG46535.1};
DE   SubName: Full=Leptin receptor overlapping transcript-like 1, isoform CRA_b {ECO:0000313|EMBL:EAW63469.1};
DE   SubName: Full=Transformation-related protein 12 {ECO:0000313|EMBL:AAQ18034.1};
DE   SubName: Full=cDNA PSEC0049 fis, clone NT2RP2000116, highly similar to Leptin receptor overlapping transcript-like 1 {ECO:0000313|EMBL:BAG52122.1};
GN   Name=LEPROTL1 {ECO:0000313|EMBL:CAG46535.1};
GN   Synonyms=TRG12 {ECO:0000313|EMBL:AAQ18034.1};
GN   ORFNames=hCG_15463 {ECO:0000313|EMBL:EAW63469.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG46535.1};
RN   [1] {ECO:0000313|EMBL:EAW63469.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAQ18034.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim J.W.;
RT   "Identification of a human transforming gene.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG46535.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG52122.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5] {ECO:0000313|EMBL:EAW63469.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY277595; AAQ18034.1; -; mRNA.
DR   EMBL; AK075363; BAG52122.1; -; mRNA.
DR   EMBL; CR541735; CAG46535.1; -; mRNA.
DR   EMBL; CR541760; CAG46560.1; -; mRNA.
DR   EMBL; CH471080; EAW63469.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63470.1; -; Genomic_DNA.
DR   RefSeq; NP_056159.2; NM_015344.2.
DR   IntAct; Q6FHL7; 2.
DR   Antibodypedia; 63110; 26 antibodies.
DR   DNASU; 23484; -.
DR   GeneID; 23484; -.
DR   KEGG; hsa:23484; -.
DR   UCSC; uc003xhw.5; human.
DR   CTD; 23484; -.
DR   EuPathDB; HostDB:ENSG00000104660.17; -.
DR   PharmGKB; PA30334; -.
DR   eggNOG; KOG2174; Eukaryota.
DR   eggNOG; ENOG4111UCZ; LUCA.
DR   ChiTaRS; LEPROTL1; human.
DR   GenomeRNAi; 23484; -.
DR   Bgee; ENSG00000104660; Expressed in forebrain and 226 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR007262; Vps55/LEPROT.
DR   PANTHER; PTHR12050; PTHR12050; 1.
DR   Pfam; PF04133; Vps55; 1.
PE   1: Evidence at protein level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAG52122.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        7..30
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        36..56
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        68..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        94..120
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
SQ   SEQUENCE   131 AA;  14428 MW;  E5E75B7C77A99DD7 CRC64;
     MAGIKALISL SFGGAIGLMF LMLGCALPIY NKYWPLFVLF FYILSPIPYC IARRLVDDTD
     AMSNACKELA IFLTTGIVVS AFGLPIVFAR AHLIEWGACA LVLTGNTVIF ATILGFFLVF
     GSNDDFSWQQ W
//
ID   B4DEE8_HUMAN            Unreviewed;       238 AA.
AC   B4DEE8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 80.
DE   SubName: Full=Methylated-DNA--protein-cysteine methyltransferase {ECO:0000313|Ensembl:ENSP00000302111};
DE   SubName: Full=cDNA FLJ56323, highly similar to Methylated-DNA--protein-cysteinemethyltransferase {ECO:0000313|EMBL:BAG57059.1};
GN   Name=MGMT {ECO:0000313|Ensembl:ENSP00000302111};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57059.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000302111, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|EMBL:BAG57059.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG57059.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000302111}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (MAY-2019) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL157832; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353725; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK293593; BAG57059.1; -; mRNA.
DR   RefSeq; NP_002403.2; NM_002412.4.
DR   Antibodypedia; 32507; 818 antibodies.
DR   DNASU; 4255; -.
DR   Ensembl; ENST00000306010; ENSP00000302111; ENSG00000170430.
DR   GeneID; 4255; -.
DR   KEGG; hsa:4255; -.
DR   CTD; 4255; -.
DR   EuPathDB; HostDB:ENSG00000170430.9; -.
DR   HGNC; HGNC:7059; MGMT.
DR   OpenTargets; ENSG00000170430; -.
DR   PharmGKB; PA239; -.
DR   eggNOG; KOG4062; Eukaryota.
DR   eggNOG; COG0350; LUCA.
DR   GeneTree; ENSGT00390000015799; -.
DR   HOGENOM; CLU_000445_52_2_1; -.
DR   KO; K00567; -.
DR   OMA; GPYMSGR; -.
DR   OrthoDB; 1573162at2759; -.
DR   PhylomeDB; B4DEE8; -.
DR   ChiTaRS; MGMT; human.
DR   GenomeRNAi; 4255; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170430; Expressed in liver and 206 other tissues.
DR   Genevisible; B4DEE8; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IEA:Ensembl.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; IEA:Ensembl.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0060548; P:negative regulation of cell death; IEA:Ensembl.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IEA:Ensembl.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051593; P:response to folic acid; IEA:Ensembl.
DR   CDD; cd06445; ATase; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001497; MethylDNA_cys_MeTrfase_AS.
DR   InterPro; IPR014048; MethylDNA_cys_MeTrfase_DNA-bd.
DR   InterPro; IPR036217; MethylDNA_cys_MeTrfase_DNAb.
DR   InterPro; IPR008332; MethylG_MeTrfase_N.
DR   InterPro; IPR036631; MGMT_N_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF01035; DNA_binding_1; 1.
DR   Pfam; PF02870; Methyltransf_1N; 1.
DR   SUPFAM; SSF46767; SSF46767; 1.
DR   SUPFAM; SSF53155; SSF53155; 1.
DR   TIGRFAMs; TIGR00589; ogt; 1.
DR   PROSITE; PS00374; MGMT; 1.
PE   1: Evidence at protein level;
KW   Methyltransferase {ECO:0000313|EMBL:BAG57059.1};
KW   Proteomics identification {ECO:0000213|EPD:B4DEE8,
KW   ECO:0000213|MaxQB:B4DEE8, ECO:0000213|PeptideAtlas:B4DEE8,
KW   ECO:0000213|ProteomicsDB:B4DEE8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transferase {ECO:0000313|EMBL:BAG57059.1}.
FT   DOMAIN          37..121
FT                   /note="Methyltransf_1N"
FT                   /evidence="ECO:0000259|Pfam:PF02870"
FT   DOMAIN          126..204
FT                   /note="DNA_binding_1"
FT                   /evidence="ECO:0000259|Pfam:PF01035"
SQ   SEQUENCE   238 AA;  25050 MW;  9A1774B6637A0788 CRC64;
     MLGQPAPLER FASRRPQVLA VRTVCDLVLG KMDKDCEMKR TTLDSPLGKL ELSGCEQGLH
     EIKLLGKGTS AADAVEVPAP AAVLGGPEPL MQCTAWLNAY FHQPEAIEEF PVPALHHPVF
     QQESFTRQVL WKLLKVVKFG EVISYQQLAA LAGNPKAARA VGGAMRGNPV PILIPCHRVV
     CSSGAVGNYS GGLAVKEWLL AHEGHRLGKP GLGGSSGLAG AWLKGAGATS GSPPAGRN
//
ID   MGMT_HUMAN              Reviewed;         207 AA.
AC   P16455; Q5VY78;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   22-APR-2020, entry version 198.
DE   RecName: Full=Methylated-DNA--protein-cysteine methyltransferase;
DE            EC=2.1.1.63;
DE   AltName: Full=6-O-methylguanine-DNA methyltransferase;
DE            Short=MGMT;
DE   AltName: Full=O-6-methylguanine-DNA-alkyltransferase;
GN   Name=MGMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-8.
RX   PubMed=2405387; DOI=10.1073/pnas.87.2.686;
RA   Tano K., Shiota S., Collier J., Foote R.S., Mitra S.;
RT   "Isolation and structural characterization of a cDNA clone encoding the
RT   human DNA repair protein for O6-alkylguanine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:686-690(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2188979;
RA   Rydberg B., Spurr N., Karran P.;
RT   "cDNA cloning and chromosomal assignment of the human O6-methylguanine-DNA
RT   methyltransferase. cDNA expression in Escherichia coli and gene expression
RT   in human cells.";
RL   J. Biol. Chem. 265:9563-9569(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2394694;
RA   Koike G., Maki H., Takeya H., Hayakawa H., Sekiguchi M.;
RT   "Purification, structure, and biochemical properties of human O6-
RT   methylguanine-DNA methyltransferase.";
RL   J. Biol. Chem. 265:14754-14762(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2359121; DOI=10.1016/s0022-2836(05)80260-8;
RA   Hayakawa H., Koike G., Sekiguchi M.;
RT   "Expression and cloning of complementary DNA for a human enzyme that
RT   repairs O6-methylguanine in DNA.";
RL   J. Mol. Biol. 213:739-747(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, AND ALKYL GROUP ACCEPTOR.
RX   PubMed=1985934;
RA   von Wronski M.A., Shiota S., Tano K., Mitra S., Bigner D.D., Brent T.P.;
RT   "Structural and immunological comparison of indigenous human O6-
RT   methylguanine-DNA methyltransferase with that encoded by a cloned cDNA.";
RL   J. Biol. Chem. 266:1064-1070(1991).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=8202360; DOI=10.1093/nar/22.9.1613;
RA   Liem L.-K., Lim A., Li B.F.L.;
RT   "Specificities of human, rat and E. coli O6-methylguanine-DNA
RT   methyltransferases towards the repair of O6-methyl and O6-ethylguanine in
RT   DNA.";
RL   Nucleic Acids Res. 22:1613-1619(1994).
RN   [11]
RP   MUTAGENESIS OF PRO-138; PRO-140 AND GLY-156.
RX   PubMed=7954470;
RA   Crone T.M., Goodtzova K., Edara S., Pegg A.E.;
RT   "Mutations in human O6-alkylguanine-DNA alkyltransferase imparting
RT   resistance to O6-benzylguanine.";
RL   Cancer Res. 54:6221-6227(1994).
RN   [12]
RP   MUTAGENESIS OF TYR-114; ARG-128 AND CYS-145.
RX   PubMed=7766621; DOI=10.1021/bi00021a024;
RA   Kanugula S., Goodtzova K., Edara S., Pegg A.E.;
RT   "Alteration of arginine-128 to alanine abolishes the ability of human O6-
RT   alkylguanine-DNA alkyltransferase to repair methylated DNA but has no
RT   effect on its reaction with O6-benzylguanine.";
RL   Biochemistry 34:7113-7119(1995).
RN   [13]
RP   MUTAGENESIS OF TYR-158.
RX   PubMed=7614699; DOI=10.1093/carcin/16.7.1637;
RA   Edara S., Goodtzova K., Pegg A.E.;
RT   "The role of tyrosine-158 in O6-alkylguanine-DNA alkyltransferase
RT   activity.";
RL   Carcinogenesis 16:1637-1642(1995).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-201, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH DNA AND ZINC IONS,
RP   AND MUTAGENESIS OF ARG-128 AND CYS-145.
RX   PubMed=10747039; DOI=10.1093/emboj/19.7.1719;
RA   Daniels D.S., Mol C.D., Arvai A.S., Kanugula S., Pegg A.E., Tainer J.A.;
RT   "Active and alkylated human AGT structures: a novel zinc site, inhibitor
RT   and extrahelical base binding.";
RL   EMBO J. 19:1719-1730(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-176.
RX   PubMed=10606635; DOI=10.1093/nar/28.2.393;
RA   Wibley J.E., Pegg A.E., Moody P.C.;
RT   "Crystal structure of the human O(6)-alkylguanine-DNA alkyltransferase.";
RL   Nucleic Acids Res. 28:393-401(2000).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-179 IN COMPLEX WITH DNA AND ZINC
RP   IONS.
RX   PubMed=15964013; DOI=10.1016/j.jmb.2005.05.028;
RA   Duguid E.M., Rice P.A., He C.;
RT   "The structure of the human AGT protein bound to DNA and its implications
RT   for damage detection.";
RL   J. Mol. Biol. 350:657-666(2005).
CC   -!- FUNCTION: Involved in the cellular defense against the biological
CC       effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in
CC       DNA. Repairs the methylated nucleobase in DNA by stoichiometrically
CC       transferring the methyl group to a cysteine residue in the enzyme. This
CC       is a suicide reaction: the enzyme is irreversibly inactivated.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 6-O-methyl-2'-deoxyguanosine in DNA + L-cysteinyl-[protein]
CC         = a 2'-deoxyguanosine in DNA + S-methyl-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:24000, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:10132,
CC         Rhea:RHEA-COMP:11367, Rhea:RHEA-COMP:11368, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:82612, ChEBI:CHEBI:85445, ChEBI:CHEBI:85448; EC=2.1.1.63;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 4-O-methyl-thymidine in DNA + L-cysteinyl-[protein] = a
CC         thymidine in DNA + S-methyl-L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:53428, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:10132,
CC         Rhea:RHEA-COMP:13555, Rhea:RHEA-COMP:13556, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:82612, ChEBI:CHEBI:137386, ChEBI:CHEBI:137387;
CC         EC=2.1.1.63; Evidence={ECO:0000255|PROSITE-ProRule:PRU10017};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion.;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- MISCELLANEOUS: This enzyme catalyzes only one turnover and therefore is
CC       not strictly catalytic. According to one definition, an enzyme is a
CC       biocatalyst that acts repeatedly and over many reaction cycles.
CC   -!- SIMILARITY: Belongs to the MGMT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X54228; CAA38137.1; -; mRNA.
DR   EMBL; M29971; AAA59596.1; -; mRNA.
DR   EMBL; M31767; AAA52317.1; -; mRNA.
DR   EMBL; M60761; AAA59594.1; -; mRNA.
DR   EMBL; BT006714; AAP35360.1; -; mRNA.
DR   EMBL; AL157832; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355531; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49166.1; -; Genomic_DNA.
DR   EMBL; BC000824; AAH00824.1; -; mRNA.
DR   CCDS; CCDS7660.2; -.
DR   PIR; A34889; XUHUMC.
DR   RefSeq; NP_002403.2; NM_002412.4.
DR   RefSeq; XP_005252739.1; XM_005252682.2.
DR   PDB; 1EH6; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH7; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH8; X-ray; 2.50 A; A=1-207.
DR   PDB; 1QNT; X-ray; 1.90 A; A=1-176.
DR   PDB; 1T38; X-ray; 3.20 A; A=1-176.
DR   PDB; 1T39; X-ray; 3.30 A; A/B=1-176.
DR   PDB; 1YFH; X-ray; 3.01 A; A/B/C=1-179.
DR   PDBsum; 1EH6; -.
DR   PDBsum; 1EH7; -.
DR   PDBsum; 1EH8; -.
DR   PDBsum; 1QNT; -.
DR   PDBsum; 1T38; -.
DR   PDBsum; 1T39; -.
DR   PDBsum; 1YFH; -.
DR   SMR; P16455; -.
DR   BioGrid; 110411; 78.
DR   IntAct; P16455; 1.
DR   STRING; 9606.ENSP00000302111; -.
DR   BindingDB; P16455; -.
DR   ChEMBL; CHEMBL2864; -.
DR   DrugBank; DB04531; Benzylcysteine.
DR   DrugBank; DB00151; Cysteine.
DR   DrugBank; DB11831; Dinitrochlorobenzene.
DR   DrugBank; DB02216; S-Methylcysteine.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   GlyConnect; 1505; -.
DR   iPTMnet; P16455; -.
DR   PhosphoSitePlus; P16455; -.
DR   BioMuta; MGMT; -.
DR   DMDM; 127069; -.
DR   EPD; P16455; -.
DR   jPOST; P16455; -.
DR   MassIVE; P16455; -.
DR   MaxQB; P16455; -.
DR   PaxDb; P16455; -.
DR   PeptideAtlas; P16455; -.
DR   PRIDE; P16455; -.
DR   ProteomicsDB; 53365; -.
DR   Antibodypedia; 32507; 818 antibodies.
DR   Ensembl; ENST00000651593; ENSP00000498729; ENSG00000170430.
DR   GeneID; 4255; -.
DR   KEGG; hsa:4255; -.
DR   UCSC; uc001lkh.3; human.
DR   CTD; 4255; -.
DR   DisGeNET; 4255; -.
DR   GeneCards; MGMT; -.
DR   HGNC; HGNC:7059; MGMT.
DR   HPA; ENSG00000170430; Low tissue specificity.
DR   MalaCards; MGMT; -.
DR   MIM; 156569; gene.
DR   neXtProt; NX_P16455; -.
DR   OpenTargets; ENSG00000170430; -.
DR   Orphanet; 618; Familial melanoma.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   eggNOG; KOG4062; Eukaryota.
DR   eggNOG; COG0350; LUCA.
DR   GeneTree; ENSGT00390000015799; -.
DR   HOGENOM; CLU_000445_52_2_1; -.
DR   InParanoid; P16455; -.
DR   KO; K00567; -.
DR   PhylomeDB; P16455; -.
DR   TreeFam; TF314064; -.
DR   BRENDA; 2.1.1.63; 2681.
DR   Reactome; R-HSA-5657655; MGMT-mediated DNA damage reversal.
DR   SIGNOR; P16455; -.
DR   ChiTaRS; MGMT; human.
DR   EvolutionaryTrace; P16455; -.
DR   GeneWiki; O-6-methylguanine-DNA_methyltransferase; -.
DR   GenomeRNAi; 4255; -.
DR   Pharos; P16455; Tchem.
DR   PRO; PR:P16455; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P16455; protein.
DR   Bgee; ENSG00000170430; Expressed in liver and 206 other tissues.
DR   ExpressionAtlas; P16455; baseline and differential.
DR   Genevisible; P16455; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0009008; F:DNA-methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IBA:GO_Central.
DR   GO; GO:0008168; F:methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:Reactome.
DR   GO; GO:0006266; P:DNA ligation; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:BHF-UCL.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; IDA:BHF-UCL.
DR   CDD; cd06445; ATase; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001497; MethylDNA_cys_MeTrfase_AS.
DR   InterPro; IPR014048; MethylDNA_cys_MeTrfase_DNA-bd.
DR   InterPro; IPR036217; MethylDNA_cys_MeTrfase_DNAb.
DR   InterPro; IPR008332; MethylG_MeTrfase_N.
DR   InterPro; IPR036631; MGMT_N_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF01035; DNA_binding_1; 1.
DR   Pfam; PF02870; Methyltransf_1N; 1.
DR   SUPFAM; SSF46767; SSF46767; 1.
DR   SUPFAM; SSF53155; SSF53155; 1.
DR   TIGRFAMs; TIGR00589; ogt; 1.
DR   PROSITE; PS00374; MGMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; DNA damage; DNA repair;
KW   DNA-binding; Metal-binding; Methyltransferase; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Zinc.
FT   CHAIN           1..207
FT                   /note="Methylated-DNA--protein-cysteine methyltransferase"
FT                   /id="PRO_0000139359"
FT   ACT_SITE        145
FT                   /note="Nucleophile; methyl group acceptor"
FT   METAL           5
FT                   /note="Zinc"
FT   METAL           24
FT                   /note="Zinc"
FT   METAL           29
FT                   /note="Zinc"
FT   METAL           85
FT                   /note="Zinc"
FT   BINDING         95
FT                   /note="DNA; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   BINDING         114
FT                   /note="DNA"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   BINDING         115
FT                   /note="DNA; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   BINDING         123
FT                   /note="DNA"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   BINDING         128
FT                   /note="DNA"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   BINDING         151
FT                   /note="DNA; via amide nitrogen"
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:15964013"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   VARIANT         30
FT                   /note="E -> K (in dbSNP:rs2020893)"
FT                   /id="VAR_014750"
FT   VARIANT         53
FT                   /note="L -> F (in dbSNP:rs12917)"
FT                   /id="VAR_056129"
FT   VARIANT         58
FT                   /note="P -> S (in dbSNP:rs2308322)"
FT                   /id="VAR_029112"
FT   VARIANT         65
FT                   /note="W -> C (in dbSNP:rs2282164)"
FT                   /id="VAR_020354"
FT   VARIANT         84
FT                   /note="L -> F (in dbSNP:rs12917)"
FT                   /id="VAR_014751"
FT   VARIANT         112
FT                   /note="I -> V (in dbSNP:rs2308321)"
FT                   /id="VAR_056130"
FT   VARIANT         143
FT                   /note="I -> V (in dbSNP:rs2308321)"
FT                   /id="VAR_014752"
FT   VARIANT         160
FT                   /note="G -> R (in dbSNP:rs2308318)"
FT                   /id="VAR_014753"
FT   VARIANT         166
FT                   /note="E -> D (in dbSNP:rs2308320)"
FT                   /id="VAR_014754"
FT   VARIANT         178
FT                   /note="K -> R (in dbSNP:rs2308327)"
FT                   /id="VAR_014755"
FT   MUTAGEN         114
FT                   /note="Y->A: Decreases activity towards methylated DNA over
FT                   1000-fold. Slightly reduced reactivity with O6-
FT                   benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7766621"
FT   MUTAGEN         114
FT                   /note="Y->E: Loss of DNA repair activity. Slightly reduced
FT                   reactivity with O6-benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7766621"
FT   MUTAGEN         128
FT                   /note="R->A,D: Decreases activity towards methylated DNA
FT                   over 1000-fold. No effect on reactivity with O6-
FT                   benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:7766621"
FT   MUTAGEN         128
FT                   /note="R->G: Loss of DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:7766621"
FT   MUTAGEN         128
FT                   /note="R->K,L: Slightly reduced DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:7766621"
FT   MUTAGEN         138
FT                   /note="P->K: Decreased reactivity with O6-benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7954470"
FT   MUTAGEN         140
FT                   /note="P->A: Decreased reactivity with O6-benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7954470"
FT   MUTAGEN         145
FT                   /note="C->A: Loss of DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:10747039,
FT                   ECO:0000269|PubMed:7766621"
FT   MUTAGEN         156
FT                   /note="G->A: Decreased reactivity with O6-benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7954470"
FT   MUTAGEN         158
FT                   /note="Y->A: Reduced DNA repair activity. Decreased
FT                   reactivity with O6-benzylguanine."
FT                   /evidence="ECO:0000269|PubMed:7614699"
FT   MUTAGEN         158
FT                   /note="Y->F: Slightly reduced DNA repair activity."
FT                   /evidence="ECO:0000269|PubMed:7614699"
FT   CONFLICT        127
FT                   /note="A -> T (in Ref. 2; AAA52317)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..12
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   STRAND          19..24
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   STRAND          27..33
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   STRAND          50..52
FT                   /evidence="ECO:0000244|PDB:1EH6"
FT   HELIX           57..71
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           73..78
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           87..90
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           94..105
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           114..120
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   TURN            124..126
FT                   /evidence="ECO:0000244|PDB:1T38"
FT   HELIX           127..134
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   STRAND          138..140
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           145..147
FT                   /evidence="ECO:0000244|PDB:1QNT"
FT   HELIX           162..171
FT                   /evidence="ECO:0000244|PDB:1QNT"
SQ   SEQUENCE   207 AA;  21646 MW;  76BBF19DFC4512D6 CRC64;
     MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA AVLGGPEPLM
     QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW KLLKVVKFGE VISYQQLAAL
     AGNPKAARAV GGAMRGNPVP ILIPCHRVVC SSGAVGNYSG GLAVKEWLLA HEGHRLGKPG
     LGGSSGLAGA WLKGAGATSG SPPAGRN
//
ID   B2ZZ87_HUMAN            Unreviewed;      1690 AA.
AC   B2ZZ87;
DT   22-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2008, sequence version 1.
DT   11-DEC-2019, entry version 48.
DE   SubName: Full=Nedd4 binding protein 2 {ECO:0000313|EMBL:BAG48313.1};
GN   Name=N4BP2 {ECO:0000313|EMBL:BAG48313.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG48313.1};
RN   [1] {ECO:0000313|EMBL:BAG48313.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=18487259; DOI=10.1093/dnares/dsn010;
RA   Oshikawa M., Sugai Y., Usami R., Ohtoko K., Toyama S., Kato S.;
RT   "Fine expression profiling of full-length transcripts using a size-unbiased
RT   cDNA library prepared with the vector-capping method.";
RL   DNA Res. 15:123-136(2008).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB371584; BAG48313.1; -; mRNA.
DR   RefSeq; NP_001305288.1; NM_001318359.1.
DR   RefSeq; NP_060647.2; NM_018177.5.
DR   PeptideAtlas; B2ZZ87; -.
DR   PRIDE; B2ZZ87; -.
DR   GeneID; 55728; -.
DR   KEGG; hsa:55728; -.
DR   CTD; 55728; -.
DR   eggNOG; KOG2401; Eukaryota.
DR   eggNOG; ENOG41101K4; LUCA.
DR   KO; K15720; -.
DR   OrthoDB; 76267at2759; -.
DR   ChiTaRS; N4BP2; human.
DR   GenomeRNAi; 55728; -.
DR   InterPro; IPR013899; DUF1771.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002625; Smr_dom.
DR   InterPro; IPR036063; Smr_dom_sf.
DR   Pfam; PF08590; DUF1771; 1.
DR   Pfam; PF01713; Smr; 1.
DR   SMART; SM01162; DUF1771; 1.
DR   SMART; SM00463; SMR; 1.
DR   SUPFAM; SSF160443; SSF160443; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50828; SMR; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          1611..1690
FT                   /note="Smr"
FT                   /evidence="ECO:0000259|PROSITE:PS50828"
FT   REGION          15..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          632..676
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          715..742
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          756..782
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          810..833
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1500..1526
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33..49
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        632..669
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        716..733
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        763..777
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1507..1526
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1690 AA;  189839 MW;  A896B367A0E10CCC CRC64;
     MDCLLELSAT DTKIEESSSQ SFVASENQVG AAESKIMEKR PEEESEDSKM DSFLDMQLTE
     DLDSLIQNAF EKLNSSPDDQ VYSFLPSQDV NSFNDSSEFI NPDSSNMTPI FSTQNMNLNG
     ENLENSGSTL SLNPLPSHSV LNESKCFIKD NTLALESNYP EDSLLSSSLN VASDSIAGCS
     SLNQKQKELL ESECVEAQFS EAPVDLDASE PQACLNLPGL DLPGTGGDQK STRVSDVFLP
     SEGFNFKPHK HPELPTKGKD VSYCPVLAPL PLLLPPPPPP PMWNPMIPAF DLFQGNHGFV
     APVVTTAAHW RSVNYTFPPS VISHTSPTKV WRNKDGTSAY QVQETPVSQV VRKKTSYVGL
     VLVLLRGLPG SGKSFLARTL QEDNPSGVIL STDDYFYING QYQFDVKYLG EAHEWNQNRA
     KEAFEKKISP IIIDNTNLQA WEMKPYVALS QKHKYKVLFR EPDTWWKFKP KELARRNIHG
     VSKEKITRML EHYQRFVSVP IIMSSSVPEK IERIELCAYS CEDRSTSPRD NEDIISEKEE
     NILSLSLKHL EFTEEKNLDV TKETMLPENV AYLSNADLNK RRKEISDMNP SIQSALILET
     PHMYFSDSES KLQATDKSEN EQIEMVAVKG YSKTDTDSSM ERVSPSTCCS ENNQEDCDLA
     NSGPLQNEKS SPGEIVEERA TVTKKAFGKQ KSKSTLEKFP RHELSNFVGD WPVDKTIGQR
     TKRNRKTEKT SSVQSDKKYN YPQSHKLVNS VSVNTDCVQQ RGSPHESVED GRKSQCDDAS
     EPLNSYKYDA YKNIDKNSFN IMGDWPSSDS LAQREHRSRM PKTGLSEPNL EIGTNDKMNE
     ISLSTAHEAC WGTSSQKLKT LGSSNLGSSE MLLSEMTCES QTCLSKKSHG QHTSLPLTFT
     NSAPTVSGVV EPQTLAECQE QMPKRDPGKE VGMCTQTEPQ DFALLWKIEK NKISISDSIK
     VLTGRLDGFK PKVFNINTKS DVQEAIPYRV MYDKSTFVEE SELTSADESE NLNILCKLFG
     SFSLEALKDL YERCNKDIIW ATSLLLDSET KLCEDTEFEN FQKSCDGSQI GPFSLGLNLK
     EIISQRGTLE NSNSPVPEFS HGIGISNADS QSTCDAERGN SEQAEMRAVT PENHESMTSI
     FPSAAVGLKN NNDILPNSQE ELLYSSKQSF PGILKATTPK DMSETEKNLV VTETGDNIHS
     PSHFSDIFNF VSSTSNLELN EEIYFTDSLE IKRNENFPKD YVKFSDEEEF MNEDEKEMKE
     ILMAGSSLSA GVSGEDKTEI LNPTPAMAKS LTIDCLELAL PPELAFQLNE LFGPVGIDSG
     SLTVEDCVVH IDLNLAKVIH EKWKESVMER QRQEEVSCGK FMQDPSLVGH TGLDNPEQKS
     SQRTGKKLLK TLTASEMLPL LDHWNTQTKK VSLREIMSEE IALQEKHNLK RETLMFEKDC
     ATKLKEKQLF KIFPAINQNF LVDIFKDHNY SLEHTVQFLN CVLEGDPVKT VVAQEFVHQN
     ENVTSHTGQK SKEKKPKKLK ETEETPSELS FQDFEYPDYD DYRAEAFLHQ QKRMECYSKA
     KEAYRIGKKN VATFYAQQGT LHEQKMKEAN HLAAIEIFEK VNASLLPQNV LDLHGLHVDE
     ALEHLMRVLE KKTEEFKQNG GKPYLSVITG RGNHSQGGVA RIKPAVIKYL ISHSFRFSEI
     KPGCLKVMLK
//
ID   N4BP2_HUMAN             Reviewed;        1770 AA.
AC   Q86UW6; A0AVR3; Q9NVK2; Q9P2D4;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 2.
DT   22-APR-2020, entry version 158.
DE   RecName: Full=NEDD4-binding protein 2;
DE            Short=N4BP2;
DE            EC=3.-.-.-;
DE   AltName: Full=BCL-3-binding protein;
GN   Name=N4BP2; Synonyms=B3BP, KIAA1413;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH BCL3 AND
RP   CREBBP, AND VARIANT ASN-611.
RC   TISSUE=T-cell;
RX   PubMed=12730195; DOI=10.1074/jbc.m303518200;
RA   Watanabe N., Wachi S., Fujita T.;
RT   "Identification and characterization of BCL-3-binding protein: implications
RT   for transcription and DNA repair or recombination.";
RL   J. Biol. Chem. 278:26102-26110(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ASN-611.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-659.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 355-1770 (ISOFORM 2), AND VARIANT
RP   ASN-611.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND THR-1210, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 1688-1770.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SMR domain of NEDD4-binding protein 2.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-283.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Has 5'-polynucleotide kinase and nicking endonuclease
CC       activity. May play a role in DNA repair or recombination.
CC       {ECO:0000269|PubMed:12730195}.
CC   -!- SUBUNIT: Binds NEDD4 (By similarity). Binds BCL3 and CREBBP.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86UW6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UW6-2; Sequence=VSP_009721;
CC   -!- DOMAIN: The Smr domain has nicking endonuclease activity, but no
CC       significant double strand cleavage or exonuclease activity.
CC   -!- PTM: Ubiquitinated; this targets the protein for degradation by the
CC       proteasome. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY267013; AAP22172.1; -; mRNA.
DR   EMBL; BC126466; AAI26467.1; -; mRNA.
DR   EMBL; AK001542; BAA91748.1; -; mRNA.
DR   EMBL; AB037834; BAA92651.1; -; mRNA.
DR   CCDS; CCDS3457.1; -. [Q86UW6-1]
DR   RefSeq; NP_001305288.1; NM_001318359.1.
DR   RefSeq; NP_060647.2; NM_018177.5. [Q86UW6-1]
DR   RefSeq; XP_011512020.1; XM_011513718.2. [Q86UW6-1]
DR   RefSeq; XP_016863887.1; XM_017008398.1. [Q86UW6-1]
DR   PDB; 2D9I; NMR; -; A=1688-1770.
DR   PDB; 2VKC; NMR; -; A=1657-1770.
DR   PDB; 3BHB; X-ray; 2.20 A; C=129-138.
DR   PDB; 3FAU; X-ray; 1.90 A; A/B/C/D=1691-1770.
DR   PDBsum; 2D9I; -.
DR   PDBsum; 2VKC; -.
DR   PDBsum; 3BHB; -.
DR   PDBsum; 3FAU; -.
DR   SMR; Q86UW6; -.
DR   BioGrid; 120848; 18.
DR   CORUM; Q86UW6; -.
DR   IntAct; Q86UW6; 10.
DR   STRING; 9606.ENSP00000261435; -.
DR   iPTMnet; Q86UW6; -.
DR   PhosphoSitePlus; Q86UW6; -.
DR   BioMuta; N4BP2; -.
DR   DMDM; 145559498; -.
DR   EPD; Q86UW6; -.
DR   jPOST; Q86UW6; -.
DR   MassIVE; Q86UW6; -.
DR   MaxQB; Q86UW6; -.
DR   PaxDb; Q86UW6; -.
DR   PeptideAtlas; Q86UW6; -.
DR   PRIDE; Q86UW6; -.
DR   ProteomicsDB; 69917; -. [Q86UW6-1]
DR   ProteomicsDB; 69918; -. [Q86UW6-2]
DR   Antibodypedia; 23545; 26 antibodies.
DR   Ensembl; ENST00000261435; ENSP00000261435; ENSG00000078177. [Q86UW6-1]
DR   GeneID; 55728; -.
DR   KEGG; hsa:55728; -.
DR   UCSC; uc003guy.5; human. [Q86UW6-1]
DR   CTD; 55728; -.
DR   DisGeNET; 55728; -.
DR   GeneCards; N4BP2; -.
DR   HGNC; HGNC:29851; N4BP2.
DR   HPA; ENSG00000078177; Tissue enhanced (lymphoid).
DR   neXtProt; NX_Q86UW6; -.
DR   OpenTargets; ENSG00000078177; -.
DR   PharmGKB; PA162396580; -.
DR   eggNOG; KOG2401; Eukaryota.
DR   eggNOG; ENOG41101K4; LUCA.
DR   GeneTree; ENSGT00940000160604; -.
DR   InParanoid; Q86UW6; -.
DR   KO; K15720; -.
DR   OMA; FEYPEYD; -.
DR   OrthoDB; 76267at2759; -.
DR   PhylomeDB; Q86UW6; -.
DR   TreeFam; TF327016; -.
DR   ChiTaRS; N4BP2; human.
DR   EvolutionaryTrace; Q86UW6; -.
DR   GenomeRNAi; 55728; -.
DR   Pharos; Q86UW6; Tbio.
DR   PRO; PR:Q86UW6; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q86UW6; protein.
DR   Bgee; ENSG00000078177; Expressed in tibia and 176 other tissues.
DR   ExpressionAtlas; Q86UW6; baseline and differential.
DR   Genevisible; Q86UW6; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:MGI.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IDA:MGI.
DR   GO; GO:0004519; F:endonuclease activity; IDA:MGI.
DR   CDD; cd14365; CUE_N4BP2; 1.
DR   InterPro; IPR003892; CUE.
DR   InterPro; IPR013899; DUF1771.
DR   InterPro; IPR041801; N4BP2_CUE.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR002625; Smr_dom.
DR   InterPro; IPR036063; Smr_dom_sf.
DR   InterPro; IPR009060; UBA-like_sf.
DR   Pfam; PF08590; DUF1771; 1.
DR   Pfam; PF01713; Smr; 1.
DR   SMART; SM01162; DUF1771; 1.
DR   SMART; SM00463; SMR; 1.
DR   SUPFAM; SSF160443; SSF160443; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51140; CUE; 1.
DR   PROSITE; PS50828; SMR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Coiled coil; Cytoplasm;
KW   Hydrolase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..1770
FT                   /note="NEDD4-binding protein 2"
FT                   /id="PRO_0000096681"
FT   DOMAIN          46..89
FT                   /note="CUE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00468"
FT   DOMAIN          1691..1770
FT                   /note="Smr"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00321"
FT   NP_BIND         447..454
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   COILED          90..177
FT                   /evidence="ECO:0000255"
FT   COILED          218..259
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        328..368
FT                   /note="Pro-rich"
FT   MOD_RES         906
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1210
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1596..1612
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10718198"
FT                   /id="VSP_009721"
FT   VARIANT         101
FT                   /note="S -> I (in dbSNP:rs17511668)"
FT                   /id="VAR_051215"
FT   VARIANT         196
FT                   /note="M -> V (in dbSNP:rs10014170)"
FT                   /id="VAR_051216"
FT   VARIANT         283
FT                   /note="P -> A (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035474"
FT   VARIANT         611
FT                   /note="D -> N (in dbSNP:rs794001)"
FT                   /evidence="ECO:0000269|PubMed:10718198,
FT                   ECO:0000269|PubMed:12730195, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051217"
FT   VARIANT         1587
FT                   /note="T -> A (in dbSNP:rs2271395)"
FT                   /id="VAR_051218"
FT   CONFLICT        118
FT                   /note="E -> K (in Ref. 2; AAI26467)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="S -> F (in Ref. 3; BAA91748)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        660
FT                   /note="K -> Q (in Ref. 1; AAP22172)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        778
FT                   /note="K -> E (in Ref. 4; BAA92651)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1353
FT                   /note="S -> R (in Ref. 2; AAI26467 and 4; BAA92651)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1524
FT                   /note="L -> V (in Ref. 1; AAP22172)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1591
FT                   /note="S -> F (in Ref. 1; AAP22172)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1669..1685
FT                   /evidence="ECO:0000244|PDB:2VKC"
FT   HELIX           1686..1688
FT                   /evidence="ECO:0000244|PDB:2VKC"
FT   STRAND          1690..1692
FT                   /evidence="ECO:0000244|PDB:2D9I"
FT   HELIX           1698..1719
FT                   /evidence="ECO:0000244|PDB:3FAU"
FT   STRAND          1724..1728
FT                   /evidence="ECO:0000244|PDB:3FAU"
FT   STRAND          1734..1736
FT                   /evidence="ECO:0000244|PDB:3FAU"
FT   HELIX           1742..1752
FT                   /evidence="ECO:0000244|PDB:3FAU"
FT   STRAND          1757..1761
FT                   /evidence="ECO:0000244|PDB:3FAU"
FT   STRAND          1764..1768
FT                   /evidence="ECO:0000244|PDB:3FAU"
SQ   SEQUENCE   1770 AA;  198801 MW;  9A49FAB19C1BD56D CRC64;
     MPRRRKNLGG NPFRKTANPK EVVVSSVASR EEPTTTLPSM GETKVDQEEL FTSISEIFSD
     LDPDVVYLML SECDFKVENA MDCLLELSAT DTKIEESSSQ SFVASENQVG AAESKIMEKR
     PEEESEDSKM DSFLDMQLTE DLDSLIQNAF EKLNSSPDDQ VYSFLPSQDV NSFNDSSEFI
     NPDSSNMTPI FSTQNMNLNG ENLENSGSTL SLNPLPSHSV LNESKCFIKD NTLALESNYP
     EDSLLSSSLN VASDSIAGCS SLNQKQKELL ESECVEAQFS EAPVDLDASE PQACLNLPGL
     DLPGTGGDQK STRVSDVFLP SEGFNFKPHK HPELPTKGKD VSYCPVLAPL PLLLPPPPPP
     PMWNPMIPAF DLFQGNHGFV APVVTTAAHW RSVNYTFPPS VISHTSPTKV WRNKDGTSAY
     QVQETPVSQV VRKKTSYVGL VLVLLRGLPG SGKSFLARTL QEDNPSGVIL STDDYFYING
     QYQFDVKYLG EAHEWNQNRA KEAFEKKISP IIIDNTNLQA WEMKPYVALS QKHKYKVLFR
     EPDTWWKFKP KELARRNIHG VSKEKITRML EHYQRFVSVP IIMSSSVPEK IERIELCAYS
     CEDRSTSPRD DEDIISEKEE NILSLSLKHL EFTEEKNLDV TKETMLPENV AYLSNADLNK
     RRKEISDMNP SIQSALILET PHMYFSDSES KLQATDKSEN EQIEMVAVKG YSKTDTDSSM
     ERVSPSTCCS ENNQEDCDLA NSGPLQNEKS SPGEIVEERA TVTKKAFGKQ KSKSTLEKFP
     RHELSNFVGD WPVDKTIGQR TKRNRKTEKT SSVQSDKKYN YPQSHKLVNS VSVNTDCVQQ
     RGSPHESVED GRKSQCDDAS EPLNSYKYDA YKNIDKNSFN IMGDWPSSDS LAQREHRSRM
     PKTGLSEPNL EIGTNDKMNE ISLSTAHEAC WGTSSQKLKT LGSSNLGSSE MLLSEMTCES
     QTCLSKKSHG QHTSLPLTFT NSAPTVSGVV EPQTLAECQE QMPKRDPGKE VGMCTQTEPQ
     DFALLWKIEK NKISISDSIK VLTGRLDGFK PKVFNINTKS DVQEAIPYRV MYDKSTFVEE
     SELTSADESE NLNILCKLFG SFSLEALKDL YERCNKDIIW ATSLLLDSET KLCEDTEFEN
     FQKSCDGSQI GPFSLGLNLK EIISQRGTLE NSNSPVPEFS HGIGISNADS QSTCDAERGN
     SEQAEMRAVT PENHESMTSI FPSAAVGLKN NNDILPNSQE ELLYSSKQSF PGILKATTPK
     DMSETEKNLV VTETGDNIHS PSHFSDIFNF VSSTSNLELN EEIYFTDSLE IKRNENFPKD
     YVKFSDEEEF MNEDEKEMKE ILMAGSSLSA GVSGEDKTEI LNPTPAMAKS LTIDCLELAL
     PPELAFQLNE LFGPVGIDSG SLTVEDCVVH IDLNLAKVIH EKWKESVMER QRQEEVSCGK
     FMQDPSLVGH TGLDNPEQKS SQRTGKKLLK TLTASEMLPL LDHWNTQTKK VSLREIMSEE
     IALQEKHNLK RETLMFEKDC ATKLKEKQLF KIFPAINQNF LVDIFKDHNY SLEHTVQFLN
     CVLEGDPVKT VVAQEFVHQN ENVTSHTGQK SKEKKPKKLK ETEETPSELS FQDFEYPDYD
     DYRAEAFLHQ QKRMECYSKA KEAYRIGKKN VATFYAQQGT LHEQKMKEAN HLAAIEIFEK
     VNASLLPQNV LDLHGLHVDE ALEHLMRVLE KKTEEFKQNG GKPYLSVITG RGNHSQGGVA
     RIKPAVIKYL ISHSFRFSEI KPGCLKVMLK
//
ID   E5KTI5_HUMAN            Unreviewed;       312 AA.
AC   E5KTI5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   22-APR-2020, entry version 79.
DE   RecName: Full=Endonuclease III-like protein 1 {ECO:0000256|HAMAP-Rule:MF_03183};
DE            EC=3.2.2.- {ECO:0000256|HAMAP-Rule:MF_03183};
DE            EC=4.2.99.18 {ECO:0000256|HAMAP-Rule:MF_03183};
DE   AltName: Full=Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000256|HAMAP-Rule:MF_03183};
DE            Short=DNA glycosylase/AP lyase {ECO:0000256|HAMAP-Rule:MF_03183};
GN   Name=NTHL1 {ECO:0000256|HAMAP-Rule:MF_03183, ECO:0000313|EMBL:EAW85562.1};
GN   ORFNames=hCG_1989994 {ECO:0000313|EMBL:EAW85562.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP92214.1};
RN   [1] {ECO:0000313|EMBL:EAW85562.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW85562.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP92214.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W., Mindrinos M.,
RA   Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
CC   -!- FUNCTION: Bifunctional DNA N-glycosylase with associated
CC       apurinic/apyrimidinic (AP) lyase function that catalyzes the first step
CC       in base excision repair (BER), the primary repair pathway for the
CC       repair of oxidative DNA damage. The DNA N-glycosylase activity releases
CC       the damaged DNA base from DNA by cleaving the N-glycosidic bond,
CC       leaving an AP site. The AP lyase activity cleaves the phosphodiester
CC       bond 3' to the AP site by a beta-elimination. Primarily recognizes and
CC       repairs oxidative base damage of pyrimidines. {ECO:0000256|HAMAP-
CC       Rule:MF_03183}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The C-O-P bond 3' to the apurinic or apyrimidinic site in DNA
CC         is broken by a beta-elimination reaction, leaving a 3'-terminal
CC         unsaturated sugar and a product with a terminal 5'-phosphate.;
CC         EC=4.2.99.18; Evidence={ECO:0000256|HAMAP-Rule:MF_03183};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03183};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play a
CC       role in catalysis, but is probably involved in the proper positioning
CC       of the enzyme along the DNA strand. {ECO:0000256|HAMAP-Rule:MF_03183};
CC   -!- SUBUNIT: Interacts with YBX1. {ECO:0000256|HAMAP-Rule:MF_03183}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|HAMAP-Rule:MF_03183}.
CC       Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03183}.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000256|HAMAP-
CC       Rule:MF_03183}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ206266; ADP92214.1; -; Genomic_DNA.
DR   EMBL; HQ206267; ADP92215.1; -; Genomic_DNA.
DR   EMBL; HQ206268; ADP92216.1; -; Genomic_DNA.
DR   EMBL; HQ206269; ADP92217.1; -; Genomic_DNA.
DR   EMBL; HQ206270; ADP92218.1; -; Genomic_DNA.
DR   EMBL; HQ206271; ADP92219.1; -; Genomic_DNA.
DR   EMBL; HQ206272; ADP92220.1; -; Genomic_DNA.
DR   EMBL; HQ206273; ADP92221.1; -; Genomic_DNA.
DR   EMBL; HQ206274; ADP92222.1; -; Genomic_DNA.
DR   EMBL; HQ206275; ADP92223.1; -; Genomic_DNA.
DR   EMBL; HQ206276; ADP92224.1; -; Genomic_DNA.
DR   EMBL; HQ206277; ADP92225.1; -; Genomic_DNA.
DR   EMBL; HQ206278; ADP92226.1; -; Genomic_DNA.
DR   EMBL; HQ206279; ADP92227.1; -; Genomic_DNA.
DR   EMBL; HQ206280; ADP92228.1; -; Genomic_DNA.
DR   EMBL; HQ206281; ADP92229.1; -; Genomic_DNA.
DR   EMBL; HQ206282; ADP92230.1; -; Genomic_DNA.
DR   EMBL; HQ206283; ADP92231.1; -; Genomic_DNA.
DR   EMBL; HQ206284; ADP92232.1; -; Genomic_DNA.
DR   EMBL; HQ206285; ADP92233.1; -; Genomic_DNA.
DR   EMBL; HQ206286; ADP92234.1; -; Genomic_DNA.
DR   EMBL; HQ206287; ADP92235.1; -; Genomic_DNA.
DR   EMBL; HQ206288; ADP92236.1; -; Genomic_DNA.
DR   EMBL; HQ206289; ADP92237.1; -; Genomic_DNA.
DR   EMBL; HQ206290; ADP92238.1; -; Genomic_DNA.
DR   EMBL; HQ206291; ADP92239.1; -; Genomic_DNA.
DR   EMBL; HQ206292; ADP92240.1; -; Genomic_DNA.
DR   EMBL; HQ206293; ADP92241.1; -; Genomic_DNA.
DR   EMBL; HQ206294; ADP92242.1; -; Genomic_DNA.
DR   EMBL; HQ206295; ADP92243.1; -; Genomic_DNA.
DR   EMBL; HQ206296; ADP92244.1; -; Genomic_DNA.
DR   EMBL; HQ206297; ADP92245.1; -; Genomic_DNA.
DR   EMBL; HQ206298; ADP92246.1; -; Genomic_DNA.
DR   EMBL; HQ206299; ADP92247.1; -; Genomic_DNA.
DR   EMBL; HQ206300; ADP92248.1; -; Genomic_DNA.
DR   EMBL; HQ206301; ADP92249.1; -; Genomic_DNA.
DR   EMBL; HQ206302; ADP92250.1; -; Genomic_DNA.
DR   EMBL; HQ206303; ADP92251.1; -; Genomic_DNA.
DR   EMBL; HQ206304; ADP92252.1; -; Genomic_DNA.
DR   EMBL; HQ206305; ADP92253.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85562.1; -; Genomic_DNA.
DR   RefSeq; NP_002519.1; NM_002528.6.
DR   Antibodypedia; 23443; 226 antibodies.
DR   GeneID; 4913; -.
DR   KEGG; hsa:4913; -.
DR   CTD; 4913; -.
DR   EuPathDB; HostDB:ENSG00000065057.7; -.
DR   eggNOG; KOG1921; Eukaryota.
DR   eggNOG; COG0177; LUCA.
DR   HOGENOM; CLU_012862_4_2_1; -.
DR   KO; K10773; -.
DR   OMA; WQQFTHL; -.
DR   OrthoDB; 1322642at2759; -.
DR   GenomeRNAi; 4913; -.
DR   Bgee; ENSG00000065057; Expressed in right lobe of liver and 172 other tissues.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000703; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; IEA:UniProtKB-UniRule.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IEA:Ensembl.
DR   CDD; cd00056; ENDO3c; 1.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   HAMAP; MF_03183; Endonuclease_III_Nth; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR003651; Endonuclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR000445; HhH_motif.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   InterPro; IPR030841; NTH1.
DR   Pfam; PF00633; HHH; 1.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
PE   3: Inferred from homology;
KW   4Fe-4S {ECO:0000256|HAMAP-Rule:MF_03183};
KW   DNA damage {ECO:0000256|HAMAP-Rule:MF_03183};
KW   DNA repair {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Endonuclease {ECO:0000313|EMBL:ADP92214.1};
KW   Glycosidase {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Hydrolase {ECO:0000256|HAMAP-Rule:MF_03183, ECO:0000313|EMBL:ADP92214.1};
KW   Iron {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Iron-sulfur {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Lyase {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03183};
KW   Nuclease {ECO:0000313|EMBL:ADP92214.1};
KW   Nucleus {ECO:0000256|HAMAP-Rule:MF_03183}.
FT   DOMAIN          138..288
FT                   /note="ENDO3c"
FT                   /evidence="ECO:0000259|SMART:SM00478"
FT   REGION          1..79
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        34..52
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        62..79
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        220
FT                   /note="Nucleophile; for N-glycosylase activity"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
FT   METAL           290
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
FT   METAL           297
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
FT   METAL           300
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
FT   METAL           306
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
FT   SITE            239
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000256|HAMAP-Rule:MF_03183"
SQ   SEQUENCE   312 AA;  34390 MW;  379816A1E0B45050 CRC64;
     MCSPQESGMT ALSARMLTRS RSLGPGAGPR GCREEPGPLR RREAAAEARK SHSPVKRPRK
     AQRLRVAYEG SDSEKGEGAE PLKVPVWEPQ DWQQQLVNIR AMRNKKDAPV DHLGTEHCYD
     SSAPPKVRRY QVLLSLMLSS QTKDQVTAGA MQRLRARGLT VDSILQTDDA TLGKLIYPVG
     FWRSKVKYIK QTSAILQQHY GGDIPASVAE LVALPGVGPK MAHLAMAVAW GTVSGIAVDT
     HVHRIANRLR WTKKATKSPE ETRAALEEWL PRELWHEING LLVGFGQQTC LPVHPRCHAC
     LNQALCPAAQ GL
//
ID   NTH_HUMAN               Reviewed;         312 AA.
AC   P78549; Q1MVR1; Q99566; Q99794; Q9BPX2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   22-APR-2020, entry version 189.
DE   RecName: Full=Endonuclease III-like protein 1 {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=hNTH1;
DE            EC=3.2.2.- {ECO:0000255|HAMAP-Rule:MF_03183};
DE            EC=4.2.99.18 {ECO:0000255|HAMAP-Rule:MF_03183};
DE   AltName: Full=Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE            Short=DNA glycosylase/AP lyase {ECO:0000255|HAMAP-Rule:MF_03183};
DE   Flags: Precursor;
GN   Name=NTHL1 {ECO:0000255|HAMAP-Rule:MF_03183}; Synonyms=NTH1, OCTS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAM11786.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8990169; DOI=10.1073/pnas.94.1.109;
RA   Aspinwall R., Rothwell D.G., Roldan-Arjona T., Anselmino C., Ward C.J.,
RA   Cheadle J.P., Sampson J.R., Lindahl T., Harris P.C., Hickson I.D.;
RT   "Cloning and characterization of a functional human homolog of Escherichia
RT   coli endonuclease III.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:109-114(1997).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=9831664; DOI=10.1016/s0378-1119(98)00485-5;
RA   Imai K., Sarker A.H., Akiyama K., Ikeda S., Yao M., Tsutsui K.,
RA   Shohmori T., Seki S.;
RT   "Genomic structure and sequence of a human homologue (NTHL1/NTH1) of
RT   Escherichia coli endonuclease III with those of the adjacent parts of TSC2
RT   and SLC9A3R2 genes.";
RL   Gene 222:287-295(1998).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAM11786.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS TRP-21 AND LEU-234.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ACTIVE SITE, AND
RP   MUTAGENESIS OF LYS-220.
RC   TISSUE=Bone marrow;
RX   PubMed=9705289; DOI=10.1074/jbc.273.34.21585;
RA   Ikeda S., Biswas T., Roy R., Izumi T., Boldogh I., Kurosky A., Sarker A.H.,
RA   Seki S., Mitra S.;
RT   "Purification and characterization of human NTH1, a homolog of Escherichia
RT   coli endonuclease III. Direct identification of Lys-212 as the active
RT   nucleophilic residue.";
RL   J. Biol. Chem. 273:21585-21593(1998).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=Spleen;
RX   PubMed=9045706; DOI=10.1074/jbc.272.10.6733;
RA   Hilbert T.P., Chaung W., Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Cloning and expression of the cDNA encoding the human homologue of the DNA
RT   repair enzyme, Escherichia coli endonuclease III.";
RL   J. Biol. Chem. 272:6733-6740(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-312 (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-312, FUNCTION, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=10882850; DOI=10.1016/s0921-8777(00)00015-x;
RA   Luna L., Bjoras M., Hoff E., Rognes T., Seeberg E.;
RT   "Cell-cycle regulation, intracellular sorting and induced overexpression of
RT   the human NTH1 DNA glycosylase involved in removal of formamidopyrimidine
RT   residues from DNA.";
RL   Mutat. Res. 460:95-104(2000).
RN   [9]
RP   PROTEIN SEQUENCE OF 31-37; 48-56; 61-78; 107-113; 120-126 AND 221-227,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12144783; DOI=10.1016/s0022-2836(02)00623-x;
RA   Liu X., Roy R.;
RT   "Truncation of amino-terminal tail stimulates activity of human
RT   endonuclease III (hNTH1).";
RL   J. Mol. Biol. 321:265-276(2002).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9611236; DOI=10.1093/nar/26.12.2917;
RA   Takao M., Aburatani H., Kobayashi K., Yasui A.;
RT   "Mitochondrial targeting of human DNA glycosylases for repair of oxidative
RT   DNA damage.";
RL   Nucleic Acids Res. 26:2917-2922(1998).
RN   [11]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9890904; DOI=10.1021/bi9819071;
RA   Dizdaroglu M., Karahalil B., Senturker S., Buckley T.J., Roldan-Arjona T.;
RT   "Excision of products of oxidative DNA base damage by human NTH1 protein.";
RL   Biochemistry 38:243-246(1999).
RN   [12]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11380260; DOI=10.1021/bi0028901;
RA   Eide L., Luna L., Gustad E.C., Henderson P.T., Essigmann J.M., Demple B.,
RA   Seeberg E.;
RT   "Human endonuclease III acts preferentially on DNA damage opposite guanine
RT   residues in DNA.";
RL   Biochemistry 40:6653-6659(2001).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF LYS-220.
RX   PubMed=11695910; DOI=10.1021/bi011053b;
RA   Liu X., Roy R.;
RT   "Mutation at active site lysine 212 to arginine uncouples the glycosylase
RT   activity from the lyase activity of human endonuclease III.";
RL   Biochemistry 40:13617-13622(2001).
RN   [14]
RP   CATALYTIC ACTIVITY, INTERACTION WITH YBX1, AND ACTIVITY REGULATION.
RX   PubMed=11287425; DOI=10.1074/jbc.m101594200;
RA   Marenstein D.R., Ocampo M.T., Chan M.K., Altamirano A., Basu A.K.,
RA   Boorstein R.J., Cunningham R.P., Teebor G.W.;
RT   "Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-
RT   binding protein B). Interaction between a base excision repair enzyme and a
RT   transcription factor.";
RL   J. Biol. Chem. 276:21242-21249(2001).
RN   [15]
RP   FUNCTION.
RX   PubMed=11328882; DOI=10.1093/nar/29.9.1975;
RA   Matsumoto Y., Zhang Q.M., Takao M., Yasui A., Yonei S.;
RT   "Escherichia coli Nth and human hNTH1 DNA glycosylases are involved in
RT   removal of 8-oxoguanine from 8-oxoguanine/guanine mispairs in DNA.";
RL   Nucleic Acids Res. 29:1975-1981(2001).
RN   [16] {ECO:0000305}
RP   SUBCELLULAR LOCATION, ALTERNATIVE INITIATION, AND MUTAGENESIS OF
RP   40-ARG--ARG-42; ARG-42 AND ARG-57.
RX   PubMed=12531031; DOI=10.1016/s1568-7864(02)00145-3;
RA   Ikeda S., Kohmoto T., Tabata R., Seki Y.;
RT   "Differential intracellular localization of the human and mouse
RT   endonuclease III homologs and analysis of the sorting signals.";
RL   DNA Repair 1:847-854(2002).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12140329; DOI=10.1093/nar/gkf460;
RA   Miyabe I., Zhang Q.M., Kino K., Sugiyama H., Takao M., Yasui A., Yonei S.;
RT   "Identification of 5-formyluracil DNA glycosylase activity of human hNTH1
RT   protein.";
RL   Nucleic Acids Res. 30:3443-3448(2002).
RN   [18]
RP   FUNCTION, SUBSTRATES, AND ACTIVITY REGULATION.
RX   PubMed=12519758; DOI=10.1074/jbc.m212168200;
RA   Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J.,
RA   Cunningham R.P., Teebor G.W.;
RT   "Substrate specificity of human endonuclease III (hNTH1). Effect of human
RT   APE1 on hNTH1 activity.";
RL   J. Biol. Chem. 278:9005-9012(2003).
RN   [19]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=14734554; DOI=10.1074/jbc.m400393200;
RA   Katafuchi A., Nakano T., Masaoka A., Terato H., Iwai S., Hanaoka F.,
RA   Ide H.;
RT   "Differential specificity of human and Escherichia coli endonuclease III
RT   and VIII homologues for oxidative base lesions.";
RL   J. Biol. Chem. 279:14464-14471(2004).
RN   [20]
RP   FUNCTION, AND SUBSTRATES.
RX   PubMed=15533839; DOI=10.1016/j.dnarep.2004.08.002;
RA   Zhang Q.M., Yonekura S., Takao M., Yasui A., Sugiyama H., Yonei S.;
RT   "DNA glycosylase activities for thymine residues oxidized in the methyl
RT   group are functions of the hNEIL1 and hNTH1 enzymes in human cells.";
RL   DNA Repair 4:71-79(2005).
RN   [21]
RP   FUNCTION.
RX   PubMed=17923696; DOI=10.1128/mcb.00791-07;
RA   Prasad A., Wallace S.S., Pederson D.S.;
RT   "Initiation of base excision repair of oxidative lesions in nucleosomes by
RT   the human, bifunctional DNA glycosylase NTH1.";
RL   Mol. Cell. Biol. 27:8442-8453(2007).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   FUNCTION.
RX   PubMed=20005182; DOI=10.1016/j.dnarep.2009.11.005;
RA   Odell I.D., Newick K., Heintz N.H., Wallace S.S., Pederson D.S.;
RT   "Non-specific DNA binding interferes with the efficient excision of
RT   oxidative lesions from chromatin by the human DNA glycosylase, NEIL1.";
RL   DNA Repair 9:134-143(2010).
RN   [24]
RP   FUNCTION.
RX   PubMed=20110254; DOI=10.1093/nar/gkq022;
RA   Matsumoto N., Toga T., Hayashi R., Sugasawa K., Katayanagi K., Ide H.,
RA   Kuraoka I., Iwai S.;
RT   "Fluorescent probes for the analysis of DNA strand scission in base
RT   excision repair.";
RL   Nucleic Acids Res. 38:E101-E101(2010).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   FUNCTION.
RX   PubMed=21930793; DOI=10.1128/mcb.05715-11;
RA   Odell I.D., Barbour J.E., Murphy D.L., Della-Maria J.A., Sweasy J.B.,
RA   Tomkinson A.E., Wallace S.S., Pederson D.S.;
RT   "Nucleosome disruption by DNA ligase III-XRCC1 promotes efficient base
RT   excision repair.";
RL   Mol. Cell. Biol. 31:4623-4632(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71 AND SER-73, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   INVOLVEMENT IN FAP3.
RX   PubMed=25938944; DOI=10.1038/ng.3287;
RA   Weren R.D., Ligtenberg M.J., Kets C.M., de Voer R.M., Verwiel E.T.,
RA   Spruijt L., van Zelst-Stams W.A., Jongmans M.C., Gilissen C.,
RA   Hehir-Kwa J.Y., Hoischen A., Shendure J., Boyle E.A., Kamping E.J.,
RA   Nagtegaal I.D., Tops B.B., Nagengast F.M., Geurts van Kessel A.,
RA   van Krieken J.H., Kuiper R.P., Hoogerbrugge N.;
RT   "A germline homozygous mutation in the base-excision repair gene NTHL1
RT   causes adenomatous polyposis and colorectal cancer.";
RL   Nat. Genet. 47:668-671(2015).
CC   -!- FUNCTION: Bifunctional DNA N-glycosylase with associated
CC       apurinic/apyrimidinic (AP) lyase function that catalyzes the first step
CC       in base excision repair (BER), the primary repair pathway for the
CC       repair of oxidative DNA damage. The DNA N-glycosylase activity releases
CC       the damaged DNA base from DNA by cleaving the N-glycosidic bond,
CC       leaving an AP site. The AP-lyase activity cleaves the phosphodiester
CC       bond 3' to the AP site by a beta-elimination. Primarily recognizes and
CC       repairs oxidative base damage of pyrimidines. Has also 8-oxo-7,8-
CC       dihydroguanine (8-oxoG) DNA glycosylase activity. Acts preferentially
CC       on DNA damage opposite guanine residues in DNA. Is able to process
CC       lesions in nucleosomes without requiring or inducing nucleosome
CC       disruption. {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:10882850, ECO:0000269|PubMed:11328882,
CC       ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:11695910,
CC       ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783,
CC       ECO:0000269|PubMed:12519758, ECO:0000269|PubMed:14734554,
CC       ECO:0000269|PubMed:15533839, ECO:0000269|PubMed:17923696,
CC       ECO:0000269|PubMed:20005182, ECO:0000269|PubMed:20110254,
CC       ECO:0000269|PubMed:21930793, ECO:0000269|PubMed:8990169,
CC       ECO:0000269|PubMed:9045706, ECO:0000269|PubMed:9705289,
CC       ECO:0000269|PubMed:9890904}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The C-O-P bond 3' to the apurinic or apyrimidinic site in DNA
CC         is broken by a beta-elimination reaction, leaving a 3'-terminal
CC         unsaturated sugar and a product with a terminal 5'-phosphate.;
CC         EC=4.2.99.18; Evidence={ECO:0000250|UniProtKB:P20625,
CC         ECO:0000255|HAMAP-Rule:MF_03183, ECO:0000269|PubMed:11287425,
CC         ECO:0000269|PubMed:12140329, ECO:0000269|PubMed:12144783};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03183};
CC       Note=Binds 1 [4Fe-4S] cluster. The cluster does not appear to play a
CC       role in catalysis, but is probably involved in the proper positioning
CC       of the enzyme along the DNA strand. {ECO:0000255|HAMAP-Rule:MF_03183};
CC   -!- ACTIVITY REGULATION: APE1 displaces NTHL1 from the N-glycosylase-
CC       generated AP site in DNA, thereby increasing the turnover of the DNA N-
CC       glycosylase activity. AP lyase activity is stimulated by YBX1.
CC       {ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12519758}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=371 nM for 5-hydroxy-6-hydrothymine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=1093 nM for 5-hydroxyuracil containing duplex oligonucleotides (N-
CC         glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=548 nM for 5-hydroxycytosine containing duplex oligonucleotides
CC         (N-glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=1101 nM for thymine glycol containing duplex oligonucleotides (N-
CC         glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=718 nM for 5,6-dihydroxycytosine containing duplex
CC         oligonucleotides (N-glycosylase activity)
CC         {ECO:0000269|PubMed:11380260, ECO:0000269|PubMed:9890904};
CC         KM=0.05 nM for 5-hydroxycytosine-G containing duplex oligonucleotides
CC         (N-glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC         KM=0.2 nM for 5-hydroxycytosine-A containing duplex oligonucleotides
CC         (N-glycosylase activity) {ECO:0000269|PubMed:11380260,
CC         ECO:0000269|PubMed:9890904};
CC   -!- SUBUNIT: Interacts with YBX1. {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:11287425}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03183,
CC       ECO:0000269|PubMed:10882850, ECO:0000269|PubMed:12531031,
CC       ECO:0000269|PubMed:9611236}. Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03183, ECO:0000269|PubMed:9611236}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=1; Synonyms=M-8;
CC         IsoId=P78549-1; Sequence=Displayed;
CC       Name=2; Synonyms=M+1;
CC         IsoId=P78549-2; Sequence=VSP_054293;
CC       Name=3; Synonyms=M+8;
CC         IsoId=P78549-3; Sequence=VSP_054292;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in heart and
CC       lowest levels in lung and liver. {ECO:0000269|PubMed:8990169,
CC       ECO:0000269|PubMed:9831664}.
CC   -!- DEVELOPMENTAL STAGE: Expression levels are regulated during the cell
CC       cycle with increased levels during early and mid S-phase.
CC       {ECO:0000269|PubMed:10882850}.
CC   -!- DISEASE: Familial adenomatous polyposis 3 (FAP3) [MIM:616415]: A form
CC       of familial adenomatous polyposis, a condition characterized by the
CC       development of multiple colorectal adenomatous polyps, benign neoplasms
CC       derived from glandular epithelium. Some affected individuals may
CC       develop colorectal carcinoma. {ECO:0000269|PubMed:25938944}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the Nth/MutY family. {ECO:0000255|HAMAP-
CC       Rule:MF_03183}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nthl1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U79718; AAB41534.1; -; mRNA.
DR   EMBL; AB014460; BAA32695.1; -; Genomic_DNA.
DR   EMBL; AF498098; AAM11786.1; -; Genomic_DNA.
DR   EMBL; AC005600; AAC34209.1; -; Genomic_DNA.
DR   EMBL; AB001575; BAA19413.1; -; mRNA.
DR   EMBL; U81285; AAC51136.1; -; mRNA.
DR   EMBL; BC003014; AAH03014.1; -; mRNA.
DR   EMBL; BC000391; AAH00391.2; -; mRNA.
DR   EMBL; Y09687; CAA70865.1; -; mRNA.
DR   CCDS; CCDS10457.1; -. [P78549-2]
DR   RefSeq; NP_001305122.1; NM_001318193.1.
DR   RefSeq; NP_001305123.1; NM_001318194.1.
DR   RefSeq; NP_002519.1; NM_002528.6. [P78549-2]
DR   SMR; P78549; -.
DR   BioGrid; 110968; 25.
DR   IntAct; P78549; 6.
DR   STRING; 9606.ENSP00000219066; -.
DR   iPTMnet; P78549; -.
DR   PhosphoSitePlus; P78549; -.
DR   BioMuta; NTHL1; -.
DR   DMDM; 29840795; -.
DR   EPD; P78549; -.
DR   jPOST; P78549; -.
DR   MassIVE; P78549; -.
DR   MaxQB; P78549; -.
DR   PaxDb; P78549; -.
DR   PeptideAtlas; P78549; -.
DR   PRIDE; P78549; -.
DR   ProteomicsDB; 57648; -. [P78549-1]
DR   Antibodypedia; 23443; 226 antibodies.
DR   GeneID; 4913; -.
DR   KEGG; hsa:4913; -.
DR   UCSC; uc002col.1; human. [P78549-1]
DR   CTD; 4913; -.
DR   DisGeNET; 4913; -.
DR   GeneCards; NTHL1; -.
DR   HGNC; HGNC:8028; NTHL1.
DR   HPA; ENSG00000065057; Low tissue specificity.
DR   MalaCards; NTHL1; -.
DR   MIM; 602656; gene.
DR   MIM; 616415; phenotype.
DR   neXtProt; NX_P78549; -.
DR   OpenTargets; ENSG00000065057; -.
DR   Orphanet; 454840; NTHL1-related attenuated familial adenomatous polyposis.
DR   PharmGKB; PA31811; -.
DR   eggNOG; KOG1921; Eukaryota.
DR   eggNOG; COG0177; LUCA.
DR   GeneTree; ENSGT00510000047513; -.
DR   HOGENOM; CLU_012862_4_2_1; -.
DR   InParanoid; P78549; -.
DR   KO; K10773; -.
DR   OMA; WQQFTHL; -.
DR   OrthoDB; 1322642at2759; -.
DR   PhylomeDB; P78549; -.
DR   TreeFam; TF314967; -.
DR   BRENDA; 4.2.99.18; 2681.
DR   Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine.
DR   Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine.
DR   Reactome; R-HSA-110357; Displacement of DNA glycosylase by APEX1.
DR   Reactome; R-HSA-9630221; Defective NTHL1 substrate processing.
DR   Reactome; R-HSA-9630222; Defective NTHL1 substrate binding.
DR   SABIO-RK; P78549; -.
DR   GeneWiki; NTHL1; -.
DR   GenomeRNAi; 4913; -.
DR   Pharos; P78549; Tbio.
DR   PRO; PR:P78549; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; P78549; protein.
DR   Bgee; ENSG00000065057; Expressed in right lobe of liver and 172 other tissues.
DR   ExpressionAtlas; P78549; baseline and differential.
DR   Genevisible; P78549; HS.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:CACAO.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:FlyBase.
DR   GO; GO:0019104; F:DNA N-glycosylase activity; IDA:UniProtKB.
DR   GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0004519; F:endonuclease activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008534; F:oxidized purine nucleobase lesion DNA N-glycosylase activity; TAS:Reactome.
DR   GO; GO:0000703; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; IBA:GO_Central.
DR   GO; GO:0006285; P:base-excision repair, AP site formation; IDA:UniProtKB.
DR   GO; GO:0045008; P:depyrimidination; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IDA:UniProtKB.
DR   CDD; cd00056; ENDO3c; 1.
DR   Gene3D; 1.10.1670.10; -; 1.
DR   HAMAP; MF_03183; Endonuclease_III_Nth; 1.
DR   InterPro; IPR011257; DNA_glycosylase.
DR   InterPro; IPR004036; Endonuclease-III-like_CS2.
DR   InterPro; IPR003651; Endonuclease3_FeS-loop_motif.
DR   InterPro; IPR003265; HhH-GPD_domain.
DR   InterPro; IPR000445; HhH_motif.
DR   InterPro; IPR023170; HTH_base_excis_C.
DR   InterPro; IPR030841; NTH1.
DR   Pfam; PF00633; HHH; 1.
DR   Pfam; PF00730; HhH-GPD; 1.
DR   SMART; SM00478; ENDO3c; 1.
DR   SMART; SM00525; FES; 1.
DR   SUPFAM; SSF48150; SSF48150; 1.
DR   PROSITE; PS01155; ENDONUCLEASE_III_2; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Alternative initiation; Direct protein sequencing; DNA damage;
KW   DNA repair; Glycosidase; Hydrolase; Iron; Iron-sulfur; Lyase;
KW   Metal-binding; Mitochondrion; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..30
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183,
FT                   ECO:0000269|PubMed:12144783"
FT   CHAIN           31..312
FT                   /note="Endonuclease III-like protein 1"
FT                   /id="PRO_0000102227"
FT   DOMAIN          199..223
FT                   /note="HhH"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183"
FT   MOTIF           36..60
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        220
FT                   /note="Nucleophile; for N-glycosylase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183,
FT                   ECO:0000269|PubMed:9705289"
FT   METAL           290
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183"
FT   METAL           297
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183"
FT   METAL           300
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183"
FT   METAL           306
FT                   /note="Iron-sulfur (4Fe-4S)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03183"
FT   SITE            239
FT                   /note="Important for catalytic activity"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   VAR_SEQ         1..15
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054292"
FT   VAR_SEQ         1..8
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9045706, ECO:0000303|PubMed:9705289,
FT                   ECO:0000303|PubMed:9831664"
FT                   /id="VSP_054293"
FT   VARIANT         21
FT                   /note="R -> W (in dbSNP:rs3087469)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_016125"
FT   VARIANT         33
FT                   /note="R -> K (in dbSNP:rs2302172)"
FT                   /id="VAR_016126"
FT   VARIANT         176
FT                   /note="I -> T (in dbSNP:rs1805378)"
FT                   /id="VAR_016127"
FT   VARIANT         234
FT                   /note="S -> L (in dbSNP:rs3211977)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_029318"
FT   VARIANT         239
FT                   /note="D -> Y (in dbSNP:rs3087468)"
FT                   /id="VAR_016128"
FT   MUTAGEN         40..42
FT                   /note="Missing: Sorted to the cytoplasm."
FT                   /evidence="ECO:0000269|PubMed:12531031"
FT   MUTAGEN         42
FT                   /note="R->A: Sorted to both nuclei and mitochondria."
FT                   /evidence="ECO:0000269|PubMed:12531031"
FT   MUTAGEN         42
FT                   /note="R->D: Sorted to the cytoplasm."
FT                   /evidence="ECO:0000269|PubMed:12531031"
FT   MUTAGEN         57
FT                   /note="R->A,D: Sorted to both nuclei and mitochondria."
FT                   /evidence="ECO:0000269|PubMed:12531031"
FT   MUTAGEN         220
FT                   /note="K->Q: Inactivates enzyme."
FT                   /evidence="ECO:0000269|PubMed:11695910,
FT                   ECO:0000269|PubMed:9705289"
FT   MUTAGEN         220
FT                   /note="K->R: 85-fold reduction in activity. Uncouples the
FT                   glycosylase activity from the lyase activity. Shows
FT                   glycosylase activity without any detectable AP-lyase
FT                   activity during the first 10 min of the reaction."
FT                   /evidence="ECO:0000269|PubMed:11695910,
FT                   ECO:0000269|PubMed:9705289"
FT   CONFLICT        9..10
FT                   /note="MT -> TS (in Ref. 8; CAA70865)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="Missing (in Ref. 8; CAA70865)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151
FT                   /note="M -> I (in Ref. 1; AAB41534)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        160
FT                   /note="T -> A (in Ref. 1; AAB41534)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   312 AA;  34390 MW;  379816A1E0B45050 CRC64;
     MCSPQESGMT ALSARMLTRS RSLGPGAGPR GCREEPGPLR RREAAAEARK SHSPVKRPRK
     AQRLRVAYEG SDSEKGEGAE PLKVPVWEPQ DWQQQLVNIR AMRNKKDAPV DHLGTEHCYD
     SSAPPKVRRY QVLLSLMLSS QTKDQVTAGA MQRLRARGLT VDSILQTDDA TLGKLIYPVG
     FWRSKVKYIK QTSAILQQHY GGDIPASVAE LVALPGVGPK MAHLAMAVAW GTVSGIAVDT
     HVHRIANRLR WTKKATKSPE ETRAALEEWL PRELWHEING LLVGFGQQTC LPVHPRCHAC
     LNQALCPAAQ GL
//
ID   E5KNU5_HUMAN            Unreviewed;      1239 AA.
AC   E5KNU5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   22-APR-2020, entry version 81.
DE   SubName: Full=DNA polymerase subunit gamma-1 {ECO:0000313|EMBL:ADP90854.1};
DE   SubName: Full=Mitochondrial polymerase gamma catalytic subunit {ECO:0000313|EMBL:AZB52146.1};
DE            EC=2.7.7.7 {ECO:0000313|EMBL:AZB52146.1};
DE   SubName: Full=Polymerase (DNA directed), gamma, isoform CRA_a {ECO:0000313|EMBL:EAX02045.1};
GN   Name=POLG {ECO:0000313|EMBL:AZB52146.1};
GN   ORFNames=hCG_28647 {ECO:0000313|EMBL:EAX02045.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP90854.1};
RN   [1] {ECO:0000313|EMBL:EAX02045.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX02045.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP90854.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W., Mindrinos M.,
RA   Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4] {ECO:0000313|EMBL:AZB52146.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=30423451;
RA   Piekutowska-Abramczuk D., Kaliszewska M., Sulek A., Jurkowska N.,
RA   Oltarzewski M., Jablonska E., Trubicka J., Glowacka A., Ciara E.,
RA   Kowalski P., Langiewicz-Wojciechowska K., Tesarova M., Zeman J.,
RA   Kierdaszuk B., Kuczynski D., Chmielewski D., Szymanska E., Bakula A.,
RA   Lusakowska A., Lipowska M., Brodacki B., Pera J., Dorobek M., Rydzanicz M.,
RA   Ploski R., Chrzanowska Krystyna H., Bartnik E., Placha G., Kaminska A.,
RA   Kostera-Pruszczyk A., Krajewska-Walasek M., Tonska K., Pronicka E.;
RT   "The frequency of mitochondrial polymerase gamma related disorders in a
RT   large Polish population cohort.";
RL   Mitochondrion 0:0-0(2018).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ205386; ADP90854.1; -; Genomic_DNA.
DR   EMBL; HQ205387; ADP90855.1; -; Genomic_DNA.
DR   EMBL; HQ205388; ADP90856.1; -; Genomic_DNA.
DR   EMBL; HQ205389; ADP90857.1; -; Genomic_DNA.
DR   EMBL; HQ205390; ADP90858.1; -; Genomic_DNA.
DR   EMBL; HQ205391; ADP90859.1; -; Genomic_DNA.
DR   EMBL; HQ205392; ADP90860.1; -; Genomic_DNA.
DR   EMBL; HQ205393; ADP90861.1; -; Genomic_DNA.
DR   EMBL; HQ205394; ADP90862.1; -; Genomic_DNA.
DR   EMBL; HQ205395; ADP90863.1; -; Genomic_DNA.
DR   EMBL; HQ205396; ADP90864.1; -; Genomic_DNA.
DR   EMBL; HQ205397; ADP90865.1; -; Genomic_DNA.
DR   EMBL; HQ205398; ADP90866.1; -; Genomic_DNA.
DR   EMBL; HQ205400; ADP90868.1; -; Genomic_DNA.
DR   EMBL; HQ205401; ADP90869.1; -; Genomic_DNA.
DR   EMBL; HQ205402; ADP90870.1; -; Genomic_DNA.
DR   EMBL; HQ205404; ADP90872.1; -; Genomic_DNA.
DR   EMBL; HQ205405; ADP90873.1; -; Genomic_DNA.
DR   EMBL; HQ205406; ADP90874.1; -; Genomic_DNA.
DR   EMBL; HQ205407; ADP90875.1; -; Genomic_DNA.
DR   EMBL; HQ205408; ADP90876.1; -; Genomic_DNA.
DR   EMBL; HQ205409; ADP90877.1; -; Genomic_DNA.
DR   EMBL; HQ205410; ADP90878.1; -; Genomic_DNA.
DR   EMBL; HQ205411; ADP90879.1; -; Genomic_DNA.
DR   EMBL; HQ205412; ADP90880.1; -; Genomic_DNA.
DR   EMBL; HQ205413; ADP90881.1; -; Genomic_DNA.
DR   EMBL; HQ205414; ADP90882.1; -; Genomic_DNA.
DR   EMBL; HQ205415; ADP90883.1; -; Genomic_DNA.
DR   EMBL; HQ205417; ADP90885.1; -; Genomic_DNA.
DR   EMBL; HQ205418; ADP90886.1; -; Genomic_DNA.
DR   EMBL; HQ205419; ADP90887.1; -; Genomic_DNA.
DR   EMBL; HQ205420; ADP90888.1; -; Genomic_DNA.
DR   EMBL; HQ205421; ADP90889.1; -; Genomic_DNA.
DR   EMBL; HQ205422; ADP90890.1; -; Genomic_DNA.
DR   EMBL; HQ205423; ADP90891.1; -; Genomic_DNA.
DR   EMBL; HQ205424; ADP90892.1; -; Genomic_DNA.
DR   EMBL; HQ205425; ADP90893.1; -; Genomic_DNA.
DR   EMBL; MH973638; AZB52146.1; -; Genomic_DNA.
DR   EMBL; CH471101; EAX02045.1; -; Genomic_DNA.
DR   EMBL; CH471101; EAX02047.1; -; Genomic_DNA.
DR   RefSeq; NP_001119603.1; NM_001126131.1.
DR   RefSeq; NP_002684.1; NM_002693.2.
DR   Antibodypedia; 28558; 199 antibodies.
DR   GeneID; 5428; -.
DR   KEGG; hsa:5428; -.
DR   CTD; 5428; -.
DR   EuPathDB; HostDB:ENSG00000140521.11; -.
DR   eggNOG; KOG3657; Eukaryota.
DR   eggNOG; COG0749; LUCA.
DR   HOGENOM; CLU_001524_2_2_1; -.
DR   KO; K02332; -.
DR   OMA; DTEVMWK; -.
DR   OrthoDB; 86850at2759; -.
DR   ChiTaRS; POLG; human.
DR   GenomeRNAi; 5428; -.
DR   Bgee; ENSG00000140521; Expressed in tendon of biceps brachii and 239 other tissues.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005760; C:gamma DNA polymerase complex; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR002297; DNA-dir_DNA_pol_A_mt.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR041336; DNApol_Exo.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   PANTHER; PTHR10267; PTHR10267; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   Pfam; PF18136; DNApol_Exo; 1.
DR   PIRSF; PIRSF000797; DNA_pol_mt; 1.
DR   PRINTS; PR00867; DNAPOLG.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotidyltransferase {ECO:0000313|EMBL:AZB52146.1};
KW   Transferase {ECO:0000313|EMBL:AZB52146.1}.
FT   DOMAIN          871..1145
FT                   /note="POLAc"
FT                   /evidence="ECO:0000259|SMART:SM00482"
FT   REGION          1..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          318..340
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          506..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          438..465
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          691..711
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        29..67
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1239 AA;  139562 MW;  2D9ECCD75AD6E01E CRC64;
     MSRLLWRKVA GATVGPGPVP APGRWVSSSV PASDPSDGQR RRQQQQQQQQ QQQQQPQQPQ
     VLSSEGGQLR HNPLDIQMLS RGLHEQIFGQ GGEMPGEAAV RRSVEHLQKH GLWGQPAVPL
     PDVELRLPPL YGDNLDQHFR LLAQKQSLPY LEAANLLLQA QLPPKPPAWA WAEGWTRYGP
     EGEAVPVAIP EERALVFDVE VCLAEGTCPT LAVAISPSAW YSWCSQRLVE ERYSWTSQLS
     PADLIPLEVP TGASSPTQRD WQEQLVVGHN VSFDRAHIRE QYLIQGSRMR FLDTMSMHMA
     ISGLSSFQRS LWIAAKQGKH KVQPPTKQGQ KSQRKARRGP AISSWDWLDI SSVNSLAEVH
     RLYVGGPPLE KEPRELFVKG TMKDIRENFQ DLMQYCAQDV WATHEVFQQQ LPLFLERCPH
     PVTLAGMLEM GVSYLPVNQN WERYLAEAQG TYEELQREMK KSLMDLANDA CQLLSGERYK
     EDPWLWDLEW DLQEFKQKKA KKVKKEPATA SKLPIEGAGA PGDPMDQEDL GPCSEEEEFQ
     QDVMARACLQ KLKGTTELLP KRPQHLPGHP GWYRKLCPRL DDPAWTPGPS LLSLQMRVTP
     KLMALTWDGF PLHYSERHGW GYLVPGRRDN LAKLPTGTTL ESAGVVCPYR AIESLYRKHC
     LEQGKQQLMP QEAGLAEEFL LTDNSAIWQT VEELDYLEVE AEAKMENLRA AVPGQPLALT
     ARGGPKDTQP SYHHGNGPYN DVDIPGCWFF KLPHKDGNSC NVGSPFAKDF LPKMEDGTLQ
     AGPGGASGPR ALEINKMISF WRNAHKRISS QMVVWLPRSA LPRAVIRHPD YDEEGLYGAI
     LPQVVTAGTI TRRAVEPTWL TASNARPDRV GSELKAMVQA PPGYTLVGAD VDSQELWIAA
     VLGDAHFAGM HGCTAFGWMT LQGRKSRGTD LHSKTATTVG ISREHAKIFN YGRIYGAGQP
     FAERLLMQFN HRLTQQEAAE KAQQMYAATK GLRWYRLSDE GEWLVRELNL PVDRTEGGWI
     SLQDLRKVQR ETARKSQWKK WEVVAERAWK GGTESEMFNK LESIATSDIP RTPVLGCCIS
     RALEPSAVQE EFMTSRVNWV VQSSAVDYLH LMLVAMKWLF EEFAIDGRFC ISIHDEVRYL
     VREEDRYRAA LALQITNLLT RCMFAYKLGL NDLPQSVAFF SAVDIDRCLR KEVTMDCKTP
     SNPTGMERRY GIPQGEALDI YQIIELTKGS LEKRSQPGP
//
ID   DPOG1_HUMAN             Reviewed;        1239 AA.
AC   P54098; Q8NFM2; Q92515;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 209.
DE   RecName: Full=DNA polymerase subunit gamma-1;
DE            EC=2.7.7.7;
DE   AltName: Full=Mitochondrial DNA polymerase catalytic subunit;
DE   AltName: Full=PolG-alpha;
GN   Name=POLG; Synonyms=MDP1, POLG1, POLGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8884268; DOI=10.1006/geno.1996.0490;
RA   Ropp P.A., Copeland W.C.;
RT   "Cloning and characterization of the human mitochondrial DNA polymerase,
RT   DNA polymerase gamma.";
RL   Genomics 36:449-458(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9034326; DOI=10.1016/s0378-1119(96)00663-4;
RA   Lecrenier N.L., van der Bruggen P., Foury F.;
RT   "Mitochondrial DNA polymerases from yeast to man: a new family of
RT   polymerases.";
RL   Gene 185:147-152(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-GLN-55 INS.
RC   TISSUE=Brain;
RA   Watanabe T.K., Shimizu F., Nishino N., Fujiwara T., Kanemoto N., Suzuki M.,
RA   Nakamura Y., Hirai Y., Maekawa H., Takahashi E.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-55 INS; GLN-193;
RP   CYS-546; LYS-662; TRP-1142; GLY-1143; CYS-1146 AND HIS-1236.
RG   NIEHS SNPs program;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, ASSOCIATION WITH MITOCHONDRIAL DNA, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18063578; DOI=10.1074/jbc.m708444200;
RA   Bogenhagen D.F., Rousseau D., Burke S.;
RT   "The layered structure of human mitochondrial DNA nucleoids.";
RL   J. Biol. Chem. 283:3665-3675(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   INVOLVEMENT IN SCAE, AND VARIANTS SCAE THR-467; HIS-497 AND SER-748.
RX   PubMed=26942291; DOI=10.1016/j.ajhg.2016.01.009;
RA   Sandford E., Bird T.D., Li J.Z., Burmeister M.;
RT   "PRICKLE2 mutations might not be involved in epilepsy.";
RL   Am. J. Hum. Genet. 98:588-589(2016).
RN   [9]
RP   INTERACTION WITH TTC3.
RX   PubMed=29290964; DOI=10.18632/oncotarget.22476;
RA   Gong Y., Wang X., Shang X., Xiao S.P., Li W., Shang Y., Dou F.;
RT   "Tetratricopeptide repeat domain 3 overexpression tends to form aggregates
RT   and inhibit ubiquitination and degradation of DNA polymerase gamma.";
RL   Oncotarget 8:106475-106485(2017).
RN   [10]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955.
RX   PubMed=11431686; DOI=10.1038/90034;
RA   Van Goethem G., Dermaut B., Loefgren A., Martin J.-J., Van Broeckhoven C.;
RT   "Mutation of POLG is associated with progressive external ophthalmoplegia
RT   characterized by mtDNA deletions.";
RL   Nat. Genet. 28:211-212(2001).
RN   [11]
RP   VARIANTS PEOA1 ASP-923; HIS-943; CYS-955; SER-957 AND LEU-1176, AND
RP   VARIANTS PEO ILE-251; LEU-309 AND SER-848.
RX   PubMed=12210792; DOI=10.1002/ana.10278;
RA   Lamantea E., Tiranti V., Bordoni A., Toscano A., Bono F., Servidei S.,
RA   Papadimitriou A., Spelbrink H., Silvestri L., Casari G., Comi G.P.,
RA   Zeviani M.;
RT   "Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of
RT   autosomal dominant or recessive progressive external ophthalmoplegia.";
RL   Ann. Neurol. 52:211-219(2002).
RN   [12]
RP   CHARACTERIZATION OF VARIANT PEOA1 CYS-955.
RX   PubMed=11897778; DOI=10.1074/jbc.c200100200;
RA   Ponamarev M.V., Longley M.J., Nguyen D., Kunkel T.A., Copeland W.C.;
RT   "Active site mutation in DNA polymerase gamma associated with progressive
RT   external ophthalmoplegia causes error-prone DNA synthesis.";
RL   J. Biol. Chem. 277:15225-15228(2002).
RN   [13]
RP   VARIANTS PEOB1 TRP-579; LEU-587; THR-889 AND VAL-1076, AND VARIANT
RP   HIS-1236.
RX   PubMed=12975295; DOI=10.1001/archneur.60.9.1279;
RA   Filosto M., Mancuso M., Nishigaki Y., Pancrudo J., Harati Y., Gooch C.,
RA   Mankodi A., Bayne L., Bonilla E., Shanske S., Hirano M., DiMauro S.;
RT   "Clinical and genetic heterogeneity in progressive external ophthalmoplegia
RT   due to mutations in polymerase gamma.";
RL   Arch. Neurol. 60:1279-1284(2003).
RN   [14]
RP   VARIANTS MTDPS4B ILE-251; LEU-587 AND SER-864.
RX   PubMed=12825077; DOI=10.1038/sj.ejhg.5201002;
RA   Van Goethem G., Schwartz M., Loefgren A., Dermaut B., Van Broeckhoven C.,
RA   Vissing J.;
RT   "Novel POLG mutations in progressive external ophthalmoplegia mimicking
RT   mitochondrial neurogastrointestinal encephalomyopathy.";
RL   Eur. J. Hum. Genet. 11:547-549(2003).
RN   [15]
RP   VARIANT PEOB1 SER-848.
RX   PubMed=12872260; DOI=10.1002/humu.10246;
RA   Van Goethem G., Loefgren A., Dermaut B., Ceuterick C., Martin J.-J.,
RA   Van Broeckhoven C.;
RT   "Digenic progressive external ophthalmoplegia in a sporadic patient:
RT   recessive mutations in POLG and C10orf2/Twinkle.";
RL   Hum. Mutat. 22:175-176(2003).
RN   [16]
RP   VARIANTS PEOB1 ILE-251; ALA-268; ARG-312; THR-467; GLN-562; LEU-587;
RP   PRO-807 AND TYR-932, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=14635118; DOI=10.1002/humu.9203;
RA   Di Fonzo A., Bordoni A., Crimi M., Sara G., Del Bo R., Bresolin N.,
RA   Comi G.P.;
RT   "POLG mutations in sporadic mitochondrial disorders with multiple mtDNA
RT   deletions.";
RL   Hum. Mutat. 22:498-499(2003).
RN   [17]
RP   VARIANTS PEOB1 TRP-227; ILE-251; ARG-312; VAL-431; THR-467; GLN-1047;
RP   CYS-1096 AND CYS-1104.
RX   PubMed=12707443; DOI=10.1212/01.wnl.0000056088.09408.3c;
RA   Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F.,
RA   Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., Zeviani M.;
RT   "Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external
RT   ophthalmoplegia (PEO).";
RL   Neurology 60:1354-1356(2003).
RN   [18]
RP   VARIANT MERRF THR-467.
RX   PubMed=14694057; DOI=10.1212/01.wnl.0000098997.23471.65;
RA   Van Goethem G., Mercelis R., Loefgren A., Seneca S., Ceuterick C.,
RA   Martin J.-J., Van Broeckhoven C.;
RT   "Patient homozygous for a recessive POLG mutation presents with features of
RT   MERRF.";
RL   Neurology 61:1811-1813(2003).
RN   [19]
RP   VARIANTS PEOB1 PRO-3; ARG-304; THR-467 AND CYS-955, AND VARIANT SANDO
RP   TRP-627.
RX   PubMed=12565911; DOI=10.1016/s0960-8966(02)00216-x;
RA   Van Goethem G., Martin J.-J., Dermaut B., Loefgren A., Wibail A.,
RA   Ververken D., Tack P., Dehaene I., Van Zandijcke M., Moonen M.,
RA   Ceuterick C., De Jonghe P., Van Broeckhoven C.;
RT   "Recessive POLG mutations presenting with sensory and ataxic neuropathy in
RT   compound heterozygote patients with progressive external ophthalmoplegia.";
RL   Neuromuscul. Disord. 13:133-142(2003).
RN   [20]
RP   VARIANT MTDPS4A THR-467.
RX   PubMed=15122711; DOI=10.1002/ana.20079;
RA   Naviaux R.K., Nguyen K.V.;
RT   "POLG mutations associated with Alpers' syndrome and mitochondrial DNA
RT   depletion.";
RL   Ann. Neurol. 55:706-712(2004).
RN   [21]
RP   VARIANTS PEOB1 TRP-227; ILE-251 LEU-309; LEU-587; SER-848 ILE-1106 AND
RP   LEU-1176.
RX   PubMed=15349879; DOI=10.1002/ana.20219;
RA   Lamantea E., Zeviani M.;
RT   "Sequence analysis of familial PEO shows additional mutations associated
RT   with the 752C-->T and 3527C-->T changes in the POLG1 gene.";
RL   Ann. Neurol. 56:454-455(2004).
RN   [22]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=15534189; DOI=10.1001/archneur.61.11.1777;
RA   Mancuso M., Filosto M., Oh S.J., DiMauro S.;
RT   "A novel polymerase gamma mutation in a family with ophthalmoplegia,
RT   neuropathy, and parkinsonism.";
RL   Arch. Neurol. 61:1777-1779(2004).
RN   [23]
RP   VARIANTS PEOA1 CYS-953 AND CYS-955, AND VARIANTS PEOB1 ASP-468 AND
RP   THR-1105.
RX   PubMed=15351195; DOI=10.1016/s0140-6736(04)16983-3;
RA   Luoma P., Melberg A., Rinne J.O., Kaukonen J.A., Nupponen N.N.,
RA   Chalmers R.M., Oldfors A., Rautakorpi I., Peltonen L., Majamaa K.,
RA   Somer H., Suomalainen A.;
RT   "Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma
RT   mutations: clinical and molecular genetic study.";
RL   Lancet 364:875-882(2004).
RN   [24]
RP   VARIANTS SANDO TYR-932 AND ARG-1051.
RX   PubMed=14745080; DOI=10.1212/wnl.62.2.316;
RA   Mancuso M., Filosto M., Bellan M., Liguori R., Montagna P., Baruzzi A.,
RA   DiMauro S., Carelli V.;
RT   "POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy,
RT   ataxia, and deafness.";
RL   Neurology 62:316-318(2004).
RN   [25]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=15477547; DOI=10.1212/01.wnl.0000140494.58732.83;
RA   Van Goethem G., Luoma P., Rantamaeki M., Al-Memar A., Kaakkola S.,
RA   Hackman P., Krahe R., Loefgren A., Martin J.-J., De Jonghe P.,
RA   Suomalainen A., Udd B., Van Broeckhoven C.;
RT   "POLG mutations in neurodegenerative disorders with ataxia but no muscle
RT   involvement.";
RL   Neurology 63:1251-1257(2004).
RN   [26]
RP   VARIANT SANDO SER-748, AND VARIANT GLY-1143.
RX   PubMed=16080118; DOI=10.1086/444548;
RA   Hakonen A.H., Heiskanen S., Juvonen V., Lappalainen I., Luoma P.T.,
RA   Rantamaeki M., Van Goethem G., Loefgren A., Hackman P., Paetau A.,
RA   Kaakkola S., Majamaa K., Varilo T., Udd B., Kaeaeriaeinen H., Bindoff L.A.,
RA   Suomalainen A.;
RT   "Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal
RT   recessive ataxia with ancient European origin.";
RL   Am. J. Hum. Genet. 77:430-441(2005).
RN   [27]
RP   VARIANTS MTDPS4A SER-748 AND SER-848.
RX   PubMed=15929042; DOI=10.1002/ana.20498;
RA   Davidzon G., Mancuso M., Ferraris S., Quinzii C., Hirano M., Peters H.L.,
RA   Kirby D., Thorburn D.R., DiMauro S.;
RT   "POLG mutations and Alpers syndrome.";
RL   Ann. Neurol. 57:921-923(2005).
RN   [28]
RP   VARIANTS MTDPS4A GLY-232; PRO-244; ILE-251 THR-467; LEU-587; SER-748
RP   SER-848 AND PRO-957, AND VARIANT GLY-1143.
RX   PubMed=15689359; DOI=10.1093/brain/awh410;
RA   Ferrari G., Lamantea E., Donati A., Filosto M., Briem E., Carrara F.,
RA   Parini R., Simonati A., Santer R., Zeviani M.;
RT   "Infantile hepatocerebral syndromes associated with mutations in the
RT   mitochondrial DNA polymerase-gammaA.";
RL   Brain 128:723-731(2005).
RN   [29]
RP   VARIANT PEOB1 THR-467, VARIANT SANDO GLN-627, VARIANT HIS-1236,
RP   CHARACTERIZATION OF VARIANT PEOB1 THR-467, AND CHARACTERIZATION OF VARIANT
RP   SANDO GLN-627.
RX   PubMed=15917273; DOI=10.1093/hmg/ddi196;
RA   Luoma P.T., Luo N., Loescher W.N., Farr C.L., Horvath R., Wanschitz J.,
RA   Kiechl S., Kaguni L.S., Suomalainen A.;
RT   "Functional defects due to spacer-region mutations of human mitochondrial
RT   DNA polymerase in a family with an ataxia-myopathy syndrome.";
RL   Hum. Mol. Genet. 14:1907-1920(2005).
RN   [30]
RP   VARIANTS SANDO THR-467; HIS-497 AND SER-748.
RX   PubMed=15824347; DOI=10.1212/01.wnl.0000156516.77696.5a;
RA   Winterthun S., Ferrari G., He L., Taylor R.W., Zeviani M., Turnbull D.M.,
RA   Engelsen B.A., Moen G., Bindoff L.A.;
RT   "Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial
RT   polymerase gamma mutations.";
RL   Neurology 64:1204-1208(2005).
RN   [31]
RP   VARIANTS PEOB1 ARG-737 AND TRP-853.
RX   PubMed=16634032; DOI=10.1002/ana.20831;
RA   Davidzon G., Greene P., Mancuso M., Klos K.J., Ahlskog J.E., Hirano M.,
RA   DiMauro S.;
RT   "Early-onset familial parkinsonism due to POLG mutations.";
RL   Ann. Neurol. 59:859-862(2006).
RN   [32]
RP   VARIANTS PEOB1 LEU-603; TRP-853; CYS-1146 AND ASN-1184.
RX   PubMed=16401742; DOI=10.1001/archneur.63.1.107;
RA   Gonzalez-Vioque E., Blazquez A., Fernandez-Moreira D., Bornstein B.,
RA   Bautista J., Arpa J., Navarro C., Campos Y., Fernandez-Moreno M.A.,
RA   Garesse R., Arenas J., Martin M.A.;
RT   "Association of novel POLG mutations and multiple mitochondrial DNA
RT   deletions with variable clinical phenotypes in a Spanish population.";
RL   Arch. Neurol. 63:107-111(2006).
RN   [33]
RP   VARIANTS PEOB1 HIS-308; TRP-574 AND ARG-648, VARIANT SANDO VAL-517, AND
RP   VARIANTS MTDPS4A ASP-767; HIS-879; SER-885; PRO-914; HIS-1096 AND ASN-1191.
RX   PubMed=16621917; DOI=10.1093/brain/awl088;
RA   Horvath R., Hudson G., Ferrari G., Fuetterer N., Ahola S., Lamantea E.,
RA   Prokisch H., Lochmueller H., McFarland R., Ramesh V., Klopstock T.,
RA   Freisinger P., Salvi F., Mayr J.A., Santer R., Tesarova M., Zeman J.,
RA   Udd B., Taylor R.W., Turnbull D., Hanna M., Fialho D., Suomalainen A.,
RA   Zeviani M., Chinnery P.F.;
RT   "Phenotypic spectrum associated with mutations of the mitochondrial
RT   polymerase gamma gene.";
RL   Brain 129:1674-1684(2006).
RN   [34]
RP   VARIANTS PEOB1 ARG-304; ASP-380 AND THR-467, VARIANT SANDO SER-748, VARIANT
RP   MTDPS4A PRO-914, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=16639411; DOI=10.1038/sj.ejhg.5201627;
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RT   "Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple
RT   deletions or depletion of mitochondrial DNA by a dHPLC-based assay.";
RL   Eur. J. Hum. Genet. 14:917-922(2006).
RN   [35]
RP   ERRATUM OF PUBMED:16639411.
RA   Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C.,
RA   Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C.,
RA   Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D.,
RA   Paquis-Flucklinger V.;
RL   Eur. J. Hum. Genet. 15:607-607(2006).
RN   [36]
RP   VARIANTS SANDO ARG-648 AND CYS-807.
RX   PubMed=16919951; DOI=10.1016/j.nmd.2006.05.016;
RA   Gago M.F., Rosas M.J., Guimaraes J., Ferreira M., Vilarinho L., Castro L.,
RA   Carpenter S.;
RT   "SANDO: two novel mutations in POLG1 gene.";
RL   Neuromuscul. Disord. 16:507-509(2006).
RN   [37]
RP   VARIANT PEOA1 ASN-511, AND VARIANT PHE-463.
RX   PubMed=17420318; DOI=10.1001/archneur.64.4.553;
RA   Hudson G., Schaefer A.M., Taylor R.W., Tiangyou W., Gibson A., Venables G.,
RA   Griffiths P., Burn D.J., Turnbull D.M., Chinnery P.F.;
RT   "Mutation of the linker region of the polymerase gamma-1 (POLG1) gene
RT   associated with progressive external ophthalmoplegia and Parkinsonism.";
RL   Arch. Neurol. 64:553-557(2007).
RN   [38]
RP   VARIANT PEOA1 CYS-831.
RX   PubMed=17846414; DOI=10.1212/01.wnl.0000276955.23735.eb;
RA   Luoma P.T., Eerola J., Ahola S., Hakonen A.H., Hellstroem O.,
RA   Kivistoe K.T., Tienari P.J., Suomalainen A.;
RT   "Mitochondrial DNA polymerase gamma variants in idiopathic sporadic
RT   Parkinson disease.";
RL   Neurology 69:1152-1159(2007).
RN   [39]
RP   VARIANT PEOA1 HIS-1186.
RX   PubMed=18575922; DOI=10.1007/s00415-008-0926-3;
RA   Virgilio R., Ronchi D., Hadjigeorgiou G.M., Bordoni A., Saladino F.,
RA   Moggio M., Adobbati L., Kafetsouli D., Tsironi E., Previtali S.,
RA   Papadimitriou A., Bresolin N., Comi G.P.;
RT   "Novel Twinkle (PEO1) gene mutations in Mendelian progressive external
RT   ophthalmoplegia.";
RL   J. Neurol. 255:1384-1391(2008).
RN   [40]
RP   VARIANTS LS HIS-232 AND SER-848, VARIANTS MTDPS4A ILE-251; THR-467;
RP   LEU-587; SER-748; CYS-831; SER-848; PRO-914; TYR-1110; ARG-1134 AND
RP   LYS-1136, AND VARIANTS GLY-1143 AND HIS-1236.
RX   PubMed=18828154; DOI=10.1002/humu.20852;
RA   Taanman J.-W., Rahman S., Pagnamenta A.T., Morris A.A.M.,
RA   Bitner-Glindzicz M., Wolf N.I., Leonard J.V., Clayton P.T.,
RA   Schapira A.H.V.;
RT   "Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA
RT   depletion.";
RL   Hum. Mutat. 30:248-254(2009).
RN   [41]
RP   VARIANTS MTDPS4B TRP-227 AND SER-848.
RX   PubMed=19307547; DOI=10.1212/01.wnl.0000345002.47396.e1;
RA   Giordano C., Powell H., Leopizzi M., de Curtis M., Travaglini C.,
RA   Sebastiani M., Gallo P., Taylor R.W., d'Amati G.;
RT   "Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to
RT   POLG1 mutations.";
RL   Neurology 72:1103-1105(2009).
RN   [42]
RP   VARIANT MTDPS4A CYS-1096.
RX   PubMed=25129007; DOI=10.1007/s13312-014-0475-z;
RA   Bijarnia-Mahay S., Mohan N., Goyal D., Verma I.C.;
RT   "Mitochondrial DNA depletion syndrome causing liver failure.";
RL   Indian Pediatr. 51:666-668(2014).
CC   -!- FUNCTION: Involved in the replication of mitochondrial DNA. Associates
CC       with mitochondrial DNA.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:11130,
CC         Rhea:RHEA-COMP:11131, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:83828; EC=2.7.7.7;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Heterotrimer composed of a catalytic subunit and a homodimer
CC       of accessory subunits (By similarity). Interacts with TTC3
CC       (PubMed:29290964). {ECO:0000250|UniProtKB:Q27607,
CC       ECO:0000269|PubMed:29290964}.
CC   -!- INTERACTION:
CC       P54098; Q9UHN1: POLG2; NbExp=11; IntAct=EBI-852624, EBI-852642;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:18063578}.
CC       Mitochondrion matrix, mitochondrion nucleoid
CC       {ECO:0000269|PubMed:18063578}.
CC   -!- POLYMORPHISM: The poly-Gln region seems to be polymorphic.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA
CC       deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A disorder
CC       characterized by progressive weakness of ocular muscles and levator
CC       muscle of the upper eyelid. In a minority of cases, it is associated
CC       with skeletal myopathy, which predominantly involves axial or proximal
CC       muscles and which causes abnormal fatigability and even permanent
CC       muscle weakness. Ragged-red fibers and atrophy are found on muscle
CC       biopsy. A large proportion of chronic ophthalmoplegias are associated
CC       with other symptoms, leading to a multisystemic pattern of this
CC       disease. Additional symptoms are variable, and may include cataracts,
CC       hearing loss, sensory axonal neuropathy, ataxia, depression,
CC       hypogonadism, and parkinsonism. {ECO:0000269|PubMed:11897778,
CC       ECO:0000269|PubMed:12210792, ECO:0000269|PubMed:15351195,
CC       ECO:0000269|PubMed:15534189, ECO:0000269|PubMed:17420318,
CC       ECO:0000269|PubMed:17846414, ECO:0000269|PubMed:18575922}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA
CC       deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]: A severe form
CC       of progressive external ophthalmoplegia, a disorder characterized by
CC       progressive weakness of ocular muscles and levator muscle of the upper
CC       eyelid. It is clinically more heterogeneous than the autosomal dominant
CC       forms. {ECO:0000269|PubMed:11431686, ECO:0000269|PubMed:12565911,
CC       ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12872260,
CC       ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118,
CC       ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15351195,
CC       ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15917273,
CC       ECO:0000269|PubMed:16401742, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16634032, ECO:0000269|PubMed:16639411}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Sensory ataxic neuropathy dysarthria and ophthalmoparesis
CC       (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial
CC       dysfunction associated with mitochondrial depletion in skeletal muscle
CC       and peripheral nerve tissue. The clinical triad of symptoms consists of
CC       sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However,
CC       the phenotype varies widely, even within the same family, and can also
CC       include myopathy, seizures, and hearing loss.
CC       {ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:14745080,
CC       ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15824347,
CC       ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16080118,
CC       ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411,
CC       ECO:0000269|PubMed:16919951}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4A (MTDPS4A)
CC       [MIM:203700]: An autosomal recessive hepatocerebral syndrome due to
CC       mitochondrial dysfunction. The typical course of the disease includes
CC       severe developmental delay, intractable seizures, liver failure, and
CC       death in childhood. Refractory seizures, cortical blindness,
CC       progressive liver dysfunction, and acute liver failure after exposure
CC       to valproic acid are considered diagnostic features. The
CC       neuropathological hallmarks are neuronal loss, spongiform degeneration,
CC       and astrocytosis of the visual cortex. Liver biopsy results show
CC       steatosis, often progressing to cirrhosis.
CC       {ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15689359,
CC       ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:16621917,
CC       ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154,
CC       ECO:0000269|PubMed:25129007}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 4B (MTDPS4B)
CC       [MIM:613662]: An autosomal recessive progressive multisystem disorder
CC       due to mitochondrial dysfunction. It is clinically characterized by
CC       chronic gastrointestinal dysmotility and pseudo-obstruction, cachexia,
CC       progressive external ophthalmoplegia, axonal sensory ataxic neuropathy,
CC       and muscle weakness. {ECO:0000269|PubMed:12825077,
CC       ECO:0000269|PubMed:19307547}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive
CC       neurodegenerative disorder characterized by the presence of focal,
CC       bilateral lesions in one or more areas of the central nervous system
CC       including the brainstem, thalamus, basal ganglia, cerebellum and spinal
CC       cord. Clinical features depend on which areas of the central nervous
CC       system are involved and include subacute onset of psychomotor
CC       retardation, hypotonia, ataxia, weakness, vision loss, eye movement
CC       abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:18828154}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Spinocerebellar ataxia with epilepsy (SCAE) [MIM:607459]: An
CC       autosomal recessive syndrome characterized by headaches and/or seizures
CC       manifesting in childhood or adolescence, cerebellar and sensory ataxia,
CC       dysarthria, and myoclonus manifesting in early adulthood.
CC       Neuropathological findings include spinocerebellar degeneration
CC       associated with cortical neuronal degeneration in advanced cases.
CC       {ECO:0000269|PubMed:26942291}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/polg/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U60325; AAC50712.1; -; mRNA.
DR   EMBL; X98093; CAA66719.1; -; mRNA.
DR   EMBL; D84103; BAA12223.1; -; mRNA.
DR   EMBL; AF497906; AAM77583.1; -; Genomic_DNA.
DR   EMBL; BC042571; AAH42571.1; -; mRNA.
DR   EMBL; BC050559; AAH50559.1; -; mRNA.
DR   CCDS; CCDS10350.1; -.
DR   PIR; G02750; G02750.
DR   RefSeq; NP_001119603.1; NM_001126131.1.
DR   RefSeq; NP_002684.1; NM_002693.2.
DR   PDB; 3IKM; X-ray; 3.24 A; A/D=70-1239.
DR   PDB; 4ZTU; X-ray; 3.30 A; A=30-1239.
DR   PDB; 4ZTZ; X-ray; 3.44 A; A=30-1239.
DR   PDB; 5C51; X-ray; 3.43 A; A=25-1239.
DR   PDB; 5C52; X-ray; 3.64 A; A=25-1239.
DR   PDB; 5C53; X-ray; 3.57 A; A=25-1239.
DR   PDBsum; 3IKM; -.
DR   PDBsum; 4ZTU; -.
DR   PDBsum; 4ZTZ; -.
DR   PDBsum; 5C51; -.
DR   PDBsum; 5C52; -.
DR   PDBsum; 5C53; -.
DR   SMR; P54098; -.
DR   BioGrid; 111424; 28.
DR   ComplexPortal; CPX-2093; DNA polymerase gamma complex.
DR   IntAct; P54098; 22.
DR   MINT; P54098; -.
DR   STRING; 9606.ENSP00000268124; -.
DR   BindingDB; P54098; -.
DR   ChEMBL; CHEMBL2732; -.
DR   DrugCentral; P54098; -.
DR   iPTMnet; P54098; -.
DR   PhosphoSitePlus; P54098; -.
DR   BioMuta; POLG; -.
DR   DMDM; 1706507; -.
DR   EPD; P54098; -.
DR   jPOST; P54098; -.
DR   MassIVE; P54098; -.
DR   MaxQB; P54098; -.
DR   PaxDb; P54098; -.
DR   PeptideAtlas; P54098; -.
DR   PRIDE; P54098; -.
DR   ProteomicsDB; 56642; -.
DR   Antibodypedia; 28558; 199 antibodies.
DR   Ensembl; ENST00000268124; ENSP00000268124; ENSG00000140521.
DR   Ensembl; ENST00000442287; ENSP00000399851; ENSG00000140521.
DR   GeneID; 5428; -.
DR   KEGG; hsa:5428; -.
DR   UCSC; uc002bnr.5; human.
DR   CTD; 5428; -.
DR   DisGeNET; 5428; -.
DR   GeneCards; POLG; -.
DR   GeneReviews; POLG; -.
DR   HGNC; HGNC:9179; POLG.
DR   HPA; ENSG00000140521; Low tissue specificity.
DR   MalaCards; POLG; -.
DR   MIM; 157640; phenotype.
DR   MIM; 174763; gene.
DR   MIM; 203700; phenotype.
DR   MIM; 256000; phenotype.
DR   MIM; 258450; phenotype.
DR   MIM; 607459; phenotype.
DR   MIM; 613662; phenotype.
DR   neXtProt; NX_P54098; -.
DR   OpenTargets; ENSG00000140521; -.
DR   Orphanet; 726; Alpers-Huttenlocher syndrome.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   Orphanet; 254886; Autosomal recessive progressive external ophthalmoplegia.
DR   Orphanet; 298; Mitochondrial neurogastrointestinal encephalomyopathy.
DR   Orphanet; 402082; Progressive myoclonic epilepsy type 5.
DR   Orphanet; 94125; Recessive mitochondrial ataxia syndrome.
DR   Orphanet; 70595; Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome.
DR   Orphanet; 254881; Spinocerebellar ataxia with epilepsy.
DR   PharmGKB; PA33500; -.
DR   eggNOG; KOG3657; Eukaryota.
DR   eggNOG; COG0749; LUCA.
DR   GeneTree; ENSGT00390000000453; -.
DR   HOGENOM; CLU_001524_2_2_1; -.
DR   InParanoid; P54098; -.
DR   KO; K02332; -.
DR   OMA; DTEVMWK; -.
DR   OrthoDB; 86850at2759; -.
DR   PhylomeDB; P54098; -.
DR   SIGNOR; P54098; -.
DR   ChiTaRS; POLG; human.
DR   GeneWiki; POLG; -.
DR   GenomeRNAi; 5428; -.
DR   Pharos; P54098; Tchem.
DR   PRO; PR:P54098; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P54098; protein.
DR   Bgee; ENSG00000140521; Expressed in tendon of biceps brachii and 239 other tissues.
DR   ExpressionAtlas; P54098; baseline and differential.
DR   Genevisible; P54098; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005760; C:gamma DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IDA:FlyBase.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; IDA:MGI.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IDA:UniProtKB.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IMP:UniProtKB.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR002297; DNA-dir_DNA_pol_A_mt.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR041336; DNApol_Exo.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   PANTHER; PTHR10267; PTHR10267; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   Pfam; PF18136; DNApol_Exo; 1.
DR   PIRSF; PIRSF000797; DNA_pol_mt; 1.
DR   PRINTS; PR00867; DNAPOLG.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disease mutation; DNA replication; DNA-binding;
KW   DNA-directed DNA polymerase; Epilepsy; Leigh syndrome; Magnesium;
KW   Mitochondrion; Mitochondrion nucleoid; Neurodegeneration; Neuropathy;
KW   Nucleotidyltransferase; Polymorphism; Primary mitochondrial disease;
KW   Progressive external ophthalmoplegia; Reference proteome; Transferase.
FT   CHAIN           1..1239
FT                   /note="DNA polymerase subunit gamma-1"
FT                   /id="PRO_0000101270"
FT   COMPBIAS        43..60
FT                   /note="Poly-Gln"
FT   COMPBIAS        535..538
FT                   /note="Poly-Glu"
FT   VARIANT         3
FT                   /note="R -> P (in PEOB1; dbSNP:rs121918045)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911"
FT                   /id="VAR_012153"
FT   VARIANT         18
FT                   /note="P -> S (in dbSNP:rs3087373)"
FT                   /id="VAR_014904"
FT   VARIANT         55
FT                   /note="Q -> QQ"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019265"
FT   VARIANT         55
FT                   /note="Q -> QQQ"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019266"
FT   VARIANT         193
FT                   /note="R -> Q (in dbSNP:rs3176162)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_019267"
FT   VARIANT         227
FT                   /note="R -> W (in PEOB1 and MTDPS4B; dbSNP:rs121918056)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:19307547"
FT                   /id="VAR_023663"
FT   VARIANT         232
FT                   /note="R -> G (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058870"
FT   VARIANT         232
FT                   /note="R -> H (in LS; dbSNP:rs113994093)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058871"
FT   VARIANT         244
FT                   /note="L -> P (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058872"
FT   VARIANT         251
FT                   /note="T -> I (in PEOB1, MTDPS4A and MTDPS4B;
FT                   dbSNP:rs113994094)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12825077,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|PubMed:26942291"
FT                   /id="VAR_023664"
FT   VARIANT         268
FT                   /note="G -> A (in PEOB1; sporadic case; dbSNP:rs61752784)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058873"
FT   VARIANT         304
FT                   /note="L -> R (in PEOB1; also found in SANDO;
FT                   dbSNP:rs121918044)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:16639411"
FT                   /id="VAR_012154"
FT   VARIANT         304
FT                   /note="L -> SANDO (in PEOB1)"
FT                   /id="VAR_058874"
FT   VARIANT         308
FT                   /note="Q -> H (in PEOB1; sporadic case; dbSNP:rs745539599)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058875"
FT   VARIANT         309
FT                   /note="R -> L (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023665"
FT   VARIANT         312
FT                   /note="W -> R (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:14635118"
FT                   /id="VAR_023666"
FT   VARIANT         324
FT                   /note="P -> S (in dbSNP:rs2307437)"
FT                   /id="VAR_014905"
FT   VARIANT         380
FT                   /note="G -> D (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:16639411"
FT                   /id="VAR_058876"
FT   VARIANT         431
FT                   /note="G -> V (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023667"
FT   VARIANT         463
FT                   /note="L -> F (in dbSNP:rs150828914)"
FT                   /evidence="ECO:0000269|PubMed:17420318"
FT                   /id="VAR_058877"
FT   VARIANT         467
FT                   /note="A -> T (in PEOB1, SANDO, SCAE and MTDPS4A; results
FT                   in clearly decreased activity, DNA binding and processivity
FT                   of the polymerase; dbSNP:rs113994095)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:14694057,
FT                   ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15477547,
FT                   ECO:0000269|PubMed:15689359, ECO:0000269|PubMed:15824347,
FT                   ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154, ECO:0000269|PubMed:26942291"
FT                   /id="VAR_012155"
FT   VARIANT         468
FT                   /note="N -> D (in PEOB1; dbSNP:rs145843073)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023668"
FT   VARIANT         497
FT                   /note="Q -> H (in SANDO and SCAE; dbSNP:rs121918052)"
FT                   /evidence="ECO:0000269|PubMed:15824347,
FT                   ECO:0000269|PubMed:26942291"
FT                   /id="VAR_023669"
FT   VARIANT         511
FT                   /note="S -> N (in PEOA1; dbSNP:rs121918055)"
FT                   /evidence="ECO:0000269|PubMed:17420318"
FT                   /id="VAR_058878"
FT   VARIANT         517
FT                   /note="G -> V (in SANDO; dbSNP:rs61752783)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058879"
FT   VARIANT         546
FT                   /note="R -> C (in dbSNP:rs2307447)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014906"
FT   VARIANT         562
FT                   /note="R -> Q (in PEOB1; sporadic case; dbSNP:rs781168350)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058880"
FT   VARIANT         574
FT                   /note="R -> W (in PEOB1; sporadic case; dbSNP:rs774474723)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058881"
FT   VARIANT         579
FT                   /note="R -> W (in PEOB1; dbSNP:rs556925652)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023670"
FT   VARIANT         587
FT                   /note="P -> L (in PEOB1, MTDPS4A and MTDPS4B;
FT                   dbSNP:rs113994096)"
FT                   /evidence="ECO:0000269|PubMed:12825077,
FT                   ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023671"
FT   VARIANT         603
FT                   /note="M -> L (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:16401742"
FT                   /id="VAR_058882"
FT   VARIANT         627
FT                   /note="R -> Q (in SANDO; shows DNA binding affinity and
FT                   processivities similar to the controls; dbSNP:rs375305567)"
FT                   /evidence="ECO:0000269|PubMed:15917273"
FT                   /id="VAR_058883"
FT   VARIANT         627
FT                   /note="R -> W (in SANDO; sporadic case; dbSNP:rs121918046)"
FT                   /evidence="ECO:0000269|PubMed:12565911"
FT                   /id="VAR_023672"
FT   VARIANT         648
FT                   /note="P -> R (in PEOB1; sporadic case; also in SANDO;
FT                   dbSNP:rs796052906)"
FT                   /evidence="ECO:0000269|PubMed:16621917,
FT                   ECO:0000269|PubMed:16919951"
FT                   /id="VAR_058884"
FT   VARIANT         662
FT                   /note="E -> K (in dbSNP:rs2307450)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014907"
FT   VARIANT         737
FT                   /note="G -> R (in PEOB1; with absence of progressive
FT                   external ophthalmoplegia; dbSNP:rs121918054)"
FT                   /evidence="ECO:0000269|PubMed:16634032"
FT                   /id="VAR_058885"
FT   VARIANT         748
FT                   /note="W -> S (in SANDO, SCAE and MTDPS4A; unknown
FT                   pathological significance; dbSNP:rs113994097)"
FT                   /evidence="ECO:0000269|PubMed:15477547,
FT                   ECO:0000269|PubMed:15824347, ECO:0000269|PubMed:15929042,
FT                   ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023673"
FT   VARIANT         767
FT                   /note="A -> D (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058886"
FT   VARIANT         807
FT                   /note="R -> C (in SANDO; dbSNP:rs769827124)"
FT                   /evidence="ECO:0000269|PubMed:16919951"
FT                   /id="VAR_058887"
FT   VARIANT         807
FT                   /note="R -> P (in PEOB1; sporadic case)"
FT                   /evidence="ECO:0000269|PubMed:14635118"
FT                   /id="VAR_058888"
FT   VARIANT         831
FT                   /note="Y -> C (in PEOA1 and MTDPS4A; unknown pathological
FT                   significance; dbSNP:rs41549716)"
FT                   /evidence="ECO:0000269|PubMed:15534189,
FT                   ECO:0000269|PubMed:17846414, ECO:0000269|PubMed:18828154"
FT                   /id="VAR_023674"
FT   VARIANT         848
FT                   /note="G -> S (in PEOB1, MTDPS4A, MTDPS4B and LS;
FT                   dbSNP:rs113994098)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12872260, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|PubMed:19307547"
FT                   /id="VAR_023675"
FT   VARIANT         853
FT                   /note="R -> W (in PEOB1; with absence of progressive
FT                   external ophthalmoplegia; dbSNP:rs121918053)"
FT                   /evidence="ECO:0000269|PubMed:16401742,
FT                   ECO:0000269|PubMed:16634032"
FT                   /id="VAR_058889"
FT   VARIANT         864
FT                   /note="N -> S (in MTDPS4B; dbSNP:rs121918050)"
FT                   /evidence="ECO:0000269|PubMed:12825077"
FT                   /id="VAR_023676"
FT   VARIANT         879
FT                   /note="Q -> H (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058890"
FT   VARIANT         885
FT                   /note="T -> S (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058891"
FT   VARIANT         889
FT                   /note="A -> T (in PEOB1; dbSNP:rs763393580)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023677"
FT   VARIANT         914
FT                   /note="T -> P (in MTDPS4A; dbSNP:rs139590686)"
FT                   /evidence="ECO:0000269|PubMed:16621917,
FT                   ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058892"
FT   VARIANT         923
FT                   /note="G -> D (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023678"
FT   VARIANT         932
FT                   /note="H -> Y (in SANDO and PEOB1; sporadic case;
FT                   dbSNP:rs121918048)"
FT                   /evidence="ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:14745080"
FT                   /id="VAR_023679"
FT   VARIANT         943
FT                   /note="R -> H (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023680"
FT   VARIANT         953
FT                   /note="R -> C (in PEOA1; dbSNP:rs11546842)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023681"
FT   VARIANT         955
FT                   /note="Y -> C (in PEOA1; can underlie parkinsonism; 45-fold
FT                   decrease in apparent binding affinity for the incoming
FT                   nucleoside triphosphate; 2-fold less accurate for basepair
FT                   substitutions than wild-type; dbSNP:rs113994099)"
FT                   /evidence="ECO:0000269|PubMed:11431686,
FT                   ECO:0000269|PubMed:11897778, ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:15351195"
FT                   /id="VAR_012156"
FT   VARIANT         957
FT                   /note="A -> P (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:15689359"
FT                   /id="VAR_058893"
FT   VARIANT         957
FT                   /note="A -> S (in PEOA1; dbSNP:rs121918051)"
FT                   /evidence="ECO:0000269|PubMed:12210792"
FT                   /id="VAR_023682"
FT   VARIANT         1047
FT                   /note="R -> Q (in PEOB1; sporadic case; dbSNP:rs768028281)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023683"
FT   VARIANT         1051
FT                   /note="G -> R (in SANDO; dbSNP:rs121918049)"
FT                   /evidence="ECO:0000269|PubMed:14745080"
FT                   /id="VAR_023684"
FT   VARIANT         1076
FT                   /note="G -> V (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:12975295"
FT                   /id="VAR_023685"
FT   VARIANT         1096
FT                   /note="R -> C (in PEOB1 and MTDPS4A; dbSNP:rs201732356)"
FT                   /evidence="ECO:0000269|PubMed:12707443,
FT                   ECO:0000269|PubMed:25129007"
FT                   /id="VAR_023686"
FT   VARIANT         1096
FT                   /note="R -> H (in MTDPS4A; dbSNP:rs368435864)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058894"
FT   VARIANT         1104
FT                   /note="S -> C (in PEOB1; sporadic case;
FT                   dbSNP:rs1010372555)"
FT                   /evidence="ECO:0000269|PubMed:12707443"
FT                   /id="VAR_023687"
FT   VARIANT         1105
FT                   /note="A -> T (in PEOB1; dbSNP:rs753410045)"
FT                   /evidence="ECO:0000269|PubMed:15351195"
FT                   /id="VAR_023688"
FT   VARIANT         1106
FT                   /note="V -> I (in PEOB1)"
FT                   /evidence="ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023689"
FT   VARIANT         1110
FT                   /note="H -> Y (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058895"
FT   VARIANT         1134
FT                   /note="H -> R (in MTDPS4A)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_058896"
FT   VARIANT         1136
FT                   /note="E -> K (in MTDPS4A; dbSNP:rs56047213)"
FT                   /evidence="ECO:0000269|PubMed:18828154"
FT                   /id="VAR_065092"
FT   VARIANT         1142
FT                   /note="R -> W (in dbSNP:rs2307442)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_014908"
FT   VARIANT         1143
FT                   /note="E -> G (in dbSNP:rs2307441)"
FT                   /evidence="ECO:0000269|PubMed:14635118,
FT                   ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15689359,
FT                   ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16639411,
FT                   ECO:0000269|PubMed:18828154, ECO:0000269|Ref.4"
FT                   /id="VAR_014909"
FT   VARIANT         1146
FT                   /note="R -> C (in PEOB1; dbSNP:rs2307440)"
FT                   /evidence="ECO:0000269|PubMed:16401742, ECO:0000269|Ref.4"
FT                   /id="VAR_014910"
FT   VARIANT         1176
FT                   /note="S -> L (in PEOA1; dbSNP:rs776031396)"
FT                   /evidence="ECO:0000269|PubMed:12210792,
FT                   ECO:0000269|PubMed:15349879"
FT                   /id="VAR_023690"
FT   VARIANT         1184
FT                   /note="D -> N (in PEOB1; dbSNP:rs1131691575)"
FT                   /evidence="ECO:0000269|PubMed:16401742"
FT                   /id="VAR_058897"
FT   VARIANT         1186
FT                   /note="D -> H (in PEOA1)"
FT                   /evidence="ECO:0000269|PubMed:18575922"
FT                   /id="VAR_065119"
FT   VARIANT         1191
FT                   /note="K -> N (in MTDPS4A; dbSNP:rs1085307741)"
FT                   /evidence="ECO:0000269|PubMed:16621917"
FT                   /id="VAR_058898"
FT   VARIANT         1236
FT                   /note="Q -> H (in dbSNP:rs3087374)"
FT                   /evidence="ECO:0000269|PubMed:12975295,
FT                   ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:15917273,
FT                   ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_014911"
FT   STRAND          75..77
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           83..86
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           97..105
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            106..111
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          114..116
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          132..134
FT                   /evidence="ECO:0000244|PDB:5C51"
FT   HELIX           135..159
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          173..178
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          179..181
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          184..189
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          192..195
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          198..201
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           203..205
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          207..210
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           224..227
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          235..237
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          240..242
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            243..247
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           248..251
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          254..256
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          260..262
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          265..268
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          271..274
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           277..279
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          282..285
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          290..293
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           296..301
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           306..317
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           347..349
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           356..360
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          373..376
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            377..380
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           385..415
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           422..431
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          435..438
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           440..473
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           478..480
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           483..490
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          503..505
FT                   /evidence="ECO:0000244|PDB:5C51"
FT   STRAND          519..521
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          537..540
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           541..558
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          559..561
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          563..568
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           571..575
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          587..589
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            592..595
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            597..604
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          607..610
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          616..618
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          627..629
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           636..644
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           647..671
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           716..721
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            738..740
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          743..745
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   TURN            755..757
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           770..775
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          776..778
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          784..786
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           787..810
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          818..821
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            822..829
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          833..835
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          837..840
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          845..848
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   TURN            849..851
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          853..855
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           859..861
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          867..869
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   TURN            870..873
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           875..878
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          884..890
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           894..906
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          907..909
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            914..919
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            924..926
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           929..937
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           944..955
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           960..969
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           974..990
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          992..995
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          997..999
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1001..1009
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1010..1013
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1027..1030
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1033..1035
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1037..1040
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            1041..1046
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1047..1058
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1061..1065
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1068..1070
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   TURN            1073..1075
FT                   /evidence="ECO:0000244|PDB:5C51"
FT   TURN            1081..1083
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   HELIX           1093..1121
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1122..1124
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1130..1133
FT                   /evidence="ECO:0000244|PDB:4ZTU"
FT   STRAND          1136..1143
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1146..1168
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1175..1178
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1184..1188
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1193..1195
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1200..1203
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1207..1209
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   HELIX           1220..1227
FT                   /evidence="ECO:0000244|PDB:3IKM"
FT   STRAND          1232..1235
FT                   /evidence="ECO:0000244|PDB:3IKM"
SQ   SEQUENCE   1239 AA;  139562 MW;  2D9ECCD75AD6E01E CRC64;
     MSRLLWRKVA GATVGPGPVP APGRWVSSSV PASDPSDGQR RRQQQQQQQQ QQQQQPQQPQ
     VLSSEGGQLR HNPLDIQMLS RGLHEQIFGQ GGEMPGEAAV RRSVEHLQKH GLWGQPAVPL
     PDVELRLPPL YGDNLDQHFR LLAQKQSLPY LEAANLLLQA QLPPKPPAWA WAEGWTRYGP
     EGEAVPVAIP EERALVFDVE VCLAEGTCPT LAVAISPSAW YSWCSQRLVE ERYSWTSQLS
     PADLIPLEVP TGASSPTQRD WQEQLVVGHN VSFDRAHIRE QYLIQGSRMR FLDTMSMHMA
     ISGLSSFQRS LWIAAKQGKH KVQPPTKQGQ KSQRKARRGP AISSWDWLDI SSVNSLAEVH
     RLYVGGPPLE KEPRELFVKG TMKDIRENFQ DLMQYCAQDV WATHEVFQQQ LPLFLERCPH
     PVTLAGMLEM GVSYLPVNQN WERYLAEAQG TYEELQREMK KSLMDLANDA CQLLSGERYK
     EDPWLWDLEW DLQEFKQKKA KKVKKEPATA SKLPIEGAGA PGDPMDQEDL GPCSEEEEFQ
     QDVMARACLQ KLKGTTELLP KRPQHLPGHP GWYRKLCPRL DDPAWTPGPS LLSLQMRVTP
     KLMALTWDGF PLHYSERHGW GYLVPGRRDN LAKLPTGTTL ESAGVVCPYR AIESLYRKHC
     LEQGKQQLMP QEAGLAEEFL LTDNSAIWQT VEELDYLEVE AEAKMENLRA AVPGQPLALT
     ARGGPKDTQP SYHHGNGPYN DVDIPGCWFF KLPHKDGNSC NVGSPFAKDF LPKMEDGTLQ
     AGPGGASGPR ALEINKMISF WRNAHKRISS QMVVWLPRSA LPRAVIRHPD YDEEGLYGAI
     LPQVVTAGTI TRRAVEPTWL TASNARPDRV GSELKAMVQA PPGYTLVGAD VDSQELWIAA
     VLGDAHFAGM HGCTAFGWMT LQGRKSRGTD LHSKTATTVG ISREHAKIFN YGRIYGAGQP
     FAERLLMQFN HRLTQQEAAE KAQQMYAATK GLRWYRLSDE GEWLVRELNL PVDRTEGGWI
     SLQDLRKVQR ETARKSQWKK WEVVAERAWK GGTESEMFNK LESIATSDIP RTPVLGCCIS
     RALEPSAVQE EFMTSRVNWV VQSSAVDYLH LMLVAMKWLF EEFAIDGRFC ISIHDEVRYL
     VREEDRYRAA LALQITNLLT RCMFAYKLGL NDLPQSVAFF SAVDIDRCLR KEVTMDCKTP
     SNPTGMERRY GIPQGEALDI YQIIELTKGS LEKRSQPGP
//
ID   PRDM2_HUMAN             Reviewed;        1718 AA.
AC   Q13029; B1AJZ4; B5MC68; Q13149; Q14550; Q5THJ1; Q5VUL9;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 3.
DT   22-APR-2020, entry version 206.
DE   RecName: Full=PR domain zinc finger protein 2;
DE            EC=2.1.1.355;
DE   AltName: Full=GATA-3-binding protein G3B;
DE   AltName: Full=Lysine N-methyltransferase 8;
DE   AltName: Full=MTB-ZF;
DE   AltName: Full=MTE-binding protein;
DE   AltName: Full=PR domain-containing protein 2;
DE   AltName: Full=Retinoblastoma protein-interacting zinc finger protein;
DE   AltName: Full=Zinc finger protein RIZ;
GN   Name=PRDM2; Synonyms=KMT8, RIZ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain, and Retinoblastoma;
RX   PubMed=7538672; DOI=10.1073/pnas.92.10.4467;
RA   Buyse I.M., Shao G., Huang S.;
RT   "The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares
RT   an epitope with the adenovirus E1A protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4467-4471(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 3), ALTERNATIVE INITIATION, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9006946; DOI=10.1074/jbc.272.5.2984;
RA   Liu L., Shao G., Steele-Perkins G., Huang S.;
RT   "The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-
RT   lacking product through an internal promoter.";
RL   J. Biol. Chem. 272:2984-2991(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 159-550, AND INTERACTION WITH GATA3.
RX   PubMed=7590293; DOI=10.1016/0378-1119(95)00420-b;
RA   Shapiro V.S., Lee P., Winoto A.;
RT   "Identification and cloning of the G3B cDNA encoding a 3' segment of a
RT   protein binding to GATA-3.";
RL   Gene 163:329-330(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 202-1718 (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=8654390; DOI=10.1111/j.1432-1033.1996.00471.x;
RA   Muraosa Y., Takahashi K., Yoshizawa M., Shibahara S.;
RT   "cDNA cloning of a novel protein containing two zinc-finger domains that
RT   may function as a transcription factor for the human heme-oxygenase-1
RT   gene.";
RL   Eur. J. Biochem. 235:471-479(1996).
RN   [8]
RP   FUNCTION, MUTAGENESIS OF CYS-106; ALA-159 AND ILE-188, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14633678;
RA   Kim K.-C., Geng L., Huang S.;
RT   "Inactivation of a histone methyltransferase by mutations in human
RT   cancers.";
RL   Cancer Res. 63:7619-7623(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421; SER-643; SER-743 AND
RP   SER-796, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-651 AND LYS-774, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-347; LYS-651; LYS-690; LYS-692;
RP   LYS-774; LYS-866; LYS-879; LYS-1147; LYS-1151; LYS-1257 AND LYS-1281, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [15]
RP   STRUCTURE BY NMR OF 1-161, AND INTERACTION WITH HISTONE H3.
RX   PubMed=18082620; DOI=10.1016/j.bbrc.2007.12.034;
RA   Briknarova K., Zhou X., Satterthwait A., Hoyt D.W., Ely K.R., Huang S.;
RT   "Structural studies of the SET domain from RIZ1 tumor suppressor.";
RL   Biochem. Biophys. Res. Commun. 366:807-813(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 2-148.
RX   PubMed=20084102; DOI=10.1371/journal.pone.0008570;
RA   Wu H., Min J., Lunin V.V., Antoshenko T., Dombrovski L., Zeng H.,
RA   Allali-Hassani A., Campagna-Slater V., Vedadi M., Arrowsmith C.H.,
RA   Plotnikov A.N., Schapira M.;
RT   "Structural biology of human H3K9 methyltransferases.";
RL   PLoS ONE 5:E8570-E8570(2010).
CC   -!- FUNCTION: S-adenosyl-L-methionine-dependent histone methyltransferase
CC       that specifically methylates 'Lys-9' of histone H3. May function as a
CC       DNA-binding transcription factor. Binds to the macrophage-specific TPA-
CC       responsive element (MTE) of the HMOX1 (heme oxygenase 1) gene and may
CC       act as a transcriptional activator of this gene.
CC       {ECO:0000269|PubMed:14633678}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(9)-[histone H3] + 3 S-adenosyl-L-methionine = 3 H(+) +
CC         N(6),N(6),N(6)-trimethyl-L-lysyl(9)-[histone H3] + 3 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60276, Rhea:RHEA-COMP:15538, Rhea:RHEA-
CC         COMP:15546, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61961; EC=2.1.1.355;
CC   -!- SUBUNIT: Binds to the retinoblastoma protein (RB). Interacts with
CC       GATA3. {ECO:0000269|PubMed:18082620, ECO:0000269|PubMed:7590293}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14633678,
CC       ECO:0000269|PubMed:7538672, ECO:0000269|PubMed:9006946}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=5;
CC       Name=1; Synonyms=RIZ1;
CC         IsoId=Q13029-1; Sequence=Displayed;
CC       Name=2; Synonyms=MTB-Zf;
CC         IsoId=Q13029-2; Sequence=VSP_006927, VSP_006928;
CC       Name=3; Synonyms=RIZ2;
CC         IsoId=Q13029-3; Sequence=VSP_018974;
CC       Name=4;
CC         IsoId=Q13029-4; Sequence=VSP_046421, VSP_046422;
CC       Name=5;
CC         IsoId=Q13029-5; Sequence=VSP_018974, VSP_006927, VSP_006928;
CC   -!- TISSUE SPECIFICITY: Highly expressed in retinoblastoma cell lines and
CC       in brain tumors. Also expressed in a number of other cell lines and in
CC       brain, heart, skeletal muscle, liver and spleen. Isoform 1 is expressed
CC       in testis at much higher level than isoform 3.
CC       {ECO:0000269|PubMed:8654390, ECO:0000269|PubMed:9006946}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative initiation at Met-
CC       202 of isoform 1. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA08110.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PRDM2ID41834ch1p36.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U17838; AAC50820.2; -; mRNA.
DR   EMBL; BX647310; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL031277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014468; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U23736; AAA87023.1; -; mRNA.
DR   EMBL; D45132; BAA08110.1; ALT_INIT; mRNA.
DR   CCDS; CCDS150.1; -. [Q13029-1]
DR   CCDS; CCDS151.1; -. [Q13029-2]
DR   CCDS; CCDS30603.1; -. [Q13029-5]
DR   CCDS; CCDS44061.1; -. [Q13029-4]
DR   PIR; I38902; I38902.
DR   RefSeq; NP_001007258.1; NM_001007257.2. [Q13029-5]
DR   RefSeq; NP_001129082.1; NM_001135610.1. [Q13029-4]
DR   RefSeq; NP_036363.2; NM_012231.4. [Q13029-1]
DR   RefSeq; NP_056950.2; NM_015866.4. [Q13029-2]
DR   RefSeq; XP_016857744.1; XM_017002255.1. [Q13029-1]
DR   RefSeq; XP_016857745.1; XM_017002256.1. [Q13029-1]
DR   RefSeq; XP_016857746.1; XM_017002257.1. [Q13029-2]
DR   RefSeq; XP_016857748.1; XM_017002259.1. [Q13029-3]
DR   RefSeq; XP_016857749.1; XM_017002260.1. [Q13029-3]
DR   RefSeq; XP_016857750.1; XM_017002261.1. [Q13029-3]
DR   RefSeq; XP_016857751.1; XM_017002262.1. [Q13029-5]
DR   RefSeq; XP_016857752.1; XM_017002263.1. [Q13029-3]
DR   PDB; 2JV0; NMR; -; A=1-161.
DR   PDB; 2QPW; X-ray; 1.79 A; A=2-148.
DR   PDBsum; 2JV0; -.
DR   PDBsum; 2QPW; -.
DR   SMR; Q13029; -.
DR   BioGrid; 113575; 14.
DR   DIP; DIP-428N; -.
DR   IntAct; Q13029; 6.
DR   STRING; 9606.ENSP00000235372; -.
DR   iPTMnet; Q13029; -.
DR   PhosphoSitePlus; Q13029; -.
DR   BioMuta; PRDM2; -.
DR   DMDM; 56757653; -.
DR   EPD; Q13029; -.
DR   jPOST; Q13029; -.
DR   MassIVE; Q13029; -.
DR   MaxQB; Q13029; -.
DR   PaxDb; Q13029; -.
DR   PeptideAtlas; Q13029; -.
DR   PRIDE; Q13029; -.
DR   ProteomicsDB; 3002; -.
DR   ProteomicsDB; 59110; -. [Q13029-1]
DR   ProteomicsDB; 59111; -. [Q13029-2]
DR   ProteomicsDB; 59112; -. [Q13029-3]
DR   ProteomicsDB; 65150; -.
DR   Antibodypedia; 1774; 253 antibodies.
DR   DNASU; 7799; -.
DR   Ensembl; ENST00000235372; ENSP00000235372; ENSG00000116731. [Q13029-1]
DR   Ensembl; ENST00000311066; ENSP00000312352; ENSG00000116731. [Q13029-2]
DR   Ensembl; ENST00000343137; ENSP00000341621; ENSG00000116731. [Q13029-5]
DR   Ensembl; ENST00000376048; ENSP00000365216; ENSG00000116731. [Q13029-4]
DR   Ensembl; ENST00000413440; ENSP00000411103; ENSG00000116731. [Q13029-5]
DR   GeneID; 7799; -.
DR   KEGG; hsa:7799; -.
DR   UCSC; uc001avg.4; human. [Q13029-1]
DR   CTD; 7799; -.
DR   DisGeNET; 7799; -.
DR   GeneCards; PRDM2; -.
DR   HGNC; HGNC:9347; PRDM2.
DR   HPA; ENSG00000116731; Low tissue specificity.
DR   MIM; 601196; gene.
DR   neXtProt; NX_Q13029; -.
DR   OpenTargets; ENSG00000116731; -.
DR   PharmGKB; PA33715; -.
DR   eggNOG; KOG2461; Eukaryota.
DR   eggNOG; ENOG410ZFVU; LUCA.
DR   GeneTree; ENSGT00940000159410; -.
DR   HOGENOM; CLU_002916_1_0_1; -.
DR   InParanoid; Q13029; -.
DR   KO; K11432; -.
DR   OMA; GSPPCFD; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q13029; -.
DR   TreeFam; TF332173; -.
DR   SIGNOR; Q13029; -.
DR   ChiTaRS; PRDM2; human.
DR   EvolutionaryTrace; Q13029; -.
DR   GeneWiki; PRDM2; -.
DR   GenomeRNAi; 7799; -.
DR   Pharos; Q13029; Tbio.
DR   PRO; PR:Q13029; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q13029; protein.
DR   Bgee; ENSG00000116731; Expressed in middle temporal gyrus and 228 other tissues.
DR   ExpressionAtlas; Q13029; baseline and differential.
DR   Genevisible; Q13029; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0031490; F:chromatin DNA binding; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   DisProt; DP01757; -.
DR   InterPro; IPR009170; RIZ_retinblastoma-bd_prot.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00856; SET; 1.
DR   Pfam; PF00096; zf-C2H2; 2.
DR   PIRSF; PIRSF002395; RIZ_SET; 1.
DR   SMART; SM00317; SET; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50280; SET; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative initiation; Alternative splicing;
KW   DNA-binding; Isopeptide bond; Metal-binding; Methyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1718
FT                   /note="PR domain zinc finger protein 2"
FT                   /id="PRO_0000041634"
FT   DOMAIN          28..141
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   ZN_FING         360..382
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         390..412
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         483..506
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1134..1156
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1162..1185
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1191..1214
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1333..1355
FT                   /note="C2H2-type 7; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         1455..1478
FT                   /note="C2H2-type 8; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          294..316
FT                   /note="Retinoblastoma protein binding"
FT   MOTIF           970..979
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           985..998
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1028..1052
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        268..296
FT                   /note="Asp/Glu-rich (acidic)"
FT   COMPBIAS        933..1049
FT                   /note="Pro-rich"
FT   COMPBIAS        1052..1074
FT                   /note="Poly-Ser"
FT   COMPBIAS        1361..1447
FT                   /note="Arg/Lys-rich (basic)"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         743
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63755"
FT   MOD_RES         785
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63755"
FT   MOD_RES         796
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        347
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        651
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        690
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        692
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        774
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        866
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        879
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1147
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1151
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1257
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1281
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..201
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_018974"
FT   VAR_SEQ         171..226
FT                   /note="GKKKSQENKNKGNKIQDIQLKTSEPDFTSANMRDSAEGPKEDEEKPSASALE
FT                   QPAT -> ATASAWRPDALHQRPRTSPGSIGRSKLQLQPSSRDHSSKSRHSGCSLTAPE
FT                   VTWNQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046421"
FT   VAR_SEQ         227..1718
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046422"
FT   VAR_SEQ         1679..1682
FT                   /note="SYSL -> RNFL (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:8654390"
FT                   /id="VSP_006927"
FT   VAR_SEQ         1683..1718
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:8654390"
FT                   /id="VSP_006928"
FT   VARIANT         283
FT                   /note="D -> E (in dbSNP:rs2076324)"
FT                   /id="VAR_052929"
FT   VARIANT         450
FT                   /note="S -> N (in dbSNP:rs17350795)"
FT                   /id="VAR_052930"
FT   MUTAGEN         106
FT                   /note="C->Y: Reduced histone methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:14633678"
FT   MUTAGEN         159
FT                   /note="A->V: Reduced histone methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:14633678"
FT   MUTAGEN         188
FT                   /note="I->V: Loss of histone methyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:14633678"
FT   CONFLICT        164
FT                   /note="S -> T (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        196
FT                   /note="D -> S (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="A -> G (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        276..293
FT                   /note="EDEEEEEDDDDDELEDEG -> VGGGGGVVVVVSWKARGE (in Ref. 6;
FT                   AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        307..318
FT                   /note="EPEIRCDEKPED -> SQKYGVMRSQKI (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        336..337
FT                   /note="EV -> DL (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="T -> I (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        466..467
FT                   /note="DT -> VS (in Ref. 6; AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        530
FT                   /note="Q -> L (in Ref. 3; BX647310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        534..550
FT                   /note="TQNVYVPSTEPEEEGEA -> PRTCMYQAQSRRGRGSR (in Ref. 6;
FT                   AAA87023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        703
FT                   /note="P -> PP (in Ref. 1 and 7)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="H -> R (in Ref. 3; BX647310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1456
FT                   /note="I -> T (in Ref. 3; BX647310)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..7
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           15..17
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           20..24
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          27..29
FT                   /evidence="ECO:0000244|PDB:2JV0"
FT   STRAND          30..34
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   TURN            36..39
FT                   /evidence="ECO:0000244|PDB:2JV0"
FT   STRAND          41..48
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          54..59
FT                   /evidence="ECO:0000244|PDB:2JV0"
FT   STRAND          62..64
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           66..68
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          72..80
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   TURN            81..83
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          84..89
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           93..95
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           98..101
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          106..110
FT                   /evidence="ECO:0000244|PDB:2JV0"
FT   STRAND          113..118
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   STRAND          121..128
FT                   /evidence="ECO:0000244|PDB:2QPW"
FT   HELIX           146..158
FT                   /evidence="ECO:0000244|PDB:2JV0"
FT   CONFLICT        Q13029-4:198
FT                   /note="Q -> R (in Ref. 5; BC014468)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1718 AA;  188915 MW;  536BD68667AFE433 CRC64;
     MNQNTTEPVA ATETLAEVPE HVLRGLPEEV RLFPSAVDKT RIGVWATKPI LKGKKFGPFV
     GDKKKRSQVK NNVYMWEVYY PNLGWMCIDA TDPEKGNWLR YVNWACSGEE QNLFPLEINR
     AIYYKTLKPI APGEELLVWY NGEDNPEIAA AIEEERASAR SKRSSPKSRK GKKKSQENKN
     KGNKIQDIQL KTSEPDFTSA NMRDSAEGPK EDEEKPSASA LEQPATLQEV ASQEVPPELA
     TPAPAWEPQP EPDERLEAAA CEVNDLGEEE EEEEEEDEEE EEDDDDDELE DEGEEEASMP
     NENSVKEPEI RCDEKPEDLL EEPKTTSEET LEDCSEVTPA MQIPRTKEEA NGDVFETFMF
     PCQHCERKFT TKQGLERHMH IHISTVNHAF KCKYCGKAFG TQINRRRHER RHEAGLKRKP
     SQTLQPSEDL ADGKASGENV ASKDDSSPPS LGPDCLIMNS EKASQDTINS SVVEENGEVK
     ELHPCKYCKK VFGTHTNMRR HQRRVHERHL IPKGVRRKGG LEEPQPPAEQ AQATQNVYVP
     STEPEEEGEA DDVYIMDISS NISENLNYYI DGKIQTNNNT SNCDVIEMES ASADLYGINC
     LLTPVTVEIT QNIKTTQVPV TEDLPKEPLG STNSEAKKRR TASPPALPKI KAETDSDPMV
     PSCSLSLPLS ISTTEAVSFH KEKSVYLSSK LKQLLQTQDK LTPAGISATE IAKLGPVCVS
     APASMLPVTS SRFKRRTSSP PSSPQHSPAL RDFGKPSDGK AAWTDAGLTS KKSKLESHSD
     SPAWSLSGRD ERETVSPPCF DEYKMSKEWT ASSAFSSVCN QQPLDLSSGV KQKAEGTGKT
     PVQWESVLDL SVHKKHCSDS EGKEFKESHS VQPTCSAVKK RKPTTCMLQK VLLNEYNGID
     LPVENPADGT RSPSPCKSLE AQPDPDLGPG SGFPAPTVES TPDVCPSSPA LQTPSLSSGQ
     LPPLLIPTDP SSPPPCPPVL TVATPPPPLL PTVPLPAPSS SASPHPCPSP LSNATAQSPL
     PILSPTVSPS PSPIPPVEPL MSAASPGPPT LSSSSSSSSS SSSFSSSSSS SSPSPPPLSA
     ISSVVSSGDN LEASLPMISF KQEELENEGL KPREEPQSAA EQDVVVQETF NKNFVCNVCE
     SPFLSIKDLT KHLSIHAEEW PFKCEFCVQL FKDKTDLSEH RFLLHGVGNI FVCSVCKKEF
     AFLCNLQQHQ RDLHPDKVCT HHEFESGTLR PQNFTDPSKA HVEHMQSLPE DPLETSKEEE
     ELNDSSEELY TTIKIMASGI KTKDPDVRLG LNQHYPSFKP PPFQYHHRNP MGIGVTATNF
     TTHNIPQTFT TAIRCTKCGK GVDNMPELHK HILACASASD KKRYTPKKNP VPLKQTVQPK
     NGVVVLDNSG KNAFRRMGQP KRLNFSVELS KMSSNKLKLN ALKKKNQLVQ KAILQKNKSA
     KQKADLKNAC ESSSHICPYC NREFTYIGSL NKHAAFSCPK KPLSPPKKKV SHSSKKGGHS
     SPASSDKNSN SNHRRRTADA EIKMQSMQTP LGKTRARSSG PTQVPLPSSS FRSKQNVKFA
     ASVKSKKPSS SSLRNSSPIR MAKITHVEGK KPKAVAKNHS AQLSSKTSRS LHVRVQKSKA
     VLQSKSTLAS KKRTDRFNIK SRERSGGPVT RSLQLAAAAD LSENKREDGS AKQELKDFSY
     SLRLASRCSP PAAPYITRQY RKVKAPAAAQ FQGPFFKE
//
ID   PTN6_HUMAN              Reviewed;         595 AA.
AC   P29350; A8K306; G3V0F8; Q969V8; Q9UK67;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   22-APR-2020, entry version 230.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 6;
DE            EC=3.1.3.48;
DE   AltName: Full=Hematopoietic cell protein-tyrosine phosphatase;
DE   AltName: Full=Protein-tyrosine phosphatase 1C;
DE            Short=PTP-1C;
DE   AltName: Full=Protein-tyrosine phosphatase SHP-1;
DE   AltName: Full=SH-PTP1;
GN   Name=PTPN6; Synonyms=HCP, PTP1C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1732748; DOI=10.1128/mcb.12.2.836;
RA   Yi T., Cleveland J.L., Ihle J.N.;
RT   "Protein tyrosine phosphatase containing SH2 domains: characterization,
RT   preferential expression in hematopoietic cells, and localization to human
RT   chromosome 12p12-p13.";
RL   Mol. Cell. Biol. 12:836-846(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Mammary gland;
RX   PubMed=1652101; DOI=10.1038/352736a0;
RA   Shen S.H., Bastien L., Posner B.I., Chretien P.;
RT   "A protein-tyrosine phosphatase with sequence similarity to the SH2 domain
RT   of the protein-tyrosine kinases.";
RL   Nature 352:736-739(1991).
RN   [3]
RP   ERRATUM OF PUBMED:1652101, AND SEQUENCE REVISION.
RA   Shen S.H., Bastien L., Posner B.I., Chretien P.;
RL   Nature 353:868-868(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1736296; DOI=10.1073/pnas.89.3.1123;
RA   Plutzky J., Neel B.G., Rosenberg R.D.;
RT   "Isolation of a src homology 2-containing tyrosine phosphatase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1123-1127(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3).
RX   PubMed=7665165; DOI=10.1006/geno.1995.1020;
RA   Banville D., Stocco R., Shen S.H.;
RT   "Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate
RT   promoter usage and exon skipping generate multiple transcripts.";
RL   Genomics 27:165-173(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=10497187; DOI=10.1074/jbc.274.40.28301;
RA   Jin Y.J., Yu C.L., Burakoff S.J.;
RT   "Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure
RT   and catalytic activity.";
RL   J. Biol. Chem. 274:28301-28307(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RA   Oka T., Ouchida M.;
RT   "Gene silencing of SHP-1 gene in leukemias/lymphomas by aberrant
RT   methylation.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PHOSPHORYLATION.
RX   PubMed=7781604; DOI=10.1002/j.1460-2075.1995.tb07249.x;
RA   Li R.Y., Gaits F., Ragab A., Ragab-Thomas J.M.F., Chap H.;
RT   "Tyrosine phosphorylation of an SH2-containing protein tyrosine phosphatase
RT   is coupled to platelet thrombin receptor via a pertussis toxin-sensitive
RT   heterotrimeric G-protein.";
RL   EMBO J. 14:2519-2526(1995).
RN   [14]
RP   INTERACTION WITH LILRB1.
RX   PubMed=9285411; DOI=10.1016/s1074-7613(00)80529-4;
RA   Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.-L.;
RT   "A novel immunoglobulin superfamily receptor for cellular and viral MHC
RT   class I molecules.";
RL   Immunity 7:273-282(1997).
RN   [15]
RP   INTERACTION WITH LILRB2.
RX   PubMed=9842885;
RX   DOI=10.1002/(sici)1521-4141(199811)28:11<3423::aid-immu3423>3.0.co;2-2;
RA   Fanger N.A., Cosman D., Peterson L., Braddy S.C., Maliszewski C.R.,
RA   Borges L.;
RT   "The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-
RT   mediated signaling in monocytes.";
RL   Eur. J. Immunol. 28:3423-3434(1998).
RN   [16]
RP   INTERACTION WITH SIRPA.
RX   PubMed=9712903; DOI=10.1074/jbc.273.35.22719;
RA   Veillette A., Thibaudeau E., Latour S.;
RT   "High expression of inhibitory receptor SHPS-1 and its association with
RT   protein tyrosine phosphatase SHP-1 in macrophages.";
RL   J. Biol. Chem. 273:22719-22728(1998).
RN   [17]
RP   INTERACTION WITH LYN, AND PHOSPHORYLATION AT TYR-564.
RX   PubMed=10574931; DOI=10.1074/jbc.274.49.34663;
RA   Yoshida K., Kharbanda S., Kufe D.;
RT   "Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the
RT   apoptotic response to DNA damage.";
RL   J. Biol. Chem. 274:34663-34668(1999).
RN   [18]
RP   INTERACTION WITH FCRL2 AND FCRL3.
RX   PubMed=11162587; DOI=10.1006/bbrc.2000.4213;
RA   Xu M.-J., Zhao R., Zhao Z.J.;
RT   "Molecular cloning and characterization of SPAP1, an inhibitory receptor.";
RL   Biochem. Biophys. Res. Commun. 280:768-775(2001).
RN   [19]
RP   INTERACTION WITH CD84.
RX   PubMed=11414741; DOI=10.1006/clim.2001.5035;
RA   Lewis J., Eiben L.J., Nelson D.L., Cohen J.I., Nichols K.E., Ochs H.D.,
RA   Notarangelo L.D., Duckett C.S.;
RT   "Distinct interactions of the X-linked lymphoproliferative syndrome gene
RT   product SAP with cytoplasmic domains of members of the CD2 receptor
RT   family.";
RL   Clin. Immunol. 100:15-23(2001).
RN   [20]
RP   FUNCTION IN ROS1 DEPHOSPHORYLATION, AND INTERACTION WITH ROS1.
RX   PubMed=11266449; DOI=10.1083/jcb.152.2.325;
RA   Keilhack H., Mueller M., Boehmer S.A., Frank C., Weidner K.M.,
RA   Birchmeier W., Ligensa T., Berndt A., Kosmehl H., Guenther B., Mueller T.,
RA   Birchmeier C., Boehmer F.D.;
RT   "Negative regulation of Ros receptor tyrosine kinase signaling. An
RT   epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1.";
RL   J. Cell Biol. 152:325-334(2001).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [22]
RP   INTERACTION WITH FCRL4.
RX   PubMed=14597715; DOI=10.1073/pnas.1935944100;
RA   Ehrhardt G.R.A., Davis R.S., Hsu J.T., Leu C.-M., Ehrhardt A., Cooper M.D.;
RT   "The inhibitory potential of Fc receptor homolog 4 on memory B cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13489-13494(2003).
RN   [23]
RP   INTERACTION WITH CD300LF.
RX   PubMed=15184070; DOI=10.1016/j.bbrc.2004.05.065;
RA   Sui L., Li N., Liu Q., Zhang W., Wan T., Wang B., Luo K., Sun H., Cao X.;
RT   "IgSF13, a novel human inhibitory receptor of the immunoglobulin
RT   superfamily, is preferentially expressed in dendritic cells and
RT   monocytes.";
RL   Biochem. Biophys. Res. Commun. 319:920-928(2004).
RN   [24]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=15526160; DOI=10.1007/s00018-004-4189-6;
RA   Ronnstrand L.;
RT   "Signal transduction via the stem cell factor receptor/c-Kit.";
RL   Cell. Mol. Life Sci. 61:2535-2548(2004).
RN   [25]
RP   REVIEW ON ROLE IN KIT SIGNALING.
RX   PubMed=16129412; DOI=10.1016/j.bbrc.2005.08.055;
RA   Roskoski R. Jr.;
RT   "Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.";
RL   Biochem. Biophys. Res. Commun. 337:1-13(2005).
RN   [26]
RP   INTERACTION WITH KIR2DL1.
RX   PubMed=18604210; DOI=10.1038/ni.1635;
RA   Yu M.-C., Su L.-L., Zou L., Liu Y., Wu N., Kong L., Zhuang Z.-H., Sun L.,
RA   Liu H.P., Hu J.-H., Li D., Strominger J.L., Zang J.-W., Pei G., Ge B.-X.;
RT   "An essential function for beta-arrestin 2 in the inhibitory signaling of
RT   natural killer cells.";
RL   Nat. Immunol. 9:898-907(2008).
RN   [27]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PDPK1.
RX   PubMed=19591923; DOI=10.1016/j.cellsig.2009.06.010;
RA   Sephton C.F., Zhang D., Lehmann T.M., Pennington P.R., Scheid M.P.,
RA   Mousseau D.D.;
RT   "The nuclear localization of 3'-phosphoinositide-dependent kinase-1 is
RT   dependent on its association with the protein tyrosine phosphatase SHP-1.";
RL   Cell. Signal. 21:1634-1644(2009).
RN   [28]
RP   INTERACTION WITH FCRL3.
RX   PubMed=19843936; DOI=10.4049/jimmunol.0901982;
RA   Kochi Y., Myouzen K., Yamada R., Suzuki A., Kurosaki T., Nakamura Y.,
RA   Yamamoto K.;
RT   "FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-
RT   cell receptor-mediated signaling.";
RL   J. Immunol. 183:5502-5510(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-64, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CDK2.
RX   PubMed=21262353; DOI=10.1016/j.cellsig.2011.01.019;
RA   Fiset A., Xu E., Bergeron S., Marette A., Pelletier G., Siminovitch K.A.,
RA   Olivier M., Beauchemin N., Faure R.L.;
RT   "Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and
RT   regulates insulin internalization.";
RL   Cell. Signal. 23:911-919(2011).
RN   [32]
RP   INTERACTION WITH FCRL6.
RX   PubMed=20933011; DOI=10.1016/j.imlet.2010.09.023;
RA   Kulemzin S.V., Zamoshnikova A.Y., Yurchenko M.Y., Vitak N.Y.,
RA   Najakshin A.M., Fayngerts S.A., Chikaev N.A., Reshetnikova E.S.,
RA   Kashirina N.M., Peclo M.M., Rutkevich P.N., Shevelev A.Y.,
RA   Yanushevskaya E.V., Baranov K.O., Mamonkin M., Vlasik T.N., Sidorenko S.P.,
RA   Taranin A.V., Mechetina L.V.;
RT   "FCRL6 receptor: expression and associated proteins.";
RL   Immunol. Lett. 134:174-182(2011).
RN   [33]
RP   INTERACTION WITH EGFR.
RX   PubMed=21258366; DOI=10.1038/ncb2158;
RA   Hsu J.M., Chen C.T., Chou C.K., Kuo H.P., Li L.Y., Lin C.Y., Lee H.J.,
RA   Wang Y.N., Liu M., Liao H.W., Shi B., Lai C.C., Bedford M.T., Tsai C.H.,
RA   Hung M.C.;
RT   "Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation
RT   negatively modulates EGFR-mediated ERK activation.";
RL   Nat. Cell Biol. 13:174-181(2011).
RN   [34]
RP   INTERACTION WITH MPIG6B.
RX   PubMed=23112346; DOI=10.1126/scisignal.2002936;
RA   Mazharian A., Wang Y.J., Mori J., Bem D., Finney B., Heising S., Gissen P.,
RA   White J.G., Berndt M.C., Gardiner E.E., Nieswandt B., Douglas M.R.,
RA   Campbell R.D., Watson S.P., Senis Y.A.;
RT   "Mice lacking the ITIM-containing receptor G6b-B exhibit
RT   macrothrombocytopenia and aberrant platelet function.";
RL   Sci. Signal. 5:RA78-RA78(2012).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 248-399.
RX   PubMed=9774441; DOI=10.1074/jbc.273.43.28199;
RA   Yang J., Liang X., Niu T., Meng W., Zhao Z., Zhou G.W.;
RT   "Crystal structure of the catalytic domain of protein-tyrosine phosphatase
RT   SHP-1.";
RL   J. Biol. Chem. 273:28199-28207(1998).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-532, AND DOMAIN SH2.
RX   PubMed=12482860; DOI=10.1074/jbc.m210430200;
RA   Yang J., Liu L., He D., Song X., Liang X., Zhao Z.J., Zhou G.W.;
RT   "Crystal structure of human protein-tyrosine phosphatase SHP-1.";
RL   J. Biol. Chem. 278:6516-6520(2003).
RN   [39]
RP   STRUCTURE BY NMR OF 110-214.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the SH2 domain of human protein-tyrosine
RT   phosphatase SHP-1.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS), AND DOMAIN SH2.
RX   PubMed=21465528; DOI=10.1002/jcb.23125;
RA   Wang W., Liu L., Song X., Mo Y., Komma C., Bellamy H.D., Zhao Z.J.,
RA   Zhou G.W.;
RT   "Crystal structure of human protein tyrosine phosphatase SHP-1 in the open
RT   conformation.";
RL   J. Cell. Biochem. 112:2062-2071(2011).
CC   -!- FUNCTION: Modulates signaling by tyrosine phosphorylated cell surface
CC       receptors such as KIT and the EGF receptor/EGFR. The SH2 regions may
CC       interact with other cellular components to modulate its own phosphatase
CC       activity against interacting substrates. Together with MTUS1, induces
CC       UBE2V2 expression upon angiotensin II stimulation. Plays a key role in
CC       hematopoiesis. {ECO:0000269|PubMed:11266449}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Monomer. Interacts with MTUS1 (By similarity). Interacts with
CC       MILR1 (tyrosine-phosphorylated) (By similarity). Interacts with KIT (By
CC       similarity). Interacts with SIRPA/PTPNS1 (PubMed:9712903). Interacts
CC       with LILRB1 and LILRB2 (PubMed:9285411, PubMed:9842885). Interacts with
CC       FCRL2 and FCRL4 (PubMed:11162587, PubMed:14597715). Interacts with
CC       FCRL3 and FCRL6 (tyrosine phosphorylated form) (PubMed:20933011,
CC       PubMed:11162587, PubMed:19843936). Interacts with CD84
CC       (PubMed:11414741). Interacts with CD300LF (PubMed:15184070). Interacts
CC       with CDK2 (PubMed:21262353). Interacts with KIR2DL1; the interaction is
CC       enhanced by ARRB2 (PubMed:18604210). Interacts (via SH2 1 domain) with
CC       ROS1; the interaction is direct and promotes ROS1 dephosphorylation
CC       (PubMed:11266449). Interacts with EGFR; inhibits EGFR-dependent
CC       activation of MAPK/ERK (PubMed:21258366). Interacts with LYN
CC       (PubMed:10574931). Interacts with the tyrosine phosphorylated form of
CC       PDPK1 (PubMed:19591923). Interacts with CEACAM1 (via cytoplasmic
CC       domain); this interaction depends on the monomer/dimer equilibrium and
CC       is phosphorylation-dependent (By similarity). Interacts with MPIG6B
CC       (via ITIM motif) (PubMed:23112346). Interacts with moesin/MSN.
CC       {ECO:0000250|UniProtKB:P29351, ECO:0000250|UniProtKB:P81718,
CC       ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:11162587,
CC       ECO:0000269|PubMed:11266449, ECO:0000269|PubMed:11414741,
CC       ECO:0000269|PubMed:14597715, ECO:0000269|PubMed:15184070,
CC       ECO:0000269|PubMed:18604210, ECO:0000269|PubMed:19591923,
CC       ECO:0000269|PubMed:19843936, ECO:0000269|PubMed:20933011,
CC       ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:21262353,
CC       ECO:0000269|PubMed:23112346, ECO:0000269|PubMed:9285411,
CC       ECO:0000269|PubMed:9712903, ECO:0000269|PubMed:9842885}.
CC   -!- INTERACTION:
CC       P29350; Q14790: CASP8; NbExp=3; IntAct=EBI-78260, EBI-78060;
CC       P29350; P20273: CD22; NbExp=4; IntAct=EBI-78260, EBI-78277;
CC       P29350; Q9BZW8: CD244; NbExp=2; IntAct=EBI-78260, EBI-1580565;
CC       P29350; P20138: CD33; NbExp=10; IntAct=EBI-78260, EBI-3906571;
CC       P29350; P11049: CD37; NbExp=4; IntAct=EBI-78260, EBI-6139068;
CC       P29350; P19235: EPOR; NbExp=11; IntAct=EBI-78260, EBI-617321;
CC       P29350; P31994: FCGR2B; NbExp=3; IntAct=EBI-78260, EBI-724784;
CC       P29350; Q13643: FHL3; NbExp=3; IntAct=EBI-78260, EBI-741101;
CC       P29350; P62993: GRB2; NbExp=3; IntAct=EBI-78260, EBI-401755;
CC       P29350; P08069: IGF1R; NbExp=3; IntAct=EBI-78260, EBI-475981;
CC       P29350; P35968: KDR; NbExp=2; IntAct=EBI-78260, EBI-1005487;
CC       P29350; P43626: KIR2DL1; NbExp=4; IntAct=EBI-78260, EBI-8684277;
CC       P29350; P43628: KIR2DL3; NbExp=13; IntAct=EBI-78260, EBI-8632435;
CC       P29350; Q6GTX8: LAIR1; NbExp=5; IntAct=EBI-78260, EBI-965864;
CC       P29350; P06239: LCK; NbExp=5; IntAct=EBI-78260, EBI-1348;
CC       P29350; Q8NHL6: LILRB1; NbExp=4; IntAct=EBI-78260, EBI-2805262;
CC       P29350; Q8N423: LILRB2; NbExp=3; IntAct=EBI-78260, EBI-2816428;
CC       P29350; O75022: LILRB3; NbExp=4; IntAct=EBI-78260, EBI-2830524;
CC       P29350; Q8NHJ6: LILRB4; NbExp=4; IntAct=EBI-78260, EBI-2805248;
CC       P29350; O94916-1: NFAT5; NbExp=4; IntAct=EBI-78260, EBI-15828651;
CC       P29350; P16284: PECAM1; NbExp=4; IntAct=EBI-78260, EBI-716404;
CC       P29350; Q9UKJ1: PILRA; NbExp=5; IntAct=EBI-78260, EBI-965833;
CC       P29350; O35274: Ppp1r9b; Xeno; NbExp=2; IntAct=EBI-78260, EBI-80022;
CC       P29350-3; Q05397: PTK2; NbExp=3; IntAct=EBI-7399369, EBI-702142;
CC       P29350; P08922: ROS1; NbExp=2; IntAct=EBI-78260, EBI-7371065;
CC       P29350; Q8N1K5: THEMIS; NbExp=4; IntAct=EBI-78260, EBI-2873538;
CC       P29350; B7UM99: tir; Xeno; NbExp=4; IntAct=EBI-78260, EBI-2504426;
CC       P29350; Q7DB77: tir; Xeno; NbExp=2; IntAct=EBI-78260, EBI-6480811;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=In neurons, translocates
CC       into the nucleus after treatment with angiotensin II (By similarity).
CC       Shuttles between the cytoplasm and nucleus via its association with
CC       PDPK1. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=P29350-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29350-3; Sequence=VSP_007775;
CC       Name=3; Synonyms=Short;
CC         IsoId=P29350-2; Sequence=VSP_005129, VSP_005130;
CC       Name=4; Synonyms=70-kDa, SHP-1L;
CC         IsoId=P29350-4; Sequence=VSP_044447;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in hematopoietic cells.
CC       Isoform 2 is expressed in non-hematopoietic cells.
CC   -!- DOMAIN: The N-terminal SH2 domain functions as an auto-inhibitory
CC       domain, blocking the catalytic domain in the ligand-free close
CC       conformation. {ECO:0000269|PubMed:12482860,
CC       ECO:0000269|PubMed:21465528}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Binding of KITLG/SCF to KIT
CC       increases tyrosine phosphorylation (By similarity). Phosphorylation at
CC       Tyr-564 enhances phosphatase activity. {ECO:0000250,
CC       ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:7781604}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class 2 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPN6ID41920ch12p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M74903; AAA35963.1; -; mRNA.
DR   EMBL; X62055; CAA43982.1; -; mRNA.
DR   EMBL; M77273; AAA36610.1; -; mRNA.
DR   EMBL; U15528; AAA82880.1; -; Genomic_DNA.
DR   EMBL; U15536; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15535; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15534; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15533; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15532; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15531; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15530; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15529; AAA82880.1; JOINED; Genomic_DNA.
DR   EMBL; U15528; AAA82879.1; -; Genomic_DNA.
DR   EMBL; U15537; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15535; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15534; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15533; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15532; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15531; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15530; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U15529; AAA82879.1; JOINED; Genomic_DNA.
DR   EMBL; U47924; AAB51322.1; -; Genomic_DNA.
DR   EMBL; U47924; AAB51323.1; -; Genomic_DNA.
DR   EMBL; AF178946; AAD53317.1; -; mRNA.
DR   EMBL; AB079851; BAC81774.1; -; Genomic_DNA.
DR   EMBL; AB079851; BAC81775.1; -; Genomic_DNA.
DR   EMBL; AK290421; BAF83110.1; -; mRNA.
DR   EMBL; CH471116; EAW88703.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88704.1; -; Genomic_DNA.
DR   EMBL; BC002523; AAH02523.1; -; mRNA.
DR   EMBL; BC007667; AAH07667.1; -; mRNA.
DR   CCDS; CCDS41744.1; -. [P29350-3]
DR   CCDS; CCDS44820.1; -. [P29350-1]
DR   CCDS; CCDS44821.1; -. [P29350-4]
DR   PIR; B42031; S20825.
DR   RefSeq; NP_002822.2; NM_002831.5. [P29350-1]
DR   RefSeq; NP_536858.1; NM_080548.4. [P29350-3]
DR   RefSeq; NP_536859.1; NM_080549.3. [P29350-4]
DR   RefSeq; XP_011519290.1; XM_011520988.1. [P29350-3]
DR   PDB; 1FPR; X-ray; 2.50 A; A=243-526.
DR   PDB; 1GWZ; X-ray; 2.50 A; A=243-541.
DR   PDB; 1X6C; NMR; -; A=110-214.
DR   PDB; 2B3O; X-ray; 2.80 A; A=1-532.
DR   PDB; 2RMX; NMR; -; A=110-214.
DR   PDB; 2YU7; NMR; -; A=110-214.
DR   PDB; 3PS5; X-ray; 3.10 A; A=1-595.
DR   PDB; 4GRY; X-ray; 1.70 A; A=243-528.
DR   PDB; 4GRZ; X-ray; 1.37 A; A=243-528.
DR   PDB; 4GS0; X-ray; 1.80 A; A/B=243-528.
DR   PDB; 4HJP; X-ray; 1.40 A; A=243-528.
DR   PDB; 4HJQ; X-ray; 1.80 A; A/B=243-528.
DR   PDBsum; 1FPR; -.
DR   PDBsum; 1GWZ; -.
DR   PDBsum; 1X6C; -.
DR   PDBsum; 2B3O; -.
DR   PDBsum; 2RMX; -.
DR   PDBsum; 2YU7; -.
DR   PDBsum; 3PS5; -.
DR   PDBsum; 4GRY; -.
DR   PDBsum; 4GRZ; -.
DR   PDBsum; 4GS0; -.
DR   PDBsum; 4HJP; -.
DR   PDBsum; 4HJQ; -.
DR   SMR; P29350; -.
DR   BioGrid; 111742; 137.
DR   DIP; DIP-31002N; -.
DR   IntAct; P29350; 122.
DR   MINT; P29350; -.
DR   STRING; 9606.ENSP00000391592; -.
DR   BindingDB; P29350; -.
DR   ChEMBL; CHEMBL3166; -.
DR   DrugCentral; P29350; -.
DR   MoonDB; P29350; Predicted.
DR   DEPOD; P29350; -.
DR   iPTMnet; P29350; -.
DR   PhosphoSitePlus; P29350; -.
DR   BioMuta; PTPN6; -.
DR   DMDM; 131469; -.
DR   OGP; P29350; -.
DR   EPD; P29350; -.
DR   jPOST; P29350; -.
DR   MassIVE; P29350; -.
DR   MaxQB; P29350; -.
DR   PaxDb; P29350; -.
DR   PeptideAtlas; P29350; -.
DR   PRIDE; P29350; -.
DR   ProteomicsDB; 32184; -.
DR   ProteomicsDB; 54543; -. [P29350-1]
DR   ProteomicsDB; 54544; -. [P29350-2]
DR   ProteomicsDB; 54545; -. [P29350-3]
DR   Antibodypedia; 728; 946 antibodies.
DR   DNASU; 5777; -.
DR   Ensembl; ENST00000318974; ENSP00000326010; ENSG00000111679. [P29350-1]
DR   Ensembl; ENST00000399448; ENSP00000382376; ENSG00000111679. [P29350-3]
DR   Ensembl; ENST00000456013; ENSP00000391592; ENSG00000111679. [P29350-4]
DR   GeneID; 5777; -.
DR   KEGG; hsa:5777; -.
DR   UCSC; uc001qsb.3; human. [P29350-1]
DR   CTD; 5777; -.
DR   DisGeNET; 5777; -.
DR   GeneCards; PTPN6; -.
DR   HGNC; HGNC:9658; PTPN6.
DR   HPA; ENSG00000111679; Tissue enhanced (blood, lymphoid tissue).
DR   MIM; 176883; gene.
DR   neXtProt; NX_P29350; -.
DR   OpenTargets; ENSG00000111679; -.
DR   PharmGKB; PA34002; -.
DR   eggNOG; KOG0790; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000159480; -.
DR   InParanoid; P29350; -.
DR   KO; K05697; -.
DR   OMA; IMCENGR; -.
DR   OrthoDB; 411281at2759; -.
DR   PhylomeDB; P29350; -.
DR   TreeFam; TF351632; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1433559; Regulation of KIT signaling.
DR   Reactome; R-HSA-210990; PECAM1 interactions.
DR   Reactome; R-HSA-388841; Costimulation by the CD28 family.
DR   Reactome; R-HSA-389948; PD-1 signaling.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-432142; Platelet sensitization by LDL.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-877312; Regulation of IFNG signaling.
DR   Reactome; R-HSA-9008059; Interleukin-37 signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-HSA-912694; Regulation of IFNA signaling.
DR   Reactome; R-HSA-982772; Growth hormone receptor signaling.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P29350; -.
DR   SIGNOR; P29350; -.
DR   ChiTaRS; PTPN6; human.
DR   EvolutionaryTrace; P29350; -.
DR   GeneWiki; PTPN6; -.
DR   GenomeRNAi; 5777; -.
DR   Pharos; P29350; Tchem.
DR   PRO; PR:P29350; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P29350; protein.
DR   Bgee; ENSG00000111679; Expressed in blood and 216 other tissues.
DR   ExpressionAtlas; P29350; baseline and differential.
DR   Genevisible; P29350; HS.
DR   GO; GO:0042105; C:alpha-beta T cell receptor complex; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IMP:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IEA:Ensembl.
DR   GO; GO:0140031; F:phosphorylation-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IMP:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:Ensembl.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0033277; P:abortive mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:1905867; P:epididymis development; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; NAS:UniProtKB.
DR   GO; GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0070527; P:platelet aggregation; IEA:Ensembl.
DR   GO; GO:0030220; P:platelet formation; IEA:Ensembl.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:ProtInc.
DR   GO; GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   Gene3D; 3.30.505.10; -; 2.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Hydrolase; Nucleus;
KW   Phosphoprotein; Protein phosphatase; Reference proteome; Repeat;
KW   SH2 domain.
FT   CHAIN           1..595
FT                   /note="Tyrosine-protein phosphatase non-receptor type 6"
FT                   /id="PRO_0000094758"
FT   DOMAIN          4..100
FT                   /note="SH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          110..213
FT                   /note="SH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          244..515
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          453..459
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        453
FT                   /note="Phosphocysteine intermediate"
FT   BINDING         419
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         500
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P81718"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         64
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         377
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         536
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         564
FT                   /note="Phosphotyrosine; by LYN"
FT                   /evidence="ECO:0000269|PubMed:10574931"
FT   VAR_SEQ         1..39
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1652101"
FT                   /id="VSP_005129"
FT   VAR_SEQ         1..3
FT                   /note="MVR -> MLSRG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007775"
FT   VAR_SEQ         40..44
FT                   /note="SLSVR -> MLSRG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1652101"
FT                   /id="VSP_005130"
FT   VAR_SEQ         559..595
FT                   /note="HKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK -> SLESSAGTVAA
FT                   SPVRRGGQRGLPVPGPPVLSPDLHQLPVLAPLHPAADTRRMCMRTCTLRTRGRRK (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10497187"
FT                   /id="VSP_044447"
FT   CONFLICT        6
FT                   /note="H -> L (in Ref. 5; AAA82880)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="L -> V (in Ref. 4; AAA36610 and 7; AAD53317)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146
FT                   /note="V -> E (in Ref. 5; AAA82880/AAA82879)"
FT                   /evidence="ECO:0000305"
FT   HELIX           11..21
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          26..31
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          33..45
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          48..55
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          57..59
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          61..63
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          68..70
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   HELIX           72..80
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          89..91
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   HELIX           105..107
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          111..114
FT                   /evidence="ECO:0000244|PDB:3PS5"
FT   HELIX           117..127
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          132..137
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          139..141
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          145..154
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          155..157
FT                   /evidence="ECO:0000244|PDB:2RMX"
FT   STRAND          162..170
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   HELIX           172..174
FT                   /evidence="ECO:0000244|PDB:3PS5"
FT   STRAND          175..181
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          184..186
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   HELIX           187..197
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          199..201
FT                   /evidence="ECO:0000244|PDB:2RMX"
FT   STRAND          202..204
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          205..207
FT                   /evidence="ECO:0000244|PDB:2RMX"
FT   HELIX           221..223
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          236..238
FT                   /evidence="ECO:0000244|PDB:3PS5"
FT   HELIX           244..256
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   TURN            257..259
FT                   /evidence="ECO:0000244|PDB:4HJP"
FT   HELIX           263..266
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           268..273
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          275..278
FT                   /evidence="ECO:0000244|PDB:1GWZ"
FT   TURN            283..285
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          286..288
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          290..292
FT                   /evidence="ECO:0000244|PDB:4GS0"
FT   STRAND          294..296
FT                   /evidence="ECO:0000244|PDB:3PS5"
FT   TURN            297..300
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          301..307
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          309..312
FT                   /evidence="ECO:0000244|PDB:1GWZ"
FT   HELIX           314..316
FT                   /evidence="ECO:0000244|PDB:1FPR"
FT   STRAND          321..324
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           329..331
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           332..341
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          346..349
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          353..355
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          356..358
FT                   /evidence="ECO:0000244|PDB:1FPR"
FT   STRAND          371..374
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          377..386
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          388..399
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           400..402
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          403..405
FT                   /evidence="ECO:0000244|PDB:1FPR"
FT   STRAND          407..414
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          419..421
FT                   /evidence="ECO:0000244|PDB:2B3O"
FT   STRAND          424..426
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           427..442
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          443..445
FT                   /evidence="ECO:0000244|PDB:4HJQ"
FT   STRAND          449..452
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   STRAND          454..457
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           458..476
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           484..492
FT                   /evidence="ECO:0000244|PDB:4GRZ"
FT   HELIX           502..523
FT                   /evidence="ECO:0000244|PDB:4GRZ"
SQ   SEQUENCE   595 AA;  67561 MW;  4D7736C21D3542D2 CRC64;
     MVRWFHRDLS GLDAETLLKG RGVHGSFLAR PSRKNQGDFS LSVRVGDQVT HIRIQNSGDF
     YDLYGGEKFA TLTELVEYYT QQQGVLQDRD GTIIHLKYPL NCSDPTSERW YHGHMSGGQA
     ETLLQAKGEP WTFLVRESLS QPGDFVLSVL SDQPKAGPGS PLRVTHIKVM CEGGRYTVGG
     LETFDSLTDL VEHFKKTGIE EASGAFVYLR QPYYATRVNA ADIENRVLEL NKKQESEDTA
     KAGFWEEFES LQKQEVKNLH QRLEGQRPEN KGKNRYKNIL PFDHSRVILQ GRDSNIPGSD
     YINANYIKNQ LLGPDENAKT YIASQGCLEA TVNDFWQMAW QENSRVIVMT TREVEKGRNK
     CVPYWPEVGM QRAYGPYSVT NCGEHDTTEY KLRTLQVSPL DNGDLIREIW HYQYLSWPDH
     GVPSEPGGVL SFLDQINQRQ ESLPHAGPII VHCSAGIGRT GTIIVIDMLM ENISTKGLDC
     DIDIQKTIQM VRAQRSGMVQ TEAQYKFIYV AIAQFIETTK KKLEVLQSQK GQESEYGNIT
     YPPAMKNAHA KASRTSSKHK EDVYENLHTK NKREEKVKKQ RSADKEKSKG SLKRK
//
ID   Q53XS4_HUMAN            Unreviewed;       597 AA.
AC   Q53XS4;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 147.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type {ECO:0000256|PIRNR:PIRNR000929};
DE            EC=3.1.3.48 {ECO:0000256|PIRNR:PIRNR000929};
GN   Name=PTPN6 {ECO:0000313|EMBL:EAW88702.1};
GN   ORFNames=hCG_25941 {ECO:0000313|EMBL:EAW88702.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAP36054.1};
RN   [1] {ECO:0000313|EMBL:EAW88702.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP36054.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW88702.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG36177.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:BAG36177.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|PIRNR:PIRNR000929,
CC         ECO:0000256|SAAS:SAAS01128831};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|PIRNR:PIRNR000929}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class 2 subfamily. {ECO:0000256|PIRNR:PIRNR000929}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BT007390; AAP36054.1; -; mRNA.
DR   EMBL; AK313379; BAG36177.1; -; mRNA.
DR   EMBL; CH471116; EAW88702.1; -; Genomic_DNA.
DR   RefSeq; NP_536858.1; NM_080548.4.
DR   RefSeq; XP_011519290.1; XM_011520988.1.
DR   Antibodypedia; 728; 946 antibodies.
DR   DNASU; 5777; -.
DR   GeneID; 5777; -.
DR   UCSC; uc001qsa.1; human.
DR   CTD; 5777; -.
DR   EuPathDB; HostDB:ENSG00000111679.16; -.
DR   PharmGKB; PA34002; -.
DR   eggNOG; KOG0790; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   ChiTaRS; PTPN6; human.
DR   GenomeRNAi; 5777; -.
DR   Bgee; ENSG00000111679; Expressed in blood and 216 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.30.505.10; -; 2.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|PIRNR:PIRNR000929};
KW   Hydrolase {ECO:0000256|PIRNR:PIRNR000929, ECO:0000256|SAAS:SAAS01031415};
KW   Protein phosphatase {ECO:0000256|PIRNR:PIRNR000929,
KW   ECO:0000256|SAAS:SAAS01031415}; Receptor {ECO:0000313|EMBL:AAP36054.1};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191}.
FT   DOMAIN          6..102
FT                   /note="SH2"
FT                   /evidence="ECO:0000259|PROSITE:PS50001"
FT   DOMAIN          112..215
FT                   /note="SH2"
FT                   /evidence="ECO:0000259|PROSITE:PS50001"
FT   DOMAIN          246..517
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          432..508
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   REGION          537..597
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        556..591
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        455
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR000929-1,
FT                   ECO:0000256|PROSITE-ProRule:PRU00160"
FT   BINDING         421
FT                   /note="Substrate"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR000929-2"
FT   BINDING         502
FT                   /note="Substrate"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR000929-2"
SQ   SEQUENCE   597 AA;  67719 MW;  6A291A2860159389 CRC64;
     MLSRGWFHRD LSGLDAETLL KGRGVHGSFL ARPSRKNQGD FSLSVRVGDQ VTHIRIQNSG
     DFYDLYGGEK FATLTELVEY YTQQQGVLQD RDGTIIHLKY PLNCSDPTSE RWYHGHMSGG
     QAETLLQAKG EPWTFLVRES LSQPGDFVLS VLSDQPKAGP GSPLRVTHIK VMCEGGRYTV
     GGLETFDSLT DLVEHFKKTG IEEASGAFVY LRQPYYATRV NAADIENRVL ELNKKQESED
     TAKAGFWEEF ESLQKQEVKN LHQRLEGQRP ENKGKNRYKN ILPFDHSRVI LQGRDSNIPG
     SDYINANYIK NQLLGPDENA KTYIASQGCL EATVNDFWQM AWQENSRVIV MTTREVEKGR
     NKCVPYWPEV GMQRAYGPYS VTNCGEHDTT EYKLRTLQVS PLDNGDLIRE IWHYQYLSWP
     DHGVPSEPGG VLSFLDQINQ RQESLPHAGP IIVHCSAGIG RTGTIIVIDM LMENISTKGL
     DCDIDIQKTI QMVRAQRSGM VQTEAQYKFI YVAIAQFIET TKKKLEVLQS QKGQESEYGN
     ITYPPAMKNA HAKASRTSSK HKEDVYENLH TKNKREEKVK KQRSADKEKS KGSLKRK
//
ID   PTPRD_HUMAN             Reviewed;        1912 AA.
AC   P23468; B1ALA0; F5GWT7; Q3KPJ0; Q3KPJ1; Q3KPJ2;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-APR-2020, entry version 211.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase delta;
DE            Short=Protein-tyrosine phosphatase delta;
DE            Short=R-PTP-delta;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=PTPRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CLEAVAGE SITE, AND MUTAGENESIS OF
RP   ARG-1178 AND ARG-1181.
RX   PubMed=7896816; DOI=10.1074/jbc.270.12.6722;
RA   Pulido R., Krueger N.X., Serra-Pages C., Saito H., Streuli M.;
RT   "Molecular characterization of the human transmembrane protein-tyrosine
RT   phosphatase delta. Evidence for tissue-specific expression of alternative
RT   human transmembrane protein-tyrosine phosphatase delta isoforms.";
RL   J. Biol. Chem. 270:6722-6728(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 390-1912.
RC   TISSUE=Placenta;
RX   PubMed=2170109; DOI=10.1002/j.1460-2075.1990.tb07523.x;
RA   Krueger N.X., Streuli M., Saito H.;
RT   "Structural diversity and evolution of human receptor-like protein tyrosine
RT   phosphatases.";
RL   EMBO J. 9:3241-3252(1990).
RN   [5]
RP   INTERACTION WITH PPFIA1; PPFIA2 AND PPFIA3.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [6]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [7]
RP   STRUCTURE BY NMR OF 405-607.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second and third FN3 domain of human receptor-
RT   type tyrosine-protein phosphatase delta.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-28; PRO-276 AND ALA-901.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Can bidirectionally induce pre- and post-synaptic
CC       differentiation of neurons by mediating interaction with IL1RAP and
CC       IL1RAPL1 trans-synaptically. Involved in pre-synaptic differentiation
CC       through interaction with SLITRK2. {ECO:0000250|UniProtKB:Q64487}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Interacts with PPFIA1, PPFIA2 and PPFIA3 (PubMed:9624153).
CC       Interacts (via extracellular domain) with SLITRK4 (via LRR 1 and 2
CC       repeats). Interacts with SLITRK2; induces presynaptic differentiation.
CC       Interacts (via the second immunoglobilin domain) with IL1RAPL1 (via the
CC       first immunoglobilin domain); induces pre- and postsynaptic
CC       differentiation of neurons and synapse formation. Interacts (via the
CC       third immunoglobilin domain) with IL1RAP (via the first immunoglobilin
CC       domain); induces pre- and postsynaptic differentiation of neurons (By
CC       similarity). {ECO:0000250|UniProtKB:Q64487,
CC       ECO:0000269|PubMed:9624153}.
CC   -!- INTERACTION:
CC       P23468; O14965: AURKA; NbExp=2; IntAct=EBI-2682990, EBI-448680;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P23468-1; Sequence=Displayed;
CC       Name=2; Synonyms=Kidney;
CC         IsoId=P23468-2; Sequence=VSP_005147, VSP_005148, VSP_005149;
CC       Name=3; Synonyms=Fetal brain;
CC         IsoId=P23468-3; Sequence=VSP_005150;
CC       Name=4;
CC         IsoId=P23468-4; Sequence=VSP_043384, VSP_043385, VSP_043386,
CC                                  VSP_043387, VSP_043390;
CC       Name=5;
CC         IsoId=P23468-5; Sequence=VSP_043386, VSP_043387, VSP_043388;
CC       Name=6;
CC         IsoId=P23468-6; Sequence=VSP_043386, VSP_043387, VSP_043389;
CC       Name=7;
CC         IsoId=P23468-7; Sequence=VSP_054220, VSP_054221, VSP_043388;
CC   -!- PTM: A cleavage occurs, separating the extracellular domain from the
CC       transmembrane segment. This process called 'ectodomain shedding' is
CC       thought to be involved in receptor desensitization, signal transduction
CC       and/or membrane localization. {ECO:0000269|PubMed:7896816}.
CC   -!- MISCELLANEOUS: [Isoform 1]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2A subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPRDID41927ch9p23.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L38929; AAC41749.1; -; mRNA.
DR   EMBL; AL137125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL135790; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137851; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL354722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356054; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL441884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590307; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591622; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC106713; AAI06714.1; -; mRNA.
DR   EMBL; BC106714; AAI06715.1; -; mRNA.
DR   EMBL; BC106715; AAI06716.1; -; mRNA.
DR   EMBL; X54133; CAA38068.1; -; mRNA.
DR   CCDS; CCDS43786.1; -. [P23468-1]
DR   CCDS; CCDS55288.1; -. [P23468-7]
DR   CCDS; CCDS55289.1; -. [P23468-4]
DR   CCDS; CCDS55290.1; -. [P23468-6]
DR   CCDS; CCDS6472.2; -. [P23468-5]
DR   PIR; A56178; A56178.
DR   RefSeq; NP_001164496.1; NM_001171025.1. [P23468-4]
DR   RefSeq; NP_002830.1; NM_002839.3. [P23468-1]
DR   RefSeq; NP_569075.2; NM_130391.3. [P23468-5]
DR   RefSeq; NP_569076.2; NM_130392.3. [P23468-6]
DR   RefSeq; XP_006716895.1; XM_006716832.3. [P23468-4]
DR   RefSeq; XP_006716896.1; XM_006716833.3. [P23468-5]
DR   RefSeq; XP_006716898.1; XM_006716835.3. [P23468-7]
DR   RefSeq; XP_011516294.1; XM_011517992.2. [P23468-1]
DR   RefSeq; XP_016870480.1; XM_017014991.1. [P23468-6]
DR   PDB; 1X5Z; NMR; -; A=506-607.
DR   PDB; 2DLH; NMR; -; A=407-514.
DR   PDB; 2YD6; X-ray; 1.35 A; A=21-226.
DR   PDB; 2YD7; X-ray; 1.98 A; A/B=21-226.
DR   PDB; 4RCA; X-ray; 2.99 A; A=21-322.
DR   PDB; 5WY8; X-ray; 3.07 A; A=21-318.
DR   PDB; 5XNP; X-ray; 3.73 A; D/E=21-320.
DR   PDBsum; 1X5Z; -.
DR   PDBsum; 2DLH; -.
DR   PDBsum; 2YD6; -.
DR   PDBsum; 2YD7; -.
DR   PDBsum; 4RCA; -.
DR   PDBsum; 5WY8; -.
DR   PDBsum; 5XNP; -.
DR   SMR; P23468; -.
DR   BioGrid; 111753; 85.
DR   DIP; DIP-17023N; -.
DR   IntAct; P23468; 56.
DR   MINT; P23468; -.
DR   STRING; 9606.ENSP00000370593; -.
DR   GuidetoPHARMACOLOGY; 1853; -.
DR   DEPOD; P23468; -.
DR   iPTMnet; P23468; -.
DR   PhosphoSitePlus; P23468; -.
DR   BioMuta; PTPRD; -.
DR   DMDM; 1709906; -.
DR   EPD; P23468; -.
DR   jPOST; P23468; -.
DR   MassIVE; P23468; -.
DR   MaxQB; P23468; -.
DR   PaxDb; P23468; -.
DR   PeptideAtlas; P23468; -.
DR   PRIDE; P23468; -.
DR   ProteomicsDB; 24215; -.
DR   ProteomicsDB; 54101; -. [P23468-1]
DR   ProteomicsDB; 54102; -. [P23468-2]
DR   ProteomicsDB; 54103; -. [P23468-3]
DR   ProteomicsDB; 54104; -. [P23468-4]
DR   ProteomicsDB; 54105; -. [P23468-5]
DR   ProteomicsDB; 54106; -. [P23468-6]
DR   Antibodypedia; 24342; 134 antibodies.
DR   Ensembl; ENST00000355233; ENSP00000347373; ENSG00000153707. [P23468-6]
DR   Ensembl; ENST00000356435; ENSP00000348812; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000381196; ENSP00000370593; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000397606; ENSP00000380731; ENSG00000153707. [P23468-4]
DR   Ensembl; ENST00000397611; ENSP00000380735; ENSG00000153707. [P23468-7]
DR   Ensembl; ENST00000486161; ENSP00000417093; ENSG00000153707. [P23468-5]
DR   Ensembl; ENST00000540109; ENSP00000438164; ENSG00000153707. [P23468-1]
DR   Ensembl; ENST00000634556; ENSP00000489063; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000634583; ENSP00000489509; ENSG00000282932. [P23468-5]
DR   Ensembl; ENST00000634608; ENSP00000489257; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000635012; ENSP00000489439; ENSG00000282932. [P23468-1]
DR   Ensembl; ENST00000635279; ENSP00000488982; ENSG00000282932. [P23468-4]
DR   Ensembl; ENST00000635611; ENSP00000489155; ENSG00000282932. [P23468-7]
DR   Ensembl; ENST00000635613; ENSP00000489038; ENSG00000282932. [P23468-6]
DR   GeneID; 5789; -.
DR   KEGG; hsa:5789; -.
DR   UCSC; uc003zkp.4; human. [P23468-1]
DR   CTD; 5789; -.
DR   DisGeNET; 5789; -.
DR   GeneCards; PTPRD; -.
DR   HGNC; HGNC:9668; PTPRD.
DR   HPA; ENSG00000153707; Tissue enhanced (brain, parathyroid gland).
DR   MIM; 601598; gene.
DR   neXtProt; NX_P23468; -.
DR   OpenTargets; ENSG00000153707; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000153617; -.
DR   HOGENOM; CLU_001645_4_3_1; -.
DR   InParanoid; P23468; -.
DR   KO; K06777; -.
DR   OMA; IGRAPMS; -.
DR   OrthoDB; 220353at2759; -.
DR   PhylomeDB; P23468; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   Reactome; R-HSA-8849932; Synaptic adhesion-like molecules.
DR   SignaLink; P23468; -.
DR   SIGNOR; P23468; -.
DR   ChiTaRS; PTPRD; human.
DR   EvolutionaryTrace; P23468; -.
DR   GeneWiki; PTPRD; -.
DR   GenomeRNAi; 5789; -.
DR   Pharos; P23468; Tbio.
DR   PRO; PR:P23468; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P23468; protein.
DR   Bgee; ENSG00000153707; Expressed in forebrain and 195 other tissues.
DR   ExpressionAtlas; P23468; baseline and differential.
DR   Genevisible; P23468; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:BHF-UCL.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0030182; P:neuron differentiation; ISS:BHF-UCL.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; NAS:ProtInc.
DR   GO; GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IBA:GO_Central.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; IEA:Ensembl.
DR   GO; GO:1905606; P:regulation of presynapse assembly; IDA:SynGO.
DR   GO; GO:0099560; P:synaptic membrane adhesion; IDA:SynGO.
DR   GO; GO:0099545; P:trans-synaptic signaling by trans-synaptic complex; IDA:SynGO.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 11.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Immunoglobulin domain; Membrane; Polymorphism;
KW   Protein phosphatase; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..1912
FT                   /note="Receptor-type tyrosine-protein phosphatase delta"
FT                   /id="PRO_0000025437"
FT   TOPO_DOM        21..1265
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1266..1290
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1291..1912
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          24..114
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          126..224
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          236..318
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          325..415
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          420..516
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          518..607
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          612..709
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          714..822
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          823..916
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          921..1016
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1020..1106
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1357..1612
FT                   /note="Tyrosine-protein phosphatase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   DOMAIN          1644..1903
FT                   /note="Tyrosine-protein phosphatase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          180..189
FT                   /note="Interaction with IL1RAPL1"
FT                   /evidence="ECO:0000250"
FT   REGION          181..189
FT                   /note="Mini-exon peptide A9; sufficient for interaction
FT                   with IL1RAPL1"
FT                   /evidence="ECO:0000250|UniProtKB:Q64487"
FT   REGION          227..230
FT                   /note="Mini-exon peptide B; required for interaction with
FT                   SLITRK2 and in the function in pre-synaptic
FT                   differentiation; Acts as an adjustable linker to control
FT                   relative positions and orientations of the PTPRD second and
FT                   third immunoglobilin domains for their simultaneous
FT                   interactions with the first immunoglobilin domain of
FT                   IL1RAPL1 and IL1RAP; Modulates affinity for IL1RAPL1 and
FT                   IL1RAP"
FT                   /evidence="ECO:0000250|UniProtKB:Q64487"
FT   REGION          1553..1559
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1553
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1844
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1521
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1597
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            266
FT                   /note="Required for interaction with IL1RAP"
FT                   /evidence="ECO:0000250|UniProtKB:Q64487"
FT   SITE            1181..1182
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000305"
FT   CARBOHYD        254
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        299
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        724
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        832
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        45..98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        147..207
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        257..302
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         181..189
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005147"
FT   VAR_SEQ         181..183
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054220"
FT   VAR_SEQ         184..189
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043384"
FT   VAR_SEQ         226..229
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005148"
FT   VAR_SEQ         227..230
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043385"
FT   VAR_SEQ         608..1019
FT                   /note="KPSAPPQDISCTSPSSTSILVSWQPPPVEKQNGIITEYSIKYTAVDGEDDKP
FT                   HEILGIPSDTTKYLLEQLEKWTEYRITVTAHTDVGPGPESLSVLIRTNEDVPSGPPRKV
FT                   EVEAVNSTSVKVSWRSPVPNKQHGQIRGYQVHYVRMENGEPKGQPMLKDVMLADAQWEF
FT                   DDTTEHDMIISGLQPETSYSLTVTAYTTKGDGARSKPKLVSTTGAVPGKPRLVINHTQM
FT                   NTALIQWHPPVDTFGPLQGYRLKFGRKDMEPLTTLEFSEKEDHFTATDIHKGASYVFRL
FT                   SARNKVGFGEEMVKEISIPEEVPTGFPQNLHSEGTTSTSVQLSWQPPVLAERNGIITKY
FT                   TLLYRDINIPLLPMEQLIVPADTTMTLTGLKPDTTYDVKVRAHTSKGPGPYSPSVQFRT
FT                   LPVDQV -> M (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054221"
FT   VAR_SEQ         608
FT                   /note="K -> M (in isoform 4, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043386"
FT   VAR_SEQ         609..1137
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005150"
FT   VAR_SEQ         609..1019
FT                   /note="Missing (in isoform 4, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043387"
FT   VAR_SEQ         775..783
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005149"
FT   VAR_SEQ         1291
FT                   /note="K -> KSKPD (in isoform 5 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043388"
FT   VAR_SEQ         1291
FT                   /note="K -> KSSKPD (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043389"
FT   VAR_SEQ         1330
FT                   /note="G -> GSDDSGYPGNLHSSS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043390"
FT   VARIANT         28
FT                   /note="R -> Q (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1353675904)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035645"
FT   VARIANT         276
FT                   /note="L -> P (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035646"
FT   VARIANT         447
FT                   /note="Q -> E (in dbSNP:rs10977171)"
FT                   /id="VAR_024581"
FT   VARIANT         901
FT                   /note="V -> A (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035647"
FT   VARIANT         995
FT                   /note="R -> C (in dbSNP:rs35929428)"
FT                   /id="VAR_061761"
FT   VARIANT         1078
FT                   /note="E -> D (in dbSNP:rs7869444)"
FT                   /id="VAR_051761"
FT   MUTAGEN         1178
FT                   /note="R->A: 2.5-fold reduction in cleavage. 10-fold
FT                   reduction in cleavage; when associated with A-1181."
FT                   /evidence="ECO:0000269|PubMed:7896816"
FT   MUTAGEN         1181
FT                   /note="R->A: No reduction in cleavage. 10-fold reduction in
FT                   cleavage; when associated with A-1178."
FT                   /evidence="ECO:0000269|PubMed:7896816"
FT   STRAND          22..28
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          33..36
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          41..51
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          54..59
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          69..74
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   HELIX           75..77
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          79..84
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   TURN            89..92
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          94..102
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          105..116
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   HELIX           118..120
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          127..130
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          135..138
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          143..150
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          156..161
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          170..172
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          175..180
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          184..186
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          190..194
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   HELIX           199..201
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          203..211
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          214..217
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          221..226
FT                   /evidence="ECO:0000244|PDB:2YD6"
FT   STRAND          234..240
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          245..247
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          251..263
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          266..271
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   HELIX           279..281
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          284..294
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          298..306
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          309..319
FT                   /evidence="ECO:0000244|PDB:4RCA"
FT   STRAND          422..426
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          430..433
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          436..439
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          448..454
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   TURN            463..465
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          475..477
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          487..498
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          507..510
FT                   /evidence="ECO:0000244|PDB:2DLH"
FT   STRAND          520..525
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          527..537
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          546..549
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          551..556
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          566..573
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          580..583
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          585..588
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          593..596
FT                   /evidence="ECO:0000244|PDB:1X5Z"
FT   STRAND          600..603
FT                   /evidence="ECO:0000244|PDB:1X5Z"
SQ   SEQUENCE   1912 AA;  214760 MW;  3AE8CBCD32182E26 CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGGTPIRG ALQIEQSEES DQGKYECVAT NSAGTRYSAP ANLYVRELRE VRRVPPRFSI
     PPTNHEIMPG GSVNITCVAV GSPMPYVKWM LGAEDLTPED DMPIGRNVLE LNDVRQSANY
     TCVAMSTLGV IEAIAQITVK ALPKPPGTPV VTESTATSIT LTWDSGNPEP VSYYIIQHKP
     KNSEELYKEI DGVATTRYSV AGLSPYSDYE FRVVAVNNIG RGPPSEPVLT QTSEQAPSSA
     PRDVQARMLS STTILVQWKE PEEPNGQIQG YRVYYTMDPT QHVNNWMKHN VADSQITTIG
     NLVPQKTYSV KVLAFTSIGD GPLSSDIQVI TQTGVPGQPL NFKAEPESET SILLSWTPPR
     SDTIANYELV YKDGEHGEEQ RITIEPGTSY RLQGLKPNSL YYFRLAARSP QGLGASTAEI
     SARTMQSKPS APPQDISCTS PSSTSILVSW QPPPVEKQNG IITEYSIKYT AVDGEDDKPH
     EILGIPSDTT KYLLEQLEKW TEYRITVTAH TDVGPGPESL SVLIRTNEDV PSGPPRKVEV
     EAVNSTSVKV SWRSPVPNKQ HGQIRGYQVH YVRMENGEPK GQPMLKDVML ADAQWEFDDT
     TEHDMIISGL QPETSYSLTV TAYTTKGDGA RSKPKLVSTT GAVPGKPRLV INHTQMNTAL
     IQWHPPVDTF GPLQGYRLKF GRKDMEPLTT LEFSEKEDHF TATDIHKGAS YVFRLSARNK
     VGFGEEMVKE ISIPEEVPTG FPQNLHSEGT TSTSVQLSWQ PPVLAERNGI ITKYTLLYRD
     INIPLLPMEQ LIVPADTTMT LTGLKPDTTY DVKVRAHTSK GPGPYSPSVQ FRTLPVDQVF
     AKNFHVKAVM KTSVLLSWEI PENYNSAMPF KILYDDGKMV EEVDGRATQK LIVNLKPEKS
     YSFVLTNRGN SAGGLQHRVT AKTAPDVLRT KPAFIGKTNL DGMITVQLPE VPANENIKGY
     YIIIVPLKKS RGKFIKPWES PDEMELDELL KEISRKRRSI RYGREVELKP YIAAHFDVLP
     TEFTLGDDKH YGGFTNKQLQ SGQEYVFFVL AVMEHAESKM YATSPYSDPV VSMDLDPQPI
     TDEEEGLIWV VGPVLAVVFI ICIVIAILLY KRKRAESDSR KSSIPNNKEI PSHHPTDPVE
     LRRLNFQTPG MASHPPIPIL ELADHIERLK ANDNLKFSQE YESIDPGQQF TWEHSNLEVN
     KPKNRYANVI AYDHSRVLLS AIEGIPGSDY VNANYIDGYR KQNAYIATQG SLPETFGDFW
     RMIWEQRSAT VVMMTKLEER SRVKCDQYWP SRGTETHGLV QVTLLDTVEL ATYCVRTFAL
     YKNGSSEKRE VRQFQFTAWP DHGVPEHPTP FLAFLRRVKT CNPPDAGPMV VHCSAGVGRT
     GCFIVIDAML ERIKHEKTVD IYGHVTLMRA QRNYMVQTED QYIFIHDALL EAVTCGNTEV
     PARNLYAYIQ KLTQIETGEN VTGMELEFKR LASSKAHTSR FISANLPCNK FKNRLVNIMP
     YESTRVCLQP IRGVEGSDYI NASFIDGYRQ QKAYIATQGP LAETTEDFWR MLWEHNSTIV
     VMLTKLREMG REKCHQYWPA ERSARYQYFV VDPMAEYNMP QYILREFKVT DARDGQSRTV
     RQFQFTDWPE QGVPKSGEGF IDFIGQVHKT KEQFGQDGPI SVHCSAGVGR TGVFITLSIV
     LERMRYEGVV DIFQTVKMLR TQRPAMVQTE DQYQFSYRAA LEYLGSFDHY AT
//
ID   Q2HXI4_HUMAN            Unreviewed;      1912 AA.
AC   Q2HXI4;
DT   21-MAR-2006, integrated into UniProtKB/TrEMBL.
DT   21-MAR-2006, sequence version 1.
DT   11-DEC-2019, entry version 116.
DE   SubName: Full=Protein tyrosine phosphatase receptor type D {ECO:0000313|EMBL:BAE79816.1};
GN   Name=PTPRD {ECO:0000313|EMBL:BAE79816.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE79816.1};
RN   [1] {ECO:0000313|EMBL:BAE79816.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sato M., Kohno T., Yokota J.;
RT   "Identification of Chromosome Arm 9p as the Most Frequent Target of
RT   Homozygous Deletions in Lung Cancer.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB211400; BAE79816.1; -; mRNA.
DR   RefSeq; NP_002830.1; NM_002839.3.
DR   PeptideAtlas; Q2HXI4; -.
DR   PRIDE; Q2HXI4; -.
DR   GeneID; 5789; -.
DR   KEGG; hsa:5789; -.
DR   CTD; 5789; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   KO; K06777; -.
DR   OrthoDB; 220353at2759; -.
DR   ChiTaRS; PTPRD; human.
DR   GenomeRNAi; 5789; -.
DR   Genevisible; Q2HXI4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 11.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:BAE79816.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00747680,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           21..1912
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004209372"
FT   TRANSMEM        1267..1290
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          24..114
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          126..224
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          236..318
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          325..415
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          420..516
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          518..607
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          612..709
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          714..822
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          823..916
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          921..1016
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1020..1106
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          1357..1612
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1532..1603
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   DOMAIN          1644..1903
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1821..1894
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   REGION          603..623
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1298..1318
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1553
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1844
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
SQ   SEQUENCE   1912 AA;  214786 MW;  0889DDDA9AD62D2F CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGGTPIRG ALQIEQSEES DQGKYECVAT NSAGTRYSAP ANLYVRELRE VRRVPPRFSI
     PPTNHEIMPG GSVNITCVAV GSPMPYVKWM LGAEDLTPED DMPIGRNVLE LNDVRQSANY
     TCVAMSTLGV IEAIAQITVK PLPKPPGTPV VTESTATSIT LTWDSGNPEP VSYYIIQHKP
     KNSEELYKEI DGVATTRYSV AGLSPYSDYE FRVVAVNNIG RGPPSEPVLT QTSEQAPSSA
     PRDVQARMLS STTILVQWKE PEEPNGQIQG YRVYYTMDPT QHVNNWMKHN VADSQITTIG
     NLVPQKTYSV KVLAFTSIGD GPLSSDIQVI TQTGVPGQPL NFKAEPESET SILLSWTPPR
     SDTIANYELV YKDGEHGEEQ RITIEPGTSY RLQGLKPNSL YYFRLAARSP QGLGASTAEI
     SARTMQSKPS APPQDISCTS PSSTSILVSW QPPPVEKQNG IITEYSIKYT AVDGEDDKPH
     EILGIPSDTT KYLLEQLEKW TEYRITVTAH TDVGPGPESL SVLIRTNEDV PSGPPRKVEV
     EAVNSTSVKV SWRSPVPNKQ HGQIRGYQVH YVRMENGEPK GQPMLKDVML ADAQWEFDDT
     TEHDMIISGL QPETSYSLTV TAYTTKGDGA RSKPKLVSTT GAVPGKPRLV INHTQMNTAL
     IQWHPPVDTF GPLQGYRLKF GRKDMEPLTT LEFSEKEDHF TATDIHKGAS YVFRLSARNK
     VGFGEEMVKE ISIPEEVPTG FPQNLHSEGT TSTSVQLSWQ PPVLAERNGI ITKYTLLYRD
     INIPLLPMEQ LIVPADTTMT LTGLKPDTTY DVKVRAHTSK GPGPYSPSVQ FRTLPVDQVF
     AKNFHVKAVM KTSVLLSWEI PENYNSAMPF KILYDDGKMV EEVDGRATQK LIVNLKPEKS
     YSFVLTNRGN SAGGLQHRVT AKTAPDVLRT KPAFIGKTNL DGMITVQLPE VPANENIKGY
     YIIIVPLKKS RGKFIKPWES PDEMELDELL KEISRKRRSI RYGREVELKP YIAAHFDVLP
     TEFTLGDDKH YGGFTNKQLQ SGQEYVFFVL AVMEHAESKM YATSPYSDPV VSMDLDPQPI
     TDEEEGLIWV VGPVLAVVFI ICIVIAILLY KRKRAESDSR KSSIPNNKEI PSHHPTDPVE
     LRRLNFQTPG MASHPPIPIL ELADHIERLK ANDNLKFSQE YESIDPGQQF TWEHSNLEVN
     KPKNRYANVI AYDHSRVLLS AIEGIPGSDY VNANYIDGYR KQNAYIATQG SLPETFGDFW
     RMIWEQRSAT VVMMTKLEER SRVKCDQYWP SRGTETHGLV QVTLLDTVEL ATYCVRTFAL
     YKNGSSEKRE VRQFQFTAWP DHGVPEHPTP FLAFLRRVKT CNPPDAGPMV VHCSAGVGRT
     GCFIVIDAML ERIKHEKTVD IYGHVTLMRA QRNYMVQTED QYIFIHDALL EAVTCGNTEV
     PARNLYAYIQ KLTQIETGEN VTGMELEFKR LASSKAHTSR FISANLPCNK FKNRLVNIMP
     YESTRVCLQP IRGVEGSDYI NASFIDGYRQ QKAYIATQGP LAETTEDFWR MLWEHNSTIV
     VMLTKLREMG REKCHQYWPA ERSARYQYFV VDPMAEYNMP QYILREFKVT DARDGQSRTV
     RQFQFTDWPE QGVPKSGEGF IDFIGQVHKT KEQFGQDGPI SVHCSAGVGR TGVFITLSIV
     LERMRYEGVV DIFQTVKMLR TQRPAMVQTE DQYQFSYRAA LEYLGSFDHY AT
//
ID   Q3KPI9_HUMAN            Unreviewed;      1496 AA.
AC   Q3KPI9; F5GWY7;
DT   08-NOV-2005, integrated into UniProtKB/TrEMBL.
DT   08-NOV-2005, sequence version 1.
DT   22-APR-2020, entry version 137.
DE   SubName: Full=PTPRD protein {ECO:0000313|EMBL:AAI06717.1};
DE   SubName: Full=Receptor-type tyrosine-protein phosphatase delta {ECO:0000313|Ensembl:ENSP00000440515};
GN   Name=PTPRD {ECO:0000313|EMBL:AAI06717.1,
GN   ECO:0000313|Ensembl:ENSP00000440515};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI06717.1};
RN   [1] {ECO:0000313|EMBL:AAI06717.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000440515, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000440515}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000313|Ensembl:ENSP00000489264}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2015) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC245202; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445926; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC106716; AAI06717.1; -; mRNA.
DR   RefSeq; NP_569077.2; NM_130393.3.
DR   RefSeq; XP_006716900.1; XM_006716837.3.
DR   ProteomicsDB; 24259; -.
DR   Antibodypedia; 24342; 134 antibodies.
DR   Ensembl; ENST00000537002; ENSP00000440515; ENSG00000153707.
DR   Ensembl; ENST00000634498; ENSP00000489264; ENSG00000282932.
DR   GeneID; 5789; -.
DR   UCSC; uc003zkr.4; human.
DR   CTD; 5789; -.
DR   EuPathDB; HostDB:ENSG00000153707.15; -.
DR   HGNC; HGNC:9668; PTPRD.
DR   OpenTargets; ENSG00000153707; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000153617; -.
DR   HOGENOM; CLU_001645_4_0_1; -.
DR   OrthoDB; 220353at2759; -.
DR   ChiTaRS; PTPRD; human.
DR   GenomeRNAi; 5789; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000153707; Expressed in forebrain and 195 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 7.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Proteomics identification {ECO:0000213|MaxQB:Q3KPI9,
KW   ECO:0000213|PeptideAtlas:Q3KPI9, ECO:0000213|ProteomicsDB:Q3KPI9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00747680,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           21..1496
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014586318"
FT   TRANSMEM        851..874
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          24..114
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          126..218
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          230..312
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          319..409
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          414..510
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          512..601
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          604..690
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          941..1196
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1116..1187
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   DOMAIN          1228..1487
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1405..1478
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   REGION          882..902
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1137
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1428
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
SQ   SEQUENCE   1496 AA;  168666 MW;  BB9C92B895E91FE1 CRC64;
     MVHVARLLLL LLTFFLRTDA ETPPRFTRTP VDQTGVSGGV ASFICQATGD PRPKIVWNKK
     GKKVSNQRFE VIEFDDGSGS VLRIQPLRTP RDEAIYECVA SNNVGEISVS TRLTVLREDQ
     IPRGFPTIDM GPQLKVVERT RTATMLCAAS GNPDPEITWF KDFLPVDTSN NNGRIKQLRS
     ESIGALQIEQ SEESDQGKYE CVATNSAGTR YSAPANLYVR ELREVRRVPP RFSIPPTNHE
     IMPGGSVNIT CVAVGSPMPY VKWMLGAEDL TPEDDMPIGR NVLELNDVRQ SANYTCVAMS
     TLGVIEAIAQ ITVKALPKPP GTPVVTESTA TSITLTWDSG NPEPVSYYII QHKPKNSEEL
     YKEIDGVATT RYSVAGLSPY SDYEFRVVAV NNIGRGPPSE PVLTQTSEQA PSSAPRDVQA
     RMLSSTTILV QWKEPEEPNG QIQGYRVYYT MDPTQHVNNW MKHNVADSQI TTIGNLVPQK
     TYSVKVLAFT SIGDGPLSSD IQVITQTGVP GQPLNFKAEP ESETSILLSW TPPRSDTIAN
     YELVYKDGEH GEEQRITIEP GTSYRLQGLK PNSLYYFRLA ARSPQGLGAS TAEISARTMQ
     STVFAKNFHV KAVMKTSVLL SWEIPENYNS AMPFKILYDD GKMVEEVDGR ATQKLIVNLK
     PEKSYSFVLT NRGNSAGGLQ HRVTAKTAPD VLRTKPAFIG KTNLDGMITV QLPEVPANEN
     IKGYYIIIVP LKKSRGKFIK PWESPDEMEL DELLKEISRK RRSIRYGREV ELKPYIAAHF
     DVLPTEFTLG DDKHYGGFTN KQLQSGQEYV FFVLAVMEHA ESKMYATSPY SDPVVSMDLD
     PQPITDEEEG LIWVVGPVLA VVFIICIVIA ILLYKRKRAE SDSRKSSIPN NKEIPSHHPT
     DPVELRRLNF QTPGMASHPP IPILELADHI ERLKANDNLK FSQEYESIDP GQQFTWEHSN
     LEVNKPKNRY ANVIAYDHSR VLLSAIEGIP GSDYVNANYI DGYRKQNAYI ATQGSLPETF
     GDFWRMIWEQ RSATVVMMTK LEERSRVKCD QYWPSRGTET HGLVQVTLLD TVELATYCVR
     TFALYKNGSS EKREVRQFQF TAWPDHGVPE HPTPFLAFLR RVKTCNPPDA GPMVVHCSAG
     VGRTGCFIVI DAMLERIKHE KTVDIYGHVT LMRAQRNYMV QTEDQYIFIH DALLEAVTCG
     NTEVPARNLY AYIQKLTQIE TGENVTGMEL EFKRLASSKA HTSRFISANL PCNKFKNRLV
     NIMPYESTRV CLQPIRGVEG SDYINASFID GYRQQKAYIA TQGPLAETTE DFWRMLWEHN
     STIVVMLTKL REMGREKCHQ YWPAERSARY QYFVVDPMAE YNMPQYILRE FKVTDARDGQ
     SRTVRQFQFT DWPEQGVPKS GEGFIDFIGQ VHKTKEQFGQ DGPISVHCSA GVGRTGVFIT
     LSIVLERMRY EGVVDIFQTV KMLRTQRPAM VQTEDQYQFS YRAALEYLGS FDHYAT
//
ID   Q59H90_HUMAN            Unreviewed;      1478 AA.
AC   Q59H90;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   11-DEC-2019, entry version 112.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, D isoform 4 variant {ECO:0000313|EMBL:BAD92106.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92106.1};
RN   [1] {ECO:0000313|EMBL:BAD92106.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92106.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB208869; BAD92106.1; -; mRNA.
DR   RefSeq; NP_001035802.1; NM_001040712.2.
DR   PeptideAtlas; Q59H90; -.
DR   PRIDE; Q59H90; -.
DR   GeneID; 5789; -.
DR   CTD; 5789; -.
DR   PharmGKB; PA34013; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   OrthoDB; 220353at2759; -.
DR   GenomeRNAi; 5789; -.
DR   Genevisible; Q59H90; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 7.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|PROSITE-ProRule:PRU00160};
KW   Membrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAD92106.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00747680,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        829..852
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          1..90
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          102..197
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          209..291
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          298..388
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          393..489
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          491..580
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          582..668
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          923..1178
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1098..1169
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   DOMAIN          1210..1469
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1387..1460
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   REGION          860..885
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1119
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1410
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAD92106.1"
SQ   SEQUENCE   1478 AA;  166527 MW;  7243A931A8CAF631 CRC64;
     RFTRTPVDQT GVSGGVASFI CQATGDPRPK IVWNKKGKKV SNQRFEVIEF DDGSGSVLRI
     QPLRTPRDEA IYECVASNNV GEISVSTRLT VLREDQIPRG FPTIDMGPQL KVVERTRTAT
     MLCAASGNPD PEITWFKDFL PVDTSNNNGR IKQLRSGGTP IRGALQIEQS EESDQGKYEC
     VATNSAGTRY SAPANLYVRE LREVRRVPPR FSIPPTNHEI MPGGSVNITC VAVGSPMPYV
     KWMLGAEDLT PEDDMPIGRN VLELNDVRQS ANYTCVAMST LGVIEAIAQI TVKALPKPPG
     TPVVTESTAT SITLTWDSGN PEPVSYYIIQ HKPKNSEELY KEIDGVATTR YSVAGLSPYS
     DYEFRVVAVN NIGRGPPSEP VLTQTSEQAP SSAPRDVQAR MLSSTTILVQ WKEPEEPNGQ
     IQGYRVYYTM DPTQHVNNWM KHNVADSQIT TIGNLVPQKT YSVKVLAFTS IGDGPLSSDI
     QVITQTGVPG QPLNFKAEPE SETSILLSWT PPRSDTIANY ELVYKDGEHG EEQRITIEPG
     TSYRLQGLKP NSLYYFRLAA RSPQGLGAST AEISARTMQS MFAKNFHVKA VMKTSVLLSW
     EIPENYNSAM PFKILYDDGK MVEEVDGRAT QKLIVNLKPE KSYSFVLTNR GNSAGGLQHR
     VTAKTAPDVL RTKPAFIGKT NLDGMITVQL PEVPANENIK GYYIIIVPLK KSRGKFIKPW
     ESPDEMELDE LLKEISRKRR SIRYGREVEL KPYIAAHFDV LPTEFTLGDD KHYGGFTNKQ
     LQSGQEYVFF VLAVMEHAES KMYATSPYSD PVVSMDLDPQ PITDEEEGLI WVVGPVLAVV
     FIICIVIAIL LYKSKPDRKR AESDSRKSSI PNNKEIPSHH PTDPVELRRL NFQTPGMASH
     PPIPILELAD HIERLKANDN LKFSQEYESI DPGQQFTWEH SNLEVNKPKN RYANVIAYDH
     SRVLLSAIEG IPGSDYVNAN YIDGYRKQNA YIATQGSLPE TFGDFWRMIW EQRSATVVMM
     TKLEERSRVK CDQYWPSRGT ETHGLVQVTL LDTVELATYC VRTFALYKNG SSEKREVRQF
     QFTAWPDHGV PEHPTPFLAF LRRVKTCNPP DAGPMVVHCS AGVGRTGCFI VIDAMLERIK
     HEKTVDIYGH VTLMRAQRNY MVQTEDQYIF IHDALLEAVT CGNTEVPARN LYAYIQKLTQ
     IETGENVTGM ELEFKRLASS KAHTSRFISA NLPCNKFKNR LVNIMPYEST RVCLQPIRGV
     EGSDYINASF IDGYRQQKAY IATQGPLAET TEDFWRMLWE HNSTIVVMLT KLREMGREKC
     HQYWPAERSA RYQYFVVDPM AEYNMPQYIL REFKVTDARD GQSRTVRQFQ FTDWPEQGVP
     KSGEGFIDFI GQVHKTKEQF GQDGPISVHC SAGVGRTGVF ITLSIVLERM RYEGVVDIFQ
     TVKMLRTQRP AMVQTEDQYQ FSYRAALEYL GSFDHYAT
//
ID   RAD17_HUMAN             Reviewed;         681 AA.
AC   O75943; A8K8X2; D3DWA5; O75714; Q7Z3S4; Q9UNK7; Q9UNR7; Q9UNR8; Q9UPF5;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   22-APR-2020, entry version 177.
DE   RecName: Full=Cell cycle checkpoint protein RAD17;
DE            Short=hRad17;
DE   AltName: Full=RF-C/activator 1 homolog;
GN   Name=RAD17; Synonyms=R24L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9878245; DOI=10.1006/geno.1998.5587;
RA   Dean F.B., Lian L., O'Donnell M.;
RT   "cDNA cloning and gene mapping of human homologs for Schizosaccharomyces
RT   pombe rad17, rad1, and hus1 and cloning of homologs from mouse,
RT   Caenorhabditis elegans, and Drosophila melanogaster.";
RL   Genomics 54:424-436(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH RAD1.
RC   TISSUE=Neuroblastoma;
RX   PubMed=9660800; DOI=10.1074/jbc.273.29.18340;
RA   Parker A.E., Van de Weyer I., Laus M.C., Verhasselt P., Luyten W.H.M.L.;
RT   "Identification of a human homologue of the Schizosaccharomyces pombe
RT   rad17+ checkpoint gene.";
RL   J. Biol. Chem. 273:18340-18346(1998).
RN   [3]
RP   ERRATUM OF PUBMED:9660800.
RA   Parker A.E., Van de Weyer I., Laus M.C., Verhasselt P., Luyten W.H.M.L.;
RL   J. Biol. Chem. 274:24438-24438(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND VARIANT ARG-557.
RC   TISSUE=Fibroblast;
RX   PubMed=10232579;
RA   Bao S., Chang M.-S., Auclair D., Sun Y., Wang Y., Wong W.-K., Zhang J.,
RA   Liu Y., Qian X., Sutherland R., Magi-Galluzi C., Weisberg E., Cheng E.Y.S.,
RA   Hao L., Sasaki H., Campbell M.S., Kraeft S.-K., Loda M., Lo K.-M.,
RA   Chen L.B.;
RT   "HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene
RT   rad17, is overexpressed in colon carcinoma.";
RL   Cancer Res. 59:2023-2028(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Thymus;
RX   PubMed=9933569; DOI=10.1006/geno.1998.5642;
RA   Bluyssen H.A.R., Naus N.C., van Os R.I., Jaspers I., Hoeijmakers J.H.J.,
RA   de Klein A.;
RT   "Human and mouse homologs of the Schizosaccharomyces pombe rad17+ cell
RT   cycle checkpoint control gene.";
RL   Genomics 55:219-228(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=10480350; DOI=10.1007/s004399900067;
RA   von Deimling F., Scharf J.M., Liehr T., Rothe M., Kelter A.-R., Albers P.,
RA   Dietrich W.F., Kunkel L.M., Wernert N., Wirth B.;
RT   "Human and mouse RAD17 genes: identification, localization, genomic
RT   structure and histological expression pattern in normal testis and
RT   seminoma.";
RL   Hum. Genet. 105:17-27(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10208430; DOI=10.1038/sj.onc.1202469;
RA   Li L., Peterson C.A., Kanter-Smoler G., Wei Y.-F., Ramagli L.S.,
RA   Sunnerhagen P., Siciliano M.J., Legerski R.J.;
RT   "hRAD17, a structural homolog of the Schizosaccharomyces pombe RAD17 cell
RT   cycle checkpoint gene, stimulates p53 accumulation.";
RL   Oncogene 18:1689-1699(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=11715513;
RA   Han Y., Zhu Y.;
RT   "Human hR24L gene is involved in DNA excision repair and recombination
RT   repair.";
RL   Zhonghua Yi Xue Za Zhi 79:941-943(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), INDUCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon, and Fibroblast;
RX   PubMed=11602352; DOI=10.1016/s0378-1119(01)00692-8;
RA   Chen M.-S., Higashikubo R., Laszlo A., Roti Roti J.;
RT   "Multiple alternative splicing forms of human RAD17 and their differential
RT   response to ionizing radiation.";
RL   Gene 277:145-152(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-32; LEU-487; GLU-535
RP   AND ARG-557.
RG   NIEHS SNPs program;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ARG-557.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SNU13.
RX   PubMed=10593953; DOI=10.1074/jbc.274.51.36544;
RA   Chang M.-S., Sasaki H., Campbell M.S., Kraeft S.-K., Sutherland R.,
RA   Yang C.-Y., Liu Y., Auclair D., Hao L., Sonoda H., Ferland L.H., Chen L.B.;
RT   "HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV
RT   irradiation.";
RL   J. Biol. Chem. 274:36544-36549(1999).
RN   [17]
RP   INTERACTION WITH THE RAD1/RAD9/HUS1 COMPLEX AND RFC3, AND MUTAGENESIS OF
RP   LYS-143.
RX   PubMed=10884395; DOI=10.1074/jbc.m005782200;
RA   Rauen M., Burtelow M.A., Dufault V.M., Karnitz L.M.;
RT   "The human checkpoint protein hRad17 interacts with the PCNA-like proteins
RT   hRad1, hHus1, and hRad9.";
RL   J. Biol. Chem. 275:29767-29771(2000).
RN   [18]
RP   FUNCTION, INTERACTION WITH ATM; ATR AND RAD1, PHOSPHORYLATION AT SER-646
RP   AND SER-656, AND MUTAGENESIS OF SER-646 AND SER-656.
RX   PubMed=11418864; DOI=10.1038/35082110;
RA   Bao S., Tibbetts R.S., Brumbaugh K.M., Fang Y., Richardson D.A., Ali A.,
RA   Chen S.M., Abraham R.T., Wang X.-F.;
RT   "ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic
RT   stress responses.";
RL   Nature 411:969-974(2001).
RN   [19]
RP   IDENTIFICATION IN A COMPLEX WITH RFC2; RFC3; RFC4 AND RFC5.
RX   PubMed=11572977; DOI=10.1073/pnas.201373498;
RA   Lindsey-Boltz L.A., Bermudez V.P., Hurwitz J., Sancar A.;
RT   "Purification and characterization of human DNA damage checkpoint Rad
RT   complexes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11236-11241(2001).
RN   [20]
RP   FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, INTERACTION WITH RFC4,
RP   AND MUTAGENESIS OF SER-191; SER-646 AND SER-656.
RX   PubMed=11687627; DOI=10.1073/pnas.231364598;
RA   Post S.M., Weng Y.-C., Cimprich K., Chen L.B., Xu Y., Lee E.Y.-H.P.;
RT   "Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle
RT   regulated and is required for G(1)/S checkpoint activation in response to
RT   DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13102-13107(2001).
RN   [21]
RP   FUNCTION, PHOSPHORYLATION, MUTAGENESIS OF LYS-143, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11799063; DOI=10.1101/gad.950302;
RA   Zou L., Cortez D., Elledge S.J.;
RT   "Regulation of ATR substrate selection by Rad17-dependent loading of Rad9
RT   complexes onto chromatin.";
RL   Genes Dev. 16:198-208(2002).
RN   [22]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH RFC4.
RX   PubMed=12400013; DOI=10.1038/sj.onc.1205872;
RA   Dahm K., Huebscher U.;
RT   "Colocalization of human Rad17 and PCNA in late S phase of the cell cycle
RT   upon replication block.";
RL   Oncogene 21:7710-7719(2002).
RN   [23]
RP   FUNCTION.
RX   PubMed=12672690; DOI=10.1101/gad.1065103;
RA   Wang X., Zou L., Zheng H., Wei Q., Elledge S.J., Li L.;
RT   "Genomic instability and endoreduplication triggered by RAD17 deletion.";
RL   Genes Dev. 17:965-970(2003).
RN   [24]
RP   INTERACTION WITH RAD9B.
RX   PubMed=14611806; DOI=10.1016/s0888-7543(03)00200-3;
RA   Dufault V.M., Oestreich A.J., Vroman B.T., Karnitz L.M.;
RT   "Identification and characterization of RAD9B, a paralog of the RAD9
RT   checkpoint gene.";
RL   Genomics 82:644-651(2003).
RN   [25]
RP   FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, MUTAGENESIS OF SER-646
RP   AND SER-656, AND INTERACTION WITH POLE.
RX   PubMed=14500819; DOI=10.1093/nar/gkg765;
RA   Post S.M., Tomkinson A.E., Lee E.Y.-H.P.;
RT   "The human checkpoint Rad protein Rad17 is chromatin-associated throughout
RT   the cell cycle, localizes to DNA replication sites, and interacts with DNA
RT   polymerase epsilon.";
RL   Nucleic Acids Res. 31:5568-5575(2003).
RN   [26]
RP   FUNCTION, INTERACTION WITH RFC2; RFC3; RFC4 AND RFC5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=14624239; DOI=10.1371/journal.pbio.0000033;
RA   Ellison V., Stillman B.;
RT   "Biochemical characterization of DNA damage checkpoint complexes: clamp
RT   loader and clamp complexes with specificity for 5' recessed DNA.";
RL   PLoS Biol. 1:231-243(2003).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH RAD1 AND RAD9.
RX   PubMed=12578958; DOI=10.1073/pnas.0437927100;
RA   Bermudez V.P., Lindsey-Boltz L.A., Cesare A.J., Maniwa Y., Griffith J.D.,
RA   Hurwitz J., Sancar A.;
RT   "Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint
RT   clamp loader hRad17-replication factor C complex in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1633-1638(2003).
RN   [28]
RP   INTERACTION WITH PPP5C, AND PHOSPHORYLATION AT SER-646.
RX   PubMed=14871926; DOI=10.1101/gad.1176004;
RA   Ali A., Zhang J., Bao S., Liu I., Otterness D., Dean N.M., Abraham R.T.,
RA   Wang X.F.;
RT   "Requirement of protein phosphatase 5 in DNA-damage-induced ATM
RT   activation.";
RL   Genes Dev. 18:249-254(2004).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH MCM7.
RX   PubMed=15538388; DOI=10.1038/sj.emboj.7600463;
RA   Tsao C.-C., Geisen C., Abraham R.T.;
RT   "Interaction between human MCM7 and Rad17 proteins is required for
RT   replication checkpoint signaling.";
RL   EMBO J. 23:4660-4669(2004).
RN   [30]
RP   FUNCTION, AND MUTAGENESIS OF LYS-143; SER-646 AND SER-656.
RX   PubMed=15235112;
RA   Garg R., Callens S., Lim D.-S., Canman C.E., Kastan M.B., Xu B.;
RT   "Chromatin association of rad17 is required for an ataxia telangiectasia
RT   and rad-related kinase-mediated S-phase checkpoint in response to low-dose
RT   ultraviolet radiation.";
RL   Mol. Cancer Res. 2:362-369(2004).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   FUNCTION.
RX   PubMed=21659603; DOI=10.1126/science.1203430;
RA   Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E., Harper J.W.,
RA   Elledge S.J.;
RT   "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1
RT   interacting protein required for ATR signaling.";
RL   Science 332:1313-1317(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-86 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Essential for sustained cell growth, maintenance of
CC       chromosomal stability, and ATR-dependent checkpoint activation upon DNA
CC       damage. Has a weak ATPase activity required for binding to chromatin.
CC       Participates in the recruitment of the RAD1-RAD9-HUS1 complex and RHNO1
CC       onto chromatin, and in CHEK1 activation. May also serve as a sensor of
CC       DNA replication progression, and may be involved in homologous
CC       recombination. {ECO:0000269|PubMed:10208430,
CC       ECO:0000269|PubMed:11418864, ECO:0000269|PubMed:11687627,
CC       ECO:0000269|PubMed:11799063, ECO:0000269|PubMed:12578958,
CC       ECO:0000269|PubMed:12672690, ECO:0000269|PubMed:14500819,
CC       ECO:0000269|PubMed:14624239, ECO:0000269|PubMed:15235112,
CC       ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:21659603}.
CC   -!- SUBUNIT: Part of a DNA-binding complex containing RFC2, RFC3, RFC4 and
CC       RFC5. Interacts with RAD1 and RAD9 within the RAD1-RAD9-HUS1 complex.
CC       Interacts with RAD9B, POLE, SNU13 and MCM7. DNA damage promotes
CC       interaction with ATR or ATM and disrupts interaction with the RAD1-
CC       RAD9-HUS1 complex. {ECO:0000269|PubMed:10593953,
CC       ECO:0000269|PubMed:10884395, ECO:0000269|PubMed:11418864,
CC       ECO:0000269|PubMed:11572977, ECO:0000269|PubMed:11687627,
CC       ECO:0000269|PubMed:12400013, ECO:0000269|PubMed:12578958,
CC       ECO:0000269|PubMed:14500819, ECO:0000269|PubMed:14611806,
CC       ECO:0000269|PubMed:14624239, ECO:0000269|PubMed:14871926,
CC       ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:9660800}.
CC   -!- INTERACTION:
CC       O75943; Q9UM11: FZR1; NbExp=2; IntAct=EBI-968231, EBI-724997;
CC       O75943; P49959: MRE11; NbExp=2; IntAct=EBI-968231, EBI-396513;
CC       O75943; O60934: NBN; NbExp=5; IntAct=EBI-968231, EBI-494844;
CC       O75943; Q92878: RAD50; NbExp=2; IntAct=EBI-968231, EBI-495494;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10232579,
CC       ECO:0000269|PubMed:10593953, ECO:0000269|PubMed:11799063,
CC       ECO:0000269|PubMed:12400013}. Note=Phosphorylated form redistributes to
CC       discrete nuclear foci upon DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Rad17Sp, FM2;
CC         IsoId=O75943-1; Sequence=Displayed;
CC       Name=2; Synonyms=Rad17Sp2, FM1;
CC         IsoId=O75943-2; Sequence=VSP_013308;
CC       Name=3; Synonyms=FM3;
CC         IsoId=O75943-3; Sequence=VSP_013306;
CC       Name=4; Synonyms=FM4;
CC         IsoId=O75943-4; Sequence=VSP_013307, VSP_013309;
CC   -!- TISSUE SPECIFICITY: Overexpressed in various cancer cell lines and in
CC       colon carcinoma (at protein level). Isoform 2 and isoform 3 are the
CC       most abundant isoforms in non irradiated cells (at protein level).
CC       Ubiquitous at low levels. Highly expressed in testis, where it is
CC       expressed within the germinal epithelium of the seminiferous tubuli.
CC       Weakly expressed in seminomas (testicular tumors).
CC       {ECO:0000269|PubMed:10208430, ECO:0000269|PubMed:10232579,
CC       ECO:0000269|PubMed:10480350, ECO:0000269|PubMed:11602352,
CC       ECO:0000269|PubMed:9660800}.
CC   -!- INDUCTION: Isoform 1, isoform 3 and isoform 4 are induced by X-ray
CC       irradiation. {ECO:0000269|PubMed:11602352}.
CC   -!- PTM: Phosphorylated. Phosphorylation on Ser-646 and Ser-656 is cell
CC       cycle-regulated, enhanced by genotoxic stress, and required for
CC       activation of checkpoint signaling. Phosphorylation is mediated by ATR
CC       upon UV or replication arrest, whereas it may be mediated both by ATR
CC       and ATM upon ionizing radiation. Phosphorylation on both sites is
CC       required for interaction with RAD1 but dispensable for interaction with
CC       RFC3 or RFC4. {ECO:0000269|PubMed:11418864,
CC       ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:11799063,
CC       ECO:0000269|PubMed:14500819, ECO:0000269|PubMed:14871926}.
CC   -!- SIMILARITY: Belongs to the rad17/RAD24 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rad17/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF076838; AAC95520.1; -; mRNA.
DR   EMBL; AJ004977; CAA06251.1; -; mRNA.
DR   EMBL; AF112263; AAD38878.1; -; mRNA.
DR   EMBL; AF085736; AAC36334.1; -; mRNA.
DR   EMBL; AJ001642; CAA04894.1; -; mRNA.
DR   EMBL; AJ131296; CAB46364.1; -; Genomic_DNA.
DR   EMBL; AJ131297; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131298; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131299; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131300; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131301; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131302; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131303; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131304; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131305; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131306; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131307; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AJ131308; CAB46364.1; JOINED; Genomic_DNA.
DR   EMBL; AF017748; AAD01620.1; -; mRNA.
DR   EMBL; AF126424; AAD17334.1; -; mRNA.
DR   EMBL; AF098533; AAC97950.1; -; mRNA.
DR   EMBL; AF098534; AAC97951.1; -; mRNA.
DR   EMBL; AL122068; CAB59244.1; -; mRNA.
DR   EMBL; AK292487; BAF85176.1; -; mRNA.
DR   EMBL; BX537441; CAD97683.1; -; mRNA.
DR   EMBL; AY612854; AAT09763.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51283.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51284.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51285.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51286.1; -; Genomic_DNA.
DR   EMBL; CH471137; EAW51288.1; -; Genomic_DNA.
DR   EMBL; BC032304; AAH32304.1; -; mRNA.
DR   CCDS; CCDS4003.1; -. [O75943-1]
DR   CCDS; CCDS4004.1; -. [O75943-2]
DR   CCDS; CCDS4005.1; -. [O75943-4]
DR   CCDS; CCDS47226.1; -. [O75943-3]
DR   PIR; T34548; T34548.
DR   RefSeq; NP_001265551.1; NM_001278622.1. [O75943-2]
DR   RefSeq; NP_002864.1; NM_002873.1. [O75943-2]
DR   RefSeq; NP_579916.1; NM_133338.2. [O75943-2]
DR   RefSeq; NP_579917.1; NM_133339.2. [O75943-1]
DR   RefSeq; NP_579918.1; NM_133340.2. [O75943-3]
DR   RefSeq; NP_579919.1; NM_133341.2. [O75943-4]
DR   RefSeq; NP_579920.1; NM_133342.2. [O75943-2]
DR   RefSeq; NP_579921.1; NM_133343.1. [O75943-2]
DR   RefSeq; NP_579922.1; NM_133344.2. [O75943-2]
DR   RefSeq; XP_016865168.1; XM_017009679.1.
DR   RefSeq; XP_016865169.1; XM_017009680.1.
DR   RefSeq; XP_016865170.1; XM_017009681.1. [O75943-2]
DR   SMR; O75943; -.
DR   BioGrid; 111821; 35.
DR   CORUM; O75943; -.
DR   DIP; DIP-24254N; -.
DR   DIP; DIP-34896N; -.
DR   IntAct; O75943; 17.
DR   MINT; O75943; -.
DR   STRING; 9606.ENSP00000426191; -.
DR   iPTMnet; O75943; -.
DR   PhosphoSitePlus; O75943; -.
DR   BioMuta; RAD17; -.
DR   jPOST; O75943; -.
DR   MassIVE; O75943; -.
DR   MaxQB; O75943; -.
DR   PaxDb; O75943; -.
DR   PeptideAtlas; O75943; -.
DR   PRIDE; O75943; -.
DR   ProteomicsDB; 50304; -. [O75943-1]
DR   ProteomicsDB; 50305; -. [O75943-2]
DR   ProteomicsDB; 50306; -. [O75943-3]
DR   ProteomicsDB; 50307; -. [O75943-4]
DR   Antibodypedia; 1389; 610 antibodies.
DR   DNASU; 5884; -.
DR   Ensembl; ENST00000282891; ENSP00000282891; ENSG00000152942. [O75943-4]
DR   Ensembl; ENST00000305138; ENSP00000303134; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000345306; ENSP00000311227; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000354312; ENSP00000346271; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000354868; ENSP00000346938; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000358030; ENSP00000350725; ENSG00000152942. [O75943-3]
DR   Ensembl; ENST00000361732; ENSP00000355226; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000380774; ENSP00000370151; ENSG00000152942. [O75943-1]
DR   Ensembl; ENST00000509734; ENSP00000426191; ENSG00000152942. [O75943-1]
DR   Ensembl; ENST00000521422; ENSP00000427743; ENSG00000152942. [O75943-3]
DR   Ensembl; ENST00000610770; ENSP00000478167; ENSG00000276618.
DR   Ensembl; ENST00000611523; ENSP00000477962; ENSG00000276618.
DR   Ensembl; ENST00000612044; ENSP00000477996; ENSG00000276618.
DR   Ensembl; ENST00000616488; ENSP00000484854; ENSG00000276618.
DR   Ensembl; ENST00000616683; ENSP00000482775; ENSG00000152942. [O75943-2]
DR   Ensembl; ENST00000616759; ENSP00000479160; ENSG00000276618.
DR   Ensembl; ENST00000620889; ENSP00000482371; ENSG00000276618.
DR   GeneID; 5884; -.
DR   KEGG; hsa:5884; -.
DR   UCSC; uc003jwg.4; human. [O75943-1]
DR   CTD; 5884; -.
DR   DisGeNET; 5884; -.
DR   GeneCards; RAD17; -.
DR   HGNC; HGNC:9807; RAD17.
DR   HPA; ENSG00000152942; Low tissue specificity.
DR   MIM; 603139; gene.
DR   neXtProt; NX_O75943; -.
DR   OpenTargets; ENSG00000152942; -.
DR   PharmGKB; PA34167; -.
DR   eggNOG; KOG1970; Eukaryota.
DR   eggNOG; COG0470; LUCA.
DR   GeneTree; ENSGT00440000039046; -.
DR   HOGENOM; CLU_018598_0_0_1; -.
DR   InParanoid; O75943; -.
DR   KO; K06662; -.
DR   OMA; EPWVDRY; -.
DR   OrthoDB; 674169at2759; -.
DR   PhylomeDB; O75943; -.
DR   Reactome; R-HSA-176187; Activation of ATR in response to replication stress.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   SIGNOR; O75943; -.
DR   ChiTaRS; RAD17; human.
DR   GeneWiki; RAD17; -.
DR   GenomeRNAi; 5884; -.
DR   Pharos; O75943; Tbio.
DR   PRO; PR:O75943; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O75943; protein.
DR   Bgee; ENSG00000152942; Expressed in testis and 233 other tissues.
DR   ExpressionAtlas; O75943; baseline and differential.
DR   Genevisible; O75943; HS.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0031389; C:Rad17 RFC-like complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003689; F:DNA clamp loader activity; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IBA:GO_Central.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0000076; P:DNA replication checkpoint; TAS:ProtInc.
DR   GO; GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0033314; P:mitotic DNA replication checkpoint; IBA:GO_Central.
DR   GO; GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:0042325; P:regulation of phosphorylation; IMP:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   InterPro; IPR004582; Checkpoint_prot_Rad17_Rad24.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR018324; Rad17/Rad24_fun/met.
DR   PANTHER; PTHR12172; PTHR12172; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00602; rad24; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; DNA damage;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..681
FT                   /note="Cell cycle checkpoint protein RAD17"
FT                   /id="PRO_0000209948"
FT   NP_BIND         137..144
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          432..681
FT                   /note="Interaction with MCM7"
FT                   /evidence="ECO:0000269|PubMed:15538388"
FT   MOD_RES         55
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9XT62"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         646
FT                   /note="Phosphoserine; by ATR and ATM"
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819,
FT                   ECO:0000269|PubMed:14871926"
FT   MOD_RES         656
FT                   /note="Phosphoserine; by ATR and ATM"
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819"
FT   VAR_SEQ         1..176
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11602352"
FT                   /id="VSP_013306"
FT   VAR_SEQ         1..97
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11602352"
FT                   /id="VSP_013307"
FT   VAR_SEQ         1..14
FT                   /note="MSKTFLRPKVSSTK -> MNQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10208430,
FT                   ECO:0000303|PubMed:10232579, ECO:0000303|PubMed:10480350,
FT                   ECO:0000303|PubMed:11230166, ECO:0000303|PubMed:11602352,
FT                   ECO:0000303|PubMed:11715513, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:9660800, ECO:0000303|PubMed:9878245"
FT                   /id="VSP_013308"
FT   VAR_SEQ         98..99
FT                   /note="ET -> MN (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11602352"
FT                   /id="VSP_013309"
FT   VARIANT         32
FT                   /note="V -> I (in dbSNP:rs17229831)"
FT                   /evidence="ECO:0000269|Ref.13"
FT                   /id="VAR_021574"
FT   VARIANT         487
FT                   /note="R -> L (in dbSNP:rs17236478)"
FT                   /evidence="ECO:0000269|Ref.13"
FT                   /id="VAR_021575"
FT   VARIANT         535
FT                   /note="K -> E (in dbSNP:rs17236485)"
FT                   /evidence="ECO:0000269|Ref.13"
FT                   /id="VAR_021576"
FT   VARIANT         557
FT                   /note="L -> R (in dbSNP:rs1045051)"
FT                   /evidence="ECO:0000269|PubMed:10232579,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.13"
FT                   /id="VAR_021577"
FT   MUTAGEN         143
FT                   /note="K->E: Impairs phosphorylation on S-656. Abolishes
FT                   interaction with the RAD1-RAD9-HUS1 complex; does not
FT                   affect interaction with RFC3."
FT                   /evidence="ECO:0000269|PubMed:10884395,
FT                   ECO:0000269|PubMed:11799063, ECO:0000269|PubMed:15235112"
FT   MUTAGEN         143
FT                   /note="K->G: Impairs phosphorylation. Impairs interaction
FT                   with DNA and the RAD1-RAD9-HUS1 complex; does not affect
FT                   interaction with RFC3."
FT                   /evidence="ECO:0000269|PubMed:10884395,
FT                   ECO:0000269|PubMed:11799063, ECO:0000269|PubMed:15235112"
FT   MUTAGEN         191
FT                   /note="S->A: No effect on phosphorylation by ATR."
FT                   /evidence="ECO:0000269|PubMed:11687627"
FT   MUTAGEN         646
FT                   /note="S->A: Reduces by 50% phosphorylation by ATR, and
FT                   abolishes interaction with RAD1. Abolishes phosphorylation
FT                   by ATR and checkpoint activation without affecting
FT                   interaction with RFC3, RFC4, ATM or ATR; when associated
FT                   with A-656."
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819,
FT                   ECO:0000269|PubMed:15235112"
FT   MUTAGEN         646
FT                   /note="S->D: Abolishes interaction with RAD1; when
FT                   associated with D-656."
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819,
FT                   ECO:0000269|PubMed:15235112"
FT   MUTAGEN         656
FT                   /note="S->A: Reduces by 50% phosphorylation by ATR, and
FT                   abolishes interaction with RAD1. Abolishes phosphorylation
FT                   by ATR and checkpoint activation without affecting
FT                   interaction with RFC3, RFC4, ATM or ATR; when associated
FT                   with A-646."
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819,
FT                   ECO:0000269|PubMed:15235112"
FT   MUTAGEN         656
FT                   /note="S->D: Abolishes interaction with RAD1; when
FT                   associated with D-646."
FT                   /evidence="ECO:0000269|PubMed:11418864,
FT                   ECO:0000269|PubMed:11687627, ECO:0000269|PubMed:14500819,
FT                   ECO:0000269|PubMed:15235112"
FT   CONFLICT        75
FT                   /note="I -> V (in Ref. 12; CAD97683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        187
FT                   /note="F -> L (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="A -> S (in Ref. 7; AAD01620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        340
FT                   /note="L -> P (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="P -> S (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        462
FT                   /note="M -> T (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        648
FT                   /note="N -> D (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        672
FT                   /note="I -> M (in Ref. 5; AAC36334)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   681 AA;  77055 MW;  796C2BD48F7995A3 CRC64;
     MSKTFLRPKV SSTKVTDWVD PSFDDFLECS GVSTITATSL GVNNSSHRRK NGPSTLESSR
     FPARKRGNLS SLEQIYGLEN SKEYLSENEP WVDKYKPETQ HELAVHKKKI EEVETWLKAQ
     VLERQPKQGG SILLITGPPG CGKTTTLKIL SKEHGIQVQE WINPVLPDFQ KDDFKGMFNT
     ESSFHMFPYQ SQIAVFKEFL LRATKYNKLQ MLGDDLRTDK KIILVEDLPN QFYRDSHTLH
     EVLRKYVRIG RCPLIFIISD SLSGDNNQRL LFPKEIQEEC SISNISFNPV APTIMMKFLN
     RIVTIEANKN GGKITVPDKT SLELLCQGCS GDIRSAINSL QFSSSKGENN LRPRKKGMSL
     KSDAVLSKSK RRKKPDRVFE NQEVQAIGGK DVSLFLFRAL GKILYCKRAS LTELDSPRLP
     SHLSEYERDT LLVEPEEVVE MSHMPGDLFN LYLHQNYIDF FMEIDDIVRA SEFLSFADIL
     SGDWNTRSLL REYSTSIATR GVMHSNKARG YAHCQGGGSS FRPLHKPQWF LINKKYRENC
     LAAKALFPDF CLPALCLQTQ LLPYLALLTI PMRNQAQISF IQDIGRLPLK RHFGRLKMEA
     LTDREHGMID PDSGDEAQLN GGHSAEESLG EPTQATVPET WSLPLSQNSA SELPASQPQP
     FSAQGDMEEN IIIEDYESDG T
//
ID   RFWD3_HUMAN             Reviewed;         774 AA.
AC   Q6PCD5; A8K585; B2RE35; D3DUJ8; Q5XKR3; Q9H9Q3; Q9NVT4;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   22-APR-2020, entry version 152.
DE   RecName: Full=E3 ubiquitin-protein ligase RFWD3 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658};
DE   AltName: Full=RING finger and WD repeat domain-containing protein 3;
DE   AltName: Full=RING finger protein 201;
GN   Name=RFWD3 {ECO:0000312|HGNC:HGNC:25539};
GN   Synonyms=RNF201 {ECO:0000312|HGNC:HGNC:25539};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-564.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS LYS-392 AND THR-770.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   FUNCTION, INTERACTION WITH MDM2 AND TP53, SUBCELLULAR LOCATION,
RP   PHOSPHORYLATION AT SER-46 AND SER-63, AND MUTAGENESIS OF SER-46; SER-63 AND
RP   CYS-315.
RX   PubMed=20173098; DOI=10.1073/pnas.0912094107;
RA   Fu X., Yucer N., Liu S., Li M., Yi P., Mu J.J., Yang T., Chu J., Jung S.Y.,
RA   O'Malley B.W., Gu W., Qin J., Wang Y.;
RT   "RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in
RT   response to DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4579-4584(2010).
RN   [7]
RP   FUNCTION, INTERACTION WITH RPA2, AND SUBCELLULAR LOCATION.
RX   PubMed=21504906; DOI=10.1074/jbc.m111.222869;
RA   Gong Z., Chen J.;
RT   "E3 ligase RFWD3 participates in replication checkpoint control.";
RL   J. Biol. Chem. 286:22308-22313(2011).
RN   [8]
RP   FUNCTION, INTERACTION WITH RPA2, SUBCELLULAR LOCATION, PHOSPHORYLATION,
RP   DEVELOPMENTAL STAGE, AND MUTAGENESIS OF CYS-315.
RX   PubMed=21558276; DOI=10.1074/jbc.m111.222802;
RA   Liu S., Chu J., Yucer N., Leng M., Wang S.Y., Chen B.P., Hittelman W.N.,
RA   Wang Y.;
RT   "RING finger and WD repeat domain 3 (RFWD3) associates with replication
RT   protein A (RPA) and facilitates RPA-mediated DNA damage response.";
RL   J. Biol. Chem. 286:22314-22322(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=26474068; DOI=10.1016/j.molcel.2015.09.011;
RA   Elia A.E., Wang D.C., Willis N.A., Boardman A.P., Hajdu I., Adeyemi R.O.,
RA   Lowry E., Gygi S.P., Scully R., Elledge S.J.;
RT   "RFWD3-dependent ubiquitination of RPA regulates repair at stalled
RT   replication forks.";
RL   Mol. Cell 60:280-293(2015).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-46 AND SER-63, INVOLVEMENT IN FANCW, VARIANT FANCW LYS-639,
RP   CHARACTERIZATION OF VARIANT FANCW LYS-639, AND MUTAGENESIS OF CYS-315;
RP   GLN-499; LEU-518 AND TRP-543.
RX   PubMed=28575657; DOI=10.1016/j.molcel.2017.04.021;
RA   Feeney L., Munoz I.M., Lachaud C., Toth R., Appleton P.L., Schindler D.,
RA   Rouse J.;
RT   "RPA-mediated recruitment of the E3 ligase RFWD3 is vital for interstrand
RT   crosslink repair and human health.";
RL   Mol. Cell 66:610-621(2017).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN FANCW, VARIANT FANCW
RP   LYS-639, AND CHARACTERIZATION OF VARIANT FANCW LYS-639.
RX   PubMed=28691929; DOI=10.1172/jci92069;
RA   Knies K., Inano S., Ramirez M.J., Ishiai M., Surralles J., Takata M.,
RA   Schindler D.;
RT   "Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.";
RL   J. Clin. Invest. 127:3013-3027(2017).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION AT SER-46 AND SER-63, AND
RP   MUTAGENESIS OF 36-LEU--PRO-38; 53-LEU--PRO-55; 70-LEU--PRO-72 AND CYS-315.
RX   PubMed=28575658; DOI=10.1016/j.molcel.2017.04.022;
RA   Inano S., Sato K., Katsuki Y., Kobayashi W., Tanaka H., Nakajima K.,
RA   Nakada S., Miyoshi H., Knies K., Takaori-Kondo A., Schindler D., Ishiai M.,
RA   Kurumizaka H., Takata M.;
RT   "RFWD3-mediated ubiquitination promotes timely removal of both RPA and
RT   RAD51 from dna damage sites to facilitate homologous recombination.";
RL   Mol. Cell 66:622-634(2017).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase required for the repair of DNA
CC       interstrand cross-links (ICL) in response to DNA damage
CC       (PubMed:21504906, PubMed:21558276, PubMed:26474068, PubMed:28575657,
CC       PubMed:28575658). Plays a key role in RPA-mediated DNA damage signaling
CC       and repair (PubMed:21504906, PubMed:21558276, PubMed:26474068,
CC       PubMed:28575657, PubMed:28575658, PubMed:28691929). Acts by mediating
CC       ubiquitination of the RPA complex (RPA1, RPA2 and RPA3 subunits) and
CC       RAD51 at stalled replication forks, leading to remove them from DNA
CC       damage sites and promote homologous recombination (PubMed:26474068,
CC       PubMed:28575657, PubMed:28575658). Also mediates the ubiquitination of
CC       p53/TP53 in the late response to DNA damage, and acts as a positive
CC       regulator of p53/TP53 stability, thereby regulating the G1/S DNA damage
CC       checkpoint (PubMed:20173098). May act by catalyzing the formation of
CC       short polyubiquitin chains on p53/TP53 that are not targeted to the
CC       proteasome (PubMed:20173098). In response to ionizing radiation,
CC       interacts with MDM2 and enhances p53/TP53 ubiquitination, possibly by
CC       restricting MDM2 from extending polyubiquitin chains on ubiquitinated
CC       p53/TP53 (PubMed:20173098). {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:21558276,
CC       ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28575658, ECO:0000269|PubMed:28691929}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:26474068,
CC         ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28575658}.
CC   -!- SUBUNIT: Interacts with MDM2 and p53/TP53 (PubMed:20173098). Binds to
CC       the RPA complex via direct interaction with RPA2 (PubMed:21504906,
CC       PubMed:21558276, PubMed:26474068, PubMed:28575658). Interacts with
CC       RAD51 (PubMed:28575658). {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:21558276,
CC       ECO:0000269|PubMed:26474068, ECO:0000269|PubMed:28575658}.
CC   -!- INTERACTION:
CC       Q6PCD5; Q00987: MDM2; NbExp=2; IntAct=EBI-2129159, EBI-389668;
CC       Q6PCD5; Q00987-11: MDM2; NbExp=5; IntAct=EBI-2129159, EBI-5279149;
CC       Q6PCD5; P15927: RPA2; NbExp=3; IntAct=EBI-2129159, EBI-621404;
CC       Q6PCD5; P04637: TP53; NbExp=5; IntAct=EBI-2129159, EBI-366083;
CC       Q6PCD5; P61088: UBE2N; NbExp=2; IntAct=EBI-2129159, EBI-1052908;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:21558276,
CC       ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28691929}. Nucleus, PML
CC       body {ECO:0000269|PubMed:21558276}. Cytoplasm
CC       {ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:28691929}. Note=In
CC       undamaged cells, found both in the cytoplasm and in the nucleus,
CC       partially associated with PML nuclear bodies (PubMed:21558276). In
CC       response to replication block, such as that caused by hydroxyurea
CC       treatment, or to DNA damage caused by ionizing radiations or
CC       doxorubicin, recruited to the nucleus, to stalled replication forks or
CC       to sites of DNA repair (PubMed:21504906, PubMed:28575657). This
CC       recruitment depends upon RPA2 (PubMed:21504906).
CC       {ECO:0000269|PubMed:21504906, ECO:0000269|PubMed:28575657}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated in the S-G2 phase.
CC       {ECO:0000269|PubMed:21558276}.
CC   -!- DOMAIN: The coiled coil domain may be involved in RPA2-binding.
CC       {ECO:0000269|PubMed:21558276}.
CC   -!- PTM: Phosphorylated at Ser-46 and Ser-63 upon DNA damage by ATM or ATR.
CC       ATM phosphorylation occurs at early times upon DNA damage, while ATR is
CC       the major kinase at later times. Phosphorylation by ATM and ATR is
CC       required to stabilize p53/TP53. Part of the phosphorylation depends
CC       upon RPA2 presence. {ECO:0000269|PubMed:20173098,
CC       ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28575658}.
CC   -!- DISEASE: Fanconi anemia, complementation group W (FANCW) [MIM:617784]:
CC       A form of Fanconi anemia, a disorder affecting all bone marrow elements
CC       and resulting in anemia, leukopenia and thrombopenia. It is associated
CC       with cardiac, renal and limb malformations, dermal pigmentary changes,
CC       and a predisposition to the development of malignancies. At the
CC       cellular level it is associated with hypersensitivity to DNA-damaging
CC       agents, chromosomal instability (increased chromosome breakage) and
CC       defective DNA repair. {ECO:0000269|PubMed:28575657,
CC       ECO:0000269|PubMed:28691929}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91662.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAF83889.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG38132.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK001382; BAA91662.1; ALT_INIT; mRNA.
DR   EMBL; AK022673; BAB14169.1; -; mRNA.
DR   EMBL; AK291200; BAF83889.1; ALT_INIT; mRNA.
DR   EMBL; AK315786; BAG38132.1; ALT_INIT; mRNA.
DR   EMBL; AC109599; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471114; EAW95680.1; -; Genomic_DNA.
DR   EMBL; CH471114; EAW95681.1; -; Genomic_DNA.
DR   EMBL; BC002574; AAH02574.2; -; mRNA.
DR   EMBL; BC059371; AAH59371.2; -; mRNA.
DR   CCDS; CCDS32486.1; -.
DR   RefSeq; NP_060594.3; NM_018124.3.
DR   RefSeq; XP_005256078.1; XM_005256021.4.
DR   RefSeq; XP_005256079.1; XM_005256022.4.
DR   RefSeq; XP_011521493.1; XM_011523191.2.
DR   RefSeq; XP_016878880.1; XM_017023391.1.
DR   PDB; 6CVZ; X-ray; 1.80 A; A/B/C=425-774.
DR   PDBsum; 6CVZ; -.
DR   SMR; Q6PCD5; -.
DR   BioGrid; 120460; 59.
DR   DIP; DIP-52688N; -.
DR   IntAct; Q6PCD5; 49.
DR   MINT; Q6PCD5; -.
DR   STRING; 9606.ENSP00000354361; -.
DR   iPTMnet; Q6PCD5; -.
DR   PhosphoSitePlus; Q6PCD5; -.
DR   BioMuta; RFWD3; -.
DR   DMDM; 126253679; -.
DR   EPD; Q6PCD5; -.
DR   jPOST; Q6PCD5; -.
DR   MassIVE; Q6PCD5; -.
DR   MaxQB; Q6PCD5; -.
DR   PaxDb; Q6PCD5; -.
DR   PeptideAtlas; Q6PCD5; -.
DR   PRIDE; Q6PCD5; -.
DR   ProteomicsDB; 67062; -.
DR   Antibodypedia; 30261; 102 antibodies.
DR   Ensembl; ENST00000361070; ENSP00000354361; ENSG00000168411.
DR   Ensembl; ENST00000571750; ENSP00000460049; ENSG00000168411.
DR   GeneID; 55159; -.
DR   KEGG; hsa:55159; -.
DR   UCSC; uc002fda.4; human.
DR   CTD; 55159; -.
DR   DisGeNET; 55159; -.
DR   GeneCards; RFWD3; -.
DR   GeneReviews; RFWD3; -.
DR   HGNC; HGNC:25539; RFWD3.
DR   HPA; ENSG00000168411; Low tissue specificity.
DR   MalaCards; RFWD3; -.
DR   MIM; 614151; gene.
DR   MIM; 617784; phenotype.
DR   neXtProt; NX_Q6PCD5; -.
DR   OpenTargets; ENSG00000168411; -.
DR   Orphanet; 84; Fanconi anemia.
DR   PharmGKB; PA134960063; -.
DR   eggNOG; KOG1645; Eukaryota.
DR   eggNOG; ENOG410XPPE; LUCA.
DR   GeneTree; ENSGT00390000008931; -.
DR   HOGENOM; CLU_021009_1_0_1; -.
DR   InParanoid; Q6PCD5; -.
DR   KO; K15691; -.
DR   OMA; LEGACFW; -.
DR   OrthoDB; 1451258at2759; -.
DR   PhylomeDB; Q6PCD5; -.
DR   TreeFam; TF323359; -.
DR   SignaLink; Q6PCD5; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RFWD3; human.
DR   GenomeRNAi; 55159; -.
DR   Pharos; Q6PCD5; Tbio.
DR   PRO; PR:Q6PCD5; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q6PCD5; protein.
DR   Bgee; ENSG00000168411; Expressed in oocyte and 175 other tissues.
DR   ExpressionAtlas; Q6PCD5; baseline and differential.
DR   Genevisible; Q6PCD5; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0090734; C:site of DNA damage; IDA:UniProtKB.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0031052; P:chromosome breakage; ISS:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0036297; P:interstrand cross-link repair; IMP:UniProtKB.
DR   GO; GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000001; P:regulation of DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0031297; P:replication fork processing; IDA:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR037381; RFWD3.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR16047; PTHR16047; 1.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00320; WD40; 3.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Cytoplasm; Disease mutation; DNA damage;
KW   DNA repair; Fanconi anemia; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation pathway; WD repeat; Zinc; Zinc-finger.
FT   CHAIN           1..774
FT                   /note="E3 ubiquitin-protein ligase RFWD3"
FT                   /id="PRO_0000278234"
FT   REPEAT          495..537
FT                   /note="WD 1"
FT   REPEAT          539..577
FT                   /note="WD 2"
FT   REPEAT          583..628
FT                   /note="WD 3"
FT   ZN_FING         287..331
FT                   /note="RING-type; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   COILED          361..413
FT                   /evidence="ECO:0000255"
FT   MOD_RES         46
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000269|PubMed:20173098,
FT                   ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658"
FT   MOD_RES         63
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000269|PubMed:20173098,
FT                   ECO:0000269|PubMed:28575657, ECO:0000269|PubMed:28575658"
FT   VARIANT         90
FT                   /note="T -> N (in dbSNP:rs8058922)"
FT                   /id="VAR_030700"
FT   VARIANT         392
FT                   /note="R -> K (in dbSNP:rs17854997)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030701"
FT   VARIANT         564
FT                   /note="I -> V (in dbSNP:rs7193541)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_030702"
FT   VARIANT         639
FT                   /note="I -> K (in FANCW; abolishes interaction with the RPA
FT                   complex and subsequent recruitment of the protein at DNA
FT                   damage sites; decreased function in double-strand break
FT                   repair via homologous recombination; dbSNP:rs1555524842)"
FT                   /evidence="ECO:0000269|PubMed:28575657,
FT                   ECO:0000269|PubMed:28691929"
FT                   /id="VAR_078953"
FT   VARIANT         770
FT                   /note="I -> T (in dbSNP:rs17854996)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030703"
FT   MUTAGEN         36..38
FT                   /note="LQP->AAA: Decreased interaction with RAD51; when
FT                   associated with 53-A--A-55 and 70-A--A-72."
FT                   /evidence="ECO:0000269|PubMed:28575658"
FT   MUTAGEN         46
FT                   /note="S->A: Markedly decreases phosphorylation following
FT                   ionizing radiation and abolishes ability to stimulate
FT                   p53/TP53 ubiquitination; when associated with A-63."
FT                   /evidence="ECO:0000269|PubMed:20173098"
FT   MUTAGEN         53..55
FT                   /note="LQP->AAA: Decreased interaction with RAD51; when
FT                   associated with 36-A--A-38 and 70-A--A-72."
FT                   /evidence="ECO:0000269|PubMed:28575658"
FT   MUTAGEN         63
FT                   /note="S->A: Markedly decreases phosphorylation following
FT                   ionizing radiation and abolishes ability to stimulate
FT                   p53/TP53 ubiquitination; when associated with A-46."
FT                   /evidence="ECO:0000269|PubMed:20173098"
FT   MUTAGEN         70..72
FT                   /note="LQP->AAA: Decreased interaction with RAD51; when
FT                   associated with 36-A--A-38 and 53-A--A-55."
FT                   /evidence="ECO:0000269|PubMed:28575658"
FT   MUTAGEN         315
FT                   /note="C->A: Abolishes ability to stimulate p53/TP53
FT                   ubiquitination. No effect on nuclear localization in
FT                   response to DNA damage."
FT                   /evidence="ECO:0000269|PubMed:20173098,
FT                   ECO:0000269|PubMed:21558276, ECO:0000269|PubMed:28575657,
FT                   ECO:0000269|PubMed:28575658"
FT   MUTAGEN         499
FT                   /note="Q->A: Does not affect interaction with the RPA
FT                   complex and subsequent recruitment at DNA damage sites."
FT                   /evidence="ECO:0000269|PubMed:28575657"
FT   MUTAGEN         518
FT                   /note="L->A: Does not affect interaction with the RPA
FT                   complex and subsequent recruitment at DNA damage sites."
FT                   /evidence="ECO:0000269|PubMed:28575657"
FT   MUTAGEN         543
FT                   /note="W->A: Abolishes interaction with the RPA complex and
FT                   subsequent recruitment at DNA damage sites."
FT                   /evidence="ECO:0000269|PubMed:28575657"
FT   CONFLICT        221
FT                   /note="S -> P (in Ref. 1; BAF83889)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="A -> T (in Ref. 1; BAA91662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        597
FT                   /note="A -> V (in Ref. 1; BAA91662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        741
FT                   /note="Q -> R (in Ref. 1; BAB14169)"
FT                   /evidence="ECO:0000305"
FT   STRAND          435..443
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          453..456
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            457..460
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          461..467
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            470..472
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          475..483
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            484..487
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          491..498
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          500..505
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          507..509
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          512..517
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          520..526
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            527..530
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          531..537
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          542..547
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          550..552
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          554..559
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          564..568
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          572..574
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          576..579
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          588..594
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          606..611
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          614..620
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          626..630
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          635..644
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            645..648
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          649..660
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          664..674
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          680..691
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          703..706
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          714..718
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          725..730
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   TURN            731..733
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          736..741
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          748..754
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          757..763
FT                   /evidence="ECO:0000244|PDB:6CVZ"
FT   STRAND          765..774
FT                   /evidence="ECO:0000244|PDB:6CVZ"
SQ   SEQUENCE   774 AA;  85094 MW;  EF6E0E186FD2E580 CRC64;
     MAHEAMEYDV QVQLNHAEQQ PAPAGMASSQ GGPALLQPVP ADVVSSQGVP SILQPAPAEV
     ISSQATPPLL QPAPQLSVDL TEVEVLGEDT VENINPRTSE QHRQGSDGNH TIPASSLHSM
     TNFISGLQRL HGMLEFLRPS SSNHSVGPMR TRRRVSASRR ARAGGSQRTD SARLRAPLDA
     YFQVSRTQPD LPATTYDSET RNPVSEELQV SSSSDSDSDS SAEYGGVVDQ AEESGAVILE
     EQLAGVSAEQ EVTCIDGGKT LPKQPSPQKS EPLLPSASMD EEEGDTCTIC LEQWTNAGDH
     RLSALRCGHL FGYRCISTWL KGQVRKCPQC NKKARHSDIV VLYARTLRAL DTSEQERMKS
     SLLKEQMLRK QAELESAQCR LQLQVLTDKC TRLQRRVQDL QKLTSHQSQN LQQPRGSQAW
     VLSCSPSSQG QHKHKYHFQK TFTVSQAGNC RIMAYCDALS CLVISQPSPQ ASFLPGFGVK
     MLSTANMKSS QYIPMHGKQI RGLAFSSYLR GLLLSASLDN TIKLTSLETN TVVQTYNAGR
     PVWSCCWCLD EANYIYAGLA NGSILVYDVR NTSSHVQELV AQKARCPLVS LSYMPRAASA
     AFPYGGVLAG TLEDASFWEQ KMDFSHWPHV LPLEPGGCID FQTENSSRHC LVTYRPDKNH
     TTIRSVLMEM SYRLDDTGNP ICSCQPVHTF FGGPTCKLLT KNAIFQSPEN DGNILVCTGD
     EAANSALLWD AASGSLLQDL QTDQPVLDIC PFEVNRNSYL ATLTEKMVHI YKWE
//
ID   ROBO2_HUMAN             Reviewed;        1378 AA.
AC   Q9HCK4; O43608; Q19AB4; Q19AB5;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2004, sequence version 2.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=Roundabout homolog 2;
DE   Flags: Precursor;
GN   Name=ROBO2; Synonyms=KIAA1568;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND ALTERNATIVE SPLICING.
RX   PubMed=16829019; DOI=10.1016/j.ygeno.2006.05.011;
RA   Yue Y., Grossmann B., Galetzka D., Zechner U., Haaf T.;
RT   "Isolation and differential expression of two isoforms of the ROBO2/Robo2
RT   axon guidance receptor gene in humans and mice.";
RL   Genomics 88:772-778(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Yue Y., Grossmann B., Galetzka D., Zechner U., Haaf T.;
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 845-1378 (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 323-607.
RX   PubMed=9458045; DOI=10.1016/s0092-8674(00)80915-0;
RA   Kidd T., Brose K., Mitchell K.J., Fetter R.D., Tessier-Lavigne M.,
RA   Goodman C.S., Tear G.;
RT   "Roundabout controls axon crossing of the CNS midline and defines a novel
RT   subfamily of evolutionarily conserved guidance receptors.";
RL   Cell 92:205-215(1998).
RN   [7]
RP   INTERACTION WITH SLIT2.
RX   PubMed=10102268; DOI=10.1016/s0092-8674(00)80590-5;
RA   Brose K., Bland K.S., Wang K.H., Arnott D., Henzel W., Goodman C.S.,
RA   Tessier-Lavigne M., Kidd T.;
RT   "Slit proteins bind Robo receptors and have an evolutionarily conserved
RT   role in repulsive axon guidance.";
RL   Cell 96:795-806(1999).
RN   [8]
RP   INTERACTION WITH SLIT2.
RX   PubMed=11404413; DOI=10.1523/jneurosci.21-12-04281.2001;
RA   Nguyen-Ba-Charvet K.T., Brose K., Ma L., Wang K.H., Marillat V., Sotelo C.,
RA   Tessier-Lavigne M., Chedotal A.;
RT   "Diversity and specificity of actions of Slit2 proteolytic fragments in
RT   axon guidance.";
RL   J. Neurosci. 21:4281-4289(2001).
RN   [9]
RP   STRUCTURE BY NMR OF 417-734.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fifth Ig-like domain and of first and second
RT   fibronectin type III domain from human roundabout homolog 2.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [10]
RP   VARIANTS VUR2 THR-945 AND THR-1236, AND CHROMOSOMAL TRANSLOCATION WITH
RP   PCDH11Y.
RX   PubMed=17357069; DOI=10.1086/512735;
RA   Lu W., van Eerde A.M., Fan X., Quintero-Rivera F., Kulkarni S.,
RA   Ferguson H., Kim H.-G., Fan Y., Xi Q., Li Q.-G., Sanlaville D., Andrews W.,
RA   Sundaresan V., Bi W., Yan J., Giltay J.C., Wijmenga C., de Jong T.P.V.M.,
RA   Feather S.A., Woolf A.S., Rao Y., Lupski J.R., Eccles M.R., Quade B.J.,
RA   Gusella J.F., Morton C.C., Maas R.L.;
RT   "Disruption of ROBO2 is associated with urinary tract anomalies and confers
RT   risk of vesicoureteral reflux.";
RL   Am. J. Hum. Genet. 80:616-632(2007).
CC   -!- FUNCTION: Receptor for SLIT2, and probably SLIT1, which are thought to
CC       act as molecular guidance cue in cellular migration, including axonal
CC       navigation at the ventral midline of the neural tube and projection of
CC       axons to different regions during neuronal development.
CC   -!- SUBUNIT: Interacts with SLIT2. {ECO:0000269|PubMed:10102268,
CC       ECO:0000269|PubMed:11404413}.
CC   -!- INTERACTION:
CC       Q9HCK4; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-399800, EBI-13345167;
CC       Q9HCK4; Q96Q45-2: TMEM237; NbExp=5; IntAct=EBI-399800, EBI-10982110;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HCK4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCK4-2; Sequence=VSP_010647;
CC       Name=3;
CC         IsoId=Q9HCK4-3; Sequence=VSP_043394;
CC   -!- DISEASE: Vesicoureteral reflux 2 (VUR2) [MIM:610878]: A disease
CC       belonging to the group of congenital anomalies of the kidney and
CC       urinary tract. It is characterized by the reflux of urine from the
CC       bladder into the ureters and sometimes into the kidneys, and is a risk
CC       factor for urinary tract infections. Primary disease results from a
CC       developmental defect of the ureterovesical junction. In combination
CC       with intrarenal reflux, the resulting inflammatory reaction may result
CC       in renal injury or scarring, also called reflux nephropathy. Extensive
CC       renal scarring impairs renal function and may predispose patients to
CC       hypertension, proteinuria, renal insufficiency and end-stage renal
CC       disease. {ECO:0000269|PubMed:17357069}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ROBO2 is a cause of
CC       multiple congenital abnormalities, including severe bilateral VUR with
CC       ureterovesical junction defects. Translocation t(Y;3)(p11;p12) with
CC       PCDH11Y. This translocation disrupts ROBO2 and produces dominant-
CC       negative ROBO2 proteins that abrogate SLIT-ROBO signaling in vitro.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. ROBO family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC39576.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB13394.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ533874; ABF83431.1; -; mRNA.
DR   EMBL; AB046788; BAB13394.1; ALT_INIT; mRNA.
DR   EMBL; DQ533873; ABF83430.1; -; mRNA.
DR   EMBL; AC016942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC067717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117515; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC126467; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130004; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131005; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC133040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138974; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC064374; AAH64374.1; -; mRNA.
DR   EMBL; BC146772; AAI46773.1; -; mRNA.
DR   EMBL; AF040991; AAC39576.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS43109.1; -. [Q9HCK4-1]
DR   CCDS; CCDS54609.1; -. [Q9HCK4-3]
DR   RefSeq; NP_001122401.1; NM_001128929.3. [Q9HCK4-3]
DR   RefSeq; NP_001276968.1; NM_001290039.1.
DR   RefSeq; NP_001276969.1; NM_001290040.1.
DR   RefSeq; NP_001276994.1; NM_001290065.1.
DR   RefSeq; NP_002933.1; NM_002942.4. [Q9HCK4-1]
DR   PDB; 1UEM; NMR; -; A=514-617.
DR   PDB; 1UJT; NMR; -; A=628-734.
DR   PDB; 2EDJ; NMR; -; A=417-509.
DR   PDB; 5NOI; X-ray; 2.40 A; A=311-509.
DR   PDB; 6I9S; X-ray; 2.48 A; A/B=126-312.
DR   PDB; 6IAA; X-ray; 3.60 A; A/B/C=22-859.
DR   PDBsum; 1UEM; -.
DR   PDBsum; 1UJT; -.
DR   PDBsum; 2EDJ; -.
DR   PDBsum; 5NOI; -.
DR   PDBsum; 6I9S; -.
DR   PDBsum; 6IAA; -.
DR   SMR; Q9HCK4; -.
DR   BioGrid; 112019; 22.
DR   IntAct; Q9HCK4; 28.
DR   MINT; Q9HCK4; -.
DR   STRING; 9606.ENSP00000417335; -.
DR   iPTMnet; Q9HCK4; -.
DR   PhosphoSitePlus; Q9HCK4; -.
DR   BioMuta; ROBO2; -.
DR   DMDM; 49036496; -.
DR   EPD; Q9HCK4; -.
DR   jPOST; Q9HCK4; -.
DR   MassIVE; Q9HCK4; -.
DR   MaxQB; Q9HCK4; -.
DR   PaxDb; Q9HCK4; -.
DR   PeptideAtlas; Q9HCK4; -.
DR   PRIDE; Q9HCK4; -.
DR   ProteomicsDB; 81744; -. [Q9HCK4-1]
DR   ProteomicsDB; 81745; -. [Q9HCK4-2]
DR   ProteomicsDB; 81746; -. [Q9HCK4-3]
DR   Antibodypedia; 2693; 234 antibodies.
DR   Ensembl; ENST00000461745; ENSP00000417164; ENSG00000185008. [Q9HCK4-1]
DR   Ensembl; ENST00000487694; ENSP00000417335; ENSG00000185008. [Q9HCK4-3]
DR   GeneID; 6092; -.
DR   KEGG; hsa:6092; -.
DR   UCSC; uc003dpy.5; human. [Q9HCK4-1]
DR   CTD; 6092; -.
DR   DisGeNET; 6092; -.
DR   GeneCards; ROBO2; -.
DR   HGNC; HGNC:10250; ROBO2.
DR   HPA; ENSG00000185008; Tissue enhanced (brain).
DR   MalaCards; ROBO2; -.
DR   MIM; 602431; gene.
DR   MIM; 610878; phenotype.
DR   neXtProt; NX_Q9HCK4; -.
DR   OpenTargets; ENSG00000185008; -.
DR   Orphanet; 289365; Familial vesicoureteral reflux.
DR   PharmGKB; PA34621; -.
DR   eggNOG; KOG4222; Eukaryota.
DR   eggNOG; ENOG410XPQS; LUCA.
DR   GeneTree; ENSGT00940000156324; -.
DR   InParanoid; Q9HCK4; -.
DR   KO; K06754; -.
DR   OrthoDB; 45439at2759; -.
DR   PhylomeDB; Q9HCK4; -.
DR   TreeFam; TF351053; -.
DR   Reactome; R-HSA-376176; Signaling by ROBO receptors.
DR   Reactome; R-HSA-428542; Regulation of commissural axon pathfinding by SLIT and ROBO.
DR   Reactome; R-HSA-8985801; Regulation of cortical dendrite branching.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9010642; ROBO receptors bind AKAP5.
DR   ChiTaRS; ROBO2; human.
DR   EvolutionaryTrace; Q9HCK4; -.
DR   GeneWiki; ROBO2; -.
DR   GenomeRNAi; 6092; -.
DR   Pharos; Q9HCK4; Tbio.
DR   PRO; PR:Q9HCK4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9HCK4; protein.
DR   Bgee; ENSG00000185008; Expressed in forebrain and 147 other tissues.
DR   ExpressionAtlas; Q9HCK4; baseline and differential.
DR   Genevisible; Q9HCK4; HS.
DR   GO; GO:0030673; C:axolemma; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0035904; P:aorta development; ISS:BHF-UCL.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0061364; P:apoptotic process involved in luteolysis; IEP:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEP:UniProtKB.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; NAS:UniProtKB.
DR   GO; GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; ISS:UniProtKB.
DR   GO; GO:0050925; P:negative regulation of negative chemotaxis; IDA:UniProtKB.
DR   GO; GO:0051964; P:negative regulation of synapse assembly; ISS:UniProtKB.
DR   GO; GO:0021891; P:olfactory bulb interneuron development; ISS:UniProtKB.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IDA:UniProtKB.
DR   GO; GO:0035481; P:positive regulation of Notch signaling pathway involved in heart induction; ISS:BHF-UCL.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0001657; P:ureteric bud development; IMP:UniProtKB.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
DR   CDD; cd00063; FN3; 3.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 2.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 5.
DR   SMART; SM00406; IGv; 3.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chemotaxis; Chromosomal rearrangement;
KW   Developmental protein; Differentiation; Disease mutation; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Neurogenesis;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1378
FT                   /note="Roundabout homolog 2"
FT                   /id="PRO_0000031036"
FT   TOPO_DOM        22..859
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        860..880
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        881..1378
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..127
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          133..220
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          225..309
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          314..409
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          418..504
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          524..618
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          637..735
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          739..836
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOD_RES         1154
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TPD3"
FT   MOD_RES         1156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TPD3"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        752
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        782
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        789
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        845
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        52..110
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        154..203
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        246..293
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        335..391
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        439..488
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..20
FT                   /note="MSLLMFTQLLLCGFLYVRVD -> MARRHERVTRRMWTWAPGLLMMTVVFWG
FT                   HQGNGQGQ (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_043394"
FT   VAR_SEQ         1186..1378
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010647"
FT   VARIANT         945
FT                   /note="I -> T (in VUR2; dbSNP:rs267607014)"
FT                   /evidence="ECO:0000269|PubMed:17357069"
FT                   /id="VAR_032960"
FT   VARIANT         1236
FT                   /note="A -> T (in VUR2; dbSNP:rs267607015)"
FT                   /evidence="ECO:0000269|PubMed:17357069"
FT                   /id="VAR_032961"
FT   CONFLICT        497
FT                   /note="T -> A (in Ref. 5)"
FT                   /evidence="ECO:0000305"
FT   STRAND          142..145
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          150..153
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          159..161
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          164..169
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          181..184
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          187..190
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   HELIX           195..197
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          199..207
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          210..213
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          217..229
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          234..240
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          242..244
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          247..252
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          255..260
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   TURN            267..269
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          274..276
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          278..282
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   HELIX           285..287
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          289..297
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          300..311
FT                   /evidence="ECO:0000244|PDB:6I9S"
FT   STRAND          312..318
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          323..326
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          331..333
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          336..341
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          345..349
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          367..370
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          376..378
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   HELIX           383..385
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          387..394
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          399..409
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          419..422
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          427..430
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          434..437
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          440..442
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          448..453
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          456..458
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          464..467
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          469..471
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          473..477
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   HELIX           480..482
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          484..492
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          495..508
FT                   /evidence="ECO:0000244|PDB:5NOI"
FT   STRAND          529..533
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          538..541
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          548..550
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          554..561
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   TURN            562..564
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          565..575
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          577..582
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          590..599
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   STRAND          602..606
FT                   /evidence="ECO:0000244|PDB:1UEM"
FT   HELIX           630..636
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          639..641
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          651..660
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          667..679
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   TURN            680..682
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          685..688
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          696..701
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          704..718
FT                   /evidence="ECO:0000244|PDB:1UJT"
FT   STRAND          727..731
FT                   /evidence="ECO:0000244|PDB:1UJT"
SQ   SEQUENCE   1378 AA;  151200 MW;  60F7CE3E53622B50 CRC64;
     MSLLMFTQLL LCGFLYVRVD GSRLRQEDFP PRIVEHPSDV IVSKGEPTTL NCKAEGRPTP
     TIEWYKDGER VETDKDDPRS HRMLLPSGSL FFLRIVHGRR SKPDEGSYVC VARNYLGEAV
     SRNASLEVAL LRDDFRQNPT DVVVAAGEPA ILECQPPRGH PEPTIYWKKD KVRIDDKEER
     ISIRGGKLMI SNTRKSDAGM YTCVGTNMVG ERDSDPAELT VFERPTFLRR PINQVVLEEE
     AVEFRCQVQG DPQPTVRWKK DDADLPRGRY DIKDDYTLRI KKTMSTDEGT YMCIAENRVG
     KMEASATLTV RAPPQFVVRP RDQIVAQGRT VTFPCETKGN PQPAVFWQKE GSQNLLFPNQ
     PQQPNSRCSV SPTGDLTITN IQRSDAGYYI CQALTVAGSI LAKAQLEVTD VLTDRPPPII
     LQGPANQTLA VDGTALLKCK ATGDPLPVIS WLKEGFTFPG RDPRATIQEQ GTLQIKNLRI
     SDTGTYTCVA TSSSGETSWS AVLDVTESGA TISKNYDLSD LPGPPSKPQV TDVTKNSVTL
     SWQPGTPGTL PASAYIIEAF SQSVSNSWQT VANHVKTTLY TVRGLRPNTI YLFMVRAINP
     QGLSDPSPMS DPVRTQDISP PAQGVDHRQV QKELGDVLVR LHNPVVLTPT TVQVTWTVDR
     QPQFIQGYRV MYRQTSGLQA TSSWQNLDAK VPTERSAVLV NLKKGVTYEI KVRPYFNEFQ
     GMDSESKTVR TTEEAPSAPP QSVTVLTVGS YNSTSISVSW DPPPPDHQNG IIQEYKIWCL
     GNETRFHINK TVDAAIRSVI IGGLFPGIQY RVEVAASTSA GVGVKSEPQP IIIGRRNEVV
     ITENNNSITE QITDVVKQPA FIAGIGGACW VILMGFSIWL YWRRKKRKGL SNYAVTFQRG
     DGGLMSNGSR PGLLNAGDPS YPWLADSWPA TSLPVNNSNS GPNEIGNFGR GDVLPPVPGQ
     GDKTATMLSD GAIYSSIDFT TKTSYNSSSQ ITQATPYATT QILHSNSIHE LAVDLPDPQW
     KSSIQQKTDL MGFGYSLPDQ NKGNNGGKGG KKKKNKNSSK PQKNNGSTWA NVPLPPPPVQ
     PLPGTELEHY AVEQQENGYD SDSWCPPLPV QTYLHQGLED ELEEDDDRVP TPPVRGVASS
     PAISFGQQST ATLTPSPREE MQPMLQAHLD ELTRAYQFDI AKQTWHIQSN NQPPQPPVPP
     LGYVSGALIS DLETDVADDD ADDEEEALEI PRPLRALDQT PGSSMDNLDS SVTGKAFTSS
     QRPRPTSPFS TDSNTSAALS QSQRPRPTKK HKGGRMDQQP ALPHRREGMT DEEALVPYSK
     PSFPSPGGHS SSGTASSKGS TGPRKTEVLR AGHQRNASDL LDIGYMGSNS QGQFTGEL
//
ID   SET1B_HUMAN             Reviewed;        1966 AA.
AC   Q9UPS6; F6MFW1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   19-MAR-2014, sequence version 3.
DT   22-APR-2020, entry version 150.
DE   RecName: Full=Histone-lysine N-methyltransferase SETD1B;
DE            EC=2.1.1.354 {ECO:0000269|PubMed:17355966};
DE   AltName: Full=Lysine N-methyltransferase 2G;
DE   AltName: Full=SET domain-containing protein 1B;
DE            Short=hSET1B;
GN   Name=SETD1B; Synonyms=KIAA1076, KMT2G, SET1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RBM15, AND
RP   MUTAGENESIS OF LEU-577 AND ASP-579.
RX   PubMed=22927943; DOI=10.1371/journal.pone.0042965;
RA   Lee J.H., Skalnik D.G.;
RT   "Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via
RT   a SPOC domain that is required for cytokine-independent proliferation.";
RL   PLoS ONE 7:E42965-E42965(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1163-1966 (ISOFORM 1/2).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   ENZYME ACTIVITY, SUBCELLULAR LOCATION, AND IDENTIFICATION IN THE SET1
RP   COMPLEX.
RX   PubMed=17355966; DOI=10.1074/jbc.m609809200;
RA   Lee J.-H., Tate C.M., You J.-S., Skalnik D.G.;
RT   "Identification and characterization of the human Set1B histone H3-Lys4
RT   methyltransferase complex.";
RL   J. Biol. Chem. 282:13419-13428(2007).
RN   [5]
RP   IDENTIFICATION IN SET1 COMPLEX, AND INTERACTION WITH WDR82; ASH2L AND
RP   POLR2A.
RX   PubMed=17998332; DOI=10.1128/mcb.01356-07;
RA   Lee J.H., Skalnik D.G.;
RT   "Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A
RT   Histone H3-Lys4 methyltransferase complex to transcription start sites of
RT   transcribed human genes.";
RL   Mol. Cell. Biol. 28:609-618(2008).
RN   [6]
RP   IDENTIFICATION IN SET1 COMPLEX.
RX   PubMed=18838538; DOI=10.1128/mcb.00976-08;
RA   Wu M., Wang P.F., Lee J.S., Martin-Brown S., Florens L., Washburn M.,
RA   Shilatifard A.;
RT   "Molecular regulation of H3K4 trimethylation by Wdr82, a component of human
RT   Set1/COMPASS.";
RL   Mol. Cell. Biol. 28:7337-7344(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1659, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-986; SER-994 AND SER-1031,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1335, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000244|PDB:4ES0}
RP   X-RAY CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 1741-1754 IN COMPLEX WITH WDR5,
RP   INTERACTION WITH WDR5, AND MOTIF WIN.
RX   PubMed=22665483; DOI=10.1074/jbc.m112.364125;
RA   Dharmarajan V., Lee J.H., Patel A., Skalnik D.G., Cosgrove M.S.;
RT   "Structural basis for WDR5 interaction (Win) motif recognition in human
RT   SET1 family histone methyltransferases.";
RL   J. Biol. Chem. 287:27275-27289(2012).
RN   [12] {ECO:0000244|PDB:3UVO}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1745-1755 IN COMPLEX WITH WDR5,
RP   INTERACTION WITH WDR5, AND MOTIF WIN.
RX   PubMed=22266653; DOI=10.1093/nar/gkr1235;
RA   Zhang P., Lee H., Brunzelle J.S., Couture J.F.;
RT   "The plasticity of WDR5 peptide-binding cleft enables the binding of the
RT   SET1 family of histone methyltransferases.";
RL   Nucleic Acids Res. 40:4237-4246(2012).
CC   -!- FUNCTION: Histone methyltransferase that specifically methylates 'Lys-
CC       4' of histone H3, when part of the SET1 histone methyltransferase (HMT)
CC       complex, but not if the neighboring 'Lys-9' residue is already
CC       methylated. H3 'Lys-4' methylation represents a specific tag for
CC       epigenetic transcriptional activation. The non-overlapping localization
CC       with SETD1A suggests that SETD1A and SETD1B make non-redundant
CC       contributions to the epigenetic control of chromatin structure and gene
CC       expression. Specifically tri-methylates 'Lys-4' of histone H3 in vitro.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-methionine = 3 H(+) +
CC         N(6),N(6),N(6)-trimethyl-L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:60260, Rhea:RHEA-COMP:15537, Rhea:RHEA-
CC         COMP:15547, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61961; EC=2.1.1.354;
CC         Evidence={ECO:0000269|PubMed:17355966};
CC   -!- SUBUNIT: Component of the SET1 complex, at least composed of the
CC       catalytic subunit (SETD1A or SETD1B), WDR5, WDR82, RBBP5, ASH2L/ASH2,
CC       CXXC1/CFP1, HCFC1 and DPY30. Interacts with HCFC1 and ASH2L/ASH2.
CC       Interacts (via the RRM domain) with WDR82. Interacts (via the RRM
CC       domain) with hyperphosphorylated C-terminal domain (CTD) of RNA
CC       polymerase II large subunit (POLR2A) only in the presence of WDR82.
CC       Binds specifically to CTD heptad repeats phosphorylated on 'Ser-5' of
CC       each heptad. Interacts with RBM15. Interacts (via WIN motif) with WDR5
CC       (PubMed:22665483, PubMed:22266653). {ECO:0000269|PubMed:17355966,
CC       ECO:0000269|PubMed:17998332, ECO:0000269|PubMed:18838538,
CC       ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:22665483,
CC       ECO:0000269|PubMed:22927943}.
CC   -!- INTERACTION:
CC       Q9UPS6-2; Q9UBL3-3: ASH2L; NbExp=2; IntAct=EBI-16197836, EBI-16130425;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:17355966}.
CC       Chromosome {ECO:0000269|PubMed:17355966}. Note=Localizes to a largely
CC       non-overlapping set of euchromatic nuclear speckles with SETD1A,
CC       suggesting that SETD1A and SET1B each bind to a unique set of target
CC       genes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPS6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPS6-2; Sequence=VSP_053875, VSP_053876;
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JF813787; AEG67286.1; -; mRNA.
DR   EMBL; AC079360; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB028999; BAA83028.1; -; mRNA.
DR   CCDS; CCDS86338.1; -. [Q9UPS6-1]
DR   RefSeq; NP_055863.1; NM_015048.1.
DR   RefSeq; XP_005253915.1; XM_005253858.4. [Q9UPS6-1]
DR   RefSeq; XP_006719359.1; XM_006719296.3. [Q9UPS6-1]
DR   PDB; 3UVO; X-ray; 2.20 A; B=1745-1755.
DR   PDB; 4ES0; X-ray; 1.82 A; C=1741-1754.
DR   PDBsum; 3UVO; -.
DR   PDBsum; 4ES0; -.
DR   SMR; Q9UPS6; -.
DR   BioGrid; 116702; 30.
DR   CORUM; Q9UPS6; -.
DR   DIP; DIP-61947N; -.
DR   ELM; Q9UPS6; -.
DR   IntAct; Q9UPS6; 17.
DR   STRING; 9606.ENSP00000442924; -.
DR   ChEMBL; CHEMBL4105837; -.
DR   iPTMnet; Q9UPS6; -.
DR   PhosphoSitePlus; Q9UPS6; -.
DR   BioMuta; SETD1B; -.
DR   DMDM; 166977692; -.
DR   EPD; Q9UPS6; -.
DR   jPOST; Q9UPS6; -.
DR   MassIVE; Q9UPS6; -.
DR   PaxDb; Q9UPS6; -.
DR   PeptideAtlas; Q9UPS6; -.
DR   PRIDE; Q9UPS6; -.
DR   ProteomicsDB; 85430; -. [Q9UPS6-1]
DR   Antibodypedia; 9774; 109 antibodies.
DR   Ensembl; ENST00000542440; ENSP00000442924; ENSG00000139718. [Q9UPS6-2]
DR   Ensembl; ENST00000604567; ENSP00000474253; ENSG00000139718. [Q9UPS6-1]
DR   Ensembl; ENST00000619791; ENSP00000481531; ENSG00000139718. [Q9UPS6-1]
DR   GeneID; 23067; -.
DR   UCSC; uc021rfg.2; human. [Q9UPS6-1]
DR   CTD; 23067; -.
DR   DisGeNET; 23067; -.
DR   GeneCards; SETD1B; -.
DR   HGNC; HGNC:29187; SETD1B.
DR   HPA; ENSG00000139718; Low tissue specificity.
DR   MIM; 611055; gene.
DR   neXtProt; NX_Q9UPS6; -.
DR   OpenTargets; ENSG00000139718; -.
DR   PharmGKB; PA143485611; -.
DR   eggNOG; KOG1080; Eukaryota.
DR   eggNOG; COG2940; LUCA.
DR   GeneTree; ENSGT00940000154575; -.
DR   HOGENOM; CLU_001226_0_0_1; -.
DR   InParanoid; Q9UPS6; -.
DR   OMA; GQHFSMP; -.
DR   OrthoDB; 1234689at2759; -.
DR   TreeFam; TF106436; -.
DR   Reactome; R-HSA-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   GenomeRNAi; 23067; -.
DR   Pharos; Q9UPS6; Tbio.
DR   PRO; PR:Q9UPS6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9UPS6; protein.
DR   Bgee; ENSG00000139718; Expressed in endometrium and 239 other tissues.
DR   ExpressionAtlas; Q9UPS6; baseline and differential.
DR   Genevisible; Q9UPS6; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0035097; C:histone methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; IDA:UniProtKB.
DR   GO; GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0044648; P:histone H3-K4 dimethylation; IDA:CACAO.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB.
DR   GO; GO:0097692; P:histone H3-K4 monomethylation; IDA:CACAO.
DR   GO; GO:0080182; P:histone H3-K4 trimethylation; IDA:CACAO.
DR   CDD; cd12549; RRM_Set1B; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR024657; COMPASS_Set1_N-SET.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034468; Set1B_RRM.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR037842; SETD1B.
DR   PANTHER; PTHR45814:SF1; PTHR45814:SF1; 1.
DR   Pfam; PF11764; N-SET; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00856; SET; 1.
DR   SMART; SM01291; N-SET; 1.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromatin regulator;
KW   Chromosome; Coiled coil; Methyltransferase; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN           1..1966
FT                   /note="Histone-lysine N-methyltransferase SETD1B"
FT                   /id="PRO_0000316993"
FT   DOMAIN          93..181
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          1827..1944
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   DOMAIN          1950..1966
FT                   /note="Post-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT   COILED          1173..1204
FT                   /evidence="ECO:0000255"
FT   MOTIF           1745..1750
FT                   /note="WDR5 interaction motif (WIN)"
FT                   /evidence="ECO:0000269|PubMed:22266653,
FT                   ECO:0000269|PubMed:22665483"
FT   COMPBIAS        366..1671
FT                   /note="Pro-rich"
FT   COMPBIAS        1040..1175
FT                   /note="Ser-rich"
FT   COMPBIAS        1068..1312
FT                   /note="Glu-rich"
FT   COMPBIAS        1103..1138
FT                   /note="Asp-rich"
FT   BINDING         1943
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   MOD_RES         986
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         994
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1031
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CFT2"
FT   MOD_RES         1283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CFT2"
FT   MOD_RES         1335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1659
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CFT2"
FT   VAR_SEQ         1043..1068
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053875"
FT   VAR_SEQ         1088..1104
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053876"
FT   MUTAGEN         577
FT                   /note="L->A: Abolishes interaction with RBM15."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   MUTAGEN         579
FT                   /note="D->A: Abolishes interaction with RBM15."
FT                   /evidence="ECO:0000269|PubMed:22927943"
FT   HELIX           1747..1750
FT                   /evidence="ECO:0000244|PDB:4ES0"
SQ   SEQUENCE   1966 AA;  212803 MW;  164F81BC84EAD2C2 CRC64;
     MENSHPPHHH HQQPPPQPGP SGERRNHHWR SYKLMIDPAL KKGHHKLYRY DGQHFSLAMS
     SNRPVEIVED PRVVGIWTKN KELELSVPKF KIDEFYVGPV PPKQVTFAKL NDNIRENFLR
     DMCKKYGEVE EVEILYNPKT KKHLGIAKVV FATVRGAKDA VQHLHSTSVM GNIIHVELDT
     KGETRMRFYE LLVTGRYTPQ TLPVGELDAV SPIVNETLQL SDALKRLKDG GLSAGCGSGS
     SSVTPNSGGT PFSQDTAYSS CRLDTPNSYG QGTPLTPRLG TPFSQDSSYS SRQPTPSYLF
     SQDPAVTFKA RRHESKFTDA YNRRHEHHYV HNSPAVTAVA GATAAFRGSS DLPFGAVGGT
     GGSSGPPFKA QPQDSATFAH TPPPAQATPA PGFKSAFSPY QTPVAHFPPP PEEPTATAAF
     GARDSGEFRR APAPPPLPPA EPLAKEKPGT PPGPPPPDTN SMELGGRPTF GWSPEPCDSP
     GTPTLESSPA GPEKPHDSLD SRIEMLLKEQ RTKLLFLREP DSDTELQMEG SPISSSSSQL
     SPLAPFGTNS QPGFRGPTPP SSRPSSTGLE DISPTPLPDS DEDEELDLGL GPRPPPEPGP
     PDPAGLLSQT AEVALDLVGD RTPTSEKMDE GQQSSGEDME ISDDEMPSAP ITSADCPKPM
     VVTPGAAAVA APSVLAPTLP LPPPPGFPPL PPPPPPPPPQ PGFPMPPPLP PPPPPPPPAH
     PAVTVPPPPL PAPPGVPPPP ILPPLPPFPP GLFPVMQVDM SHVLGGQWGG MPMSFQMQTQ
     VLSRLMTGQG ACPYPPFMAA AAAAASAGLQ FVNLPPYRGP FSLSNSGPGR GQHWPPLPKF
     DPSVPPPGYM PRQEDPHKAT VDGVLLVVLK ELKAIMKRDL NRKMVEVVAF RAFDEWWDKK
     ERMAKASLTP VKSGEHKDED RPKPKDRIAS CLLESWGKGE GLGYEGLGLG IGLRGAIRLP
     SFKVKRKEPP DTTSSGDQKR LRPSTSVDEE DEESERERDR DMADTPCELA KRDPKGVGVR
     RRPARPLELD SGGEEDEKES LSASSSSSAS SSSGSSTTSP SSSASDKEEE QESTEEEEEA
     EEEEEEEVPR SQLSSSSTSS TSDKDDDDDD SDDRDESEND DEDTALSEAS EKDEGDSDEE
     ETVSIVTSKA EATSSSESSE SSEFESSSES SPSSSEDEEE VVAREEEEEE EEEEMVAEES
     MASAGPEDFE QDGEEAALAP GAPAVDSLGM EEEVDIETEA VAPEERPSML DEPPLPVGVE
     EPADSREPPE EPGLSQEGAM LLSPEPPAKE VEARPPLSPE RAPEHDLEVE PEPPMMLPLP
     LQPPLPPPRP PRPPSPPPEP ETTDASHPSV PPEPLAEDHP PHTPGLCGSL AKSQSTETVP
     ATPGGEPPLS GGSSGLSLSS PQVPGSPFSY PAPSPSLSSG GLPRTPGRDF SFTPTFSEPS
     GPLLLPVCPL PTGRRDERSG PLASPVLLET GLPLPLPLPL PLPLALPAVL RAQARAPTPL
     PPLLPAPLAS CPPPMKRKPG RPRRSPPSML SLDGPLVRPP AGAALGRELL LLPGQPQTPV
     FPSTHDPRTV TLDFRNAGIP APPPPLPPQP PPPPPPPPVE PTKLPFKELD NQWPSEAIPP
     GPRGRDEVTE EYMELAKSRG PWRRPPKKRH EDLVPPAGSP ELSPPQPLFR PRSEFEEMTI
     LYDIWNGGID EEDIRFLCVT YERLLQQDNG MDWLNDTLWV YHPSTSLSSA KKKKRDDGIR
     EHVTGCARSE GFYTIDKKDK LRYLNSSRAS TDEPPADTQG MSIPAQPHAS TRAGSERRSE
     QRRLLSSFTG SCDSDLLKFN QLKFRKKKLK FCKSHIHDWG LFAMEPIAAD EMVIEYVGQN
     IRQVIADMRE KRYEDEGIGS SYMFRVDHDT IIDATKCGNF ARFINHSCNP NCYAKVITVE
     SQKKIVIYSK QHINVNEEIT YDYKFPIEDV KIPCLCGSEN CRGTLN
//
ID   SHPS1_HUMAN             Reviewed;         504 AA.
AC   P78324; A2A2E1; A8K411; B2R6C3; O00683; O43799; Q8N517; Q8TAL8; Q9H0Z2;
AC   Q9UDX2; Q9UIJ6; Q9Y4U9;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 2.
DT   22-APR-2020, entry version 205.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type substrate 1;
DE            Short=SHP substrate 1;
DE            Short=SHPS-1;
DE   AltName: Full=Brain Ig-like molecule with tyrosine-based activation motifs;
DE            Short=Bit;
DE   AltName: Full=CD172 antigen-like family member A;
DE   AltName: Full=Inhibitory receptor SHPS-1;
DE   AltName: Full=Macrophage fusion receptor;
DE   AltName: Full=MyD-1 antigen;
DE   AltName: Full=Signal-regulatory protein alpha-1;
DE            Short=Sirp-alpha-1;
DE   AltName: Full=Signal-regulatory protein alpha-2;
DE            Short=Sirp-alpha-2;
DE   AltName: Full=Signal-regulatory protein alpha-3;
DE            Short=Sirp-alpha-3;
DE   AltName: Full=p84;
DE   AltName: CD_antigen=CD172a;
DE   Flags: Precursor;
GN   Name=SIRPA; Synonyms=BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-44; SER-50;
RP   ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96; GLU-100; SER-107; SER-109
RP   AND THR-132.
RC   TISSUE=Brain;
RX   PubMed=9070220; DOI=10.1006/bbrc.1996.6047;
RA   Yamao T., Matozaki T., Amano K., Matsuda Y., Takahashi N., Ochi F.,
RA   Fujioka Y., Kasuga M.;
RT   "Mouse and human SHPS-1: molecular cloning of cDNAs and chromosomal
RT   localization of genes.";
RL   Biochem. Biophys. Res. Commun. 231:61-67(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), POLYMORPHISM, PHOSPHORYLATION,
RP   GLYCOSYLATION, INTERACTION WITH PTPN11; PTPN6 AND GRB2, AND VARIANTS
RP   SER-44; SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96; GLU-100;
RP   SER-107; SER-109 AND THR-132.
RC   TISSUE=Placenta;
RX   PubMed=9062191; DOI=10.1038/386181a0;
RA   Kharitonenkov A., Chen Z., Sures I., Wang H., Schilling J., Ullrich A.;
RT   "A family of proteins that inhibit signalling through tyrosine kinase
RT   receptors.";
RL   Nature 386:181-186(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10585853; DOI=10.1042/bj3440667;
RA   Sano S., Ohnishi H., Kubota M.;
RT   "Gene structure of mouse BIT/SHPS-1.";
RL   Biochem. J. 344:667-675(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS SER-44;
RP   SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96; GLU-100; SER-107;
RP   SER-109 AND THR-132.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   SER-44; SER-50; ILE-52; HIS-54; VAL-57; ALA-75; GLU-95; SER-96; GLU-100;
RP   SER-107; SER-109 AND THR-132.
RC   TISSUE=Brain, Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 76-504.
RC   TISSUE=Monocyte;
RX   PubMed=9485180;
RX   DOI=10.1002/(sici)1521-4141(199801)28:01<1::aid-immu1>3.0.co;2-v;
RA   Brooke G.P., Parsons K.R., Howard C.J.;
RT   "Cloning of two members of the SIRP alpha family of protein tyrosine
RT   phosphatase binding proteins in cattle that are expressed on monocytes and
RT   a subpopulation of dendritic cells and which mediate binding to CD4 T
RT   cells.";
RL   Eur. J. Immunol. 28:1-11(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH FYB1; SCAP2 AND PTK2B.
RX   PubMed=10469599; DOI=10.1016/s0960-9822(99)80401-1;
RA   Timms J.F., Swanson K.D., Marie-Cardine A., Raab M., Rudd C.E.,
RA   Schraven B., Neel B.G.;
RT   "SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-
RT   protein complexes in macrophages.";
RL   Curr. Biol. 9:927-930(1999).
RN   [9]
RP   PHOSPHORYLATION BY JAK2, AND INTERACTION WITH PTPN11 AND JAK2.
RX   PubMed=10842184; DOI=10.1074/jbc.m004238200;
RA   Stofega M.R., Argetsinger L.S., Wang H., Ullrich A., Carter-Su C.;
RT   "Negative regulation of growth hormone receptor/JAK2 signaling by signal
RT   regulatory protein alpha.";
RL   J. Biol. Chem. 275:28222-28229(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH CD47.
RX   PubMed=11509594; DOI=10.4049/jimmunol.167.5.2547;
RA   Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J.,
RA   Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A., Delespesse G.,
RA   Sarfati M.;
RT   "Bidirectional negative regulation of human T and dendritic cells by CD47
RT   and its cognate receptor signal-regulator protein-alpha: down-regulation of
RT   IL-12 responsiveness and inhibition of dendritic cell activation.";
RL   J. Immunol. 167:2547-2554(2001).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-245.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-270 AND ASN-292.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-496, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 31-149, AND DISULFIDE BOND.
RX   PubMed=17369261; DOI=10.1074/jbc.m611511200;
RA   Hatherley D., Harlos K., Dunlop D.C., Stuart D.I., Barclay A.N.;
RT   "The structure of the macrophage signal regulatory protein alpha
RT   (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that
RT   used by T cell receptors.";
RL   J. Biol. Chem. 282:14567-14575(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 31-149 IN COMPLEX WITH CD47, AND
RP   DISULFIDE BOND.
RX   PubMed=18657508; DOI=10.1016/j.molcel.2008.05.026;
RA   Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I., Barclay A.N.;
RT   "Paired receptor specificity explained by structures of signal regulatory
RT   proteins alone and complexed with CD47.";
RL   Mol. Cell 31:266-277(2008).
CC   -!- FUNCTION: Immunoglobulin-like cell surface receptor for CD47. Acts as
CC       docking protein and induces translocation of PTPN6, PTPN11 and other
CC       binding partners from the cytosol to the plasma membrane. Supports
CC       adhesion of cerebellar neurons, neurite outgrowth and glial cell
CC       attachment. May play a key role in intracellular signaling during
CC       synaptogenesis and in synaptic function (By similarity). Involved in
CC       the negative regulation of receptor tyrosine kinase-coupled cellular
CC       responses induced by cell adhesion, growth factors or insulin. Mediates
CC       negative regulation of phagocytosis, mast cell activation and dendritic
CC       cell activation. CD47 binding prevents maturation of immature dendritic
CC       cells and inhibits cytokine production by mature dendritic cells.
CC       {ECO:0000250, ECO:0000269|PubMed:10469599,
CC       ECO:0000269|PubMed:11509594}.
CC   -!- SUBUNIT: Binds PTPN11 when tyrosine-phosphorylated, except in
CC       macrophages, where it primarily binds PTPN6. Binds GRB2 in vitro. Binds
CC       FGR (By similarity). Binds JAK2 irrespective of its phosphorylation
CC       status and forms a stable complex. Binds SCAP1 and/or SCAP2. The
CC       resulting complex recruits FYB1. Binds PTK2B. {ECO:0000250,
CC       ECO:0000269|PubMed:18657508}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P78324-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78324-2; Sequence=VSP_007030;
CC       Name=4;
CC         IsoId=P78324-4; Sequence=VSP_040799;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in brain. Detected on
CC       myeloid cells, but not T-cells. Detected at lower levels in heart,
CC       placenta, lung, testis, ovary, colon, liver, small intestine, prostate,
CC       spleen, kidney, skeletal muscle and pancreas.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:9062191}.
CC   -!- PTM: Phosphorylated on tyrosine residues in response to stimulation
CC       with EGF, growth hormone, insulin and PDGF. Dephosphorylated by PTPN11.
CC       {ECO:0000269|PubMed:10842184, ECO:0000269|PubMed:9062191}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D86043; BAA12974.1; -; mRNA.
DR   EMBL; Y10375; CAA71403.1; -; mRNA.
DR   EMBL; AB023430; BAA87929.1; -; mRNA.
DR   EMBL; AK290776; BAF83465.1; -; mRNA.
DR   EMBL; AK312521; BAG35420.1; -; mRNA.
DR   EMBL; AL034562; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026692; AAH26692.1; -; mRNA.
DR   EMBL; BC033092; AAH33092.1; -; mRNA.
DR   EMBL; BC038510; AAH38510.1; -; mRNA.
DR   EMBL; BC075849; AAH75849.1; -; mRNA.
DR   EMBL; Y11047; CAA71944.1; -; mRNA.
DR   CCDS; CCDS13022.1; -. [P78324-1]
DR   CCDS; CCDS82593.1; -. [P78324-2]
DR   PIR; JC5287; JC5287.
DR   RefSeq; NP_001035111.1; NM_001040022.1. [P78324-1]
DR   RefSeq; NP_001035112.1; NM_001040023.1. [P78324-1]
DR   RefSeq; NP_001317657.1; NM_001330728.1. [P78324-2]
DR   RefSeq; NP_542970.1; NM_080792.2. [P78324-1]
DR   RefSeq; XP_005260727.1; XM_005260670.3. [P78324-2]
DR   PDB; 2JJS; X-ray; 1.85 A; A/B=31-149.
DR   PDB; 2JJT; X-ray; 2.30 A; A/B=31-149.
DR   PDB; 2UV3; X-ray; 1.80 A; A/B=31-149.
DR   PDB; 2WNG; X-ray; 2.49 A; A=31-350.
DR   PDB; 4CMM; X-ray; 1.92 A; A=31-149.
DR   PDB; 6BIT; X-ray; 2.19 A; G/H=31-147.
DR   PDB; 6NMR; X-ray; 2.42 A; E/I/M/S=31-149.
DR   PDB; 6NMS; X-ray; 2.11 A; C/S=31-149.
DR   PDB; 6NMT; X-ray; 1.83 A; C=31-149.
DR   PDB; 6NMU; X-ray; 2.55 A; C/S=31-149.
DR   PDB; 6NMV; X-ray; 2.61 A; S=31-149.
DR   PDBsum; 2JJS; -.
DR   PDBsum; 2JJT; -.
DR   PDBsum; 2UV3; -.
DR   PDBsum; 2WNG; -.
DR   PDBsum; 4CMM; -.
DR   PDBsum; 6BIT; -.
DR   PDBsum; 6NMR; -.
DR   PDBsum; 6NMS; -.
DR   PDBsum; 6NMT; -.
DR   PDBsum; 6NMU; -.
DR   PDBsum; 6NMV; -.
DR   SMR; P78324; -.
DR   BioGrid; 126752; 74.
DR   IntAct; P78324; 9.
DR   STRING; 9606.ENSP00000382941; -.
DR   GlyConnect; 650; -.
DR   iPTMnet; P78324; -.
DR   PhosphoSitePlus; P78324; -.
DR   UniCarbKB; P78324; -.
DR   BioMuta; SIRPA; -.
DR   DMDM; 327478534; -.
DR   EPD; P78324; -.
DR   jPOST; P78324; -.
DR   MassIVE; P78324; -.
DR   MaxQB; P78324; -.
DR   PaxDb; P78324; -.
DR   PeptideAtlas; P78324; -.
DR   PRIDE; P78324; -.
DR   ProteomicsDB; 57564; -. [P78324-1]
DR   ProteomicsDB; 57565; -. [P78324-2]
DR   ProteomicsDB; 57566; -. [P78324-4]
DR   ABCD; P78324; -.
DR   Antibodypedia; 3458; 830 antibodies.
DR   DNASU; 140885; -.
DR   Ensembl; ENST00000356025; ENSP00000348307; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000358771; ENSP00000351621; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000400068; ENSP00000382941; ENSG00000198053. [P78324-1]
DR   Ensembl; ENST00000622179; ENSP00000478763; ENSG00000198053. [P78324-2]
DR   GeneID; 140885; -.
DR   KEGG; hsa:140885; -.
DR   UCSC; uc002wfq.3; human. [P78324-1]
DR   CTD; 140885; -.
DR   DisGeNET; 140885; -.
DR   GeneCards; SIRPA; -.
DR   HGNC; HGNC:9662; SIRPA.
DR   HPA; ENSG00000198053; Tissue enhanced (brain).
DR   MIM; 602461; gene.
DR   neXtProt; NX_P78324; -.
DR   OpenTargets; ENSG00000198053; -.
DR   PharmGKB; PA34006; -.
DR   eggNOG; ENOG410IKYM; Eukaryota.
DR   eggNOG; ENOG410YKK2; LUCA.
DR   GeneTree; ENSGT00960000186656; -.
DR   HOGENOM; CLU_044430_2_0_1; -.
DR   InParanoid; P78324; -.
DR   KO; K06551; -.
DR   OMA; QSEYACI; -.
DR   OrthoDB; 904196at2759; -.
DR   PhylomeDB; P78324; -.
DR   TreeFam; TF341862; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P78324; -.
DR   SIGNOR; P78324; -.
DR   ChiTaRS; SIRPA; human.
DR   EvolutionaryTrace; P78324; -.
DR   GeneWiki; Signal-regulatory_protein_alpha; -.
DR   GenomeRNAi; 140885; -.
DR   Pharos; P78324; Tbio.
DR   PRO; PR:P78324; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P78324; protein.
DR   Bgee; ENSG00000198053; Expressed in anterior cingulate cortex and 216 other tissues.
DR   Genevisible; P78324; HS.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IPI:ARUK-UCL.
DR   GO; GO:0030695; F:GTPase regulator activity; ISS:ARUK-UCL.
DR   GO; GO:1990405; F:protein antigen binding; IPI:ARUK-UCL.
DR   GO; GO:0086080; F:protein binding involved in heterotypic cell-cell adhesion; ISS:ARUK-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:ARUK-UCL.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; ISS:ARUK-UCL.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; ISS:ARUK-UCL.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISS:ARUK-UCL.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; ISS:ARUK-UCL.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISS:ARUK-UCL.
DR   GO; GO:0071349; P:cellular response to interleukin-12; IMP:ARUK-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:ARUK-UCL.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0035696; P:monocyte extravasation; ISS:ARUK-UCL.
DR   GO; GO:0071650; P:negative regulation of chemokine (C-C motif) ligand 5 production; ISS:ARUK-UCL.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISS:ARUK-UCL.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:ARUK-UCL.
DR   GO; GO:1903720; P:negative regulation of I-kappaB phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:ARUK-UCL.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; ISS:ARUK-UCL.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISS:ARUK-UCL.
DR   GO; GO:0071641; P:negative regulation of macrophage inflammatory protein 1 alpha production; ISS:ARUK-UCL.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:ARUK-UCL.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; ISS:ARUK-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IBA:GO_Central.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; IMP:ARUK-UCL.
DR   GO; GO:0032651; P:regulation of interleukin-1 beta production; ISS:ARUK-UCL.
DR   GO; GO:0032675; P:regulation of interleukin-6 production; ISS:ARUK-UCL.
DR   GO; GO:0045428; P:regulation of nitric oxide biosynthetic process; ISS:ARUK-UCL.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; IGI:ARUK-UCL.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07654; C1-set; 2.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00407; IGc1; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; SH3-binding; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..504
FT                   /note="Tyrosine-protein phosphatase non-receptor type
FT                   substrate 1"
FT                   /id="PRO_0000014941"
FT   TOPO_DOM        31..373
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        374..394
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        395..504
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          32..137
FT                   /note="Ig-like V-type"
FT   DOMAIN          148..247
FT                   /note="Ig-like C1-type 1"
FT   DOMAIN          254..348
FT                   /note="Ig-like C1-type 2"
FT   MOTIF           429..432
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           439..444
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           453..456
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           470..473
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           496..499
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         429
FT                   /note="Phosphotyrosine; by Tyr-kinases"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         453
FT                   /note="Phosphotyrosine; by Tyr-kinases"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         470
FT                   /note="Phosphotyrosine; by Tyr-kinases"
FT                   /evidence="ECO:0000250|UniProtKB:P97710"
FT   MOD_RES         496
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        270
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        319
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        55..121
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17369261, ECO:0000269|PubMed:18657508"
FT   DISULFID        170..228
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        273..331
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         130
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040799"
FT   VAR_SEQ         422
FT                   /note="Q -> QVQSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007030"
FT   VARIANT         6..7
FT                   /note="PA -> RS"
FT                   /id="VAR_015462"
FT   VARIANT         20
FT                   /note="A -> P"
FT                   /id="VAR_015463"
FT   VARIANT         40
FT                   /note="D -> E (in dbSNP:rs1349896458)"
FT                   /id="VAR_015464"
FT   VARIANT         44
FT                   /note="L -> S (in dbSNP:rs143735290)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015465"
FT   VARIANT         50
FT                   /note="T -> S (in dbSNP:rs17855609)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015466"
FT   VARIANT         52
FT                   /note="T -> I (in dbSNP:rs17855610)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015468"
FT   VARIANT         54
FT                   /note="R -> H (in dbSNP:rs17855611)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015470"
FT   VARIANT         57
FT                   /note="A -> V (in dbSNP:rs17855612)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015471"
FT   VARIANT         61
FT                   /note="I -> N (in dbSNP:rs1371837011)"
FT                   /id="VAR_015472"
FT   VARIANT         68
FT                   /note="W -> R"
FT                   /id="VAR_015473"
FT   VARIANT         75
FT                   /note="G -> A (in dbSNP:rs1057114)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015474"
FT   VARIANT         77
FT                   /note="E -> K (in dbSNP:rs1182420620)"
FT                   /id="VAR_015475"
FT   VARIANT         81
FT                   /note="N -> H"
FT                   /id="VAR_015477"
FT   VARIANT         95
FT                   /note="D -> E (in dbSNP:rs138283486)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015478"
FT   VARIANT         96
FT                   /note="L -> S"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015479"
FT   VARIANT         100
FT                   /note="N -> E (requires 2 nucleotide substitutions;
FT                   dbSNP:rs386811662)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015480"
FT   VARIANT         107
FT                   /note="R -> S (in dbSNP:rs17855615)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015483"
FT   VARIANT         109
FT                   /note="G -> S (in dbSNP:rs17855616)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015484"
FT   VARIANT         125
FT                   /note="R -> Q (in dbSNP:rs767136065)"
FT                   /id="VAR_015485"
FT   VARIANT         132
FT                   /note="V -> T (requires 2 nucleotide substitutions;
FT                   dbSNP:rs386811663)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9062191,
FT                   ECO:0000269|PubMed:9070220"
FT                   /id="VAR_015486"
FT   VARIANT         134
FT                   /note="F -> L"
FT                   /id="VAR_015487"
FT   VARIANT         163
FT                   /note="Q -> D (requires 2 nucleotide substitutions)"
FT                   /id="VAR_015488"
FT   VARIANT         181
FT                   /note="T -> S"
FT                   /id="VAR_015489"
FT   VARIANT         190
FT                   /note="E -> Q"
FT                   /id="VAR_015490"
FT   VARIANT         201..202
FT                   /note="VG -> AR"
FT                   /id="VAR_015491"
FT   VARIANT         214
FT                   /note="K -> N"
FT                   /id="VAR_015492"
FT   VARIANT         220
FT                   /note="E -> G"
FT                   /id="VAR_015493"
FT   VARIANT         222
FT                   /note="V -> I (in dbSNP:rs143385810)"
FT                   /id="VAR_015494"
FT   VARIANT         236
FT                   /note="Q -> R"
FT                   /id="VAR_015495"
FT   VARIANT         239..240
FT                   /note="PL -> SF"
FT                   /id="VAR_015496"
FT   VARIANT         251
FT                   /note="R -> Q (in dbSNP:rs377448893)"
FT                   /id="VAR_015497"
FT   VARIANT         261
FT                   /note="Q -> L"
FT                   /id="VAR_015498"
FT   VARIANT         263
FT                   /note="V -> M (in dbSNP:rs754806675)"
FT                   /id="VAR_015499"
FT   VARIANT         271
FT                   /note="V -> I"
FT                   /id="VAR_015500"
FT   VARIANT         276
FT                   /note="R -> T"
FT                   /id="VAR_015501"
FT   VARIANT         302
FT                   /note="V -> L (in dbSNP:rs2422666)"
FT                   /id="VAR_015502"
FT   VARIANT         339
FT                   /note="P -> S"
FT                   /id="VAR_015503"
FT   VARIANT         353
FT                   /note="P -> L (in dbSNP:rs138876160)"
FT                   /id="VAR_015504"
FT   VARIANT         357
FT                   /note="G -> S (in dbSNP:rs1200233096)"
FT                   /id="VAR_015505"
FT   VARIANT         367
FT                   /note="S -> P"
FT                   /id="VAR_015506"
FT   VARIANT         370
FT                   /note="R -> Q (in dbSNP:rs778218860)"
FT                   /id="VAR_015507"
FT   VARIANT         389
FT                   /note="A -> E"
FT                   /id="VAR_015508"
FT   VARIANT         443
FT                   /note="Q -> R"
FT                   /id="VAR_015509"
FT   VARIANT         460
FT                   /note="P -> L (in dbSNP:rs1168490568)"
FT                   /id="VAR_015510"
FT   VARIANT         486
FT                   /note="A -> L (requires 2 nucleotide substitutions)"
FT                   /id="VAR_015511"
FT   VARIANT         491
FT                   /note="P -> L (in dbSNP:rs367629199)"
FT                   /id="VAR_015512"
FT   CONFLICT        259
FT                   /note="T -> I (in Ref. 7; CAA71944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503
FT                   /note="R -> K (in Ref. 7; CAA71944)"
FT                   /evidence="ECO:0000305"
FT   STRAND          41..46
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          51..53
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          56..58
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          66..70
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          77..85
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          90..94
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          96..98
FT                   /evidence="ECO:0000244|PDB:6NMU"
FT   STRAND          106..110
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   HELIX           113..115
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          117..125
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          127..129
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          132..136
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          140..145
FT                   /evidence="ECO:0000244|PDB:2UV3"
FT   STRAND          152..154
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          165..178
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          181..186
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          194..199
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          207..216
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   HELIX           221..223
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          225..231
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          240..245
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   HELIX           246..248
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          255..261
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          269..281
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          283..289
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          292..298
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          310..318
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          328..335
FT                   /evidence="ECO:0000244|PDB:2WNG"
FT   STRAND          341..346
FT                   /evidence="ECO:0000244|PDB:2WNG"
SQ   SEQUENCE   504 AA;  54967 MW;  18D2FD04F6182AD0 CRC64;
     MEPAGPAPGR LGPLLCLLLA ASCAWSGVAG EEELQVIQPD KSVLVAAGET ATLRCTATSL
     IPVGPIQWFR GAGPGRELIY NQKEGHFPRV TTVSDLTKRN NMDFSIRIGN ITPADAGTYY
     CVKFRKGSPD DVEFKSGAGT ELSVRAKPSA PVVSGPAARA TPQHTVSFTC ESHGFSPRDI
     TLKWFKNGNE LSDFQTNVDP VGESVSYSIH STAKVVLTRE DVHSQVICEV AHVTLQGDPL
     RGTANLSETI RVPPTLEVTQ QPVRAENQVN VTCQVRKFYP QRLQLTWLEN GNVSRTETAS
     TVTENKDGTY NWMSWLLVNV SAHRDDVKLT CQVEHDGQPA VSKSHDLKVS AHPKEQGSNT
     AAENTGSNER NIYIVVGVVC TLLVALLMAA LYLVRIRQKK AQGSTSSTRL HEPEKNAREI
     TQDTNDITYA DLNLPKGKKP APQAAEPNNH TEYASIQTSP QPASEDTLTY ADLDMVHLNR
     TPKQPAPKPE PSFSEYASVQ VPRK
//
ID   A0A384MR33_HUMAN        Unreviewed;      1233 AA.
AC   A0A384MR33;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 11.
DE   RecName: Full=Structural maintenance of chromosomes protein {ECO:0000256|PIRNR:PIRNR005719};
GN   Name=SMC1L1 {ECO:0000313|EMBL:EAW93150.1};
GN   ORFNames=hCG_18494 {ECO:0000313|EMBL:EAW93150.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22411.1};
RN   [1] {ECO:0000313|EMBL:EAW93150.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW93150.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22411.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
CC   -!- SIMILARITY: Belongs to the SMC family. {ECO:0000256|PIRNR:PIRNR005719}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ900894; ADO22411.1; -; mRNA.
DR   EMBL; CH471154; EAW93150.1; -; Genomic_DNA.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   Antibodypedia; 491; 920 antibodies.
DR   GeneID; 8243; -.
DR   KEGG; hsa:8243; -.
DR   CTD; 8243; -.
DR   KO; K06636; -.
DR   OMA; YMEAIVV; -.
DR   ChiTaRS; SMC1A; human.
DR   GO; GO:0030893; C:meiotic cohesin complex; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0036033; F:mediator complex binding; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:Ensembl.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
FT   DOMAIN          513..629
FT                   /note="SMC hinge"
FT                   /evidence="ECO:0000259|SMART:SM00968"
FT   REGION          284..308
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          348..369
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          947..966
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          189..222
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          407..490
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          664..711
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          748..775
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          789..814
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          828..925
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          992..1016
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1024..1065
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        949..966
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1233 AA;  143233 MW;  E0A44CA7476C88A6 CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKVETEAK
     IKQKLREIEE NQKRIEKLEE YITTSKQSLE EQKKLEGELT EEVEMAKRRI DEINKELNQV
     MEQLGDARID RQESSRQQRK AEIMESIKRL YPGSVYGRLI DLCQPTQKKY QIAVTKVLGK
     NMDAIIVDSE KTGRDCIQYI KEQRGEPETF LPLDYLEVKP TDEKLRELKG AKLVIDVIRY
     EPPHIKKALQ YACGNALVCD NVEDARRIAF GGHQRHKTVA LDGTLFQKSG VISGGASDLK
     AKARRWDEKA VDKLKEKKER LTEELKEQMK AKRKEAELRQ VQSQAHGLQM RLKYSQSDLE
     QTKTRHLALN LQEKSKLESE LANFGPRIND IKRIIQSRER EMKDLKEKMN QVEDEVFEEF
     CREIGVRNIR EFEEEKVKRQ NEIAKKRLEF ENQKTRLGIQ LDFEKNQLKE DQDKVHMWEQ
     TVKKDENEIE KLKKEEQRHM KIIDETMAQL QDLKNQHLAK KSEVNDKNHE MEEIRKKLGG
     ANKEMTHLQK EVTAIETKLE QKRSDRHNLL QACKMQDIKL PLSKGTMDDI SQEEGSSQGE
     DSVSGSQRIS SIYAREALIE IDYGDLCEDL KDAQAEEEIK QEMNTLQQKL NEQQSVLQRI
     AAPNMKAMEK LESVRDKFQE TSDEFEAARK RAKKAKQAFE QIKKERFDRF NACFESVATN
     IDEIYKALSR NSSAQAFLGP ENPEEPYLDG INYNCVAPGK RFRPMDNLSG GEKTVAALAL
     LFAIHSYKPA PFFVLDEIDA ALDNTNIGKV ANYIKEQSTC NFQAIVISLK EEFYTKAESL
     IGVYPEQGDC VISKVLTFDL TKYPDANPNP NEQ
//
ID   G8JLG1_HUMAN            Unreviewed;      1211 AA.
AC   G8JLG1;
DT   25-JAN-2012, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   22-APR-2020, entry version 68.
DE   RecName: Full=Structural maintenance of chromosomes protein {ECO:0000256|PIRNR:PIRNR005719};
GN   Name=SMC1A {ECO:0000313|Ensembl:ENSP00000364489};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000364489, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000364489, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000364489}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2011) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PIRNR:PIRNR005719}.
CC   -!- SIMILARITY: Belongs to the SMC family. {ECO:0000256|PIRNR:PIRNR005719}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC233728; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001268392.1; NM_001281463.1.
DR   MetOSite; G8JLG1; -.
DR   EPD; G8JLG1; -.
DR   jPOST; G8JLG1; -.
DR   PeptideAtlas; G8JLG1; -.
DR   PRIDE; G8JLG1; -.
DR   ProteomicsDB; 34217; -.
DR   Antibodypedia; 491; 920 antibodies.
DR   Ensembl; ENST00000375340; ENSP00000364489; ENSG00000072501.
DR   GeneID; 8243; -.
DR   UCSC; uc011moe.3; human.
DR   CTD; 8243; -.
DR   EuPathDB; HostDB:ENSG00000072501.17; -.
DR   HGNC; HGNC:11111; SMC1A.
DR   OpenTargets; ENSG00000072501; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   GeneTree; ENSGT00940000155614; -.
DR   ChiTaRS; SMC1A; human.
DR   GenomeRNAi; 8243; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000072501; Expressed in tendon of biceps brachii and 233 other tissues.
DR   ExpressionAtlas; G8JLG1; baseline and differential.
DR   GO; GO:0008278; C:cohesin complex; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleus {ECO:0000256|PIRNR:PIRNR005719};
KW   Proteomics identification {ECO:0000213|EPD:G8JLG1,
KW   ECO:0000213|MaxQB:G8JLG1, ECO:0000213|PeptideAtlas:G8JLG1,
KW   ECO:0000213|ProteomicsDB:G8JLG1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          491..607
FT                   /note="SMC hinge"
FT                   /evidence="ECO:0000259|SMART:SM00968"
FT   REGION          262..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          328..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          925..944
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          167..200
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          385..468
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          642..689
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          726..753
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          767..792
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          806..903
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          970..994
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1002..1043
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        927..944
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1211 AA;  140859 MW;  9E837EFEA36AD4D2 CRC64;
     MLEVSIPTPH RYVRGKSNLM DAISFVLGEK TSNLRVKTLR DLIHGAPVGK PAANRAFVSM
     VYSEEGAEDR TFARVIVGGS SEYKINNKVV QLHEYSEELE KLGILIKARN FLVFQGAVES
     IAMKNPKERT ALFEEISRSG ELAQEYDKRK KEMVKAEEDT QFNYHRKKNI AAERKEAKQE
     KEEADRYQRL KDEVVRAQVQ LQLFKLYHNE VEIEKLNKEL ASKNKEIEKD KKRMDKVEDE
     LKEKKKELGK MMREQQQIEK EIKEKDSELN QKRPQYIKAK ENTSHKIKKL EAAKKSLQNA
     QKHYKKRKGD MDELEKEMLS VEKARQEFEE RMEEESQSQG RDLTLEENQV KKYHRLKEEA
     SKRAATLAQE LEKFNRDQKA DQDRLDLEER KKVETEAKIK QKLREIEENQ KRIEKLEEYI
     TTSKQSLEEQ KKLEGELTEE VEMAKRRIDE INKELNQVME QLGDARIDRQ ESSRQQRKAE
     IMESIKRLYP GSVYGRLIDL CQPTQKKYQI AVTKVLGKNM DAIIVDSEKT GRDCIQYIKE
     QRGEPETFLP LDYLEVKPTD EKLRELKGAK LVIDVIRYEP PHIKKALQYA CGNALVCDNV
     EDARRIAFGG HQRHKTVALD GTLFQKSGVI SGGASDLKAK ARRWDEKAVD KLKEKKERLT
     EELKEQMKAK RKEAELRQVQ SQAHGLQMRL KYSQSDLEQT KTRHLALNLQ EKSKLESELA
     NFGPRINDIK RIIQSREREM KDLKEKMNQV EDEVFEEFCR EIGVRNIREF EEEKVKRQNE
     IAKKRLEFEN QKTRLGIQLD FEKNQLKEDQ DKVHMWEQTV KKDENEIEKL KKEEQRHMKI
     IDETMAQLQD LKNQHLAKKS EVNDKNHEME EIRKKLGGAN KEMTHLQKEV TAIETKLEQK
     RSDRHNLLQA CKMQDIKLPL SKGTMDDISQ EEGSSQGEDS VSGSQRISSI YAREALIEID
     YGDLCEDLKD AQAEEEIKQE MNTLQQKLNE QQSVLQRIAA PNMKAMEKLE SVRDKFQETS
     DEFEAARKRA KKAKQAFEQI KKERFDRFNA CFESVATNID EIYKALSRNS SAQAFLGPEN
     PEEPYLDGIN YNCVAPGKRF RPMDNLSGGE KTVAALALLF AIHSYKPAPF FVLDEIDAAL
     DNTNIGKVAN YIKEQSTCNF QAIVISLKEE FYTKAESLIG VYPEQGDCVI SKVLTFDLTK
     YPDANPNPNE Q
//
ID   SMC1A_HUMAN             Reviewed;        1233 AA.
AC   Q14683; O14995; Q16351; Q2M228;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 2.
DT   22-APR-2020, entry version 211.
DE   RecName: Full=Structural maintenance of chromosomes protein 1A;
DE            Short=SMC protein 1A;
DE            Short=SMC-1-alpha;
DE            Short=SMC-1A;
DE   AltName: Full=Sb1.8;
GN   Name=SMC1A; Synonyms=DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RX   PubMed=7757074; DOI=10.1093/hmg/4.2.243;
RA   Rocques P.J., Clark J., Ball S., Crew J., Gill S., Christodoulou Z.,
RA   Borts R.H., Louis E.J., Davies K.E., Cooper C.S.;
RT   "The human SB1.8 gene (DXS423E) encodes a putative chromosome segregation
RT   protein conserved in lower eukaryotes and prokaryotes.";
RL   Hum. Mol. Genet. 4:243-249(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V. The
RT   coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 945-984, FUNCTION, INTERACTION WITH BRCA1,
RP   PHOSPHORYLATION AT SER-957 AND SER-966, AND MUTAGENESIS OF SER-957 AND
RP   SER-966.
RX   PubMed=11877377; DOI=10.1101/gad.970702;
RA   Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y.-H.P., Qin J.;
RT   "SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase
RT   checkpoint.";
RL   Genes Dev. 16:571-582(2002).
RN   [7]
RP   INTERACTION WITH NDC80.
RX   PubMed=9295362; DOI=10.1074/jbc.272.38.24081;
RA   Chen Y., Sharp Z.D., Lee W.-H.;
RT   "HEC binds to the seventh regulatory subunit of the 26 S proteasome and
RT   modulates the proteolysis of mitotic cyclins.";
RL   J. Biol. Chem. 272:24081-24087(1997).
RN   [8]
RP   INTERACTION WITH NDC80.
RX   PubMed=10409732; DOI=10.1128/mcb.19.8.5417;
RA   Zheng L., Chen Y., Lee W.-H.;
RT   "Hec1p, an evolutionarily conserved coiled-coil protein, modulates
RT   chromosome segregation through interaction with SMC proteins.";
RL   Mol. Cell. Biol. 19:5417-5428(1999).
RN   [9]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC3; STAG1 OR STAG2.
RX   PubMed=11076961; DOI=10.1083/jcb.151.4.749;
RA   Sumara I., Vorlaufer E., Gieffers C., Peters B.H., Peters J.-M.;
RT   "Characterization of vertebrate cohesin complexes and their regulation in
RT   prophase.";
RL   J. Cell Biol. 151:749-762(2000).
RN   [10]
RP   SUBCELLULAR LOCATION DURING CELL CYCLE.
RX   PubMed=12199140; DOI=10.1023/a:1016563523208;
RA   Gregson H.C., Van Hooser A.A., Ball A.R. Jr., Brinkley B.R., Yokomori K.;
RT   "Localization of human SMC1 protein at kinetochores.";
RL   Chromosome Res. 10:267-277(2002).
RN   [11]
RP   PHOSPHORYLATION AT SER-966, AND MUTAGENESIS OF SER-966.
RX   PubMed=14657349; DOI=10.1073/pnas.2536810100;
RA   Wang Y., Qin J.;
RT   "MSH2 and ATR form a signaling module and regulate two branches of the
RT   damage response to DNA methylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15387-15392(2003).
RN   [12]
RP   IDENTIFICATION IN A COMPLEX WITH CDCA5; SMC3; RAD21; PDS5A AND PDS5B.
RX   PubMed=15837422; DOI=10.1016/j.molcel.2005.03.017;
RA   Rankin S., Ayad N.G., Kirschner M.W.;
RT   "Sororin, a substrate of the anaphase-promoting complex, is required for
RT   sister chromatid cohesion in vertebrates.";
RL   Mol. Cell 18:185-200(2005).
RN   [13]
RP   ERRATUM OF PUBMED:15837422.
RA   Rankin S., Ayad N.G., Kirschner M.W.;
RL   Mol. Cell 18:609-609(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-358; SER-360 AND SER-966, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND SER-970, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-957, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-648 AND LYS-713, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND SER-966, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH BRAT1, AND PHOSPHORYLATION AT SER-966.
RX   PubMed=22977523; DOI=10.3892/etm.2011.232;
RA   So E.Y., Ouchi T.;
RT   "Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK
RT   catalytic subunit.";
RL   Exp. Ther. Med. 2:443-447(2011).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC3; STAG1 AND RAD21, AND
RP   INTERACTION WITH SMC3 AND HETERODIMER NIPB-MAU2.
RX   PubMed=22628566; DOI=10.1073/pnas.1206840109;
RA   Bermudez V.P., Farina A., Higashi T.L., Du F., Tappin I., Takahashi T.S.,
RA   Hurwitz J.;
RT   "In vitro loading of human cohesin on DNA by the human Scc2-Scc4 loader
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:9366-9371(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-957 AND SER-962, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   UBIQUITINATION.
RX   PubMed=31452512; DOI=10.7554/elife.47362;
RA   Pech M.F., Fong L.E., Villalta J.E., Chan L.J., Kharbanda S., O'Brien J.J.,
RA   McAllister F.E., Firestone A.J., Jan C.H., Settleman J.;
RT   "Systematic identification of cancer cell vulnerabilities to natural killer
RT   cell-mediated immune surveillance.";
RL   Elife 8:0-0(2019).
RN   [26]
RP   VARIANTS CDLS2 ALA-493 AND GLN-832 DEL.
RX   PubMed=16604071; DOI=10.1038/ng1779;
RA   Musio A., Selicorni A., Focarelli M.L., Gervasini C., Milani D., Russo S.,
RA   Vezzoni P., Larizza L.;
RT   "X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations.";
RL   Nat. Genet. 38:528-530(2006).
RN   [27]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; VAL-133; HIS-196; CYS-496; HIS-496;
RP   TRP-711; GLN-790 AND LEU-1122.
RX   PubMed=17273969; DOI=10.1086/511888;
RA   Deardorff M.A., Kaur M., Yaeger D., Rampuria A., Korolev S., Pie J.,
RA   Gil-Rodriguez C., Arnedo M., Loeys B., Kline A.D., Wilson M., Lillquist K.,
RA   Siu V., Ramos F.J., Musio A., Jackson L.S., Dorsett D., Krantz I.D.;
RT   "Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant
RT   of Cornelia de Lange syndrome with predominant mental retardation.";
RL   Am. J. Hum. Genet. 80:485-494(2007).
RN   [28]
RP   VARIANTS CDLS2 HIS-196 AND CYS-1085.
RX   PubMed=17221863; DOI=10.1002/humu.9478;
RA   Borck G., Zarhrate M., Bonnefont J.-P., Munnich A., Cormier-Daire V.,
RA   Colleaux L.;
RT   "Incidence and clinical features of X-linked Cornelia de Lange syndrome due
RT   to SMC1L1 mutations.";
RL   Hum. Mutat. 28:205-206(2007).
RN   [29]
RP   CHARACTERIZATION OF VARIANTS CDLS2 ALA-493; CYS-496 AND HIS-496, AND
RP   GENOMIC INSTABILITY OF CDLS CELL LINES TO IONIZING RADIATION.
RX   PubMed=18996922; DOI=10.1093/hmg/ddn369;
RA   Revenkova E., Focarelli M.L., Susani L., Paulis M., Bassi M.T., Mannini L.,
RA   Frattini A., Delia D., Krantz I., Vezzoni P., Jessberger R., Musio A.;
RT   "Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to
RT   DNA.";
RL   Hum. Mol. Genet. 18:418-427(2009).
RN   [30]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; VAL-133; LYS-141; HIS-196; LYS-268 DEL;
RP   SER-306 DEL; GLN-398; CYS-496; HIS-496; GLU-683 DEL; GLY-693; TRP-711;
RP   PHE-781; GLN-790; GLY-816; GLN-1049; LEU-1122 AND TRP-1123.
RX   PubMed=19701948; DOI=10.1002/humu.21095;
RA   Liu J., Feldman R., Zhang Z., Deardorff M.A., Haverfield E.V., Kaur M.,
RA   Li J.R., Clark D., Kline A.D., Waggoner D.J., Das S., Jackson L.G.,
RA   Krantz I.D.;
RT   "SMC1A expression and mechanism of pathogenicity in probands with X-Linked
RT   Cornelia de Lange syndrome.";
RL   Hum. Mutat. 30:1535-1542(2009).
RN   [31]
RP   VARIANTS CDLS2 HIS-196; LYS-268 DEL AND GLN-711.
RX   PubMed=20358602; DOI=10.1002/ajmg.a.33348;
RA   Pie J., Gil-Rodriguez M.C., Ciero M., Lopez-Vinas E., Ribate M.P.,
RA   Arnedo M., Deardorff M.A., Puisac B., Legarreta J., de Karam J.C.,
RA   Rubio E., Bueno I., Baldellou A., Calvo M.T., Casals N., Olivares J.L.,
RA   Losada A., Hegardt F.G., Krantz I.D., Gomez-Puertas P., Ramos F.J.;
RT   "Mutations and variants in the cohesion factor genes NIPBL, SMC1A, and SMC3
RT   in a cohort of 30 unrelated patients with Cornelia de Lange syndrome.";
RL   Am. J. Med. Genet. A 152:924-929(2010).
RN   [32]
RP   VARIANT CDLS2 THR-784.
RX   PubMed=20635401; DOI=10.1002/ajmg.a.33486;
RA   Limongelli G., Russo S., Digilio M.C., Masciadri M., Pacileo G., Fratta F.,
RA   Martone F., Maddaloni V., D'Alessandro R., Calabro P., Russo M.G.,
RA   Calabro R., Larizza L.;
RT   "Hypertrophic cardiomyopathy in a girl with Cornelia de Lange syndrome due
RT   to mutation in SMC1A.";
RL   Am. J. Med. Genet. A 152:2127-2129(2010).
RN   [33]
RP   VARIANTS CDLS2 58-VAL--ARG-62 DEL; GLY-398; MET-651; GLN-693; THR-784;
RP   GLN-790; THR-1166 AND PHE-1189.
RX   PubMed=24124034; DOI=10.1002/ajmg.a.36252;
RA   Gervasini C., Russo S., Cereda A., Parenti I., Masciadri M., Azzollini J.,
RA   Melis D., Aravena T., Doray B., Ferrarini A., Garavelli L., Selicorni A.,
RA   Larizza L.;
RT   "Cornelia de Lange individuals with new and recurrent SMC1A mutations
RT   enhance delineation of mutation repertoire and phenotypic spectrum.";
RL   Am. J. Med. Genet. A 161A:2909-2919(2013).
CC   -!- FUNCTION: Involved in chromosome cohesion during cell cycle and in DNA
CC       repair. Central component of cohesin complex. The cohesin complex is
CC       required for the cohesion of sister chromatids after DNA replication.
CC       The cohesin complex apparently forms a large proteinaceous ring within
CC       which sister chromatids can be trapped. At anaphase, the complex is
CC       cleaved and dissociates from chromatin, allowing sister chromatids to
CC       segregate. The cohesin complex may also play a role in spindle pole
CC       assembly during mitosis. Involved in DNA repair via its interaction
CC       with BRCA1 and its related phosphorylation by ATM, or via its
CC       phosphorylation by ATR. Works as a downstream effector both in the
CC       ATM/NBS1 branch and in the ATR/MSH2 branch of S-phase checkpoint.
CC       {ECO:0000269|PubMed:11877377}.
CC   -!- SUBUNIT: Forms a heterodimer with SMC3 in cohesin complexes
CC       (PubMed:22628566). Cohesin complexes are composed of the SMC1 (SMC1A or
CC       SMC1B) and SMC3 heterodimer attached via their SMC hinge domain, RAD21
CC       which link them, and one STAG protein (STAG1, STAG2 or STAG3), which
CC       interacts with RAD21 (PubMed:11076961). In germ cell cohesin complexes,
CC       SMC1A is mutually exclusive with SMC1B (By similarity). Interacts with
CC       BRCA1 (PubMed:11877377). Found in a complex with CDCA5, SMC3 and RAD21,
CC       PDS5A/SCC-112 and PDS5B/APRIN (PubMed:15837422). Interacts with NDC80
CC       (PubMed:9295362, PubMed:10409732,). Interacts with BRAT1
CC       (PubMed:22977523). Found in a complex containing POLE and SMC3.
CC       Interacts with RPGR, STAG3 and SYCP2 (By similarity). Found in a
CC       cohesin complex with SMC3, STAG1 and RAD21 (PubMed:22628566). The
CC       SMC1A-SMC3 heterodimer interacts with the NIPBL-MAU2 heterodimer
CC       (PubMed:22628566). {ECO:0000250|UniProtKB:O97593,
CC       ECO:0000250|UniProtKB:Q9CU62, ECO:0000250|UniProtKB:Q9Z1M9,
CC       ECO:0000269|PubMed:10409732, ECO:0000269|PubMed:11076961,
CC       ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:15837422,
CC       ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:22977523,
CC       ECO:0000269|PubMed:9295362}.
CC   -!- INTERACTION:
CC       Q14683; PRO_0000045603 [Q99IB8]; Xeno; NbExp=3; IntAct=EBI-80690, EBI-6927928;
CC       Q14683; Q96FF9: CDCA5; NbExp=6; IntAct=EBI-80690, EBI-718805;
CC       Q14683; Q92915-2: FGF14; NbExp=3; IntAct=EBI-80690, EBI-12836320;
CC       Q14683; P33993: MCM7; NbExp=8; IntAct=EBI-80690, EBI-355924;
CC       Q14683; O60216: RAD21; NbExp=15; IntAct=EBI-80690, EBI-80739;
CC       Q14683; P78406: RAE1; NbExp=5; IntAct=EBI-80690, EBI-724495;
CC       Q14683; Q5FBB7: SGO1; NbExp=9; IntAct=EBI-80690, EBI-989069;
CC       Q14683; Q9UQE7: SMC3; NbExp=14; IntAct=EBI-80690, EBI-80718;
CC       Q14683; Q8N3U4: STAG2; NbExp=9; IntAct=EBI-80690, EBI-1057252;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12199140}. Chromosome
CC       {ECO:0000269|PubMed:12199140}. Chromosome, centromere, kinetochore
CC       {ECO:0000269|PubMed:12199140}. Note=Associates with chromatin. Before
CC       prophase it is scattered along chromosome arms. During prophase, most
CC       of cohesin complexes dissociate from chromatin probably because of
CC       phosphorylation by PLK, except at centromeres, where cohesin complexes
CC       remain. At anaphase, the RAD21 subunit of the cohesin complex is
CC       cleaved, leading to the dissociation of the complex from chromosomes,
CC       allowing chromosome separation. In germ cells, cohesin complex
CC       dissociates from chromatin at prophase I, and may be replaced by a
CC       meiosis-specific cohesin complex. The phosphorylated form on Ser-957
CC       and Ser-966 associates with chromatin during G1/S/G2 phases but not
CC       during M phase, suggesting that phosphorylation does not regulate
CC       cohesin function. Integral component of the functional centromere-
CC       kinetochore complex at the kinetochore region during mitosis.
CC   -!- DOMAIN: The flexible SMC hinge domain, which separates the large
CC       intramolecular coiled coil regions, allows the heterotypic interaction
CC       with the corresponding domain of SMC3, forming a V-shaped heterodimer.
CC       The two heads of the heterodimer are then connected by different ends
CC       of the cleavable RAD21 protein, forming a ring structure (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by the DCX(DCAF15) complex, leading to its
CC       degradation. {ECO:0000269|PubMed:31452512}.
CC   -!- PTM: Phosphorylated by ATM upon ionizing radiation in a NBS1-dependent
CC       manner. Phosphorylated by ATR upon DNA methylation in a MSH2/MSH6-
CC       dependent manner. Phosphorylation of Ser-957 and Ser-966 activates it
CC       and is required for S-phase checkpoint activation.
CC       {ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:14657349}.
CC   -!- DISEASE: Cornelia de Lange syndrome 2 (CDLS2) [MIM:300590]: A form of
CC       Cornelia de Lange syndrome, a clinically heterogeneous developmental
CC       disorder associated with malformations affecting multiple systems.
CC       Characterized by facial dysmorphisms, abnormal hands and feet, growth
CC       delay, cognitive retardation, hirsutism, gastroesophageal dysfunction
CC       and cardiac, ophthalmologic and genitourinary anomalies.
CC       {ECO:0000269|PubMed:16604071, ECO:0000269|PubMed:17221863,
CC       ECO:0000269|PubMed:17273969, ECO:0000269|PubMed:18996922,
CC       ECO:0000269|PubMed:19701948, ECO:0000269|PubMed:20358602,
CC       ECO:0000269|PubMed:20635401, ECO:0000269|PubMed:24124034}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: Mutated Cornelia de Lange cell lines display genomic
CC       instability and sensitivity to ionizing radiation and interstrand
CC       cross-linking agents.
CC   -!- SIMILARITY: Belongs to the SMC family. SMC1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S78271; AAB34405.1; -; mRNA.
DR   EMBL; D80000; BAA11495.2; -; mRNA.
DR   EMBL; AL161779; CAI42089.1; -; Genomic_DNA.
DR   EMBL; Z97054; CAI42089.1; JOINED; Genomic_DNA.
DR   EMBL; Z97054; CAI42646.1; -; Genomic_DNA.
DR   EMBL; AL161779; CAI42646.1; JOINED; Genomic_DNA.
DR   EMBL; BC112127; AAI12128.1; -; mRNA.
DR   CCDS; CCDS14352.1; -.
DR   PIR; I54383; I54383.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   SMR; Q14683; -.
DR   BioGrid; 113871; 187.
DR   CORUM; Q14683; -.
DR   DIP; DIP-30911N; -.
DR   IntAct; Q14683; 115.
DR   MINT; Q14683; -.
DR   STRING; 9606.ENSP00000323421; -.
DR   ChEMBL; CHEMBL4105747; -.
DR   iPTMnet; Q14683; -.
DR   MetOSite; Q14683; -.
DR   PhosphoSitePlus; Q14683; -.
DR   SwissPalm; Q14683; -.
DR   BioMuta; SMC1A; -.
DR   DMDM; 29336622; -.
DR   EPD; Q14683; -.
DR   jPOST; Q14683; -.
DR   MassIVE; Q14683; -.
DR   MaxQB; Q14683; -.
DR   PaxDb; Q14683; -.
DR   PeptideAtlas; Q14683; -.
DR   PRIDE; Q14683; -.
DR   ProteomicsDB; 60117; -.
DR   Antibodypedia; 491; 920 antibodies.
DR   Ensembl; ENST00000322213; ENSP00000323421; ENSG00000072501.
DR   GeneID; 8243; -.
DR   KEGG; hsa:8243; -.
DR   UCSC; uc004dsg.4; human.
DR   CTD; 8243; -.
DR   DisGeNET; 8243; -.
DR   GeneCards; SMC1A; -.
DR   GeneReviews; SMC1A; -.
DR   HGNC; HGNC:11111; SMC1A.
DR   HPA; ENSG00000072501; Low tissue specificity.
DR   MalaCards; SMC1A; -.
DR   MIM; 300040; gene.
DR   MIM; 300590; phenotype.
DR   neXtProt; NX_Q14683; -.
DR   OpenTargets; ENSG00000072501; -.
DR   Orphanet; 199; Cornelia de Lange syndrome.
DR   Orphanet; 319182; Wiedemann-Steiner syndrome.
DR   PharmGKB; PA35961; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   GeneTree; ENSGT00940000155614; -.
DR   HOGENOM; CLU_001042_0_2_1; -.
DR   InParanoid; Q14683; -.
DR   KO; K06636; -.
DR   OMA; YMEAIVV; -.
DR   OrthoDB; 326079at2759; -.
DR   PhylomeDB; Q14683; -.
DR   TreeFam; TF101156; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2468052; Establishment of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2470946; Cohesin Loading onto Chromatin.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; Q14683; -.
DR   SIGNOR; Q14683; -.
DR   ChiTaRS; SMC1A; human.
DR   GeneWiki; SMC1A; -.
DR   GenomeRNAi; 8243; -.
DR   Pharos; Q14683; Tbio.
DR   PRO; PR:Q14683; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q14683; protein.
DR   Bgee; ENSG00000072501; Expressed in tendon of biceps brachii and 233 other tissues.
DR   ExpressionAtlas; Q14683; baseline and differential.
DR   Genevisible; Q14683; HS.
DR   GO; GO:0005694; C:chromosome; TAS:Reactome.
DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:Reactome.
DR   GO; GO:0008278; C:cohesin complex; IDA:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0000794; C:condensed nuclear chromosome; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0030893; C:meiotic cohesin complex; IDA:UniProtKB.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0036033; F:mediator complex binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; TAS:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; TAS:UniProtKB.
DR   GO; GO:0000070; P:mitotic sister chromatid segregation; TAS:UniProtKB.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0072423; P:response to DNA damage checkpoint signaling; IDA:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; IEP:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR024704; SMC.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   InterPro; IPR010935; SMC_hinge.
DR   InterPro; IPR036277; SMC_hinge_sf.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF06470; SMC_hinge; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   PIRSF; PIRSF005719; SMC; 1.
DR   SMART; SM00968; SMC_hinge; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF75553; SSF75553; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cell division; Centromere;
KW   Chromosome; Coiled coil; Direct protein sequencing; Disease mutation;
KW   DNA damage; DNA repair; Kinetochore; Meiosis; Mental retardation; Mitosis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..1233
FT                   /note="Structural maintenance of chromosomes protein 1A"
FT                   /id="PRO_0000118989"
FT   DOMAIN          515..629
FT                   /note="SMC hinge"
FT   NP_BIND         32..39
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   COILED          104..124
FT                   /evidence="ECO:0000255"
FT   COILED          163..503
FT                   /evidence="ECO:0000255"
FT   COILED          660..935
FT                   /evidence="ECO:0000255"
FT   COILED          991..1068
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1128..1163
FT                   /note="Ala/Asp-rich (DA-box)"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         648
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         713
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         957
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:11877377"
FT   MOD_RES         962
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         966
FT                   /note="Phosphoserine; by ATM and ATR"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000269|PubMed:11877377,
FT                   ECO:0000269|PubMed:14657349, ECO:0000269|PubMed:22977523"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1037
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CU62"
FT   VARIANT         28
FT                   /note="T -> P (in dbSNP:rs34530151)"
FT                   /id="VAR_052438"
FT   VARIANT         58..62
FT                   /note="Missing (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:19701948, ECO:0000269|PubMed:24124034"
FT                   /id="VAR_062785"
FT   VARIANT         133
FT                   /note="F -> V (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062786"
FT   VARIANT         141
FT                   /note="E -> K (in CDLS2; dbSNP:rs587784420)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062787"
FT   VARIANT         196
FT                   /note="R -> H (in CDLS2; dbSNP:rs1556890815)"
FT                   /evidence="ECO:0000269|PubMed:17221863,
FT                   ECO:0000269|PubMed:17273969, ECO:0000269|PubMed:19701948,
FT                   ECO:0000269|PubMed:20358602"
FT                   /id="VAR_062788"
FT   VARIANT         268
FT                   /note="Missing (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948,
FT                   ECO:0000269|PubMed:20358602"
FT                   /id="VAR_062789"
FT   VARIANT         306
FT                   /note="Missing (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062790"
FT   VARIANT         398
FT                   /note="R -> G (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:24124034"
FT                   /id="VAR_078274"
FT   VARIANT         398
FT                   /note="R -> Q (in CDLS2; dbSNP:rs587784403)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062791"
FT   VARIANT         493
FT                   /note="E -> A (in CDLS2; affects the affinity of SMC hinge
FT                   dimers for DNA; mutated hinge dimers bind DNA with higher
FT                   affinity than wild-type proteins; dbSNP:rs122454122)"
FT                   /evidence="ECO:0000269|PubMed:16604071,
FT                   ECO:0000269|PubMed:18996922"
FT                   /id="VAR_026529"
FT   VARIANT         496
FT                   /note="R -> C (in CDLS2; affects the affinity of SMC hinge
FT                   dimers for DNA; mutated hinge dimers bind DNA with higher
FT                   affinity than wild-type proteins)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:18996922, ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062792"
FT   VARIANT         496
FT                   /note="R -> H (in CDLS2; affects the affinity of SMC hinge
FT                   dimers for DNA; mutated hinge dimers bind DNA with higher
FT                   affinity than wild-type proteins; dbSNP:rs122454123)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:18996922, ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062793"
FT   VARIANT         651
FT                   /note="V -> M (in CDLS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:24124034"
FT                   /id="VAR_078275"
FT   VARIANT         683
FT                   /note="Missing (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062794"
FT   VARIANT         693
FT                   /note="R -> G (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062795"
FT   VARIANT         693
FT                   /note="R -> Q (in CDLS2; dbSNP:rs587784408)"
FT                   /evidence="ECO:0000269|PubMed:24124034"
FT                   /id="VAR_078276"
FT   VARIANT         711
FT                   /note="R -> Q (in CDLS2; dbSNP:rs782176647)"
FT                   /evidence="ECO:0000269|PubMed:20358602"
FT                   /id="VAR_064542"
FT   VARIANT         711
FT                   /note="R -> W (in CDLS2; dbSNP:rs587784409)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062796"
FT   VARIANT         781
FT                   /note="C -> F (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062797"
FT   VARIANT         784
FT                   /note="I -> T (in CDLS2; dbSNP:rs387906702)"
FT                   /evidence="ECO:0000269|PubMed:20635401,
FT                   ECO:0000269|PubMed:24124034"
FT                   /id="VAR_064543"
FT   VARIANT         790
FT                   /note="R -> Q (in CDLS2; dbSNP:rs797045993)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:19701948, ECO:0000269|PubMed:24124034"
FT                   /id="VAR_062798"
FT   VARIANT         816
FT                   /note="R -> G (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062799"
FT   VARIANT         832
FT                   /note="Missing (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:16604071"
FT                   /id="VAR_026530"
FT   VARIANT         1049
FT                   /note="R -> Q (in CDLS2; dbSNP:rs587784416)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062800"
FT   VARIANT         1085
FT                   /note="Y -> C (in CDLS2; dbSNP:rs587784418)"
FT                   /evidence="ECO:0000269|PubMed:17221863"
FT                   /id="VAR_062801"
FT   VARIANT         1122
FT                   /note="F -> L (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:17273969,
FT                   ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062802"
FT   VARIANT         1123
FT                   /note="R -> W (in CDLS2)"
FT                   /evidence="ECO:0000269|PubMed:19701948"
FT                   /id="VAR_062803"
FT   VARIANT         1166
FT                   /note="N -> T (in CDLS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:24124034"
FT                   /id="VAR_078277"
FT   VARIANT         1189
FT                   /note="L -> F (in CDLS2; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:24124034"
FT                   /id="VAR_078278"
FT   MUTAGEN         957
FT                   /note="S->A: Reduces phosphorylation and the S-phase
FT                   checkpoint activation. Abolishes S-phase activation; when
FT                   associated with A-966."
FT                   /evidence="ECO:0000269|PubMed:11877377"
FT   MUTAGEN         966
FT                   /note="S->A: Reduces phosphorylation and the S-phase
FT                   checkpoint activation. Increases sensitivity to DNA
FT                   methylation. Abolishes S-phase activation; when associated
FT                   with A-957."
FT                   /evidence="ECO:0000269|PubMed:11877377,
FT                   ECO:0000269|PubMed:14657349"
FT   CONFLICT        163..164
FT                   /note="EL -> DV (in Ref. 1; AAB34405)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1233 AA;  143233 MW;  E0A44CA7476C88A6 CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKVETEAK
     IKQKLREIEE NQKRIEKLEE YITTSKQSLE EQKKLEGELT EEVEMAKRRI DEINKELNQV
     MEQLGDARID RQESSRQQRK AEIMESIKRL YPGSVYGRLI DLCQPTQKKY QIAVTKVLGK
     NMDAIIVDSE KTGRDCIQYI KEQRGEPETF LPLDYLEVKP TDEKLRELKG AKLVIDVIRY
     EPPHIKKALQ YACGNALVCD NVEDARRIAF GGHQRHKTVA LDGTLFQKSG VISGGASDLK
     AKARRWDEKA VDKLKEKKER LTEELKEQMK AKRKEAELRQ VQSQAHGLQM RLKYSQSDLE
     QTKTRHLALN LQEKSKLESE LANFGPRIND IKRIIQSRER EMKDLKEKMN QVEDEVFEEF
     CREIGVRNIR EFEEEKVKRQ NEIAKKRLEF ENQKTRLGIQ LDFEKNQLKE DQDKVHMWEQ
     TVKKDENEIE KLKKEEQRHM KIIDETMAQL QDLKNQHLAK KSEVNDKNHE MEEIRKKLGG
     ANKEMTHLQK EVTAIETKLE QKRSDRHNLL QACKMQDIKL PLSKGTMDDI SQEEGSSQGE
     DSVSGSQRIS SIYAREALIE IDYGDLCEDL KDAQAEEEIK QEMNTLQQKL NEQQSVLQRI
     AAPNMKAMEK LESVRDKFQE TSDEFEAARK RAKKAKQAFE QIKKERFDRF NACFESVATN
     IDEIYKALSR NSSAQAFLGP ENPEEPYLDG INYNCVAPGK RFRPMDNLSG GEKTVAALAL
     LFAIHSYKPA PFFVLDEIDA ALDNTNIGKV ANYIKEQSTC NFQAIVISLK EEFYTKAESL
     IGVYPEQGDC VISKVLTFDL TKYPDANPNP NEQ
//
ID   Q68EN4_HUMAN            Unreviewed;       417 AA.
AC   Q68EN4;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   11-DEC-2019, entry version 84.
DE   SubName: Full=SMC1A protein {ECO:0000313|EMBL:AAH80185.1};
DE   Flags: Fragment;
GN   Name=SMC1A {ECO:0000313|EMBL:AAH80185.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH80185.1};
RN   [1] {ECO:0000313|EMBL:AAH80185.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH80185.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC080185; AAH80185.1; -; mRNA.
DR   RefSeq; NP_006297.2; NM_006306.3.
DR   PeptideAtlas; Q68EN4; -.
DR   PRIDE; Q68EN4; -.
DR   GeneID; 8243; -.
DR   KEGG; hsa:8243; -.
DR   CTD; 8243; -.
DR   eggNOG; KOG0018; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   KO; K06636; -.
DR   OrthoDB; 326079at2759; -.
DR   ChiTaRS; SMC1A; human.
DR   GenomeRNAi; 8243; -.
DR   GO; GO:0008278; C:cohesin complex; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:InterPro.
DR   GO; GO:0007064; P:mitotic sister chromatid cohesion; IEA:InterPro.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR029683; SMC1A_metazoan.
DR   PANTHER; PTHR18937:SF170; PTHR18937:SF170; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          3..129
FT                   /note="SMC_N"
FT                   /evidence="ECO:0000259|Pfam:PF02463"
FT   REGION          348..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          397..417
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          189..222
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          232..293
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         417
FT                   /evidence="ECO:0000313|EMBL:AAH80185.1"
SQ   SEQUENCE   417 AA;  48888 MW;  EA7302053D16FD4A CRC64;
     MGFLKLIEIE NFKSYKGRQI IGPFQRFTAI IGPNGSGKSN LMDAISFVLG EKTSNLRVKT
     LRDLIHGAPV GKPAANRAFV SMVYSEEGAE DRTFARVIVG GSSEYKINNK VVQLHEYSEE
     LEKLGILIKA RNFLVFQGAV ESIAMKNPKE RTALFEEISR SGELAQEYDK RKKEMVKAEE
     DTQFNYHRKK NIAAERKEAK QEKEEADRYQ RLKDEVVRAQ VQLQLFKLYH NEVEIEKLNK
     ELASKNKEIE KDKKRMDKVE DELKEKKKEL GKMMREQQQI EKEIKEKDSE LNQKRPQYIK
     AKENTSHKIK KLEAAKKSLQ NAQKHYKKRK GDMDELEKEM LSVEKARQEF EERMEEESQS
     QGRDLTLEEN QVKKYHRLKE EASKRAATLA QELEKFNRDQ KADQDRLDLE ERKKKKK
//
ID   SOX21_HUMAN             Reviewed;         276 AA.
AC   Q9Y651; P35715; Q15504; Q5TBS1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-APR-2020, entry version 156.
DE   RecName: Full=Transcription factor SOX-21;
DE   AltName: Full=SOX-A;
GN   Name=SOX21; Synonyms=SOX25, SOXA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10441749; DOI=10.1007/s003359901118;
RA   Malas S., Duthie S., Deloukas P., Episkopou V.;
RT   "The isolation and high-resolution chromosomal mapping of human SOX14 and
RT   SOX21; two members of the SOX gene family related to SOX1, SOX2, and
RT   SOX3.";
RL   Mamm. Genome 10:934-937(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-87.
RC   TISSUE=Spinal cord;
RA   Stevanovic M.;
RL   Submitted (APR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-72.
RX   PubMed=1614875; DOI=10.1093/nar/20.11.2887;
RA   Denny P., Swift S., Brand N., Dabhade N., Barton P., Ashworth A.;
RT   "A conserved family of genes related to the testis determining gene, SRY.";
RL   Nucleic Acids Res. 20:2887-2887(1992).
CC   -!- FUNCTION: May play a role as an activator of transcription of OPRM1.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF107044; AAC95381.1; -; Genomic_DNA.
DR   EMBL; AL137061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX08946.1; -; Genomic_DNA.
DR   EMBL; X71136; CAA50466.1; -; mRNA.
DR   EMBL; X65666; CAA46617.1; -; mRNA.
DR   CCDS; CCDS9473.1; -.
DR   PIR; I38238; I38238.
DR   PIR; S22937; S22937.
DR   RefSeq; NP_009015.1; NM_007084.3.
DR   SMR; Q9Y651; -.
DR   BioGrid; 116337; 3.
DR   IntAct; Q9Y651; 1.
DR   STRING; 9606.ENSP00000366144; -.
DR   iPTMnet; Q9Y651; -.
DR   PhosphoSitePlus; Q9Y651; -.
DR   BioMuta; SOX21; -.
DR   DMDM; 6831690; -.
DR   EPD; Q9Y651; -.
DR   jPOST; Q9Y651; -.
DR   MassIVE; Q9Y651; -.
DR   MaxQB; Q9Y651; -.
DR   PaxDb; Q9Y651; -.
DR   PeptideAtlas; Q9Y651; -.
DR   PRIDE; Q9Y651; -.
DR   ProteomicsDB; 86600; -.
DR   Antibodypedia; 24798; 177 antibodies.
DR   DNASU; 11166; -.
DR   Ensembl; ENST00000376945; ENSP00000366144; ENSG00000125285.
DR   GeneID; 11166; -.
DR   KEGG; hsa:11166; -.
DR   UCSC; uc001vma.4; human.
DR   CTD; 11166; -.
DR   DisGeNET; 11166; -.
DR   GeneCards; SOX21; -.
DR   HGNC; HGNC:11197; SOX21.
DR   HPA; ENSG00000125285; Tissue enhanced (brain, skin, stomach).
DR   MIM; 604974; gene.
DR   neXtProt; NX_Q9Y651; -.
DR   OpenTargets; ENSG00000125285; -.
DR   PharmGKB; PA36034; -.
DR   eggNOG; ENOG410IPZA; Eukaryota.
DR   eggNOG; ENOG4110UF6; LUCA.
DR   GeneTree; ENSGT00940000162795; -.
DR   HOGENOM; CLU_021123_3_1_1; -.
DR   InParanoid; Q9Y651; -.
DR   KO; K09267; -.
DR   OMA; MSKPMDH; -.
DR   OrthoDB; 1335452at2759; -.
DR   PhylomeDB; Q9Y651; -.
DR   TreeFam; TF351735; -.
DR   ChiTaRS; SOX21; human.
DR   GeneWiki; SOX21; -.
DR   GenomeRNAi; 11166; -.
DR   Pharos; Q9Y651; Tbio.
DR   PRO; PR:Q9Y651; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q9Y651; protein.
DR   Bgee; ENSG00000125285; Expressed in amygdala and 43 other tissues.
DR   Genevisible; Q9Y651; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0044798; C:nuclear transcription factor complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; IDA:UniProtKB.
DR   Gene3D; 1.10.30.10; -; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR022097; SOX_fam.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12336; SOXp; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Activator; DNA-binding; Nucleus; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..276
FT                   /note="Transcription factor SOX-21"
FT                   /id="PRO_0000048770"
FT   DNA_BIND        8..76
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   VARIANT         230
FT                   /note="G -> R (in dbSNP:rs6492735)"
FT                   /id="VAR_049562"
FT   CONFLICT        41
FT                   /note="R -> P (in Ref. 4; CAA50466)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83
FT                   /note="P -> T (in Ref. 4; CAA50466)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   276 AA;  28580 MW;  99DC899B7EC9A96B CRC64;
     MSKPVDHVKR PMNAFMVWSR AQRRKMAQEN PKMHNSEISK RLGAEWKLLT ESEKRPFIDE
     AKRLRAMHMK EHPDYKYRPR RKPKTLLKKD KFAFPVPYGL GGVADAEHPA LKAGAGLHAG
     AGGGLVPESL LANPEKAAAA AAAAAARVFF PQSAAAAAAA AAAAAAGSPY SLLDLGSKMA
     EISSSSSGLP YASSLGYPTA GAGAFHGAAA AAAAAAAAAG GHTHSHPSPG NPGYMIPCNC
     SAWPSPGLQP PLAYILLPGM GKPQLDPYPA AYAAAL
//
ID   Q4LE48_HUMAN            Unreviewed;      1275 AA.
AC   Q4LE48;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   26-FEB-2020, entry version 79.
DE   SubName: Full=STAG1 variant protein {ECO:0000313|EMBL:BAE06105.1};
DE   Flags: Fragment;
GN   Name=STAG1 variant protein {ECO:0000313|EMBL:BAE06105.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06105.1};
RN   [1] {ECO:0000313|EMBL:BAE06105.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M., Ohara R.,
RA   Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long cDNAs
RT   encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB210023; BAE06105.1; -; mRNA.
DR   RefSeq; NP_005853.2; NM_005862.2.
DR   PeptideAtlas; Q4LE48; -.
DR   PRIDE; Q4LE48; -.
DR   GeneID; 10274; -.
DR   KEGG; hsa:10274; -.
DR   CTD; 10274; -.
DR   eggNOG; KOG2011; Eukaryota.
DR   eggNOG; COG5537; LUCA.
DR   KO; K06671; -.
DR   OrthoDB; 167826at2759; -.
DR   ChiTaRS; STAG1; human.
DR   GenomeRNAi; 10274; -.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR039662; Cohesin_Scc3/SA.
DR   InterPro; IPR020839; SCD.
DR   InterPro; IPR013721; STAG.
DR   PANTHER; PTHR11199; PTHR11199; 1.
DR   Pfam; PF08514; STAG; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51425; SCD; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          313..398
FT                   /note="SCD"
FT                   /evidence="ECO:0000259|PROSITE:PS51425"
FT   REGION          25..101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1072..1113
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1146..1165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          277..307
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        38..52
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        66..81
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1074..1094
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAE06105.1"
SQ   SEQUENCE   1275 AA;  146339 MW;  670E3573E6ACBE74 CRC64;
     VVQHLIILLH CERTSPAMIT SELPVLQDST NETTAHSDAG SELEETEVKG KRKRGRPGRP
     PSTNKKPRKS PGEKSRIEAG IRGAGRGRAN GHPQQNGEGE PVTLFEVVKL GKSAMQSVVD
     DWIESYKQDR DIALLDLINF FIQCSGCRGT VRIEMFRNMQ NAEIIRKMTE EFDEDSGDYP
     LTMPGPQWKK FRSNFCEFIG VLIRQCQYSI IYDEYMMDTV ISLLTGLSDS QVRAFRHTST
     LAAMKLMTAL VNVALNLSIH QDNTQRQYEA ERNKMIGKRA NERLELLLQK RKELQENQDE
     IENMMNSIFK GIFVHRYRDA IAEIRAICIE EIGVWMKMYS DAFLNDSYLK YVGWTLHDRQ
     GEVRLKCLKA LQSLYTNREL FPKLELFTNR FKDRIVSMTL DKEYDVAVEA IRLVTLILHG
     SEEALSNEDC ENVYHLVYSA HRPVAVAAGE FLHKKLFSRH DPQAEEALAK RRGRNSPNGN
     LIRMLVLFFL ESELHEHAAY LVDSLWESSQ ELLKDWECMT ELLLEEPVQG EEAMSDRQES
     ALIELMVCTI RQAAEAHPPV GRGTGKRVLT AKERKTQIDD RNKLTEHFII TLPMLLSKYS
     ADAEKVANLL QIPQYFDLEI YSTGRMEKHL DALLKQIKFV VEKHVESDVL EACSKTYSIL
     CSEEYTIQNR VDIARSQLID EFVDRFNHSV EDLLQEGEEA DDDDIYNVLS TLKRLTSFHN
     AHDLTKWDLF GNCYRLLKTG IEHGAMPEQI VVQALQCSHY SILWQLVKIT DGSPSKEDLL
     VLRKTVKSFL AVCQQCLSNV NTPVKEQAFM LLCDLLMIFS HQLMTGGREG LQPLVFNPDT
     GLQSELLSFV MDHVFIDQDE ENQSMEGDEE DEANKIEALH KRRNLLAAFS KLIIYDIVDM
     HAAADIFKHY MKYYNDYGDI IKETLSKTRQ IDKIQCAKTL ILSLQQLFNE LVQEQGPNLD
     RTSAHVSGIK ELARRFALTF GLDQIKTREA VATLHKDGIE FAFKYQNQKG QEYPPPNLAF
     LEVLSEFSSK LLRQDKKTVH SYLEKFLTEQ MMERREDVWL PLISYRNSLV TGGEDDRMSV
     NSGSSSSKTS SVRNKKGRPP LHKKRVEDES LDNTWLNRTD TMIQTPGPLP APQLTSTVLR
     ENSRPMGDQI QEPESEHGSE PDFLHNPQMQ ISWLGQPKLE DLNRKDRTGM NYMKVRTGVR
     HAVRGLMEED AEPIFEDVMM SSRSQLEDMN EEFEDTMVID LPPSRNRRER AELRPDFFDS
     AAIIEDDSGF GMPMF
//
ID   STAG1_HUMAN             Reviewed;        1258 AA.
AC   Q8WVM7; O00539; Q6P275;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 3.
DT   22-APR-2020, entry version 170.
DE   RecName: Full=Cohesin subunit SA-1;
DE   AltName: Full=SCC3 homolog 1;
DE   AltName: Full=Stromal antigen 1;
GN   Name=STAG1; Synonyms=SA1, SCC3 {ECO:0000303|PubMed:22628566};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=9305759; DOI=10.1016/s0378-1119(97)00121-2;
RA   Carramolino L., Lee B.C., Zaballos A., Peled A., Barthelemy I.,
RA   Shav-Tal Y., Prieto I., Carmi P., Gothelf Y., Gonzalez de Buitrago G.,
RA   Aracil M., Marquez G., Barbero J.L., Zipori D.;
RT   "SA-1, a nuclear protein encoded by one member of a novel gene family:
RT   molecular cloning and detection in hemopoietic organs.";
RL   Gene 195:151-159(1997).
RN   [2]
RP   ERRATUM OF PUBMED:9305759.
RA   Carramolino L., Lee B.C., Zaballos A., Peled A., Barthelemy I.,
RA   Shav-Tal Y., Prieto I., Carmi P., Gothelf Y., Gonzalez de Buitrago G.,
RA   Aracil M., Marquez G., Barbero J.L., Zipori D.;
RL   Gene 206:283-286(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 787-1258 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC1A AND SMC3.
RX   PubMed=11076961; DOI=10.1083/jcb.151.4.749;
RA   Sumara I., Vorlaufer E., Gieffers C., Peters B.H., Peters J.-M.;
RT   "Characterization of vertebrate cohesin complexes and their regulation in
RT   prophase.";
RL   J. Cell Biol. 151:749-762(2000).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1062, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION IN A COHESIN COMPLEX WITH SMC1A; SMC3 AND RAD21.
RX   PubMed=22628566; DOI=10.1073/pnas.1206840109;
RA   Bermudez V.P., Farina A., Higashi T.L., Du F., Tappin I., Takahashi T.S.,
RA   Hurwitz J.;
RT   "In vitro loading of human cohesin on DNA by the human Scc2-Scc4 loader
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:9366-9371(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-756 AND SER-1093, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   INVOLVEMENT IN MRD47, AND VARIANTS MRD47 ARG-214; GLY-216; ARG-220;
RP   GLN-333; TRP-351; GLN-373; PRO-478 AND ARG-979.
RX   PubMed=28119487; DOI=10.1136/jmedgenet-2016-104468;
RA   Lehalle D., Mosca-Boidron A.L., Begtrup A., Boute-Benejean O., Charles P.,
RA   Cho M.T., Clarkson A., Devinsky O., Duffourd Y., Duplomb-Jego L.,
RA   Gerard B., Jacquette A., Kuentz P., Masurel-Paulet A., McDougall C.,
RA   Moutton S., Olivie H., Park S.M., Rauch A., Revencu N., Riviere J.B.,
RA   Rubin K., Simonic I., Shears D.J., Smol T., Taylor Tavares A.L., Terhal P.,
RA   Thevenon J., Van Gassen K., Vincent-Delorme C., Willemsen M.H.,
RA   Wilson G.N., Zackai E., Zweier C., Callier P., Thauvin-Robinet C.,
RA   Faivre L.;
RT   "STAG1 mutations cause a novel cohesinopathy characterised by unspecific
RT   syndromic intellectual disability.";
RL   J. Med. Genet. 54:479-488(2017).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1161, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [13]
RP   VARIANTS ILE-85 AND CYS-377.
RX   PubMed=30158690; DOI=10.1038/s41436-018-0085-6;
RG   DDD Study;
RA   Yuan B., Neira J., Pehlivan D., Santiago-Sim T., Song X., Rosenfeld J.,
RA   Posey J.E., Patel V., Jin W., Adam M.P., Baple E.L., Dean J., Fong C.T.,
RA   Hickey S.E., Hudgins L., Leon E., Madan-Khetarpal S., Rawlins L.,
RA   Rustad C.F., Stray-Pedersen A., Tveten K., Wenger O., Diaz J., Jenkins L.,
RA   Martin L., McGuire M., Pietryga M., Ramsdell L., Slattery L., Abid F.,
RA   Bertuch A.A., Grange D., Immken L., Schaaf C.P., Van Esch H., Bi W.,
RA   Cheung S.W., Breman A.M., Smith J.L., Shaw C., Crosby A.H., Eng C.,
RA   Yang Y., Lupski J.R., Xiao R., Liu P.;
RT   "Clinical exome sequencing reveals locus heterogeneity and phenotypic
RT   variability of cohesinopathies.";
RL   Genet. Med. 21:663-675(2019).
CC   -!- FUNCTION: Component of cohesin complex, a complex required for the
CC       cohesion of sister chromatids after DNA replication. The cohesin
CC       complex apparently forms a large proteinaceous ring within which sister
CC       chromatids can be trapped. At anaphase, the complex is cleaved and
CC       dissociates from chromatin, allowing sister chromatids to segregate.
CC       The cohesin complex may also play a role in spindle pole assembly
CC       during mitosis.
CC   -!- SUBUNIT: Cohesin complexes are composed of a heterodimer between a SMC1
CC       protein (SMC1A or SMC1B) and SMC3, which are attached via their hinge
CC       domain, and RAD21 which link them at their heads, and one STAG protein
CC       (STAG1, STAG2 or STAG3). In cohesin complexes, STAG1 is mutually
CC       exclusive with STAG2 and STAG3 (PubMed:11076961). Interacts directly
CC       with RAD21 in cohesin complex (By similarity). Found in a cohesin
CC       complex with SMC1A, SMC3 and RAD21 (PubMed:22628566).
CC       {ECO:0000250|UniProtKB:Q9DGN1, ECO:0000269|PubMed:11076961,
CC       ECO:0000269|PubMed:22628566}.
CC   -!- INTERACTION:
CC       Q8WVM7; Q29RF7: PDS5A; NbExp=3; IntAct=EBI-1175097, EBI-1175454;
CC       Q8WVM7; Q9NTI5: PDS5B; NbExp=4; IntAct=EBI-1175097, EBI-1175604;
CC       Q8WVM7; Q9UQE7: SMC3; NbExp=13; IntAct=EBI-1175097, EBI-80718;
CC       Q8WVM7; Q8N3U4: STAG2; NbExp=4; IntAct=EBI-1175097, EBI-1057252;
CC       Q8WVM7; P54274: TERF1; NbExp=4; IntAct=EBI-1175097, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere.
CC       Note=Associates with chromatin. Before prophase it is scattered along
CC       chromosome arms. During prophase, most of cohesin complexes dissociate
CC       from chromatin probably because of phosphorylation by PLK1, except at
CC       centromeres, where cohesin complexes remain. At anaphase, the RAD21
CC       subunit of cohesin is cleaved, leading to the dissociation of the
CC       complex from chromosomes, allowing chromosome separation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WVM7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WVM7-2; Sequence=VSP_054496;
CC   -!- PTM: Phosphorylated by PLK1. The large dissociation of cohesin from
CC       chromosome arms during prophase is partly due to its phosphorylation
CC       (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Mental retardation, autosomal dominant 47 (MRD47)
CC       [MIM:617635]: A form of mental retardation, a disorder characterized by
CC       significantly below average general intellectual functioning associated
CC       with impairments in adaptive behavior and manifested during the
CC       developmental period. MRD47 patients manifest developmental delay and
CC       mild to moderate intellectual disability, usually with delayed speech.
CC       {ECO:0000269|PubMed:28119487}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SCC3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z75330; CAA99731.1; -; mRNA.
DR   EMBL; AC069514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117382; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017735; AAH17735.1; -; mRNA.
DR   EMBL; BC064699; AAH64699.1; -; mRNA.
DR   CCDS; CCDS3090.1; -. [Q8WVM7-1]
DR   RefSeq; NP_005853.2; NM_005862.2. [Q8WVM7-1]
DR   PDB; 5QSM; X-ray; 2.74 A; A/B=459-915.
DR   PDB; 5QSN; X-ray; 2.66 A; A/B=459-915.
DR   PDB; 5QSO; X-ray; 2.70 A; A/B=457-900.
DR   PDB; 5QSP; X-ray; 2.89 A; A/B=457-900.
DR   PDB; 5QSQ; X-ray; 2.48 A; A/B=459-915.
DR   PDB; 5QSR; X-ray; 3.28 A; A/B=459-915.
DR   PDB; 5QSS; X-ray; 3.08 A; A/B=459-915.
DR   PDB; 5QST; X-ray; 2.58 A; A/B/C/D=86-420.
DR   PDB; 5QSU; X-ray; 2.73 A; A/B/C/D=86-420.
DR   PDB; 5QSV; X-ray; 2.76 A; A/B/C/D=86-420.
DR   PDB; 5QSW; X-ray; 3.03 A; A/B/C/D=86-420.
DR   PDB; 5QSX; X-ray; 2.34 A; A/B/C/D=86-420.
DR   PDB; 5QSY; X-ray; 2.40 A; A/B=459-915.
DR   PDB; 5QSZ; X-ray; 3.08 A; A/B=459-915.
DR   PDB; 6QB5; X-ray; 2.02 A; A/B/C/D=86-420.
DR   PDB; 6R7O; X-ray; 2.31 A; A/B=459-915.
DR   PDB; 6RRC; X-ray; 2.37 A; A/C=86-420.
DR   PDB; 6RRK; X-ray; 3.17 A; A/B=459-915.
DR   PDBsum; 5QSM; -.
DR   PDBsum; 5QSN; -.
DR   PDBsum; 5QSO; -.
DR   PDBsum; 5QSP; -.
DR   PDBsum; 5QSQ; -.
DR   PDBsum; 5QSR; -.
DR   PDBsum; 5QSS; -.
DR   PDBsum; 5QST; -.
DR   PDBsum; 5QSU; -.
DR   PDBsum; 5QSV; -.
DR   PDBsum; 5QSW; -.
DR   PDBsum; 5QSX; -.
DR   PDBsum; 5QSY; -.
DR   PDBsum; 5QSZ; -.
DR   PDBsum; 6QB5; -.
DR   PDBsum; 6R7O; -.
DR   PDBsum; 6RRC; -.
DR   PDBsum; 6RRK; -.
DR   SMR; Q8WVM7; -.
DR   BioGrid; 115564; 38.
DR   CORUM; Q8WVM7; -.
DR   DIP; DIP-35421N; -.
DR   IntAct; Q8WVM7; 34.
DR   MINT; Q8WVM7; -.
DR   STRING; 9606.ENSP00000372689; -.
DR   iPTMnet; Q8WVM7; -.
DR   PhosphoSitePlus; Q8WVM7; -.
DR   BioMuta; STAG1; -.
DR   DMDM; 209572720; -.
DR   EPD; Q8WVM7; -.
DR   jPOST; Q8WVM7; -.
DR   MassIVE; Q8WVM7; -.
DR   MaxQB; Q8WVM7; -.
DR   PaxDb; Q8WVM7; -.
DR   PeptideAtlas; Q8WVM7; -.
DR   PRIDE; Q8WVM7; -.
DR   ProteomicsDB; 66881; -.
DR   ProteomicsDB; 74804; -. [Q8WVM7-1]
DR   Antibodypedia; 17829; 247 antibodies.
DR   Ensembl; ENST00000236698; ENSP00000236698; ENSG00000118007. [Q8WVM7-2]
DR   Ensembl; ENST00000383202; ENSP00000372689; ENSG00000118007. [Q8WVM7-1]
DR   GeneID; 10274; -.
DR   KEGG; hsa:10274; -.
DR   UCSC; uc003era.2; human. [Q8WVM7-1]
DR   CTD; 10274; -.
DR   DisGeNET; 10274; -.
DR   GeneCards; STAG1; -.
DR   HGNC; HGNC:11354; STAG1.
DR   HPA; ENSG00000118007; Low tissue specificity.
DR   MalaCards; STAG1; -.
DR   MIM; 604358; gene.
DR   MIM; 617635; phenotype.
DR   neXtProt; NX_Q8WVM7; -.
DR   OpenTargets; ENSG00000118007; -.
DR   Orphanet; 502434; STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome.
DR   PharmGKB; PA36176; -.
DR   eggNOG; KOG2011; Eukaryota.
DR   eggNOG; COG5537; LUCA.
DR   GeneTree; ENSGT00950000182972; -.
DR   HOGENOM; CLU_005067_1_0_1; -.
DR   InParanoid; Q8WVM7; -.
DR   KO; K06671; -.
DR   OMA; EAMPEKY; -.
DR   PhylomeDB; Q8WVM7; -.
DR   TreeFam; TF314604; -.
DR   Reactome; R-HSA-1221632; Meiotic synapsis.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2468052; Establishment of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-2470946; Cohesin Loading onto Chromatin.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   ChiTaRS; STAG1; human.
DR   GeneWiki; STAG1; -.
DR   GenomeRNAi; 10274; -.
DR   Pharos; Q8WVM7; Tbio.
DR   PRO; PR:Q8WVM7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8WVM7; protein.
DR   Bgee; ENSG00000118007; Expressed in intestine and 231 other tissues.
DR   ExpressionAtlas; Q8WVM7; baseline and differential.
DR   Genevisible; Q8WVM7; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; TAS:Reactome.
DR   GO; GO:0000775; C:chromosome, centromeric region; TAS:Reactome.
DR   GO; GO:0008278; C:cohesin complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0097431; C:mitotic spindle pole; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1901673; P:regulation of mitotic spindle assembly; IMP:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; IBA:GO_Central.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR039662; Cohesin_Scc3/SA.
DR   InterPro; IPR020839; SCD.
DR   InterPro; IPR013721; STAG.
DR   PANTHER; PTHR11199; PTHR11199; 1.
DR   Pfam; PF08514; STAG; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51425; SCD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division; Centromere;
KW   Chromosome; Chromosome partition; Disease mutation; Isopeptide bond;
KW   Mental retardation; Mitosis; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..1258
FT                   /note="Cohesin subunit SA-1"
FT                   /id="PRO_0000120182"
FT   DOMAIN          296..381
FT                   /note="SCD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00750"
FT   COMPBIAS        684..687
FT                   /note="Poly-Asp"
FT   COMPBIAS        1065..1070
FT                   /note="Poly-Ser"
FT   MOD_RES         24
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         756
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1062
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1065
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D3E6"
FT   MOD_RES         1093
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        1161
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1150..1186
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054496"
FT   VARIANT         85
FT                   /note="V -> I (found in a patient with cohesinopathy;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:30158690"
FT                   /id="VAR_082291"
FT   VARIANT         214
FT                   /note="Q -> R (in MRD47; dbSNP:rs1553738694)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079487"
FT   VARIANT         216
FT                   /note="R -> G (in MRD47; dbSNP:rs1553738686)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079488"
FT   VARIANT         220
FT                   /note="H -> R (in MRD47; dbSNP:rs1057519153)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079489"
FT   VARIANT         333
FT                   /note="K -> Q (in MRD47; dbSNP:rs1553728634)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079490"
FT   VARIANT         351
FT                   /note="L -> W (in MRD47; dbSNP:rs1553727865)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079491"
FT   VARIANT         373
FT                   /note="R -> Q (in MRD47; dbSNP:rs1376334317)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079492"
FT   VARIANT         377
FT                   /note="R -> C (found in a patient with cohesinopathy)"
FT                   /evidence="ECO:0000269|PubMed:30158690"
FT                   /id="VAR_082292"
FT   VARIANT         478
FT                   /note="H -> P (in MRD47; dbSNP:rs1553722309)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079493"
FT   VARIANT         979
FT                   /note="K -> R (in MRD47; dbSNP:rs1471479119)"
FT                   /evidence="ECO:0000269|PubMed:28119487"
FT                   /id="VAR_079494"
FT   VARIANT         1132
FT                   /note="Q -> H (in dbSNP:rs34149860)"
FT                   /id="VAR_046968"
FT   CONFLICT        645
FT                   /note="S -> N (in Ref. 1; CAA99731)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        702
FT                   /note="H -> Q (in Ref. 1; CAA99731)"
FT                   /evidence="ECO:0000305"
FT   HELIX           87..93
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           97..111
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           113..127
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           136..141
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           144..152
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   STRAND          158..160
FT                   /evidence="ECO:0000244|PDB:6RRC"
FT   HELIX           163..165
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   TURN            170..173
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           174..189
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   TURN            190..192
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           193..195
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   STRAND          196..198
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           199..211
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           216..255
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   TURN            259..261
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           265..294
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           296..299
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   STRAND          302..304
FT                   /evidence="ECO:0000244|PDB:6RRC"
FT   HELIX           305..321
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           323..326
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           329..338
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           344..358
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           361..367
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           368..380
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           381..383
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           387..403
FT                   /evidence="ECO:0000244|PDB:6QB5"
FT   HELIX           405..407
FT                   /evidence="ECO:0000244|PDB:6RRC"
FT   HELIX           410..416
FT                   /evidence="ECO:0000244|PDB:6RRC"
FT   HELIX           460..474
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           478..480
FT                   /evidence="ECO:0000244|PDB:6RRK"
FT   HELIX           481..496
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           499..507
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           519..538
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   TURN            543..545
FT                   /evidence="ECO:0000244|PDB:5QSR"
FT   HELIX           554..581
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   TURN            582..584
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           586..592
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           596..598
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           603..606
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           610..626
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           630..643
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           648..677
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   TURN            680..682
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           685..701
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   TURN            702..704
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           707..709
FT                   /evidence="ECO:0000244|PDB:5QSS"
FT   HELIX           712..725
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           731..754
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           759..779
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   STRAND          782..784
FT                   /evidence="ECO:0000244|PDB:5QSQ"
FT   HELIX           785..801
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           804..807
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   TURN            808..810
FT                   /evidence="ECO:0000244|PDB:6RRK"
FT   HELIX           812..817
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           823..836
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           856..877
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           883..893
FT                   /evidence="ECO:0000244|PDB:6R7O"
FT   HELIX           895..909
FT                   /evidence="ECO:0000244|PDB:6R7O"
SQ   SEQUENCE   1258 AA;  144427 MW;  FAF911998EC52179 CRC64;
     MITSELPVLQ DSTNETTAHS DAGSELEETE VKGKRKRGRP GRPPSTNKKP RKSPGEKSRI
     EAGIRGAGRG RANGHPQQNG EGEPVTLFEV VKLGKSAMQS VVDDWIESYK QDRDIALLDL
     INFFIQCSGC RGTVRIEMFR NMQNAEIIRK MTEEFDEDSG DYPLTMPGPQ WKKFRSNFCE
     FIGVLIRQCQ YSIIYDEYMM DTVISLLTGL SDSQVRAFRH TSTLAAMKLM TALVNVALNL
     SIHQDNTQRQ YEAERNKMIG KRANERLELL LQKRKELQEN QDEIENMMNS IFKGIFVHRY
     RDAIAEIRAI CIEEIGVWMK MYSDAFLNDS YLKYVGWTLH DRQGEVRLKC LKALQSLYTN
     RELFPKLELF TNRFKDRIVS MTLDKEYDVA VEAIRLVTLI LHGSEEALSN EDCENVYHLV
     YSAHRPVAVA AGEFLHKKLF SRHDPQAEEA LAKRRGRNSP NGNLIRMLVL FFLESELHEH
     AAYLVDSLWE SSQELLKDWE CMTELLLEEP VQGEEAMSDR QESALIELMV CTIRQAAEAH
     PPVGRGTGKR VLTAKERKTQ IDDRNKLTEH FIITLPMLLS KYSADAEKVA NLLQIPQYFD
     LEIYSTGRME KHLDALLKQI KFVVEKHVES DVLEACSKTY SILCSEEYTI QNRVDIARSQ
     LIDEFVDRFN HSVEDLLQEG EEADDDDIYN VLSTLKRLTS FHNAHDLTKW DLFGNCYRLL
     KTGIEHGAMP EQIVVQALQC SHYSILWQLV KITDGSPSKE DLLVLRKTVK SFLAVCQQCL
     SNVNTPVKEQ AFMLLCDLLM IFSHQLMTGG REGLQPLVFN PDTGLQSELL SFVMDHVFID
     QDEENQSMEG DEEDEANKIE ALHKRRNLLA AFSKLIIYDI VDMHAAADIF KHYMKYYNDY
     GDIIKETLSK TRQIDKIQCA KTLILSLQQL FNELVQEQGP NLDRTSAHVS GIKELARRFA
     LTFGLDQIKT REAVATLHKD GIEFAFKYQN QKGQEYPPPN LAFLEVLSEF SSKLLRQDKK
     TVHSYLEKFL TEQMMERRED VWLPLISYRN SLVTGGEDDR MSVNSGSSSS KTSSVRNKKG
     RPPLHKKRVE DESLDNTWLN RTDTMIQTPG PLPAPQLTST VLRENSRPMG DQIQEPESEH
     GSEPDFLHNP QMQISWLGQP KLEDLNRKDR TGMNYMKVRT GVRHAVRGLM EEDAEPIFED
     VMMSSRSQLE DMNEEFEDTM VIDLPPSRNR RERAELRPDF FDSAAIIEDD SGFGMPMF
//
ID   A0A024RBD7_HUMAN        Unreviewed;       712 AA.
AC   A0A024RBD7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 59.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase {ECO:0000256|RuleBase:RU366025};
DE            EC=3.4.19.12 {ECO:0000256|RuleBase:RU366025};
GN   Name=USP44 {ECO:0000313|EMBL:EAW97542.1};
GN   ORFNames=hCG_1642341 {ECO:0000313|EMBL:EAW97542.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW97542.1};
RN   [1] {ECO:0000313|EMBL:EAW97542.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97542.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Deubiquitinating enzyme that removes conjugated ubiquitin
CC       from specific proteins to regulate different cellular processes.
CC       {ECO:0000256|RuleBase:RU366025}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000256|RuleBase:RU366025,
CC         ECO:0000256|SAAS:SAAS01117307};
CC   -!- SIMILARITY: Belongs to the peptidase C19 family.
CC       {ECO:0000256|RuleBase:RU366025, ECO:0000256|SAAS:SAAS01045498}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471054; EAW97540.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97541.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97542.1; -; Genomic_DNA.
DR   RefSeq; NP_001035862.1; NM_001042403.2.
DR   RefSeq; NP_001265322.1; NM_001278393.1.
DR   RefSeq; NP_001334865.1; NM_001347936.1.
DR   RefSeq; NP_001334866.1; NM_001347937.1.
DR   RefSeq; NP_115523.2; NM_032147.4.
DR   RefSeq; XP_016875499.1; XM_017020010.1.
DR   Antibodypedia; 17590; 267 antibodies.
DR   GeneID; 84101; -.
DR   KEGG; hsa:84101; -.
DR   CTD; 84101; -.
DR   EuPathDB; HostDB:ENSG00000136014.11; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   HOGENOM; CLU_008279_13_1_1; -.
DR   KO; K11834; -.
DR   OMA; SRNMELI; -.
DR   OrthoDB; 1230415at2759; -.
DR   ChiTaRS; USP44; human.
DR   GenomeRNAi; 84101; -.
DR   Bgee; ENSG00000136014; Expressed in secondary oocyte and 101 other tissues.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007059; P:chromosome segregation; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016579; P:protein deubiquitination; IEA:UniProtKB-UniRule.
DR   GO; GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   3: Inferred from homology;
KW   Hydrolase {ECO:0000256|RuleBase:RU366025, ECO:0000256|SAAS:SAAS01044269};
KW   Metal-binding {ECO:0000256|SAAS:SAAS01044352};
KW   Protease {ECO:0000256|RuleBase:RU366025, ECO:0000256|SAAS:SAAS01044269};
KW   Thiol protease {ECO:0000256|RuleBase:RU366025,
KW   ECO:0000256|SAAS:SAAS01044269};
KW   Ubl conjugation pathway {ECO:0000256|RuleBase:RU366025,
KW   ECO:0000256|SAAS:SAAS01044331}; Zinc {ECO:0000256|SAAS:SAAS01044352};
KW   Zinc-finger {ECO:0000256|SAAS:SAAS01044352}.
FT   DOMAIN          27..88
FT                   /note="UBP-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50271"
FT   DOMAIN          273..678
FT                   /note="USP"
FT                   /evidence="ECO:0000259|PROSITE:PS50235"
FT   ZN_FING         27..88
FT                   /note="UBP-type"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00502"
FT   REGION          690..712
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   712 AA;  81185 MW;  A8211DFAD78EE731 CRC64;
     MLAMDTCKHV GQLQLAQDHS SLNPQKWHCV DCNTTESIWA CLSCSHVACG RYIEEHALKH
     FQESSHPVAL EVNEMYVFCY LCDDYVLNDN TTGDLKLLRR TLSAIKSQNY HCTTRSGRFL
     RSMGTGDDSY FLHDGAQSLL QSEDQLYTAL WHRRRILMGK IFRTWFEQSP IGRKKQEEPF
     QEKIVVKREV KKRRQELEYQ VKAELESMPP RKSLRLQGLA QSTIIEIVSV QVPAQTPASP
     AKDKVLSTSE NEISQKVSDS SVKRRPIVTP GVTGLRNLGN TCYMNSVLQV LSHLLIFRQC
     FLKLDLNQWL AMTASEKTRS CKHPPVTDTV VYQMNECQEK DTGFVCSRQS SLSSGLSGGA
     SKGRKMELIQ PKEPTSQYIS LCHELHTLFQ VMWSGKWALV SPFAMLHSVW RLIPAFRGYA
     QQDAQEFLCE LLDKIQRELE TTGTSLPALI PTSQRKLIKQ VLNVVNNIFH GQLLSQVTCL
     ACDNKSNTIE PFWDLSLEFP ERYQCSGKDI ASQPCLVTEM LAKFTETEAL EGKIYVCDQC
     NSKRRRFSSK PVVLTEAQKQ LMICHLPQVL RLHLKRFRWS GRNNREKIGV HVGFEEILNM
     EPYCCRETLK SLRPECFIYD LSAVVMHHGK GFGSGHYTAY CYNSEGGFWV HCNDSKLSMC
     TMDEVCKAQA YILFYTQRVT ENGHSKLLPP ELLLGSQHPN EDADTSSNEI LS
//
ID   UBP44_HUMAN             Reviewed;         712 AA.
AC   Q9H0E7; B2RDW3;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   22-APR-2020, entry version 159.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 44;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 44;
DE   AltName: Full=Ubiquitin thioesterase 44;
DE   AltName: Full=Ubiquitin-specific-processing protease 44;
GN   Name=USP44;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-91.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND ENZYME ACTIVITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C., Cal S.,
RA   Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION, DEVELOPMENTAL STAGE, AND
RP   MUTAGENESIS OF CYS-282.
RX   PubMed=17443180; DOI=10.1038/nature05694;
RA   Stegmeier F., Rape M., Draviam V.M., Nalepa G., Sowa M.E., Ang X.L.,
RA   McDonald E.R. III, Li M.Z., Hannon G.J., Sorger P.K., Kirschner M.W.,
RA   Harper J.W., Elledge S.J.;
RT   "Anaphase initiation is regulated by antagonistic ubiquitination and
RT   deubiquitination activities.";
RL   Nature 446:876-881(2007).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, UBIQUITINATION, AND MUTAGENESIS
RP   OF CYS-282.
RX   PubMed=20402667; DOI=10.1042/cbi20090144;
RA   Suresh B., Ramakrishna S., Lee H.J., Choi J.H., Kim J.Y., Ahn W.S.,
RA   Baek K.H.;
RT   "K48- and K63-linked polyubiquitination of deubiquitinating enzyme USP44.";
RL   Cell Biol. Int. 34:799-808(2010).
RN   [8]
RP   INDUCTION.
RX   PubMed=20505756; DOI=10.1371/journal.pone.0010709;
RA   Jung M., Peterson H., Chavez L., Kahlem P., Lehrach H., Vilo J., Adjaye J.;
RT   "A data integration approach to mapping OCT4 gene regulatory networks
RT   operative in embryonic stem cells and embryonal carcinoma cells.";
RL   PLoS ONE 5:E10709-E10709(2010).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=21853124; DOI=10.1371/journal.pone.0023389;
RA   Zhang Y., van Deursen J., Galardy P.J.;
RT   "Overexpression of ubiquitin specific protease 44 (USP44) induces
RT   chromosomal instability and is frequently observed in human T-cell
RT   leukemia.";
RL   PLoS ONE 6:E23389-E23389(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=22681888; DOI=10.1016/j.molcel.2012.05.023;
RA   Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S.,
RA   Golomb L., Pribluda A., Zhang F., Haj-Yahya M., Feldmesser E., Brik A.,
RA   Yu X., Hanna J., Aberdam D., Domany E., Oren M.;
RT   "RNF20 and USP44 regulate stem cell differentiation by modulating H2B
RT   monoubiquitylation.";
RL   Mol. Cell 46:662-673(2012).
RN   [11]
RP   PHOSPHORYLATION AT SER-169; SER-239; THR-269 AND SER-401, AND
RP   DEPHOSPHORYLATION.
RX   PubMed=22692537; DOI=10.1038/ncomms1886;
RA   Visconti R., Palazzo L., Della Monica R., Grieco D.;
RT   "Fcp1-dependent dephosphorylation is required for M-phase-promoting factor
RT   inactivation at mitosis exit.";
RL   Nat. Commun. 3:894-894(2012).
CC   -!- FUNCTION: Deubiquitinase that plays a key regulatory role in the
CC       spindle assembly checkpoint or mitotic checkpoint by preventing
CC       premature anaphase onset. Acts by specifically mediating
CC       deubiquitination of CDC20, a negative regulator of the anaphase
CC       promoting complex/cyclosome (APC/C). Deubiquitination of CDC20 leads to
CC       stabilize the MAD2L1-CDC20-APC/C ternary complex (also named mitotic
CC       checkpoint complex), thereby preventing premature activation of the
CC       APC/C. Promotes association of MAD2L1 with CDC20 and reinforces the
CC       spindle assembly checkpoint. Acts as a negative regulator of histone
CC       H2B (H2BK120ub1) ubiquitination. {ECO:0000269|PubMed:17443180,
CC       ECO:0000269|PubMed:22681888}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:14715245,
CC         ECO:0000269|PubMed:17443180, ECO:0000269|PubMed:20402667};
CC   -!- INTERACTION:
CC       Q9H0E7; P41208: CETN2; NbExp=2; IntAct=EBI-2512823, EBI-1789926;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20402667}. Note=Peaks
CC       in interphase, with relatively low levels maintained throughout
CC       mitosis. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis. Expressed at high levels in T-
CC       cell acute lymphoblastic leukemia. {ECO:0000269|PubMed:14715245,
CC       ECO:0000269|PubMed:21853124}.
CC   -!- DEVELOPMENTAL STAGE: Elevated in mitosis; levels increase in mitotic
CC       cells and rapidly decrease once cells have completed chromosome
CC       attachment and exit from mitosis. {ECO:0000269|PubMed:17443180}.
CC   -!- INDUCTION: Transcriptionally regulated by POU5F1/OCT4 in embryonic stem
CC       cells and embryonal carcinoma cells. {ECO:0000269|PubMed:20505756}.
CC   -!- PTM: Dephosphorylated by CTDP1.
CC   -!- PTM: Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitination and is degraded by the proteasome.
CC       {ECO:0000269|PubMed:20402667}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP44 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136825; CAB66759.1; -; mRNA.
DR   EMBL; AK315697; BAG38060.1; -; mRNA.
DR   EMBL; AC018475; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030704; AAH30704.1; -; mRNA.
DR   CCDS; CCDS9053.1; -.
DR   RefSeq; NP_001035862.1; NM_001042403.2.
DR   RefSeq; NP_001265322.1; NM_001278393.1.
DR   RefSeq; NP_001334865.1; NM_001347936.1.
DR   RefSeq; NP_001334866.1; NM_001347937.1.
DR   RefSeq; NP_115523.2; NM_032147.4.
DR   RefSeq; XP_016875499.1; XM_017020010.1.
DR   SMR; Q9H0E7; -.
DR   BioGrid; 123890; 23.
DR   IntAct; Q9H0E7; 11.
DR   STRING; 9606.ENSP00000258499; -.
DR   MEROPS; C19.057; -.
DR   iPTMnet; Q9H0E7; -.
DR   PhosphoSitePlus; Q9H0E7; -.
DR   BioMuta; USP44; -.
DR   DMDM; 300669621; -.
DR   EPD; Q9H0E7; -.
DR   MassIVE; Q9H0E7; -.
DR   PaxDb; Q9H0E7; -.
DR   PeptideAtlas; Q9H0E7; -.
DR   PRIDE; Q9H0E7; -.
DR   ProteomicsDB; 80264; -.
DR   Antibodypedia; 17590; 267 antibodies.
DR   DNASU; 84101; -.
DR   Ensembl; ENST00000258499; ENSP00000258499; ENSG00000136014.
DR   Ensembl; ENST00000393091; ENSP00000376806; ENSG00000136014.
DR   Ensembl; ENST00000537435; ENSP00000442629; ENSG00000136014.
DR   GeneID; 84101; -.
DR   KEGG; hsa:84101; -.
DR   UCSC; uc001teg.5; human.
DR   CTD; 84101; -.
DR   DisGeNET; 84101; -.
DR   GeneCards; USP44; -.
DR   HGNC; HGNC:20064; USP44.
DR   HPA; ENSG00000136014; Tissue enhanced (testis).
DR   MIM; 610993; gene.
DR   neXtProt; NX_Q9H0E7; -.
DR   OpenTargets; ENSG00000136014; -.
DR   PharmGKB; PA134931457; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00940000160526; -.
DR   HOGENOM; CLU_008279_13_1_1; -.
DR   InParanoid; Q9H0E7; -.
DR   KO; K11834; -.
DR   OMA; SRNMELI; -.
DR   OrthoDB; 1230415at2759; -.
DR   PhylomeDB; Q9H0E7; -.
DR   TreeFam; TF315281; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP44; human.
DR   GeneWiki; USP44; -.
DR   GenomeRNAi; 84101; -.
DR   Pharos; Q9H0E7; Tbio.
DR   PRO; PR:Q9H0E7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9H0E7; protein.
DR   Bgee; ENSG00000136014; Expressed in secondary oocyte and 101 other tissues.
DR   ExpressionAtlas; Q9H0E7; baseline and differential.
DR   Genevisible; Q9H0E7; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IMP:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IEA:Ensembl.
DR   GO; GO:1904667; P:negative regulation of ubiquitin protein ligase activity; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; ISS:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Hydrolase; Metal-binding; Mitosis; Nucleus;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome; Thiol protease;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..712
FT                   /note="Ubiquitin carboxyl-terminal hydrolase 44"
FT                   /id="PRO_0000080673"
FT   DOMAIN          273..678
FT                   /note="USP"
FT   ZN_FING         27..88
FT                   /note="UBP-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00502"
FT   ACT_SITE        282
FT                   /note="Nucleophile"
FT   ACT_SITE        636
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:22692537"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:22692537"
FT   MOD_RES         269
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000305|PubMed:22692537"
FT   MOD_RES         401
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:22692537"
FT   VARIANT         91
FT                   /note="T -> A (in dbSNP:rs3812813)"
FT                   /evidence="ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_017125"
FT   VARIANT         316
FT                   /note="E -> Q (in dbSNP:rs7305024)"
FT                   /id="VAR_057043"
FT   VARIANT         348
FT                   /note="R -> G (in dbSNP:rs7135642)"
FT                   /id="VAR_057044"
FT   MUTAGEN         282
FT                   /note="C->S,A: Abolishes deubiquitinase activity."
FT                   /evidence="ECO:0000269|PubMed:17443180,
FT                   ECO:0000269|PubMed:20402667"
SQ   SEQUENCE   712 AA;  81185 MW;  A8211DFAD78EE731 CRC64;
     MLAMDTCKHV GQLQLAQDHS SLNPQKWHCV DCNTTESIWA CLSCSHVACG RYIEEHALKH
     FQESSHPVAL EVNEMYVFCY LCDDYVLNDN TTGDLKLLRR TLSAIKSQNY HCTTRSGRFL
     RSMGTGDDSY FLHDGAQSLL QSEDQLYTAL WHRRRILMGK IFRTWFEQSP IGRKKQEEPF
     QEKIVVKREV KKRRQELEYQ VKAELESMPP RKSLRLQGLA QSTIIEIVSV QVPAQTPASP
     AKDKVLSTSE NEISQKVSDS SVKRRPIVTP GVTGLRNLGN TCYMNSVLQV LSHLLIFRQC
     FLKLDLNQWL AMTASEKTRS CKHPPVTDTV VYQMNECQEK DTGFVCSRQS SLSSGLSGGA
     SKGRKMELIQ PKEPTSQYIS LCHELHTLFQ VMWSGKWALV SPFAMLHSVW RLIPAFRGYA
     QQDAQEFLCE LLDKIQRELE TTGTSLPALI PTSQRKLIKQ VLNVVNNIFH GQLLSQVTCL
     ACDNKSNTIE PFWDLSLEFP ERYQCSGKDI ASQPCLVTEM LAKFTETEAL EGKIYVCDQC
     NSKRRRFSSK PVVLTEAQKQ LMICHLPQVL RLHLKRFRWS GRNNREKIGV HVGFEEILNM
     EPYCCRETLK SLRPECFIYD LSAVVMHHGK GFGSGHYTAY CYNSEGGFWV HCNDSKLSMC
     TMDEVCKAQA YILFYTQRVT ENGHSKLLPP ELLLGSQHPN EDADTSSNEI LS
//
ID   F8W9F9_HUMAN            Unreviewed;      2217 AA.
AC   F8W9F9;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   22-APR-2020, entry version 69.
DE   SubName: Full=Serine/threonine-protein kinase WNK2 {ECO:0000313|Ensembl:ENSP00000378860};
GN   Name=WNK2 {ECO:0000313|Ensembl:ENSP00000378860};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000378860, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000378860, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000378860}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL354991; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390760; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_006639.3; NM_006648.3.
DR   RefSeq; XP_005252198.1; XM_005252141.2.
DR   iPTMnet; F8W9F9; -.
DR   jPOST; F8W9F9; -.
DR   MaxQB; F8W9F9; -.
DR   PeptideAtlas; F8W9F9; -.
DR   PRIDE; F8W9F9; -.
DR   ProteomicsDB; 30320; -.
DR   Antibodypedia; 28371; 159 antibodies.
DR   Ensembl; ENST00000395477; ENSP00000378860; ENSG00000165238.
DR   GeneID; 65268; -.
DR   UCSC; uc004atj.3; human.
DR   CTD; 65268; -.
DR   EuPathDB; HostDB:ENSG00000165238.16; -.
DR   HGNC; HGNC:14542; WNK2.
DR   OpenTargets; ENSG00000165238; -.
DR   eggNOG; KOG0584; Eukaryota.
DR   eggNOG; ENOG410XQWZ; LUCA.
DR   GeneTree; ENSGT00940000157161; -.
DR   HOGENOM; CLU_000550_3_0_1; -.
DR   OrthoDB; 27514at2759; -.
DR   SignaLink; F8W9F9; -.
DR   ChiTaRS; WNK2; human.
DR   GenomeRNAi; 65268; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165238; Expressed in apex of heart and 180 other tissues.
DR   ExpressionAtlas; F8W9F9; baseline and differential.
DR   Genevisible; F8W9F9; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|MaxQB:F8W9F9,
KW   ECO:0000213|PeptideAtlas:F8W9F9, ECO:0000213|ProteomicsDB:F8W9F9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          195..453
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000259|PROSITE:PS50011"
FT   REGION          1..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          89..183
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          579..630
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          699..751
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          917..1022
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1117..1185
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1262..1297
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1323..1443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1455..1547
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1584..1828
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1933..1953
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1974..1998
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2086..2105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2160..2217
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1894..1925
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        146..172
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..630
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        705..751
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        939..1009
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1117..1148
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1165..1179
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1275..1297
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1324..1338
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1339..1373
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1374..1390
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1406..1435
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1471..1496
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1517..1534
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1635..1650
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1733..1761
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2217 AA;  234380 MW;  60E5F2982D5235A1 CRC64;
     MDGDGGRRDV PGTLMEPGRG AGPAGMAEPR AKAARPGPQR FLRRSVVESD QEEPPGLEAA
     EAPGPQPPQP LQRRVLLLCK TRRLIAERAR GRPAAPAPAA LVAQPGAPGA PADAGPEPVG
     TQEPGPDPIA AAVETAPAPD GGPREEAAAT VRKEDEGAAE AKPEPGRTRR DEPEEEEDDE
     DDLKAVATSL DGRFLKFDIE LGRGSFKTVY KGLDTETWVE VAWCELQDRK LTKLERQRFK
     EEAEMLKGLQ HPNIVRFYDF WESSAKGKRC IVLVTELMTS GTLKTYLKRF KVMKPKVLRS
     WCRQILKGLL FLHTRTPPII HRDLKCDNIF ITGPTGSVKI GDLGLATLKR ASFAKSVIGT
     PEFMAPEMYE EHYDESVDVY AFGMCMLEMA TSEYPYSECQ NAAQIYRKVT CGIKPASFEK
     VHDPEIKEII GECICKNKEE RYEIKDLLSH AFFAEDTGVR VELAEEDHGR KSTIALRLWV
     EDPKKLKGKP KDNGAIEFTF DLEKETPDEV AQEMIESGFF HESDVKIVAK SIRDRVALIQ
     WRRERIWPAL QPKEQQDVGS PDKARGPPVP LQVQVTYHAQ AGQPGPPEPE EPEADQHLLP
     PTLPTSATSL ASDSTFDSGQ GSTVYSDSQS SQQSVMLGSL ADAAPSPAQC VCSPPVSEGP
     VLPQSLPSLG AYQQPTAAPG LPVGSVPAPA CPPSLQQHFP DPAMSFAPVL PPPSTPMPTG
     PGQPAPPGQQ PPPLAQPTPL PQVLAPQPVV PLQPVPPHLP PYLAPASQVG APAQLKPLQM
     PQAPLQPLAQ VPPQMPPIPV VPPITPLAGI DGLPPALPDL PTATVPPVPP PQYFSPAVIL
     PSLAAPLPPA SPALPLQAVK LPHPPGAPLA MPCRTIVPNA PATIPLLAVA PPGVAALSIH
     SAVAQLPGQP VYPAAFPQMA PTDVPPSPHH TVQNMRATPP QPALPPQPTL PPQPVLPPQP
     TLPPQPVLPP QPTRPPQPVL PPQPMLPPQP VLPPQPALPV RPEPLQPHLP EQAAPAATPG
     SQILLGHPAP YAVDVAAQVP TVPVPPAAVL SPPLPEVLLP AAPELLPQFP SSLATVSASV
     QSVPTQTATL LPPANPPLPG GPGIASPCPT VQLTVEPVQE EQASQDKPPG LPQSCESYGG
     SDVTSGKELS DSCEGAFGGG RLEGRAARKH HRRSTRARSR QERASRPRLT ILNVCNTGDK
     MVECQLETHN HKMVTFKFDL DGDAPDEIAT YMVEHDFILQ AERETFIEQM KDVMDKAEDM
     LSEDTDADRG SDPGTSPPHL STCGLGTGEE SRQSQANAPV YQQNVLHTGK RWFIICPVAE
     HPAPEAPESS PPLPLSSLPP EASQDSAPYK DQLSSKEQPS FLASQQLLSQ AGPSNPPGAP
     PAPLAPSSPP VTALPQDGAA PATSTMPEPA SGTASQAGGP GTPQGLTSEL ETSQPLAETH
     EAPLAVQPLV VGLAPCTPAP EAASTRDASA PREPLPPPAP EPSPHSGTPQ PALGQPAPLL
     PAAVGAVSLA TSQLPSPPLG PTVPPQPPSA LESDGEGPPP RVGFVDSTIK SLDEKLRTLL
     YQEHVPTSSA SAGTPVEVGD RDFTLEPLRG DQPRSEVCGG DLALPPVPKE AVSGRVQLPQ
     PLVEKSELAP TRGAVMEQGT SSSMTAESSP RSMLGYDRDG RQVASDSHVV PSVPQDVPAF
     VRPARVEPTD RDGGEAGESS AEPPPSDMGT VGGQASHPQT LGARALGSPR KRPEQQDVSS
     PAKTVGRFSV VSTQDEWTLA SPHSLRYSAP PDVYLDEAPS SPDVKLAVRR AQTASSIEVG
     VGEPVSSDSG DEGPRARPPV QKQASLPVSG SVAGDFVKKA TAFLQRPSRA GSLGPETPSR
     VGMKVPTISV TSFHSQSSYI SSDNDSELED ADIKKELQSL REKHLKEISE LQSQQKQEIE
     ALYRRLGKPL PPNVGFFHTA PPTGRRRKTS KSKLKAGKLL NPLVRQLKVV ASSTGHLADS
     SRGPPAKDPA QASVGLTADS TGLSGKAVQT QQPCSVRASL SSDICSGLAS DGGGARGQGW
     TVYHPTSERV TYKSSSKPRA RFLSGPVSVS IWSALKRLCL GKEHSSRSST SSLAPGPEPG
     PQPALHVQAQ VNNSNNKKGT FTDDLHKLVD EWTSKTVGAA QLKPTLNQLK QTQKLQDMEA
     QAGWAAPGEA RAMTAPRAGV GMPRLPPAPG PLSTTVIPGA APTLSVPTPD PESEKPD
//
ID   WNK2_HUMAN              Reviewed;        2297 AA.
AC   Q9Y3S1; Q5VWF1; Q5VWF2; Q8IY36; Q9C0A3; Q9H3P4;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 4.
DT   22-APR-2020, entry version 176.
DE   RecName: Full=Serine/threonine-protein kinase WNK2 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9H4A3};
DE   AltName: Full=Antigen NY-CO-43;
DE   AltName: Full=Protein kinase lysine-deficient 2 {ECO:0000312|HGNC:HGNC:14542};
DE   AltName: Full=Protein kinase with no lysine 2 {ECO:0000303|PubMed:11571656};
DE   AltName: Full=Serologically defined colon cancer antigen 43;
GN   Name=WNK2 {ECO:0000312|HGNC:HGNC:14542};
GN   Synonyms=KIAA1760 {ECO:0000312|EMBL:BAB21851.2},
GN   PRKWNK2 {ECO:0000312|HGNC:HGNC:14542},
GN   SDCCAG43 {ECO:0000312|HGNC:HGNC:14542}; ORFNames=P/OKcl.13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND CHROMOSOMAL
RP   LOCATION.
RC   TISSUE=Colon epithelium {ECO:0000269|PubMed:11571656};
RX   PubMed=11571656; DOI=10.1038/sj.onc.1204726;
RA   Verissimo F., Jordan P.;
RT   "WNK kinases, a novel protein kinase subfamily in multi-cellular
RT   organisms.";
RL   Oncogene 20:5562-5569(2001).
RN   [2] {ECO:0000305}
RP   SEQUENCE REVISION.
RA   Jordan P.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-845 (ISOFORM 3).
RC   TISSUE=Pancreatic cancer {ECO:0000269|PubMed:11280764};
RX   PubMed=11280764;
RA   Ito M., Shichijo S., Tsuda N., Ochi M., Harashima N., Saito N., Itoh K.;
RT   "Molecular basis of T cell-mediated recognition of pancreatic cancer
RT   cells.";
RL   Cancer Res. 61:2038-2046(2001).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-2297 (ISOFORM 2).
RC   TISSUE=Brain {ECO:0000312|EMBL:BAB21851.2};
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [6] {ECO:0000305}
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1609-2297 (ISOFORM 4).
RC   TISSUE=Lung {ECO:0000269|PubMed:15489334};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=17667937; DOI=10.1038/sj.onc.1210706;
RA   Moniz S., Verissimo F., Matos P., Brazao R., Silva E., Kotelevets L.,
RA   Kotevelets L., Chastre E., Gespach C., Jordan P.;
RT   "Protein kinase WNK2 inhibits cell proliferation by negatively modulating
RT   the activation of MEK1/ERK1/2.";
RL   Oncogene 26:6071-6081(2007).
RN   [9]
RP   ERRATUM OF PUBMED:17667937.
RA   Moniz S., Verissimo F., Matos P., Brazao R., Silva E., Kotelevets L.,
RA   Kotevelets L., Chastre E., Gespach C., Jordan P.;
RL   Oncogene 27:155-155(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=18593598; DOI=10.1016/j.cellsig.2008.06.002;
RA   Moniz S., Matos P., Jordan P.;
RT   "WNK2 modulates MEK1 activity through the Rho GTPase pathway.";
RL   Cell. Signal. 20:1762-1768(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1817 AND SER-1818, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-45; SER-560;
RP   SER-1150; SER-1262; SER-1588; SER-1685; SER-1736; SER-1817; SER-1818;
RP   SER-1862 AND SER-2067.
RX   PubMed=21733846; DOI=10.1074/jbc.m111.222893;
RA   Rinehart J., Vazquez N., Kahle K.T., Hodson C.A., Ring A.M., Gulcicek E.E.,
RA   Louvi A., Bobadilla N.A., Gamba G., Lifton R.P.;
RT   "WNK2 is a novel regulator of essential neuronal cation-chloride
RT   cotransporters.";
RL   J. Biol. Chem. 286:30171-30180(2011).
CC   -!- FUNCTION: Serine/threonine kinase which plays an important role in the
CC       regulation of electrolyte homeostasis, cell signaling, survival, and
CC       proliferation. Acts as an activator and inhibitor of sodium-coupled
CC       chloride cotransporters and potassium-coupled chloride cotransporters
CC       respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and
CC       inhibits SLC12A5. Negatively regulates the EGF-induced activation of
CC       the ERK/MAPK-pathway and the downstream cell cycle progression. Affects
CC       MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this
CC       modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by
CC       interfering with the activity of PAK1 by controlling the balance of the
CC       activity of upstream regulators of PAK1 activity, RHOA and RAC1, which
CC       display reciprocal activity. {ECO:0000269|PubMed:17667937,
CC       ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- ACTIVITY REGULATION: Activation requires autophosphorylation of Ser-
CC       356. Phosphorylation of Ser-352 also promotes increased activity (By
CC       similarity). {ECO:0000250|UniProtKB:Q9JIH7}.
CC   -!- SUBUNIT: Forms a complex with the phosphorylated form of STK39.
CC       {ECO:0000250|UniProtKB:Q3UH66}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17667937,
CC       ECO:0000269|PubMed:18593598}. Cell membrane
CC       {ECO:0000269|PubMed:18593598}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1 {ECO:0000269|PubMed:11571656};
CC         IsoId=Q9Y3S1-1; Sequence=Displayed;
CC       Name=2 {ECO:0000303|PubMed:11214970};
CC         IsoId=Q9Y3S1-2; Sequence=VSP_050643, VSP_050644, VSP_050647;
CC       Name=3 {ECO:0000269|PubMed:11280764};
CC         IsoId=Q9Y3S1-3; Sequence=VSP_050639, VSP_050640, VSP_050641,
CC                                  VSP_050642;
CC       Name=4 {ECO:0000303|PubMed:15489334};
CC         IsoId=Q9Y3S1-4; Sequence=VSP_050645, VSP_050646;
CC   -!- TISSUE SPECIFICITY: Expressed in various cancer cell lines (at protein
CC       level). Predominantly expressed in heart, brain, skeletal muscle and
CC       colon. {ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:17667937,
CC       ECO:0000269|PubMed:21733846}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:18593598,
CC       ECO:0000269|PubMed:21733846}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Incomplete sequence.
CC       {ECO:0000269|PubMed:11280764}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. WNK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: Was named WNK/'with no lysine(K)' because key residues for
CC       catalysis, including the lysine involved in ATP binding, are either not
CC       conserved or differ compared to the residues described in other kinase
CC       family proteins. {ECO:0000250|UniProtKB:Q9H4A3}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37965.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/WNK2ID41867ch9q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ242724; CAB44308.5; -; mRNA.
DR   EMBL; AL354991; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390760; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL583839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB044546; BAB18648.1; -; mRNA.
DR   EMBL; AB051547; BAB21851.2; -; mRNA.
DR   EMBL; BC037965; AAH37965.1; ALT_INIT; mRNA.
DR   CCDS; CCDS75858.1; -. [Q9Y3S1-1]
DR   RefSeq; NP_001269323.1; NM_001282394.1. [Q9Y3S1-1]
DR   RefSeq; XP_005252197.1; XM_005252140.2. [Q9Y3S1-2]
DR   PDB; 6ELM; X-ray; 1.14 A; A=454-549.
DR   PDB; 6FBK; X-ray; 1.74 A; A=454-549.
DR   PDBsum; 6ELM; -.
DR   PDBsum; 6FBK; -.
DR   SMR; Q9Y3S1; -.
DR   BioGrid; 122423; 15.
DR   ELM; Q9Y3S1; -.
DR   IntAct; Q9Y3S1; 14.
DR   STRING; 9606.ENSP00000297954; -.
DR   BindingDB; Q9Y3S1; -.
DR   ChEMBL; CHEMBL5639; -.
DR   GuidetoPHARMACOLOGY; 2281; -.
DR   iPTMnet; Q9Y3S1; -.
DR   PhosphoSitePlus; Q9Y3S1; -.
DR   BioMuta; WNK2; -.
DR   DMDM; 41688799; -.
DR   EPD; Q9Y3S1; -.
DR   jPOST; Q9Y3S1; -.
DR   MassIVE; Q9Y3S1; -.
DR   PaxDb; Q9Y3S1; -.
DR   PeptideAtlas; Q9Y3S1; -.
DR   PRIDE; Q9Y3S1; -.
DR   ProteomicsDB; 86071; -. [Q9Y3S1-1]
DR   ProteomicsDB; 86072; -. [Q9Y3S1-2]
DR   ProteomicsDB; 86073; -. [Q9Y3S1-3]
DR   ProteomicsDB; 86074; -. [Q9Y3S1-4]
DR   Antibodypedia; 28371; 159 antibodies.
DR   Ensembl; ENST00000297954; ENSP00000297954; ENSG00000165238. [Q9Y3S1-1]
DR   GeneID; 65268; -.
DR   KEGG; hsa:65268; -.
DR   UCSC; uc004ati.3; human. [Q9Y3S1-1]
DR   CTD; 65268; -.
DR   DisGeNET; 65268; -.
DR   GeneCards; WNK2; -.
DR   HGNC; HGNC:14542; WNK2.
DR   HPA; ENSG00000165238; Tissue enhanced (heart muscle, pancreas, salivary gland, skeletal muscle).
DR   MIM; 606249; gene.
DR   neXtProt; NX_Q9Y3S1; -.
DR   OpenTargets; ENSG00000165238; -.
DR   PharmGKB; PA33783; -.
DR   eggNOG; KOG0584; Eukaryota.
DR   eggNOG; ENOG410XQWZ; LUCA.
DR   GeneTree; ENSGT00940000157161; -.
DR   InParanoid; Q9Y3S1; -.
DR   KO; K08867; -.
DR   OMA; INITSFH; -.
DR   OrthoDB; 27514at2759; -.
DR   PhylomeDB; Q9Y3S1; -.
DR   TreeFam; TF315363; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9Y3S1; -.
DR   ChiTaRS; WNK2; human.
DR   GeneWiki; WNK2; -.
DR   GenomeRNAi; 65268; -.
DR   Pharos; Q9Y3S1; Tchem.
DR   PRO; PR:Q9Y3S1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9Y3S1; protein.
DR   Bgee; ENSG00000165238; Expressed in apex of heart and 180 other tissues.
DR   ExpressionAtlas; Q9Y3S1; baseline and differential.
DR   Genevisible; Q9Y3S1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0019869; F:chloride channel inhibitor activity; IBA:GO_Central.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IBA:GO_Central.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0050801; P:ion homeostasis; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0010766; P:negative regulation of sodium ion transport; IBA:GO_Central.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:FlyBase.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:1903288; P:positive regulation of potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; Cytoplasm;
KW   Kinase; Membrane; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..2297
FT                   /note="Serine/threonine-protein kinase WNK2"
FT                   /id="PRO_0000086822"
FT   DOMAIN          195..453
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         275..278
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   ACT_SITE        342
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIH7"
FT   BINDING         205
FT                   /note="ATP; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   BINDING         325
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   MOD_RES         19
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UH66"
FT   MOD_RES         30
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UH66"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         352
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIH7"
FT   MOD_RES         356
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIH7"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1736
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1817
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:21733846"
FT   MOD_RES         1818
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000269|PubMed:21733846"
FT   MOD_RES         1862
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   MOD_RES         1889
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UH66"
FT   MOD_RES         2067
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21733846"
FT   VAR_SEQ         1..14
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11280764"
FT                   /id="VSP_050639"
FT   VAR_SEQ         680..731
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11280764"
FT                   /id="VSP_050640"
FT   VAR_SEQ         843..845
FT                   /note="LAA -> RTR (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11280764"
FT                   /id="VSP_050641"
FT   VAR_SEQ         846..2297
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11280764"
FT                   /id="VSP_050642"
FT   VAR_SEQ         1345..1381
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214970"
FT                   /id="VSP_050643"
FT   VAR_SEQ         2247..2261
FT                   /note="DGALGTARRNQVWFG -> GSCGPRAVSTPTSYT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214970"
FT                   /id="VSP_050644"
FT   VAR_SEQ         2248..2254
FT                   /note="GALGTAR -> PESEKPD (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_050645"
FT   VAR_SEQ         2255..2297
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_050646"
FT   VAR_SEQ         2262..2297
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214970"
FT                   /id="VSP_050647"
FT   VARIANT         828
FT                   /note="V -> M (in dbSNP:rs10761203)"
FT                   /id="VAR_057114"
FT   VARIANT         974
FT                   /note="R -> L (in dbSNP:rs10114908)"
FT                   /id="VAR_059773"
FT   STRAND          458..465
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   STRAND          469..481
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   HELIX           483..485
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   STRAND          496..501
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   TURN            502..504
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   HELIX           507..516
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   HELIX           522..524
FT                   /evidence="ECO:0000244|PDB:6ELM"
FT   HELIX           525..545
FT                   /evidence="ECO:0000244|PDB:6ELM"
SQ   SEQUENCE   2297 AA;  242676 MW;  33D2EF2BFA6A1BD2 CRC64;
     MDGDGGRRDV PGTLMEPGRG AGPAGMAEPR AKAARPGPQR FLRRSVVESD QEEPPGLEAA
     EAPGPQPPQP LQRRVLLLCK TRRLIAERAR GRPAAPAPAA LVAQPGAPGA PADAGPEPVG
     TQEPGPDPIA AAVETAPAPD GGPREEAAAT VRKEDEGAAE AKPEPGRTRR DEPEEEEDDE
     DDLKAVATSL DGRFLKFDIE LGRGSFKTVY KGLDTETWVE VAWCELQDRK LTKLERQRFK
     EEAEMLKGLQ HPNIVRFYDF WESSAKGKRC IVLVTELMTS GTLKTYLKRF KVMKPKVLRS
     WCRQILKGLL FLHTRTPPII HRDLKCDNIF ITGPTGSVKI GDLGLATLKR ASFAKSVIGT
     PEFMAPEMYE EHYDESVDVY AFGMCMLEMA TSEYPYSECQ NAAQIYRKVT CGIKPASFEK
     VHDPEIKEII GECICKNKEE RYEIKDLLSH AFFAEDTGVR VELAEEDHGR KSTIALRLWV
     EDPKKLKGKP KDNGAIEFTF DLEKETPDEV AQEMIESGFF HESDVKIVAK SIRDRVALIQ
     WRRERIWPAL QPKEQQDVGS PDKARGPPVP LQVQVTYHAQ AGQPGPPEPE EPEADQHLLP
     PTLPTSATSL ASDSTFDSGQ GSTVYSDSQS SQQSVMLGSL ADAAPSPAQC VCSPPVSEGP
     VLPQSLPSLG AYQQPTAAPG LPVGSVPAPA CPPSLQQHFP DPAMSFAPVL PPPSTPMPTG
     PGQPAPPGQQ PPPLAQPTPL PQVLAPQPVV PLQPVPPHLP PYLAPASQVG APAQLKPLQM
     PQAPLQPLAQ VPPQMPPIPV VPPITPLAGI DGLPPALPDL PTATVPPVPP PQYFSPAVIL
     PSLAAPLPPA SPALPLQAVK LPHPPGAPLA MPCRTIVPNA PATIPLLAVA PPGVAALSIH
     SAVAQLPGQP VYPAAFPQMA PTDVPPSPHH TVQNMRATPP QPALPPQPTL PPQPVLPPQP
     TLPPQPVLPP QPTRPPQPVL PPQPMLPPQP VLPPQPALPV RPEPLQPHLP EQAAPAATPG
     SQILLGHPAP YAVDVAAQVP TVPVPPAAVL SPPLPEVLLP AAPELLPQFP SSLATVSASV
     QSVPTQTATL LPPANPPLPG GPGIASPCPT VQLTVEPVQE EQASQDKPPG LPQSCESYGG
     SDVTSGKELS DSCEGAFGGG RLEGRAARKH HRRSTRARSR QERASRPRLT ILNVCNTGDK
     MVECQLETHN HKMVTFKFDL DGDAPDEIAT YMVEHDFILQ AERETFIEQM KDVMDKAEDM
     LSEDTDADRG SDPGTSPPHL STCGLGTGEE SRQSQANAPV YQQNVLHTGK RWFIICPVAE
     HPAPEAPESS PPLPLSSLPP EASQGPCRGL TLPCLPWRRA ACGAVFLSLF SAESAQSKQP
     PDSAPYKDQL SSKEQPSFLA SQQLLSQAGP SNPPGAPPAP LAPSSPPVTA LPQDGAAPAT
     STMPEPASGT ASQAGGPGTP QGLTSELETS QPLAETHEAP LAVQPLVVGL APCTPAPEAA
     STRDASAPRE PLPPPAPEPS PHSGTPQPAL GQPAPLLPAA VGAVSLATSQ LPSPPLGPTV
     PPQPPSALES DGEGPPPRVG FVDSTIKSLD EKLRTLLYQE HVPTSSASAG TPVEVGDRDF
     TLEPLRGDQP RSEVCGGDLA LPPVPKEAVS GRVQLPQPLV EKSELAPTRG AVMEQGTSSS
     MTAESSPRSM LGYDRDGRQV ASDSHVVPSV PQDVPAFVRP ARVEPTDRDG GEAGESSAEP
     PPSDMGTVGG QASHPQTLGA RALGSPRKRP EQQDVSSPAK TVGRFSVVST QDEWTLASPH
     SLRYSAPPDV YLDEAPSSPD VKLAVRRAQT ASSIEVGVGE PVSSDSGDEG PRARPPVQKQ
     ASLPVSGSVA GDFVKKATAF LQRPSRAGSL GPETPSRVGM KVPTISVTSF HSQSSYISSD
     NDSELEDADI KKELQSLREK HLKEISELQS QQKQEIEALY RRLGKPLPPN VGFFHTAPPT
     GRRRKTSKSK LKAGKLLNPL VRQLKVVASS TGHLADSSRG PPAKDPAQAS VGLTADSTGL
     SGKAVQTQQP CSVRASLSSD ICSGLASDGG GARGQGWTVY HPTSERVTYK SSSKPRARFL
     SGPVSVSIWS ALKRLCLGKE HSSRSSTSSL APGPEPGPQP ALHVQAQVNN SNNKKGTFTD
     DLHKLVDEWT SKTVGAAQLK PTLNQLKQTQ KLQDMEAQAG WAAPGEARAM TAPRAGVGMP
     RLPPAPGPLS TTVIPGAAPT LSVPTPDGAL GTARRNQVWF GLRVPPTACC GHSTQPRGGQ
     RVGSKTASFA ASDPVRS
//
ID   A8K3Z7_HUMAN            Unreviewed;       495 AA.
AC   A8K3Z7;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   SubName: Full=cDNA FLJ77082, highly similar to Homo sapiens zinc finger, MYM-type 3, mRNA {ECO:0000313|EMBL:BAF83451.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF83451.1};
RN   [1] {ECO:0000313|EMBL:BAF83451.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK290762; BAF83451.1; -; mRNA.
DR   RefSeq; NP_001164634.1; NM_001171163.1.
DR   RefSeq; NP_005087.1; NM_005096.3.
DR   PeptideAtlas; A8K3Z7; -.
DR   PRIDE; A8K3Z7; -.
DR   DNASU; 9203; -.
DR   GeneID; 9203; -.
DR   KEGG; hsa:9203; -.
DR   CTD; 9203; -.
DR   PharmGKB; PA37632; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   GenomeRNAi; 9203; -.
DR   Genevisible; A8K3Z7; HS.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF06467; zf-FCS; 3.
DR   SMART; SM00746; TRASH; 4.
PE   2: Evidence at transcript level;
FT   DOMAIN          311..347
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          353..393
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          409..444
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   DOMAIN          451..492
FT                   /note="TRASH"
FT                   /evidence="ECO:0000259|SMART:SM00746"
FT   REGION          1..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          88..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        155..170
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..214
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        230..252
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..275
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   495 AA;  52527 MW;  D0C0BE49CA296D53 CRC64;
     MDPSDFPSPF DPLTLPEKPL AGDLPVDMEF GEDLLESQTA PTRGWAPPGP SPSSGALDLL
     DTPAGLEKDP GVPDGATELL GLGGLLYKAP SPPEVDHDPE GTLAWDAGDQ TLEPGPGGQT
     PEVVPPDPGA GANSCSPEGL LEPLAPDSPI TLQSPHIEEE ETTSIATARR GSPGQEEELP
     QGQPQSPNAP PSPSVGETLG DGINSSQTKP GGSSPPAHPS LPGDGLTAKA SEKPPERKRS
     ERVRRAEPPK PEVVDSTESI PVSDEDSDAM VDDPNDEDFV PFRPRRSPRM SLRSSVSQRA
     GRSAVGTKMT CAHCRTPLQK GQTAYQRKGL PQLFCSSSCL TTFSKKPSGK KTCTFCKKEI
     WNTKDSVVAQ TGSGGSFHEF CTSVCLSLYE AQQQRPIPQS GDPADATRCS ICQKTGEVLH
     EVSNGSVVHR LCSDSCFSKF RANKGLKTNC CDQCGAYIYT KTGSPGPELL FHEGQQKRFC
     NTTCLGAYKK VGPRE
//
ID   ZMYM3_HUMAN             Reviewed;        1370 AA.
AC   Q14202; D3DVV3; O15089; Q96E26;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   22-APR-2020, entry version 166.
DE   RecName: Full=Zinc finger MYM-type protein 3;
DE   AltName: Full=Zinc finger protein 261;
GN   Name=ZMYM3; Synonyms=DXS6673E, KIAA0385, ZNF261;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=8817323; DOI=10.1093/hmg/5.7.887;
RA   van der Maarel S.M., Scholten I.H.G.M., Huber I., Phillippe C.,
RA   Suijkerbuijk R.F., Gilgenkrantz S., Kere J., Cremers F.P.M., Ropers H.-H.;
RT   "Cloning and characterization of DXS6673E, a candidate gene for X-linked
RT   mental retardation in Xq13.1.";
RL   Hum. Mol. Genet. 5:887-897(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lymph, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION IN THE BHC COMPLEX WITH GSE1; GTF2I; HDAC1; HDAC2; HMG20B;
RP   KDM1A; RCOR1; PHF21A; ZNF217 AND ZMYM2.
RX   PubMed=12493763; DOI=10.1074/jbc.m208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 AND SER-267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263; SER-267 AND SER-464, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   FUNCTION.
RX   PubMed=21834987; DOI=10.1186/1741-7007-9-54;
RA   Bai S.W., Herrera-Abreu M.T., Rohn J.L., Racine V., Tajadura V.,
RA   Suryavanshi N., Bechtel S., Wiemann S., Baum B., Ridley A.J.;
RT   "Identification and characterization of a set of conserved and new
RT   regulators of cytoskeletal organisation, cell morphology and migration.";
RL   BMC Biol. 9:54-54(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464; THR-795; THR-817 AND
RP   THR-826, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-817, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-308; LYS-320; LYS-328; LYS-778;
RP   LYS-786; LYS-804; LYS-847; LYS-861; LYS-920 AND LYS-1275, SUMOYLATION
RP   [LARGE SCALE ANALYSIS] AT LYS-786 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Plays a role in the regulation of cell morphology and
CC       cytoskeletal organization. {ECO:0000269|PubMed:21834987}.
CC   -!- SUBUNIT: May be a component of a BHC histone deacetylase complex that
CC       contains HDAC1, HDAC2, HMG20B/BRAF35, KDM1A, RCOR1/CoREST,
CC       PHF21A/BHC80, ZMYM2, ZNF217, ZMYM3, GSE1 and GTF2I.
CC       {ECO:0000269|PubMed:12493763}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q14202-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14202-2; Sequence=VSP_004492;
CC       Name=3;
CC         IsoId=Q14202-3; Sequence=VSP_043262, VSP_043263;
CC   -!- TISSUE SPECIFICITY: Most abundant in brain, moderate in muscle and
CC       heart, low in other tissues except placenta.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZMYM3 may be a cause
CC       of X-linked mental retardation in Xq13.1. Translocation
CC       t(X;13)(q13.1;?). {ECO:0000269|PubMed:8817323}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20839.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X95808; CAA65075.1; -; mRNA.
DR   EMBL; AB002383; BAA20839.2; ALT_INIT; mRNA.
DR   EMBL; BT007095; AAP35759.1; -; mRNA.
DR   EMBL; AL590762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471132; EAX05302.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05303.1; -; Genomic_DNA.
DR   EMBL; BC069057; AAH69057.1; -; mRNA.
DR   EMBL; BC013009; AAH13009.1; -; mRNA.
DR   CCDS; CCDS14409.1; -. [Q14202-1]
DR   CCDS; CCDS55443.1; -. [Q14202-3]
DR   CCDS; CCDS55444.1; -. [Q14202-2]
DR   RefSeq; NP_001164633.1; NM_001171162.1. [Q14202-2]
DR   RefSeq; NP_001164634.1; NM_001171163.1. [Q14202-3]
DR   RefSeq; NP_005087.1; NM_005096.3. [Q14202-1]
DR   RefSeq; NP_963893.1; NM_201599.2. [Q14202-1]
DR   RefSeq; XP_005262366.1; XM_005262309.3. [Q14202-1]
DR   RefSeq; XP_005262367.1; XM_005262310.2. [Q14202-2]
DR   RefSeq; XP_011529364.1; XM_011531062.2. [Q14202-1]
DR   SMR; Q14202; -.
DR   BioGrid; 114637; 71.
DR   CORUM; Q14202; -.
DR   IntAct; Q14202; 38.
DR   MINT; Q14202; -.
DR   STRING; 9606.ENSP00000322845; -.
DR   iPTMnet; Q14202; -.
DR   PhosphoSitePlus; Q14202; -.
DR   BioMuta; ZMYM3; -.
DR   DMDM; 12644413; -.
DR   EPD; Q14202; -.
DR   jPOST; Q14202; -.
DR   MassIVE; Q14202; -.
DR   MaxQB; Q14202; -.
DR   PaxDb; Q14202; -.
DR   PeptideAtlas; Q14202; -.
DR   PRIDE; Q14202; -.
DR   ProteomicsDB; 59922; -. [Q14202-1]
DR   ProteomicsDB; 59923; -. [Q14202-2]
DR   ProteomicsDB; 59924; -. [Q14202-3]
DR   Antibodypedia; 524; 139 antibodies.
DR   DNASU; 9203; -.
DR   Ensembl; ENST00000314425; ENSP00000322845; ENSG00000147130. [Q14202-1]
DR   Ensembl; ENST00000373981; ENSP00000363093; ENSG00000147130. [Q14202-3]
DR   Ensembl; ENST00000373998; ENSP00000363110; ENSG00000147130. [Q14202-2]
DR   GeneID; 9203; -.
DR   KEGG; hsa:9203; -.
DR   UCSC; uc004dzh.3; human. [Q14202-1]
DR   CTD; 9203; -.
DR   DisGeNET; 9203; -.
DR   GeneCards; ZMYM3; -.
DR   HGNC; HGNC:13054; ZMYM3.
DR   HPA; ENSG00000147130; Low tissue specificity.
DR   MIM; 300061; gene.
DR   neXtProt; NX_Q14202; -.
DR   OpenTargets; ENSG00000147130; -.
DR   PharmGKB; PA37632; -.
DR   eggNOG; ENOG410IE8I; Eukaryota.
DR   eggNOG; ENOG410XQR6; LUCA.
DR   GeneTree; ENSGT00940000160693; -.
DR   HOGENOM; CLU_004099_1_0_1; -.
DR   InParanoid; Q14202; -.
DR   OrthoDB; 587724at2759; -.
DR   PhylomeDB; Q14202; -.
DR   TreeFam; TF336988; -.
DR   ChiTaRS; ZMYM3; human.
DR   GeneWiki; ZMYM3; -.
DR   GenomeRNAi; 9203; -.
DR   Pharos; Q14202; Tbio.
DR   PRO; PR:Q14202; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q14202; protein.
DR   Bgee; ENSG00000147130; Expressed in left ovary and 224 other tissues.
DR   ExpressionAtlas; Q14202; baseline and differential.
DR   Genevisible; Q14202; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR021893; DUF3504.
DR   InterPro; IPR011017; TRASH_dom.
DR   InterPro; IPR010507; Znf_MYM.
DR   Pfam; PF12012; DUF3504; 1.
DR   Pfam; PF06467; zf-FCS; 8.
DR   SMART; SM00746; TRASH; 10.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..1370
FT                   /note="Zinc finger MYM-type protein 3"
FT                   /id="PRO_0000191378"
FT   ZN_FING         332..366
FT                   /note="MYM-type 1"
FT   ZN_FING         378..422
FT                   /note="MYM-type 2"
FT   ZN_FING         429..464
FT                   /note="MYM-type 3"
FT   ZN_FING         477..511
FT                   /note="MYM-type 4"
FT   ZN_FING         521..559
FT                   /note="MYM-type 5"
FT   ZN_FING         567..604
FT                   /note="MYM-type 6"
FT   ZN_FING         612..646
FT                   /note="MYM-type 7"
FT   ZN_FING         653..692
FT                   /note="MYM-type 8"
FT   ZN_FING         699..733
FT                   /note="MYM-type 9"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648"
FT   MOD_RES         464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         795
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         817
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         826
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        308
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        320
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        778
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        786
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        804
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        847
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        861
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        920
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1275
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         491..495
FT                   /note="KNTRV -> VGPRE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_043262"
FT   VAR_SEQ         496..1370
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_043263"
FT   VAR_SEQ         793..804
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8817323"
FT                   /id="VSP_004492"
FT   CROSSLNK        Q14202-2:786
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
SQ   SEQUENCE   1370 AA;  152379 MW;  088B5E01E7EE9C30 CRC64;
     MDPSDFPSPF DPLTLPEKPL AGDLPVDMEF GEDLLESQTA PTRGWAPPGP SPSSGALDLL
     DTPAGLEKDP GVLDGATELL GLGGLLYKAP SPPEVDHGPE GTLAWDAGDQ TLEPGPGGQT
     PEVVPPDPGA GANSCSPEGL LEPLAPDSPI TLQSPHIEEE ETTSIATARR GSPGQEEELP
     QGQPQSPNAP PSPSVGETLG DGINSSQTKP GGSSPPAHPS LPGDGLTAKA SEKPPERKRS
     ERVRRAEPPK PEVVDSTESI PVSDEDSDAM VDDPNDEDFV PFRPRRSPRM SLRSSVSQRA
     GRSAVGTKMT CAHCRTPLQK GQTAYQRKGL PQLFCSSSCL TTFSKKPSGK KTCTFCKKEI
     WNTKDSVVAQ TGSGGSFHEF CTSVCLSLYE AQQQRPIPQS GDPADATRCS ICQKTGEVLH
     EVSNGSVVHR LCSDSCFSKF RANKGLKTNC CDQCGAYIYT KTGSPGPELL FHEGQQKRFC
     NTTCLGAYKK KNTRVYPCVW CKTLCKNFEM LSHVDRNGKT SLFCSLCCTT SYKVKQAGLT
     GPPRPCSFCR RSLSDPCYYN KVDRTVYQFC SPSCWTKFQR TSPEGGIHLS CHYCHSLFSG
     KPEVLDWQDQ VFQFCCRDCC EDFKRLRGVV SQCEHCRQEK LLHEKLRFSG VEKSFCSEGC
     VLLYKQDFTK KLGLCCITCT YCSQTCQRGV TEQLDGSTWD FCSEDCKSKY LLWYCKAARC
     HACKRQGKLL ETIHWRGQIR HFCNQQCLLR FYSQQNQPNL DTQSGPESLL NSQSPESKPQ
     TPSQTKVENS NTVRTPEENG NLGKIPVKTR SAPTAPTPPP PPPPATPRKN KAAMCKPLMQ
     NRGVSCKVEM KSKGSQTEEW KPQVIVLPIP VPIFVPVPMH LYCQKVPVPF SMPIPVPVPM
     FLPTTLESTD KIVETIEELK VKIPSNPLEA DILAMAEMIA EAEELDKASS DLCDLVSNQS
     AEGLLEDCDL FGPARDDVLA MAVKMANVLD EPGQDLEADF PKNPLDINPS VDFLFDCGLV
     GPEDVSTEQD LPRTMRKGQK RLVLSESCSR DSMSSQPSCT GLNYSYGVNA WKCWVQSKYA
     NGETSKGDEL RFGPKPMRIK EDILACSAAE LNYGLAQFVR EITRPNGERY EPDSIYYLCL
     GIQQYLLENN RMVNIFTDLY YLTFVQELNK SLSTWQPTLL PNNTVFSRVE EEHLWECKQL
     GVYSPFVLLN TLMFFNTKFF GLQTAEEHMQ LSFTNVVRQS RKCTTPRGTT KVVSIRYYAP
     VRQRKGRDTG PGKRKREDEA PILEQRENRM NPLRCPVKFY EFYLSKCPES LRTRNDVFYL
     QPERSCIAES PLWYSVIPMD RSMLESMLNR ILAVREIYEE LGRPGEEDLD
//
ID   A0A024R1J1_HUMAN        Unreviewed;       936 AA.
AC   A0A024R1J1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=HCG40978, isoform CRA_b {ECO:0000313|EMBL:EAW59769.1};
GN   ORFNames=hCG_40978 {ECO:0000313|EMBL:EAW59769.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59769.1};
RN   [1] {ECO:0000313|EMBL:EAW59769.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59769.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471095; EAW59768.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59769.1; -; Genomic_DNA.
DR   RefSeq; NP_001193927.1; NM_001206998.1.
DR   Antibodypedia; 48546; 84 antibodies.
DR   GeneID; 84133; -.
DR   KEGG; hsa:84133; -.
DR   CTD; 84133; -.
DR   EuPathDB; HostDB:ENSG00000183579.15; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   KO; K16273; -.
DR   OMA; CHPGARD; -.
DR   OrthoDB; 1487241at2759; -.
DR   GenomeRNAi; 84133; -.
DR   Bgee; ENSG00000183579; Expressed in caput epididymis and 195 other tissues.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl.
DR   GO; GO:0072089; P:stem cell proliferation; IEA:Ensembl.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR040700; ZNRF-3_ecto.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   Pfam; PF18212; ZNRF_3_ecto; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}.
FT   TRANSMEM        216..238
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          293..334
FT                   /note="RING-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50089"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          608..693
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          739..758
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          849..875
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          892..936
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        9..27
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        653..687
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        905..936
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   936 AA;  100574 MW;  EE68B810BD3C9C74 CRC64;
     MRPRSGGRPG ATGRRRRRLR RRPRGLRCSR LPPPPPLPLL LGLLLAAAGP GAARAKETAF
     VEVVLFESSP SGDYTTYTTG LTGRFSRAGA TLSAEGEIVQ MHPLGLCNNN DEEDLYEYGW
     VGVVKLEQPE LDPKPCLTVL GKAKRAVQRG ATAVIFDVSE NPEAIDQLNQ GSEDPLKRPV
     VYVKGADAIK LMNIVNKQKV ARARIQHRPP RQPTEYFDMG IFLAFFVVVS LVCLILLVKI
     KLKQRRSQNS MNRLAVQALE KMETRKFNSK SKGRREGSCG ALDTLSSSST SDCAICLEKY
     IDGEELRVIP CTHRFHRKCV DPWLLQHHTC PHCRHNIIEQ KGNPSAVCVE TSNLSRGRQQ
     RVTLPVHYPG RVHRTNAIPA YPTRTSMDSH GNPVTLLTMD RHGEQSLYSP QTPAYIRSYP
     PLHLDHSLAA HRCGLEHRAY SPAHPFRRPK LSGRSFSKAA CFSQYETMYQ HYYFQGLSYP
     EQEGQSPPSL APRGPARAFP PSGSGSLLFP TVVHVAPPSH LESGSTSSFS CYHGHRSVCS
     GYLADCPGSD SSSSSSSGQC HCSSSDSVVD CTEVSNQGVY GSCSTFRSSL SSDYDPFIYR
     SRSPCRASEA GGSGSSGRGP ALCFEGSPPP EELPAVHSHG AGRGEPWPGP ASPSGDQVST
     CSLEMNYSSN SSLEHRGPNS STSEVGLEAS PGAAPDLRRT WKGGHELPSC ACCCEPQPSP
     AGPSAGAAGS STLFLGPHLY EGSGPAGGEP QSGSSQGLYG LHPDHLPRTD GVKYEGLPCC
     FYEEKQVARG GGGGSGCYTE DYSVSVQYTL TEEPPPGCYP GARDLSQRIP IIPEDVDCDL
     GLPSDCQGTH SLGSWGGTRG PDTPRPHRGL GATREEERAL CCQARALLRP GCPPEEAGAV
     RANFPSALQD TQESSTTATE AAGPRSHSAD SSSPGA
//
ID   ZNRF3_HUMAN             Reviewed;         936 AA.
AC   Q9ULT6; B3KU18; Q6ICH1; Q6NTF8; Q8WU18;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   22-APR-2020, entry version 146.
DE   RecName: Full=E3 ubiquitin-protein ligase ZNRF3;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 203;
DE   AltName: Full=RING-type E3 ubiquitin transferase ZNRF3;
DE   AltName: Full=Zinc/RING finger protein 3;
DE   Flags: Precursor;
GN   Name=ZNRF3; Synonyms=KIAA1133, RNF203;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 46-936 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis from
RT   size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 77-936 (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 284-936.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, ACTIVITY REGULATION, INTERACTION WITH FZD4;
RP   FZD5; FZD6; FZD8; LRP6 AND RSPO1, AND MUTAGENESIS OF PRO-103.
RX   PubMed=22575959; DOI=10.1038/nature11019;
RA   Hao H.X., Xie Y., Zhang Y., Charlat O., Oster E., Avello M., Lei H.,
RA   Mickanin C., Liu D., Ruffner H., Mao X., Ma Q., Zamponi R., Bouwmeester T.,
RA   Finan P.M., Kirschner M.W., Porter J.A., Serluca F.C., Cong F.;
RT   "ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.";
RL   Nature 485:195-200(2012).
RN   [8]
RP   INTERACTION WITH RSPO2.
RX   PubMed=29769720; DOI=10.1038/s41586-018-0118-y;
RA   Szenker-Ravi E., Altunoglu U., Leushacke M., Bosso-Lefevre C., Khatoo M.,
RA   Thi Tran H., Naert T., Noelanders R., Hajamohideen A., Beneteau C.,
RA   de Sousa S.B., Karaman B., Latypova X., Basaran S., Yuecel E.B., Tan T.T.,
RA   Vlaminck L., Nayak S.S., Shukla A., Girisha K.M., Le Caignec C.,
RA   Soshnikova N., Uyguner Z.O., Vleminckx K., Barker N., Kayserili H.,
RA   Reversade B.;
RT   "RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently
RT   of LGR4/5/6.";
RL   Nature 557:564-569(2018).
RN   [9]
RP   INTERACTION WITH LMBR1L.
RX   PubMed=31073040; DOI=10.1126/science.aau0812;
RA   Choi J.H., Zhong X., McAlpine W., Liao T.C., Zhang D., Fang B., Russell J.,
RA   Ludwig S., Nair-Gill E., Zhang Z., Wang K.W., Misawa T., Zhan X., Choi M.,
RA   Wang T., Li X., Tang M., Sun Q., Yu L., Murray A.R., Moresco E.M.Y.,
RA   Beutler B.;
RT   "LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling.";
RL   Science 364:0-0(2019).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that acts as a negative regulator
CC       of the Wnt signaling pathway by mediating the ubiquitination and
CC       subsequent degradation of Wnt receptor complex components Frizzled and
CC       LRP6. Acts on both canonical and non-canonical Wnt signaling pathway.
CC       Acts as a tumor suppressor in the intestinal stem cell zone by
CC       inhibiting the Wnt signaling pathway, thereby resticting the size of
CC       the intestinal stem cell zone (PubMed:22575959). Along with RSPO2 and
CC       RNF43, constitutes a master switch that governs limb specification (By
CC       similarity). {ECO:0000250|UniProtKB:Q08D68,
CC       ECO:0000269|PubMed:22575959}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- ACTIVITY REGULATION: Negatively regulated by R-spondin proteins such as
CC       RSPO1: interaction with RSPO1 induces the indirect association between
CC       ZNRF3 and LGR4, promoting membrane clearance of ZNRF3.
CC       {ECO:0000269|PubMed:22575959}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with LRP6, FZD4, FZD5, FZD6 and FZD8
CC       (PubMed:22575959). Interacts with RSPO1; interaction promotes indirect
CC       interaction with LGR4 and membrane clearance of ZNRF3
CC       (PubMed:22575959). Also interacts with RSPO2 (PubMed:29769720).
CC       Interacts with LMBR1L (PubMed:31073040). {ECO:0000269|PubMed:22575959,
CC       ECO:0000269|PubMed:29769720, ECO:0000305|PubMed:31073040}.
CC   -!- INTERACTION:
CC       Q9ULT6; O60353: FZD6; NbExp=2; IntAct=EBI-949772, EBI-8754490;
CC       Q9ULT6; Q9BXB1: LGR4; NbExp=2; IntAct=EBI-949772, EBI-10965764;
CC       Q9ULT6; O75581: LRP6; NbExp=2; IntAct=EBI-949772, EBI-910915;
CC       Q9ULT6; Q2MKA7: RSPO1; NbExp=6; IntAct=EBI-949772, EBI-10045219;
CC       Q9ULT6; Q5BVD1: TTMP; NbExp=3; IntAct=EBI-949772, EBI-10243654;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22575959};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9ULT6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ULT6-2; Sequence=VSP_044043;
CC   -!- SIMILARITY: Belongs to the ZNRF3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG30283.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK096397; BAG53280.1; -; mRNA.
DR   EMBL; Z95113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL021393; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031596; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB051436; BAB33319.1; -; mRNA.
DR   EMBL; CR456397; CAG30283.1; ALT_INIT; mRNA.
DR   EMBL; BC021570; AAH21570.1; -; mRNA.
DR   EMBL; BC069019; AAH69019.1; -; mRNA.
DR   EMBL; BC094857; AAH94857.1; -; mRNA.
DR   CCDS; CCDS42999.1; -. [Q9ULT6-2]
DR   CCDS; CCDS56225.1; -. [Q9ULT6-1]
DR   RefSeq; NP_001193927.1; NM_001206998.1. [Q9ULT6-1]
DR   RefSeq; NP_115549.2; NM_032173.3. [Q9ULT6-2]
DR   SMR; Q9ULT6; -.
DR   BioGrid; 123905; 18.
DR   DIP; DIP-50030N; -.
DR   IntAct; Q9ULT6; 9.
DR   MINT; Q9ULT6; -.
DR   STRING; 9606.ENSP00000443824; -.
DR   iPTMnet; Q9ULT6; -.
DR   PhosphoSitePlus; Q9ULT6; -.
DR   BioMuta; ZNRF3; -.
DR   DMDM; 126253847; -.
DR   EPD; Q9ULT6; -.
DR   jPOST; Q9ULT6; -.
DR   MassIVE; Q9ULT6; -.
DR   PaxDb; Q9ULT6; -.
DR   PeptideAtlas; Q9ULT6; -.
DR   PRIDE; Q9ULT6; -.
DR   ProteomicsDB; 85106; -. [Q9ULT6-1]
DR   ProteomicsDB; 85107; -. [Q9ULT6-2]
DR   Antibodypedia; 48546; 84 antibodies.
DR   DNASU; 84133; -.
DR   Ensembl; ENST00000402174; ENSP00000384456; ENSG00000183579. [Q9ULT6-2]
DR   Ensembl; ENST00000406323; ENSP00000384553; ENSG00000183579. [Q9ULT6-2]
DR   Ensembl; ENST00000544604; ENSP00000443824; ENSG00000183579. [Q9ULT6-1]
DR   GeneID; 84133; -.
DR   KEGG; hsa:84133; -.
DR   UCSC; uc003aeg.4; human. [Q9ULT6-1]
DR   CTD; 84133; -.
DR   DisGeNET; 84133; -.
DR   GeneCards; ZNRF3; -.
DR   HGNC; HGNC:18126; ZNRF3.
DR   HPA; ENSG00000183579; Low tissue specificity.
DR   MIM; 612062; gene.
DR   neXtProt; NX_Q9ULT6; -.
DR   OpenTargets; ENSG00000183579; -.
DR   PharmGKB; PA134983897; -.
DR   eggNOG; KOG0800; Eukaryota.
DR   eggNOG; ENOG41121N2; LUCA.
DR   GeneTree; ENSGT00940000154006; -.
DR   HOGENOM; CLU_018099_1_0_1; -.
DR   InParanoid; Q9ULT6; -.
DR   KO; K16273; -.
DR   OMA; CHPGARD; -.
DR   OrthoDB; 1487241at2759; -.
DR   PhylomeDB; Q9ULT6; -.
DR   TreeFam; TF317074; -.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   SIGNOR; Q9ULT6; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; ZNRF3; human.
DR   GenomeRNAi; 84133; -.
DR   Pharos; Q9ULT6; Tbio.
DR   PRO; PR:Q9ULT6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9ULT6; protein.
DR   Bgee; ENSG00000183579; Expressed in caput epididymis and 195 other tissues.
DR   ExpressionAtlas; Q9ULT6; baseline and differential.
DR   Genevisible; Q9ULT6; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005109; F:frizzled binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0060173; P:limb development; ISS:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl.
DR   GO; GO:0072089; P:stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0038018; P:Wnt receptor catabolic process; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR040700; ZNRF-3_ecto.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   Pfam; PF18212; ZNRF_3_ecto; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Developmental protein; Membrane;
KW   Metal-binding; Reference proteome; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Ubl conjugation pathway; Wnt signaling pathway; Zinc;
KW   Zinc-finger.
FT   SIGNAL          1..55
FT                   /evidence="ECO:0000255"
FT   CHAIN           56..936
FT                   /note="E3 ubiquitin-protein ligase ZNRF3"
FT                   /id="PRO_0000277806"
FT   TOPO_DOM        56..219
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        220..240
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        241..936
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         293..334
FT                   /note="RING-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   VAR_SEQ         1..100
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_044043"
FT   MUTAGEN         103
FT                   /note="P->A: Abolishes interaction with RSPO1 and prevents
FT                   subsequent membrane clearance."
FT                   /evidence="ECO:0000269|PubMed:22575959"
SQ   SEQUENCE   936 AA;  100574 MW;  EE68B810BD3C9C74 CRC64;
     MRPRSGGRPG ATGRRRRRLR RRPRGLRCSR LPPPPPLPLL LGLLLAAAGP GAARAKETAF
     VEVVLFESSP SGDYTTYTTG LTGRFSRAGA TLSAEGEIVQ MHPLGLCNNN DEEDLYEYGW
     VGVVKLEQPE LDPKPCLTVL GKAKRAVQRG ATAVIFDVSE NPEAIDQLNQ GSEDPLKRPV
     VYVKGADAIK LMNIVNKQKV ARARIQHRPP RQPTEYFDMG IFLAFFVVVS LVCLILLVKI
     KLKQRRSQNS MNRLAVQALE KMETRKFNSK SKGRREGSCG ALDTLSSSST SDCAICLEKY
     IDGEELRVIP CTHRFHRKCV DPWLLQHHTC PHCRHNIIEQ KGNPSAVCVE TSNLSRGRQQ
     RVTLPVHYPG RVHRTNAIPA YPTRTSMDSH GNPVTLLTMD RHGEQSLYSP QTPAYIRSYP
     PLHLDHSLAA HRCGLEHRAY SPAHPFRRPK LSGRSFSKAA CFSQYETMYQ HYYFQGLSYP
     EQEGQSPPSL APRGPARAFP PSGSGSLLFP TVVHVAPPSH LESGSTSSFS CYHGHRSVCS
     GYLADCPGSD SSSSSSSGQC HCSSSDSVVD CTEVSNQGVY GSCSTFRSSL SSDYDPFIYR
     SRSPCRASEA GGSGSSGRGP ALCFEGSPPP EELPAVHSHG AGRGEPWPGP ASPSGDQVST
     CSLEMNYSSN SSLEHRGPNS STSEVGLEAS PGAAPDLRRT WKGGHELPSC ACCCEPQPSP
     AGPSAGAAGS STLFLGPHLY EGSGPAGGEP QSGSSQGLYG LHPDHLPRTD GVKYEGLPCC
     FYEEKQVARG GGGGSGCYTE DYSVSVQYTL TEEPPPGCYP GARDLSQRIP IIPEDVDCDL
     GLPSDCQGTH SLGSWGGTRG PDTPRPHRGL GATREEERAL CCQARALLRP GCPPEEAGAV
     RANFPSALQD TQESSTTATE AAGPRSHSAD SSSPGA
//
